Citrus Sinensis ID: 041655
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 238 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SKB2 | 641 | Leucine-rich repeat recep | yes | no | 1.0 | 0.371 | 0.583 | 2e-85 | |
| Q9SYM9 | 355 | Receptor-like serine/thre | no | no | 0.789 | 0.529 | 0.375 | 3e-32 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.861 | 0.169 | 0.351 | 4e-32 | |
| Q9M345 | 677 | L-type lectin-domain cont | no | no | 0.873 | 0.307 | 0.363 | 7e-32 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.861 | 0.169 | 0.351 | 8e-32 | |
| C0LGI5 | 591 | Probable LRR receptor-lik | no | no | 0.802 | 0.323 | 0.36 | 1e-31 | |
| Q9C7S5 | 1095 | Tyrosine-sulfated glycope | no | no | 0.823 | 0.178 | 0.336 | 2e-31 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.810 | 0.175 | 0.389 | 2e-31 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.827 | 0.172 | 0.351 | 3e-31 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.802 | 0.188 | 0.384 | 3e-31 |
| >sp|Q9SKB2|SBIR1_ARATH Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 OS=Arabidopsis thaliana GN=SOBIR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 315 bits (806), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 157/269 (58%), Positives = 190/269 (70%), Gaps = 31/269 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
+IA++K++QPP DA L + DSK L ++M QIRSEI T+G IRHRN+LPLLAH++RP CH
Sbjct: 373 IIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPECH 432
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ----------- 109
LVYE+M+ GSLQDIL DV G ++L W AR++ GIA+GLEYLHM
Sbjct: 433 YLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKP 492
Query: 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
A VLLD DMEARIS+FGLAK P+A THITTS V GT GYIAPE+ QT T CDIYSF
Sbjct: 493 ANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSF 552
Query: 170 GVLLA----------------EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GV+L +EMSL+KWMRN++TSENP AID KL+ G++EQMLLVL
Sbjct: 553 GVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLLVL 612
Query: 214 KTACFCTLDDPKER----HVRCMLSQIQQ 238
K AC+CTLDDPK+R VR MLSQI+
Sbjct: 613 KIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Promotes the activation of plant defense and cell death. Functions as an inhibitor/regulator of abscission, probably by regulating membrane trafficking during abscission. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 138 bits (348), Expect = 3e-32, Method: Compositional matrix adjust.
Identities = 83/221 (37%), Positives = 120/221 (54%), Gaps = 33/221 (14%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
E+ + I+HRNI+ L + P +LL+YE M NGSL L+ GR+ LDW +RYR
Sbjct: 119 ELEAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLH----GRKALDWASRYRI 174
Query: 95 VRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDV 143
G A G+ YLH +H+ + +LLDH+MEAR+S+FGLA + TH++T V
Sbjct: 175 AVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTF-V 233
Query: 144 VGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS---------------LVKWMRNVMT 188
GT GY+APEY T T D+YSFGV+L E ++ LV W++ V+
Sbjct: 234 AGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGTKLVTWVKGVVR 293
Query: 189 SENPKRAIDSKLLGNGYE--EQMLLVLKTACFCTLDDPKER 227
+ + ID++L G+ + E+M V A C +P R
Sbjct: 294 DQREEVVIDNRLRGSSVQENEEMNDVFGIAMMCLEPEPAIR 334
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 138 bits (347), Expect = 4e-32, Method: Composition-based stats.
Identities = 84/239 (35%), Positives = 128/239 (53%), Gaps = 34/239 (14%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
+ +E+ T+G+I+HRN++PLL + LLVYE+MK GSL+D+L+D + +L+W A
Sbjct: 928 EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLNWPA 987
Query: 91 RYRTVRGIASGLEYLH-----------MHQALVLLDHDMEARISEFGLAKVFPEAHTHIT 139
R + G A GL +LH M + VLLD ++EAR+S+FG+A++ TH++
Sbjct: 988 RRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLS 1047
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS--------------LVKWMRN 185
S + GT GY+ PEY Q+ + D+YS+GV+L E ++ LV W++
Sbjct: 1048 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVK- 1106
Query: 186 VMTSENPKRAIDSKLLGN--GYEEQMLLVLKTACFCTLDD-----PKERHVRCMLSQIQ 237
+ D +LL E ++L LK AC C LDD P V M +IQ
Sbjct: 1107 LHAKGKITDVFDRELLKEDASIEIELLQHLKVACAC-LDDRHWKRPTMIQVMAMFKEIQ 1164
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 137 bits (345), Expect = 7e-32, Method: Compositional matrix adjust.
Identities = 88/242 (36%), Positives = 131/242 (54%), Gaps = 34/242 (14%)
Query: 14 ATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQ 73
A V DSK + M + +EIV++G++ HRN++PLL + R G LLVY++M NGSL
Sbjct: 374 AVKRVSHDSK---QGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLD 430
Query: 74 DILNDVSRGRRQLDWLARYRTVRGIASGLEYLH-------MHQAL----VLLDHDMEARI 122
L + LDW R ++G+ASGL YLH +H+ + VLLD D R+
Sbjct: 431 KYL--YNNPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRL 488
Query: 123 SEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS---- 178
+FGLA+++ + T+ VVGT GY+APE+ +T T D+Y+FG L E +S
Sbjct: 489 GDFGLARLYDHG-SDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRP 547
Query: 179 ------------LVKWMRNVMTSENPKRAIDSKLLGNGYE-EQMLLVLKTACFCTLDDPK 225
LV+W+ ++ N A D KL +GY+ E++ +VLK C+ DP+
Sbjct: 548 IEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPR 607
Query: 226 ER 227
R
Sbjct: 608 AR 609
|
Required during pollen development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 137 bits (344), Expect = 8e-32, Method: Composition-based stats.
Identities = 84/239 (35%), Positives = 128/239 (53%), Gaps = 34/239 (14%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
+ +E+ T+G+I+HRN++PLL + LLVYE+MK GSL+D+L+D + +L+W A
Sbjct: 928 EFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLNWPA 987
Query: 91 RYRTVRGIASGLEYLH-----------MHQALVLLDHDMEARISEFGLAKVFPEAHTHIT 139
R + G A GL +LH M + VLLD ++EAR+S+FG+A++ TH++
Sbjct: 988 RRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLS 1047
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS--------------LVKWMRN 185
S + GT GY+ PEY Q+ + D+YS+GV+L E ++ LV W++
Sbjct: 1048 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVK- 1106
Query: 186 VMTSENPKRAIDSKLLGN--GYEEQMLLVLKTACFCTLDD-----PKERHVRCMLSQIQ 237
+ D +LL E ++L LK AC C LDD P V M +IQ
Sbjct: 1107 LHAKGKITDVFDRELLKEDASIEIELLQHLKVACAC-LDDRHWKRPTMIQVMAMFKEIQ 1164
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGI5|Y1699_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g69990 OS=Arabidopsis thaliana GN=At1g69990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 136 bits (343), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 81/225 (36%), Positives = 118/225 (52%), Gaps = 34/225 (15%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
Q RSEI LGQIRH N++PLL LLVY+ M NG+L L + +DW
Sbjct: 335 QFRSEINKLGQIRHPNLVPLLGFCVVEDEILLVYKHMANGTLYSQLQ-----QWDIDWPT 389
Query: 91 RYRTVRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHIT 139
R R G A GL +LH MHQ + +LLD D +AR+ ++GL K+ +
Sbjct: 390 RVRVAVGAARGLAWLHHGCQPLYMHQYISSNVILLDEDFDARVIDYGLGKLVSSQDSK-D 448
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE-----------------EMSLVKW 182
+S G GY+APEY T+ + D+Y FG++L E + SLV+W
Sbjct: 449 SSFSNGKFGYVAPEYSSTMVASLSGDVYGFGIVLLEIVTGQKPVLINNGEEGFKESLVEW 508
Query: 183 MRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
+ +++ K AID ++ G GY+++++ VL+ AC C + PKER
Sbjct: 509 VSKHLSNGRSKDAIDRRIFGKGYDDEIMQVLRIACSCVVSRPKER 553
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C7S5|PSYR1_ARATH Tyrosine-sulfated glycopeptide receptor 1 OS=Arabidopsis thaliana GN=PSYR1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 136 bits (342), Expect = 2e-31, Method: Composition-based stats.
Identities = 75/223 (33%), Positives = 119/223 (53%), Gaps = 27/223 (12%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
+ ++E+ L + +H N++ L + +L+Y FM+NGSL L++ G QLDW
Sbjct: 843 EFKAEVEVLSRAKHENLVALQGYCVHDSARILIYSFMENGSLDYWLHENPEGPAQLDWPK 902
Query: 91 RYRTVRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHIT 139
R +RG +SGL Y+H +H+ + +LLD + +A +++FGL+++ TH+T
Sbjct: 903 RLNIMRGASSGLAYMHQICEPHIVHRDIKSSNILLDGNFKAYVADFGLSRLILPYRTHVT 962
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS---------------LVKWMR 184
T ++VGT GYI PEY Q T D+YSFGV++ E ++ LV W+
Sbjct: 963 T-ELVGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGKRPMEVFRPKMSRELVAWVH 1021
Query: 185 NVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
+ P+ D+ L +G EE ML VL AC C +P +R
Sbjct: 1022 TMKRDGKPEEVFDTLLRESGNEEAMLRVLDIACMCVNQNPMKR 1064
|
Tyrosine-sulfated glycopeptide receptor with a serine/threonine-protein kinase activity. Regulates, in response to tyrosine-sulfated glycopeptide binding, a signaling cascade involved in cellular proliferation and plant growth. Not involved in PSK perception. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 135 bits (341), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 88/226 (38%), Positives = 122/226 (53%), Gaps = 33/226 (14%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ--LDW 88
R+EI TLG+IRHRNI+ L +LL+YE+M GSL + + RG + LDW
Sbjct: 841 SFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGE---QLQRGEKNCLLDW 897
Query: 89 LARYRTVRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTH 137
ARYR G A GL YLH +H+ + +LLD +A + +FGLAK+ +++
Sbjct: 898 NARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK 957
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-------------LVKWMR 184
+ S V G+ GYIAPEY T+ +T CDIYSFGV+L E ++ LV W+R
Sbjct: 958 -SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVR 1016
Query: 185 NVMTSENPK-RAIDSKLLGNGYE--EQMLLVLKTACFCTLDDPKER 227
+ + P D++L N +M LVLK A FCT + P R
Sbjct: 1017 RSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASR 1062
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 135 bits (340), Expect = 3e-31, Method: Composition-based stats.
Identities = 84/239 (35%), Positives = 119/239 (49%), Gaps = 42/239 (17%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG--RRQLDW 88
+ +E+ TLG+I+HRN++PLL + LLVYEFM+ GSL+++L+ G RR L W
Sbjct: 878 EFMAEMETLGKIKHRNLVPLLGYCKIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRILGW 937
Query: 89 LARYRTVRGIASGLEYLH-----------MHQALVLLDHDMEARISEFGLAKVFPEAHTH 137
R + +G A GL +LH M + VLLD DMEAR+S+FG+A++ TH
Sbjct: 938 EERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDFGMARLISALDTH 997
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS--------------LVKWM 183
++ S + GT GY+ PEY Q+ T D+YS GV++ E +S LV W
Sbjct: 998 LSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSGKRPTDKEEFGDTNLVGWS 1057
Query: 184 RNVMTSENPKRAIDSKLLGNGYEE---------------QMLLVLKTACFCTLDDPKER 227
+ ID LL G E +ML L+ A C D P +R
Sbjct: 1058 KMKAREGKHMEVIDEDLLKEGSSESLNEKEGFEGGVIVKEMLRYLEIALRCVDDFPSKR 1116
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 135 bits (340), Expect = 3e-31, Method: Composition-based stats.
Identities = 85/221 (38%), Positives = 126/221 (57%), Gaps = 30/221 (13%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVSRGRRQLDWLARYR 93
E+ LG++RHRNI+ LL L ++VYEFM NG+L D I + GR +DW++RY
Sbjct: 748 EVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYN 807
Query: 94 TVRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSD 142
G+A GL YLH +H+ + +LLD +++ARI++FGLA++ A T S
Sbjct: 808 IALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--ARKKETVSM 865
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLL--------------AEEMSLVKWM-RNVM 187
V G+ GYIAPEY TL + DIYS+GV+L E + +V+W+ R +
Sbjct: 866 VAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIR 925
Query: 188 TSENPKRAIDSKLLGNGY-EEQMLLVLKTACFCTLDDPKER 227
+ + + A+D + Y +E+MLLVL+ A CT PK+R
Sbjct: 926 DNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDR 966
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 238 | ||||||
| 255540437 | 633 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.995 | 0.374 | 0.649 | 2e-96 | |
| 224133744 | 630 | predicted protein [Populus trichocarpa] | 1.0 | 0.377 | 0.639 | 3e-93 | |
| 24421095 | 633 | receptor-like protein kinase [Nicotiana | 1.0 | 0.375 | 0.628 | 7e-93 | |
| 224119518 | 627 | predicted protein [Populus trichocarpa] | 1.0 | 0.379 | 0.620 | 2e-92 | |
| 356508750 | 636 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.374 | 0.628 | 2e-92 | |
| 356516603 | 631 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.377 | 0.609 | 5e-90 | |
| 449440606 | 643 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.370 | 0.598 | 3e-88 | |
| 225456834 | 632 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.376 | 0.624 | 9e-88 | |
| 297822929 | 641 | hypothetical protein ARALYDRAFT_482113 [ | 0.995 | 0.369 | 0.589 | 5e-85 | |
| 15225153 | 641 | putative leucine-rich repeat transmembra | 1.0 | 0.371 | 0.583 | 1e-83 |
| >gi|255540437|ref|XP_002511283.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550398|gb|EEF51885.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 357 bits (916), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 174/268 (64%), Positives = 203/268 (75%), Gaps = 31/268 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
MIAI+KIVQPP DA L E D+KLL ++M QIRSEI T+GQIRHRN+LPLLAH++RP CH
Sbjct: 365 MIAIKKIVQPPRDAAELTEEDTKLLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSRPDCH 424
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH-----------MHQ 109
LVYEFMKNGSLQDIL+DV +G+R+LDWLAR+R G+ASGLEYLH +
Sbjct: 425 CLVYEFMKNGSLQDILSDVEQGKRELDWLARHRIAIGVASGLEYLHTSHSPRIIHRDLKP 484
Query: 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
A VLLD DMEARI++FGLAK P+A+TH+TTS+V GT GYIAPEY QTL T CDIYSF
Sbjct: 485 ANVLLDDDMEARIADFGLAKAMPDANTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDIYSF 544
Query: 170 GVLLA----------------EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GVLL EMSLVKWMRN+MTSENP +AID K+ GNG+EEQMLLVL
Sbjct: 545 GVLLGVLVMGKLPSDEFFQTTREMSLVKWMRNIMTSENPSQAIDPKMNGNGFEEQMLLVL 604
Query: 214 KTACFCTLDDPKER----HVRCMLSQIQ 237
K ACFCTLDDP++R +RCMLSQI+
Sbjct: 605 KIACFCTLDDPRQRPNSKDIRCMLSQIK 632
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133744|ref|XP_002321650.1| predicted protein [Populus trichocarpa] gi|222868646|gb|EEF05777.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 347 bits (889), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 172/269 (63%), Positives = 198/269 (73%), Gaps = 31/269 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
MIAI+KI+QPP DA L E DSKLL ++M QI+SEI T+G IRHRN+LPLLAH++RP CH
Sbjct: 362 MIAIKKIIQPPKDAAELTEEDSKLLHKKMRQIQSEINTVGHIRHRNLLPLLAHVSRPDCH 421
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ----------- 109
LVYE MKNGSLQD LN V+ GRR+LDWLAR+R G+ASGLEYLH+
Sbjct: 422 YLVYELMKNGSLQDALNHVTEGRRELDWLARHRIAVGVASGLEYLHLSHSPRIIHRDLKP 481
Query: 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
A VLLD MEARI++FGLAK P+A THITTS+V GT GYIAPEY QTL T CDIYSF
Sbjct: 482 ANVLLDDSMEARIADFGLAKAMPDAQTHITTSNVAGTVGYIAPEYHQTLKFTDKCDIYSF 541
Query: 170 GVLLA----------------EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GV+L EMSLVKWMRN+MTSENP++AID KL+GNG EEQMLLVL
Sbjct: 542 GVVLGVLVMGKLPSDEFFQNTREMSLVKWMRNIMTSENPRQAIDPKLMGNGLEEQMLLVL 601
Query: 214 KTACFCTLDDPKER----HVRCMLSQIQQ 238
K ACFCT+DDPK+R VRCMLSQI+
Sbjct: 602 KIACFCTIDDPKQRPNSKDVRCMLSQIKH 630
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|24421095|dbj|BAC07504.2| receptor-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 345 bits (886), Expect = 7e-93, Method: Compositional matrix adjust.
Identities = 169/269 (62%), Positives = 201/269 (74%), Gaps = 31/269 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
+IAI+KI+QPPMDA L E D+K L ++M Q++SEI LGQIRHRN+LPLLAH+ RP CH
Sbjct: 365 IIAIKKILQPPMDAAELAEEDTKALNKKMRQVKSEIQILGQIRHRNLLPLLAHMPRPDCH 424
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ----------- 109
LVYE+MKNGSLQDIL V+ G R+LDWL R+R GIA+GLEYLH++
Sbjct: 425 YLVYEYMKNGSLQDILQQVTEGTRELDWLGRHRIAVGIATGLEYLHINHSQCIIHRDLKP 484
Query: 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
A VLLD DMEARI++FGLAK P+AHTH+TTS+V GT GYIAPEY QTL T CDIYSF
Sbjct: 485 ANVLLDDDMEARIADFGLAKAVPDAHTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDIYSF 544
Query: 170 GVLLA----------------EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GV+LA EMSLVKW+RNVMTSE+PKRAID KL+G+G+EEQMLLVL
Sbjct: 545 GVVLAVLVIGKLPSDEFFQHTPEMSLVKWLRNVMTSEDPKRAIDPKLIGSGFEEQMLLVL 604
Query: 214 KTACFCTLDDPKER----HVRCMLSQIQQ 238
K ACFCTL++PKER VRCML+QI+
Sbjct: 605 KIACFCTLENPKERPNSKDVRCMLTQIKH 633
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119518|ref|XP_002318094.1| predicted protein [Populus trichocarpa] gi|222858767|gb|EEE96314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 344 bits (883), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 167/269 (62%), Positives = 199/269 (73%), Gaps = 31/269 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
MIA++KI+QPP DA L E DSK+L ++M QI+SEI T+G IRHRN+LPLLAH++RP CH
Sbjct: 359 MIAVKKIIQPPKDAAELSEEDSKVLNKKMRQIQSEINTVGHIRHRNLLPLLAHVSRPDCH 418
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ----------- 109
LVYEFMKNGSLQD+LN V+ G+R+LDWLAR++ G+ASGLEYLH+
Sbjct: 419 YLVYEFMKNGSLQDVLNQVTEGKRELDWLARHKIAVGVASGLEYLHLSHSPQIIHRDLKP 478
Query: 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
A VLLD DMEARI++FGLAK P+A THITTS+V GT GYIAPEY QTL T CDIYSF
Sbjct: 479 ANVLLDDDMEARIADFGLAKAMPDAKTHITTSNVAGTVGYIAPEYHQTLKFTEKCDIYSF 538
Query: 170 GVLLA----------------EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GV+L E+SLVKWMRN+M SENP +AID KL+G+G EEQMLLVL
Sbjct: 539 GVVLGVLVMGKLPSDAFFQSTRELSLVKWMRNIMISENPSQAIDPKLIGHGLEEQMLLVL 598
Query: 214 KTACFCTLDDPKER----HVRCMLSQIQQ 238
K ACFCT+DDPK+R VRCMLSQI+
Sbjct: 599 KIACFCTIDDPKQRPSSKDVRCMLSQIKH 627
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508750|ref|XP_003523117.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 343 bits (881), Expect = 2e-92, Method: Compositional matrix adjust.
Identities = 169/269 (62%), Positives = 197/269 (73%), Gaps = 31/269 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
MIAI+KIVQPP D L E DSK+L ++M QIRSEI T+GQIRHRN+LPLLAH++RP CH
Sbjct: 368 MIAIKKIVQPPKDGAELAEEDSKVLNKKMRQIRSEINTVGQIRHRNLLPLLAHVSRPECH 427
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ----------- 109
LVYEFMKNGSLQD L+ V RG +LDWL+R++ G+A+GLEYLHM+
Sbjct: 428 YLVYEFMKNGSLQDTLSKVERGESELDWLSRHKISLGVAAGLEYLHMNHNPRIIHRDLKP 487
Query: 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
A +LLD DMEARI++FGLAK P+ THITTS+V GT GYIAPEY Q L T CDIYS+
Sbjct: 488 ANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIYSY 547
Query: 170 GVLLA----------------EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GV+L EEMSLVKWMR ++SENPK AI+SKLLGNGYEEQMLLVL
Sbjct: 548 GVILGVLVIGKLPSDDFFQHTEEMSLVKWMRKTLSSENPKEAINSKLLGNGYEEQMLLVL 607
Query: 214 KTACFCTLDDPKER----HVRCMLSQIQQ 238
K ACFCT+DDPKER VRCMLSQI+
Sbjct: 608 KIACFCTMDDPKERPNSKDVRCMLSQIKH 636
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516603|ref|XP_003526983.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 336 bits (861), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 164/269 (60%), Positives = 196/269 (72%), Gaps = 31/269 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
MIAI+KI+QPP + L E DSK+L ++M QIRSEI T+GQIRHRN+LPLLAH++RPGCH
Sbjct: 363 MIAIKKIIQPPKEGAELAEEDSKVLNKKMRQIRSEITTVGQIRHRNLLPLLAHVSRPGCH 422
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ----------- 109
LVYEFMKNGSL D L+ V G +LDWL+R++ G+A+GLEYLH++
Sbjct: 423 YLVYEFMKNGSLHDTLSKVEVGEFELDWLSRHKIALGVAAGLEYLHLNHNPRIIHRDLKP 482
Query: 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
A +LLD DMEARI++FGLAK P+ THITTS+V GT GYIAPEY Q L T CDIYSF
Sbjct: 483 ANILLDDDMEARIADFGLAKAMPDYKTHITTSNVAGTVGYIAPEYHQILKFTDKCDIYSF 542
Query: 170 GVLLA----------------EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GV+L EEMSLVKWMR +++SENPK AID+KLLGNGYE+QMLLVL
Sbjct: 543 GVILGVLVIGKLPSHEFFQHTEEMSLVKWMRKILSSENPKEAIDTKLLGNGYEDQMLLVL 602
Query: 214 KTACFCTLDDPKER----HVRCMLSQIQQ 238
K ACFCT+DDPKER V CMLSQI+
Sbjct: 603 KIACFCTMDDPKERPNSKDVWCMLSQIKH 631
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440606|ref|XP_004138075.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] gi|449501343|ref|XP_004161343.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 330 bits (846), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 161/269 (59%), Positives = 194/269 (72%), Gaps = 31/269 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
M AI+KI QPP DA L+E +S+ ++++M QI+SEI T+G+IRHRN+LPL+AH+ RP CH
Sbjct: 365 MFAIKKITQPPKDAAELIEEESRHMSKKMRQIKSEIRTVGEIRHRNLLPLVAHVPRPDCH 424
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ----------- 109
LVYE MKNGSLQD+LN VS G ++LDWL R+ G+ASGLEYLHM+
Sbjct: 425 YLVYELMKNGSLQDMLNQVSAGVKELDWLTRHNIALGVASGLEYLHMNHTPRIIHRDLKP 484
Query: 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
A VLLD MEARI++FGLAK P+A TH+T S+V GT GYIAPEY QTL T CDIY F
Sbjct: 485 ANVLLDDGMEARIADFGLAKAMPDAQTHMTASNVAGTVGYIAPEYHQTLKFTDKCDIYGF 544
Query: 170 GVLLA----------------EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GVLL +EMSLVKWM+NVMTS+NP+ AID KLLGNG+EEQMLL L
Sbjct: 545 GVLLGVLVIGKLPSDEFFQNTDEMSLVKWMKNVMTSDNPRGAIDPKLLGNGWEEQMLLAL 604
Query: 214 KTACFCTLDDPKER----HVRCMLSQIQQ 238
K ACFCT+D+PKER VRCMLSQI+
Sbjct: 605 KIACFCTMDNPKERPNSKDVRCMLSQIKH 633
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456834|ref|XP_002276125.1| PREDICTED: leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 328 bits (842), Expect = 9e-88, Method: Compositional matrix adjust.
Identities = 168/269 (62%), Positives = 197/269 (73%), Gaps = 31/269 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
+IAI+KIVQPP DA L E DSKLL ++M QIRSEI T+G IRHRN+LPLLAH++RP CH
Sbjct: 364 LIAIKKIVQPPKDAAELAEEDSKLLNKKMRQIRSEIQTVGNIRHRNLLPLLAHVSRPNCH 423
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-------HQAL-- 111
LVYEFMKNGSLQD+L VS G R+LDWLAR+R G+A+GLEYLHM H+ L
Sbjct: 424 YLVYEFMKNGSLQDMLTQVSEGTRELDWLARHRVALGVAAGLEYLHMSHSPRIIHRDLKP 483
Query: 112 --VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
+LLD DMEARI++FGLAK P+A+TH+TTS+V GT GYIAPEY QTL T CDIYSF
Sbjct: 484 GNILLDDDMEARIADFGLAKAVPDANTHVTTSNVAGTVGYIAPEYHQTLKFTDKCDIYSF 543
Query: 170 GVLL----------------AEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GVLL EMSLVKWM N+ TS++P RAID KL+GNG+EEQMLLVL
Sbjct: 544 GVLLGVLVVGKLPSDDFFQHTAEMSLVKWMANIRTSDDPSRAIDRKLMGNGFEEQMLLVL 603
Query: 214 KTACFCTLDD----PKERHVRCMLSQIQQ 238
K ACFCT+DD P + VR MLSQI+
Sbjct: 604 KIACFCTVDDAKIRPNSKDVRTMLSQIKH 632
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297822929|ref|XP_002879347.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] gi|297325186|gb|EFH55606.1| hypothetical protein ARALYDRAFT_482113 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 319 bits (818), Expect = 5e-85, Method: Compositional matrix adjust.
Identities = 158/268 (58%), Positives = 193/268 (72%), Gaps = 31/268 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
+IA++K++QPP DA L + DSK + ++M QIRSEI T+GQIRHRN+LPLLAH++RP CH
Sbjct: 373 IIAVKKVIQPPKDADELTDEDSKFMNKKMRQIRSEISTVGQIRHRNLLPLLAHVSRPECH 432
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ----------- 109
LVYE+M+ GSLQDIL DV G ++L W AR++ GIA+GLEYLHM
Sbjct: 433 YLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKP 492
Query: 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
A VLLD DMEARIS+FGLAKV P+A THITTS+V GT GYIAPE+ QT T CDIYSF
Sbjct: 493 ANVLLDDDMEARISDFGLAKVMPDAVTHITTSNVAGTVGYIAPEFYQTHKFTAKCDIYSF 552
Query: 170 GVLLA----------------EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GV+L +EMSL+KWMRN++TSENP AID KL+ G++EQMLLVL
Sbjct: 553 GVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMEQGFDEQMLLVL 612
Query: 214 KTACFCTLDDPKER----HVRCMLSQIQ 237
K AC+CTLDDPK+R VR MLSQI+
Sbjct: 613 KIACYCTLDDPKQRPNSKDVRTMLSQIK 640
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225153|ref|NP_180747.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] gi|75265989|sp|Q9SKB2.1|SBIR1_ARATH RecName: Full=Leucine-rich repeat receptor-like serine/threonine/tyrosine-protein kinase SOBIR1; AltName: Full=Protein EVERSHED; AltName: Full=Protein SUPPRESSOR OF BIR1-1; Flags: Precursor gi|13877675|gb|AAK43915.1|AF370596_1 putative receptor-like protein kinase [Arabidopsis thaliana] gi|4887748|gb|AAD32284.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589537|gb|ACN59302.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330253505|gb|AEC08599.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 315 bits (806), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 157/269 (58%), Positives = 190/269 (70%), Gaps = 31/269 (11%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
+IA++K++QPP DA L + DSK L ++M QIRSEI T+G IRHRN+LPLLAH++RP CH
Sbjct: 373 IIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPECH 432
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ----------- 109
LVYE+M+ GSLQDIL DV G ++L W AR++ GIA+GLEYLHM
Sbjct: 433 YLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKP 492
Query: 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
A VLLD DMEARIS+FGLAK P+A THITTS V GT GYIAPE+ QT T CDIYSF
Sbjct: 493 ANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSF 552
Query: 170 GVLLA----------------EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVL 213
GV+L +EMSL+KWMRN++TSENP AID KL+ G++EQMLLVL
Sbjct: 553 GVILGILVIGKLPSDEFFQHTDEMSLIKWMRNIITSENPSLAIDPKLMDQGFDEQMLLVL 612
Query: 214 KTACFCTLDDPKER----HVRCMLSQIQQ 238
K AC+CTLDDPK+R VR MLSQI+
Sbjct: 613 KIACYCTLDDPKQRPNSKDVRTMLSQIKH 641
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 238 | ||||||
| TAIR|locus:2045228 | 641 | SOBIR1 "SUPPRESSOR OF BIR1 1" | 0.726 | 0.269 | 0.614 | 2.6e-54 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.802 | 0.173 | 0.397 | 2.5e-28 | |
| TAIR|locus:2091980 | 432 | CDG1 "CONSTITUTIVE DIFFERENTIA | 0.600 | 0.331 | 0.416 | 2.7e-28 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.798 | 0.187 | 0.387 | 3.6e-28 | |
| TAIR|locus:2203000 | 355 | AT1G78530 [Arabidopsis thalian | 0.571 | 0.383 | 0.447 | 2.2e-27 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.945 | 0.619 | 0.339 | 1.2e-26 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.794 | 0.319 | 0.365 | 1.5e-26 | |
| TAIR|locus:2168907 | 966 | XIP1 "XYLEM INTERMIXED WITH PH | 0.911 | 0.224 | 0.326 | 3.6e-26 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.827 | 0.169 | 0.346 | 3.8e-26 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.609 | 0.121 | 0.403 | 4e-26 |
| TAIR|locus:2045228 SOBIR1 "SUPPRESSOR OF BIR1 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 561 (202.5 bits), Expect = 2.6e-54, P = 2.6e-54
Identities = 113/184 (61%), Positives = 137/184 (74%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
+IA++K++QPP DA L + DSK L ++M QIRSEI T+G IRHRN+LPLLAH++RP CH
Sbjct: 373 IIAVKKVIQPPKDADELTDEDSKFLNKKMRQIRSEINTVGHIRHRNLLPLLAHVSRPECH 432
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-------HQAL-- 111
LVYE+M+ GSLQDIL DV G ++L W AR++ GIA+GLEYLHM H+ L
Sbjct: 433 YLVYEYMEKGSLQDILTDVQAGNQELMWPARHKIALGIAAGLEYLHMDHNPRIIHRDLKP 492
Query: 112 --VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
VLLD DMEARIS+FGLAK P+A THITTS V GT GYIAPE+ QT T CDIYSF
Sbjct: 493 ANVLLDDDMEARISDFGLAKAMPDAVTHITTSHVAGTVGYIAPEFYQTHKFTDKCDIYSF 552
Query: 170 GVLL 173
GV+L
Sbjct: 553 GVIL 556
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 328 (120.5 bits), Expect = 2.5e-28, P = 2.5e-28
Identities = 89/224 (39%), Positives = 122/224 (54%)
Query: 33 RSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ--LDWLA 90
R+EI TLG+IRHRNI+ L +LL+YE+M GSL + L RG + LDW A
Sbjct: 843 RAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQ---RGEKNCLLDWNA 899
Query: 91 RYRTVRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHIT 139
RYR G A GL YLH +H+ + +LLD +A + +FGLAK+ +++ +
Sbjct: 900 RYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSK-S 958
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-------------LVKWMRNV 186
S V G+ GYIAPEY T+ +T CDIYSFGV+L E ++ LV W+R
Sbjct: 959 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRS 1018
Query: 187 MTSENPK-RAIDSKLLGNGYE--EQMLLVLKTACFCTLDDPKER 227
+ + P D++L N +M LVLK A FCT + P R
Sbjct: 1019 IRNMIPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASR 1062
|
|
| TAIR|locus:2091980 CDG1 "CONSTITUTIVE DIFFERENTIAL GROWTH 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 286 (105.7 bits), Expect = 2.7e-28, Sum P(2) = 2.7e-28
Identities = 65/156 (41%), Positives = 95/156 (60%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
E++ L + HRN++ L + A L+VYE+M GS++D L D+S G+ LDW R +
Sbjct: 118 EVLMLSLLHHRNLVHLFGYCAEGDQRLVVYEYMPLGSVEDHLYDLSEGQEALDWKTRMKI 177
Query: 95 VRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFP-EAHTHITTSD 142
G A GL +LH +++ L +LLDHD + ++S+FGLAK P + +H++T
Sbjct: 178 ALGAAKGLAFLHNEAQPPVIYRDLKTSNILLDHDYKPKLSDFGLAKFGPSDDMSHVSTR- 236
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
V+GT GY APEY T +T DIYSFGV+L E +S
Sbjct: 237 VMGTHGYCAPEYANTGKLTLKSDIYSFGVVLLELIS 272
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 326 (119.8 bits), Expect = 3.6e-28, P = 3.6e-28
Identities = 86/222 (38%), Positives = 129/222 (58%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR-GRRQLDWLARYR 93
E+ LG++RHRNI+ LL L ++VYEFM NG+L D ++ + GR +DW++RY
Sbjct: 748 EVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYN 807
Query: 94 TVRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSD 142
G+A GL YLH +H+ + +LLD +++ARI++FGLA++ A T S
Sbjct: 808 IALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--ARKKETVSM 865
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLL--------------AEEMSLVKWMRN-VM 187
V G+ GYIAPEY TL + DIYS+GV+L E + +V+W+R +
Sbjct: 866 VAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWVRRKIR 925
Query: 188 TSENPKRAIDSKLLGN-GY-EEQMLLVLKTACFCTLDDPKER 227
+ + + A+D + GN Y +E+MLLVL+ A CT PK+R
Sbjct: 926 DNISLEEALDPNV-GNCRYVQEEMLLVLQIALLCTTKLPKDR 966
|
|
| TAIR|locus:2203000 AT1G78530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 2.2e-27, P = 2.2e-27
Identities = 68/152 (44%), Positives = 92/152 (60%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
E+ + I+HRNI+ L + P +LL+YE M NGSL L+ GR+ LDW +RYR
Sbjct: 119 ELEAMADIKHRNIVTLHGYFTSPHYNLLIYELMPNGSLDSFLH----GRKALDWASRYRI 174
Query: 95 VRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDV 143
G A G+ YLH +H+ + +LLDH+MEAR+S+FGLA + TH++T V
Sbjct: 175 AVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLMEPDKTHVSTF-V 233
Query: 144 VGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
GT GY+APEY T T D+YSFGV+L E
Sbjct: 234 AGTFGYLAPEYFDTGKATMKGDVYSFGVVLLE 265
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 300 (110.7 bits), Expect = 1.2e-26, P = 1.2e-26
Identities = 87/256 (33%), Positives = 136/256 (53%)
Query: 8 VQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFM 67
++ P A+ + D L + + E++ L + HRN++ L+ + A LLVYE+M
Sbjct: 66 LENPAQVVAVKQLDRNGL-QGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYM 124
Query: 68 KNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH-------MHQAL----VLLDH 116
GSL+D L D+ G++ LDW R + G A G+EYLH +++ L +LLD
Sbjct: 125 PLGSLEDHLLDLEPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDP 184
Query: 117 DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176
+ A++S+FGLAK+ P T +S V+GT GY APEYQ+T +T D+YSFGV+L E
Sbjct: 185 EYVAKLSDFGLAKLGPVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLEL 244
Query: 177 MS---LVKWMR-----NVMT-----SENPKR--AIDSKLLGNGYEEQML-LVLKTACFCT 220
+S ++ MR N++T +P R + LL Y E+ L + A C
Sbjct: 245 ISGRRVIDTMRPSHEQNLVTWALPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCL 304
Query: 221 LDDPKERHVRCMLSQI 236
++P VR ++S +
Sbjct: 305 HEEPT---VRPLMSDV 317
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 306 (112.8 bits), Expect = 1.5e-26, P = 1.5e-26
Identities = 80/219 (36%), Positives = 119/219 (54%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
E+ LG I+HR ++ L + P LL+Y+++ GSL + L+ V RG QLDW +R
Sbjct: 350 ELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALH-VERGE-QLDWDSRVNI 407
Query: 95 VRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDV 143
+ G A GL YLH +H+ + +LLD ++EAR+S+FGLAK+ + +HITT V
Sbjct: 408 IIGAAKGLSYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLEDEESHITTI-V 466
Query: 144 VGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS---------------LVKWMRNVMT 188
GT GY+APEY Q+ T D+YSFGVL+ E +S +V W++ +++
Sbjct: 467 AGTFGYLAPEYMQSGRATEKTDVYSFGVLVLEVLSGKRPTDASFIEKGLNVVGWLKFLIS 526
Query: 189 SENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
+ P+ +D G E L L A C P+ER
Sbjct: 527 EKRPRDIVDPNCEGMQMESLDAL-LSIATQCVSPSPEER 564
|
|
| TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 307 (113.1 bits), Expect = 3.6e-26, P = 3.6e-26
Identities = 83/254 (32%), Positives = 133/254 (52%)
Query: 1 MIAIRKI-VQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGC 59
++A++K+ Q D+ + D L +E+ ++E+ TLG IRH+NI+ L ++ + C
Sbjct: 680 VVAVKKLWSQSNKDSAS---EDKMHLNKEL---KTEVETLGSIRHKNIVKLFSYFSSLDC 733
Query: 60 HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH-------MHQAL- 111
LLVYE+M NG+L D L+ +G L+W R++ G+A GL YLH +H+ +
Sbjct: 734 SLLVYEYMPNGNLWDALH---KGFVHLEWRTRHQIAVGVAQGLAYLHHDLSPPIIHRDIK 790
Query: 112 ---VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYS 168
+LLD + + ++++FG+AKV TT+ + GT GY+APEY + T CD+YS
Sbjct: 791 STNILLDVNYQPKVADFGIAKVLQARGKDSTTTVMAGTYGYLAPEYAYSSKATIKCDVYS 850
Query: 169 FGVLL--------------AEEMSLVKWMRN-VMTSENPKRAIDSKLLGNGYEEQMLLVL 213
FGV+L E ++V W+ + T E +D K L + M+ L
Sbjct: 851 FGVVLMELITGKKPVDSCFGENKNIVNWVSTKIDTKEGLIETLD-KRLSESSKADMINAL 909
Query: 214 KTACFCTLDDPKER 227
+ A CT P R
Sbjct: 910 RVAIRCTSRTPTIR 923
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 308 (113.5 bits), Expect = 3.8e-26, P = 3.8e-26
Identities = 78/225 (34%), Positives = 123/225 (54%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILND-VSRGRRQLDWL 89
+ +E+ T+G+I+HRN++PLL + LLVYE+MK GSL+ +L++ +G LDW
Sbjct: 898 EFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWS 957
Query: 90 ARYRTVRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
AR + G A GL +LH +H+ + VLLD D AR+S+FG+A++ TH+
Sbjct: 958 ARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHL 1017
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS---------------LVKWM 183
+ S + GT GY+ PEY Q+ T D+YS+GV+L E +S LV W
Sbjct: 1018 SVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWA 1077
Query: 184 RNVMTSENPKRAIDSKLLGN-GYEEQMLLVLKTACFCTLDDPKER 227
+ + + +D +L+ + + ++L LK A C D P +R
Sbjct: 1078 KQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRPFKR 1122
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 308 (113.5 bits), Expect = 4.0e-26, P = 4.0e-26
Identities = 63/156 (40%), Positives = 99/156 (63%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
+ +E+ T+G+I+HRN++PLL + LLVYEFMK GSL+D+L+D + +L+W
Sbjct: 923 EFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPKKAGVKLNWST 982
Query: 91 RYRTVRGIASGLEYLH-------MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHIT 139
R + G A GL +LH +H+ + VLLD ++EAR+S+FG+A++ TH++
Sbjct: 983 RRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLS 1042
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
S + GT GY+ PEY Q+ + D+YS+GV+L E
Sbjct: 1043 VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLE 1078
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 238 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-27 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-21 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-18 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-18 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-16 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-16 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-15 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-10 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-09 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-07 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-07 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-07 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-06 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-05 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-05 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-05 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-05 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-05 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-04 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-04 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-04 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.001 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.001 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.001 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.002 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.002 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.002 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.002 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 0.002 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.002 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.002 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.003 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.003 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.003 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.003 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.003 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.003 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.003 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.003 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.003 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.003 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.004 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-27
Identities = 51/189 (26%), Positives = 87/189 (46%), Gaps = 16/189 (8%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
+ + + ++ EI L ++ H NI+ L LV E+ + GSL+D+L
Sbjct: 27 KKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK--- 83
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHD-MEARISEFGLAKVF 131
+L R + I GLEYLH + + +LLD D + ++++FGL+K+
Sbjct: 84 ENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143
Query: 132 PEAHTHITTSDVVGTAGYIAPE-YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSE 190
+ +VGT Y+APE + DI+S GV+L E L +R M +
Sbjct: 144 TSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRK-MLQK 200
Query: 191 NPKRAIDSK 199
+P++ +K
Sbjct: 201 DPEKRPSAK 209
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-27
Identities = 51/163 (31%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
K + ++ +I EI L +++H NI+ L LV E+ + G L D+L
Sbjct: 33 KKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL--KK 90
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFP 132
RGR D Y +R I S LEYLH + +LLD D ++++FGLA+
Sbjct: 91 RGRLSEDEARFY--LRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQL- 147
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ VGT Y+APE DI+S GV+L E
Sbjct: 148 --DPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 1e-21
Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
++ R EI L ++ H NI+ L+ LV E+ + G L D L L
Sbjct: 40 KKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL----SRGGPL 95
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
+ I GLEYLH +H+ L +LLD + +I++FGLAK ++ + +
Sbjct: 96 SEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL 155
Query: 139 TTSDVVGTAGYIAPE-YQQTLSITYMCDIYSFGVLLAE 175
TT VGT Y+APE D++S GV+L E
Sbjct: 156 TT--FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYE 191
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 5e-18
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 12/161 (7%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+++ + E + ++ H N++ LL +V E+M+ G L L R +L
Sbjct: 43 QQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKL 99
Query: 87 DWLARYRTVRGIASGLEYLHMHQ------AL--VLLDHDMEARISEFGLAKVFPEAHTHI 138
IA G+EYL A L+ ++ +IS+FGL++ + +
Sbjct: 100 SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYR 159
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ ++APE + T D++SFGVLL E +L
Sbjct: 160 KRGGKLPIR-WMAPESLKEGKFTSKSDVWSFGVLLWEIFTL 199
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 7e-18
Identities = 42/168 (25%), Positives = 70/168 (41%), Gaps = 23/168 (13%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+++ + E + ++ H NI+ LL ++V E+M G L D L ++
Sbjct: 42 EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKE 99
Query: 86 LDWLARYRTVRGIASGLEYLHMHQ------AL--VLLDHDMEARISEFGLAKVFPEAHTH 137
L IA G+EYL A L+ ++ +IS+FGL++
Sbjct: 100 LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD------- 152
Query: 138 ITTSDVVGTAG------YIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ D G ++APE + T D++SFGVLL E +L
Sbjct: 153 LYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL 200
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 2e-17
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 14/164 (8%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLL-AHLARPGCHLLVY-EFMKNGSLQDILNDV 79
S EE+ + EI L ++H NI+ + L ++ E++ GSL +L
Sbjct: 36 SGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-- 93
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVF 131
G+ + +Y R I GL YLH + A +L+D D ++++FG AK
Sbjct: 94 KFGKLPEPVIRKY--TRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRL 151
Query: 132 PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ T T V GT ++APE + DI+S G + E
Sbjct: 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIE 195
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 1e-16
Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 34/181 (18%)
Query: 17 LVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDIL 76
L E S+ EE ++ E + ++ H NI+ LL + +V E+M G L D L
Sbjct: 36 LKEGASEEEREEFLE---EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL 92
Query: 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLA 128
+ +L + IA G+EYL + L+ ++ +IS+FGL+
Sbjct: 93 ---RKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
Query: 129 KVFPEAHTHITTSDVVGTAGYI-----APEYQQTLSITYMC-----DIYSFGVLLAEEMS 178
+ + G + APE S+ D++SFGVLL E +
Sbjct: 150 RD-----IYEDDYYRKRGGGKLPIKWMAPE-----SLKDGKFTSKSDVWSFGVLLWEIFT 199
Query: 179 L 179
L
Sbjct: 200 L 200
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 1e-16
Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL------LVYEFMKNGSLQDILNDVS 80
E+ +I +EI L + +H NI+ G +L +V EF GSL+D+L +
Sbjct: 39 EKKEKIINEIQILKKCKHPNIVKYY------GSYLKKDELWIVMEFCSGGSLKDLLK-ST 91
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFP 132
+A Y + + GLEYLH +H+ + +LL D E ++ +FGL+
Sbjct: 92 NQTLTESQIA-Y-VCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ T VGT ++APE Y DI+S G+ E
Sbjct: 150 DTKARNTM---VGTPYWMAPEVINGKPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 1e-16
Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 23/171 (13%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLL--AHLARPGCHLLVYEFMKNGSLQDIL-------N 77
EE E + ++ H N++ LL P LV E+M+ G L D L
Sbjct: 38 EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFP 95
Query: 78 DVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ------AL--VLLDHDMEARISEFGLAK 129
+ L L + IA G+EYL + A L+ D+ +IS+FGL++
Sbjct: 96 SPEKSTLSLKDLLSF--AIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
Query: 130 -VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
V+ + + T + ++APE + T D++SFGVLL E +L
Sbjct: 154 DVYDDDYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTL 203
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
SEI +G+++H NI+ L+ L++E+++ +L ++L ++S RR+ +
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRR-------K 784
Query: 94 TVRGIASGLEYLH-----------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSD 142
GIA L +LH + +++D E + L + +S
Sbjct: 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS- 842
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM--------------SLVKWMRNVMT 188
Y+APE ++T IT DIY FG++L E + S+V+W R +
Sbjct: 843 -----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS 897
Query: 189 SENPKRAIDSKLLGNG--YEEQMLLVLKTACFCTLDDPKER 227
+ ID + G+ + +++ V+ A CT DP R
Sbjct: 898 DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTAR 938
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 75.9 bits (185), Expect = 4e-16
Identities = 55/166 (33%), Positives = 81/166 (48%), Gaps = 18/166 (10%)
Query: 27 EEMMQIRSEIVTLGQIRH-RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+E+ + EI L + H NI+ L G LV E++ GSL+D+L + R
Sbjct: 39 KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPL 98
Query: 86 LDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHD-MEARISEFGLAKVFPEAHT 136
+ A + I S LEYLH +H+ + +LLD D ++ +FGLAK+ P+ +
Sbjct: 99 SESEAL-FILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157
Query: 137 H----ITTSDVVGTAGYIAPEYQQTLSITYMC---DIYSFGVLLAE 175
S VGT GY+APE LS+ Y DI+S G+ L E
Sbjct: 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE 203
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 1e-15
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL-LVYEFMKNGSLQDILNDVS 80
K+ E + I EI L ++H NI+ + L ++ E+ +NGSL+ I+
Sbjct: 36 EKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS-IETSDSLYIILEYAENGSLRQIIK--K 92
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH----MHQ----ALVLLDHDMEARISEFGLAKVFP 132
G +A Y V + GL YLH +H+ A +L D ++++FG+A
Sbjct: 93 FGPFPESLVAVY--VYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN 150
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ + VVGT ++APE + + DI+S G + E
Sbjct: 151 DVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIE 191
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 6e-15
Identities = 48/169 (28%), Positives = 69/169 (40%), Gaps = 28/169 (16%)
Query: 29 MMQIR-SEIVTLGQIRH----RNILPLLAHLARPGCH---------LLVYEFMKNGSLQD 74
M ++ +I+ ++ H RNIL + H H LV E+ G L
Sbjct: 23 MKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFS 82
Query: 75 ILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFG 126
L+ GR + Y I LEYLH +++ L +LLD D ++++FG
Sbjct: 83 HLS--KEGRFSEERARFY--AAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFG 138
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
LAK + T GT Y+APE D +S GVLL E
Sbjct: 139 LAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 9e-15
Identities = 42/153 (27%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
+E +GQ H NI+ L + + +++ E+M+NGSL L +
Sbjct: 54 TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVG 110
Query: 94 TVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
+RGIASG++YL ++H+ L +L++ ++ ++S+FGL++ ++ TT
Sbjct: 111 MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI 170
Query: 146 TAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
+ APE T D++SFG+++ E MS
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 5e-14
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 27/165 (16%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR-GRR 84
E Q+ E+ TL ++ + G +V E+M GSL D+L V +
Sbjct: 40 EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEP 99
Query: 85 QLDWLARYRTVRGIASGLEYLH--MHQ-------ALVLLDHDMEARISEFGLAKVFPEAH 135
L ++AR I GL+YLH H + +L++ E +I++FG++KV
Sbjct: 100 VLAYIARQ-----ILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKV----- 149
Query: 136 THITTSDV-----VGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ + VGT Y++PE Q S +Y DI+S G+ L E
Sbjct: 150 --LENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-13
Identities = 54/188 (28%), Positives = 82/188 (43%), Gaps = 24/188 (12%)
Query: 10 PPMDATALVEADSKLLTEEMMQIRS----EIVTLGQIRHRNILPLLAHLARPGC--HLLV 63
P D T A L Q RS EI L + H NI+ +PG L+
Sbjct: 27 PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86
Query: 64 YEFMKNGSLQDILNDVSRGRRQLDWLARYRTVR---GIASGLEYLH----MHQAL----V 112
E++ +GSL+D L +R D + R + I G++YL +H+ L +
Sbjct: 87 MEYLPSGSLRDYL------QRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNI 140
Query: 113 LLDHDMEARISEFGLAKVFPEAHTHITT-SDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171
L++ + +IS+FGLAKV PE + + APE +T + D++SFGV
Sbjct: 141 LVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGV 200
Query: 172 LLAEEMSL 179
L E +
Sbjct: 201 TLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-13
Identities = 46/156 (29%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
SE +GQ H NI+ L + + +++ E+M+NG+L L D +
Sbjct: 55 SEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG--- 111
Query: 94 TVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKV---FPEAHTHITTSD 142
+RGIA+G++YL ++H+ L +L++ ++E ++S+FGL++V PE T+ T+
Sbjct: 112 MLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGG 170
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
+ + APE T D++SFG+++ E MS
Sbjct: 171 KIPIR-WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-12
Identities = 43/153 (28%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
E + ++ H+N++ LL + G ++ V E M G+L + L +RGR + + +
Sbjct: 48 EETAVMTKLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLR--TRGRALVSVIQLLQ 104
Query: 94 TVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
+A G+EYL +H+ L +L+ D A++S+FGLA+V + S +
Sbjct: 105 FSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---VDNSKL-- 159
Query: 146 TAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
+ APE + + D++S+GVLL E S
Sbjct: 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-12
Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 15/149 (10%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
E + +RH N++ LL + + +V E+M GSL D L SRGR + +
Sbjct: 50 EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGF 107
Query: 95 VRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGT 146
+ G+EYL +H+ L VL+ D+ A++S+FGLAK EA + +
Sbjct: 108 ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--P 162
Query: 147 AGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ APE + + D++SFG+LL E
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 3e-12
Identities = 38/157 (24%), Positives = 56/157 (35%), Gaps = 30/157 (19%)
Query: 43 RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102
H I+ L V E+ NG L + G R+ I L
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKC-TRFYAAE-ILLAL 115
Query: 103 EYLH----MHQAL----VLLDHDMEARISEFGLAKVF------------------PEAHT 136
EYLH +H+ L +LLD DM +I++FG AKV
Sbjct: 116 EYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 137 HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ VGTA Y++PE D+++ G ++
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCII 212
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-12
Identities = 44/158 (27%), Positives = 82/158 (51%), Gaps = 18/158 (11%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDIL--NDVSRGRRQLDWLAR 91
SE +GQ H NI+ L + + +++ EFM+NG+L L ND Q +
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND-----GQFTVIQL 108
Query: 92 YRTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDV 143
+RGIA+G++YL ++H+ L +L++ ++ ++S+FGL++ + + T +
Sbjct: 109 VGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168
Query: 144 VG---TAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
+G + APE T D++S+G+++ E MS
Sbjct: 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-12
Identities = 57/181 (31%), Positives = 78/181 (43%), Gaps = 20/181 (11%)
Query: 10 PPMDATALVEADSKLLTEEMMQIRS----EIVTLGQIRHRNILPLLAHLARPGCH--LLV 63
P D T + A L E Q S EI L + H NI+ + G L+
Sbjct: 27 PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86
Query: 64 YEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLD 115
E++ GSL+D L QL A+ I G+ YLH +H+ L VLLD
Sbjct: 87 MEYVPLGSLRDYLPKHKLNLAQLLLFAQQ-----ICEGMAYLHSQHYIHRDLAARNVLLD 141
Query: 116 HDMEARISEFGLAKVFPEAHTHITTS-DVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174
+D +I +FGLAK PE H + D + A E + +Y D++SFGV L
Sbjct: 142 NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201
Query: 175 E 175
E
Sbjct: 202 E 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-12
Identities = 51/175 (29%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
SE +GQ H NI+ L + + ++V E+M+NGSL L + Q +
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVG 110
Query: 94 TVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVF---PEAHTHITTSD 142
+RGIASG++YL ++H+ L +L++ ++ ++S+FGL++V PEA TT
Sbjct: 111 MLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA--AYTTRG 168
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID 197
+ APE T D++S+G+++ E MS + M++++ +AI+
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-11
Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 18/160 (11%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVY-EFMKNGSLQDILNDV 79
D + E + Q+ EI L +++H NI+ L R +L ++ E + GSL +L
Sbjct: 38 DGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKY 96
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLH----MHQ----ALVLLDHDMEARISEFGLAKVF 131
+ + Y R I GLEYLH +H+ A +L+D + ++++FG+AK
Sbjct: 97 GSFPEPV--IRLY--TRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152
Query: 132 PEAHTHITTSDVVGTAGYIAPEY-QQTLSITYMCDIYSFG 170
E G+ ++APE Q DI+S G
Sbjct: 153 VE---FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLG 189
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 6e-11
Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 22/172 (12%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVS 80
S + +E +E+ L ++ H NI+ G +V E+ G L I
Sbjct: 36 SNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKK 95
Query: 81 RGR-----RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGL 127
G+ + LDW + + L+YLH +H+ + + L + ++ +FG+
Sbjct: 96 EGKPFPEEQILDWFVQ------LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGI 149
Query: 128 AKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+KV T VVGT Y++PE Q Y DI+S G +L E +L
Sbjct: 150 SKVLSSTVDLAKT--VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARP-GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
+E + Q+RH N++ LL + G +V E+M GSL D L SRGR L
Sbjct: 48 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLL 105
Query: 93 RTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
+ + +EYL +H+ L VL+ D A++S+FGL K EA + T +
Sbjct: 106 KFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL- 161
Query: 145 GTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ APE + + D++SFG+LL E
Sbjct: 162 -PVKWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-10
Identities = 49/185 (26%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
M+A++++ P A + + +RSEI TL + H NI+ L
Sbjct: 28 MMAVKQVELPATIA----GRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----V 112
+ E++ GS+ L R QL R+ T + GL YLH +H+ L +
Sbjct: 84 SIFLEYVPGGSIGSCLRTYGRFEEQL---VRFFT-EQVLEGLAYLHSKGILHRDLKADNL 139
Query: 113 LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY--MCDIYSFG 170
L+D D +IS+FG++K + + + + G+ ++APE + S Y DI+S G
Sbjct: 140 LVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLG 199
Query: 171 VLLAE 175
++ E
Sbjct: 200 CVVLE 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 5e-10
Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 29/157 (18%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHL------LVYEFMKNGSLQDIL--NDVSRGRRQL 86
EI+ + +H NI+ +L +V E+M GSL DI+ N V Q+
Sbjct: 65 EILIMKDCKHPNIVDYY------DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI 118
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
++ R ++ GLEYLH +H+ + +LL D ++++FG A + +
Sbjct: 119 AYVCR-EVLQ----GLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ VVGT ++APE + DI+S G++ E
Sbjct: 174 NS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-10
Identities = 51/144 (35%), Positives = 66/144 (45%), Gaps = 28/144 (19%)
Query: 49 PLLAHLA---RPGCHLL-VYEFMKNGSLQDILNDVSRGRRQLDWLARYRTV---RGIASG 101
P L HL + HL V EF+ G L + D +GR L YR I G
Sbjct: 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDL-----YRATFYAAEIVCG 108
Query: 102 LEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTAGYIA 151
L++LH + V+LD D +I++FG+ K VF + S GT YIA
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA----STFCGTPDYIA 164
Query: 152 PEYQQTLSITYMCDIYSFGVLLAE 175
PE Q L T+ D +SFGVLL E
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYE 188
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
+E +TLGQ H NI+ L + R ++V E+M NG+L L + QL
Sbjct: 55 AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMG 111
Query: 94 TVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
+ G+ASG++YL ++H+ L VL++ D+ +IS F + ++ TT
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTTMSGKS 170
Query: 146 TAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
+ APE Q + D++SFG+++ E MS
Sbjct: 171 PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-09
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 22/165 (13%)
Query: 25 LTEEMMQIRSEIVTLGQIRHRNILPL----LAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
L++ M E + + H N++ L L H ++V E GSL D L +
Sbjct: 36 LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPL-----MMVTELAPLGSLLDRLRKDA 90
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHM----HQAL----VLLDHDMEARISEFGLAKVFP 132
G + L Y IA+G+ YL H+ L +LL D + +I +FGL + P
Sbjct: 91 LGHFLISTLCDYAV--QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALP 148
Query: 133 EAHTHITTSD--VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ H + V A + APE +T + ++ D++ FGV L E
Sbjct: 149 QNEDHYVMEEHLKVPFA-WCAPESLRTRTFSHASDVWMFGVTLWE 192
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 2e-09
Identities = 55/202 (27%), Positives = 86/202 (42%), Gaps = 56/202 (27%)
Query: 1 MIAIRKI-VQPP------MDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAH 53
++AI+KI + ++ TAL E KLL E ++H NI+ LL
Sbjct: 27 IVAIKKIKLGERKEAKDGINFTALREI--KLLQE--------------LKHPNIIGLLDV 70
Query: 54 LARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLD---WLARYRTVRGIASGLEYLHMHQA 110
LV+EFM+ L+ ++ D S D ++ T+RG LEYLH +
Sbjct: 71 FGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM--TLRG----LEYLHSNWI 123
Query: 111 L--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE-------YQ 155
L +L+ D ++++FGLA+ F + +T V T Y APE Y
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ--VVTRWYRAPELLFGARHY- 180
Query: 156 QTLSITYMCDIYSFGVLLAEEM 177
D++S G + AE +
Sbjct: 181 -----GVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 43/162 (26%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILN-DVSRGRRQ 85
+ ++R E+ + Q H N++ LV ++ GSL DI+ RG
Sbjct: 41 TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD 100
Query: 86 LDWLARYRTV-RGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF--PEA 134
+A TV + + GLEYLH + + +LL D +I++FG++
Sbjct: 101 EAIIA---TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157
Query: 135 HTHITTSDVVGTAGYIAPE-YQQTLSITYMCDIYSFGVLLAE 175
T VGT ++APE +Q + DI+SFG+ E
Sbjct: 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 4e-09
Identities = 41/154 (26%), Positives = 62/154 (40%), Gaps = 17/154 (11%)
Query: 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWL 89
+ +E L IRH ++ L LV E++ G L L GR
Sbjct: 46 EHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV- 102
Query: 90 ARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTS 141
AR+ + + LEYLH + +LLD D +I++FG AK T
Sbjct: 103 ARFYAAQ-VVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTY 156
Query: 142 DVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ GT Y+APE + D ++ G+L+ E
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYE 190
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 42/178 (23%), Positives = 84/178 (47%), Gaps = 25/178 (14%)
Query: 14 ATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQ 73
A ++++D L ++ + E+ L ++RH++++ L A + ++ E M+ GSL
Sbjct: 34 AIKILKSDDLLKQQDF---QKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90
Query: 74 DILNDVSRGRRQ-----LDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEA 120
L G+ +D + +A G+ YL +H+ L +L+ D+
Sbjct: 91 AFLRS-PEGQVLPVASLIDMACQ------VAEGMAYLEEQNSIHRDLAARNILVGEDLVC 143
Query: 121 RISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
++++FGLA++ E +SD + APE + + D++SFG+LL E +
Sbjct: 144 KVADFGLARLIKE--DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-09
Identities = 40/126 (31%), Positives = 61/126 (48%), Gaps = 14/126 (11%)
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----V 112
V EF+ G D++ + + RR + AR+ I S L +LH +++ L V
Sbjct: 72 FFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAE-ITSALMFLHDKGIIYRDLKLDNV 127
Query: 113 LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172
LLDH+ ++++FG+ K TTS GT YIAPE Q + D ++ GVL
Sbjct: 128 LLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVL 185
Query: 173 LAEEMS 178
L E +
Sbjct: 186 LYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-09
Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 16/124 (12%)
Query: 63 VYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLL 114
V E++ G D++ + R R + AR+ I GL++LH + VLL
Sbjct: 74 VMEYVNGG---DLMFHIQRSGRFDEPRARFYAAE-IVLGLQFLHERGIIYRDLKLDNVLL 129
Query: 115 DHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
D + +I++FG+ K E +TTS GT YIAPE D ++ GVLL
Sbjct: 130 DSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLL 186
Query: 174 AEEM 177
E +
Sbjct: 187 YEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 18/165 (10%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+R EI L ++ H NI+ LL G LV+EFM D+ + +R
Sbjct: 40 GIPKTALR-EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD----TDLYKLIKDRQRG 94
Query: 86 LDW-LARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHT 136
L L + + + GL + H H L +L++ + ++++FGLA+ F
Sbjct: 95 LPESLIKSYLYQ-LLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153
Query: 137 HITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEEMSLV 180
T V T Y APE + DI+S G + AE +S
Sbjct: 154 PYT--HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 18/143 (12%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I SGLE+LH + + VLLD+D RIS+ GLA + + T GT G+
Sbjct: 106 IISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGF 163
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMR----NVMTSENPKRAIDSKLLGNGY 205
+APE Q + D ++ GV L E ++ R V E +R ++ + Y
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV---TY 220
Query: 206 EEQMLLVLKTACFCTLD-DPKER 227
++ K+ C L DP++R
Sbjct: 221 PDKFSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 46/147 (31%), Positives = 60/147 (40%), Gaps = 34/147 (23%)
Query: 49 PLLAHLARPGC------HLL-VYEFMKNGSL----QDILN-DVSRGRRQLDWLARYRTVR 96
P L HL C HL V E++ G L Q D +R AR+
Sbjct: 56 PFLTHLF---CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR--------ARFYAAE 104
Query: 97 GIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAG 148
I GL++LH + VLLD D +I++FG+ K + S GT
Sbjct: 105 -IICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPD 161
Query: 149 YIAPEYQQTLSITYMCDIYSFGVLLAE 175
YIAPE + D +SFGVLL E
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYE 188
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 28/86 (32%), Positives = 35/86 (40%), Gaps = 11/86 (12%)
Query: 98 IASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I GLE+LH + VLLD RIS+ GLA GT GY
Sbjct: 104 IICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGY 160
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAE 175
+APE Q + D ++ G L E
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYE 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-08
Identities = 41/164 (25%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 23 KLLTEEMMQIR---SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDV 79
K L E+ M++ E + +I+H N++ LL R ++ EFM G+L D L +
Sbjct: 37 KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 96
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLH----MHQALV----LLDHDMEARISEFGLAKVF 131
R++++ + I+S +EYL +H+ L L+ + ++++FGL+++
Sbjct: 97 --NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 154
Query: 132 PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
T+ + + APE + D+++FGVLL E
Sbjct: 155 TG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 197
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 51/224 (22%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
++L +E +EIV L ++H NI+ H L+ E+ G+L D +
Sbjct: 36 TRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV---- 91
Query: 82 GRRQLDWLARYRTV----RGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAK 129
RQ L V I S + Y+H +H+ + + L ++ +FG++K
Sbjct: 92 --RQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISK 149
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTS 189
+ ++ T VVGT Y++PE Q + + DI++ G +L E ++L + +
Sbjct: 150 ILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL----KRTFDA 203
Query: 190 ENPKRAIDSKLLGN------GYEEQMLLVLKTACFCTLDDPKER 227
NP + + GN Y +++ ++ + DP++R
Sbjct: 204 TNPLNLVVKIVQGNYTPVVSVYSSELISLVHS---LLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-08
Identities = 54/182 (29%), Positives = 88/182 (48%), Gaps = 33/182 (18%)
Query: 18 VEADSKLLTEEMMQ-IRSEIVTLGQIRHRNILPLLAHLARPGC-----HLLVY-EFMKNG 70
V A SK M+ + EI L +++H NI+ L G HL ++ E++ G
Sbjct: 38 VSASSKDRKRSMLDALAREIALLKELQHENIVQYL------GSSLDADHLNIFLEYVPGG 91
Query: 71 SLQDILNDVSRGRRQLDWLARYRT-VRGIASGLEYLHM----HQ----ALVLLDHDMEAR 121
S+ +LN+ L R VR I GL YLH H+ A +L+D+ +
Sbjct: 92 SVAALLNNYGAFEETL-----VRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIK 146
Query: 122 ISEFGLAKVFPEAHTHITTSD-----VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176
IS+FG++K EA++ T ++ + G+ ++APE + S T DI+S G L+ E
Sbjct: 147 ISDFGISKKL-EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205
Query: 177 MS 178
++
Sbjct: 206 LT 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-08
Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 11/142 (7%)
Query: 42 IRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101
++H ++ L A + + ++ E+M GSL D L G+ L L + IA G
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA--QIAEG 115
Query: 102 LEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153
+ Y+ ++H+ L VL+ + +I++FGLA+V E + + + APE
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPE 174
Query: 154 YQQTLSITYMCDIYSFGVLLAE 175
S T D++SFG+LL E
Sbjct: 175 AINFGSFTIKSDVWSFGILLYE 196
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-08
Identities = 42/146 (28%), Positives = 65/146 (44%), Gaps = 17/146 (11%)
Query: 41 QIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100
++RH ++ L A +V E MK GSL + L R L +AS
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVAS 114
Query: 101 GLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYI-- 150
G+ YL ++H+ L VL+ + ++++FGLA+V E I + G I
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE---DIYEARE-GAKFPIKW 170
Query: 151 -APEYQQTLSITYMCDIYSFGVLLAE 175
APE + D++SFG+LL E
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-08
Identities = 40/173 (23%), Positives = 67/173 (38%), Gaps = 27/173 (15%)
Query: 19 EADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDIL-- 76
+ DS +E+ + EI L ++H I+ L + E+M GS++D L
Sbjct: 38 DPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA 97
Query: 77 -----NDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARIS 123
V+R + R I G+EYLH + A +L D ++
Sbjct: 98 YGALTETVTR-----------KYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLG 146
Query: 124 EFGLAKVFPEAHTHIT-TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+FG +K + T V GT +++PE D++S G + E
Sbjct: 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVE 199
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-08
Identities = 41/164 (25%), Positives = 79/164 (48%), Gaps = 12/164 (7%)
Query: 42 IRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101
++H ++ L A + + +++ EFM GSL D L ++ L L + IA G
Sbjct: 58 LQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSA--QIAEG 114
Query: 102 LEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153
+ ++ ++H+ L +L+ + +I++FGLA+V E + + + APE
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPE 173
Query: 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID 197
S T D++SFG+LL E ++ + M++ RA++
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 217
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-08
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 17/175 (9%)
Query: 16 ALVEADSKLLTE-EMMQIRSEIVTLGQIRHRNILPLLAHLAR-PGCHL-LVYEFMKNGSL 72
AL E D +++ E +EI L + H NI+ A G L +V E+ G L
Sbjct: 29 ALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY--KEAFLDGNKLCIVMEYAPFGDL 86
Query: 73 QDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISE 124
++ + R+ + +R + GL+ LH + L +LL + +I +
Sbjct: 87 SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGD 146
Query: 125 FGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
G++KV +GT Y+APE + +Y DI+S G LL E +
Sbjct: 147 LGISKVL----KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 14/162 (8%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+E + ++E L + H NI+ + ++V E+ G+L + + R L
Sbjct: 41 DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLL 98
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLD-HDMEARISEFGLAKVFPEAHTH 137
D I L ++H L +LLD H M +I +FG++K+ +
Sbjct: 99 DEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SK 155
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
VVGT YI+PE + DI++ G +L E SL
Sbjct: 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 14/160 (8%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
E++ +I EI L Q I+ + +V E+ GS+ DI+ +
Sbjct: 39 EEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK---ITNKT 95
Query: 86 LDWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTH 137
L + GLEYLH ++ +LL+ + +A++++FG++ T
Sbjct: 96 LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTM 153
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177
+ V+GT ++APE Q + DI+S G+ A EM
Sbjct: 154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI-TAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-07
Identities = 44/187 (23%), Positives = 80/187 (42%), Gaps = 36/187 (19%)
Query: 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL 61
+A++ + M A ++ E + ++RH ++ L A +
Sbjct: 33 VAVKTLKPGTMSPEAFLQ---------------EAQIMKKLRHDKLVQLYAVCSEEEPIY 77
Query: 62 LVYEFMKNGSLQDILNDVSRGRRQ-----LDWLARYRTVRGIASGLEYL----HMHQAL- 111
+V E+M GSL D L G++ +D A+ IA G+ YL ++H+ L
Sbjct: 78 IVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQ------IAEGMAYLESRNYIHRDLA 130
Query: 112 ---VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYS 168
+L+ ++ +I++FGLA++ E + + APE T D++S
Sbjct: 131 ARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWS 189
Query: 169 FGVLLAE 175
FG+LL E
Sbjct: 190 FGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 34/124 (27%), Positives = 51/124 (41%), Gaps = 21/124 (16%)
Query: 65 EFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDH 116
E+ G L IL D RG ++ AR+ + EYLH + +LLD
Sbjct: 73 EYCLGGELWTILRD--RGLFD-EYTARFYIA-CVVLAFEYLHNRGIIYRDLKPENLLLDS 128
Query: 117 DMEARISEFGLAKVF---PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ ++ +FG AK + T GT Y+APE + D +S G+LL
Sbjct: 129 NGYVKLVDFGFAKKLKSGQKTWT------FCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182
Query: 174 AEEM 177
E +
Sbjct: 183 YELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 35/125 (28%), Positives = 61/125 (48%), Gaps = 16/125 (12%)
Query: 63 VYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLL 114
V E++ G D++ + R R+ + +R+ + L +LH H + +LL
Sbjct: 74 VMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAE-VTLALMFLHRHGVIYRDLKLDNILL 129
Query: 115 DHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
D + ++++FG+ K E + +TT+ GT YIAPE Q L D ++ GVL+
Sbjct: 130 DAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLM 186
Query: 174 AEEMS 178
E M+
Sbjct: 187 YEMMA 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 27/185 (14%)
Query: 10 PPMDATALVEADSKL---LTEEMMQIRSEIVTLGQIRHRNILP---LLAHLARPGCHLLV 63
P D T V A KL E + EI L ++H NI+ + R L V
Sbjct: 27 PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL-V 85
Query: 64 YEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL----HMHQAL----VLLD 115
E++ GSL+D L + R +LD I G+EYL ++H+ L +L++
Sbjct: 86 MEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE 142
Query: 116 HDMEARISEFGLAKVFPEAHTHITTSDVVGTAG-----YIAPEYQQTLSITYMCDIYSFG 170
+ +I +FGL KV P+ + V G + APE + D++SFG
Sbjct: 143 SENRVKIGDFGLTKVLPQDKEYYK----VREPGESPIFWYAPESLTESKFSVASDVWSFG 198
Query: 171 VLLAE 175
V+L E
Sbjct: 199 VVLYE 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 28/180 (15%)
Query: 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILND--------- 78
E+ + SE L Q+ H +++ L ++ G LL+ E+ K GSL+ L +
Sbjct: 46 ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYL 105
Query: 79 VSRGRRQLDWL----ARYRTVRG-------IASGLEYLH----MHQAL----VLLDHDME 119
S G R +L R T+ I+ G++YL +H+ L VL+ +
Sbjct: 106 GSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK 165
Query: 120 ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+IS+FGL++ E +++ S ++A E T D++SFGVLL E ++L
Sbjct: 166 MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 225
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 3e-07
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 32/169 (18%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG--- 82
++ I+ EI L + RH NI+ R +V E+ GSLQDI V+RG
Sbjct: 41 GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLS 99
Query: 83 RRQLDWLARYRTVRGIASGLEYLH----MHQ----ALVLLDHDMEARISEFGLAKVFPEA 134
Q+ ++ R T++ GL YLH +H+ A +LL D + ++++FG++
Sbjct: 100 ELQIAYVCRE-TLK----GLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS------ 148
Query: 135 HTHITTS-----DVVGTAGYIAPEYQQTLSI---TYMCDIYSFGVLLAE 175
+T + +GT ++APE CDI++ G+ E
Sbjct: 149 -AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 28/161 (17%)
Query: 43 RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRR----------------QL 86
+H+NI+ LL + G ++ E+ G+L++ L R RR QL
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL----RARRPPGPDYTFDITKVPEEQL 131
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
+ +A G+EYL +H+ L VL+ D +I++FGLA+ + +
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
TS+ ++APE T+ D++SFG+L+ E +L
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-07
Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 27/174 (15%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+K+ +E + E++ L +++H NI+ A G +V E+ G D++ ++R
Sbjct: 36 TKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG---DLMKRINR 92
Query: 82 GR-------RQLDWLARYRTVRGIASGLEYLH----MH-----QALVLLDHDMEARISEF 125
R + L W + I+ GL+++H +H Q + L + M A++ +F
Sbjct: 93 QRGVLFSEDQILSWFVQ------ISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDF 146
Query: 126 GLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
G+A+ ++ T VGT Y++PE Q DI+S G +L E +L
Sbjct: 147 GIARQLNDSMELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 43/172 (25%), Positives = 68/172 (39%), Gaps = 39/172 (22%)
Query: 31 QIRSEIVTLGQIRHRNILPLLA---HLARPGCHLLVYEFMK---NGSLQDILNDVSRGRR 84
+I E+ L ++H N++ H + VY FM+ G+L+++L R
Sbjct: 45 EIADEMKVLELLKHPNLVKYYGVEVHREK------VYIFMEYCSGGTLEELL----EHGR 94
Query: 85 QLDWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHT 136
LD + GL YLH H A + LDH+ ++ +FG A T
Sbjct: 95 ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154
Query: 137 HITTS--DVVGTAGYIAPEYQQTLSITY--------MCDIYSFGVLLAEEMS 178
+ + GT Y+APE IT DI+S G ++ E +
Sbjct: 155 TMGEEVQSLAGTPAYMAPE-----VITGGKGKGHGRAADIWSLGCVVLEMAT 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 4e-07
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 26/167 (15%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLL-AHLAR--PGCH---LLVYEFMKNGSLQDILNDV 79
+E +I+ E L + H NI A + + PG LV E GS+ D++ +
Sbjct: 44 DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL 103
Query: 80 SRGRRQL--DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK 129
+ ++L +W+A Y +R GL YLH ++ + +LL + E ++ +FG++
Sbjct: 104 RKKGKRLKEEWIA-Y-ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
Query: 130 VFPEAHTHITTSDVVGTAGYIAPE-----YQQTLSITYMCDIYSFGV 171
T + +GT ++APE Q S D++S G+
Sbjct: 162 QL--DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-07
Identities = 45/142 (31%), Positives = 64/142 (45%), Gaps = 17/142 (11%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I GLE LH + + +LLD RIS+ GLA PE T VGT GY
Sbjct: 111 ICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGY 167
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEM---SLVKWMRNVMTSENPKRAIDSKLLGNGYE 206
+APE + T+ D ++ G LL E + S + + + E +R + K + Y
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KEVQEEYS 225
Query: 207 EQMLLVLKTACFCTL-DDPKER 227
E+ ++ C L DPKER
Sbjct: 226 EKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-07
Identities = 51/185 (27%), Positives = 83/185 (44%), Gaps = 27/185 (14%)
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------V 112
V E++ G D++ + R R+ + AR+ + I+ L YLH + V
Sbjct: 72 FFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNYLHERGIIYRDLKLDNV 127
Query: 113 LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172
LLD + +++++G+ K TTS GT YIAPE + + D ++ GVL
Sbjct: 128 LLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVL 185
Query: 173 LAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLL----------VLKTACFCTLD 222
+ E M+ V +S+NP + + L E+Q+ + VLK+ F
Sbjct: 186 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKS--FLN-K 242
Query: 223 DPKER 227
DPKER
Sbjct: 243 DPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-07
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 23/158 (14%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
QI EI L + H N++ G ++ EFM GSL+ G D
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQF 169
Query: 91 RYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSD 142
R I SG+ YLH +H+ + +L++ +I++FG++++ A T +
Sbjct: 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNS 227
Query: 143 VVGTAGYIAPEYQQT-----LSITYMCDIYSFGVLLAE 175
VGT Y++PE T Y DI+S GV + E
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 8e-07
Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 25/133 (18%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR--GRRQLDWLARY 92
EI L +H ++ LL +LV E+M L ++L D R Q+ R
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM 107
Query: 93 RTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVF----PEAHTHITT 140
+ G+ Y+H MH+ L +L+ D +I++FGLA++F P ++H
Sbjct: 108 -----LLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH--- 159
Query: 141 SDVVGTAGYIAPE 153
V T Y APE
Sbjct: 160 --QVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 8e-07
Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
I +EI+ + ++++ NI+ L +V E++ GSL D++ + Q+ + R
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR 122
Query: 92 YRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGL-AKVFPEAHTHITTSD 142
LE+LH +Q + VLL D ++++FG A++ PE S
Sbjct: 123 E-----CLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---ST 174
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAI 196
+VGT ++APE + DI+S G++ E + N ENP RA+
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 37/128 (28%), Positives = 56/128 (43%), Gaps = 32/128 (25%)
Query: 65 EFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH-----MHQAL----VLLD 115
E+M GSL IL +GR L + + GL YLH +H+ + +L++
Sbjct: 79 EYMDGGSLDKIL-KEVQGRIPERILGK--IAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135
Query: 116 HDMEARISEFG--------LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIY 167
+ ++ +FG LAK F VGT+ Y+APE Q + DI+
Sbjct: 136 SRGQIKLCDFGVSGQLVNSLAKTF------------VGTSSYMAPERIQGNDYSVKSDIW 183
Query: 168 SFGVLLAE 175
S G+ L E
Sbjct: 184 SLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-07
Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 20/167 (11%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRR 84
EE+ Q E + + H N+L LL L G L+V +MK+G L++ + +
Sbjct: 37 LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPT 96
Query: 85 QLDWLARYRTVRGIASGLEYL----HMHQALV----LLDHDMEARISEFGLA-----KVF 131
D + V A G+EYL +H+ L +LD ++++FGLA K +
Sbjct: 97 VKDLIGFGLQV---AKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153
Query: 132 PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
H H V ++A E QT T D++SFGVLL E M+
Sbjct: 154 YSVHNHTGAKLPVK---WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 9e-07
Identities = 25/88 (28%), Positives = 35/88 (39%), Gaps = 11/88 (12%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I LEYLH + +LLD I++F +A T+ GT GY
Sbjct: 109 IVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGY 165
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEM 177
+APE + D +S GV E +
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECL 193
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 41/194 (21%)
Query: 12 MDATALVEAD-SKLLTE-EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKN 69
DAT E D S L++E EMM+ +G+ H+NI+ LL + G +V E+ +
Sbjct: 52 DDAT---EKDLSDLVSEMEMMK------MIGK--HKNIINLLGVCTQEGPLYVVVEYAAH 100
Query: 70 GSLQDILNDVSRGRRQLDWLARYRTVR----------------GIASGLEYLH----MHQ 109
G+L+D L R RR A R +A G+E+L +H+
Sbjct: 101 GNLRDFL----RARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHR 156
Query: 110 AL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCD 165
L VL+ D +I++FGLA+ + T++ ++APE T+ D
Sbjct: 157 DLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSD 216
Query: 166 IYSFGVLLAEEMSL 179
++SFGVLL E +L
Sbjct: 217 VWSFGVLLWEIFTL 230
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
E + ++RH ++PL A ++ ++ V EFM GSL D L + +L L
Sbjct: 51 EAQIMKKLRHDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109
Query: 95 VRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGT 146
IA G+ Y+ ++H+ L +L+ ++ +I++FGLA++ E + +
Sbjct: 110 --QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFP 166
Query: 147 AGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ APE T D++SFG+LL E
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTE 195
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 46/183 (25%), Positives = 83/183 (45%), Gaps = 38/183 (20%)
Query: 35 EIVTLGQIRHRNILPLL-AHLARPGCHL-LVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E+V + +H NI+ + ++L G L +V EF++ G+L DI V+ R + +A
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLV--GDELWVVMEFLEGGALTDI---VTHTRMNEEQIA-- 118
Query: 93 RTV-RGIASGLEYLHMHQAL--------VLLDHDMEARISEFG----LAKVFPEAHTHIT 139
TV + L +LH + +LL D ++S+FG ++K P +
Sbjct: 119 -TVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--- 174
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM---------SLVKWMRNVMTSE 190
+VGT ++APE L DI+S G+++ E + ++ M+ + +
Sbjct: 175 ---LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL 231
Query: 191 NPK 193
PK
Sbjct: 232 PPK 234
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 29/178 (16%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+++ + SE+ + I +H+NI+ LL + G ++ E+ G+L++ L R RR
Sbjct: 62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRP 117
Query: 86 LDWLARYRTVR----------------GIASGLEYLH----MHQAL----VLLDHDMEAR 121
Y R +A G+EYL +H+ L VL+ + +
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMK 177
Query: 122 ISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
I++FGLA+ + T++ ++APE T+ D++SFGVL+ E +L
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-06
Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 17/173 (9%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLL--VYEFMKNGSLQDILNDV 79
+ +E Q+ SE+ L +++H NI+ + L V E+ + G L ++
Sbjct: 36 GNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKC 95
Query: 80 SRGRRQLD----W-------LARYRTVRGIASGLEYLH--MHQALVLLDHDMEARISEFG 126
+ R+ ++ W LA Y G LH + A + LD + ++ +FG
Sbjct: 96 KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
LAK+ H VGT Y++PE +S DI+S G L+ E +L
Sbjct: 156 LAKILG--HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-06
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 22/171 (12%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
SK+ +E + R E+ L ++H NI+ G +V ++ + G L +N R
Sbjct: 36 SKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINA-QR 94
Query: 82 G-----RRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLA 128
G + LDW + I L+++H + L + L D ++ +FG+A
Sbjct: 95 GVLFPEDQILDWFVQ------ICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIA 148
Query: 129 KVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+V T +GT Y++PE + DI++ G +L E +L
Sbjct: 149 RVL--NSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+E+ I+ EI L Q I + ++ E++ GS D+L G +
Sbjct: 44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEE 100
Query: 87 DWLARYRTVRGIASGLEYLH----MHQ----ALVLLDHDMEARISEFGLAKVFPEAHTHI 138
++A +R I GL+YLH +H+ A VLL + ++++FG+A + T I
Sbjct: 101 TYIAT--ILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQI 156
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ VGT ++APE + + + DI+S G+ E
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 2e-06
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 34/162 (20%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
+R EI L +++H NI+ LL + LV+E+ L+ L D G + +
Sbjct: 46 LR-EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPLSPNLIKS 102
Query: 92 YRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVF---PEAHTHITT 140
+ + GL Y H +H+ L +L++ D ++++FGLA+ F +TH
Sbjct: 103 I--MYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH--- 157
Query: 141 SDVVGTAGYIAPE-------YQQTLSITYMCDIYSFGVLLAE 175
+VV T Y APE Y + ++ DI+S G + AE
Sbjct: 158 -EVV-TLWYRAPEILLGSKHY--STAV----DIWSVGCIFAE 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 18/122 (14%)
Query: 62 LVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VL 113
LV E++ G ++ + G DW +Y + G+E LH +H+ + +L
Sbjct: 74 LVMEYLNGGDCASLIKTL--GGLPEDWAKQYIA--EVVLGVEDLHQRGIIHRDIKPENLL 129
Query: 114 LDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+D ++++FGL++ E VGT Y+APE + M D +S G ++
Sbjct: 130 IDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVI 183
Query: 174 AE 175
E
Sbjct: 184 FE 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 25/184 (13%)
Query: 8 VQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFM 67
V+ P+ L E S +E++ E + + H +++ LL + L+ + M
Sbjct: 35 VKIPVAIKVLREETSPKANKEILD---EAYVMASVDHPHVVRLLG-ICLSSQVQLITQLM 90
Query: 68 KNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQALVLLDHDMEAR------ 121
G L L+ V + + IA G+ YL + L+ D+ AR
Sbjct: 91 PLGCL---LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKT 144
Query: 122 -----ISEFGLAKVFP--EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174
I++FGLAK+ E H V ++A E T+ D++S+GV +
Sbjct: 145 PQHVKITDFGLAKLLDVDEKEYHAEGGKV--PIKWMALESILHRIYTHKSDVWSYGVTVW 202
Query: 175 EEMS 178
E M+
Sbjct: 203 ELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-06
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
I +EI+ + + ++ NI+ L +V E++ GSL D++ + Q+ + R
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 123
Query: 92 YRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGL-AKVFPEAHTHITTSD 142
LE+LH +Q + +LL D ++++FG A++ PE S
Sbjct: 124 E-----CLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---ST 175
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAI 196
+VGT ++APE + DI+S G++ E + N ENP RA+
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN----ENPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-06
Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 15/157 (9%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+E+ I+ EI L Q + + ++ E++ GS D+L Q+
Sbjct: 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI 103
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
+ +R I GL+YLH + + VLL E ++++FG+A + T I
Sbjct: 104 ATI-----LREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQI 156
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ VGT ++APE + + DI+S G+ E
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 20/153 (13%)
Query: 39 LGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRG- 97
LG H NI+ LL G L++ E+ G L + L RR+ + +
Sbjct: 95 LGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFL------RRKRESFLTLEDLLSF 146
Query: 98 ---IASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGT 146
+A G+ +L +H+ L VLL H +I +FGLA+ ++ +
Sbjct: 147 SYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 147 AGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
++APE T+ D++S+G+LL E SL
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-06
Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 37/183 (20%)
Query: 22 SKLLTE-EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
S L++E EMM++ +G +H+NI+ LL + G ++ E+ G+L++ L
Sbjct: 68 SDLISEMEMMKM------IG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL---- 115
Query: 81 RGRR----------------QLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDH 116
R RR QL + +A G+EYL +H+ L VL+
Sbjct: 116 RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175
Query: 117 DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176
D +I++FGLA+ + T++ ++APE T+ D++SFGVLL E
Sbjct: 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
Query: 177 MSL 179
+L
Sbjct: 236 FTL 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-06
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 16/166 (9%)
Query: 28 EMMQIRS------EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
EMM ++ EI L Q+ H N++ L +V E G L ++ +
Sbjct: 39 EMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKK 98
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH----MHQ----ALVLLDHDMEARISEFGLAKVFPE 133
+R + ++ + S +E++H MH+ A V + ++ + GL + F
Sbjct: 99 QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158
Query: 134 AHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
T +VGT Y++PE + DI+S G LL E +L
Sbjct: 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-06
Identities = 51/183 (27%), Positives = 85/183 (46%), Gaps = 37/183 (20%)
Query: 22 SKLLTE-EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
S L++E EMM++ +G +H+NI+ LL + G ++ E+ G+L++ L
Sbjct: 62 SDLVSEMEMMKM------IG--KHKNIINLLGACTQDGPLYVLVEYASKGNLREYL---- 109
Query: 81 RGRR----------------QLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDH 116
R RR QL + +A G+EYL +H+ L VL+
Sbjct: 110 RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169
Query: 117 DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176
D +I++FGLA+ + T++ ++APE T+ D++SFGVLL E
Sbjct: 170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
Query: 177 MSL 179
+L
Sbjct: 230 FTL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-06
Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
E + ++RH ++ L A ++ ++ V E+M GSL D L +L L
Sbjct: 51 EAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109
Query: 95 VRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGT 146
IASG+ Y+ ++H+ L +L+ ++ ++++FGLA++ E + +
Sbjct: 110 --QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFP 166
Query: 147 AGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ APE T D++SFG+LL E
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTE 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-06
Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 24/166 (14%)
Query: 28 EMMQIRS------EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
EMM ++ EI L Q+ H N++ LA +V E G L ++ +
Sbjct: 39 EMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKK 98
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH----MHQ----ALVLLDHDMEARISEFGLAKVFP- 132
+R + ++ + S LE++H MH+ A V + ++ + GL + F
Sbjct: 99 QKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158
Query: 133 ---EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
AH+ +VGT Y++PE + DI+S G LL E
Sbjct: 159 KTTAAHS------LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-06
Identities = 44/173 (25%), Positives = 80/173 (46%), Gaps = 16/173 (9%)
Query: 16 ALVEADSKLLTEEMMQIR---------SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEF 66
A V++ KL+ + M +R +E+V + +H N++ + +V EF
Sbjct: 39 ATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98
Query: 67 MKNGSLQDILNDVSRGRRQLD--WLARYRTVRGI-ASGLEYLHMHQALVLLDHDMEARIS 123
++ G+L DI+ Q+ LA + + + A G+ + + +LL HD ++S
Sbjct: 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 158
Query: 124 EFGL-AKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+FG A+V E +VGT ++APE L DI+S G+++ E
Sbjct: 159 DFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-06
Identities = 46/169 (27%), Positives = 72/169 (42%), Gaps = 24/169 (14%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLAR--PGCH----LLVYEFMKNGSLQDILNDV 79
+E +I+ EI L + HRNI + P H LV EF GS+ D++ +
Sbjct: 54 DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT 113
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF 131
+ DW+A R I GL +LH H+ + VLL + E ++ +FG++
Sbjct: 114 KGNALKEDWIA--YICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171
Query: 132 PEAHTHITTSDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAE 175
T +GT ++APE + Y DI+S G+ E
Sbjct: 172 DRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-06
Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 26/166 (15%)
Query: 27 EEMMQ-IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
EE+++ +R EI + ++ H +I+ +L L E+M GS+ +L+ G +
Sbjct: 44 EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFK 101
Query: 86 LDWLARYRTVRGIASGLEYLHMHQ--------ALVLLD---HDMEARISEFGLAKVFPEA 134
+ Y + GL YLH +Q A +L+D + RI++FG A
Sbjct: 102 EAVIINY--TEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRL--RIADFGAAA---RL 154
Query: 135 HTHITTSD-----VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
T + ++GT ++APE + CD++S G ++ E
Sbjct: 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-06
Identities = 38/153 (24%), Positives = 64/153 (41%), Gaps = 10/153 (6%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
EI L Q+ H N++ A +V E G L ++ + +R + ++
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 95 VRGIASGLEYLH----MHQ----ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGT 146
+ S LE++H MH+ A V + ++ + GL + F T +VGT
Sbjct: 112 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGT 169
Query: 147 AGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
Y++PE + DI+S G LL E +L
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-06
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 15/155 (9%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
E L Q H NI+ L+ + +V E + GSL L + + + +L +
Sbjct: 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQM 98
Query: 95 VRGIASGLEYLH----MHQALV----LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGT 146
A+G+EYL +H+ L L+ + +IS+FG+++ E T SD +
Sbjct: 99 SLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQ 156
Query: 147 --AGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ APE T D++S+G+LL E SL
Sbjct: 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-06
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGR-----RQLDWL 89
E + ++RH ++ L A ++ ++ V E+M GSL D L D GR +D
Sbjct: 51 EAQIMKKLRHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKD-GEGRALKLPNLVDMA 108
Query: 90 ARYRTVRGIASGLEYLH--MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTA 147
A+ + Y+H + A +L+ + +I++FGLA++ E + +
Sbjct: 109 AQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPI 167
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ APE T D++SFG+LL E
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTE 195
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-06
Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 30/128 (23%)
Query: 65 EFMKNGSLQDILNDV-SRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLD 115
E+ + GSL I V RG R + + + + GL YLH +H+ + +LL
Sbjct: 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLG-KIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139
Query: 116 HDMEARISEFG--------LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIY 167
+ ++ +FG LA F GT+ Y+APE Q + D++
Sbjct: 140 RKGQVKLCDFGVSGELVNSLAGTF------------TGTSFYMAPERIQGKPYSITSDVW 187
Query: 168 SFGVLLAE 175
S G+ L E
Sbjct: 188 SLGLTLLE 195
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-06
Identities = 42/143 (29%), Positives = 58/143 (40%), Gaps = 19/143 (13%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
+ GLE L + + +LLD RIS+ GLA PE T VGT GY
Sbjct: 111 LCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGY 167
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAE----EMSLVKWMRNVMTSENPKRAIDSKLLGNGY 205
+APE T+ D + G L+ E + K V E +R + + Y
Sbjct: 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ---EEY 224
Query: 206 EEQMLLVLKTACFCTL-DDPKER 227
E+ K+ C L +PKER
Sbjct: 225 SEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 40/171 (23%), Positives = 67/171 (39%), Gaps = 42/171 (24%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------- 81
E L +H NI+ ++V+E+M++G L L
Sbjct: 58 EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 82 --GRRQLDWLARYRTVRGIASGLEYL----HMHQALV----LLDHDMEARISEFGLAKVF 131
QL +A IASG+ YL +H+ L L+ +D+ +I +FG+++
Sbjct: 118 ELTLSQLLQIAVQ-----IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-- 170
Query: 132 PEAHTHITTSDVVGTAG-------YIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ T+D G ++ PE T D++SFGV+L E
Sbjct: 171 -----DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 15/157 (9%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+E+ I+ EI L Q + + ++ E++ GS D+L Q+
Sbjct: 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI 103
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
+ ++ I GL+YLH + + VLL + ++++FG+A + T I
Sbjct: 104 ATM-----LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQI 156
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ VGT ++APE Q + DI+S G+ E
Sbjct: 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 42/143 (29%), Positives = 58/143 (40%), Gaps = 19/143 (13%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I GLE LH + +LLD RIS+ GLA PE + VGT GY
Sbjct: 111 ILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGY 167
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMR----NVMTSENPKRAIDSKLLGNGY 205
+APE T D + G L+ E + R V E +R ++++ Y
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---EVY 224
Query: 206 EEQMLLVLKTACFCTL-DDPKER 227
+ K+ C L DPK+R
Sbjct: 225 SAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 18/166 (10%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+E + E+ ++ H N+L L +LLV EF G L++ L Q+
Sbjct: 37 DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQM 96
Query: 87 -DWLARYRTVRGIASGLEYLH----MHQALVL----LDHDMEARISEFGLA-KVFPEAHT 136
R +ASGL +LH +H L L L D+ +I ++GLA + +PE +
Sbjct: 97 AQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY- 155
Query: 137 HITTSDVVGTAGYIAPE----YQQTL---SITYMCDIYSFGVLLAE 175
+IT ++APE Q L T +I+S GV + E
Sbjct: 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 30/88 (34%), Positives = 41/88 (46%), Gaps = 14/88 (15%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTA 147
IA GL +LH + V+LD + +I++FG+ K +F TT GT
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFCGTP 165
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
YIAPE D ++FGVLL E
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYE 193
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-05
Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 24/169 (14%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLAR---PGCH---LLVYEFMKNGSLQDILNDV 79
+E +I+ EI L + HRNI + PG LV EF GS+ D++ +
Sbjct: 44 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 103
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF 131
+ +W+A R I GL +LH H+ + VLL + E ++ +FG++
Sbjct: 104 KGNTLKEEWIA--YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161
Query: 132 PEAHTHITTSDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAE 175
T +GT ++APE + + D++S G+ E
Sbjct: 162 DRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 47/192 (24%), Positives = 84/192 (43%), Gaps = 33/192 (17%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG--RR 84
EE+ EI L + +H NI+ L ++ EF G+L I+ ++ RG
Sbjct: 44 EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEP 103
Query: 85 QLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGL-AKVFPEAH 135
Q+ ++ R + L +LH H+ + +LL D + ++++FG+ AK
Sbjct: 104 QIRYVCRQ-----MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158
Query: 136 THITTSDVVGTAGYIAPEYQ--QTLSIT---YMCDIYSFGVLLAE---------EMSLVK 181
T +GT ++APE +T Y DI+S G+ L E E++ ++
Sbjct: 159 KRDT---FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215
Query: 182 WMRNVMTSENPK 193
+ ++ SE P
Sbjct: 216 VLLKILKSEPPT 227
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHL-LVYEFMKNGSLQDIL---NDVSRGRRQL 86
+I ++ +G + H I+ LL PG L LV + GSL D + D +R L
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
+W + IA G+ YL H+ + +LL D +I++FG+A +
Sbjct: 113 NWCVQ------IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
S+ ++A E T+ D++S+GV + E MS
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 39/134 (29%), Positives = 56/134 (41%), Gaps = 14/134 (10%)
Query: 51 LAHLARPGCHL-LVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH--- 106
LA+ HL LV M G L+ + +V G R L+ I G+ +LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 107 -----MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSIT 161
M VLLD R+S+ GLA + T + GT GY+APE + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYS 172
Query: 162 YMCDIYSFGVLLAE 175
Y D ++ G + E
Sbjct: 173 YPVDWFAMGCSIYE 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 30/88 (34%), Positives = 41/88 (46%), Gaps = 14/88 (15%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTA 147
I GL++LH + +LLD D +I++FG+ K + +A T GT
Sbjct: 105 IICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT----CTFCGTP 160
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
YIAPE D +SFGVLL E
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYE 188
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 31/164 (18%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
IR EI L ++ H NI+ LL + LV+EF+ + L+ ++ L +
Sbjct: 47 IR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKS 104
Query: 92 YRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF--P-EAHTHITT 140
Y + + GL + H H+ L +L++ + ++++FGLA+ F P +TH
Sbjct: 105 Y--LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--- 159
Query: 141 SDVVGTAGYIAPE------YQQTLSITYMCDIYSFGVLLAEEMS 178
+VV T Y APE Y T DI+S G + AE ++
Sbjct: 160 -EVV-TLWYRAPEILLGCKYYST-----AVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-05
Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 21/174 (12%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
I +EI+ + + ++ NI+ L +V E++ GSL D++ + Q+ + R
Sbjct: 63 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR 122
Query: 92 YRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGL-AKVFPEAHTHITTSD 142
L++LH +Q + +LL D ++++FG A++ PE S
Sbjct: 123 E-----CLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---ST 174
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAI 196
+VGT ++APE + DI+S G++ E + N ENP RA+
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 39/128 (30%), Positives = 59/128 (46%), Gaps = 18/128 (14%)
Query: 62 LVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VL 113
LV E++ G L +L +V G D AR I LEYLH +H+ L +L
Sbjct: 70 LVMEYLPGGDLASLLENV--GSLDEDV-ARIYIAE-IVLALEYLHSNGIIHRDLKPDNIL 125
Query: 114 LDHDMEARISEFGLAKV-FPEAHTHIT-----TSDVVGTAGYIAPEYQQTLSITYMCDIY 167
+D + ++++FGL+KV ++ +VGT YIAPE + D +
Sbjct: 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWW 185
Query: 168 SFGVLLAE 175
S G +L E
Sbjct: 186 SLGCILYE 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 31/86 (36%), Positives = 40/86 (46%), Gaps = 11/86 (12%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I GLE LH + + +LLD RIS+ GLA PE T VGT GY
Sbjct: 111 ITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGY 167
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAE 175
+APE + T+ D + G L+ E
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYE 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 46/189 (24%), Positives = 87/189 (46%), Gaps = 41/189 (21%)
Query: 2 IAIRKIVQPPMDATA-LVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
+AI+ + Q M A L EA+ +M+ Q++H ++ L A + + +
Sbjct: 33 VAIKSLKQGSMSPEAFLAEAN-------LMK---------QLQHPRLVRLYAVVTQEPIY 76
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL----HMHQAL----V 112
+ + E+M+NGSL D L + ++ L IA G+ ++ ++H+ L +
Sbjct: 77 I-ITEYMENGSLVDFLKTPEGIKLTINKLIDMAA--QIAEGMAFIERKNYIHRDLRAANI 133
Query: 113 LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAG------YIAPEYQQTLSITYMCDI 166
L+ + +I++FGLA++ I ++ G + APE + T D+
Sbjct: 134 LVSETLCCKIADFGLARL-------IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 167 YSFGVLLAE 175
+SFG+LL E
Sbjct: 187 WSFGILLTE 195
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 40/171 (23%), Positives = 71/171 (41%), Gaps = 33/171 (19%)
Query: 30 MQIRSEIVTLGQIRH----RNILPLLAH--LARPGC------HL-LVYEFMKNGSLQDIL 76
M I E++ L Q +H + +L ++H + R L ++ E++ G L L
Sbjct: 34 MAIP-EVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL 92
Query: 77 NDVSRGRRQL-DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGL 127
R + + + I LEYLH + + +LLD + ++++FG
Sbjct: 93 ----RNSGRFSNSTGLFYASE-IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGF 147
Query: 128 AKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
AK T + GT Y+APE Q+ D ++ G+L+ E +
Sbjct: 148 AK-----KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 34/122 (27%), Positives = 57/122 (46%), Gaps = 12/122 (9%)
Query: 62 LVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VL 113
+V E+ +NG L +L + RGR + +R I GL +LH + L +
Sbjct: 76 IVMEYAENGDLHKLLK-MQRGRPLPEDQV-WRFFIQILLGLAHLHSKKILHRDIKSLNLF 133
Query: 114 LDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
LD +I + G+AK+ + T +VGT Y++PE + D+++ GV+L
Sbjct: 134 LDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVL 191
Query: 174 AE 175
E
Sbjct: 192 YE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 29/82 (35%), Positives = 42/82 (51%), Gaps = 13/82 (15%)
Query: 101 GLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152
GLE++H + A +LLD RIS+ GLA F + H + VGT GY+AP
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAP 164
Query: 153 E-YQQTLSITYMCDIYSFGVLL 173
E Q+ ++ D +S G +L
Sbjct: 165 EVLQKGVAYDSSADWFSLGCML 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-05
Identities = 43/168 (25%), Positives = 70/168 (41%), Gaps = 24/168 (14%)
Query: 33 RSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDIL------------ND 78
R E + ++H NI+ LL + P C L +E++ +G L + L +
Sbjct: 56 RQEAELMSDLQHPNIVCLLGVCTKEQPTCML--FEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 79 VSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKV 130
+ LD IA+G+EYL H + L+ + +IS+FGL++
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 131 FPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
A + S + ++ PE T DI+SFGV+L E S
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-05
Identities = 37/128 (28%), Positives = 60/128 (46%), Gaps = 18/128 (14%)
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------V 112
LV E++ G D++ + R R+ + AR+ I L +LH + V
Sbjct: 72 FLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAE-ICIALNFLHERGIIYRDLKLDNV 127
Query: 113 LLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170
LLD D +++++G+ K + P TTS GT YIAPE + + D ++ G
Sbjct: 128 LLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEILRGEEYGFSVDWWALG 183
Query: 171 VLLAEEMS 178
VL+ E M+
Sbjct: 184 VLMFEMMA 191
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 4e-05
Identities = 36/125 (28%), Positives = 62/125 (49%), Gaps = 14/125 (11%)
Query: 62 LVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VL 113
V EF+ G D++ + R R+ + AR+ + I+ L +LH +++ L VL
Sbjct: 73 FVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAE-ISLALNFLHERGIIYRDLKLDNVL 128
Query: 114 LDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
LD + +++++G+ K TTS GT YIAPE + + D ++ GVL+
Sbjct: 129 LDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLM 186
Query: 174 AEEMS 178
E M+
Sbjct: 187 FEMMA 191
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 31/127 (24%), Positives = 51/127 (40%), Gaps = 13/127 (10%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
E+ L Q+RH NI+ L R G LV+E+++ + +L + L A
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE----RTLLELLEASPGGLPPDAVRSY 105
Query: 95 VRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGT 146
+ + + Y H H + +L+ ++ +FG A+ T D V T
Sbjct: 106 IWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT-DYVAT 164
Query: 147 AGYIAPE 153
Y APE
Sbjct: 165 RWYRAPE 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-05
Identities = 37/160 (23%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 33 RSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGR-----RQLD 87
R E V L +++H NI+ G +V E+ G L + RG+ L
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL-QRGKLFPEDTILQ 104
Query: 88 WLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHIT 139
W + + G++++H + L + L + + ++ +FG A++ +
Sbjct: 105 WFVQ------MCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
T VGT Y+ PE + + DI+S G +L E +L
Sbjct: 159 T--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 40/163 (24%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHL-------LVYEFMKNGSLQDILNDVSRGRRQLD 87
E+ L + H N++ LL + P L LV M D LN++ + ++ D
Sbjct: 64 ELRLLKHMDHENVIGLL-DVFTPASSLEDFQDVYLVTHLMG----AD-LNNIVKCQKLSD 117
Query: 88 WLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHIT 139
++ V I GL+Y+H +H+ L + ++ D E +I +FGLA+ HT
Sbjct: 118 DHIQF-LVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDE 171
Query: 140 TSDVVGTAGYIAPE-------YQQTLSITYMCDIYSFGVLLAE 175
+ V T Y APE Y QT+ DI+S G ++AE
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 30/85 (35%), Positives = 42/85 (49%), Gaps = 13/85 (15%)
Query: 98 IASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I GLE++H + A +LLD RIS+ GLA F + H + VGT GY
Sbjct: 106 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161
Query: 150 IAPE-YQQTLSITYMCDIYSFGVLL 173
+APE Q+ + D +S G +L
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCML 186
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-05
Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 30/145 (20%)
Query: 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL------LVYEFMKNGSLQDIL 76
K E+ I E+ L Q+RH N + GC+L LV E+ GS DIL
Sbjct: 53 KQSNEKWQDIIKEVRFLQQLRHPNTIEY------KGCYLREHTAWLVMEYCL-GSASDIL 105
Query: 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLA 128
+ ++++ A G GL YLH H+ + +LL ++++FG A
Sbjct: 106 EVHKKPLQEVEIAA---ICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA 162
Query: 129 KVFPEAHTHITTSDVVGTAGYIAPE 153
+ A++ VGT ++APE
Sbjct: 163 SLVSPANS------FVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 7e-05
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL-LVYEFMKNGSLQDILNDVSRGRRQ 85
+E+ I+ EI L Q R I + G L ++ E+ GS D+L
Sbjct: 41 DEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIMEYCGGGSCLDLLKPGKLDETY 99
Query: 86 LDWLARYRTVRGIASGLEYLH----MHQ----ALVLLDHDMEARISEFGLAKVFPEAHTH 137
+ ++ R + GLEYLH +H+ A +LL + + ++++FG++ T
Sbjct: 100 IAFILRE-----VLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL--TSTM 152
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE------EMSLVKWMRNVMTSEN 191
+ VGT ++APE + DI+S G+ E +S + MR V+
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-VLF-LI 210
Query: 192 PKRAIDSKLLGNGYEEQMLLVLKTACFCTLD-DPKER 227
PK S L GN + + K L+ DPKER
Sbjct: 211 PKNNPPS-LEGNKFSKP----FKDFVSLCLNKDPKER 242
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 19/166 (11%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDIL-NDVSRGRR 84
E++ ++ EI+T Q++H NILP + +V M GS +D+L G
Sbjct: 40 KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-- 97
Query: 85 QLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPE--- 133
L LA ++ + + L+Y+H +H+++ +LL D + +S + +
Sbjct: 98 -LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK 156
Query: 134 --AHTHITTSDVVGTAGYIAPE--YQQTLSITYMCDIYSFGVLLAE 175
H V +++PE Q DIYS G+ E
Sbjct: 157 RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACE 202
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-05
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 33/160 (20%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHL----LVYEFMKNGSLQDILNDVSR--GRRQLDW 88
EI L +RH NI+ L + G HL LV E+ + L +L+++ Q+
Sbjct: 56 EITLLLNLRHPNIVELKEVVV--GKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKC 112
Query: 89 LARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITT 140
L + + GL+YLH +H+ L +LL +I++FGLA+ + T
Sbjct: 113 L-----MLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMT 166
Query: 141 SDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAE 175
VV T Y APE T +I D+++ G +LAE
Sbjct: 167 PKVV-TLWYRAPELLLGCTTYTTAI----DMWAVGCILAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-05
Identities = 45/181 (24%), Positives = 76/181 (41%), Gaps = 21/181 (11%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
E+ ++ EI+ + +H NI+ R + EF GSLQDI + L
Sbjct: 48 EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PL 103
Query: 87 DWLARYRTVRGIASGLEYLH----MHQ----ALVLLDHDMEARISEFGLAKVFPEAHTHI 138
R GL YLH MH+ A +LL + ++++FG++ T
Sbjct: 104 SESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI--TATIA 161
Query: 139 TTSDVVGTAGYIAPE---YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRA 195
+GT ++APE ++ +CDI++ G+ E L M ++ +P RA
Sbjct: 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDL----HPMRA 217
Query: 196 I 196
+
Sbjct: 218 L 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 9e-05
Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 14/160 (8%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH--LLVYEFMKNGSLQDILNDVSRGRR 84
+ ++ EI L + H NI+ G + L+ EF+ +GSL++ L R +
Sbjct: 48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKN 104
Query: 85 QLDWLARYRTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHT 136
+++ + + I G++YL ++H+ L VL++ + + +I +FGL K
Sbjct: 105 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164
Query: 137 HITTSDVVGTAGY-IAPEYQQTLSITYMCDIYSFGVLLAE 175
+ T D + + + APE D++SFGV L E
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 1e-04
Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 29/161 (18%)
Query: 32 IRSEIVTLGQIRHRNILPL--LAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWL 89
IR EI L ++RH NI+ L + G +V+E+M + L +L+ + +
Sbjct: 46 IR-EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE-VKFTESQI 102
Query: 90 ARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTS 141
Y ++ + GL+YLH +H+ + +L+++D ++++FGLA+ + + ++ T+
Sbjct: 103 KCY--MKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160
Query: 142 DVVGTAGYIAPE-------YQQTLSITYMCDIYSFGVLLAE 175
V+ T Y PE Y D++S G +LAE
Sbjct: 161 RVI-TLWYRPPELLLGATRY------GPEVDMWSVGCILAE 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 45/193 (23%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
++AI+K ++ D K++ + M+ EI L Q+RH N++ L+ R
Sbjct: 28 IVAIKKFLESE---------DDKMVKKIAMR---EIRMLKQLRHENLVNLIEVFRRKKRL 75
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------V 112
LV+EF+ + +L+D+ + LD + + I G+E+ H H + +
Sbjct: 76 YLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131
Query: 113 LLDHDMEARISEFGLAKVFP---EAHTHITTSDVVGTAGYIAPE-------YQQTLSITY 162
L+ ++ +FG A+ E +T D V T Y APE Y + +
Sbjct: 132 LVSQSGVVKLCDFGFARTLAAPGEVYT-----DYVATRWYRAPELLVGDTKYGRAV---- 182
Query: 163 MCDIYSFGVLLAE 175
DI++ G L+ E
Sbjct: 183 --DIWAVGCLVTE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 15/90 (16%)
Query: 96 RGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTA 147
R + G+++LH H+ + +L+ D + +I++FGLA+++ +T+ VV T
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTS--VVVTL 170
Query: 148 GYIAPEYQQTLSITYM--CDIYSFGVLLAE 175
Y APE L +Y D++S G + AE
Sbjct: 171 WYRAPEV--LLQSSYATPVDMWSVGCIFAE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 32/209 (15%)
Query: 14 ATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQ 73
A ++E S+ EE+ EI L H I+ LL G ++ EF G++
Sbjct: 41 AAKVIETKSE---EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVD 97
Query: 74 DILNDVSRGRRQLDWLARYRTV-RGIASGLEYLH----MHQAL----VLLDHDMEARISE 124
I+ ++ RG + + + + R + L+YLH +H+ L VLL D + ++++
Sbjct: 98 AIMLELDRGLTE----PQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLAD 153
Query: 125 FGLAKVFPEAHTHITTSDVVGTAGYIAPEYQ--QTLSIT---YMCDIYSFGVLLAE---- 175
FG++ T +GT ++APE +T+ T Y DI+S G+ L E
Sbjct: 154 FGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 211
Query: 176 -----EMSLVKWMRNVMTSENPKRAIDSK 199
E++ ++ + + SE P + SK
Sbjct: 212 EPPHHELNPMRVLLKIAKSEPPTLSQPSK 240
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 50/199 (25%), Positives = 80/199 (40%), Gaps = 59/199 (29%)
Query: 29 MMQIR-SEIVTLGQIRH----RNIL-----PLLAHLARPGC------HL-LVYEFMKNGS 71
M +R S+++ QI H R+IL P + L HL LV E+M G
Sbjct: 31 MKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY---YSFQDEEHLYLVMEYMPGG- 86
Query: 72 LQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARIS 123
D++N + R + AR+ + + L+ +H +H+ + +L+D D +++
Sbjct: 87 --DLMNLLIRKDVFPEETARFYIAELVLA-LDSVHKLGFIHRDIKPDNILIDADGHIKLA 143
Query: 124 EFGLAKVFPEAH--------THITTSD-------------------VVGTAGYIAPEYQQ 156
+FGL K +A +H VGT YIAPE +
Sbjct: 144 DFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR 203
Query: 157 TLSITYMCDIYSFGVLLAE 175
CD +S GV+L E
Sbjct: 204 GTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 33/132 (25%), Positives = 57/132 (43%), Gaps = 20/132 (15%)
Query: 62 LVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VL 113
+V E+M NG L LN + ++ + + G+ YL Q + L
Sbjct: 76 IVTEYMSNGCL---LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCL 132
Query: 114 LDHDMEARISEFGLAK-VFPEAHTHITTSDVVGT---AGYIAPEYQQTLSITYMCDIYSF 169
+D ++S+FGL++ V + +T VG+ + PE + D+++F
Sbjct: 133 VDDQGCVKVSDFGLSRYVLDDEYT-----SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAF 187
Query: 170 GVLLAEEMSLVK 181
GVL+ E SL K
Sbjct: 188 GVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 38/151 (25%), Positives = 66/151 (43%), Gaps = 17/151 (11%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
+E+V + H N++ + +V EF++ G+L DI+ Q+
Sbjct: 68 NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----T 122
Query: 94 TVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGL-AKVFPEAHTHITTSDVV 144
+ L YLH +H+ + +LL D ++S+FG A+V E +V
Sbjct: 123 VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLV 179
Query: 145 GTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
GT ++APE L DI+S G+++ E
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 32/190 (16%)
Query: 4 IRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLV 63
+RKI P DA L K+L + +++R + T + R+IL A + P L
Sbjct: 15 VRKITGP--DAGQLYAM--KVLKKATLKVRDRVRTKME---RDIL---AEVNHPFIVKLH 64
Query: 64 YEFMKNGSLQDILNDVSRG-----RRQLDWLARYRTVR----GIASGLEYLH----MHQA 110
Y F G L IL D RG R + + V+ +A L++LH +++
Sbjct: 65 YAFQTEGKLYLIL-DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 123
Query: 111 L----VLLDHDMEARISEFGLAKVFPEAHTHIT-TSDVVGTAGYIAPEYQQTLSITYMCD 165
L +LLD + ++++FGL+K E+ H GT Y+APE T D
Sbjct: 124 LKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD 180
Query: 166 IYSFGVLLAE 175
+SFGVL+ E
Sbjct: 181 WWSFGVLMFE 190
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 27/173 (15%)
Query: 23 KLLTEEMMQIRSEIV-TLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
K+L+++ + + E+ T+G+ RNIL P L + F + L + + +S
Sbjct: 24 KVLSKKEIVAKKEVAHTIGE---RNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80
Query: 82 GRRQLDWL----ARYRTVRG---IAS---GLEYLHMHQAL--------VLLDHDMEARIS 123
G +L W R+ R IA LE+LH + + +LLD +
Sbjct: 81 G--ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALC 138
Query: 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPE-YQQTLSITYMCDIYSFGVLLAE 175
+FGL+K + TT+ GT Y+APE T D +S GVL+ E
Sbjct: 139 DFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 30/195 (15%)
Query: 9 QPPMDATALVEAD-SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFM 67
QP + A ++ AD +K + ++ EI + ++++ NI+ LL ++ E+M
Sbjct: 43 QPVLVAVKMLRADVTKTARNDFLK---EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYM 99
Query: 68 KNGSLQDIL-------------NDVSRGRRQLDWLARYRTVRGIASGLEYL----HMHQA 110
+NG L L N S L ++A IASG++YL +H+
Sbjct: 100 ENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ-----IASGMKYLASLNFVHRD 154
Query: 111 LV----LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDI 166
L L+ + +I++FG+++ + V ++A E T D+
Sbjct: 155 LATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV 214
Query: 167 YSFGVLLAEEMSLVK 181
++FGV L E +L K
Sbjct: 215 WAFGVTLWEMFTLCK 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 43/159 (27%), Positives = 64/159 (40%), Gaps = 14/159 (8%)
Query: 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLD 87
E+ +E L Q+ I+PL P LV F+ G L + + R R
Sbjct: 36 EVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL---FHHLQREGRFDL 92
Query: 88 WLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHIT 139
AR+ T + LE LH + +LLD+ + +FGL K+
Sbjct: 93 SRARFYTAE-LLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDK 149
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
T+ GT Y+APE T D ++ GVLL E ++
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 35/125 (28%), Positives = 60/125 (48%), Gaps = 12/125 (9%)
Query: 64 YEFMKNGSLQDILND-VSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL 114
Y+ + ++++L+D S G LD L+ V A G+E+L +H+ L VLL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQV---ARGMEFLASKNCVHRDLAARNVLL 270
Query: 115 DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174
+I +FGLA+ +++ ++APE T + D++S+G+LL
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330
Query: 175 EEMSL 179
E SL
Sbjct: 331 EIFSL 335
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 28/84 (33%), Positives = 41/84 (48%), Gaps = 12/84 (14%)
Query: 101 GLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI-TTSDVVGTAGYIA 151
GL+YLH ++ + +LLD + +I++FGL K E TS GT ++A
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLA 169
Query: 152 PEYQQTLSITYMCDIYSFGVLLAE 175
PE S T D + GVL+ E
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYE 193
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 5e-04
Identities = 37/140 (26%), Positives = 59/140 (42%), Gaps = 17/140 (12%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+E M+ E ++H N+L L +LLV EF G L+ L R R+
Sbjct: 37 QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYL----RSCRKA 92
Query: 87 DWLA-----RYRTVRGIASGLEYLHMHQ------AL--VLLDHDMEARISEFGLAKVFPE 133
+ + R IA GL +LH + AL LL D+ +I ++GL+ +
Sbjct: 93 ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK 152
Query: 134 AHTHITTSDVVGTAGYIAPE 153
++T + +IAPE
Sbjct: 153 EDYYVTPDQLWVPLRWIAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 13/81 (16%)
Query: 103 EYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEY 154
EYLH +++ L +LLD+ ++++FG AK P+ T + GT Y+APE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGTPEYLAPEV 186
Query: 155 QQTLSITYMCDIYSFGVLLAE 175
Q+ D ++ GVLL E
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYE 207
|
Length = 329 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 22/157 (14%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
IR EI L +++H NI+ L L + L++EF+ + L+ L+ + +G + +D
Sbjct: 47 IR-EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKG-QYMDAELV 103
Query: 92 YRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF--P-EAHTHITT 140
+ I G+ + H + L +L+D+ ++++FGLA+ F P +TH
Sbjct: 104 KSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH--- 160
Query: 141 SDVVGTAGYIAPEYQQTLSITYMC--DIYSFGVLLAE 175
+VV T Y APE S Y DI+S G + AE
Sbjct: 161 -EVV-TLWYRAPEVLLG-SPRYSTPVDIWSIGTIFAE 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 5e-04
Identities = 32/106 (30%), Positives = 44/106 (41%), Gaps = 11/106 (10%)
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFP 132
R R + AR+ IAS L YLH + +LLD +++FGL K
Sbjct: 89 RERSFPEPRARFYAAE-IASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI 147
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
E TTS GT Y+APE + D + G +L E +
Sbjct: 148 EHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY 191
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 5e-04
Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 14/161 (8%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+ + + EI ++HRNI+ L + G + E + GSL +L +
Sbjct: 46 SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD 105
Query: 86 LDWLARYRTVRGIASGLEYLHMHQAL--------VLLD-HDMEARISEFGLAKVFPEAHT 136
+ + T + I GL+YLH +Q + VL++ + +IS+FG +K A
Sbjct: 106 NEQTIIFYT-KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGI 162
Query: 137 HITTSDVVGTAGYIAPEYQQTLSITY--MCDIYSFGVLLAE 175
+ T GT Y+APE Y DI+S G + E
Sbjct: 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVE 203
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 6e-04
Identities = 38/169 (22%), Positives = 75/169 (44%), Gaps = 32/169 (18%)
Query: 28 EMMQIR---------SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILND 78
+MM +R +E+V + +H+N++ + ++ EF++ G+L DI++
Sbjct: 52 KMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ 111
Query: 79 VSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFG---- 126
Q+ + L YLH +H+ + +LL D ++S+FG
Sbjct: 112 TRLNEEQIA-----TVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQ 166
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
++K P+ + +VGT ++APE DI+S G+++ E
Sbjct: 167 ISKDVPKRKS------LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 33/175 (18%)
Query: 24 LLTEEMMQIRSEIVTLGQIRHRNILPLL-AHLARPGCHLLVYEFMKNGSLQDILNDVSRG 82
LL E + L + H+NILP+L + ++Y +M G+L+ L G
Sbjct: 55 LLQESCL--------LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG 106
Query: 83 ---------RRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEF 125
+QL +A IA G+ YLH + ++D +++ +I++
Sbjct: 107 EANNPQALSTQQLVHMAIQ-----IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161
Query: 126 GLAK-VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
L++ +FP H + ++A E + D++SFGVLL E M+L
Sbjct: 162 ALSRDLFP-MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 6e-04
Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
EE M +R E+ +L ++ H NI+ L V+E+M+ Q + R +
Sbjct: 40 EECMNLR-EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLM---KDRKGKP 95
Query: 86 LDWLARYRTVRGI----ASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPE 133
+R I GL ++H H+ L +L+ +I++FGLA+ E
Sbjct: 96 FS----ESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR---E 148
Query: 134 AHTHITTSDVVGTAGYIAPEYQQTL--SITYMC--DIYSFGVLLAE 175
+ +D V T Y APE L S +Y DI++ G ++AE
Sbjct: 149 IRSRPPYTDYVSTRWYRAPE---ILLRSTSYSSPVDIWALGCIMAE 191
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 7e-04
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 22/157 (14%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHL----LVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
E+ L +H NI+ + L PG +V + M++ L I++ S +
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIH--SDQPLTEE-HI 109
Query: 91 RYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKV---FPEAHTHIT 139
RY + + GL+Y+H +H+ L +L++ D E RI +FG+A+ P H +
Sbjct: 110 RYFLYQ-LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 140 TSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAE 175
T V T Y APE +L T D++S G + AE
Sbjct: 169 TE-YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 7e-04
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 26/156 (16%)
Query: 41 QIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100
++ H N++ L + +V E+M NG L + L + +G+ +WL +
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWL--LDMCSDVCE 111
Query: 101 GLEYLHMHQALVLLDHDMEAR-----------ISEFGLAK-VFPEAHTHITTSDVVGTAG 148
+EYL + + D+ AR +S+FGLA+ V + +T GT
Sbjct: 112 AMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-----SSQGTKF 163
Query: 149 YI---APEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181
+ PE + D++SFGVL+ E S K
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 7e-04
Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 27/164 (16%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCH------LLVYEFMKNGSLQDIL--NDVSRG 82
+I EI L +RH +I+ + H+ P +V+E M++ Q I +D++
Sbjct: 45 RILREIKLLRLLRHPDIVEIK-HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 103
Query: 83 RRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKV-FPE 133
Q +L Y+ +R L+Y+H H+ L +L + D + +I +FGLA+V F +
Sbjct: 104 HHQF-FL--YQLLRA----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156
Query: 134 AHTHITTSDVVGTAGYIAPEYQQTLSITYM--CDIYSFGVLLAE 175
T I +D V T Y APE + Y DI+S G + AE
Sbjct: 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 200
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 8e-04
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 29/160 (18%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEF--MKNGSLQDILNDVSRGRRQLDWL 89
IR EI L ++ H NI+ LL + LV+EF + D +
Sbjct: 46 IR-EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSY 104
Query: 90 ARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF--P-EAHTHI 138
Y+ ++GIA Y H H+ L +L+D + ++++FGLA+ F P +TH
Sbjct: 105 L-YQLLQGIA----YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH- 158
Query: 139 TTSDVVGTAGYIAPEY---QQTLSITYMCDIYSFGVLLAE 175
+VV T Y APE + S DI+S G + AE
Sbjct: 159 ---EVV-TLWYRAPEILLGSRQYSTP--VDIWSIGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 8e-04
Identities = 29/89 (32%), Positives = 42/89 (47%), Gaps = 10/89 (11%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
IA GL +LH + V+LD + +I++FG+ K +TT GT Y
Sbjct: 110 IAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDY 167
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
IAPE D ++FGVLL E ++
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.001
Identities = 40/172 (23%), Positives = 73/172 (42%), Gaps = 40/172 (23%)
Query: 35 EIVTLGQIRHRNILPLL--------AHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
EI L +++H N++PL+ + G +V +M + L +L + +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTE 114
Query: 87 DWLARYRTVRGIASGLEYLH----MHQ----ALVLLDHDMEARISEFGLAKVF------- 131
+ Y + + G+ YLH +H+ A +L+D+ +I++FGLA+ +
Sbjct: 115 SQIKCY--MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 132 ---PEAHTHITTSDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAE 175
T T+ VV T Y PE + T ++ DI+ G + AE
Sbjct: 173 KGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAV----DIWGIGCVFAE 219
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.001
Identities = 39/169 (23%), Positives = 71/169 (42%), Gaps = 25/169 (14%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLV--------YEFMKNGSLQDILN 77
+ +Q+ +EI+ LG++ H NIL + L ++ Y FM + +
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD--WK 261
Query: 78 DVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAK 129
D R L R ++ + +EY+H +H+ + + L+ D + + +FG A
Sbjct: 262 D-----RPLLKQTR-AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAM 315
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
F E VGT +PE + DI+S G++L + +S
Sbjct: 316 PF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.001
Identities = 17/41 (41%), Positives = 21/41 (51%)
Query: 135 HTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
H +VGT YIAPE T +CD +S GV+L E
Sbjct: 196 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 45/150 (30%), Positives = 63/150 (42%), Gaps = 26/150 (17%)
Query: 45 RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS---------RGRRQLDWLARYRTV 95
RN+L L +L P L Y F L +L+ V+ R R L+ AR+
Sbjct: 46 RNVL--LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA 103
Query: 96 RGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVG 145
+AS + YLH + +LLD +++FGL K V PE TTS G
Sbjct: 104 E-VASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE----TTSTFCG 158
Query: 146 TAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
T Y+APE + D + G +L E
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 21/94 (22%)
Query: 98 IASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHT----HITTSDVVG 145
I GL+Y+H +H+ L +L++ D E +I +FGLA+ F E +T + V
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT--EYVA 171
Query: 146 TAGYIAPE----YQQTLSITYMCDIYSFGVLLAE 175
T Y APE +Q S T D++S G +LAE
Sbjct: 172 TRWYRAPEIMLSFQ---SYTKAIDVWSVGCILAE 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 37/126 (29%), Positives = 53/126 (42%), Gaps = 18/126 (14%)
Query: 62 LVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VL 113
V E+ G L +SR R + AR+ I S LEYLH + ++
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFTEERARFYGAE-IVSALEYLHSRDVVYRDIKLENLM 127
Query: 114 LDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171
LD D +I++FGL K + A T GT Y+APE + D + GV
Sbjct: 128 LDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183
Query: 172 LLAEEM 177
++ E M
Sbjct: 184 VMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.001
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 26/166 (15%)
Query: 34 SEIVTLGQIRHRNILPLL------AHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLD 87
SE + H N++ L+ + L + +++ FMK+G L L SR +
Sbjct: 50 SEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPE 108
Query: 88 WLARYRTVR---GIASGLEYLH----MHQALV----LLDHDMEARISEFGLA-KVFPEAH 135
L ++ IA G+EYL +H+ L +L DM +++FGL+ K++ +
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168
Query: 136 ---THITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
I V +IA E T D+++FGV + E +
Sbjct: 169 YRQGRIAKMPV----KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 28/160 (17%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNG--SLQDILNDVSRGRRQLDWL 89
IR EI L +++H NI+ L + LV+E++ D D ++ R +
Sbjct: 49 IR-EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTY 107
Query: 90 ARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEA-RISEFGLAKVFP---EAHTH 137
Y+ +RGIA Y H H+ L +L+D A ++++FGLA+ F TH
Sbjct: 108 L-YQILRGIA----YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYM--CDIYSFGVLLAE 175
+VV T Y APE S Y DI+S G + AE
Sbjct: 163 ----EVV-TLWYRAPEILLG-SRHYSTPVDIWSVGCIFAE 196
|
Length = 294 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.002
Identities = 26/88 (29%), Positives = 37/88 (42%), Gaps = 10/88 (11%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I S L YLH + ++LD D +I++FGL K T GT Y
Sbjct: 104 IVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEY 161
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEM 177
+APE + D + GV++ E M
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 29/160 (18%)
Query: 98 IASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
+A G+++L +H+ + VLL A+I +FGLA+ ++ + +
Sbjct: 221 VAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKW 280
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSK---LLGNGYE 206
+APE T D++S+G+LL E SL K S P ++SK ++ GY+
Sbjct: 281 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGK-------SPYPGILVNSKFYKMVKRGYQ 333
Query: 207 --------EQMLLVLKTACFCTLDDPKERHVRCMLSQIQQ 238
++ ++K C +P ER +SQ+ Q
Sbjct: 334 MSRPDFAPPEIYSIMKM---CWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 32/119 (26%), Positives = 55/119 (46%), Gaps = 18/119 (15%)
Query: 98 IASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
+A G+ +L +H+ L +LL H +I +FGLA+ ++ + +
Sbjct: 223 VAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKW 282
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDS---KLLGNGY 205
+APE T+ D++S+G+LL E SL +S P +DS K++ GY
Sbjct: 283 MAPESIFNCVYTFESDVWSYGILLWEIFSL-------GSSPYPGMPVDSKFYKMIKEGY 334
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.002
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 22/101 (21%)
Query: 92 YRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTH-ITTSD 142
Y+ +RG L+Y+H +H+ L +LL+ + + +I +FGLA++ H H ++
Sbjct: 113 YQILRG----LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 143 VVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAEEMS 178
V T Y APE T +I DI+S G +LAE +S
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAI----DIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 38/170 (22%), Positives = 71/170 (41%), Gaps = 21/170 (12%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDIL------NDVSRG-- 82
+ + E + ++ H NI+ LL + + +++E++ G L + L +DV
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 83 -----RRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK 129
+ LD IA+G+EYL H + +L+ + +IS+ GL++
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
A + + ++ PE + DI+SFGV+L E S
Sbjct: 173 EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 43/190 (22%), Positives = 79/190 (41%), Gaps = 37/190 (19%)
Query: 23 KLLTEE-----MMQIRSEIVTLGQIRHRNILPLLAHLA--RPGCHLLVYEFMKNGSLQDI 75
K+L EE + E + + H NI+ LL A +P C L++E+M G L +
Sbjct: 41 KMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC--LLFEYMAYGDLNEF 98
Query: 76 LNDVS------------------RGRRQLDWLARYRTVRGIASGLEYL----HMHQALV- 112
L S L + + +A+G+ YL +H+ L
Sbjct: 99 LRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158
Query: 113 ---LLDHDMEARISEFGLA-KVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYS 168
L+ +M +I++FGL+ ++ + + +D + ++ PE T D+++
Sbjct: 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTESDVWA 217
Query: 169 FGVLLAEEMS 178
+GV+L E S
Sbjct: 218 YGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 17/120 (14%)
Query: 65 EFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH-----MHQAL----VLLD 115
E M GSL +L GR + L + + GL YL MH+ + +L++
Sbjct: 79 EHMDGGSLDQVLKKA--GRIPENILGK--ISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134
Query: 116 HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
E ++ +FG V + + S VGT Y++PE Q T DI+S G+ L E
Sbjct: 135 SRGEIKLCDFG---VSGQLIDSMANS-FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.002
Identities = 44/181 (24%), Positives = 73/181 (40%), Gaps = 35/181 (19%)
Query: 17 LVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDIL 76
L + +E ++ E + Q+ H I+ L+ +LV E G L L
Sbjct: 31 LKQEHIAAGKKEFLR---EASVMAQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYL 86
Query: 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLA 128
+ RR++ +A G+ YL +H+ L VLL + +A+IS+FG++
Sbjct: 87 ----KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMS 142
Query: 129 KVFPEAHTHITTSDVVGTAG-----YIAPEYQQTLSITY-----MCDIYSFGVLLAEEMS 178
+ + + TAG + APE I Y D++S+GV L E S
Sbjct: 143 RALGAGSDYYRAT----TAGRWPLKWYAPE-----CINYGKFSSKSDVWSYGVTLWEAFS 193
Query: 179 L 179
Sbjct: 194 Y 194
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 45/186 (24%), Positives = 75/186 (40%), Gaps = 16/186 (8%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH 60
+I +R+ A +++ + + +E+ +E L RH + L
Sbjct: 11 VILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL 70
Query: 61 LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------V 112
V E++ G L +SR R + R+ I S L+YLH + + +
Sbjct: 71 CFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAE-IVSALDYLHSGKIVYRDLKLENL 126
Query: 113 LLDHDMEARISEFGLAKVFPEAHTHITT-SDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171
+LD D +I++FGL K E T T GT Y+APE + D + GV
Sbjct: 127 MLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGV 183
Query: 172 LLAEEM 177
++ E M
Sbjct: 184 VMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 46/171 (26%), Positives = 70/171 (40%), Gaps = 15/171 (8%)
Query: 14 ATALVEADSKLLTEEMMQIRSEI-VTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSL 72
A +++ + L +E I SE V L ++H ++ L V +++ G L
Sbjct: 24 AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83
Query: 73 QDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISE 124
+ R R L+ AR+ IAS L YLH + +LLD +++
Sbjct: 84 ---FYHLQRERCFLEPRARFYAAE-IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTD 139
Query: 125 FGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
FGL K E + TTS GT Y+APE D + G +L E
Sbjct: 140 FGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 10/89 (11%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I+ GL +LH + V+LD + +I++FG+ K +TT GT Y
Sbjct: 110 ISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDY 167
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
IAPE D +++GVLL E ++
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 46/184 (25%), Positives = 77/184 (41%), Gaps = 33/184 (17%)
Query: 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL 61
+AI+KI++P L + + E+ L +RH NI+ L P +
Sbjct: 38 VAIKKIMKP-FSTPVLAK-----------RTYRELKLLKHLRHENIISLSDIFISPLEDI 85
Query: 62 -LVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----V 112
V E + L+ + R +Y + I GL+Y+H +H+ L +
Sbjct: 86 YFVTELLGTD-----LHRLLTSRPLEKQFIQYFLYQ-ILRGLKYVHSAGVVHRDLKPSNI 139
Query: 113 LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS-ITYMCDIYSFGV 171
L++ + + +I +FGLA++ +T V T Y APE T DI+S G
Sbjct: 140 LINENCDLKICDFGLARI---QDPQMT--GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGC 194
Query: 172 LLAE 175
+ AE
Sbjct: 195 IFAE 198
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 36/149 (24%), Positives = 61/149 (40%), Gaps = 15/149 (10%)
Query: 42 IRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101
++H NIL L +LLV+E+ + G L+ L+ RR L R IA+G
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 102 LEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153
+ ++H H L L D+ ++ ++G+ + T D ++APE
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171
Query: 154 YQQ-------TLSITYMCDIYSFGVLLAE 175
T T ++++ GV L E
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 27/182 (14%)
Query: 14 ATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLL-AHLARPGCHLLVYEFMKNGSL 72
A L+ D+ + + R E ++ H NI+ LL + A PG V+E++ +L
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 73 QDILNDVSRGRRQLDWLARYRTVRGIASGLEYL-HMH-----------QALVLLDHDME- 119
+++L + G L T R + L+ L H Q +++ +
Sbjct: 67 REVL--AADGA-----LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119
Query: 120 -ARISEFGLAKVFPEAH----THIT-TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
A++ +FG+ + P +T T++V+GT Y APE + +T D+Y++G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 174 AE 175
E
Sbjct: 180 LE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 19/130 (14%)
Query: 62 LVYEFMKNGSLQDILNDVSRGRRQLDW-LARY---RTVRGIASGLEYLHMHQAL----VL 113
LV E+ G D+L+ ++R Q D +A++ V I S + ++H+ + VL
Sbjct: 78 LVMEYQPGG---DLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134
Query: 114 LDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS----ITY--MCDIY 167
+D ++++FG A A+ + + VGT YIAPE T++ TY CD +
Sbjct: 135 IDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193
Query: 168 SFGVLLAEEM 177
S GV +A EM
Sbjct: 194 SLGV-IAYEM 202
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 36/125 (28%), Positives = 52/125 (41%), Gaps = 15/125 (12%)
Query: 62 LVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQALV--------- 112
V E+ G L +SR R + AR+ I S L+YLH + +V
Sbjct: 72 FVMEYANGGEL---FFHLSRERVFSEDRARFYGAE-IVSALDYLHSEKNVVYRDLKLENL 127
Query: 113 LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172
+LD D +I++FGL K T GT Y+APE + D + GV+
Sbjct: 128 MLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVV 185
Query: 173 LAEEM 177
+ E M
Sbjct: 186 MYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 37/153 (24%), Positives = 68/153 (44%), Gaps = 13/153 (8%)
Query: 32 IRSEIVTLGQIRHR----NILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLD 87
IR++I+ Q+ H I+ G + E M GSL +L + R ++
Sbjct: 46 IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEIL 105
Query: 88 WLARYRTVRGIASGLE-YLHMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSD 142
+RG+A E + MH+ + +L++ E ++ +FG++ ++ +
Sbjct: 106 GKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 161
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
VGT Y++PE Q + DI+S G+ L E
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.003
Identities = 23/83 (27%), Positives = 42/83 (50%), Gaps = 11/83 (13%)
Query: 101 GLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152
GL++LH H+ + +L+ + ++++FGLA+++ + + VV T Y AP
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAP 178
Query: 153 EYQQTLSITYMCDIYSFGVLLAE 175
E S D++S G + AE
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.003
Identities = 41/169 (24%), Positives = 65/169 (38%), Gaps = 40/169 (23%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94
E+ + +I+H NI+ L+ LV + M L+ +++ R L
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR----LTESQVKCI 124
Query: 95 VRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAK------VFPEAHTHIT- 139
+ I +GL LH MH+ L + ++ +I++FGLA+ T
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 140 ------TSDVVGTAGYIAPE-------YQQTLSITYMCDIYSFGVLLAE 175
TS VV T Y APE Y D++S G + AE
Sbjct: 185 QRREEMTSKVV-TLWYRAPELLMGAEKYHFA------VDMWSVGCIFAE 226
|
Length = 335 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 48/156 (30%), Positives = 78/156 (50%), Gaps = 20/156 (12%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDW-LA 90
IR EI + +++H NI+ L + +LV+E+M L+ + D R LD
Sbjct: 46 IR-EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYM-DTHGVRGALDPNTV 102
Query: 91 R---YRTVRGIASGLEYLHMHQAL----VLLDHDMEARISEFGLAKVF--PEAHTHITTS 141
+ Y+ ++GIA E +H+ L +L++ E ++++FGLA+ F P T S
Sbjct: 103 KSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN----TFS 158
Query: 142 DVVGTAGYIAPEYQQTLSITYMC--DIYSFGVLLAE 175
+ V T Y AP+ S TY DI+S G ++AE
Sbjct: 159 NEVVTLWYRAPDVLLG-SRTYSTSIDIWSVGCIMAE 193
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.004
Identities = 50/181 (27%), Positives = 72/181 (39%), Gaps = 39/181 (21%)
Query: 45 RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGR--RQLD------------WLA 90
RNIL + H P L+Y F G L IL +S G L+ +L+
Sbjct: 51 RNILEAVKH---PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 91 RYRTVRGIASGLEYLHMHQAL---------VLLDHDMEARISEFGLAKVFPEAHTHITTS 141
I+ LE+LH Q + +LLD ++++FGL K H T
Sbjct: 108 E------ISLALEHLH-QQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTH 158
Query: 142 DVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLL 201
GT Y+APE D +S G L+ + ++ T+EN K+ ID L
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAP----PFTAENRKKTIDKILK 214
Query: 202 G 202
G
Sbjct: 215 G 215
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 238 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.98 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.98 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.98 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.98 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.98 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.98 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.98 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.95 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.94 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.94 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.89 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.88 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.88 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.87 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.86 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.84 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.82 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.69 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.65 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.61 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.56 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.49 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.37 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.36 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.35 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.34 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.33 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.29 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.29 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.11 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.09 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.03 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.02 | |
| smart00090 | 237 | RIO RIO-like kinase. | 98.93 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.92 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 98.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.35 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.24 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.17 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.12 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.91 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 97.74 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 97.67 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.58 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.52 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 97.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 97.5 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 97.33 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.0 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 96.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 96.83 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 96.78 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.84 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 95.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.5 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 95.09 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 94.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 94.15 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 94.09 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 93.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 91.35 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 86.7 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 84.73 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 81.38 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=281.87 Aligned_cols=221 Identities=27% Similarity=0.372 Sum_probs=184.5
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCC-eeEEEEEeCCCCCHHHHHhhh
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPG-CHLLVYEFMKNGSLQDILNDV 79 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~ 79 (238)
+||||.+.....+.. ..+.|.+|+.+|.+++|||||+++|++.++. ..++||||+++|+|.+++...
T Consensus 67 ~vavK~~~~~~~~~~------------~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~ 134 (362)
T KOG0192|consen 67 VVAVKIISDPDFDDE------------SRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK 134 (362)
T ss_pred eEEEEEecchhcChH------------HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc
Confidence 378888877665432 2689999999999999999999999999887 789999999999999999752
Q ss_pred cCCCcccCHHHHHHHHHHHHHHhchhhccC---------ceeeecCCC-ceEEcccccccccCCcccccccccccCCCcc
Q 041655 80 SRGRRQLDWLARYRTVRGIASGLEYLHMHQ---------ALVLLDHDM-EARISEFGLAKVFPEAHTHITTSDVVGTAGY 149 (238)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~l~~gl~~lH~~~---------~~il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 149 (238)
....+++..+..++.|+++||+|||++. .|+|++.++ ++||+|||+++...... ...+...||+.|
T Consensus 135 --~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~w 210 (362)
T KOG0192|consen 135 --RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRW 210 (362)
T ss_pred --ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccc
Confidence 3578999999999999999999999776 469999997 99999999998654322 122336899999
Q ss_pred cCccccc--ccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 150 IAPEYQQ--TLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 150 ~apE~~~--~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
||||++. ...|+.++||||||+++|||+||..||.................++..+..++..+..++..||+.||+.|
T Consensus 211 MAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~R 290 (362)
T KOG0192|consen 211 MAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRR 290 (362)
T ss_pred cChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcC
Confidence 9999999 56899999999999999999999999987665333444445666677777788999999999999999999
Q ss_pred ----hHHHHHHhhh
Q 041655 228 ----HVRCMLSQIQ 237 (238)
Q Consensus 228 ----~v~~~L~~~~ 237 (238)
+++..|+.+.
T Consensus 291 P~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 291 PSFLEIVSRLESIM 304 (362)
T ss_pred CCHHHHHHHHHHHH
Confidence 7777776553
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=283.61 Aligned_cols=214 Identities=24% Similarity=0.293 Sum_probs=178.3
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+..+... -++|.+|+++|++|+|+|||+++|+|..++.+||||||++.|+|.+|+.. .
T Consensus 233 vavk~ik~~~m~---------------~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~ 295 (468)
T KOG0197|consen 233 VAVKTIKEGSMS---------------PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--R 295 (468)
T ss_pred ccceEEeccccC---------------hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--c
Confidence 677777655432 37889999999999999999999999998899999999999999999975 4
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhccC--------ceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~~--------~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
.+..++..+...++.|||+|++||+++. .|||++++..+||+|||+++...+..-... ....-+..|.|||
T Consensus 296 ~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-~~~kfPIkWtAPE 374 (468)
T KOG0197|consen 296 EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-EGGKFPIKWTAPE 374 (468)
T ss_pred CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec-CCCCCCceecCHH
Confidence 4567888999999999999999999774 469999999999999999995543332222 3334568899999
Q ss_pred cccccCCCccCCeeehhHHHHhhcch-HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcchHHHH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSL-VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKERHVRCM 232 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R~v~~~ 232 (238)
.+..+.++.+|||||||++||||+|. ..|+.. .....+...+..+.+-..|..+|..+.++|..||..+|++|+.++.
T Consensus 375 a~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~-msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 375 ALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG-MSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFET 453 (468)
T ss_pred HHhhCCcccccceeehhhhHHHHhccCCCCCCC-CCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHH
Confidence 99999999999999999999999995 555443 4445566788888888899999999999999999999999944444
Q ss_pred HH
Q 041655 233 LS 234 (238)
Q Consensus 233 L~ 234 (238)
|+
T Consensus 454 L~ 455 (468)
T KOG0197|consen 454 LR 455 (468)
T ss_pred HH
Confidence 43
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=267.34 Aligned_cols=210 Identities=20% Similarity=0.259 Sum_probs=167.7
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCcccceeee-eecCCe-eEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 24 LLTEEMMQIRSEIVTLGQIRHRNILPLLAH-LARPGC-HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 24 ~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
.+.+.+.....|+.+|++|+|||||+++++ |.++.. +++|||+|.+|+|.+.+.........+++..+++++.|+++|
T Consensus 57 md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~A 136 (375)
T KOG0591|consen 57 MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRA 136 (375)
T ss_pred ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHH
Confidence 345567788999999999999999999994 555544 889999999999999998777778889999999999999999
Q ss_pred hchhhc------------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 102 LEYLHM------------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 102 l~~lH~------------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
|.++|+ ||.||+++.+|.+||+|||+++.+..... ...+.+|||+||+||.+.+.+|+++|||||+
T Consensus 137 L~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWsl 214 (375)
T KOG0591|consen 137 LYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSL 214 (375)
T ss_pred HHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHH
Confidence 999995 58889999999999999999998755433 3466899999999999999999999999999
Q ss_pred hHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHh
Q 041655 170 GVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQ 235 (238)
Q Consensus 170 G~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~ 235 (238)
||++|||+...+||+...-...-.++-....++-.......++..++..|+..||+.| .++..+++
T Consensus 215 GCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 215 GCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred HHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 9999999999999986422111122222222222224445566667777999999999 43444443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=271.60 Aligned_cols=220 Identities=22% Similarity=0.245 Sum_probs=176.8
Q ss_pred EeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCC-eeEEEEEeCCCCCHHHHHhhhcCCC
Q 041655 5 RKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPG-CHLLVYEFMKNGSLQDILNDVSRGR 83 (238)
Q Consensus 5 K~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~ 83 (238)
|..+++...-.|.|.......++..+++.+|++++.+.+||+||.+||.|..++ ...++|||+.+|+|.+++.. .
T Consensus 97 kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~----~ 172 (364)
T KOG0581|consen 97 KVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR----V 172 (364)
T ss_pred EEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh----c
Confidence 444444444445555555666778899999999999999999999999999998 49999999999999999986 3
Q ss_pred cccCHHHHHHHHHHHHHHhchhh---------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccc
Q 041655 84 RQLDWLARYRTVRGIASGLEYLH---------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEY 154 (238)
Q Consensus 84 ~~~~~~~~~~~~~~l~~gl~~lH---------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~ 154 (238)
+.+++...-.++.++++||.||| .||.|+|+++.|.+||+|||+++.+... ...+..||..|||||.
T Consensus 173 g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPER 248 (364)
T KOG0581|consen 173 GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPER 248 (364)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhh
Confidence 66899999999999999999999 4688999999999999999999876554 2467899999999999
Q ss_pred ccccCCCccCCeeehhHHHHhhcchHHHHHHhhc-cCCC----cccccccccCCChHH-HHHHHHHHhhhhcCCCCCcc-
Q 041655 155 QQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMT-SENP----KRAIDSKLLGNGYEE-QMLLVLKTACFCTLDDPKER- 227 (238)
Q Consensus 155 ~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~-~~~~l~~~~~~cl~~~p~~R- 227 (238)
+.+..|+.++||||||++++|+.+|..|+..... ...+ ..+++ ...+..+.. +..++.+++..||++||.+|
T Consensus 249 i~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~-~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~ 327 (364)
T KOG0581|consen 249 ISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD-EPPPRLPEGEFSPEFRSFVSCCLRKDPSERP 327 (364)
T ss_pred hcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc-CCCCCCCcccCCHHHHHHHHHHhcCCcccCC
Confidence 9999999999999999999999999888765411 1111 22333 223334443 66777888888999999999
Q ss_pred hHHHHH
Q 041655 228 HVRCML 233 (238)
Q Consensus 228 ~v~~~L 233 (238)
..-++|
T Consensus 328 s~~qLl 333 (364)
T KOG0581|consen 328 SAKQLL 333 (364)
T ss_pred CHHHHh
Confidence 444333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=266.33 Aligned_cols=219 Identities=22% Similarity=0.316 Sum_probs=175.5
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+.+.......- ..+......+|+++|++|+|||||+++++|...+..|+||||++||.|.+++-.
T Consensus 200 vAiKIi~krk~~~~s~-------~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~--- 269 (475)
T KOG0615|consen 200 VAIKIINKRKSTGCSR-------AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA--- 269 (475)
T ss_pred EEeeeeehhhcccccc-------cccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHh---
Confidence 7888887766543211 112234467999999999999999999999999999999999999999999875
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCC---CceEEcccccccccCCcccccccccccCCCccc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHD---MEARISEFGLAKVFPEAHTHITTSDVVGTAGYI 150 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 150 (238)
.+.+.+..-+.+++|++.|+.||| .||.|||+..+ ..+|++|||+|+....... ..+.+|||.|.
T Consensus 270 -nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sf---m~TlCGTpsYv 345 (475)
T KOG0615|consen 270 -NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSF---MKTLCGTPSYV 345 (475)
T ss_pred -ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccccee---hhhhcCCcccc
Confidence 567788888999999999999999 55889999887 6799999999998764433 36689999999
Q ss_pred CcccccccCCC---ccCCeeehhHHHHhhcchHHHHHHhhccCCCc-ccccccc--cCCChHHHHHHHHHHhhhhcCCCC
Q 041655 151 APEYQQTLSIT---YMCDIYSFGVLLAEEMSLVKWMRNVMTSENPK-RAIDSKL--LGNGYEEQMLLVLKTACFCTLDDP 224 (238)
Q Consensus 151 apE~~~~~~~~---~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p 224 (238)
|||++.+.... .+.|+||+||+||-+++|.+||.......... .+...++ .+....+...+.+++|.++|..||
T Consensus 346 APEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP 425 (475)
T KOG0615|consen 346 APEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDP 425 (475)
T ss_pred ChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCc
Confidence 99998876543 47799999999999999999998776655333 3444444 223455667778889999999999
Q ss_pred Ccc-hHHHHHH
Q 041655 225 KER-HVRCMLS 234 (238)
Q Consensus 225 ~~R-~v~~~L~ 234 (238)
++| .+.+.|+
T Consensus 426 ~~R~s~~eaL~ 436 (475)
T KOG0615|consen 426 ENRPSADEALN 436 (475)
T ss_pred ccCcCHHHHhc
Confidence 999 6666654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=274.73 Aligned_cols=208 Identities=21% Similarity=0.287 Sum_probs=172.3
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
.||+|++.+... ....+.+...+|+++.++|+|||||+++++|++.+..|+|+|+|+.++|..+++.
T Consensus 45 ~~A~KvVpk~~l-----------~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr-- 111 (592)
T KOG0575|consen 45 VVAVKVVPKKLL-----------KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR-- 111 (592)
T ss_pred EEEEEEeehHHh-----------cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh--
Confidence 377887765433 2345678899999999999999999999999999999999999999999999985
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhccCc--------eeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQA--------LVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~~~--------~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
.+++++.+++.+++||+.||.|||++++ |++++.+.++||+|||+|..+..... ...+.+|||.|.||
T Consensus 112 --rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk~TlCGTPNYIAP 187 (592)
T KOG0575|consen 112 --RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RKKTLCGTPNYIAP 187 (592)
T ss_pred --cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc--ccceecCCCcccCh
Confidence 6889999999999999999999998865 49999999999999999998754322 22568999999999
Q ss_pred ccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 153 EYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 153 E~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|++.....++.+||||+||++|.++.|.+||+...-.+....+....+. .|........++|.++|+.||.+|
T Consensus 188 EVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--~P~~ls~~A~dLI~~lL~~~P~~R 260 (592)
T KOG0575|consen 188 EVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--MPSHLSAEAKDLIRKLLRPNPSER 260 (592)
T ss_pred hHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--cccccCHHHHHHHHHHhcCCcccC
Confidence 9999999999999999999999999999999875444444444433332 222334445667777999999999
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=257.42 Aligned_cols=219 Identities=21% Similarity=0.207 Sum_probs=179.1
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
+.||+...+..-+.++.+++.....+..+....|..+|.+++||+||.+.-.|++++.+|+|+||+.||.|.-.+.+
T Consensus 42 ~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~--- 118 (357)
T KOG0598|consen 42 FQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR--- 118 (357)
T ss_pred EEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh---
Confidence 45666666666667777777777777888999999999999999999999999999999999999999999999975
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
...+++..++-++.+|+.||.|||++ |.|||+|..|+++|+|||+++.-.... ..+.+++||+.|||||
T Consensus 119 -eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPE 195 (357)
T KOG0598|consen 119 -EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPE 195 (357)
T ss_pred -cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChH
Confidence 67799999999999999999999955 678999999999999999998532221 2345689999999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++.+..|+..+|+||+|+++|+|++|.+||..........++...+. ...+.-...+..+++.+.+..||++|
T Consensus 196 il~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-~~~p~~ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 196 ILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-PLPPGYLSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred HHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-CCCCccCCHHHHHHHHHHhccCHHHh
Confidence 99999999999999999999999999999987554444444554442 11122123334556666999999999
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=279.76 Aligned_cols=222 Identities=23% Similarity=0.280 Sum_probs=184.2
Q ss_pred ChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------C----
Q 041655 13 DATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------G---- 82 (238)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------~---- 82 (238)
..++||..++..+...+.+|.||+++|..++|||||+++|+|..++.+++|+||+..|+|.+||..... .
T Consensus 517 ~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~ 596 (774)
T KOG1026|consen 517 QLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDT 596 (774)
T ss_pred eehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCC
Confidence 345566666667777889999999999999999999999999999999999999999999999975321 1
Q ss_pred CcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEccccccccc-CCcccccccccccCCCcccCcc
Q 041655 83 RRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVF-PEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 83 ~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~-~~~~~~~~~~~~~~~~~~~apE 153 (238)
..+++..+.+.++.|||.|+.||.++ ..|+|+..+..|||+|||+++.. ....-... +.-.-+++|||||
T Consensus 597 ~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppE 675 (774)
T KOG1026|consen 597 PPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPE 675 (774)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhccc-CCceeeeecCCHH
Confidence 23489999999999999999999755 45799999999999999999843 22211111 1223468999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----h
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----H 228 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~ 228 (238)
.+..+.++++||||||||+|||+++ |..|+++..+.+-+..+..... ...|.++|.++.++|..||+.+|.+| +
T Consensus 676 sIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~e 754 (774)
T KOG1026|consen 676 SILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKE 754 (774)
T ss_pred HhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 9999999999999999999999998 6899988777666655555555 78899999999999999999999999 7
Q ss_pred HHHHHHhh
Q 041655 229 VRCMLSQI 236 (238)
Q Consensus 229 v~~~L~~~ 236 (238)
+-.+|+..
T Consensus 755 I~~~L~~~ 762 (774)
T KOG1026|consen 755 IHSRLQAW 762 (774)
T ss_pred HHHHHHHH
Confidence 77777654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=256.60 Aligned_cols=196 Identities=21% Similarity=0.275 Sum_probs=156.8
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.++..+-...|+.+|+.++|||||.+++++..++.+|+|||||.||+|.+|+.. ...+++..++.++.|++.||++
T Consensus 49 ~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~ 124 (429)
T KOG0595|consen 49 NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQF 124 (429)
T ss_pred CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Confidence 566778889999999999999999999999999999999999999999999986 4579999999999999999999
Q ss_pred hhcc--------CceeeecCC------CceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 105 LHMH--------QALVLLDHD------MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 105 lH~~--------~~~il~~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
||.+ |.|||++.. -.+||+|||+++.+..... ..+.+|++.|||||++....|+-|+|+||+|
T Consensus 125 L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG 201 (429)
T KOG0595|consen 125 LHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIG 201 (429)
T ss_pred HHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHH
Confidence 9954 778999875 4689999999998764432 3668999999999999999999999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCcccccc-cccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAIDS-KLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+++|++++|+.||+.....+....+-.. ...+..+......+.+++...+..+|..|
T Consensus 202 ~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~ 259 (429)
T KOG0595|consen 202 TILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDR 259 (429)
T ss_pred HHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCcccc
Confidence 9999999999999854433222211111 11122222222234455555677777777
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=253.14 Aligned_cols=205 Identities=38% Similarity=0.591 Sum_probs=168.5
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCC-eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPG-CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+|.+|+.++.+++|||+++++|+|.+.+ ..++|+||+++|+|.+.+...... +++|..+.+|+.++|+||+|||.
T Consensus 115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~ 192 (361)
T KOG1187|consen 115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHE 192 (361)
T ss_pred hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHcc
Confidence 355999999999999999999999999988 499999999999999999762222 88999999999999999999993
Q ss_pred -----------cCceeeecCCCceEEcccccccccCCcccccccccc-cCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 108 -----------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDV-VGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 108 -----------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~-~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
|+.|||+|.+++.||+|||+++..+...... .+. .||..|++||....+..+.++||||||+++.|
T Consensus 193 ~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllE 270 (361)
T KOG1187|consen 193 GCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLE 270 (361)
T ss_pred CCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHH
Confidence 4567999999999999999997654311111 122 78999999999998889999999999999999
Q ss_pred hcchHHHHH---------------HhhccCCCccccccccc-CCChH-HHHHHHHHHhhhhcCCCCCcc----hHHHHHH
Q 041655 176 EMSLVKWMR---------------NVMTSENPKRAIDSKLL-GNGYE-EQMLLVLKTACFCTLDDPKER----HVRCMLS 234 (238)
Q Consensus 176 ~~t~~~~~~---------------~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~~~~~cl~~~p~~R----~v~~~L~ 234 (238)
++||..+.. ..........++++.+. ...+. .....+..+..+|++.+|++| +|+++|+
T Consensus 271 litgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 271 LITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred HHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 999775443 22333356677787775 44443 688889999999999999999 8888886
Q ss_pred hhh
Q 041655 235 QIQ 237 (238)
Q Consensus 235 ~~~ 237 (238)
.+.
T Consensus 351 ~~~ 353 (361)
T KOG1187|consen 351 GIL 353 (361)
T ss_pred hhc
Confidence 653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=261.99 Aligned_cols=195 Identities=25% Similarity=0.332 Sum_probs=166.6
Q ss_pred HHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc----
Q 041655 33 RSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH---- 108 (238)
Q Consensus 33 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~---- 108 (238)
..++..|++|+||||+.+.|+|.....+||+||||+.|.|...++. +..++......|..+|+.|+.|||.+
T Consensus 160 ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hKIIH 235 (904)
T KOG4721|consen 160 ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHKIIH 235 (904)
T ss_pred hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhhHhh
Confidence 4688899999999999999999999999999999999999999986 67788999999999999999999965
Q ss_pred ----CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHH
Q 041655 109 ----QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 109 ----~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~ 184 (238)
..|||+..+..+||+|||.++....... .-++.||..|||||++++.+.+.|+|||||||+||||+||.-|+.
T Consensus 236 RDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYk 312 (904)
T KOG4721|consen 236 RDLKSPNILISYDDVVKISDFGTSKELSDKST---KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYK 312 (904)
T ss_pred hccCCCceEeeccceEEeccccchHhhhhhhh---hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcc
Confidence 4569999999999999999987655532 134789999999999999999999999999999999999999987
Q ss_pred HhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 185 NVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.......+.-+-.-.+....++.++.-|.-+++.||+.+|.+| ..-+.|.
T Consensus 313 dVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~ 363 (904)
T KOG4721|consen 313 DVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILL 363 (904)
T ss_pred ccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHH
Confidence 6554444444444455566788888889889999999999999 4444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=260.98 Aligned_cols=211 Identities=21% Similarity=0.266 Sum_probs=171.2
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||++....... .+-+.+|+.+|+..+|+|||.+++.|...+.+|+||||++||+|.+....
T Consensus 301 VaiK~m~l~~Q~~--------------keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~--- 363 (550)
T KOG0578|consen 301 VAIKRMDLRKQPK--------------KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK--- 363 (550)
T ss_pred EEEEEEEeccCCc--------------hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc---
Confidence 7888887665432 46678999999999999999999999888999999999999999999975
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
..+++.++..++++++.||+|||.+ ..||+++.+|.+||+|||++..+..... ..++..|||+|||||
T Consensus 364 --~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPE 439 (550)
T KOG0578|consen 364 --TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPE 439 (550)
T ss_pred --ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchh
Confidence 5599999999999999999999955 4569999999999999999988765443 346789999999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccc-ccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID-SKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
+.....|+++.||||||++++||+.|.+||...........+-. .......+......+.+++.+||..|+++| .+-+
T Consensus 440 Vvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 440 VVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred hhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 99999999999999999999999999999975322222222222 222233444555566777777999999999 5544
Q ss_pred HH
Q 041655 232 ML 233 (238)
Q Consensus 232 ~L 233 (238)
.|
T Consensus 520 LL 521 (550)
T KOG0578|consen 520 LL 521 (550)
T ss_pred Hh
Confidence 44
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=250.75 Aligned_cols=201 Identities=21% Similarity=0.207 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
..+.|.+|+.+|.+++||||++++|++.+ ....+++|||+++|+|.+++.. ...+++.....++.|++.||.
T Consensus 61 ~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~ 136 (283)
T PHA02988 61 LIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLY 136 (283)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHH
Confidence 35778899999999999999999999876 3467899999999999999975 456889999999999999999
Q ss_pred hhhcc---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc--cCCCccCCeeehhHH
Q 041655 104 YLHMH---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT--LSITYMCDIYSFGVL 172 (238)
Q Consensus 104 ~lH~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~--~~~~~~~DvwslG~~ 172 (238)
|||.. +.|++++.++.+|++|||+++...... ....++..|+|||++.+ ..++.++||||||++
T Consensus 137 ~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvi 211 (283)
T PHA02988 137 NLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211 (283)
T ss_pred HHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHH
Confidence 99953 578999999999999999987653322 22467889999999876 678999999999999
Q ss_pred HHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 173 LAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
+|||++|..||.....................+...+..+.+++.+||+.||++| ++++.|++++
T Consensus 212 l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 212 LWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 9999999999865432222222222222333344566778899999999999999 6666666554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=242.27 Aligned_cols=207 Identities=19% Similarity=0.210 Sum_probs=174.7
Q ss_pred CCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHH
Q 041655 10 PPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWL 89 (238)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~ 89 (238)
+..-+.++..+.....-++.++..+|..+|+.+.||+++++.+.|.+.+.+|+||||.+||.|..++.. ...+++.
T Consensus 69 g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e~ 144 (355)
T KOG0616|consen 69 GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK----SGRFSEP 144 (355)
T ss_pred CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh----cCCCCch
Confidence 333344444455555567888999999999999999999999999999999999999999999999976 5679999
Q ss_pred HHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCC
Q 041655 90 ARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSIT 161 (238)
Q Consensus 90 ~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~ 161 (238)
.++.++.|++.||+||| .||.|||+|.+|.+|+.|||.++..... +.+.+|||.|+|||++.+.+++
T Consensus 145 ~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~yn 219 (355)
T KOG0616|consen 145 HARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYN 219 (355)
T ss_pred hHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCC
Confidence 99999999999999999 4588899999999999999999876554 2568999999999999999999
Q ss_pred ccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 162 YMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 162 ~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..+|+||||+++|||+.|.+||..........+++.... ..|+....++.+++.+.++.|-.+|
T Consensus 220 kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 220 KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 999999999999999999999987665445555655544 3445555566777777999998888
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=246.90 Aligned_cols=203 Identities=24% Similarity=0.281 Sum_probs=157.0
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCC--eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPG--CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.+.+.+|+.+|.+++|||||+++|...... .+++.|||+++|+|.+++.. .++ .+++..++.+.+|+++||.|||
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~--~g~-~l~E~~v~~ytr~iL~GL~ylH 134 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKR--YGG-KLPEPLVRRYTRQILEGLAYLH 134 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHH--cCC-CCCHHHHHHHHHHHHHHHHHHH
Confidence 677899999999999999999999854444 68899999999999999986 233 7999999999999999999999
Q ss_pred cc--------CceeeecC-CCceEEcccccccccCC-cccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHh
Q 041655 107 MH--------QALVLLDH-DMEARISEFGLAKVFPE-AHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAE 175 (238)
Q Consensus 107 ~~--------~~~il~~~-~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~ 175 (238)
++ +.|||++. ++.+||+|||.+..... ...........||+.|||||++.++ ..+..+||||+||++.|
T Consensus 135 s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 135 SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred hCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 54 67899999 79999999999886553 1111223457899999999999863 33459999999999999
Q ss_pred hcchHHHHHHh-hccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 176 EMSLVKWMRNV-MTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 176 ~~t~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|+||..||... ........+......+..+...+.+..+++.+|+..||++| ++.+.|+
T Consensus 215 M~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred ccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 99998888763 11112222333333334455555666777777999999999 5555554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=249.14 Aligned_cols=218 Identities=22% Similarity=0.331 Sum_probs=167.4
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
+||||++....- .+.++.+.+|+..|..++||||++++..|..+..+|+||.|+.+|++.+.+...
T Consensus 53 ~VAIK~inLEkc-------------~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~- 118 (516)
T KOG0582|consen 53 VVAIKIINLEKC-------------NNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTY- 118 (516)
T ss_pred EEEEEEeehhhh-------------hhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHH-
Confidence 478888865443 234788999999999999999999999999999999999999999999999862
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcc-ccccc-ccccCCCccc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAH-THITT-SDVVGTAGYI 150 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~-~~~~~-~~~~~~~~~~ 150 (238)
-...+.+..+..+++++++||.|||. |+.|||++++|.+||+|||.+..+-... ..... .+..|+++||
T Consensus 119 -~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wm 197 (516)
T KOG0582|consen 119 -YPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWM 197 (516)
T ss_pred -ccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCccccc
Confidence 33458999999999999999999994 4667999999999999999987553322 12222 5679999999
Q ss_pred Ccccccc--cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccc--------cccCCChHHHHHHHHHHhhhhc
Q 041655 151 APEYQQT--LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDS--------KLLGNGYEEQMLLVLKTACFCT 220 (238)
Q Consensus 151 apE~~~~--~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~~~~~cl 220 (238)
|||++.. ..|+.|+||||||++..|+.+|..||.......-...-+.. ....+........+.+++..||
T Consensus 198 APEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL 277 (516)
T KOG0582|consen 198 APEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCL 277 (516)
T ss_pred ChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHh
Confidence 9998543 45899999999999999999999999765432211111111 1111222333446777778899
Q ss_pred CCCCCcc-hHHHHH
Q 041655 221 LDDPKER-HVRCML 233 (238)
Q Consensus 221 ~~~p~~R-~v~~~L 233 (238)
++||.+| +..+.|
T Consensus 278 ~kDP~kRptAskLl 291 (516)
T KOG0582|consen 278 VKDPSKRPTASKLL 291 (516)
T ss_pred hcCcccCCCHHHHh
Confidence 9999999 444444
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=256.25 Aligned_cols=210 Identities=23% Similarity=0.302 Sum_probs=172.7
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 23 ~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
....+++.+|.+|.++|..++||||++++|++....++++|||+|+||+|.+++.. ....++..+...++.+.+.||
T Consensus 199 ~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl 275 (474)
T KOG0194|consen 199 ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGL 275 (474)
T ss_pred cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHH
Confidence 45678899999999999999999999999999999999999999999999999986 233689999999999999999
Q ss_pred chhhccCc--------eeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 103 EYLHMHQA--------LVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 103 ~~lH~~~~--------~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
+|||+++. |+|++.++.+|++|||+++.-.. .. .......-+..|+|||.+....++.++||||||+++|
T Consensus 276 ~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-~~-~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~ 353 (474)
T KOG0194|consen 276 EYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-YV-MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLW 353 (474)
T ss_pred HHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc-ee-eccccccCcceecChhhhccCccccccchhheeeeEE
Confidence 99998754 59999999999999999875331 11 1111223568899999999999999999999999999
Q ss_pred hhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 175 EEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 175 ~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|+++ |..|+...........+.....+-..+...+..+..++.+||..+|++| ++.+.|+.+.
T Consensus 354 Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 354 EIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred eeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 9998 6777765544433344445566666666778888889999999999999 7777777653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=274.18 Aligned_cols=211 Identities=20% Similarity=0.248 Sum_probs=171.0
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc---CCCcccCHHHHHHHHHHHH
Q 041655 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS---RGRRQLDWLARYRTVRGIA 99 (238)
Q Consensus 23 ~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~~~l~ 99 (238)
..+.....+|.+|..+|+.++||||++++|++.+....++++||+++|+|..|+.+.+ .....++......++.|+|
T Consensus 733 ~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA 812 (1025)
T KOG1095|consen 733 LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVA 812 (1025)
T ss_pred cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHh
Confidence 3445678899999999999999999999999999999999999999999999998732 1256789999999999999
Q ss_pred HHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhH
Q 041655 100 SGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171 (238)
Q Consensus 100 ~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~ 171 (238)
+|++||+++ ..|+|++....+|++|||+|+.+-............-...|||||.+.+..++.++|||||||
T Consensus 813 ~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGV 892 (1025)
T KOG1095|consen 813 KGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGV 892 (1025)
T ss_pred hhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHH
Confidence 999999966 346999999999999999999443332222222224457899999999999999999999999
Q ss_pred HHHhhcch-HHHHHHhhccCCCcc-cccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 172 LLAEEMSL-VKWMRNVMTSENPKR-AIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 172 ~l~~~~t~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
++||++|. ..||.. ..+..+.. .+..+ +.+.|..++..+.++|..||+.+|++| .+++++..
T Consensus 893 llWEifslG~~PY~~-~~n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 893 LLWEIFSLGATPYPS-RSNFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred HHHHHHhCCCCCCCC-cchHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 99999995 555543 33344434 44444 778899999999999999999999999 44444443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=255.20 Aligned_cols=206 Identities=21% Similarity=0.283 Sum_probs=175.1
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
+||||.+.+... .++..+.+.+|++++++++||||+.++++|++..++|+|+||+.| +|..++..
T Consensus 29 ~vAik~i~K~gr------------~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~-- 93 (808)
T KOG0597|consen 29 VVAIKFIDKSGR------------NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQ-- 93 (808)
T ss_pred EEEEEEehhcCC------------chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHh--
Confidence 478888876533 345678899999999999999999999999999999999999976 99999986
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
+..+++..+..++.|+..||.|||++ |.||+++..+.+|++|||+++..+.+.. -.++..|||.||||
T Consensus 94 --d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~--vltsikGtPlYmAP 169 (808)
T KOG0597|consen 94 --DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS--VLTSIKGTPLYMAP 169 (808)
T ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCce--eeeeccCcccccCH
Confidence 78899999999999999999999955 7789999999999999999997655322 23567899999999
Q ss_pred ccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 153 EYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 153 E~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|+..+.+|+..+|+||+||++||+++|.+||....-......++.... ..+++....+..++...|.+||.+|
T Consensus 170 Elv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v--~~p~~~S~~f~nfl~gLL~kdP~~R 242 (808)
T KOG0597|consen 170 ELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV--KPPSTASSSFVNFLQGLLIKDPAQR 242 (808)
T ss_pred HHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC--CCcccccHHHHHHHHHHhhcChhhc
Confidence 999999999999999999999999999999987665444545554433 2344666678888888999999999
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=241.84 Aligned_cols=213 Identities=19% Similarity=0.249 Sum_probs=179.6
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
+|+|++++.... ..+...+...|.++|..++||++..+|..|+.+...|++||||+||+|...... +
T Consensus 105 fAmKVmdK~~l~-----------~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk--Q 171 (459)
T KOG0610|consen 105 FAMKVMDKESLA-----------SRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK--Q 171 (459)
T ss_pred EEEEEecHHHHh-----------hhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh--C
Confidence 677777654432 245567788899999999999999999999999999999999999999999876 5
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCC--------------------
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPE-------------------- 133 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~-------------------- 133 (238)
+...+++..++.++.+++.||+||| .||.|||+..+|++.|+||.++.....
T Consensus 172 p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~ 251 (459)
T KOG0610|consen 172 PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCR 251 (459)
T ss_pred CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccc
Confidence 6678999999999999999999999 789999999999999999998743210
Q ss_pred -------------ccc---------------------ccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 134 -------------AHT---------------------HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 134 -------------~~~---------------------~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
... .....+++||..|.|||++++...+.++|+|+||+++|||+.|
T Consensus 252 ~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG 331 (459)
T KOG0610|consen 252 SRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYG 331 (459)
T ss_pred cccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhC
Confidence 000 0112346799999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.-||......+...+++.....-....+....+.++|.+.|.+||.+|
T Consensus 332 ~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 332 TTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred CCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence 999999888888888887776544444666778899999999999999
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=258.40 Aligned_cols=211 Identities=24% Similarity=0.253 Sum_probs=176.5
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
+|||.|.+. .+........+.+|+.+|+-+.|||++++|++++++..+|+|+||.++|.|.+++-.
T Consensus 40 aaiKii~k~-----------~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~--- 105 (786)
T KOG0588|consen 40 AAIKIIPKR-----------SELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR--- 105 (786)
T ss_pred eEEEeeccc-----------cccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh---
Confidence 466666544 244455567788999999999999999999999999999999999999999999976
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
.+++++.++.++++|++.|+.|+| .||.|+++|.++++||+|||+|.+..... ...+-+|+|+|++||
T Consensus 106 -kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---lLeTSCGSPHYA~PE 181 (786)
T KOG0588|consen 106 -KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---LLETSCGSPHYAAPE 181 (786)
T ss_pred -hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc---cccccCCCcccCCch
Confidence 678999999999999999999999 56888999999999999999998654333 235679999999999
Q ss_pred cccccCC-CccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccC--CChHHHHHHHHHHhhhhcCCCCCcc-hH
Q 041655 154 YQQTLSI-TYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLG--NGYEEQMLLVLKTACFCTLDDPKER-HV 229 (238)
Q Consensus 154 ~~~~~~~-~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~cl~~~p~~R-~v 229 (238)
++.+.+| +.++||||.|++||.++||+.||+ ++++...+.....+ ..|++.+.+.++++.++++.||+.| ++
T Consensus 182 IV~G~pYdG~~sDVWSCGVILfALLtG~LPFd----DdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~ 257 (786)
T KOG0588|consen 182 IVSGRPYDGRPSDVWSCGVILFALLTGKLPFD----DDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITT 257 (786)
T ss_pred hhcCCCCCCCccccchhHHHHHHHHhCCCCCC----CccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccH
Confidence 9999988 689999999999999999999997 34454444433333 4568888889999999999999999 55
Q ss_pred HHHHH
Q 041655 230 RCMLS 234 (238)
Q Consensus 230 ~~~L~ 234 (238)
-+.++
T Consensus 258 ~eI~k 262 (786)
T KOG0588|consen 258 EEILK 262 (786)
T ss_pred HHHhh
Confidence 54443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=249.37 Aligned_cols=222 Identities=24% Similarity=0.278 Sum_probs=163.2
Q ss_pred hHHHhhhhhhHHHHHHHHHHHHHhcCC-CCCcccceeeeeecC-CeeEEEEEeCCCCCHHHHHhhhcC------------
Q 041655 16 ALVEADSKLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARP-GCHLLVYEFMKNGSLQDILNDVSR------------ 81 (238)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~------------ 81 (238)
++|.............+.+|+.++.++ +||||+++++++... +..+++|||+++|+|.+++.....
T Consensus 41 avK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~ 120 (338)
T cd05102 41 AVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQ 120 (338)
T ss_pred heeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhh
Confidence 333333333344567789999999999 899999999988764 457899999999999999864211
Q ss_pred ----------------------------------------------CCcccCHHHHHHHHHHHHHHhchhhcc-------
Q 041655 82 ----------------------------------------------GRRQLDWLARYRTVRGIASGLEYLHMH------- 108 (238)
Q Consensus 82 ----------------------------------------------~~~~~~~~~~~~~~~~l~~gl~~lH~~------- 108 (238)
....+++..+..++.|+++||.|||++
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDi 200 (338)
T cd05102 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDL 200 (338)
T ss_pred hhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCC
Confidence 023478888999999999999999944
Q ss_pred -CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hHHHHHHh
Q 041655 109 -QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNV 186 (238)
Q Consensus 109 -~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~ 186 (238)
|.||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 201 Kp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 201 AARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred ccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 7789999999999999999976533222222233456688999999988889999999999999999997 88777542
Q ss_pred hccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 187 MTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
.........+........+...+..+.+++.+||+.||++| ++++.|+++.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 281 QINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred CccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22111112222222222334455678889999999999999 7777776653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=249.68 Aligned_cols=198 Identities=23% Similarity=0.285 Sum_probs=158.7
Q ss_pred HHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
.+.+.+|+.++++++ ||||++++.++.....+|+||||+.+|+|.+++.+ ...+.+..+..++.|+++|++|+|+
T Consensus 63 ~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~ 138 (370)
T KOG0583|consen 63 DELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS 138 (370)
T ss_pred chhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh
Confidence 345568999999999 99999999999999999999999999999999986 5678889999999999999999995
Q ss_pred c--------CceeeecCC-CceEEcccccccccCCcccccccccccCCCcccCcccccccC-CC-ccCCeeehhHHHHhh
Q 041655 108 H--------QALVLLDHD-MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS-IT-YMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ~--------~~~il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~-~~-~~~DvwslG~~l~~~ 176 (238)
+ +.|++++.+ +++||+|||++.... .......+.+|++.|+|||++.+.. |+ .++||||+|++||.|
T Consensus 139 ~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~m 216 (370)
T KOG0583|consen 139 RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVL 216 (370)
T ss_pred CCEeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHH
Confidence 5 667999999 999999999998763 1122346689999999999999877 74 789999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++|..||...........+............ ..++.+++.+|+..||.+| .+.+.+
T Consensus 217 l~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 217 LCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HhCCCCCCCccHHHHHHHHhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 9999999752222222222333222222211 6667888888999999999 544444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=249.16 Aligned_cols=206 Identities=21% Similarity=0.254 Sum_probs=170.0
Q ss_pred hhhhHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 22 SKLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 22 ~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
-....+..+.+.+|-.+|.+| .||.|++|+-.|++...+|+|+||+++|+|.+++.. ...|++...+.++.+|+.
T Consensus 110 ~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIld 185 (604)
T KOG0592|consen 110 YIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILD 185 (604)
T ss_pred HHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHH
Confidence 334445566678899999999 699999999999999999999999999999999987 577999999999999999
Q ss_pred Hhchhhcc--------CceeeecCCCceEEcccccccccCCcccc---------cc--cccccCCCcccCcccccccCCC
Q 041655 101 GLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH---------IT--TSDVVGTAGYIAPEYQQTLSIT 161 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~---------~~--~~~~~~~~~~~apE~~~~~~~~ 161 (238)
||+|||++ |.|||+|.+++++|.|||.++.++..... .. ..+++||..|.+||++.+...+
T Consensus 186 AleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~ 265 (604)
T KOG0592|consen 186 ALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG 265 (604)
T ss_pred HHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCC
Confidence 99999954 77899999999999999999987643222 11 1458999999999999999999
Q ss_pred ccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcchHHHHH
Q 041655 162 YMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKERHVRCML 233 (238)
Q Consensus 162 ~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R~v~~~L 233 (238)
..+|+|+|||+||+|+.|.+||....+....+++++-.+ ..+...+....+++.+.|..||.+|-..+.|
T Consensus 266 ~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qI 335 (604)
T KOG0592|consen 266 PSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQI 335 (604)
T ss_pred cccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHH
Confidence 999999999999999999999987655555555555433 3344445667788888999999999333333
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=246.55 Aligned_cols=205 Identities=21% Similarity=0.239 Sum_probs=170.3
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCe-eEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGC-HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
+...++...+|+.++++++|||||.+.+.|..++. .+|+|+||+||++.+.+.... +..++++.+..|+.|++.|+.
T Consensus 43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ 120 (426)
T KOG0589|consen 43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVN 120 (426)
T ss_pred CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHH
Confidence 34456688999999999999999999999999888 899999999999999998733 567899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
|||.+ ..||+++.++.++|+|||+++.+..... ...+..||+.|+.||++.+.+|+.++|+|||||++||
T Consensus 121 ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yE 198 (426)
T KOG0589|consen 121 YLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYE 198 (426)
T ss_pred HHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHH
Confidence 99954 5679999999999999999998765541 2366899999999999999999999999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|++.+++|....-.....++.... ....+.....++..++..|++++|+.| .+.+.|.
T Consensus 199 m~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 199 MCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred HHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence 999999887655444444444433 233445555667778888999999999 5555443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=248.57 Aligned_cols=213 Identities=22% Similarity=0.264 Sum_probs=172.6
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
+||||.+.... .++..+.+.+|+.+|..++++||.++||.+..+..+|++|||+.||++.+.+..
T Consensus 40 ~vAiKii~Le~-------------~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~-- 104 (467)
T KOG0201|consen 40 VVAIKIIDLEE-------------AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS-- 104 (467)
T ss_pred eEEEEEechhh-------------cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc--
Confidence 37777776543 446788899999999999999999999999999999999999999999999975
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
...+.+..+.-++++++.|+.||| .+..||++..+|.+||.|||++..++.... ...++.||+.||||
T Consensus 105 --~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--rr~tfvGTPfwMAP 180 (467)
T KOG0201|consen 105 --GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--RRKTFVGTPFWMAP 180 (467)
T ss_pred --CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--ccccccccccccch
Confidence 445577888888999999999999 446779999999999999999987654322 22568999999999
Q ss_pred ccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 153 EYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 153 E~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
|++....|+.++||||||++.+||.+|.+|+..... ..+.-.+.....+.....+...+.+++..||++||+.| ...+
T Consensus 181 EVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-mrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~ 259 (467)
T KOG0201|consen 181 EVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-MRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKE 259 (467)
T ss_pred hhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-ceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHH
Confidence 999988999999999999999999999999876554 33333444444443333555567777777999999999 4444
Q ss_pred HH
Q 041655 232 ML 233 (238)
Q Consensus 232 ~L 233 (238)
.|
T Consensus 260 LL 261 (467)
T KOG0201|consen 260 LL 261 (467)
T ss_pred Hh
Confidence 44
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=233.80 Aligned_cols=202 Identities=21% Similarity=0.281 Sum_probs=170.7
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH- 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH- 106 (238)
...+++.|+.+|.+.++|++|++||.+..+..+|+|||||..|++.+.+.- .++++++.++..+++.-++||+|||
T Consensus 71 DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~ 147 (502)
T KOG0574|consen 71 DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHD 147 (502)
T ss_pred hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHH
Confidence 367889999999999999999999999999999999999999999999875 4688999999999999999999999
Q ss_pred -------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 107 -------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 107 -------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
.|..|||++.+|+.||.|||++..+++.- ....+..|||.|||||++..-.|++++||||+|++..||..|
T Consensus 148 ~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG 225 (502)
T KOG0574|consen 148 LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG 225 (502)
T ss_pred HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC
Confidence 56788999999999999999998765422 123567899999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCccccccc-ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 180 VKWMRNVMTSENPKRAIDSK-LLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
++|+........+..+-... ..-..+.....++-++++.||-++|++| +..+.++
T Consensus 226 ~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 226 RPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 99987655444443333222 2234577788889999999999999999 5555443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=244.66 Aligned_cols=222 Identities=23% Similarity=0.285 Sum_probs=172.9
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhh
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILND 78 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~ 78 (238)
.||||.+.+........-.......--..+...+|+.+|++++|||||+++.+..+. +.+|+|+|||..|.+...-.
T Consensus 124 l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~- 202 (576)
T KOG0585|consen 124 LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP- 202 (576)
T ss_pred EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC-
Confidence 489999988765332211111111111246789999999999999999999999754 67899999999887655432
Q ss_pred hcCCCcc-cCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcc---cccccccccCC
Q 041655 79 VSRGRRQ-LDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAH---THITTSDVVGT 146 (238)
Q Consensus 79 ~~~~~~~-~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~ 146 (238)
..+ +++.+++++++++..||+||| .||.|+|++++|++||+|||.+....... .........||
T Consensus 203 ----d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGT 278 (576)
T KOG0585|consen 203 ----DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGT 278 (576)
T ss_pred ----CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCC
Confidence 344 999999999999999999999 66889999999999999999997653221 11112336899
Q ss_pred CcccCcccccccC----CCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCC
Q 041655 147 AGYIAPEYQQTLS----ITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLD 222 (238)
Q Consensus 147 ~~~~apE~~~~~~----~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~ 222 (238)
|.|+|||.+.++. .+.+.||||+|++||.++.|.-||......+...+++...+......+....+.++++++|.+
T Consensus 279 PAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~K 358 (576)
T KOG0585|consen 279 PAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEK 358 (576)
T ss_pred ccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhc
Confidence 9999999987733 367899999999999999999999887776777777777775555556677788999999999
Q ss_pred CCCcc
Q 041655 223 DPKER 227 (238)
Q Consensus 223 ~p~~R 227 (238)
||++|
T Consensus 359 dP~~R 363 (576)
T KOG0585|consen 359 DPEQR 363 (576)
T ss_pred Chhhe
Confidence 99999
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=246.04 Aligned_cols=217 Identities=20% Similarity=0.304 Sum_probs=172.7
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+.-... ..++.+.|.+|+.++++-+|.||+-+.|+|..++. .||+.+|+|.+|..++..
T Consensus 417 VAVK~Lnv~~p------------t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv--- 480 (678)
T KOG0193|consen 417 VAVKLLNVDDP------------TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV--- 480 (678)
T ss_pred eEEEEEecCCC------------CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc---
Confidence 78888865543 34689999999999999999999999999998877 899999999999999976
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhccCc--------eeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMHQA--------LVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~~~--------~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
....|.......|+.|++.|+.|||.|++ ||++++++.|||+|||++..-..-..........|...|||||
T Consensus 481 ~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPE 560 (678)
T KOG0193|consen 481 QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPE 560 (678)
T ss_pred hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHH
Confidence 45789999999999999999999997754 5999999999999999986533211111124457889999999
Q ss_pred ccc---ccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc----cCCChHHHHHHHHHHhhhhcCCCCCc
Q 041655 154 YQQ---TLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL----LGNGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 154 ~~~---~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
+++ .++|++++||||||+++|||++|..||. ....+.+--.+-.++ .....++++.++.+++..||..++++
T Consensus 561 vIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~e 639 (678)
T KOG0193|consen 561 VIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREE 639 (678)
T ss_pred HHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCccc
Confidence 875 5679999999999999999999999998 333333322233332 22356788888999999999999999
Q ss_pred c----hHHHHHHh
Q 041655 227 R----HVRCMLSQ 235 (238)
Q Consensus 227 R----~v~~~L~~ 235 (238)
| ++...|+.
T Consensus 640 RP~F~~il~~l~~ 652 (678)
T KOG0193|consen 640 RPLFPQLLSKLEE 652 (678)
T ss_pred CccHHHHHHHHHH
Confidence 9 55554444
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=236.44 Aligned_cols=200 Identities=20% Similarity=0.289 Sum_probs=167.7
Q ss_pred HHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHH
Q 041655 18 VEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRG 97 (238)
Q Consensus 18 ~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 97 (238)
++++...++..+-++.+|+++|..|+||||+.++.+|++.+...+||||..+|.|.+|+.+ ...+++.+++.+++|
T Consensus 86 IrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQ 161 (668)
T KOG0611|consen 86 IRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQ 161 (668)
T ss_pred hhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHH
Confidence 3444556667788899999999999999999999999999999999999999999999987 678999999999999
Q ss_pred HHHHhchhhccC--------ceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCC-CccCCeee
Q 041655 98 IASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYS 168 (238)
Q Consensus 98 l~~gl~~lH~~~--------~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~-~~~~Dvws 168 (238)
|.+++.|+|.+. .|||+|.++++||.|||++.++..... ..+++|+|.|++||++.+.+| ++..|.||
T Consensus 162 IvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWs 238 (668)
T KOG0611|consen 162 IVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWS 238 (668)
T ss_pred HHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhh
Confidence 999999999664 469999999999999999988766554 256899999999999999888 67899999
Q ss_pred hhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 169 FGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 169 lG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
||++||.++.|.-||+.......+..+...-+.. .+.+.+...+|..+|..||+.|
T Consensus 239 LGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIRwmLmVNP~RR 294 (668)
T KOG0611|consen 239 LGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---PETPSDASGLIRWMLMVNPERR 294 (668)
T ss_pred HHHHHHHHhhcccccCCchHHHHHHHhhcccccC---CCCCchHHHHHHHHHhcCcccc
Confidence 9999999999999998755444444444333322 2223345567888999999999
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=246.03 Aligned_cols=213 Identities=22% Similarity=0.288 Sum_probs=163.6
Q ss_pred hhHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC---------------------
Q 041655 24 LLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR--------------------- 81 (238)
Q Consensus 24 ~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------------------- 81 (238)
...+..+.+.+|+.+++.+ +||||+++++++...+..+++|||+++|+|.+++.....
T Consensus 80 ~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (374)
T cd05106 80 AHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKN 159 (374)
T ss_pred CCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccc
Confidence 3344567889999999999 799999999999999999999999999999999854210
Q ss_pred ---------------------------------------------CCcccCHHHHHHHHHHHHHHhchhhcc--------
Q 041655 82 ---------------------------------------------GRRQLDWLARYRTVRGIASGLEYLHMH-------- 108 (238)
Q Consensus 82 ---------------------------------------------~~~~~~~~~~~~~~~~l~~gl~~lH~~-------- 108 (238)
....+++..+..++.|+++||.|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLk 239 (374)
T cd05106 160 ITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVA 239 (374)
T ss_pred cchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCc
Confidence 113478888999999999999999955
Q ss_pred CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hHHHHHHhh
Q 041655 109 QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNVM 187 (238)
Q Consensus 109 ~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~ 187 (238)
+.||+++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 240 p~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 240 ARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred hheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 6789999999999999999876533222112223345678999999988889999999999999999997 888886544
Q ss_pred ccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 188 TSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
.................+...+.++.+++.+||+.||.+| +++++|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 320 VNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 3332323333322222233345678888999999999999 777777765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=239.29 Aligned_cols=217 Identities=21% Similarity=0.264 Sum_probs=163.8
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhh
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILND 78 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~ 78 (238)
+||+|++....... ....-..||+.+|++|+||||+++.+...+. ..+|+|+||++. +|..++.+
T Consensus 144 ivALKKvr~d~~~~------------~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~ 210 (560)
T KOG0600|consen 144 IVALKKVRFDNEKE------------GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS 210 (560)
T ss_pred EEEEEEeecccCCC------------cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC
Confidence 47777776554321 2234457999999999999999999998776 689999999975 99999875
Q ss_pred hcCCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCccc
Q 041655 79 VSRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYI 150 (238)
Q Consensus 79 ~~~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 150 (238)
+.-.|++.+++.++.|+++||+|+| .|+.|||+|++|.+||+|||+++++....... .+..+-|..|.
T Consensus 211 ---p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYR 286 (560)
T KOG0600|consen 211 ---PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYR 286 (560)
T ss_pred ---CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeecc
Confidence 5678999999999999999999999 45778999999999999999999886654433 35567799999
Q ss_pred Ccccccc-cCCCccCCeeehhHHHHhhcchHHHHHHhhccC--------------CCccccc----cccc---------C
Q 041655 151 APEYQQT-LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSE--------------NPKRAID----SKLL---------G 202 (238)
Q Consensus 151 apE~~~~-~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~--------------~~~~~~~----~~~~---------~ 202 (238)
|||++.+ ..|+...|+||.||++.||++|++.+....+-+ ......+ ..+. .
T Consensus 287 pPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~ 366 (560)
T KOG0600|consen 287 PPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLR 366 (560)
T ss_pred ChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHH
Confidence 9997765 468999999999999999999877664332211 1111000 0000 0
Q ss_pred CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 203 NGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 203 ~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+.....+...++++..+|..||.+| ++...|+
T Consensus 367 E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 367 ETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1123345556778888999999999 6666554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=227.67 Aligned_cols=215 Identities=20% Similarity=0.267 Sum_probs=162.0
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
+||||++.....+. ...+-.+||+.+|+++.|+|+|.+..+|......++|+|||+. ++.+-+..
T Consensus 29 IVAIKkF~Esedd~------------~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~-- 93 (396)
T KOG0593|consen 29 IVAIKKFVESEDDP------------VVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELER-- 93 (396)
T ss_pred EEEEEeeccCCccH------------HHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHh--
Confidence 48888887655432 2334468999999999999999999999999999999999976 55555554
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
....++...+..++.|++.|+.|+| .||.||+++.+|.+||+|||.|+.+..... ..+....|..|.||
T Consensus 94 -~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWYRaP 170 (396)
T KOG0593|consen 94 -YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NYTDYVATRWYRAP 170 (396)
T ss_pred -ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--hhhhhhhhhhccCh
Confidence 3455888999999999999999999 457889999999999999999998764322 24567889999999
Q ss_pred ccccc-cCCCccCCeeehhHHHHhhcchHHHHHHhhcc-----------------------CCCccccc------ccccC
Q 041655 153 EYQQT-LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTS-----------------------ENPKRAID------SKLLG 202 (238)
Q Consensus 153 E~~~~-~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~-----------------------~~~~~~~~------~~~~~ 202 (238)
|.+.+ ..|+...||||+||++.||.+|.+.|.+..+- ......+. .....
T Consensus 171 ELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe 250 (396)
T KOG0593|consen 171 ELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLE 250 (396)
T ss_pred hhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchh
Confidence 98776 78999999999999999999986655322211 11111110 00011
Q ss_pred CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 203 NGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 203 ~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
..++....-+++++++||+.||.+| ...+.|
T Consensus 251 ~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 251 RKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred hhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 1233445568999999999999999 444433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=251.74 Aligned_cols=206 Identities=20% Similarity=0.209 Sum_probs=170.4
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
+|||.+.++. ....+..+....|-.++.-.+ ||+++.++..|++.+++|+||||+.||++..+..
T Consensus 396 yAIK~LKK~~-----------Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~--- 461 (694)
T KOG0694|consen 396 YAIKVLKKGD-----------ILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH--- 461 (694)
T ss_pred EEEEEeeccc-----------eeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEe---
Confidence 5666665543 455567788888888887775 9999999999999999999999999999555553
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhccCc--------eeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQA--------LVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~~~--------~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
...+++..+.-++..++.||.|||.+++ |||+|.+|++||+|||+++.-- .....+++++|||.|+||
T Consensus 462 --~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g~~TsTfCGTpey~aP 537 (694)
T KOG0694|consen 462 --TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQGDRTSTFCGTPEFLAP 537 (694)
T ss_pred --cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--CCCCccccccCChhhcCh
Confidence 3679999999999999999999998865 5999999999999999997432 122245789999999999
Q ss_pred ccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 153 EYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 153 E~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|++.+..|+..+|+|||||++|||+.|.+||....+++....++.... .+|.-.+.+.++++.+.|.+||++|
T Consensus 538 Eil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~--~yP~~ls~ea~~il~~ll~k~p~kR 610 (694)
T KOG0694|consen 538 EVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV--RYPRFLSKEAIAIMRRLLRKNPEKR 610 (694)
T ss_pred hhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--CCCCcccHHHHHHHHHHhccCcccc
Confidence 999999999999999999999999999999987666666655555443 2444555667788888999999999
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=243.48 Aligned_cols=209 Identities=22% Similarity=0.253 Sum_probs=157.3
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------------------
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------------------ 81 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------------------ 81 (238)
...+.+.+|+.++..+ +||||+++++++..++..++||||+++|+|.+++.....
T Consensus 80 ~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (375)
T cd05104 80 TEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQRE 159 (375)
T ss_pred HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhc
Confidence 3456788999999999 799999999999999999999999999999999864211
Q ss_pred -----------------------------------------------CCcccCHHHHHHHHHHHHHHhchhhcc------
Q 041655 82 -----------------------------------------------GRRQLDWLARYRTVRGIASGLEYLHMH------ 108 (238)
Q Consensus 82 -----------------------------------------------~~~~~~~~~~~~~~~~l~~gl~~lH~~------ 108 (238)
....+++..+..++.|+++||.|||++
T Consensus 160 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~D 239 (375)
T cd05104 160 MSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239 (375)
T ss_pred ccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 012478888999999999999999954
Q ss_pred --CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hHHHHHH
Q 041655 109 --QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRN 185 (238)
Q Consensus 109 --~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~ 185 (238)
|.||+++.++.+||+|||+++...............++..|+|||++.+..++.++|+||||+++|+|++ |..||..
T Consensus 240 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 240 LAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred CchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 6679999999999999999876543322111222345677999999998899999999999999999998 6666643
Q ss_pred hhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 186 VMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
..........+........+...+.++.+++..||+.||++| ++++.|++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 322222222222222222233345568889999999999999 55555543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=252.71 Aligned_cols=218 Identities=22% Similarity=0.330 Sum_probs=185.6
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
.||||-+..+- .++++..|+.|..+|-+++||||++|-|+........|++||+++|+|+.||..
T Consensus 659 ~VAIKTLK~Gy-------------tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~-- 723 (996)
T KOG0196|consen 659 TVAIKTLKAGY-------------TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ-- 723 (996)
T ss_pred eEEEeeeccCc-------------cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh--
Confidence 36777665543 356788999999999999999999999999999999999999999999999986
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCccccccccccc--CCCccc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVV--GTAGYI 150 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~--~~~~~~ 150 (238)
.+..|+..+...|++.|+.|++||..- ..|||++.+..+|++|||+++.+.+.... ..++.. -+.+|.
T Consensus 724 -~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~-~ytt~GGKIPiRWT 801 (996)
T KOG0196|consen 724 -NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-AYTTLGGKIPIRWT 801 (996)
T ss_pred -cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCc-cccccCCccceeec
Confidence 456699999999999999999999733 45799999999999999999988655422 223332 247899
Q ss_pred CcccccccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc--
Q 041655 151 APEYQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-- 227 (238)
Q Consensus 151 apE~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-- 227 (238)
|||.+....++..+||||+|+++||.++ |..|++.+.+ .++-+.+..+++...|.++|..|-++|+.||++|-..|
T Consensus 802 APEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~ 880 (996)
T KOG0196|consen 802 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPK 880 (996)
T ss_pred ChhHhhhcccCchhhccccceEEEEecccCCCcccccch-HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCC
Confidence 9999999999999999999999999887 6788886554 45567778888888999999999999999999999999
Q ss_pred --hHHHHHHhh
Q 041655 228 --HVRCMLSQI 236 (238)
Q Consensus 228 --~v~~~L~~~ 236 (238)
+++..|.++
T Consensus 881 F~qiV~~lDkl 891 (996)
T KOG0196|consen 881 FAQIVSTLDKL 891 (996)
T ss_pred HHHHHHHHHHH
Confidence 888877765
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=242.87 Aligned_cols=210 Identities=22% Similarity=0.288 Sum_probs=161.8
Q ss_pred HHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------------------
Q 041655 27 EEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------------------ 81 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------------------ 81 (238)
...+.+.+|+.++.+++ ||||+++++++.+.+..|+||||+++|+|.+++.....
T Consensus 82 ~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (400)
T cd05105 82 SEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADE 161 (400)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccc
Confidence 34567999999999996 99999999999999999999999999999998864210
Q ss_pred --------------------------------------------------------------------CCcccCHHHHHH
Q 041655 82 --------------------------------------------------------------------GRRQLDWLARYR 93 (238)
Q Consensus 82 --------------------------------------------------------------------~~~~~~~~~~~~ 93 (238)
....+++..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~ 241 (400)
T cd05105 162 STRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLS 241 (400)
T ss_pred cccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHH
Confidence 012478888899
Q ss_pred HHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCC
Q 041655 94 TVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCD 165 (238)
Q Consensus 94 ~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~D 165 (238)
++.|+++||.|||.+ +.||+++.++.+||+|||+++...............++..|+|||.+.+..++.++|
T Consensus 242 ~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 321 (400)
T cd05105 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSD 321 (400)
T ss_pred HHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhh
Confidence 999999999999955 667999999999999999987654332222223345678899999998888999999
Q ss_pred eeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 166 IYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 166 vwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|||||+++|+|++ |..||............+........+...+..+.+++.+||+.||++| ++.++|+++
T Consensus 322 iwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 322 VWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred HHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 9999999999987 7777654332222222222222233344556778899999999999999 677777665
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=243.08 Aligned_cols=191 Identities=19% Similarity=0.171 Sum_probs=154.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++..++||||+++++++.+++..+++|||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 72 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~L 147 (340)
T PTZ00426 72 QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYL 147 (340)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34566788999999999999999999999999999999999999999999975 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ |.||+++.++.+||+|||++....... ....||+.|+|||++.+..++.++|+||+||++|+|+
T Consensus 148 H~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 222 (340)
T PTZ00426 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222 (340)
T ss_pred HHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHh
Confidence 955 667999999999999999987653321 3357899999999998888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||................. ..+......+.+++.+||+.||++|
T Consensus 223 ~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R 270 (340)
T PTZ00426 223 VGCPPFYANEPLLIYQKILEGII--YFPKFLDNNCKHLMKKLLSHDLTKR 270 (340)
T ss_pred cCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHc
Confidence 99998864322111222222211 1223334456788888999999999
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=237.22 Aligned_cols=194 Identities=23% Similarity=0.253 Sum_probs=155.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.++.+++||||+++++.+..++..++||||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 34 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l 109 (312)
T cd05585 34 RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENL 109 (312)
T ss_pred hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34566788999999999999999999999999999999999999999999875 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ |.||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+||++|+|+
T Consensus 110 H~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 187 (312)
T cd05585 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187 (312)
T ss_pred HhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHH
Confidence 955 5679999999999999999875422221 123457899999999999988999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||................. ..+......+.+++.+||+.||++|
T Consensus 188 tg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 188 TGLPPFYDENVNEMYRKILQEPL--RFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred hCCCCcCCCCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 99999864322211122222111 2233344567788888999999999
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=240.98 Aligned_cols=190 Identities=19% Similarity=0.211 Sum_probs=153.7
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++.+++||||+++++.+..++..+++|||+++|+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 60 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH 135 (329)
T PTZ00263 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLH 135 (329)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999999999999999999999999999875 456788999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.++.+||+|||++....... ....|++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 136 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 210 (329)
T PTZ00263 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIA 210 (329)
T ss_pred HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHc
Confidence 55 567999999999999999987654322 23578999999999998889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||...........+..... ..+......+.+++.+||+.||.+|
T Consensus 211 g~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R 257 (329)
T PTZ00263 211 GYPPFFDDTPFRIYEKILAGRL--KFPNWFDGRARDLVKGLLQTDHTKR 257 (329)
T ss_pred CCCCCCCCCHHHHHHHHhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHc
Confidence 9998854221111111222211 1222234557788888999999999
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=234.82 Aligned_cols=203 Identities=18% Similarity=0.208 Sum_probs=151.9
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC---------------CCcccCHH
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR---------------GRRQLDWL 89 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---------------~~~~~~~~ 89 (238)
.......|.+|+.++.+++||||+++++++.+.+..+++|||+++|+|.+++..... ....+++.
T Consensus 59 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (304)
T cd05096 59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYS 138 (304)
T ss_pred CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHH
Confidence 344567899999999999999999999999999999999999999999999865211 11346788
Q ss_pred HHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCC
Q 041655 90 ARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSIT 161 (238)
Q Consensus 90 ~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~ 161 (238)
.+..++.|++.||.|||.+ +.||+++.++.+||+|||.++...............++..|+|||++.+..++
T Consensus 139 ~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 218 (304)
T cd05096 139 SLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT 218 (304)
T ss_pred HHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC
Confidence 8999999999999999954 67899999999999999998765332222222334567889999998888899
Q ss_pred ccCCeeehhHHHHhhcch--HHHHHHhhccCCCcc---ccc---ccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 162 YMCDIYSFGVLLAEEMSL--VKWMRNVMTSENPKR---AID---SKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 162 ~~~DvwslG~~l~~~~t~--~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.++|+||||+++|+|+++ ..||........... ... .......+...+..+.+++.+||+.||++|
T Consensus 219 ~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 219 TASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred chhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhC
Confidence 999999999999999864 444432211110000 000 011111233455678899999999999999
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=231.45 Aligned_cols=210 Identities=24% Similarity=0.287 Sum_probs=162.6
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCC------------CcccCHHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG------------RRQLDWLARY 92 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~ 92 (238)
.......|.+|+.++.+++||||+++++++...+..++++||+++++|.+++...... ...+++..+.
T Consensus 48 ~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 127 (283)
T cd05048 48 EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127 (283)
T ss_pred CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHH
Confidence 3445677899999999999999999999999988999999999999999999752111 1457889999
Q ss_pred HHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.|++.||.|||.+ +.||++++++.++|+|||++................+++.|+|||.+.+..++.++
T Consensus 128 ~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 207 (283)
T cd05048 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES 207 (283)
T ss_pred HHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhh
Confidence 9999999999999944 67899999999999999998754332222222334567889999999888899999
Q ss_pred CeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 165 DIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 165 DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
|+|||||++|||++ |..||....... ....+..+.....+...+..+.+++.+||+.||.+| ++.+.|++
T Consensus 208 Dv~slG~il~el~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 208 DIWSFGVVLWEIFSYGLQPYYGFSNQE-VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 99999999999998 877775433221 222222333334455667788999999999999999 55555543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=240.99 Aligned_cols=218 Identities=18% Similarity=0.229 Sum_probs=180.8
Q ss_pred ChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHH
Q 041655 13 DATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92 (238)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 92 (238)
=++++|.....-..+..+.|++|..+|+.++||||++++|+|.+. ..|+|||.++-|.|.+|+.. ....++.....
T Consensus 419 iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ 494 (974)
T KOG4257|consen 419 IAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQ---NKDSLPLRTLT 494 (974)
T ss_pred eeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHh---ccccchHHHHH
Confidence 344555554444556689999999999999999999999999876 57999999999999999986 45668888999
Q ss_pred HHHHHHHHHhchhhccC--------ceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~~--------~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.|++.+|.|||++. .||++.+...+||+|||+++.+.+...... +.-.-++.|||||.+.-..++.++
T Consensus 495 ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtAS 573 (974)
T KOG4257|consen 495 LYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTAS 573 (974)
T ss_pred HHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhc-cccccceeecCccccchhcccchh
Confidence 99999999999999774 469999999999999999998876544433 233456889999999999999999
Q ss_pred CeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 165 DIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 165 DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|||.||+++||+++ |..||... .+.++-..+..+.+...|.++|..+..++.+||+.+|.+| ++...|.++
T Consensus 574 DVWMFgVCmWEIl~lGvkPfqgv-kNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 574 DVWMFGVCMWEILSLGVKPFQGV-KNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred hHHHHHHHHHHHHHhcCCccccc-cccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 99999999999987 68888854 4445555666666778899999999999999999999999 555555554
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=233.03 Aligned_cols=206 Identities=26% Similarity=0.319 Sum_probs=156.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+..+.|.+|++.+.+++||||++++|++...+..++|+||+++|+|.+++.. .....+++..+..++.|+++||.||
T Consensus 42 ~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~--~~~~~~~~~~~~~i~~~i~~~l~~L 119 (259)
T PF07714_consen 42 EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKS--KNKEPLSEQQRLSIAIQIAEALSYL 119 (259)
T ss_dssp HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHH--TCTTTSBHHHHHHHHHHHHHHHHHH
T ss_pred cccceeeeecccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccc
Confidence 34578899999999999999999999999988889999999999999999987 2246789999999999999999999
Q ss_pred hccC--------ceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~~--------~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|+++ .||+++.++.+||+|||++....................|+|||.+.+..++.++||||||+++||++
T Consensus 120 h~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~ 199 (259)
T PF07714_consen 120 HSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEIL 199 (259)
T ss_dssp HHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9664 45999999999999999987663222222223345677899999998888999999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+ |..|+..... ......+........+...+..+.+++..||+.||++| +..+.++
T Consensus 200 ~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 200 TLGKFPFSDYDN-EEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TTSSGTTTTSCH-HHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccc-ccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 9 5676644322 22222223333344455567778889999999999999 4443333
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=249.42 Aligned_cols=200 Identities=19% Similarity=0.193 Sum_probs=157.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.+++.++||||+++++.+..++..|+||||+++|+|.+++........++++..+..++.|++.||.|+|
T Consensus 107 ~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH 186 (478)
T PTZ00267 107 RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186 (478)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34456788999999999999999999999999999999999999999988653334557899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ |.||+++.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 187 ~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t 266 (478)
T PTZ00267 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266 (478)
T ss_pred hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHh
Confidence 54 6689999999999999999987654332222345678999999999998889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||................. ...+...+..+.+++.+||+.||++|
T Consensus 267 g~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R 314 (478)
T PTZ00267 267 LHRPFKGPSQREIMQQVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALR 314 (478)
T ss_pred CCCCCCCCCHHHHHHHHHhCCC-CCCCccCCHHHHHHHHHHhccChhhC
Confidence 9988753221111111111111 11223344567888889999999999
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=236.19 Aligned_cols=190 Identities=20% Similarity=0.245 Sum_probs=153.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++||||+++++.+.+.+..+++|||+++|+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 43 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH 118 (291)
T cd05612 43 KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLH 118 (291)
T ss_pred HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999975 456889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ |.||+++.++.+||+|||++....... ....|++.|+|||++.+..++.++|||||||++|+|++
T Consensus 119 ~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~ 193 (291)
T cd05612 119 SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV 193 (291)
T ss_pred HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 55 567999999999999999987653321 23568999999999988889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||................. ..+......+.+++.+||+.||.+|
T Consensus 194 g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R 240 (291)
T cd05612 194 GYPPFFDDNPFGIYEKILAGKL--EFPRHLDLYAKDLIKKLLVVDRTRR 240 (291)
T ss_pred CCCCCCCCCHHHHHHHHHhCCc--CCCccCCHHHHHHHHHHcCCCHHHc
Confidence 9988754322111122222111 2223334567888889999999999
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=220.06 Aligned_cols=219 Identities=23% Similarity=0.312 Sum_probs=173.6
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
+|+|+|+...... ....-.+-+++-.+|+.+|+++. ||+|+.+.+.++++.++++|+|.++.|.|.+++.+
T Consensus 45 ~a~kii~~~at~~------~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts-- 116 (411)
T KOG0599|consen 45 FAVKIIDVTATTE------SGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS-- 116 (411)
T ss_pred eeEEEEEeccccc------CCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh--
Confidence 5777776554421 11223445667788999999996 99999999999999999999999999999999986
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
.-.++++..+.+++|+.+|++||| .|+.||+++++-+++|+|||.++.+..... ....+|||.|+||
T Consensus 117 --~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAP 191 (411)
T KOG0599|consen 117 --KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAP 191 (411)
T ss_pred --heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCchh---HHHhcCCCcccCh
Confidence 577999999999999999999999 457889999999999999999998766543 2557999999999
Q ss_pred ccccc------cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCC
Q 041655 153 EYQQT------LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDP 224 (238)
Q Consensus 153 E~~~~------~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p 224 (238)
|.+.+ ..|+...|+|+.|+++|.++.|.+||+-.-..--...+....+ ......+......+++.+||+.||
T Consensus 192 EtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp 271 (411)
T KOG0599|consen 192 ETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDP 271 (411)
T ss_pred hheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCc
Confidence 98764 3477789999999999999999999975433222333333333 333455666667788888999999
Q ss_pred Ccc-hHHHHH
Q 041655 225 KER-HVRCML 233 (238)
Q Consensus 225 ~~R-~v~~~L 233 (238)
.+| ++-+.|
T Consensus 272 ~~Ritake~L 281 (411)
T KOG0599|consen 272 TKRITAKEAL 281 (411)
T ss_pred hhcccHHHHh
Confidence 999 554444
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=243.44 Aligned_cols=204 Identities=20% Similarity=0.267 Sum_probs=170.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..++|+.|..+|+.+.|||+|+++|+|..+..+|||+||+..|+|.+|+.+ .....++....+.|+.||.+|++||..
T Consensus 306 eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRe--cnr~ev~avvLlyMAtQIsSaMeYLEk 383 (1157)
T KOG4278|consen 306 EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRE--CNRSEVPAVVLLYMATQISSAMEYLEK 383 (1157)
T ss_pred hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHH--hchhhcchhHHHHHHHHHHHHHHHHHH
Confidence 468999999999999999999999999999999999999999999999986 345567788889999999999999975
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ ..|+|+..+..+|+.|||+++++........ ....-.+.|.|||.+..+.++.++|||+||++|||+.|.
T Consensus 384 knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATY 462 (1157)
T KOG4278|consen 384 KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATY 462 (1157)
T ss_pred hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhc
Confidence 5 4469999999999999999998866543322 122336789999999999999999999999999999984
Q ss_pred -HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 180 -VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 180 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
-.|+. ..+...+...+..+++-+.+..|+.++.++|..||+.+|.+| ++-+.++.
T Consensus 463 GMsPYP-GidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 463 GMSPYP-GIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred CCCCCC-CccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 34443 333445556777788888899999999999999999999999 55555543
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=235.20 Aligned_cols=194 Identities=22% Similarity=0.184 Sum_probs=153.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.+++.++||||+++++.+..++..++||||+++|+|.+++.. ...+++..+..++.|++.||+||
T Consensus 36 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~L 111 (328)
T cd05593 36 KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYL 111 (328)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567788999999999999999999999999999999999999999988865 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ |.||+++.++.+||+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 112 H~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell 189 (328)
T cd05593 112 HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189 (328)
T ss_pred HhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHh
Confidence 955 6679999999999999999875322111 123357899999999998888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||................ ...+.....++.+++.+||+.||++|
T Consensus 190 tG~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 190 CGRLPFYNQDHEKLFELILMED--IKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred hCCCCCCCCCHHHHHHHhccCC--ccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 9999885422111111111111 12233345567788888999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=230.70 Aligned_cols=194 Identities=24% Similarity=0.247 Sum_probs=152.8
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.++.+++|+|++++++.+.+++..++++||+++|+|.+++.. .....+++..+..++.|++.||+|||++
T Consensus 44 ~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05631 44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQRE 121 (285)
T ss_pred HHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45678999999999999999999999999999999999999999888754 2234689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
|.||+++.++.++|+|||++........ .....|+..|+|||++.+..++.++||||+||++|+|++|.
T Consensus 122 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~ 198 (285)
T cd05631 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198 (285)
T ss_pred CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCC
Confidence 5679999999999999999876533221 13357899999999999989999999999999999999999
Q ss_pred HHHHHhhccCCCccccc--ccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSENPKRAID--SKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||.............. .......+...+.++.+++.+||+.||++|
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R 247 (285)
T cd05631 199 SPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247 (285)
T ss_pred CCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHh
Confidence 99864322111111100 011112233445567888888999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=235.87 Aligned_cols=198 Identities=17% Similarity=0.195 Sum_probs=154.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++..++||||+++++++..++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH 118 (333)
T cd05600 43 NEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALH 118 (333)
T ss_pred hHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999975 456889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.+||+|||++..... ......|++.|+|||++.+..++.++|||||||++|+|++
T Consensus 119 ~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 193 (333)
T cd05600 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193 (333)
T ss_pred HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh
Confidence 54 6679999999999999999875433 1234678999999999988899999999999999999999
Q ss_pred hHHHHHHhhccCCCccc------ccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRA------IDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||............ ...............++.+++.+||..+|.+| .+.+.+
T Consensus 194 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 194 GFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIK 255 (333)
T ss_pred CCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence 99887532211111111 11111111111335567788888999999888 444333
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=236.11 Aligned_cols=194 Identities=22% Similarity=0.167 Sum_probs=154.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.++.+++||||+++++.+..++..++||||+++++|.+++.. ...+++..+..++.|++.||+||
T Consensus 36 ~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~l 111 (323)
T cd05571 36 KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYL 111 (323)
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34456788999999999999999999999999999999999999999999875 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ +.||+++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|+||+||++|+|+
T Consensus 112 H~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 189 (323)
T cd05571 112 HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189 (323)
T ss_pred HhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhh
Confidence 955 667999999999999999987532211 1123457899999999999889999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||................ ...+.....++.+++.+||+.||++|
T Consensus 190 tg~~Pf~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 190 CGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 9998885422111111111111 12233445567888889999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=227.54 Aligned_cols=211 Identities=20% Similarity=0.251 Sum_probs=161.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc----------CCCcccCHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS----------RGRRQLDWLARYRTV 95 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~~~ 95 (238)
.+..+.+.+|++++++++|||++++++.+...+..+++|||+++++|.+++.... .....+++..+..++
T Consensus 49 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 128 (280)
T cd05049 49 NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128 (280)
T ss_pred HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHH
Confidence 3356789999999999999999999999999999999999999999999997521 123457889999999
Q ss_pred HHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCee
Q 041655 96 RGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIY 167 (238)
Q Consensus 96 ~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvw 167 (238)
.|++.|+.|||. ++.||+++.++.++|+|||.+................+++.|+|||++.+..++.++|+|
T Consensus 129 ~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 208 (280)
T cd05049 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 208 (280)
T ss_pred HHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHH
Confidence 999999999995 477899999999999999998754322211112234457889999999988999999999
Q ss_pred ehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhhh
Q 041655 168 SFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQIQ 237 (238)
Q Consensus 168 slG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~~ 237 (238)
|||+++|+|++ |..||......... ...........+...+..+.+++.+||+.||++| .+.+.++.++
T Consensus 209 slG~il~e~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 209 SFGVVLWEIFTYGKQPWYGLSNEEVI-ECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 99999999998 88887543322211 1111222222333455678889999999999999 5555555543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=230.25 Aligned_cols=209 Identities=22% Similarity=0.268 Sum_probs=158.4
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
....+.+.+|+.+++++ +||||+++++.+...+..++++||+++|+|.+++.. .....+++..+..++.|++.||.|
T Consensus 79 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~ 156 (302)
T cd05055 79 SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAF 156 (302)
T ss_pred hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHH
Confidence 34457889999999999 799999999999999999999999999999999865 222348999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||++ +.||+++.++.++++|||.++...............++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus 157 lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el 236 (302)
T cd05055 157 LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236 (302)
T ss_pred HHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHH
Confidence 9955 67899999999999999998765433221112234557789999999888899999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
++ |..||.....................+...+..+.+++.+||+.+|++| ++.+.++.+
T Consensus 237 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 237 FSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred HhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 98 8887654322222222222222222223344568888999999999999 444443333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=234.86 Aligned_cols=192 Identities=21% Similarity=0.218 Sum_probs=152.3
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.+++.++||||+++++.+..++..|++|||+++++|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 43 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~ 118 (323)
T cd05584 43 DTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQ 118 (323)
T ss_pred hHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999875 4567888889999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.+||+|||+++....... ......|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 119 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 196 (323)
T cd05584 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196 (323)
T ss_pred CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcC
Confidence 5 5679999999999999999864322211 12335789999999999888899999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||................. ..+......+.+++.+||+.||++|
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R 242 (323)
T cd05584 197 APPFTAENRKKTIDKILKGKL--NLPPYLTPEARDLLKKLLKRNPSSR 242 (323)
T ss_pred CCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHcccCHhHc
Confidence 998854322111112222111 2233344567888889999999999
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=236.36 Aligned_cols=218 Identities=18% Similarity=0.215 Sum_probs=172.7
Q ss_pred EeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCc
Q 041655 5 RKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRR 84 (238)
Q Consensus 5 K~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~ 84 (238)
|+-..++.-+.++.++..-...++.+....|.++|...++|+||+++-.|++.+.+|+||||+|||++..+|.. ..
T Consensus 161 rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~----~~ 236 (550)
T KOG0605|consen 161 RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR----KD 236 (550)
T ss_pred EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh----cC
Confidence 33444444455555666667788899999999999999999999999999999999999999999999999976 57
Q ss_pred ccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCccc--------------------
Q 041655 85 QLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHT-------------------- 136 (238)
Q Consensus 85 ~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~-------------------- 136 (238)
.|++..++.++.+++.|++-|| .||.|+|+|..|++||+|||++..+...+.
T Consensus 237 ~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (550)
T KOG0605|consen 237 TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPS 316 (550)
T ss_pred cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCc
Confidence 8999999999999999999999 668999999999999999999865421000
Q ss_pred -cc-----c-------------------cccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCC
Q 041655 137 -HI-----T-------------------TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSEN 191 (238)
Q Consensus 137 -~~-----~-------------------~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~ 191 (238)
.. . .-+..|||-|+|||++.+..|+..+|+||+||++|||+.|.+||.+......
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T 396 (550)
T KOG0605|consen 317 DFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQET 396 (550)
T ss_pred cccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 00 0 1123699999999999999999999999999999999999999987665555
Q ss_pred Ccccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 192 PKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 192 ~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..+++.-+. ..........+..++|.+|+. ||++|
T Consensus 397 ~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 397 YRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred HHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 555554332 111112222455667777888 99999
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=227.83 Aligned_cols=209 Identities=19% Similarity=0.246 Sum_probs=161.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLARYRTV 95 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~ 95 (238)
..+.+.+|+.++.+++||||+++++++..++..++||||+++++|.+++..... ....+++..+..++
T Consensus 50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 129 (291)
T cd05094 50 ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129 (291)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHH
Confidence 346788999999999999999999999999999999999999999999975211 12348899999999
Q ss_pred HHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCee
Q 041655 96 RGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIY 167 (238)
Q Consensus 96 ~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvw 167 (238)
.|++.||+|||.+ |.||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+|
T Consensus 130 ~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 209 (291)
T cd05094 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 209 (291)
T ss_pred HHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHH
Confidence 9999999999954 67899999999999999998755332222222334567889999999888899999999
Q ss_pred ehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 168 SFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 168 slG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|||+++|+|++ |..||......... ...........+...+..+.+++.+||+.+|++| ++.++|+++.
T Consensus 210 slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 210 SFGVILWEIFTYGKQPWFQLSNTEVI-ECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHH-HHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 99999999998 88876443221111 1111122222233455678889999999999999 7777777663
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=225.91 Aligned_cols=197 Identities=25% Similarity=0.284 Sum_probs=153.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+..+.+++||||++++|.+..++..++||||+++|+|.+++.. ....+++..++.++.|++.||+||
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~l 123 (266)
T cd05064 47 DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYL 123 (266)
T ss_pred HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34457799999999999999999999999999999999999999999999875 234689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.++++|||.+......... ......++..|+|||.+.+..++.++|+|||||++|+++
T Consensus 124 H~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell 202 (266)
T cd05064 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202 (266)
T ss_pred HHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHh
Confidence 944 67799999999999999987543221111 111233457899999998889999999999999999976
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+ |..||....... ....+........+...+..+.+++..||+.+|++|
T Consensus 203 ~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~R 252 (266)
T cd05064 203 SYGERPYWDMSGQD-VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGER 252 (266)
T ss_pred cCCCCCcCcCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 5 888876433221 111222222223345566778889999999999999
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=230.30 Aligned_cols=211 Identities=19% Similarity=0.223 Sum_probs=179.3
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
.||||+|++...+. ....++.+|+..|+-++|||||++|.+..+...+|+|+|.-.+|+|.+|+-.
T Consensus 45 kVAVKviDKTKlD~------------~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK-- 110 (864)
T KOG4717|consen 45 KVAVKVIDKTKLDT------------LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK-- 110 (864)
T ss_pred eeEEEEecccccch------------hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHh--
Confidence 38999998776543 3446788999999999999999999999999999999999999999999875
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhh--------ccCce-eeecCCCceEEcccccccccCCcccccccccccCCCcccC
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLH--------MHQAL-VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIA 151 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~-il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~a 151 (238)
....+++..+.+++.||+.++.|+| .||.| +++..-|-+||.|||++..+.+... .++.+|+..|.|
T Consensus 111 -He~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSA 186 (864)
T KOG4717|consen 111 -HEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSA 186 (864)
T ss_pred -hhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccC
Confidence 5677999999999999999999999 56777 5667789999999999876544332 356799999999
Q ss_pred cccccccCCC-ccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcchHH
Q 041655 152 PEYQQTLSIT-YMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKERHVR 230 (238)
Q Consensus 152 pE~~~~~~~~-~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R~v~ 230 (238)
||++.+..|+ +..||||||++||.++.|..||+.....+....+++-.+ ..|+....++.++|..||..||.+|..+
T Consensus 187 PEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAsl 264 (864)
T KOG4717|consen 187 PEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASL 264 (864)
T ss_pred chhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccH
Confidence 9999998885 579999999999999999999998777777777777655 3567777889999999999999999433
Q ss_pred H
Q 041655 231 C 231 (238)
Q Consensus 231 ~ 231 (238)
+
T Consensus 265 E 265 (864)
T KOG4717|consen 265 E 265 (864)
T ss_pred H
Confidence 3
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=222.72 Aligned_cols=202 Identities=19% Similarity=0.219 Sum_probs=158.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++.+++||||+++++++..++..++++||+++++|.+++.. ...+++..+..++.|++.||.|||.
T Consensus 47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~ 122 (263)
T cd06625 47 EVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHS 122 (263)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456788999999999999999999999999999999999999999999875 3568899999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++.++.++|+|||.++........ .......++..|+|||.+.+..++.++|+||+|+++|++++
T Consensus 123 ~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 202 (263)
T cd06625 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202 (263)
T ss_pred CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHh
Confidence 4 56799999999999999998755332111 11123457789999999998889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||.....................+...+..+.+++..||+.+|++| ++.+.|
T Consensus 203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 258 (263)
T cd06625 203 EKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258 (263)
T ss_pred CCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 9988754322222222222222223344455667888899999999999 554444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=226.90 Aligned_cols=211 Identities=17% Similarity=0.236 Sum_probs=160.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc---------CCCcccCHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS---------RGRRQLDWLARYRTVR 96 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~~ 96 (238)
......+.+|+.++.+++|||++++++.+...+..++++||+++++|.+++.... .....+++..+..++.
T Consensus 48 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 127 (288)
T cd05093 48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127 (288)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHH
Confidence 3456778999999999999999999999999999999999999999999987521 1123589999999999
Q ss_pred HHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeee
Q 041655 97 GIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYS 168 (238)
Q Consensus 97 ~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvws 168 (238)
|++.||+|||.+ |.||++++++.++|+|||.+................+++.|+|||++.+..++.++|+||
T Consensus 128 ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiws 207 (288)
T cd05093 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 207 (288)
T ss_pred HHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHH
Confidence 999999999944 678999999999999999987553322211222334567899999998888999999999
Q ss_pred hhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 169 FGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 169 lG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
||+++|+|++ |..||................ ....+...+..+.+++.+||+.||.+| ++.+.|+++.
T Consensus 208 lG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 208 LGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 9999999998 777764332211111111111 111222344568889999999999999 6666666653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=225.56 Aligned_cols=210 Identities=22% Similarity=0.261 Sum_probs=160.7
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc------------CCCcccCHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS------------RGRRQLDWLARY 92 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~ 92 (238)
......+.+|+.++.++ +||||+++++++..++..+++|||+++|+|.+++.... .....+++..+.
T Consensus 56 ~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 135 (293)
T cd05053 56 EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135 (293)
T ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHH
Confidence 34456788999999999 79999999999999999999999999999999986421 224568999999
Q ss_pred HHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.|++.||+|||.+ +.||+++.++.++|+|||.++.+.............++..|+|||.+.+..++.++
T Consensus 136 ~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 215 (293)
T cd05053 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS 215 (293)
T ss_pred HHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCccc
Confidence 9999999999999954 67899999999999999999865433222112223456789999999888899999
Q ss_pred CeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 165 DIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 165 DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|+|||||++|++++ |..||..... ...............+...+..+.+++.+||+.||++| ++++.|+++
T Consensus 216 Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 216 DVWSFGVLLWEIFTLGGSPYPGIPV-EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ceeehhhHHHHHhcCCCCCCCCCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 99999999999987 7666543211 11122222232333444556678899999999999999 566655554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=226.03 Aligned_cols=209 Identities=18% Similarity=0.266 Sum_probs=156.3
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCC------CcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG------RRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~l~~g 101 (238)
...++.+|+.+++.++||||+++++++..++..+++|||+++++|.+++...... ...+++..+..++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (277)
T cd05062 52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999998652211 2346788889999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|.|||.+ |.||+++.++.++|+|||.+................+++.|+|||.+.+..++.++|+||||+++
T Consensus 132 l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 211 (277)
T cd05062 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211 (277)
T ss_pred HHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHH
Confidence 9999944 67899999999999999998754332221111223456789999999888899999999999999
Q ss_pred Hhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhhh
Q 041655 174 AEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQIQ 237 (238)
Q Consensus 174 ~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~~ 237 (238)
|+|++ |..||...... ..............+...+..+.+++.+||+.||++| ++.+.++.++
T Consensus 212 ~el~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 212 WEIATLAEQPYQGMSNE-QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 99999 56665432111 1111111111122233455678889999999999999 6666666554
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=222.21 Aligned_cols=208 Identities=22% Similarity=0.332 Sum_probs=159.9
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.......|.+|+.++.+++||||+++++.+..++..+++|||+++++|.+++.. ....+++..+..++.|++.|+.|
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~ 121 (266)
T cd05033 45 SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKY 121 (266)
T ss_pred ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHH
Confidence 344567789999999999999999999999999999999999999999999865 23468999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||++ +.||+++.++.++++|||.+................+++.|+|||...+..++.++|+||||+++|++
T Consensus 122 Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l 201 (266)
T cd05033 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 201 (266)
T ss_pred HHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHH
Confidence 9954 67899999999999999999876422222111223446789999999888899999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++ |..||....... ....+........+...+..+.+++..||+.+|++| ++.+.|+++
T Consensus 202 ~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 202 MSYGERPYWDMSNQD-VIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HccCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 88 777764322111 111111111222234456678899999999999999 566655543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=215.94 Aligned_cols=208 Identities=24% Similarity=0.290 Sum_probs=174.0
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
+||+|++.+.. .......+++.+|+++-..|+||||+++|++|.+....|+++||.++|++...+..
T Consensus 49 IvalKVlfKsq-----------i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~-- 115 (281)
T KOG0580|consen 49 IVALKVLFKSQ-----------ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQE-- 115 (281)
T ss_pred EEEEeeeeHHH-----------HHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHh--
Confidence 36777776543 23334567789999999999999999999999999999999999999999998874
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
.....+++.....+..|++.||.|+|. +|.|+|++..+.+|++|||-+...+.+ ...+.+||.-|.+|
T Consensus 116 ~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~----kR~tlcgt~dyl~p 191 (281)
T KOG0580|consen 116 GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN----KRKTLCGTLDYLPP 191 (281)
T ss_pred cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC----CceeeecccccCCH
Confidence 345678999999999999999999994 477899999999999999998765422 23668999999999
Q ss_pred ccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 153 EYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 153 E~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|+..+...+...|+|++|++.||++.|.+||.+....+....+...... .++.......++|..|+.++|.+|
T Consensus 192 Emv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~--~p~~is~~a~dlI~~ll~~~p~~r 264 (281)
T KOG0580|consen 192 EMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK--FPSTISGGAADLISRLLVKNPIER 264 (281)
T ss_pred hhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc--CCcccChhHHHHHHHHhccCcccc
Confidence 9999999999999999999999999999999988866666665555442 235555566777888999999999
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=233.15 Aligned_cols=194 Identities=23% Similarity=0.192 Sum_probs=153.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.+++.++||||+++++.+..++..|+||||+++|+|..++.. ...+++..+..++.|++.||.||
T Consensus 36 ~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L 111 (323)
T cd05595 36 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL 111 (323)
T ss_pred hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34556778899999999999999999999999999999999999999988865 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ +.||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 112 H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 189 (323)
T cd05595 112 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189 (323)
T ss_pred HHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHH
Confidence 955 6679999999999999999864322111 123356899999999999888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||................. ..+...+..+.+++.+||+.||++|
T Consensus 190 ~g~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 190 CGRLPFYNQDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred hCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHccCCHHHh
Confidence 99988854322111111111111 1223345567788888999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=222.31 Aligned_cols=209 Identities=22% Similarity=0.221 Sum_probs=158.0
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 24 LLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 24 ~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
...+....+.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ....+++..+..++.|++.||.
T Consensus 32 ~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~ 108 (252)
T cd05084 32 LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGME 108 (252)
T ss_pred CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHH
Confidence 3445567899999999999999999999999999999999999999999999864 2345889999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
|||.+ +.||+++.++.+||+|||.+.................+..|+|||.+.+..++.++|+||||+++|+
T Consensus 109 ~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 188 (252)
T cd05084 109 YLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188 (252)
T ss_pred HHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHH
Confidence 99944 6789999999999999999875433211111112233457999999988889999999999999999
Q ss_pred hcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 176 EMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 176 ~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
|++ |..|+...... ..............+...+..+.+++.+||+.+|++| .+.+.++.+
T Consensus 189 ~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 189 AFSLGAVPYANLSNQ-QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred HHhCCCCCccccCHH-HHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 997 77776533221 1112222222223334456678889999999999999 444444443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=222.25 Aligned_cols=210 Identities=20% Similarity=0.296 Sum_probs=163.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+....+.+|+.+++.++|||++++++.+...+..++++||+++++|.+++.........+++..+..++.|++.||.||
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 122 (267)
T cd08228 43 AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122 (267)
T ss_pred HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999999999999999999999999999875434455688999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ +.||+++.++.++++|||.+........ ......+++.|+|||.+.+..++.++|+||+|+++|+|+
T Consensus 123 H~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~ 200 (267)
T cd08228 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred hhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence 955 5579999999999999999876543221 112356788999999998888899999999999999999
Q ss_pred chHHHHHHhhcc-CCCcccccc-cccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 178 SLVKWMRNVMTS-ENPKRAIDS-KLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 178 t~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
+|..||...... ......+.. ...+......+..+.+++.+||+.+|++| ++.+.|++++
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 201 ALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred cCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 998887532211 011111111 11222233455678889999999999999 6777766654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=224.17 Aligned_cols=210 Identities=19% Similarity=0.227 Sum_probs=159.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCC------CcccCHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG------RRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~l~~ 100 (238)
.....+.+|+.++..++|||++++++++...+..+++|||+++++|.+++...... ...+++..+..++.|++.
T Consensus 51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 130 (277)
T cd05032 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999998653211 124788899999999999
Q ss_pred Hhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 101 GLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
||.|||.+ |.||+++.++.+||+|||.++...............++..|+|||.+.+..++.++|+||||++
T Consensus 131 ~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 210 (277)
T cd05032 131 GMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVV 210 (277)
T ss_pred HHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHH
Confidence 99999954 6789999999999999999875533322122233456788999999988889999999999999
Q ss_pred HHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhhh
Q 041655 173 LAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQIQ 237 (238)
Q Consensus 173 l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~~ 237 (238)
+|++++ |..||......... +..........+...+..+.+++.+||+.+|++| ++.+.++.++
T Consensus 211 l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 211 LWEMATLAEQPYQGLSNEEVL-KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHhhccCCCCCccCCHHHHH-HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 999998 77776432221111 1222222223344456778899999999999999 5555555443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=222.49 Aligned_cols=204 Identities=19% Similarity=0.273 Sum_probs=157.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.++.+++|||++++++++...+..+++|||+++++|.+++.. .....+++..+..++.|+++||+|||.+
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~ 123 (263)
T cd05052 46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK 123 (263)
T ss_pred HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56788999999999999999999999999999999999999999999865 2345688999999999999999999944
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||++++++.+||+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 124 ~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g 202 (263)
T cd05052 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 202 (263)
T ss_pred CEeecccCcceEEEcCCCcEEeCCCccccccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCC
Confidence 67899999999999999998765432211 1112234567999999988889999999999999999998 7
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
..|+..... ......+........+...+..+.+++.+||+.||++| ++.+.|+++
T Consensus 203 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 203 MSPYPGIDL-SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCH-HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 777643211 11112222222233344456678889999999999999 555555543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=222.71 Aligned_cols=206 Identities=24% Similarity=0.281 Sum_probs=156.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+.+|+.++++++||||+++++++... ...+++|||+++++|.+++.. ..+++..+..++.|++.||.|
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~ 122 (283)
T cd05080 48 QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAY 122 (283)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999987653 457899999999999999865 358999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCccccc-ccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI-TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
||.+ |.||+++.++.++|+|||.++......... ......++..|+|||...+..++.++|+||||+++|+
T Consensus 123 lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~e 202 (283)
T cd05080 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYE 202 (283)
T ss_pred HHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHH
Confidence 9944 678999999999999999987654322211 1122345667999999988889999999999999999
Q ss_pred hcchHHHHHHhhccC--------------CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 176 EMSLVKWMRNVMTSE--------------NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|++|..|+....... ..............+...+..+.+++..||+.+|++| ++++.|++++
T Consensus 203 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 203 LLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred HHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 999987753321100 0000111111112233455678889999999999999 7777777765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=231.18 Aligned_cols=192 Identities=21% Similarity=0.237 Sum_probs=152.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++.+++||||+++++++..++..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~ 116 (318)
T cd05582 41 DRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS 116 (318)
T ss_pred hHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345677899999999999999999999999999999999999999999865 4568999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.++|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 117 ~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg 194 (318)
T cd05582 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194 (318)
T ss_pred CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccC
Confidence 5 5679999999999999999875433211 12345789999999999888889999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||................. ..+...+..+.+++.+||+.||++|
T Consensus 195 ~~p~~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~~P~~R 240 (318)
T cd05582 195 SLPFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLRALFKRNPANR 240 (318)
T ss_pred CCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHhHc
Confidence 988854322111111211111 1223344567788888999999999
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=230.66 Aligned_cols=151 Identities=22% Similarity=0.303 Sum_probs=132.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++.+++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.||
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l 119 (331)
T cd06649 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYL 119 (331)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999999975 35688999999999999999999
Q ss_pred hcc---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|++ +.||+++.++.++|+|||++....... .....|++.|+|||++.+..++.++|+|||||++|+|
T Consensus 120 H~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el 195 (331)
T cd06649 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195 (331)
T ss_pred hhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHH
Confidence 953 567999999999999999987553322 2345689999999999988899999999999999999
Q ss_pred cchHHHHH
Q 041655 177 MSLVKWMR 184 (238)
Q Consensus 177 ~t~~~~~~ 184 (238)
++|..||.
T Consensus 196 ~tg~~p~~ 203 (331)
T cd06649 196 AIGRYPIP 203 (331)
T ss_pred HhCCCCCC
Confidence 99998874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=210.44 Aligned_cols=220 Identities=21% Similarity=0.187 Sum_probs=168.7
Q ss_pred hhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecC-----CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHH
Q 041655 15 TALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP-----GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWL 89 (238)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~ 89 (238)
+++|+... .+.+..+..++|++..++++|||+++++++...+ ...|++++|...|+|.+.+......+..+++.
T Consensus 49 YAlKkI~c-~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~ 127 (302)
T KOG2345|consen 49 YALKKILC-HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEA 127 (302)
T ss_pred hhhheeec-cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHH
Confidence 34444333 3356788899999999999999999999987433 34899999999999999998877667789999
Q ss_pred HHHHHHHHHHHHhchhh----------ccCceeeecCCCceEEcccccccccCCc----cc---ccccccccCCCcccCc
Q 041655 90 ARYRTVRGIASGLEYLH----------MHQALVLLDHDMEARISEFGLAKVFPEA----HT---HITTSDVVGTAGYIAP 152 (238)
Q Consensus 90 ~~~~~~~~l~~gl~~lH----------~~~~~il~~~~~~~kl~dfg~~~~~~~~----~~---~~~~~~~~~~~~~~ap 152 (238)
+...++.++++||++|| .||.||++.+.+.+++.|||.+....-. .. ...-.....|..|.||
T Consensus 128 ~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAP 207 (302)
T KOG2345|consen 128 QILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAP 207 (302)
T ss_pred HHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCc
Confidence 99999999999999999 4588999999999999999998754311 10 0111234568999999
Q ss_pred cccc---ccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCc--ccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 153 EYQQ---TLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPK--RAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 153 E~~~---~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|.+. +...+.++|||||||+||+|+.|..||......+... .+....+.....+..+..+.++++.|++.||.+|
T Consensus 208 ELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qR 287 (302)
T KOG2345|consen 208 ELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQR 287 (302)
T ss_pred hheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccC
Confidence 9765 4456789999999999999999999998877655432 2333344333334466778889999999999999
Q ss_pred -hHHHHHHh
Q 041655 228 -HVRCMLSQ 235 (238)
Q Consensus 228 -~v~~~L~~ 235 (238)
.+-+.|..
T Consensus 288 P~i~~ll~~ 296 (302)
T KOG2345|consen 288 PTIPELLSK 296 (302)
T ss_pred CCHHHHHHH
Confidence 44444433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=230.77 Aligned_cols=215 Identities=20% Similarity=0.246 Sum_probs=163.2
Q ss_pred ChhhHHHhhhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCC-eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHH
Q 041655 13 DATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPG-CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90 (238)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 90 (238)
..+|||+...+..+-+.--=+||+..|++|+ ||||++++.++.+++ .+|+||||++ .+|.+.++. .+..|++..
T Consensus 36 ~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~---R~r~fse~~ 111 (538)
T KOG0661|consen 36 ELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKD---RNRLFSESD 111 (538)
T ss_pred ceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhh---cCCcCCHHH
Confidence 4456666666665532222368999999999 999999999999888 8999999995 599999987 378899999
Q ss_pred HHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccc-ccccCCC
Q 041655 91 RYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEY-QQTLSIT 161 (238)
Q Consensus 91 ~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~-~~~~~~~ 161 (238)
++.|+.||++||+|+| .||.|||+.....+||+|||+|+.+..+.. .+..+.|..|.|||+ +++..|+
T Consensus 112 irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys 188 (538)
T KOG0661|consen 112 IRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYS 188 (538)
T ss_pred HHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC---cchhhhcccccchHHhhhccccC
Confidence 9999999999999999 458899999999999999999997755443 356789999999996 5577899
Q ss_pred ccCCeeehhHHHHhhcchHHHHHHhhccCCC---------------------ccccc---ccccC----CChHHHHHHHH
Q 041655 162 YMCDIYSFGVLLAEEMSLVKWMRNVMTSENP---------------------KRAID---SKLLG----NGYEEQMLLVL 213 (238)
Q Consensus 162 ~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~---------------------~~~~~---~~~~~----~~~~~~~~~l~ 213 (238)
.+.|+|++||+++|+.+..+-|.+..+.+.+ ...+. +...+ .-.++...+.+
T Consensus 189 ~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~ 268 (538)
T KOG0661|consen 189 SPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAA 268 (538)
T ss_pred CchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHH
Confidence 9999999999999998855444222111100 00110 11111 11234677889
Q ss_pred HHhhhhcCCCCCcc-hHHHHHH
Q 041655 214 KTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 214 ~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+++..|+..||.+| +..+.|+
T Consensus 269 ~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 269 SLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HHHHHHhcCCCccCccHHHHhc
Confidence 99999999999999 5444443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=220.71 Aligned_cols=202 Identities=19% Similarity=0.239 Sum_probs=154.8
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+.+|+.++.+++||||+++++++...+..+++|||+++++|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 120 (256)
T cd05113 44 DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESKQ 120 (256)
T ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5688999999999999999999999988899999999999999999865 233689999999999999999999944
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
+.||+++.++.+|++|||.++........ ......++..|++||...+..++.++|+||||+++|+|++ |.
T Consensus 121 i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~ 199 (256)
T cd05113 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199 (256)
T ss_pred eeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence 67899999999999999998765332211 1112235577999999988889999999999999999998 77
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
.||............. .......+...+..+.+++.+||+.||++| ++.+.++.+
T Consensus 200 ~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 200 MPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 7764322111111111 111111222334667888889999999999 666666655
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=236.29 Aligned_cols=195 Identities=24% Similarity=0.269 Sum_probs=155.8
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 23 ~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
+.+.+.+.+++.|+..|.+++|||++.+-|+|..+...|+|||||- |+-.|.+.. ..+++.+..+..++.+.+.||
T Consensus 64 KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gL 139 (948)
T KOG0577|consen 64 KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGL 139 (948)
T ss_pred cccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHH
Confidence 4566788999999999999999999999999999999999999995 588888775 467899999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhH
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGV 171 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~ 171 (238)
+|||+. ..|||++..|.|||+|||.+....+. .++.|||+|||||++. .+.|+-++||||+|+
T Consensus 140 aYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGI 213 (948)
T KOG0577|consen 140 AYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 213 (948)
T ss_pred HHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch------hcccCCccccchhHheeccccccCCccceeeccc
Confidence 999954 56799999999999999998876543 4589999999999875 567889999999999
Q ss_pred HHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 172 LLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+..|+...++|.+++........+-.-..+.-...++...+..++..||++-|.+|
T Consensus 214 TCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeR 269 (948)
T KOG0577|consen 214 TCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQER 269 (948)
T ss_pred hhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccC
Confidence 99999999998876543322222111111111123444445555666999999999
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=234.28 Aligned_cols=203 Identities=22% Similarity=0.292 Sum_probs=157.7
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++..++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH 118 (350)
T cd05573 43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVH 118 (350)
T ss_pred cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999999999999999999999999999999999999976 356899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcc---------------------------cccccccccCCCcccC
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAH---------------------------THITTSDVVGTAGYIA 151 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~---------------------------~~~~~~~~~~~~~~~a 151 (238)
.+ +.||+++.++.+||+|||++....... .........|++.|+|
T Consensus 119 ~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 198 (350)
T cd05573 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIA 198 (350)
T ss_pred HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccC
Confidence 55 567999999999999999987654322 0011234578999999
Q ss_pred cccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccc--ccccCCChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 152 PEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID--SKLLGNGYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 152 pE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
||++.+..++.++|||||||++|+|++|..||.............. ...........+.++.+++.+||. ||.+| .
T Consensus 199 PE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~ 277 (350)
T cd05573 199 PEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLG 277 (350)
T ss_pred HHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCC
Confidence 9999998999999999999999999999998854332211112222 111111111235667788888997 99999 5
Q ss_pred -HHHHHH
Q 041655 229 -VRCMLS 234 (238)
Q Consensus 229 -v~~~L~ 234 (238)
+.+.|+
T Consensus 278 s~~~ll~ 284 (350)
T cd05573 278 SFEEIKS 284 (350)
T ss_pred CHHHHhc
Confidence 555554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=236.75 Aligned_cols=221 Identities=19% Similarity=0.202 Sum_probs=174.0
Q ss_pred cCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCH
Q 041655 9 QPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDW 88 (238)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~ 88 (238)
.+.....+..+.....+.+..+.|+-|+.+|...+||+|+++++.|+-.+.+|+..|||.||.....+.+ -+..+++
T Consensus 53 nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE---L~r~LtE 129 (1187)
T KOG0579|consen 53 NKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE---LGRVLTE 129 (1187)
T ss_pred cccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH---hccccch
Confidence 3344455555566677788999999999999999999999999999989999999999999999998876 3567999
Q ss_pred HHHHHHHHHHHHHhchhhccC--------ceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc----
Q 041655 89 LARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---- 156 (238)
Q Consensus 89 ~~~~~~~~~l~~gl~~lH~~~--------~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---- 156 (238)
.++.-+++|++.+|.|||++. .|||++-+|.++|.|||++..... ......++.|||+|||||+..
T Consensus 130 ~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~ 207 (1187)
T KOG0579|consen 130 DQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETF 207 (1187)
T ss_pred HHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccc
Confidence 999999999999999999764 469999999999999999864321 122335689999999999754
Q ss_pred -ccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccc-cccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 157 -TLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDS-KLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 157 -~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+.+|++++||||||++|.||..+.+|-.......-+.++-.. +...-.|+.+...+.+++.+||.+||..| ...+.|
T Consensus 208 KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 208 KDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred cCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 567999999999999999999987765432211111222222 22223577888888889999999999999 666655
Q ss_pred H
Q 041655 234 S 234 (238)
Q Consensus 234 ~ 234 (238)
+
T Consensus 288 ~ 288 (1187)
T KOG0579|consen 288 K 288 (1187)
T ss_pred h
Confidence 4
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=220.01 Aligned_cols=205 Identities=18% Similarity=0.194 Sum_probs=156.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
+...+.+.+|+.++++++||||+++++++.. +..++||||+++++|.+++.. ....+++..+..++.|++.||.||
T Consensus 36 ~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~l 111 (257)
T cd05115 36 KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYL 111 (257)
T ss_pred hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999998854 467899999999999999864 245689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCccccc-ccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI-TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|.+ +.||+++.++.+||+|||.+.......... ......++..|+|||.+.+..++.++|+||||+++|++
T Consensus 112 H~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 191 (257)
T cd05115 112 EGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEA 191 (257)
T ss_pred HhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 954 678999999999999999987654322211 11112335689999998888889999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
++ |..||...... .....+........+...+.++.+++.+||..+|++| ++.+.|+.
T Consensus 192 ~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 192 FSYGQKPYKKMKGP-EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred hcCCCCCcCcCCHH-HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 96 88877543221 1112222222333444556778889999999999999 55555543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=224.76 Aligned_cols=198 Identities=24% Similarity=0.239 Sum_probs=155.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+..|+.++++++||||+++.+++..++..+++|||+++|+|..++.........+++..+..++.|++.||.|||+
T Consensus 36 ~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~ 115 (280)
T cd05608 36 GYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115 (280)
T ss_pred HHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 44677889999999999999999999999999999999999999998875433344678999999999999999999996
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.++|+|||.+......... .....|++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 116 ~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g 193 (280)
T cd05608 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA 193 (280)
T ss_pred CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 5 55799999999999999998765433221 2335788999999999998999999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||................. ....+...+..+.+++.+||+.||++|
T Consensus 194 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 243 (280)
T cd05608 194 RGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKR 243 (280)
T ss_pred CCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHh
Confidence 988854221111111111100 112233455667888889999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=224.17 Aligned_cols=210 Identities=23% Similarity=0.277 Sum_probs=161.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC--------------------CCcc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR--------------------GRRQ 85 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------------------~~~~ 85 (238)
....+++.+|+.++..++||||+++++.+..++..++++||+++++|.+++..... ....
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 123 (290)
T cd05045 44 SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123 (290)
T ss_pred HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccc
Confidence 34457899999999999999999999999999999999999999999999864211 1235
Q ss_pred cCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc
Q 041655 86 LDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT 157 (238)
Q Consensus 86 ~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~ 157 (238)
+++..+..++.|++.||.|||.+ |.||++++++.++|+|||.++...............++..|+|||...+
T Consensus 124 l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 203 (290)
T cd05045 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203 (290)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence 78999999999999999999944 6789999999999999999876533222212223345678999999888
Q ss_pred cCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHH
Q 041655 158 LSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCM 232 (238)
Q Consensus 158 ~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~ 232 (238)
..++.++|+||||+++|+|++ |..||.... .....+..........+...+..+.+++..||+.+|++| ++++.
T Consensus 204 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~ 282 (290)
T cd05045 204 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282 (290)
T ss_pred CCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 889999999999999999998 777664321 112222233323333344455678889999999999999 66666
Q ss_pred HHhh
Q 041655 233 LSQI 236 (238)
Q Consensus 233 L~~~ 236 (238)
|+++
T Consensus 283 l~~~ 286 (290)
T cd05045 283 LEKM 286 (290)
T ss_pred HHHH
Confidence 6654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=219.83 Aligned_cols=207 Identities=20% Similarity=0.245 Sum_probs=157.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+..+.+.+|+.++++++||||+++++.+.. ...++++||+++++|.+++... ....+++..+..++.|++.||+|||
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~L~~lH 114 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKD--ALGHFLISTLCDYAVQIANGMRYLE 114 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhc--ccccCcHHHHHHHHHHHHHHHHHHH
Confidence 567889999999999999999999999988 8889999999999999999762 1156899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
.+ +.||+++.++.+||+|||.+..+...... .......++..|+|||...+..++.++|+||||+++|+|+
T Consensus 115 ~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~ 194 (257)
T cd05040 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMF 194 (257)
T ss_pred hCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHH
Confidence 54 67899999999999999998876442211 1112345678899999998888999999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
+ |..||.....................+...+..+.+++..||+.+|++| .+.+.++.+
T Consensus 195 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 195 TYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence 8 8887642221111111111111112223345678889999999999999 555555444
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=233.33 Aligned_cols=209 Identities=21% Similarity=0.249 Sum_probs=157.1
Q ss_pred HHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC-------------------------
Q 041655 28 EMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------------------- 81 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------------------- 81 (238)
..+.+.+|+.+|.++. ||||+++++.+..++..++|+||+++|+|.+++.....
T Consensus 83 ~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (401)
T cd05107 83 EKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLS 162 (401)
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccc
Confidence 3457889999999997 99999999999999999999999999999999864210
Q ss_pred ---------------------------------------------------------------------CCcccCHHHHH
Q 041655 82 ---------------------------------------------------------------------GRRQLDWLARY 92 (238)
Q Consensus 82 ---------------------------------------------------------------------~~~~~~~~~~~ 92 (238)
....+++..+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 242 (401)
T cd05107 163 QRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLV 242 (401)
T ss_pred ccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHH
Confidence 11246777888
Q ss_pred HHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.|++.||.|||.+ +.||+++.++.++|+|||+++...............++..|+|||.+.+..++.++
T Consensus 243 ~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 322 (401)
T cd05107 243 GFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS 322 (401)
T ss_pred HHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHh
Confidence 9999999999999954 66799999999999999998764322211111234567889999999888899999
Q ss_pred CeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 165 DIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 165 DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|+||||+++|||++ |..||............+........+...+.++.+++.+||..+|.+| ++++.|+++
T Consensus 323 DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 323 DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999998 6666543221111122222222223334455678889999999999999 666666554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=224.05 Aligned_cols=202 Identities=16% Similarity=0.163 Sum_probs=151.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++..++||||+++++++..++..++||||++++.+..+... ...+++..+..++.|++.||.|||.
T Consensus 43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~ 118 (287)
T cd07848 43 VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHK 118 (287)
T ss_pred chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456778999999999999999999999999999999999988666554432 3568899999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.+||+|||.+......... ......|++.|+|||++.+..++.++|+||+||++|+|++|
T Consensus 119 ~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 197 (287)
T cd07848 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197 (287)
T ss_pred CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence 4 66799999999999999998865432211 12335688999999999888899999999999999999999
Q ss_pred HHHHHHhhccCCCcc------------------------cccccc-c-----CCChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 180 VKWMRNVMTSENPKR------------------------AIDSKL-L-----GNGYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~------------------------~~~~~~-~-----~~~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
..||........... ...... . .......+..+.+++.+||+.||++| +
T Consensus 198 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s 277 (287)
T cd07848 198 QPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL 277 (287)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC
Confidence 888743211000000 000000 0 00011234568899999999999999 5
Q ss_pred HHHHHH
Q 041655 229 VRCMLS 234 (238)
Q Consensus 229 v~~~L~ 234 (238)
+.+.|+
T Consensus 278 ~~~~l~ 283 (287)
T cd07848 278 TEQCLN 283 (287)
T ss_pred HHHHhc
Confidence 555543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=233.12 Aligned_cols=200 Identities=18% Similarity=0.168 Sum_probs=152.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+
T Consensus 86 ~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~ 160 (370)
T cd05596 86 DSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS 160 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345577899999999999999999999999999999999999999999864 357888899999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc----CCCccCCeeehhHHHHh
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL----SITYMCDIYSFGVLLAE 175 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~----~~~~~~DvwslG~~l~~ 175 (238)
+ +.||+++.++.+||+|||.+......... ......|++.|+|||++.+. .++.++|+|||||++|+
T Consensus 161 ~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilye 239 (370)
T cd05596 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239 (370)
T ss_pred CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHH
Confidence 5 66799999999999999998765432211 12345789999999987643 47889999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccccC--CChHHHHHHHHHHhhhhcCCCCCc--c-hHHHHH
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKLLG--NGYEEQMLLVLKTACFCTLDDPKE--R-HVRCML 233 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~cl~~~p~~--R-~v~~~L 233 (238)
|++|..||...........+....... ......+.++.+++..||+.+|.+ | .+.+.+
T Consensus 240 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell 302 (370)
T cd05596 240 MLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIK 302 (370)
T ss_pred HHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHh
Confidence 999999986433222222222221111 111233556778888899998987 7 444433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=220.11 Aligned_cols=209 Identities=21% Similarity=0.227 Sum_probs=156.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCe------eEEEEEeCCCCCHHHHHhhhcC--CCcccCHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGC------HLLVYEFMKNGSLQDILNDVSR--GRRQLDWLARYRTVRG 97 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~ 97 (238)
....+.+.+|+..++.++|||++++++.+...+. .++++||+++++|..++..... ....+++..+..++.|
T Consensus 42 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 121 (273)
T cd05035 42 YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121 (273)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHH
Confidence 3456789999999999999999999998865543 7899999999999999864321 2346899999999999
Q ss_pred HHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 98 IASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 98 l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
++.||.|||.+ +.||++++++.+||+|||.++...............++..|+|||.+.+..++.++|+|||
T Consensus 122 i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~Sl 201 (273)
T cd05035 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 201 (273)
T ss_pred HHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHH
Confidence 99999999944 6789999999999999999876543322211122344678999999988889999999999
Q ss_pred hHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 170 GVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 170 G~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
|+++|||++ |..||..... ......+........+...+.++.+++.+||+.||++| ++.+.|++
T Consensus 202 G~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 202 GVTMWEIATRGQTPYPGVEN-HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred HHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 999999998 6666643221 11112222222223344556678889999999999999 55555544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=218.97 Aligned_cols=210 Identities=20% Similarity=0.281 Sum_probs=162.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.....++.+|+.+++.++||||+++++.+..++..++++||+++++|.+++.........+++..+..++.|++.||.||
T Consensus 43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 122 (267)
T cd08229 43 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122 (267)
T ss_pred HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34557889999999999999999999999999999999999999999999875333456789999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.++++|||.+......... .....++..|+|||...+..++.++|+||||+++|+|+
T Consensus 123 H~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~ 200 (267)
T cd08229 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred HHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH
Confidence 954 56799999999999999998765432211 12346788999999998888999999999999999999
Q ss_pred chHHHHHHhhcc-CCCcccc-cccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 178 SLVKWMRNVMTS-ENPKRAI-DSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 178 t~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
+|..||...... ......+ .....+......+..+.+++.+||+.||++| ++.+.++++.
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 201 ALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 998887532211 0111111 1111122233455678888999999999999 5666666654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=228.25 Aligned_cols=211 Identities=23% Similarity=0.281 Sum_probs=158.6
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcCC---------------------
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSRG--------------------- 82 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~--------------------- 82 (238)
....+.+.+|+.++.++ +|+||+++++++.. +...++++||+++++|.+++......
T Consensus 51 ~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 130 (337)
T cd05054 51 ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130 (337)
T ss_pred HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccc
Confidence 34456788999999999 79999999998865 45678999999999999998642110
Q ss_pred ------------------------------------CcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCC
Q 041655 83 ------------------------------------RRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDM 118 (238)
Q Consensus 83 ------------------------------------~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~ 118 (238)
...+++..+..++.|++.||+|||.+ |.||+++.++
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~ 210 (337)
T cd05054 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN 210 (337)
T ss_pred cccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC
Confidence 13688999999999999999999944 6789999999
Q ss_pred ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCccccc
Q 041655 119 EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAID 197 (238)
Q Consensus 119 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~ 197 (238)
.++|+|||++..+.............++..|+|||++.+..++.++|||||||++|+|++ |..||............+.
T Consensus 211 ~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~ 290 (337)
T cd05054 211 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290 (337)
T ss_pred cEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh
Confidence 999999999986543332222334456778999999999999999999999999999997 8777643221111111222
Q ss_pred ccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 198 SKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 198 ~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
.......+.....++.+++.+||+.+|++| ++++.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 291 EGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred ccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 222222233445668889999999999999 666666655
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=221.59 Aligned_cols=206 Identities=21% Similarity=0.221 Sum_probs=155.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.....++..|+..+.+++||||+++++++.. ...++++||+++|+|.+++.. ....+++..+..++.|++.||+||
T Consensus 50 ~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~l 125 (279)
T cd05111 50 RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYL 125 (279)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHH
Confidence 3445678889999999999999999998754 456799999999999999975 235689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.+||+|||.++...............++..|++||...+..++.++|+||||+++||++
T Consensus 126 H~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~ 205 (279)
T cd05111 126 EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205 (279)
T ss_pred HHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 954 678999999999999999998654333222223445677899999998888999999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+ |..||...... .....+........+...+.++.+++..||..||.+| ++.+.|..+
T Consensus 206 t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 206 SYGAEPYAGMRPH-EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred cCCCCCCCCCCHH-HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 8 77776432211 1111222222112222334567778889999999999 555555554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=227.20 Aligned_cols=193 Identities=24% Similarity=0.289 Sum_probs=151.5
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.....+.+|..++.++ +||||+++++++..++..++||||+++|+|..++.. ...+++..+..++.|++.||.||
T Consensus 37 ~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~l 112 (329)
T cd05618 37 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYL 112 (329)
T ss_pred hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 4456678899988777 799999999999999999999999999999988865 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ +.||+++.++.+||+|||+++....... ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 113 H~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (329)
T cd05618 113 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190 (329)
T ss_pred HHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHh
Confidence 955 5679999999999999999875322111 123467899999999999989999999999999999999
Q ss_pred chHHHHHHhhccCCC----c----c-cccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENP----K----R-AIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~----~----~-~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||......... . . .... ....+......+.+++.+||+.||++|
T Consensus 191 ~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 191 AGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred hCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHc
Confidence 999998532111111 0 0 1111 112233445567788888999999999
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=229.88 Aligned_cols=191 Identities=23% Similarity=0.209 Sum_probs=148.5
Q ss_pred HHHHHHHHH-HhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIV-TLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
...+.+|.. +++.++||||+++++.+..++..++||||+++|+|..++.. ...+++..+..++.|++.||.|||.
T Consensus 39 ~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~ 114 (323)
T cd05575 39 QKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHS 114 (323)
T ss_pred HHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345556655 56789999999999999999999999999999999998865 4568899999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 115 ~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g 192 (323)
T cd05575 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192 (323)
T ss_pred CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcC
Confidence 5 5679999999999999999864322111 12345789999999999988899999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||................. ..+...+..+.+++.+||+.||.+|
T Consensus 193 ~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R 238 (323)
T cd05575 193 LPPFYSRDTAEMYDNILNKPL--RLKPNISVSARHLLEGLLQKDRTKR 238 (323)
T ss_pred CCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhC
Confidence 988854321111111222111 1122335567888888999999999
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=221.98 Aligned_cols=210 Identities=20% Similarity=0.277 Sum_probs=158.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC-------------CCcccCHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR-------------GRRQLDWLARY 92 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~ 92 (238)
......+.+|+.++++++||||+++++.+..++..|++|||+++++|.+++..... ....+++..+.
T Consensus 48 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 127 (283)
T cd05090 48 PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127 (283)
T ss_pred HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHH
Confidence 44557788999999999999999999999999999999999999999999853211 12357888999
Q ss_pred HHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.|++.||.|||.+ |.||+++.++.+||+|||+++...............++..|+|||.+.+..++.++
T Consensus 128 ~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (283)
T cd05090 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDS 207 (283)
T ss_pred HHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchh
Confidence 9999999999999954 67899999999999999998765333222222334556789999999888899999
Q ss_pred CeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 165 DIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 165 DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
|+||||+++|+|++ |..||...... .....+........+...+..+.+++.+||+.||.+| ...+.++.+
T Consensus 208 Dv~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 208 DIWSFGVVLWEIFSFGLQPYYGFSNQ-EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred hhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 99999999999998 77776432211 1112222222222334455678888999999999999 444444433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=209.90 Aligned_cols=215 Identities=23% Similarity=0.244 Sum_probs=164.2
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||+|..+.... ..-....||+..|+.++|+||+.+.++|-..+.+.+|+||++ .+|...++.
T Consensus 30 VAIKKIkl~~~kd------------Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd--- 93 (318)
T KOG0659|consen 30 VAIKKIKLGNAKD------------GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKD--- 93 (318)
T ss_pred EEEEEeecccccc------------CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcc---
Confidence 7899887764421 112456899999999999999999999999999999999996 499999986
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
....++...++.++.++++|++|||+ ||.|+|++++|.+|++|||+++.+......... ..-|..|.|||
T Consensus 94 ~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~--~V~TRWYRAPE 171 (318)
T KOG0659|consen 94 KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH--QVVTRWYRAPE 171 (318)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc--ceeeeeccChH
Confidence 56779999999999999999999994 488999999999999999999988665443322 36688999999
Q ss_pred cccc-cCCCccCCeeehhHHHHhhcchHHHHHHhhcc------------------------CCCcccc--cccccCCChH
Q 041655 154 YQQT-LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTS------------------------ENPKRAI--DSKLLGNGYE 206 (238)
Q Consensus 154 ~~~~-~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~------------------------~~~~~~~--~~~~~~~~~~ 206 (238)
.+-+ ..|+...|+||.||++.|++-+.+.|....+- .+..++. .........+
T Consensus 172 LLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~ 251 (318)
T KOG0659|consen 172 LLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFP 251 (318)
T ss_pred HhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccc
Confidence 7655 56899999999999999998755443221110 0111111 1111112345
Q ss_pred HHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 207 EQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 207 ~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
....+.++++.++|..||.+| .+.+.|+
T Consensus 252 aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 252 AASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred cccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 556667899999999999999 6666664
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=230.51 Aligned_cols=193 Identities=22% Similarity=0.177 Sum_probs=152.5
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++..++||||+++.+++..++..++||||+++|+|..++.. ...+++..+..++.|++.||.|||
T Consensus 37 ~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH 112 (325)
T cd05594 37 DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLH 112 (325)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456778899999999999999999999999999999999999999988865 456899999999999999999999
Q ss_pred c-c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 M-H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~-~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
+ + |.||+++.++.+||+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 113 ~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (325)
T cd05594 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 190 (325)
T ss_pred hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeec
Confidence 5 3 7789999999999999999864322111 113356899999999998888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||................ ...+.....++.+++.+||+.||++|
T Consensus 191 tG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 191 CGRLPFYNQDHEKLFELILMEE--IRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred cCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 9998885322111111111111 11222344567788888999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=228.38 Aligned_cols=150 Identities=22% Similarity=0.298 Sum_probs=130.7
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|++++++++||||+++++++.+++..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH 120 (333)
T cd06650 45 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR 120 (333)
T ss_pred HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4456789999999999999999999999999999999999999999999975 345888999999999999999999
Q ss_pred cc---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MH---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
.+ +.||+++.++.+||+|||++..+.... .....|+..|+|||++.+..++.++|+|||||++|+|+
T Consensus 121 ~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 196 (333)
T cd06650 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196 (333)
T ss_pred hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 53 567999999999999999987553321 13346889999999998888999999999999999999
Q ss_pred chHHHHH
Q 041655 178 SLVKWMR 184 (238)
Q Consensus 178 t~~~~~~ 184 (238)
+|..||.
T Consensus 197 ~g~~p~~ 203 (333)
T cd06650 197 IGRYPIP 203 (333)
T ss_pred HCCCCCC
Confidence 9987764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=222.94 Aligned_cols=211 Identities=18% Similarity=0.199 Sum_probs=157.0
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC-------CCcccCHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR-------GRRQLDWLARYRTVRGIA 99 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~~l~ 99 (238)
...+.+.+|+.++.+++|||++++++++..++..++++||+++++|.+++..... ....+++..++.++.|++
T Consensus 61 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05051 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIA 140 (296)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999999875221 123689999999999999
Q ss_pred HHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhH
Q 041655 100 SGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171 (238)
Q Consensus 100 ~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~ 171 (238)
.||.|||++ |.||+++.++.++|+|||.++...............+++.|+|||.+.+..++.++||||||+
T Consensus 141 ~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 220 (296)
T cd05051 141 SGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220 (296)
T ss_pred HHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHH
Confidence 999999944 678999999999999999987653332222223455678899999988888999999999999
Q ss_pred HHHhhcc--hHHHHHHhhccCCCcccc------cccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhhh
Q 041655 172 LLAEEMS--LVKWMRNVMTSENPKRAI------DSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQIQ 237 (238)
Q Consensus 172 ~l~~~~t--~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~~ 237 (238)
++|++++ +..|+............. ........+...+.++.+++.+||+.||.+| ++.+.++.|+
T Consensus 221 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 221 TLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 9999987 444443211111000000 1111112233445678899999999999999 4444444443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=218.15 Aligned_cols=209 Identities=21% Similarity=0.272 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++|+|++++++.+...+..+++|||+++++|.+++.........+++..+..++.|++.||.|||
T Consensus 44 ~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 123 (267)
T cd08224 44 KARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123 (267)
T ss_pred hhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 44678899999999999999999999999999999999999999999998754344566899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.. +.||+++.++.++++|||.+......... .....+++.|.|||.+.+..++.++|+||||+++|+|++
T Consensus 124 ~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~ 201 (267)
T cd08224 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201 (267)
T ss_pred hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHH
Confidence 55 56799999999999999998765432211 123467889999999988889999999999999999999
Q ss_pred hHHHHHHhhcc-CCCcccccccccCCCh-HHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 179 LVKWMRNVMTS-ENPKRAIDSKLLGNGY-EEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 179 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|..||...... ...............+ ...+..+.+++.+||..+|.+| +++++|++++
T Consensus 202 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 202 LQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 98887532110 0011111111112222 2455578888999999999999 7777777765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=228.91 Aligned_cols=194 Identities=20% Similarity=0.212 Sum_probs=152.6
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.+..+.+..|..++..+ +||||+++++++..++..|+||||+++++|..++.. ...+++..+..++.|++.||.|
T Consensus 36 ~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~ 111 (321)
T cd05591 36 DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMF 111 (321)
T ss_pred hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Confidence 34556677898888866 799999999999999999999999999999998865 4568899999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||.+ +.||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++|+||+|+++|+|
T Consensus 112 LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el 189 (321)
T cd05591 112 LHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEM 189 (321)
T ss_pred HHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHH
Confidence 9954 6679999999999999999875322211 12345689999999999888899999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++|..||................. ..+.....++.+++.+||+.||++|
T Consensus 190 ~tg~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 190 MAGQPPFEADNEDDLFESILHDDV--LYPVWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHc
Confidence 999998864332222222222211 1122234567788888999999999
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=229.63 Aligned_cols=191 Identities=21% Similarity=0.190 Sum_probs=148.3
Q ss_pred HHHHHHHHHHH---hcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 28 EMMQIRSEIVT---LGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 28 ~~~~~~~E~~~---l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
..+.+.+|..+ +..++||||+++++++..++..|+||||+++++|..++.. ..+++..+..++.|++.||+|
T Consensus 42 ~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~ 116 (324)
T cd05589 42 EVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQY 116 (324)
T ss_pred HHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHH
Confidence 44566666655 4567899999999999999999999999999999888753 468999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||.+ +.||+++.++.+||+|||+++...... .......|++.|+|||.+.+..++.++|+|||||++|+|
T Consensus 117 lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el 194 (324)
T cd05589 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194 (324)
T ss_pred HHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHH
Confidence 9955 567999999999999999986432211 112346789999999999988899999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++|..||................. ..+...+..+.+++.+||+.||.+|
T Consensus 195 ~~G~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R 243 (324)
T cd05589 195 LVGESPFPGDDEEEVFDSIVNDEV--RYPRFLSREAISIMRRLLRRNPERR 243 (324)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHc
Confidence 999998854322111111211111 1223345567788889999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=228.70 Aligned_cols=196 Identities=20% Similarity=0.170 Sum_probs=151.6
Q ss_pred HHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...+.+.+|+.++..++ ||||+++++++..++..+++|||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 46 ~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~l 121 (332)
T cd05614 46 KTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHL 121 (332)
T ss_pred hHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567888999999995 99999999999999999999999999999999875 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~ 176 (238)
|.+ +.||+++.++.+||+|||+++........ ......|++.|+|||++.+. .++.++|||||||++|+|
T Consensus 122 H~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 200 (332)
T cd05614 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200 (332)
T ss_pred HHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhh
Confidence 954 66799999999999999998754332211 12345789999999998765 478899999999999999
Q ss_pred cchHHHHHHhhccCCCcccccc--cccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 177 MSLVKWMRNVMTSENPKRAIDS--KLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++|..||............... ......+...+..+.+++.+||+.||++|
T Consensus 201 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 253 (332)
T cd05614 201 LTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253 (332)
T ss_pred hcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 9999988532211111111000 11112233445567788889999999999
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=223.57 Aligned_cols=194 Identities=25% Similarity=0.248 Sum_probs=152.4
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.++++++||||+++++.+.+++..+++|||+++|+|.+++.. .....+++..+..++.|++.||.|||++
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE 121 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678899999999999999999999999999999999999999988864 2234689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||++++++.++|+|||.+........ .....|++.|+|||++.+..++.++|+||+|+++|+|++|.
T Consensus 122 ~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~ 198 (285)
T cd05605 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198 (285)
T ss_pred CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence 5569999999999999999876533221 12346889999999998888999999999999999999999
Q ss_pred HHHHHhhccCCC---cccccccccCCChHHHHHHHHHHhhhhcCCCCCcch
Q 041655 181 KWMRNVMTSENP---KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKERH 228 (238)
Q Consensus 181 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R~ 228 (238)
.||......... ...+.. .....+...+..+.+++.+||+.||++|.
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 248 (285)
T cd05605 199 SPFRQRKEKVKREEVERRVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRL 248 (285)
T ss_pred CCCCCCchhhHHHHHHHHhhh-cccccCcccCHHHHHHHHHHccCCHHHhc
Confidence 988642211111 111111 11222334455678888899999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=218.49 Aligned_cols=203 Identities=21% Similarity=0.228 Sum_probs=155.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++||||+++++++.. +..+++|||+++++|.+++.. ...+++..+..++.|++.||+|||
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH 112 (257)
T cd05116 38 ALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLE 112 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999998754 456899999999999999965 356899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCccccc-ccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI-TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
.+ |.||+++.++.++|+|||.+.......... ......++..|+|||.+.+..++.++|+||||+++|||+
T Consensus 113 ~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05116 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192 (257)
T ss_pred HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHH
Confidence 44 667999999999999999987654332211 111223457899999988888899999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
+ |..||...... .....+........+...+.++.+++.+||+.||.+| .+...|++
T Consensus 193 t~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 193 SYGQKPYKGMKGN-EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred hCCCCCCCCCCHH-HHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 8 88887543221 1222222222233344556678889999999999999 55555543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=227.76 Aligned_cols=193 Identities=24% Similarity=0.262 Sum_probs=152.2
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
+....+.+|..++..+ +||||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~l 112 (329)
T cd05588 37 EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFL 112 (329)
T ss_pred hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 4456788999999998 699999999999999999999999999999988865 35689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 113 H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~ 190 (329)
T cd05588 113 HERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190 (329)
T ss_pred HHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHH
Confidence 955 567999999999999999986421111 1123467899999999999888999999999999999999
Q ss_pred chHHHHHHhhccCCC--------cc-cccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENP--------KR-AIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||......... .. ..... ...+......+.+++.+||+.||.+|
T Consensus 191 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 191 AGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred HCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 999998532211100 00 11111 12233344567888889999999999
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=237.82 Aligned_cols=205 Identities=19% Similarity=0.224 Sum_probs=161.6
Q ss_pred hHHHHHHHHHHHHHhcCCC-CCcccceeeee-e---cC---CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQIR-HRNILPLLAHL-A---RP---GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVR 96 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~---~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 96 (238)
++...+.+.+|+++|+.|. |+|||.|++.. . .+ -.+.+.||||++|.|-++++.+... .|++.++++|+.
T Consensus 74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~ 151 (738)
T KOG1989|consen 74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFY 151 (738)
T ss_pred CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHH
Confidence 5667888999999999997 99999999932 1 11 3467999999999999999864333 399999999999
Q ss_pred HHHHHhchhh----------ccCceeeecCCCceEEcccccccccCCcc--ccc-----ccccccCCCcccCcccc---c
Q 041655 97 GIASGLEYLH----------MHQALVLLDHDMEARISEFGLAKVFPEAH--THI-----TTSDVVGTAGYIAPEYQ---Q 156 (238)
Q Consensus 97 ~l~~gl~~lH----------~~~~~il~~~~~~~kl~dfg~~~~~~~~~--~~~-----~~~~~~~~~~~~apE~~---~ 156 (238)
|+++|+.+|| .|-+|+|+..+|+.||+|||.+..-...- ... ..-....|+.|.+||++ +
T Consensus 152 dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys 231 (738)
T KOG1989|consen 152 DVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS 231 (738)
T ss_pred HHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc
Confidence 9999999999 34567999999999999999986321111 000 00123568999999964 5
Q ss_pred ccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHh
Q 041655 157 TLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQ 235 (238)
Q Consensus 157 ~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~ 235 (238)
+..++.|+|||+|||+||-+|.+..||.. .....++...+......+....+.++|..||+.||++| .+.+.++.
T Consensus 232 g~pI~eKsDIWALGclLYkLCy~t~PFe~----sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 232 GLPIGEKSDIWALGCLLYKLCYFTTPFEE----SGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred CCCCcchhHHHHHHHHHHHHHHhCCCcCc----CcceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 78899999999999999999999999964 33567778777666667777778888888999999999 44444433
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=227.66 Aligned_cols=198 Identities=22% Similarity=0.207 Sum_probs=151.6
Q ss_pred HHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+.+..|..++... +||||+++++.+..++..++||||+++|+|..++.. ...+++..+..++.|++.||.|||
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH 113 (316)
T cd05592 38 DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLH 113 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 445556677776654 799999999999999999999999999999999875 346899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 114 ~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 191 (316)
T cd05592 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLI 191 (316)
T ss_pred HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHh
Confidence 55 567999999999999999987543222 12234678999999999998889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||............... ....+.....++.+++.+||+.||.+| .+.+.+
T Consensus 192 G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 192 GQSPFHGEDEDELFDSILND--RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred CCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 99988643221111111111 112223344556778888999999999 444333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=219.01 Aligned_cols=203 Identities=21% Similarity=0.261 Sum_probs=155.8
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++|+||+++++.+...+..++++||+++++|.+++... ....+++..+..++.|++.||+|||.+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~ 122 (261)
T cd05072 45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK 122 (261)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 567899999999999999999999999999999999999999999998652 235678888999999999999999944
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||+++.++.++++|||.+.......... .....++..|+|||...+..++.++|+||||+++|+|++ |
T Consensus 123 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g 201 (261)
T cd05072 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYG 201 (261)
T ss_pred CeeccccchhhEEecCCCcEEECCCccceecCCCceec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccC
Confidence 667999999999999999998654322211 122345678999999988888999999999999999998 7
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
..||....... ....+............+.++.+++.+||+.+|++| ++.+.|++
T Consensus 202 ~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 202 KIPYPGMSNSD-VMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 77764322111 111111112222223445668889999999999999 55555543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=220.86 Aligned_cols=212 Identities=17% Similarity=0.200 Sum_probs=155.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCC-------CcccCHHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG-------RRQLDWLARYRTVRGI 98 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~~~l 98 (238)
.....++.+|+.+++.++|+||+++++++..++..+++|||+++++|.+++...... ...+++..+..++.|+
T Consensus 60 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 139 (296)
T cd05095 60 KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQI 139 (296)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999998752211 1347788899999999
Q ss_pred HHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 99 ASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 99 ~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
+.||+|||++ |.||+++.++.++|+|||.+..+.............++..|++||...+..++.++|+||||
T Consensus 140 ~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG 219 (296)
T cd05095 140 ASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 219 (296)
T ss_pred HHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHH
Confidence 9999999954 67899999999999999998754332211111223446789999988888899999999999
Q ss_pred HHHHhhcc--hHHHHHHhhccCCCccc---c---cccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhhh
Q 041655 171 VLLAEEMS--LVKWMRNVMTSENPKRA---I---DSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQIQ 237 (238)
Q Consensus 171 ~~l~~~~t--~~~~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~~ 237 (238)
|++|||++ +..||............ . ........+..++..+.+++..||+.||++| .+.+.++.++
T Consensus 220 ~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 220 VTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99999998 45565432211111000 0 0011111223445678889999999999999 4444444443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=217.71 Aligned_cols=202 Identities=20% Similarity=0.258 Sum_probs=154.6
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+.+|+.++++++||||+++++.+...+..++++||+++++|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 120 (256)
T cd05059 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG 120 (256)
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4678899999999999999999999999999999999999999999865 234689999999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
+.||++++++.+|++|||.++........ ......++..|+|||...+..++.++|+||||+++|++++ |.
T Consensus 121 i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~ 199 (256)
T cd05059 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred cccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCC
Confidence 66799999999999999998765332111 1111233457999999988889999999999999999998 67
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
.||...... .....+........+...+..+.+++.+||..+|++| ++.+.++.+
T Consensus 200 ~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 200 MPYERFSNS-EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 776432221 1112222222222333456678889999999999999 555555543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=223.31 Aligned_cols=212 Identities=21% Similarity=0.248 Sum_probs=160.8
Q ss_pred hhHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHH
Q 041655 24 LLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLA 90 (238)
Q Consensus 24 ~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~ 90 (238)
........+.+|+.++..+ +||||+++++.+...+..+++|||+++++|.+++..... ....+++..
T Consensus 59 ~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (304)
T cd05101 59 ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138 (304)
T ss_pred cchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHH
Confidence 3345567889999999999 799999999999999999999999999999999975321 123578888
Q ss_pred HHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCc
Q 041655 91 RYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY 162 (238)
Q Consensus 91 ~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~ 162 (238)
+..++.|+++||.|||.+ +.||+++.++.+||+|||.++...............+++.|+|||++.+..++.
T Consensus 139 ~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 218 (304)
T cd05101 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218 (304)
T ss_pred HHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc
Confidence 999999999999999954 678999999999999999987654332222222334567899999998888999
Q ss_pred cCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 163 MCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 163 ~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++|+||||+++|++++ |..|+..... ......+........+...+..+.+++.+||+.+|++| ++++.|+++
T Consensus 219 ~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 219 QSDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred hhhHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 9999999999999998 5665532211 11111222222222334556678889999999999999 666666655
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=230.85 Aligned_cols=216 Identities=18% Similarity=0.201 Sum_probs=164.9
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+..+.. ...+.+|.+|+++|.+++||||++++|+|..++.+++++||+++|+|.+|+...
T Consensus 565 VAVK~Lr~~a~-------------~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ah-- 629 (807)
T KOG1094|consen 565 VAVKILRPDAT-------------KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAH-- 629 (807)
T ss_pred EEEeecCcccc-------------hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhc--
Confidence 67777765443 344789999999999999999999999999999999999999999999999762
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
......-..-..++.||+.|++||.+- +.|+|++.++++|++|||+++-+=............-+.+|||+|
T Consensus 630 eapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawE 709 (807)
T KOG1094|consen 630 ELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWE 709 (807)
T ss_pred cCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHH
Confidence 111134444566999999999999633 667999999999999999998442222222234456678999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcch--HHHHHHhhccCCCcc---cccccc---cCCChHHHHHHHHHHhhhhcCCCCC
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSL--VKWMRNVMTSENPKR---AIDSKL---LGNGYEEQMLLVLKTACFCTLDDPK 225 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~--~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~l~~~~~~cl~~~p~ 225 (238)
.+.-+.+++++|+|+||+++||+++. ..||....++....+ ..+..- ....|.-++..+.++|+.||+.+.+
T Consensus 710 sillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~ 789 (807)
T KOG1094|consen 710 SILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESE 789 (807)
T ss_pred HHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhh
Confidence 99999999999999999999999885 567766554332211 222111 2234667788899999999999999
Q ss_pred cchHHHH
Q 041655 226 ERHVRCM 232 (238)
Q Consensus 226 ~R~v~~~ 232 (238)
+|+..+.
T Consensus 790 ~RPsFe~ 796 (807)
T KOG1094|consen 790 QRPSFEQ 796 (807)
T ss_pred cCCCHHH
Confidence 9933333
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=226.85 Aligned_cols=216 Identities=20% Similarity=0.251 Sum_probs=165.0
Q ss_pred ChhhHHHh-hhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHH
Q 041655 13 DATALVEA-DSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90 (238)
Q Consensus 13 ~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 90 (238)
..+++++. ....+......|.+|+.+|.+|+ |.+|++++++-..++.+|+||||- ..+|..++... ......+ .
T Consensus 386 ~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~--~~~~~~~-~ 461 (677)
T KOG0596|consen 386 QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKK--KSIDPDW-F 461 (677)
T ss_pred cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhc--cCCCchH-H
Confidence 34444443 35666778889999999999996 999999999999999999999998 45999999872 2222223 6
Q ss_pred HHHHHHHHHHHhchhhccCc--------eeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC---
Q 041655 91 RYRTVRGIASGLEYLHMHQA--------LVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS--- 159 (238)
Q Consensus 91 ~~~~~~~l~~gl~~lH~~~~--------~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~--- 159 (238)
++.+..||+.++.++|.+++ |++ -..|.+||+|||+|..+..........+.+||+.||+||.+....
T Consensus 462 lk~ywkqML~aV~~IH~~gIVHSDLKPANFL-lVkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~ 540 (677)
T KOG0596|consen 462 LKFYWKQMLLAVKTIHQHGIVHSDLKPANFL-LVKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSR 540 (677)
T ss_pred HHHHHHHHHHHHHHHHHhceeecCCCcccEE-EEeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccc
Confidence 67788999999999996644 444 346799999999999887777777778899999999999765432
Q ss_pred --------CCccCCeeehhHHHHhhcchHHHHHHhhccC-CCcccccccccCCChHH-HHHHHHHHhhhhcCCCCCcc-h
Q 041655 160 --------ITYMCDIYSFGVLLAEEMSLVKWMRNVMTSE-NPKRAIDSKLLGNGYEE-QMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 160 --------~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
.++++||||+||+||+|+.|+.||....... .+..+.++....+++.- ....++++|+.||..||++| .
T Consensus 541 ~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~s 620 (677)
T KOG0596|consen 541 ENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWS 620 (677)
T ss_pred cCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCC
Confidence 4678999999999999999999998766332 34445554332332211 12228999999999999999 4
Q ss_pred HHHHH
Q 041655 229 VRCML 233 (238)
Q Consensus 229 v~~~L 233 (238)
+-+.|
T Consensus 621 i~eLL 625 (677)
T KOG0596|consen 621 IPELL 625 (677)
T ss_pred cHHHh
Confidence 44444
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=228.61 Aligned_cols=190 Identities=23% Similarity=0.205 Sum_probs=147.5
Q ss_pred HHHHHHHH-HhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIV-TLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
..+.+|.. +++.++||||+++++.+..++..+++|||+++++|.+++.. ...+++..+..++.|+++||.|||++
T Consensus 40 ~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~ 115 (325)
T cd05602 40 KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL 115 (325)
T ss_pred HHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34445544 56888999999999999999999999999999999999875 45678888899999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++||||+||++|+|++|.
T Consensus 116 giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 193 (325)
T cd05602 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 193 (325)
T ss_pred CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCC
Confidence 5679999999999999999875322111 123457899999999999989999999999999999999999
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||................. ....+.+..+.+++.+||+.||.+|
T Consensus 194 ~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R 238 (325)
T cd05602 194 PPFYSRNTAEMYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKR 238 (325)
T ss_pred CCCCCCCHHHHHHHHHhCCc--CCCCCCCHHHHHHHHHHcccCHHHC
Confidence 98854322211112221111 1222345567788888999999999
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=218.82 Aligned_cols=203 Identities=22% Similarity=0.291 Sum_probs=158.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.+++.++|||++++++++...+..+++|||+++++|.+++.. .....+++..+..++.|++.||.|||.
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~ 122 (261)
T cd05148 45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE 122 (261)
T ss_pred hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999999999999999999999999999975 234568999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS- 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t- 178 (238)
+ +.||+++.++.++++|||.+......... .....++..|+|||...+..++.++|+||||+++|+|++
T Consensus 123 ~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~ 200 (261)
T cd05148 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200 (261)
T ss_pred CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 4 66899999999999999998765432211 123345678999999988889999999999999999998
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
|..||.......... ..........+...+..+.+++.+||+.||.+| ++.+.|+.
T Consensus 201 g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 201 GQVPYPGMNNHEVYD-QITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCcCCHHHHHH-HHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 677774432211111 122222333345556678899999999999999 44444443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=221.38 Aligned_cols=209 Identities=19% Similarity=0.229 Sum_probs=157.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc------------CCCcccCHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS------------RGRRQLDWLARYRT 94 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~ 94 (238)
...+.+.+|+.++..++||||+++++++...+..++++||+++++|.+++.... .....+++..+..+
T Consensus 50 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 129 (283)
T cd05091 50 PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129 (283)
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHH
Confidence 445778899999999999999999999999999999999999999999985311 01235788889999
Q ss_pred HHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCe
Q 041655 95 VRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDI 166 (238)
Q Consensus 95 ~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dv 166 (238)
+.|++.||.|+|.+ |.||++++++.+||+|||+++...............+++.|+|||.+.+..++.++|+
T Consensus 130 ~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 209 (283)
T cd05091 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDI 209 (283)
T ss_pred HHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhH
Confidence 99999999999944 6789999999999999999876543322222233456788999999988889999999
Q ss_pred eehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 167 YSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 167 wslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
||||+++|||++ |..||....... ....+........+...+..+.+++..||+.+|++| .+.+.++.+
T Consensus 210 ~slG~~l~el~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 210 WSYGVVLWEVFSYGLQPYCGYSNQD-VIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 999999999998 666664322211 112222222223345566778889999999999999 444444443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=238.03 Aligned_cols=200 Identities=18% Similarity=0.227 Sum_probs=155.2
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCC--------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPG--------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGI 98 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l 98 (238)
.....+.+|+..+..++|+|++++++.+...+ ..++||||+++|+|.+++.........+++..+..++.|+
T Consensus 73 ~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~ql 152 (496)
T PTZ00283 73 ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQV 152 (496)
T ss_pred HHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHH
Confidence 45567889999999999999999988775332 3679999999999999997644445678999999999999
Q ss_pred HHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 99 ASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 99 ~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
+.||.|||++ |.||+++.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||||
T Consensus 153 l~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlG 232 (496)
T PTZ00283 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG 232 (496)
T ss_pred HHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHH
Confidence 9999999954 66799999999999999999866443222223456789999999999998999999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+++|+|++|..||................ ....+...+.++.+++.+||+.||.+|
T Consensus 233 vilyeLltG~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~R 288 (496)
T PTZ00283 233 VLLYELLTLKRPFDGENMEEVMHKTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRR 288 (496)
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 99999999998875322111111111111 112234455668888999999999999
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=217.85 Aligned_cols=207 Identities=23% Similarity=0.250 Sum_probs=151.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeee-cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLA-RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
....+.+.+|+.+++.++|||++++++.+. .++..++++||+++++|.+++.. .....++..+..++.|+++||.|
T Consensus 37 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~ 113 (262)
T cd05058 37 LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEY 113 (262)
T ss_pred HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHH
Confidence 345678889999999999999999999775 45567899999999999999975 23346777888899999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
||.+ +.||+++.++.+||+|||.++........ .......++..|+|||...+..++.++||||||+++|
T Consensus 114 lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 193 (262)
T cd05058 114 LASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 193 (262)
T ss_pred HHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHH
Confidence 9944 67899999999999999998754322110 1112234567899999988888999999999999999
Q ss_pred hhcch-HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 175 EEMSL-VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 175 ~~~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
||++| ..|+.. .........+........+...+..+.+++..||+.+|++| ++++.|+++
T Consensus 194 el~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 194 ELMTRGAPPYPD-VDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred HHHcCCCCCCCC-CCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 99995 444432 11111111111111122223345568889999999999999 666665554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=231.17 Aligned_cols=197 Identities=19% Similarity=0.222 Sum_probs=149.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.++..++||||+++++.+.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||+||
T Consensus 42 ~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~l 117 (364)
T cd05599 42 KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSI 117 (364)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34556788999999999999999999999999999999999999999999875 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCccccc------------------------------------ccc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI------------------------------------TTS 141 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~------------------------------------~~~ 141 (238)
|.+ +.||+++.++.++|+|||++..+....... ...
T Consensus 118 H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (364)
T cd05599 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAY 197 (364)
T ss_pred HHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccc
Confidence 954 667999999999999999986542211000 001
Q ss_pred cccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccccc--ccCCChHHHHHHHHHHhhhh
Q 041655 142 DVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSK--LLGNGYEEQMLLVLKTACFC 219 (238)
Q Consensus 142 ~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~c 219 (238)
...||+.|+|||++.+..++.++|+|||||++|+|++|..||................ ............+.+++.+|
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l 277 (364)
T cd05599 198 STVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRL 277 (364)
T ss_pred ccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHH
Confidence 2468999999999988889999999999999999999999885432211111111111 11111112234566777778
Q ss_pred cCCCCCcc
Q 041655 220 TLDDPKER 227 (238)
Q Consensus 220 l~~~p~~R 227 (238)
+. +|.+|
T Consensus 278 l~-~p~~R 284 (364)
T cd05599 278 CC-EAERR 284 (364)
T ss_pred cc-CHhhc
Confidence 86 89999
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=227.98 Aligned_cols=193 Identities=21% Similarity=0.211 Sum_probs=151.7
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.....+.+|..++..+ +||||+++++++...+..++||||+++|+|..++.. ...+++..+..++.|++.||.||
T Consensus 37 ~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~L 112 (318)
T cd05570 37 DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFL 112 (318)
T ss_pred hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 4456778899988887 699999999999999999999999999999998865 34689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ +.||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 113 H~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~ 190 (318)
T cd05570 113 HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEML 190 (318)
T ss_pred HhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHh
Confidence 955 5679999999999999999864221111 123356899999999999989999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||................. ..+...+..+.+++.+||+.||++|
T Consensus 191 ~G~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 191 AGQSPFEGDDEDELFQSILEDEV--RYPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred hCCCCCCCCCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHccCCHHHc
Confidence 99998853222111111111111 1223345567888889999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=231.38 Aligned_cols=197 Identities=18% Similarity=0.215 Sum_probs=148.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+....+.+|+.++.+++||||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||+||
T Consensus 42 ~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~L 117 (377)
T cd05629 42 KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAV 117 (377)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 44567788999999999999999999999999999999999999999999875 45688999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccc------------c---------------------------
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH------------I--------------------------- 138 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~------------~--------------------------- 138 (238)
|++ |.||+++.++.++|+|||+++.+...... .
T Consensus 118 H~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (377)
T cd05629 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATW 197 (377)
T ss_pred HhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhh
Confidence 944 66799999999999999998632110000 0
Q ss_pred ------ccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccc--cccCCChHHHHH
Q 041655 139 ------TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDS--KLLGNGYEEQML 210 (238)
Q Consensus 139 ------~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 210 (238)
......||+.|+|||++.+..++.++|+|||||++|||++|..||...........+... ............
T Consensus 198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~ 277 (377)
T cd05629 198 KKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSV 277 (377)
T ss_pred hhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCH
Confidence 001246899999999998888999999999999999999999988532221111111111 111111112334
Q ss_pred HHHHHhhhhcCCCCCcc
Q 041655 211 LVLKTACFCTLDDPKER 227 (238)
Q Consensus 211 ~l~~~~~~cl~~~p~~R 227 (238)
++.+++.+|+. +|.+|
T Consensus 278 ~~~dli~~lL~-~~~~r 293 (377)
T cd05629 278 EAEDLIRRLIT-NAENR 293 (377)
T ss_pred HHHHHHHHHhc-CHhhc
Confidence 56777778997 77777
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=224.20 Aligned_cols=206 Identities=18% Similarity=0.180 Sum_probs=154.7
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+++.+|+.+++.++||||++++|++... ..++++||+++|+|.+++.. ....+++..+..++.|++.||+|
T Consensus 49 ~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~ 124 (316)
T cd05108 49 SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 124 (316)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHH
Confidence 344567788999999999999999999998765 46799999999999999875 23457888999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||++ +.||+++.++.+||+|||.++...............++..|++||.+.+..++.++|+||||+++|++
T Consensus 125 LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el 204 (316)
T cd05108 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 204 (316)
T ss_pred HHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHH
Confidence 9954 66799999999999999999876433222111223346789999999888899999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
++ |..||...... ..............+..+..++.+++.+||..+|.+| +++..|..
T Consensus 205 ~t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~ 267 (316)
T cd05108 205 MTFGSKPYDGIPAS-EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 267 (316)
T ss_pred HcCCCCCCCCCCHH-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 87 77776432211 1112222222222233344567888999999999999 44444443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=216.75 Aligned_cols=202 Identities=18% Similarity=0.219 Sum_probs=153.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++..++..+++|||+++|+|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~ 119 (256)
T cd05114 43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERN 119 (256)
T ss_pred HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35688999999999999999999999999999999999999999999864 224588999999999999999999944
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||+++.++.++++|||.++........ ......++..|+|||...+..++.++|+||||+++|+|++ |
T Consensus 120 ~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g 198 (256)
T cd05114 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198 (256)
T ss_pred CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCC
Confidence 67899999999999999998754322211 1122334568999999988889999999999999999999 7
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHh
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQ 235 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~ 235 (238)
..||.............. ......+...+..+.+++.+||+.+|.+| ...+.++.
T Consensus 199 ~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~ 254 (256)
T cd05114 199 KMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRA 254 (256)
T ss_pred CCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 777643222111111111 11111222334567888999999999999 55554444
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=222.94 Aligned_cols=196 Identities=20% Similarity=0.246 Sum_probs=151.1
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+..|++++++++||||+++++.+..++..+++|||+++++|.+++.. .....+++..+..++.|++.||+|||++
T Consensus 38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 115 (277)
T cd05607 38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHSMD 115 (277)
T ss_pred HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4456799999999999999999999999999999999999999988754 2344588999999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
+.||+++.++.++|+|||.+........ .....|++.|+|||++.+..++.++|+||+||++|+|++|..
T Consensus 116 ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~ 192 (277)
T cd05607 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRT 192 (277)
T ss_pred EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCC
Confidence 6779999999999999999876543221 123468899999999988889999999999999999999998
Q ss_pred HHHHhhccCCCccc----ccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 182 WMRNVMTSENPKRA----IDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 182 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
||............ ..... .......+.++.+++.+||+.||++| ++.+
T Consensus 193 p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 193 PFKDHKEKVAKEELKRRTLEDEV-KFEHQNFTEESKDICRLFLAKKPEDRLGSRE 246 (277)
T ss_pred CCCCCcchhhHHHHHHHhhcccc-ccccccCCHHHHHHHHHHhccCHhhCCCCcc
Confidence 87532211111111 11111 01112334557788888999999999 4433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=227.05 Aligned_cols=192 Identities=21% Similarity=0.186 Sum_probs=148.9
Q ss_pred HHHHHHHHHH-HhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIV-TLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
....+.+|.. +++.++||||+++++.+.+.+..|+||||+++++|...+.. ...+++..+..++.|++.||.|||
T Consensus 38 ~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH 113 (321)
T cd05603 38 EQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLH 113 (321)
T ss_pred HHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3445556655 67889999999999999999999999999999999888864 456888999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 114 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 191 (321)
T cd05603 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLY 191 (321)
T ss_pred HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhc
Confidence 54 667999999999999999986432211 11234578999999999988889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||................ ...+......+.+++.+||+.||.+|
T Consensus 192 g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R 238 (321)
T cd05603 192 GLPPFYSRDVSQMYDNILHKP--LQLPGGKTVAACDLLVGLLHKDQRRR 238 (321)
T ss_pred CCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHhhc
Confidence 999885432111111111111 12223344567788888999999999
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=215.92 Aligned_cols=204 Identities=20% Similarity=0.246 Sum_probs=161.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.++++++|||++++++.+..++..++++||+++++|.+++.. .....+++..+..++.|++.||.||
T Consensus 40 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~~l~~al~~l 117 (256)
T cd08529 40 RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKM--QRGRPLPEDQVWRFFIQILLGLAHL 117 (256)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999999999999999999999999999876 2245688999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.++|+|||.+......... .....+++.|+|||+..+..++.++|+||||+++|+|+
T Consensus 118 H~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 195 (256)
T cd08529 118 HSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC 195 (256)
T ss_pred HHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 954 67899999999999999998765433221 13346788999999998888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||.............. ......+...+..+.+++.+||+.+|++| ...+.++
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 196 TGKHPFDANNQGALILKIIR-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred hCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 99988754332111111111 22222333455678889999999999999 5555554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=230.14 Aligned_cols=202 Identities=21% Similarity=0.335 Sum_probs=165.2
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCe--eEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGC--HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 23 ~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
..+++..++|..|+.+|+.|+||||+++|..|.+... ..+|+|.+..|+|..|.++ .+..+.+.++.|++||++
T Consensus 79 ~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILk 154 (632)
T KOG0584|consen 79 TQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILK 154 (632)
T ss_pred hcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHH
Confidence 3446677899999999999999999999999976654 7799999999999999987 566888999999999999
Q ss_pred Hhchhhcc----------CceeeecCC-CceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 101 GLEYLHMH----------QALVLLDHD-MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 101 gl~~lH~~----------~~~il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
||.|||+. ..||+++.+ |.+||+|+|+|........ ....|||.|||||+.- ..|+...|||||
T Consensus 155 GL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaF 229 (632)
T KOG0584|consen 155 GLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAF 229 (632)
T ss_pred HhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc----ceeccCccccChHHHh-hhcchhhhhhhh
Confidence 99999954 557888764 8999999999987654432 3478999999999996 679999999999
Q ss_pred hHHHHhhcchHHHHHHhhccCCCcccccccccCCChH-HHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 170 GVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYE-EQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 170 G~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|+++.||+|+..|+........+.+.+..+..+.... -...++.++|.+|+.. .++| .+.+.|.
T Consensus 230 GMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 230 GMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 9999999999999988776666666666665554322 1234577788889999 8889 6666664
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=222.08 Aligned_cols=211 Identities=21% Similarity=0.267 Sum_probs=158.6
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLAR 91 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~ 91 (238)
.......+.+|+.++.++ +||||+++++++..++..++++||+++|+|.+++..... ....+++..+
T Consensus 57 ~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~ 136 (314)
T cd05099 57 TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136 (314)
T ss_pred ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHH
Confidence 344567788999999999 599999999999998899999999999999999975221 1245889999
Q ss_pred HHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCcc
Q 041655 92 YRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM 163 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~ 163 (238)
..++.|++.||.|||.+ +.||+++.++.+||+|||.++...............++..|+|||.+.+..++.+
T Consensus 137 ~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 216 (314)
T cd05099 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ 216 (314)
T ss_pred HHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc
Confidence 99999999999999954 6679999999999999999976543221111122234467999999988889999
Q ss_pred CCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 164 CDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 164 ~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+|+||||+++|++++ |..||..... ......+........+...+.++.+++.+||+.+|++| ++++.|+++
T Consensus 217 ~DiwslG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 217 SDVWSFGILMWEIFTLGGSPYPGIPV-EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred chhhHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 999999999999998 6666543211 11111222222223344556678889999999999999 566666554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=219.41 Aligned_cols=212 Identities=20% Similarity=0.227 Sum_probs=161.4
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcCC----CcccCHHHHHHHHHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSRG----RRQLDWLARYRTVRGIA 99 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~~~l~ 99 (238)
.....+.+.+|+.++++++|||++++++++.. +...+++++|+++++|.+++...... ...+++..+..++.|++
T Consensus 48 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~ 127 (280)
T cd05043 48 SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127 (280)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHH
Confidence 34556778999999999999999999998765 56788999999999999998753221 15689999999999999
Q ss_pred HHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhH
Q 041655 100 SGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171 (238)
Q Consensus 100 ~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~ 171 (238)
.||.|||.+ +.||+++.++.+|++|||+++.+.............++..|+|||.+.+..++.++||||||+
T Consensus 128 ~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~ 207 (280)
T cd05043 128 CGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGV 207 (280)
T ss_pred HHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHH
Confidence 999999954 567999999999999999998654332222222344567899999998888999999999999
Q ss_pred HHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 172 LLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 172 ~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
++|++++ |..||..... ......+........+...+..+.+++.+||..||++| ++++.|+++.
T Consensus 208 ~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 208 LLWELMTLGQTPYVEIDP-FEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHHHHhcCCCCCcCcCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 9999998 8877753211 11112222222222233445678889999999999999 7777777764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=222.85 Aligned_cols=210 Identities=23% Similarity=0.264 Sum_probs=159.3
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLARY 92 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~ 92 (238)
......+.+|+.++.++ +||||+++++.+...+..++++||+++|+|.+++..... ....+++..+.
T Consensus 64 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 143 (307)
T cd05098 64 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143 (307)
T ss_pred hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHH
Confidence 34556788999999999 799999999999999999999999999999999975321 12358899999
Q ss_pred HHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.|++.||+|||.+ +.||+++.++.++|+|||.+................+++.|+|||.+.+..++.++
T Consensus 144 ~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 223 (307)
T cd05098 144 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223 (307)
T ss_pred HHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHH
Confidence 9999999999999954 66799999999999999998755332211111122345689999999888899999
Q ss_pred CeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 165 DIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 165 DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|+||||+++|+|++ |..||.... .......+........+...+.++.+++.+||..+|++| ++++.|+++
T Consensus 224 DvwslG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 224 DVWSFGVLLWEIFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 99999999999998 666664221 111222222222333444556678889999999999999 666666654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=220.69 Aligned_cols=211 Identities=18% Similarity=0.185 Sum_probs=154.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC--------CCcccCHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR--------GRRQLDWLARYRTVRG 97 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~~ 97 (238)
......|.+|++++.+++|||++++++.+...+..+++|||+++++|.+++..... ....+++..+..++.|
T Consensus 58 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 137 (295)
T cd05097 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ 137 (295)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHH
Confidence 34567799999999999999999999999999999999999999999999864210 1124688889999999
Q ss_pred HHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 98 IASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 98 l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
++.||.|||.+ |.||+++.++.+||+|||.+................++..|+|||...+..++.++|+|||
T Consensus 138 i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl 217 (295)
T cd05097 138 IASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217 (295)
T ss_pred HHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHH
Confidence 99999999944 6789999999999999999875433222112233455678999999888889999999999
Q ss_pred hHHHHhhcc--hHHHHHHhhccCCCccc------ccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 170 GVLLAEEMS--LVKWMRNVMTSENPKRA------IDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 170 G~~l~~~~t--~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
|+++|+|++ +..||............ .........+...+..+.+++.+||+.||++| .+-+.++.|
T Consensus 218 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 218 GVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999999987 44555332111111000 00111111222345678899999999999999 444444443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=233.85 Aligned_cols=201 Identities=23% Similarity=0.244 Sum_probs=161.3
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH- 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH- 106 (238)
...-...|+.+.+.|+|.|||+++|.+..++++-+.||..|||+|.+.+...+++ -.=.+..+..+.+||++||.|||
T Consensus 615 ~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGP-lKDNEstm~fYtkQILeGLkYLHe 693 (1226)
T KOG4279|consen 615 EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGP-LKDNESTMNFYTKQILEGLKYLHE 693 (1226)
T ss_pred hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCC-CccchhHHHHHHHHHHHHhhhhhh
Confidence 3456788999999999999999999999999999999999999999999874332 22378888999999999999999
Q ss_pred -------ccCceeeec-CCCceEEcccccccccCCcccccccccccCCCcccCcccccccC--CCccCCeeehhHHHHhh
Q 041655 107 -------MHQALVLLD-HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS--ITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 107 -------~~~~~il~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~--~~~~~DvwslG~~l~~~ 176 (238)
.|+.|++++ -.|.+||+|||.++.+..-+ ..++++.||..|||||++..++ |+.++|||||||+..||
T Consensus 694 n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEM 771 (1226)
T KOG4279|consen 694 NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEM 771 (1226)
T ss_pred cceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEee
Confidence 446777764 57899999999998764432 2456789999999999997664 77899999999999999
Q ss_pred cchHHHHHHhhccCC-CcccccccccCCChHHHHHHHHHHhhhhcCCCCCcchHHH
Q 041655 177 MSLVKWMRNVMTSEN-PKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKERHVRC 231 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R~v~~ 231 (238)
.||++||...-.... ..+.---...++.|.+...+...++++|+.++|.+|..++
T Consensus 772 ATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~ 827 (1226)
T KOG4279|consen 772 ATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAK 827 (1226)
T ss_pred ccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHH
Confidence 999999975432221 1111112235677888888999999999999999994333
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=216.82 Aligned_cols=202 Identities=21% Similarity=0.240 Sum_probs=157.3
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+..+.+.+|+.++.+++||||+++++++...+..++++||+++++|.+++.. ...+++..+..++.|++.||+|||
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH 123 (267)
T cd06628 48 SMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLH 123 (267)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999999999999999999999999999975 356888999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccc----cccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTH----ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
.+ +.||++++++.++|+|||.++........ .......++..|+|||.+.+..++.++|+||+|+++|
T Consensus 124 ~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~ 203 (267)
T cd06628 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVV 203 (267)
T ss_pred hcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHH
Confidence 54 56799999999999999998766422111 1112345788999999998888899999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++++|..||............. ....+..+...+..+.+++.+||+.||.+| .+.+.+
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 262 (267)
T cd06628 204 EMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262 (267)
T ss_pred HHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 9999998875432211111111 122223334456677888899999999999 444443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=226.07 Aligned_cols=195 Identities=22% Similarity=0.204 Sum_probs=149.7
Q ss_pred HHHHHHHHHHHhcC-CCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQ-IRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
....+..|..++.. ++||||+++++++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH 113 (316)
T cd05619 38 DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLH 113 (316)
T ss_pred hHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34556677887775 4899999999999999999999999999999999875 356888999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++|+||+||++|+|++
T Consensus 114 ~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 191 (316)
T cd05619 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLI 191 (316)
T ss_pred hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 55 5679999999999999999864322111 1234568999999999988889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVR 230 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~ 230 (238)
|..||................ ...+.....++.+++.+||+.||++| .+.
T Consensus 192 G~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 192 GQSPFHGHDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred CCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHhccCHhhcCCCh
Confidence 998885422111111111111 11222334557788888999999999 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=229.28 Aligned_cols=204 Identities=18% Similarity=0.250 Sum_probs=150.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.++.+++||||+++++.+.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 42 ~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~L 117 (381)
T cd05626 42 RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESV 117 (381)
T ss_pred hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999999875 45688999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCccc-----------------------------------------
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHT----------------------------------------- 136 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~----------------------------------------- 136 (238)
|.+ |.||+++.++++||+|||++........
T Consensus 118 H~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (381)
T cd05626 118 HKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRAT 197 (381)
T ss_pred HhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccc
Confidence 944 6679999999999999998753311000
Q ss_pred ----ccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccc--cccCCChHHHHH
Q 041655 137 ----HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDS--KLLGNGYEEQML 210 (238)
Q Consensus 137 ----~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 210 (238)
........||+.|+|||++.+..++.++|||||||++|||++|..||............... ............
T Consensus 198 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 277 (381)
T cd05626 198 KQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSP 277 (381)
T ss_pred ccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCH
Confidence 00012356899999999998888999999999999999999999998643322111112111 111111112233
Q ss_pred HHHHHhhh--hcCCCCCcc-hHHHHH
Q 041655 211 LVLKTACF--CTLDDPKER-HVRCML 233 (238)
Q Consensus 211 ~l~~~~~~--cl~~~p~~R-~v~~~L 233 (238)
++.+++.+ |+..+|..| .+.+.+
T Consensus 278 ~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 278 EAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHHHHccCcccccCCCCHHHHh
Confidence 45555554 666677668 444333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=219.02 Aligned_cols=211 Identities=20% Similarity=0.215 Sum_probs=158.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC---CCcccCHHHHHHHHHHHHHHh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR---GRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~gl 102 (238)
......|.+|+.++++++|+||+++++++.+.+..+++|||+++++|.+++..... ....+++..+..++.|++.||
T Consensus 50 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 129 (277)
T cd05036 50 EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129 (277)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHH
Confidence 34456789999999999999999999999988899999999999999999876321 123589999999999999999
Q ss_pred chhhcc--------CceeeecCCC---ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhH
Q 041655 103 EYLHMH--------QALVLLDHDM---EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~ 171 (238)
+|||.+ +.||+++.++ .+||+|||.++................+..|+|||++.+..++.++|||||||
T Consensus 130 ~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 209 (277)
T cd05036 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209 (277)
T ss_pred HHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH
Confidence 999954 6779998765 58999999988653322211112233456799999998888999999999999
Q ss_pred HHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhhh
Q 041655 172 LLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQIQ 237 (238)
Q Consensus 172 ~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~~ 237 (238)
++|+|++ |..||...... .....+........+...+..+.+++.+||+.+|++| .+.+.|+.++
T Consensus 210 il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTNQ-EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 9999997 77776532211 1112222222223344456678889999999999999 6666666654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=220.91 Aligned_cols=211 Identities=20% Similarity=0.253 Sum_probs=156.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc------------------CCCcccC
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS------------------RGRRQLD 87 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------------~~~~~~~ 87 (238)
......+.+|+.++++++|||++++++++..++..++++||+++++|.+++.... .....++
T Consensus 49 ~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 128 (288)
T cd05050 49 ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccC
Confidence 3445678999999999999999999999999999999999999999999986421 1123578
Q ss_pred HHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC
Q 041655 88 WLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS 159 (238)
Q Consensus 88 ~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~ 159 (238)
+..+..++.|++.||.|||.+ +.||+++.++.++++|||.+................++..|+|||...+..
T Consensus 129 ~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (288)
T cd05050 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR 208 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC
Confidence 888999999999999999954 667999999999999999987543222111112234466799999988888
Q ss_pred CCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhhh
Q 041655 160 ITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQIQ 237 (238)
Q Consensus 160 ~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~~ 237 (238)
++.++|+||||+++|+|++ |..||................. ...+...+..+.+++.+||+.+|++| ...+.++.++
T Consensus 209 ~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 209 YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 9999999999999999997 6666543221111111111111 12233455678889999999999999 4444444443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=217.16 Aligned_cols=207 Identities=22% Similarity=0.326 Sum_probs=156.3
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
......+|..|+.+++.++||||+++++.+.+++..+++|||+++++|.+++.. ....+++..+..++.|++.||+|
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~ 121 (269)
T cd05065 45 TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKY 121 (269)
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999999999999999999999999999875 23468899999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCccccccc-cccc--CCCcccCcccccccCCCccCCeeehhHHH
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITT-SDVV--GTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~--~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
||.+ +.||+++.++.++++|||.+............ .... .+..|+|||.+.+..++.++|+||||+++
T Consensus 122 lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l 201 (269)
T cd05065 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 201 (269)
T ss_pred HHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHH
Confidence 9954 67799999999999999998765432211111 1111 23579999999888899999999999999
Q ss_pred Hhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 174 AEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 174 ~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
||+++ |..||....... ....+........+.+.+..+.+++..||+.+|.+| ++...|++
T Consensus 202 ~e~l~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 202 WEVMSYGERPYWDMSNQD-VINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred HHHhcCCCCCCCCCCHHH-HHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 99886 777775432211 111111112222234455678889999999999999 55555544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=218.19 Aligned_cols=207 Identities=18% Similarity=0.174 Sum_probs=156.2
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+.+.+|+.++..++||||+++++.+... ..++++||+++|+|.+++.. ....+++..+..++.|++.||.|
T Consensus 49 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~ 124 (279)
T cd05109 49 SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSY 124 (279)
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHH
Confidence 344567788999999999999999999998764 46799999999999999865 23468999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||++ +.||++++++.+||+|||.++...............+++.|+|||...+..++.++|+||||+++||+
T Consensus 125 lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05109 125 LEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204 (279)
T ss_pred HHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 9955 67899999999999999998866433222111223446789999999888899999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++ |..||..... ......+........+...+.++.+++.+||+.||++| ++.+.|+++
T Consensus 205 ~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 205 MTFGAKPYDGIPA-REIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HcCCCCCCCCCCH-HHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 98 6777643221 11112222222222334456678889999999999999 555555544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=216.15 Aligned_cols=203 Identities=22% Similarity=0.261 Sum_probs=155.6
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++|||++++++++...+..++++||+++++|.+++... ....+++..+..++.|++.|+.|||.+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~ 122 (261)
T cd05068 45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ 122 (261)
T ss_pred HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 356889999999999999999999999999999999999999999999752 234689999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||+++.++.++|+|||.+........... .....+..|+|||...+..++.++|+||||+++|++++ |
T Consensus 123 ~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g 201 (261)
T cd05068 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcC
Confidence 6789999999999999999886643211111 11223457999999988889999999999999999999 7
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
..||...... .....+........+...+..+.+++.+||+.+|++| ++...|++
T Consensus 202 ~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 202 RMPYPGMTNA-EVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCCHH-HHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 7776432211 1111222222222334456678889999999999999 44444443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=215.17 Aligned_cols=205 Identities=21% Similarity=0.223 Sum_probs=156.0
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+++.+|+.+++.++|||++++++++.. +..++++||+++++|.+++.. ...+++..+..++.|++.||+|||
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh 112 (257)
T cd05060 38 AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE 112 (257)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHh
Confidence 345678999999999999999999998764 467999999999999999975 346899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccc-cccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHIT-TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
.+ +.||+++.++.++|+|||.++.......... .....++..|+|||...+..++.++|+||||+++|+++
T Consensus 113 ~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~ 192 (257)
T cd05060 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192 (257)
T ss_pred hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHH
Confidence 44 6789999999999999999876543322111 11122346799999998888999999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
+ |..||..... ......+........+...+..+.+++.+||..+|++| ++.+.|+.+.
T Consensus 193 ~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 193 SYGAKPYGEMKG-AEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCcccCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 8 7887754322 11112222222223334455678889999999999999 6666665543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=216.42 Aligned_cols=207 Identities=25% Similarity=0.353 Sum_probs=158.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.++.+++|||++++.+.+...+..+++|||+++++|.+++.. ....+++..+..++.|++.|++||
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~l 123 (268)
T cd05063 47 EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYL 123 (268)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999999999999999999999999999865 235688999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCccccc-ccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI-TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|.+ +.||+++.++.++++|||++.......... .......+..|+|||.+.+..++.++|+||||+++|++
T Consensus 124 H~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~el 203 (268)
T cd05063 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 203 (268)
T ss_pred HHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHH
Confidence 944 678999999999999999987653322111 11112234579999999888889999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++ |..||....... ....+............+..+.+++.+||+.+|++| ++.+.|+++
T Consensus 204 l~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 204 MSFGERPYWDMSNHE-VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HhCCCCCCCcCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 87 888875432211 112222222222333456678889999999999999 666555543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=215.05 Aligned_cols=208 Identities=22% Similarity=0.238 Sum_probs=162.3
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCC-----CcccCHHHHHHHHHHHHHHh
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG-----RRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~gl 102 (238)
..+.+.+|+..+..++|+|++++++++......+++|||+++++|.+++...... ...+++..+..++.|++.||
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 4678899999999999999999999999999999999999999999999762111 36789999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
+|||.+ +.||+++.++.++|+|||.+................+++.|+|||...+..++.++|+||+|+++|
T Consensus 119 ~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 198 (262)
T cd00192 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLW 198 (262)
T ss_pred HHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHH
Confidence 999954 678999999999999999998765433222223456788999999998888999999999999999
Q ss_pred hhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 175 EEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 175 ~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
+|++ |..||....... ....+........+...+.++.+++.+||..||++| ++.+.++.+
T Consensus 199 ~l~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 199 EIFTLGATPYPGLSNEE-VLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred HHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 9998 477765432211 111121122223344446778889999999999999 555555544
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-33 Score=225.60 Aligned_cols=192 Identities=20% Similarity=0.180 Sum_probs=151.5
Q ss_pred HHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+.+..|..++..+. |++|+++++++...+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH 118 (323)
T cd05616 43 DVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLH 118 (323)
T ss_pred HHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4456777888887774 89999999999999999999999999999999865 356889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 119 ~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt 196 (323)
T cd05616 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196 (323)
T ss_pred HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHh
Confidence 54 667999999999999999987532211 11234578999999999999899999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||...........+..... ..+.....++.+++.+||+.||.+|
T Consensus 197 g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~l~~~p~~R 243 (323)
T cd05616 197 GQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 243 (323)
T ss_pred CCCCCCCCCHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHHcccCHHhc
Confidence 9998864332222222222211 2233445567888899999999999
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=214.95 Aligned_cols=206 Identities=19% Similarity=0.211 Sum_probs=156.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+....+.+|+.++++++|||++++++++...+..+++|||+++++|.+++.. ....+++..+..++.|++.||.|+
T Consensus 33 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~l 109 (250)
T cd05085 33 QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYL 109 (250)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34456789999999999999999999999999999999999999999999864 234578999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.++|+|||.+......... ......+++.|+|||++.+..++.++|+||||+++|+++
T Consensus 110 H~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~ 188 (250)
T cd05085 110 ESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF 188 (250)
T ss_pred HhCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHh
Confidence 944 67899999999999999998754332211 112234467799999998888899999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
+ |..||...... .....+........+...+..+.+++.+||+.+|++| .+-+.++.+
T Consensus 189 ~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 189 SLGVCPYPGMTNQ-QAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248 (250)
T ss_pred cCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHh
Confidence 8 77776432211 1111112222223334456678889999999999999 444444443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-33 Score=225.59 Aligned_cols=193 Identities=23% Similarity=0.235 Sum_probs=152.2
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...+.+.+|..++..+ +||||+++++++...+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 37 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~l 112 (320)
T cd05590 37 DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFL 112 (320)
T ss_pred cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 4456778888888876 699999999999999999999999999999998865 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ |.||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+||++|+|+
T Consensus 113 H~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 190 (320)
T cd05590 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML 190 (320)
T ss_pred HHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHh
Confidence 955 5679999999999999999865322211 123457899999999999888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||...........+..... ..+...+.++.+++.+||+.||++|
T Consensus 191 ~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 191 CGHAPFEAENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred hCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHC
Confidence 99998854322211112222111 1222345567788888999999999
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-33 Score=225.48 Aligned_cols=198 Identities=24% Similarity=0.219 Sum_probs=152.0
Q ss_pred HHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
....+..|..++... +||||+++++.+.+++..|+||||+++|+|..++.. ...+++..+..++.|++.||+|||
T Consensus 38 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH 113 (316)
T cd05620 38 DVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLH 113 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345667788877654 799999999999999999999999999999999865 356889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.++|+|||+++...... .......|++.|+|||++.+..++.++|+||+||++|+|++
T Consensus 114 ~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~ 191 (316)
T cd05620 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLI 191 (316)
T ss_pred HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHh
Confidence 54 667999999999999999986432111 11234678999999999998899999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||............... ....+.....++.+++.+||+.||++| .+.+.+
T Consensus 192 g~~Pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 192 GQSPFHGDDEDELFESIRVD--TPHYPRWITKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 99988543221111111111 111222334567788888999999999 554444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=215.34 Aligned_cols=206 Identities=24% Similarity=0.336 Sum_probs=157.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++++++||||+++++++..++..+++|||+++++|.+++.. ....+++..+..++.|++.||.||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~l 122 (267)
T cd05066 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYL 122 (267)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999999975 234689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCccccc-ccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI-TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|.+ +.|++++.++.++++|||.+.......... ......++..|++||...+..++.++|+||||+++|++
T Consensus 123 H~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el 202 (267)
T cd05066 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202 (267)
T ss_pred HHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHH
Confidence 944 678999999999999999988654322111 11112335679999999888899999999999999998
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
++ |..||......... ..+........+...+..+.+++.+||+.+|.+| ++++.|++
T Consensus 203 l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 203 MSYGERPYWEMSNQDVI-KAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred hcCCCCCcccCCHHHHH-HHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 86 88887543221111 1111122222233455678889999999999999 55555544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=217.93 Aligned_cols=202 Identities=19% Similarity=0.210 Sum_probs=154.6
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC-----------CCcccCHHHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR-----------GRRQLDWLARYR 93 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~ 93 (238)
.......+.+|+.++..++|+||+++++.+..++..++++||+++++|.+++..... ....+++..+..
T Consensus 47 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 126 (280)
T cd05092 47 SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126 (280)
T ss_pred CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHH
Confidence 344567899999999999999999999999999999999999999999999865211 113578999999
Q ss_pred HHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCC
Q 041655 94 TVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCD 165 (238)
Q Consensus 94 ~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~D 165 (238)
++.|++.|++|||.+ +.||++++++.++|+|||++................+++.|+|||...+..++.++|
T Consensus 127 ~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 206 (280)
T cd05092 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD 206 (280)
T ss_pred HHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhh
Confidence 999999999999944 677999999999999999987543322111112234567899999998888999999
Q ss_pred eeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 166 IYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 166 vwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|||||++|+|++ |..||............. .......+...+..+.+++.+||+.||.+|
T Consensus 207 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~R 268 (280)
T cd05092 207 IWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQR 268 (280)
T ss_pred HHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999999998 777775432222221121 111222233455667888999999999999
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=215.92 Aligned_cols=194 Identities=22% Similarity=0.219 Sum_probs=155.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++||||+++++.+.+++..++++||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH 110 (262)
T cd05572 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLH 110 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999999999999999999999999999999999999975 345899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.++.++|+|||.+....... ......+++.|++||.+.+..++.++|+||+|+++|++++
T Consensus 111 ~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~ 187 (262)
T cd05572 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLT 187 (262)
T ss_pred hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHh
Confidence 55 556999999999999999987664432 1133467889999999888888999999999999999999
Q ss_pred hHHHHHHhhc--cCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMT--SENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||..... ................+...+.++.+++.+||+.+|++|
T Consensus 188 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 188 GRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred CCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence 9988864331 111112221122223333446678999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=220.81 Aligned_cols=207 Identities=25% Similarity=0.274 Sum_probs=166.9
Q ss_pred hhHHHhhhhhhHH--HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHH
Q 041655 15 TALVEADSKLLTE--EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92 (238)
Q Consensus 15 ~~~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 92 (238)
+++++..++..+. ...-.++|-.+|++++.++||.+--+|++.+.+++|+..+.||+|.-.+.+ -++..+++..+.
T Consensus 213 YAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~ 290 (591)
T KOG0986|consen 213 YACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRAR 290 (591)
T ss_pred HHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeec--cCCCCCchHHHH
Confidence 4455544333332 223457899999999999999999999999999999999999999877765 345679999999
Q ss_pred HHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.+|+.||++|| .||.|||+|++|+++|+|+|++..++..... ....||..|||||++.+..|+...
T Consensus 291 FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~ 367 (591)
T KOG0986|consen 291 FYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSP 367 (591)
T ss_pred HHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCc
Confidence 99999999999999 5588999999999999999999887665543 346899999999999999999999
Q ss_pred CeeehhHHHHhhcchHHHHHHhhccCCCccccccccc---CCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLL---GNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|+||+||++|||+.|..||...-+...- +.++.+.. ..++.....+..+++...|.+||++|
T Consensus 368 Dwf~lGCllYemi~G~sPFr~~KeKvk~-eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~R 432 (591)
T KOG0986|consen 368 DWFSLGCLLYEMIAGHSPFRQRKEKVKR-EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKR 432 (591)
T ss_pred cHHHHHhHHHHHHcccCchhhhhhhhhH-HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHh
Confidence 9999999999999999999875543322 23333331 23445556667777777999999999
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=216.03 Aligned_cols=206 Identities=19% Similarity=0.194 Sum_probs=157.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+..+++++|||++++++++.. +..++++||+++|+|.+++.+ ....+++..+..++.|++.||+||
T Consensus 50 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~L 125 (279)
T cd05057 50 PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYL 125 (279)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999999887 678999999999999999875 234589999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.++|+|||.++...............++..|++||......++.++|+||||+++|+++
T Consensus 126 H~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~ 205 (279)
T cd05057 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELM 205 (279)
T ss_pred HhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHh
Confidence 954 667999999999999999998664332222212223456899999988888899999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+ |..||....... ....+........+..+..++.+++.+||..+|..| ++.+.|.++
T Consensus 206 ~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 206 TFGAKPYEGIPAVE-IPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred cCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 8 888775432211 111222222122233344567888889999999999 555555554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-33 Score=225.65 Aligned_cols=203 Identities=20% Similarity=0.155 Sum_probs=153.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+..+.+.+|+.++..++||||+++++++.+.+..++||||+++|+|.+++.. ....+++..+..++.|++.||.||
T Consensus 42 ~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~l 118 (330)
T cd05601 42 QETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSV 118 (330)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34556788999999999999999999999999999999999999999999975 235689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc------ccCCCccCCeeehhH
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ------TLSITYMCDIYSFGV 171 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~------~~~~~~~~DvwslG~ 171 (238)
|++ +.||+++.++.+||+|||.+..+...... ......|++.|+|||++. ...++.++|||||||
T Consensus 119 H~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 197 (330)
T cd05601 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGV 197 (330)
T ss_pred HHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccc
Confidence 954 67899999999999999999765433221 123357899999999876 455778999999999
Q ss_pred HHHhhcchHHHHHHhhccCCCccccccc--ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 172 LLAEEMSLVKWMRNVMTSENPKRAIDSK--LLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++|+|++|..||...........+.... .........+..+.+++.+||. +|.+| .+.+.+
T Consensus 198 il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 198 IAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred eeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 9999999999885432211111111111 1111112234556777888997 99999 444433
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=215.70 Aligned_cols=209 Identities=23% Similarity=0.259 Sum_probs=154.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhc--CCCcccCHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVS--RGRRQLDWLARYRTVRG 97 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~ 97 (238)
....+.+.+|+.+++.++||||+++++.+... ...++++||+++|+|.+++.... .....+++..+..++.|
T Consensus 41 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 120 (272)
T cd05075 41 RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120 (272)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHH
Confidence 44567889999999999999999999987432 24689999999999999875321 12345899999999999
Q ss_pred HHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 98 IASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 98 l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
++.||+|||.+ +.||+++.++.++|+|||.++...............+++.|++||...+..++.++|+|||
T Consensus 121 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 200 (272)
T cd05075 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200 (272)
T ss_pred HHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHH
Confidence 99999999954 6679999999999999999886543222111223356678999999988889999999999
Q ss_pred hHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 170 GVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 170 G~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
|+++|+|++ |..||...... .....+........+...+..+.+++.+||+.||++| ++.+.|++
T Consensus 201 G~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 201 GVTMWEIATRGQTPYPGVENS-EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred HHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 999999998 66666432211 1111122111122233455668889999999999999 45444443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=213.74 Aligned_cols=200 Identities=22% Similarity=0.297 Sum_probs=152.4
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.++.+++||||+++++.+..++..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||.+
T Consensus 50 ~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~ 125 (267)
T cd06646 50 FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK 125 (267)
T ss_pred HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35678899999999999999999999999999999999999999999865 35688999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhHHHHhhc
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l~~~~ 177 (238)
+.||+++.++.++++|||.+........ ......+++.|+|||.+. ...++.++|+||+|+++|+|+
T Consensus 126 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred CccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence 5679999999999999999876532211 112356788999999874 344678999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccC---CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLG---NGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..|+................... ......+..+.+++.+||+.+|++| .+-+.|+
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 204 ELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred hCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 9988875443222222211111111 1112334567888889999999999 5544444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=226.74 Aligned_cols=201 Identities=18% Similarity=0.191 Sum_probs=150.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.+++.++||||+++++.+.+++..|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~ 160 (370)
T cd05621 86 DSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS 160 (370)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999864 357888999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc----CCCccCCeeehhHHHHh
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL----SITYMCDIYSFGVLLAE 175 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~----~~~~~~DvwslG~~l~~ 175 (238)
+ |.||+++.++.+||+|||++........ .......||+.|+|||++.+. .++.++|+||+||++|+
T Consensus 161 ~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilye 239 (370)
T cd05621 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFE 239 (370)
T ss_pred CCeEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHH
Confidence 4 6679999999999999999976543221 112346799999999988654 37789999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccccCC--ChHHHHHHHHHHhhhhcCCCCCc--c-hHHHHHH
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKLLGN--GYEEQMLLVLKTACFCTLDDPKE--R-HVRCMLS 234 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~cl~~~p~~--R-~v~~~L~ 234 (238)
|++|..||...........+........ ........+.+++..|+..++.. | .+.+.++
T Consensus 240 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 240 MLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred HHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 9999999864332222222322211111 11223445667777788754432 5 5555443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=223.06 Aligned_cols=214 Identities=23% Similarity=0.275 Sum_probs=175.9
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
+|+|.|.+..... +...+.+.+|+.+|+++. ||||+.++++|++.+.+++|||++.||.|.+.+...
T Consensus 63 ~A~K~i~k~~~~~-----------~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~- 130 (382)
T KOG0032|consen 63 VACKVIPKRKLRG-----------KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK- 130 (382)
T ss_pred eEEEEeehhhccc-----------cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-
Confidence 6777776655432 124578899999999998 999999999999999999999999999999999863
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCC----CceEEcccccccccCCcccccccccccCCCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHD----MEARISEFGLAKVFPEAHTHITTSDVVGTAG 148 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 148 (238)
.+++..+..++.|++.++.|+|+ ||.|+++... +.+|++|||++...... ......+||+.
T Consensus 131 ----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~ 203 (382)
T KOG0032|consen 131 ----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG---ERLHTIVGTPE 203 (382)
T ss_pred ----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC---ceEeeecCCcc
Confidence 39999999999999999999994 4667776544 47999999999887652 22356899999
Q ss_pred ccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCc
Q 041655 149 YIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 149 ~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
|+|||++....|+..+|+||+|+++|.|+.|..||+.........++....+ .............+++..|+..||..
T Consensus 204 y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~ 283 (382)
T KOG0032|consen 204 YVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRK 283 (382)
T ss_pred ccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCccc
Confidence 9999999999999999999999999999999999988776665555555544 33445555666778888899999999
Q ss_pred c-hHHHHHH
Q 041655 227 R-HVRCMLS 234 (238)
Q Consensus 227 R-~v~~~L~ 234 (238)
| +..+.|+
T Consensus 284 R~ta~~~L~ 292 (382)
T KOG0032|consen 284 RLTAAQALQ 292 (382)
T ss_pred CCCHHHHhc
Confidence 9 6666664
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=214.32 Aligned_cols=203 Identities=20% Similarity=0.211 Sum_probs=156.7
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++++++|+||+++.+++.+.+..++++||+++++|.+++.+ ...+++..+..++.|++.||+|||
T Consensus 44 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH 119 (265)
T cd06631 44 KEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLH 119 (265)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999975 346789999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcc----cccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAH----THITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
.. +.||++++++.++|+|||.+....... .........++..|+|||...+..++.++|+||||+++|
T Consensus 120 ~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~ 199 (265)
T cd06631 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199 (265)
T ss_pred hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHH
Confidence 54 667999999999999999987543211 111112356788999999998888899999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccc-cccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDS-KLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++++|..||............... ...+..+......+.+++.+||+.+|.+| ++.+.|
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 260 (265)
T cd06631 200 EMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260 (265)
T ss_pred HHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 999999988643221111111111 11222333455667888889999999999 554444
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=228.01 Aligned_cols=156 Identities=21% Similarity=0.314 Sum_probs=131.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.++++++||||+++++.+.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||+||
T Consensus 42 ~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~l 117 (382)
T cd05625 42 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESV 117 (382)
T ss_pred HHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999999999999999999999999999865 34688999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcc------------------------------------------
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAH------------------------------------------ 135 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~------------------------------------------ 135 (238)
|++ |.||+++.++.+||+|||++.......
T Consensus 118 H~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (382)
T cd05625 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAA 197 (382)
T ss_pred HhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhc
Confidence 954 667999999999999999975321000
Q ss_pred ---cccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHH
Q 041655 136 ---THITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRN 185 (238)
Q Consensus 136 ---~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~ 185 (238)
.........||+.|+|||++.+..++.++|+||+||++|||++|..||..
T Consensus 198 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 198 RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred cccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 00001234689999999999988999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=224.05 Aligned_cols=195 Identities=23% Similarity=0.229 Sum_probs=152.7
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.+..+.+.+|..++.++ +||||+++++++...+..|+||||+++|+|..++.. ...+++..+..++.|++.||+|
T Consensus 36 ~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~ 111 (327)
T cd05617 36 DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNF 111 (327)
T ss_pred hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Confidence 34566788999999888 599999999999999999999999999999988865 3568999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||++ +.||+++.++.+||+|||+++....... ......|++.|+|||++.+..++.++|+||||+++|+|
T Consensus 112 lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el 189 (327)
T cd05617 112 LHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189 (327)
T ss_pred HHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHH
Confidence 9955 5679999999999999999864322111 12346789999999999988999999999999999999
Q ss_pred cchHHHHHHhhccCCC------cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 177 MSLVKWMRNVMTSENP------KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++|..||......... ....... ....+...+..+.+++.+||+.||.+|
T Consensus 190 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R 245 (327)
T cd05617 190 MAGRSPFDIITDNPDMNTEDYLFQVILEK-PIRIPRFLSVKASHVLKGFLNKDPKER 245 (327)
T ss_pred HhCCCCCCccCCCcccccHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 9999998543221111 0111111 112233344557788888999999999
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=219.81 Aligned_cols=207 Identities=21% Similarity=0.217 Sum_probs=155.5
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLAR 91 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~ 91 (238)
.......+.+|+.++.++ +||||+++++++..++..++++||+++++|.+++..... ....+++..+
T Consensus 47 ~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 126 (303)
T cd05088 47 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126 (303)
T ss_pred CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHH
Confidence 345567888999999999 799999999999999999999999999999999865211 1235789999
Q ss_pred HHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCcc
Q 041655 92 YRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM 163 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~ 163 (238)
..++.|++.||+|||++ |.|++++.++.++|+|||++....... ......++..|+|||...+..++.+
T Consensus 127 ~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~ 203 (303)
T cd05088 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTN 203 (303)
T ss_pred HHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCccc
Confidence 99999999999999954 678999999999999999986432111 1111234567999999888888999
Q ss_pred CCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 164 CDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 164 ~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
+|+||||+++|+|+| |..||....... .............+...+..+.+++.+||+.+|++| +++..|++
T Consensus 204 ~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 204 SDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred ccchhhhhHHHHHHhcCCCCcccCChHH-HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 999999999999998 777775322211 111122222222333445668889999999999999 44444443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=217.93 Aligned_cols=193 Identities=25% Similarity=0.279 Sum_probs=151.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.++.+++|+|++.+.+.+.+++..+++|||+++++|.+++.. .....+++..+..++.|++.||.|||++
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 121 (285)
T cd05630 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQE 121 (285)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45677899999999999999999999999999999999999999998864 2334689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.+........ .....|+..|+|||++.+..++.++|+||+|+++|+|++|.
T Consensus 122 ~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 198 (285)
T cd05630 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198 (285)
T ss_pred CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence 5679999999999999999875433221 12346899999999998888999999999999999999999
Q ss_pred HHHHHhhccC---CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSE---NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||....... ....... ......+.....++.+++..||+.||++|
T Consensus 199 ~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (285)
T cd05630 199 SPFQQRKKKIKREEVERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKER 247 (285)
T ss_pred CCCCCCCccchHHHHHhhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHc
Confidence 9986422111 0011111 11112223344567788888999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=212.29 Aligned_cols=204 Identities=20% Similarity=0.289 Sum_probs=158.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.....++.+|+.++++++|+||+++++++.+.+..++++||+++++|.+++... ....+++..+..++.|++.||.||
T Consensus 40 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~l 117 (256)
T cd08221 40 EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYI 117 (256)
T ss_pred hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHH
Confidence 345667889999999999999999999999999999999999999999999752 235689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ +.||+++.++.+|++|||.+........ ......+++.|.|||.+.+..++.++|+||||+++|+|+
T Consensus 118 h~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~ 195 (256)
T cd08221 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195 (256)
T ss_pred HhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH
Confidence 954 6679999999999999999876543332 123456889999999998888899999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||................. ...+...+.++.+++.+||..+|++| .+.+.|+
T Consensus 196 ~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 196 TLKRTFDATNPLNLVVKIVQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred HCCCCCCCCCHHHHHHHHHcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 99887753222111112221111 12223345667888889999999999 5555444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=212.34 Aligned_cols=207 Identities=20% Similarity=0.223 Sum_probs=157.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+....+.+|+.++++++||||+++++++...+..++++||+++++|.+++.. ....+++..+..++.+++.||.|||
T Consensus 34 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH 110 (251)
T cd05041 34 DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLE 110 (251)
T ss_pred HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3557889999999999999999999999999999999999999999999865 2345788999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 111 ~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t 190 (251)
T cd05041 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190 (251)
T ss_pred hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence 44 6789999999999999999876542221111122334567999999888889999999999999999998
Q ss_pred -hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhhh
Q 041655 179 -LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQIQ 237 (238)
Q Consensus 179 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~~ 237 (238)
|..||..... ......+........+...+..+.+++.+||..+|.+| .+.+.|+.++
T Consensus 191 ~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 191 LGDTPYPGMSN-QQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCCCccCCH-HHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 6666543221 11112222222222334455678889999999999999 6666665554
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=224.58 Aligned_cols=193 Identities=22% Similarity=0.204 Sum_probs=148.9
Q ss_pred HHHHHHHHHHH-HhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIV-TLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.....+.+|.. +++.++||||+++++.+..++..+++|||+++|+|..++.. ...+++..+..++.|++.||.||
T Consensus 37 ~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~l 112 (325)
T cd05604 37 KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYL 112 (325)
T ss_pred hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34455666665 46778999999999999999999999999999999988865 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ +.||+++.++.+||+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 113 H~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 190 (325)
T cd05604 113 HSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190 (325)
T ss_pred HHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhh
Confidence 955 5679999999999999999864322111 123457899999999999989999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||................. .........+.+++.+|++.+|.+|
T Consensus 191 ~G~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R 238 (325)
T cd05604 191 YGLPPFYCRDVAEMYDNILHKPL--VLRPGASLTAWSILEELLEKDRQRR 238 (325)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCHHHHHHHHHHhccCHHhc
Confidence 99988854322111122222111 1112234456778888999999999
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=214.02 Aligned_cols=221 Identities=19% Similarity=0.204 Sum_probs=162.1
Q ss_pred hhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC---CCcccCHHHH
Q 041655 15 TALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR---GRRQLDWLAR 91 (238)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~ 91 (238)
++++.............+.+|+.+++.++||||+++++++...+..++++||+++++|.+++..... ....+++..+
T Consensus 29 ~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 108 (269)
T cd05044 29 VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108 (269)
T ss_pred ehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHH
Confidence 3444433333344567889999999999999999999999999999999999999999999864221 2244788999
Q ss_pred HHHHHHHHHHhchhhcc--------CceeeecCCC-----ceEEcccccccccCCcccccccccccCCCcccCccccccc
Q 041655 92 YRTVRGIASGLEYLHMH--------QALVLLDHDM-----EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL 158 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~~--------~~~il~~~~~-----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~ 158 (238)
..++.|++.||.|||++ +.||+++.++ .++++|||.+................++..|+|||.+.+.
T Consensus 109 ~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (269)
T cd05044 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG 188 (269)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccC
Confidence 99999999999999955 6679999887 8999999998755332221112234456789999999988
Q ss_pred CCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 159 SITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 159 ~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
.++.++|+||||+++|+|++ |..||...... .....+........+...+..+.+++.+||..+|.+| .+-+.++.+
T Consensus 189 ~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 267 (269)
T cd05044 189 KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267 (269)
T ss_pred CcccchhHHHHHHHHHHHHHcCCCCCcccCHH-HHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 89999999999999999998 77776432211 1111112222223334456678889999999999999 444444443
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=217.33 Aligned_cols=206 Identities=20% Similarity=0.260 Sum_probs=152.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------CCcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------GRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~~l~~g 101 (238)
....+.+|+.++++++|||++++++.+..++..+++|||+++|+|.+++..... ....++...+..++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (288)
T cd05061 52 ERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHH
Confidence 345688999999999999999999999999999999999999999999975221 12345677888999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|.|||.+ +.||+++.++.++|+|||.++...............++..|+|||.+.+..++.++|+||||+++
T Consensus 132 l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 132 MAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred HHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 9999954 67899999999999999998754332221111223456789999999888899999999999999
Q ss_pred Hhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 174 AEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 174 ~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|+|++ |..||...... .....+........+...+..+.+++.+||+.||++| .+.+.++
T Consensus 212 ~el~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 212 WEITSLAEQPYQGLSNE-QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred HHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99998 56565432111 1111111111112223345678889999999999999 4434443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=214.67 Aligned_cols=208 Identities=21% Similarity=0.220 Sum_probs=156.7
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLAR 91 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~ 91 (238)
..+..+.+.+|+.++.++ +||||+++++.+...+..+++|||+++++|.+++..... ....+++..+
T Consensus 35 ~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~ 114 (270)
T cd05047 35 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114 (270)
T ss_pred CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHH
Confidence 345567889999999999 799999999999999999999999999999999865211 1235789999
Q ss_pred HHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCcc
Q 041655 92 YRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM 163 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~ 163 (238)
..++.|++.||+|||.+ |.||+++.++.+|++|||++....... .......+..|+|||+..+..++.+
T Consensus 115 ~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~ 191 (270)
T cd05047 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTN 191 (270)
T ss_pred HHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhh---hccCCCCccccCChHHHccCCCCch
Confidence 99999999999999944 778999999999999999975322111 1111233567999999988889999
Q ss_pred CCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 164 CDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 164 ~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+|+||||+++|+|++ |..||....... ....+........+...+..+.+++.+||+.||.+| +++..|+++
T Consensus 192 ~Di~slG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 192 SDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred hhHHHHHHHHHHHHcCCCCCccccCHHH-HHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 999999999999997 777775432111 111122222222333445568889999999999999 666666554
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=222.43 Aligned_cols=151 Identities=26% Similarity=0.346 Sum_probs=124.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecC-----CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARP-----GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
..++.+|+.++++++||||+++++++... ...|++|||+. ++|.+++.. ...+++..+..++.|+++||.
T Consensus 43 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~ 117 (338)
T cd07859 43 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALK 117 (338)
T ss_pred HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHH
Confidence 45688999999999999999999988543 24799999995 689998865 456899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCccc-ccccccccCCCcccCcccccc--cCCCccCCeeehhHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHT-HITTSDVVGTAGYIAPEYQQT--LSITYMCDIYSFGVL 172 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~apE~~~~--~~~~~~~DvwslG~~ 172 (238)
|||++ +.||+++.++.+||+|||+++....... ........|++.|+|||++.+ ..++.++|||||||+
T Consensus 118 ~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197 (338)
T ss_pred HHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHH
Confidence 99955 5679999999999999999875432211 111234578999999998865 578899999999999
Q ss_pred HHhhcchHHHHH
Q 041655 173 LAEEMSLVKWMR 184 (238)
Q Consensus 173 l~~~~t~~~~~~ 184 (238)
+|+|++|..||.
T Consensus 198 l~el~tg~~pf~ 209 (338)
T cd07859 198 FAEVLTGKPLFP 209 (338)
T ss_pred HHHHHcCCCCCC
Confidence 999999988774
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=214.39 Aligned_cols=208 Identities=20% Similarity=0.292 Sum_probs=153.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
......+.+|+.++++++|||++++.+++... ...+++|||+++++|.+++.. ....+++..+..++.|++.||.
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~ 123 (284)
T cd05079 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMD 123 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHH
Confidence 44557789999999999999999999998765 567899999999999999865 2345899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
|||.+ |.||+++.++.++|+|||.++.+...... .......++..|+|||.+.+..++.++|+||||+++|
T Consensus 124 ~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred HHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 99954 67899999999999999998865432211 1123355677899999988888999999999999999
Q ss_pred hhcchHHHHHHhhcc----------C-CC---cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 175 EEMSLVKWMRNVMTS----------E-NP---KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~----------~-~~---~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
+++++..|....... . .. ............+...+..+.+++.+||+.||++| .+.+.++.+
T Consensus 204 ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred hhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 999865432211000 0 00 00001111112233455678889999999999999 444444443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=220.82 Aligned_cols=212 Identities=22% Similarity=0.259 Sum_probs=159.7
Q ss_pred hhHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHH
Q 041655 24 LLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLA 90 (238)
Q Consensus 24 ~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~ 90 (238)
......+++.+|+.+++++ +||||+++++.+..++..++++||+++|+|.+++..... ....+++..
T Consensus 56 ~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 135 (334)
T cd05100 56 ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135 (334)
T ss_pred cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHH
Confidence 3445567899999999999 799999999999999999999999999999999875221 234578889
Q ss_pred HHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCc
Q 041655 91 RYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY 162 (238)
Q Consensus 91 ~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~ 162 (238)
+..++.|++.||.|||.+ +.||+++.++.+||+|||.++...............++..|+|||++.+..++.
T Consensus 136 ~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 215 (334)
T cd05100 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 215 (334)
T ss_pred HHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc
Confidence 999999999999999944 778999999999999999987654322211112233456799999998888999
Q ss_pred cCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 163 MCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 163 ~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++|+||||+++|+|++ |..||..... ......+........+...+..+.+++.+||+.+|++| ++++.|+++
T Consensus 216 ~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~ 293 (334)
T cd05100 216 QSDVWSFGVLLWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293 (334)
T ss_pred hhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 9999999999999998 6666543221 11212222222223344455678889999999999999 666665544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=214.56 Aligned_cols=199 Identities=19% Similarity=0.267 Sum_probs=154.1
Q ss_pred HHHHHHHHHHHHHhcC-CCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 26 TEEMMQIRSEIVTLGQ-IRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....++.+|+.++.+ ++|||++++++.+..++..++++||+++++|.+++.........+++..++.++.|++.||.|
T Consensus 49 ~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 128 (269)
T cd08528 49 DKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128 (269)
T ss_pred hHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 4456678889998875 789999999999999999999999999999999986544445678999999999999999999
Q ss_pred hhc-c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 105 LHM-H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 105 lH~-~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
||. + +.||+++.++.++|+|||.+....... ......++..|++||...+..++.++|+||||+++|+
T Consensus 129 lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~ 205 (269)
T cd08528 129 LHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQ 205 (269)
T ss_pred hccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHH
Confidence 995 3 446999999999999999987654332 1234567889999999988888999999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+++|..||..................+......+..+.+++.+||+.||++|
T Consensus 206 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 257 (269)
T cd08528 206 MCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEAR 257 (269)
T ss_pred HHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccC
Confidence 9999888754221111111111111111112334567888889999999999
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=212.68 Aligned_cols=201 Identities=22% Similarity=0.306 Sum_probs=151.9
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+.+|+.++.+++||||+++++.+.. +..+++|||+++++|.+++.. .....+++..+..++.|++.||+|+|.+
T Consensus 46 ~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~~~ 122 (262)
T cd05071 46 EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN 122 (262)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 568899999999999999999998754 457899999999999999965 2234578899999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
|.||+++.++.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++|++++ |.
T Consensus 123 i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~ 201 (262)
T cd05071 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201 (262)
T ss_pred ccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 67799999999999999998765433221 1122345678999999888889999999999999999999 67
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
.||......... ...............+..+.+++.+||+.||++| ++.+.|++
T Consensus 202 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 202 VPYPGMVNREVL-DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCCCCChHHHH-HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 666432221111 1111111122234556778899999999999999 44444443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=214.48 Aligned_cols=208 Identities=22% Similarity=0.288 Sum_probs=152.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+.+.+|+.++.+++|||++++++++.. ....++++||+++++|.+++.. ....+++..+..++.|++.||.
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~ 122 (284)
T cd05081 46 AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGME 122 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999998753 3467899999999999999864 2345899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccccc-cccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHIT-TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
|||.+ +.||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|
T Consensus 123 ~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 202 (284)
T cd05081 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202 (284)
T ss_pred HHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHH
Confidence 99955 6679999999999999999986644322111 11123345699999998888999999999999999
Q ss_pred hhcchHHHHHHhhc-------cCCC--------cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 175 EEMSLVKWMRNVMT-------SENP--------KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 175 ~~~t~~~~~~~~~~-------~~~~--------~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
||+++..++..... .... ...+........+...+..+.+++.+||+.+|++| ++++.|+.
T Consensus 203 el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 203 ELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 99997544321110 0000 00111111112223445678889999999999999 66666665
Q ss_pred h
Q 041655 236 I 236 (238)
Q Consensus 236 ~ 236 (238)
+
T Consensus 283 ~ 283 (284)
T cd05081 283 I 283 (284)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=238.19 Aligned_cols=201 Identities=21% Similarity=0.217 Sum_probs=153.0
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC-------CCcccCHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR-------GRRQLDWLARYRTVRGIA 99 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~~l~ 99 (238)
...+++.+|+.++.+++||||+++++++.+++..+++|||+++++|.+++..... ....+++..+..++.|++
T Consensus 44 ~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa 123 (932)
T PRK13184 44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123 (932)
T ss_pred HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHH
Confidence 3456799999999999999999999999999999999999999999999864211 123456677888999999
Q ss_pred HHhchhhc--------cCceeeecCCCceEEcccccccccCCccc----------------ccccccccCCCcccCcccc
Q 041655 100 SGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHT----------------HITTSDVVGTAGYIAPEYQ 155 (238)
Q Consensus 100 ~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~----------------~~~~~~~~~~~~~~apE~~ 155 (238)
+||+|||+ ||.||+++.++.++++|||++........ ........||+.|+|||..
T Consensus 124 ~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l 203 (932)
T PRK13184 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL 203 (932)
T ss_pred HHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh
Confidence 99999994 47789999999999999999976521100 0111235689999999999
Q ss_pred cccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcc-cccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 156 QTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKR-AIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 156 ~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.+..++.++|+||+||++|+|+||..||........... ............+.+..+.+++.+||+.||++|
T Consensus 204 ~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR 276 (932)
T PRK13184 204 LGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276 (932)
T ss_pred cCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhC
Confidence 998999999999999999999999998864221111111 111111111123445668889999999999999
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=225.07 Aligned_cols=197 Identities=22% Similarity=0.263 Sum_probs=147.7
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.+++.++|+||+++++++..++..+++|||+++++|.+.. ..++..+..++.|++.||.|||
T Consensus 114 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH 185 (353)
T PLN00034 114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLH 185 (353)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999999999999999999999999876432 3456778889999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-----cCCCccCCeeehhHHH
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-----LSITYMCDIYSFGVLL 173 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-----~~~~~~~DvwslG~~l 173 (238)
.+ +.||+++.++.+||+|||+++.+..... ......|+..|+|||++.. ...+.++|||||||++
T Consensus 186 ~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil 263 (353)
T PLN00034 186 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263 (353)
T ss_pred HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHH
Confidence 55 5579999999999999999876543211 1133578999999998743 2345689999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccc---cccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAI---DSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|+|++|..||.... ........ ........+.....++.+++.+||+.||++| .+.+.|+
T Consensus 264 ~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 264 LEFYLGRFPFGVGR-QGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHhCCCCCCCCC-CccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999998875211 11111111 1111122233455668889999999999999 5555543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=228.04 Aligned_cols=196 Identities=18% Similarity=0.236 Sum_probs=146.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++.+++||||+++++.+.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH 118 (376)
T cd05598 43 NQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVH 118 (376)
T ss_pred hhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999975 456888999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcc-----------------------------------------cc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAH-----------------------------------------TH 137 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~-----------------------------------------~~ 137 (238)
.+ +.||+++.++.+||+|||++..+.... ..
T Consensus 119 ~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (376)
T cd05598 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQR 198 (376)
T ss_pred HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccc
Confidence 54 667999999999999999975321000 00
Q ss_pred cccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccc--cccCCChHHHHHHHHHH
Q 041655 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDS--KLLGNGYEEQMLLVLKT 215 (238)
Q Consensus 138 ~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~ 215 (238)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||............... .............+.++
T Consensus 199 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 278 (376)
T cd05598 199 CLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDL 278 (376)
T ss_pred ccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHH
Confidence 0012346899999999999989999999999999999999999998643321111111111 11111111233445556
Q ss_pred hhhhcCCCCCcc
Q 041655 216 ACFCTLDDPKER 227 (238)
Q Consensus 216 ~~~cl~~~p~~R 227 (238)
+.+|+ .+|.+|
T Consensus 279 i~~l~-~~p~~R 289 (376)
T cd05598 279 ILRLC-CGAEDR 289 (376)
T ss_pred HHHHh-cCHhhc
Confidence 66665 499999
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=221.76 Aligned_cols=211 Identities=24% Similarity=0.280 Sum_probs=153.3
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecC-CeeEEEEEeCCCCCHHHHHhhhcC-----------------------
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARP-GCHLLVYEFMKNGSLQDILNDVSR----------------------- 81 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~----------------------- 81 (238)
.....+.+|+.++.++ +||||+++++.+... ...+++|||+++|+|.+++.....
T Consensus 52 ~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (343)
T cd05103 52 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDIS 131 (343)
T ss_pred HHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchh
Confidence 3456788999999999 589999999988654 567899999999999999864210
Q ss_pred ----------------------------------------CCcccCHHHHHHHHHHHHHHhchhhcc--------Cceee
Q 041655 82 ----------------------------------------GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVL 113 (238)
Q Consensus 82 ----------------------------------------~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il 113 (238)
....+++..+..++.|+++||+|||++ |.||+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 211 (343)
T cd05103 132 EDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNIL 211 (343)
T ss_pred hhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEE
Confidence 012467888899999999999999954 67899
Q ss_pred ecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCC
Q 041655 114 LDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENP 192 (238)
Q Consensus 114 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~ 192 (238)
++.++.++++|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.........
T Consensus 212 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 291 (343)
T cd05103 212 LSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291 (343)
T ss_pred EcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH
Confidence 99999999999999876533222222223445678999999988889999999999999999996 77665432111111
Q ss_pred cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 193 KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
...+........+.....++.+++..||+.||++| ++++.|+.+-
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111111222234467888999999999999 6777766653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=213.28 Aligned_cols=207 Identities=22% Similarity=0.271 Sum_probs=157.2
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
...+.|.+|+.+++.++||||+++++++.. +...++++||+++++|.+++.. ....+++..+..++.|++.||+|
T Consensus 48 ~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~ 124 (284)
T cd05038 48 QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDY 124 (284)
T ss_pred HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHH
Confidence 356789999999999999999999999877 5578999999999999999975 23358999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
||.+ +.||+++.++.++++|||.+......... .......++..|++||...+..++.++|+||||+++|+
T Consensus 125 lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~e 204 (284)
T cd05038 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYE 204 (284)
T ss_pred HHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhe
Confidence 9955 56799999999999999999876532221 11112344567999999888889999999999999999
Q ss_pred hcchHHHHHHhhccCCC--------------cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 176 EMSLVKWMRNVMTSENP--------------KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|++|..|+......... ...+........+...+..+.+++.+||+.+|.+| +++++|+.+
T Consensus 205 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 205 LFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred eeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 99998776543221100 01111111122233445678889999999999999 666666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=225.66 Aligned_cols=156 Identities=22% Similarity=0.307 Sum_probs=133.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+....+.+|+.++.+++||||+++++.+.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+||
T Consensus 42 ~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~l 117 (363)
T cd05628 42 KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSI 117 (363)
T ss_pred hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 44556788999999999999999999999999999999999999999999975 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccc---------------------------------ccccccc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH---------------------------------ITTSDVV 144 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~---------------------------------~~~~~~~ 144 (238)
|++ +.||+++.++.+||+|||+++........ .......
T Consensus 118 H~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (363)
T cd05628 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTV 197 (363)
T ss_pred HhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhcccccccccc
Confidence 955 56799999999999999998754321100 0012357
Q ss_pred CCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHH
Q 041655 145 GTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRN 185 (238)
Q Consensus 145 ~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~ 185 (238)
||+.|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 198 Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred CCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999999988999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=219.53 Aligned_cols=150 Identities=21% Similarity=0.262 Sum_probs=125.4
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.+++.++||||+++++++.+.+..++||||++ ++|.+++.. ....+++..+..++.|++.||+|||++
T Consensus 48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~ 123 (303)
T cd07869 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY 123 (303)
T ss_pred hhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 456789999999999999999999999999999999995 688888764 235588899999999999999999955
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcchH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
|.||+++.++.+||+|||.+........ ......+++.|+|||++.+ ..++.++|+||+||++|+|++|.
T Consensus 124 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 201 (303)
T cd07869 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV 201 (303)
T ss_pred eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 6679999999999999999875432221 1233567899999998765 45788999999999999999999
Q ss_pred HHHHH
Q 041655 181 KWMRN 185 (238)
Q Consensus 181 ~~~~~ 185 (238)
.||..
T Consensus 202 ~pf~~ 206 (303)
T cd07869 202 AAFPG 206 (303)
T ss_pred CCCCC
Confidence 88853
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=211.93 Aligned_cols=203 Identities=17% Similarity=0.235 Sum_probs=156.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.+++.++|||++++++.+.+++..++++||+++++|.+++.. .....+++..+..++.|++.||.|||
T Consensus 40 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH 117 (255)
T cd08219 40 SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIH 117 (255)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 3456788899999999999999999999999999999999999999998864 22345789999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.++++|||.+........ ......+++.|+|||++.+..++.++|+||||+++|+|++
T Consensus 118 ~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhh
Confidence 54 6779999999999999999876543221 1133568889999999988889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|..||.............. ......+...+..+.+++.+||+.||++| .+.+.|.
T Consensus 196 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 196 LKHPFQANSWKNLILKVCQ-GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCCCCCCCHHHHHHHHhc-CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 9988854221111111111 11112223344567888999999999999 5444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=218.80 Aligned_cols=190 Identities=21% Similarity=0.200 Sum_probs=153.3
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++||||+++++.+..++..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH 118 (290)
T cd05580 43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLH 118 (290)
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999999999999999999999999999875 356899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.++|+|||.+...... .....+++.|+|||.+.+...+.++|+||||+++|+|++
T Consensus 119 ~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 193 (290)
T cd05580 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA 193 (290)
T ss_pred HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh
Confidence 55 55799999999999999998765433 133567899999999888888899999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||................ ...+......+.+++.+||..||.+|
T Consensus 194 g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R 240 (290)
T cd05580 194 GYPPFFDDNPIQIYEKILEGK--VRFPSFFSPDAKDLIRNLLQVDLTKR 240 (290)
T ss_pred CCCCCCCCCHHHHHHHHhcCC--ccCCccCCHHHHHHHHHHccCCHHHc
Confidence 988875322111111112111 12223335667888899999999999
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=212.53 Aligned_cols=199 Identities=22% Similarity=0.288 Sum_probs=151.2
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.+++.++||||+++++.+...+..++++||+++++|.+++.. ...+++..+..++.|++.|+.|||.+
T Consensus 50 ~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~ 125 (267)
T cd06645 50 FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK 125 (267)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678899999999999999999999999999999999999999999865 45689999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhHHHHhhc
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l~~~~ 177 (238)
+.||+++.++.++|+|||.+........ ......|+..|+|||.+. ...++.++|+||+||++|+|+
T Consensus 126 ~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~ 203 (267)
T cd06645 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHh
Confidence 5679999999999999999875532211 123457889999999874 445788999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCC---ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGN---GYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..|+.................... .....+..+.+++.+||..+|++| .+.+.|
T Consensus 204 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll 263 (267)
T cd06645 204 ELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263 (267)
T ss_pred cCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 99888754322111111111111111 111233457788888999999999 444433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=215.38 Aligned_cols=203 Identities=25% Similarity=0.302 Sum_probs=155.1
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeec-----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLAR-----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
-..++..||+.+|+.++|+||+.+++++.. -+..|+|+|++ +.+|...++. +..++...+..++.|+++|
T Consensus 63 ~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrg 137 (359)
T KOG0660|consen 63 IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRG 137 (359)
T ss_pred HHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHh
Confidence 356778999999999999999999999865 35689999999 5699999986 5669999999999999999
Q ss_pred hchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccc-cccCCCccCCeeehhHH
Q 041655 102 LEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQ-QTLSITYMCDIYSFGVL 172 (238)
Q Consensus 102 l~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~-~~~~~~~~~DvwslG~~ 172 (238)
|.|+|+ ||.|++++.+..+|++|||+|+...........+....|..|.|||++ ....|+...||||.||+
T Consensus 138 LKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI 217 (359)
T KOG0660|consen 138 LKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCI 217 (359)
T ss_pred cchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHH
Confidence 999994 488899999999999999999987543222223557789999999965 56679999999999999
Q ss_pred HHhhcchHHHHHHhhcc-----------------------CCCcccccc-cc-cC----CChHHHHHHHHHHhhhhcCCC
Q 041655 173 LAEEMSLVKWMRNVMTS-----------------------ENPKRAIDS-KL-LG----NGYEEQMLLVLKTACFCTLDD 223 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~-----------------------~~~~~~~~~-~~-~~----~~~~~~~~~l~~~~~~cl~~~ 223 (238)
+.||++|++-|.+...- ......+.. +. .. ....+.....++++.++|..|
T Consensus 218 ~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fd 297 (359)
T KOG0660|consen 218 LAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFD 297 (359)
T ss_pred HHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccC
Confidence 99999977666322110 001111110 00 11 112344556788888999999
Q ss_pred CCcc-hHHHHHH
Q 041655 224 PKER-HVRCMLS 234 (238)
Q Consensus 224 p~~R-~v~~~L~ 234 (238)
|.+| ++.+.|+
T Consensus 298 P~kRita~eAL~ 309 (359)
T KOG0660|consen 298 PKKRITAEEALA 309 (359)
T ss_pred ccccCCHHHHhc
Confidence 9999 7777765
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=224.37 Aligned_cols=193 Identities=17% Similarity=0.185 Sum_probs=146.7
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.+++.++||||+++++.+.+++..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+
T Consensus 86 ~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~ 160 (371)
T cd05622 86 DSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS 160 (371)
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999864 347888899999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc----CCCccCCeeehhHHHHh
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL----SITYMCDIYSFGVLLAE 175 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~----~~~~~~DvwslG~~l~~ 175 (238)
+ |.||+++.++.+||+|||++......... ......||+.|+|||++.+. .++.++|+|||||++|+
T Consensus 161 ~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilye 239 (371)
T cd05622 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239 (371)
T ss_pred CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHH
Confidence 4 66799999999999999999765432211 12346799999999988653 37889999999999999
Q ss_pred hcchHHHHHHhhccCCCccccccc--ccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSK--LLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|++|..||...........+.... ............+.+++..|+. +|..|
T Consensus 240 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r 292 (371)
T cd05622 240 MLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVR 292 (371)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcC-Chhhh
Confidence 999999986432221222222211 1111112344556677777998 55554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=224.42 Aligned_cols=149 Identities=20% Similarity=0.227 Sum_probs=126.9
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.++++++||||+++++++..++..++++|++. ++|..++.. ...+++..+..++.|++.||.|||.+
T Consensus 128 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~ 202 (391)
T PHA03212 128 GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR 202 (391)
T ss_pred hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456789999999999999999999999999999999994 689888865 35688999999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
|.||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 203 IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 281 (391)
T PHA03212 203 IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281 (391)
T ss_pred cccCCCChHhEEEcCCCCEEEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 67899999999999999998753222111 1234578999999999988899999999999999999999986
Q ss_pred HHH
Q 041655 182 WMR 184 (238)
Q Consensus 182 ~~~ 184 (238)
|+.
T Consensus 282 p~~ 284 (391)
T PHA03212 282 SLF 284 (391)
T ss_pred CcC
Confidence 654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=228.89 Aligned_cols=209 Identities=17% Similarity=0.209 Sum_probs=171.8
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||-+..+... ..+..|++|+.+|.+|+|||++++||+..+ ....+|+|.++.|+|.+.+.. .
T Consensus 141 VAVKclr~d~l~-------------~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a 204 (1039)
T KOG0199|consen 141 VAVKCLRDDSLN-------------AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--A 204 (1039)
T ss_pred EEEEeccCCccc-------------hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--c
Confidence 677766555443 258999999999999999999999999988 567799999999999999975 3
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhccC--------ceeeecCCCceEEcccccccccCCcccccc-cccccCCCcccCc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHIT-TSDVVGTAGYIAP 152 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~~--------~~il~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~ap 152 (238)
....|.......++.||+.|+.||.++. .|+++.....+||+|||+.+-+........ .....-...|.||
T Consensus 205 ~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaP 284 (1039)
T KOG0199|consen 205 KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAP 284 (1039)
T ss_pred cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCH
Confidence 4566888889999999999999998773 468888899999999999998765443321 1223345779999
Q ss_pred ccccccCCCccCCeeehhHHHHhhcch-HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 153 EYQQTLSITYMCDIYSFGVLLAEEMSL-VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 153 E~~~~~~~~~~~DvwslG~~l~~~~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|.+....++.++|+|+|||++|||+|+ ..||.. .....+.+.++.+.+...+..++.++.++++.||..+|.+|
T Consensus 285 EsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G-~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDR 359 (1039)
T KOG0199|consen 285 ESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG-CRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADR 359 (1039)
T ss_pred hHhccccccccchhhhhhhhHHhhhccCCCCCCC-CCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCcccc
Confidence 999999999999999999999999995 566543 33334556666777777888999999999999999999999
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=224.43 Aligned_cols=193 Identities=21% Similarity=0.127 Sum_probs=145.2
Q ss_pred HHHHHHHHHHHhcCC---CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 28 EMMQIRSEIVTLGQI---RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
....+..|..++... +||||+++++.+..++..|+||||+++|+|.+++.. ...+++..+..++.|+++||+|
T Consensus 36 ~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~ 111 (330)
T cd05586 36 EVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEH 111 (330)
T ss_pred HHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Confidence 344556677766655 699999999999999999999999999999998865 4568999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAE 175 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~ 175 (238)
||++ +.||+++.++.++|+|||++........ ......|++.|+|||++.+. .++.++|+||+||++|+
T Consensus 112 LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~e 189 (330)
T cd05586 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189 (330)
T ss_pred HHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEE
Confidence 9955 5679999999999999999865322211 12345789999999988654 47899999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|++|..||................... ........+.+++.+||+.||.+|
T Consensus 190 lltG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 190 MCCGWSPFYAEDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred eccCCCCCCCCCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCCHHHC
Confidence 999998875422111111111111111 011223456778888999999999
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=212.79 Aligned_cols=193 Identities=22% Similarity=0.266 Sum_probs=155.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++.+++|||++++++.+.+++..++||||+++++|.+++.. ..+++..+..++.|++.||+|+|
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh 118 (277)
T cd06640 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLH 118 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH
Confidence 4467889999999999999999999999999999999999999999998864 35788889999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 119 ~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06640 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAK 196 (277)
T ss_pred hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHH
Confidence 55 6679999999999999999876543321 1233467888999999988888999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..|+......... ...............+..+.+++.+||+.+|++|
T Consensus 197 g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 244 (277)
T cd06640 197 GEPPNSDMHPMRVL-FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFR 244 (277)
T ss_pred CCCCCCCcChHhHh-hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccC
Confidence 99887543222111 1112222233344566778899999999999999
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=214.52 Aligned_cols=203 Identities=19% Similarity=0.223 Sum_probs=154.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++..++|||++++++.+..++..++++||+++++|..++.. ....+++..+..++.|++.||.||
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~L 119 (282)
T cd06643 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYL 119 (282)
T ss_pred HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999999999999999999999999888754 245689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-----ccCCCccCCeeehhHH
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-----TLSITYMCDIYSFGVL 172 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~DvwslG~~ 172 (238)
|++ +.||+++.++.++++|||++........ ......+++.|+|||++. +..++.++|+||+||+
T Consensus 120 H~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi 197 (282)
T cd06643 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGIT 197 (282)
T ss_pred HHCCeeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHH
Confidence 954 6679999999999999999875432211 123356889999999874 3456789999999999
Q ss_pred HHhhcchHHHHHHhhccCCCccccccc-ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 173 LAEEMSLVKWMRNVMTSENPKRAIDSK-LLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|+|++|..||................ .....+...+.++.+++.+||+.||.+| .+.+.|
T Consensus 198 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 198 LIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred HHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 999999998875432221111111111 1111223345567888999999999999 544443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=212.70 Aligned_cols=195 Identities=19% Similarity=0.218 Sum_probs=150.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+....+.+|+.++++++|||++++++.+...+..++++||+++++|..+. .+++..+..++.|++.||.|||
T Consensus 41 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH 112 (279)
T cd06619 41 ELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLW 112 (279)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999886542 3678888899999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 113 ~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 188 (279)
T cd06619 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL 188 (279)
T ss_pred HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHh
Confidence 55 567999999999999999987653322 133578899999999988889999999999999999999
Q ss_pred hHHHHHHhhccCCCc---c---c-ccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPK---R---A-IDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~---~---~-~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||.......... . . .............+.++.+++.+||+.+|++| .+-+.|
T Consensus 189 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil 251 (279)
T cd06619 189 GRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251 (279)
T ss_pred CCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 999886533221110 0 0 00111111112234567888899999999999 444433
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=225.66 Aligned_cols=197 Identities=21% Similarity=0.254 Sum_probs=148.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+....+.+|+.++..++||||+++++.+.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||+||
T Consensus 42 ~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~l 117 (360)
T cd05627 42 KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAI 117 (360)
T ss_pred hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 44567788999999999999999999999999999999999999999999875 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCccc---------------------------------cccccccc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHT---------------------------------HITTSDVV 144 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~---------------------------------~~~~~~~~ 144 (238)
|++ +.||+++.++.++|+|||++..+..... ........
T Consensus 118 H~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (360)
T cd05627 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTV 197 (360)
T ss_pred HHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccC
Confidence 954 6679999999999999999865422110 00012346
Q ss_pred CCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccccc--ccCCChHHHHHHHHHHhhhhcCC
Q 041655 145 GTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSK--LLGNGYEEQMLLVLKTACFCTLD 222 (238)
Q Consensus 145 ~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~cl~~ 222 (238)
||+.|+|||++.+..++.++|+|||||++|+|++|..||...........+.... ...........++.+++.+|+ .
T Consensus 198 gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~ 276 (360)
T cd05627 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-T 276 (360)
T ss_pred CCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-c
Confidence 8999999999999899999999999999999999999885433222212222111 110111112334555555555 4
Q ss_pred CCCcc
Q 041655 223 DPKER 227 (238)
Q Consensus 223 ~p~~R 227 (238)
||++|
T Consensus 277 ~p~~R 281 (360)
T cd05627 277 DSENR 281 (360)
T ss_pred Chhhc
Confidence 99998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=221.76 Aligned_cols=193 Identities=20% Similarity=0.172 Sum_probs=150.8
Q ss_pred HHHHHHHHHHHHhcCCCC-CcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQIRH-RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...+.+..|..++..++| ++|+++++++...+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~l 117 (324)
T cd05587 42 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFL 117 (324)
T ss_pred hHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 445678889999999976 4688899999999999999999999999999865 35688999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ |.||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++|+||+||++|+|+
T Consensus 118 H~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell 195 (324)
T cd05587 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195 (324)
T ss_pred HHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHH
Confidence 955 5679999999999999999864321111 123457899999999999988999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||................ ...+......+.+++.+||+.||.+|
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R 243 (324)
T cd05587 196 AGQPPFDGEDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLLTKHPAKR 243 (324)
T ss_pred hCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHc
Confidence 9999885432221122222111 12223344567788888999999999
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=213.36 Aligned_cols=193 Identities=22% Similarity=0.277 Sum_probs=153.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++||||+++++.+..++..++|+||+++++|.+++.. ..+++..+..++.|+++|+.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH 118 (277)
T cd06642 44 DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLH 118 (277)
T ss_pred HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh
Confidence 4457889999999999999999999999999999999999999999998853 45789999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.++++|||.+..+..... ......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 119 ~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t 196 (277)
T cd06642 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAK 196 (277)
T ss_pred cCCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHh
Confidence 55 6679999999999999999876543221 1123467889999999988889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..|+......... ..+............+..+.+++.+||+.+|++|
T Consensus 197 g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 244 (277)
T cd06642 197 GEPPNSDLHPMRVL-FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFR 244 (277)
T ss_pred CCCCCcccchhhHH-hhhhcCCCCCCCcccCHHHHHHHHHHccCCcccC
Confidence 98887543221111 1111111222233445668889999999999999
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=211.34 Aligned_cols=194 Identities=23% Similarity=0.309 Sum_probs=148.4
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++|||++++++++.. +..+++|||+++++|.+++.. .....+++..+..++.|++.||.|||.+
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~ 121 (260)
T cd05069 45 PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIERM 121 (260)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3568899999999999999999998754 567899999999999999975 2234578999999999999999999944
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||++++++.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++|+|++ |
T Consensus 122 ~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g 200 (260)
T cd05069 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 200 (260)
T ss_pred CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCC
Confidence 67799999999999999998765332211 1122345677999999888889999999999999999999 7
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||......... ...........+...+..+.+++.+||+.||++|
T Consensus 201 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (260)
T cd05069 201 RVPYPGMVNREVL-EQVERGYRMPCPQGCPESLHELMKLCWKKDPDER 247 (260)
T ss_pred CCCCCCCCHHHHH-HHHHcCCCCCCCcccCHHHHHHHHHHccCCcccC
Confidence 7776542221111 1111122222234456678889999999999999
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=217.47 Aligned_cols=199 Identities=19% Similarity=0.225 Sum_probs=148.1
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.++++++||||+++++++..++..++||||++ ++|.+++.. ....+++..+..++.|++.||+|||++
T Consensus 48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 123 (288)
T cd07871 48 CTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK 123 (288)
T ss_pred hhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456789999999999999999999999999999999996 489998864 234578899999999999999999955
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcchH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
|.||+++.++.+||+|||.++....... ......+++.|+|||++.+ ..++.++|+||+||++|+|++|.
T Consensus 124 ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~ 201 (288)
T cd07871 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201 (288)
T ss_pred cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCC
Confidence 5679999999999999999875432211 1133567899999998765 56889999999999999999998
Q ss_pred HHHHHhhccCCC------------------------cccccccccCCC----hHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 181 KWMRNVMTSENP------------------------KRAIDSKLLGNG----YEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 181 ~~~~~~~~~~~~------------------------~~~~~~~~~~~~----~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
.||......... ............ ......+..+++.+||+.||.+| ++.+
T Consensus 202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~ 281 (288)
T cd07871 202 PMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281 (288)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 887432111000 000000000000 01223457788999999999999 6655
Q ss_pred HHH
Q 041655 232 MLS 234 (238)
Q Consensus 232 ~L~ 234 (238)
.|+
T Consensus 282 ~l~ 284 (288)
T cd07871 282 ALR 284 (288)
T ss_pred Hhc
Confidence 554
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=210.81 Aligned_cols=199 Identities=25% Similarity=0.307 Sum_probs=151.2
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeee-cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLA-RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
.+.+.+|+.++++++|+|++++++++. .++..++++||+++++|.+++.. .....+++..+..++.|++.||+|||.
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~ 120 (256)
T cd05082 43 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEA 120 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457889999999999999999999764 55678999999999999999875 233458899999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS- 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t- 178 (238)
+ |.||+++.++.+||+|||.+....... ....++..|+|||...+..++.++|+||||+++|+|++
T Consensus 121 ~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~ 195 (256)
T cd05082 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred CCEeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhC
Confidence 4 678999999999999999987543222 22344567999999988889999999999999999997
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
|..||..... ......+........+...+..+.+++.+||+.+|++| ++.+.|++
T Consensus 196 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 196 GRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 7766542111 11111111122222334456678889999999999999 55555543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=210.62 Aligned_cols=193 Identities=22% Similarity=0.306 Sum_probs=148.7
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+.+|+.++++++|+|++++++.+.. +..+++|||+++++|.+++.. .....+++..+..++.|++.||.|||.+
T Consensus 46 ~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~~~ 122 (260)
T cd05070 46 ESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERMN 122 (260)
T ss_pred HHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 568899999999999999999998754 457899999999999999865 2334589999999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
+.||++++++.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++|++++ |.
T Consensus 123 i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~ 201 (260)
T cd05070 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201 (260)
T ss_pred cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCC
Confidence 67899999999999999998765432211 1122334567999999888889999999999999999999 77
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||...... ..............+...+..+.+++.+||..+|++|
T Consensus 202 ~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (260)
T cd05070 202 VPYPGMNNR-EVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEER 247 (260)
T ss_pred CCCCCCCHH-HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccC
Confidence 777432211 1112222222223344455678899999999999999
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=212.84 Aligned_cols=210 Identities=20% Similarity=0.230 Sum_probs=156.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCC-----CcccCHHHHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG-----RRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~ 100 (238)
......+.+|+.++++++|||++++++++.+.+..+++|||+++++|.+++...... ...+++..+..++.|++.
T Consensus 49 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 128 (275)
T cd05046 49 ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128 (275)
T ss_pred hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHH
Confidence 345678999999999999999999999999988999999999999999999752211 126899999999999999
Q ss_pred Hhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 101 GLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
||+|||++ |.|++++.++.++++|||.+........ .......++..|+|||.+.+...+.++|+||||++
T Consensus 129 ~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~ 207 (275)
T cd05046 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVL 207 (275)
T ss_pred HHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHH
Confidence 99999944 6789999999999999999864322111 11123355678999999888888899999999999
Q ss_pred HHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 173 LAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 173 l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
+|++++ |..||.....................+...+..+.+++.+||+.+|++| .+-+.+..+
T Consensus 208 l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 208 MWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred HHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 999998 5666643222111111111111112233455678889999999999999 555555444
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=214.82 Aligned_cols=192 Identities=21% Similarity=0.230 Sum_probs=151.7
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.+++.++|||++++++.+..++..++|+||+++++|.+++.. ..+++..+..++.|++.||.|||.+
T Consensus 61 ~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~ 135 (296)
T cd06654 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN 135 (296)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999999864 3578889999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.+......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 136 gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~ 213 (296)
T cd06654 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (296)
T ss_pred CcccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence 56799999999999999998754332211 12346788999999998888899999999999999999999
Q ss_pred HHHHHhhccCCCccccc-ccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSENPKRAID-SKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||.............. .......+...+..+.+++.+||..+|++|
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 261 (296)
T cd06654 214 PPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261 (296)
T ss_pred CCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccC
Confidence 98854322111111111 111112233445668889999999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=211.09 Aligned_cols=200 Identities=25% Similarity=0.309 Sum_probs=154.5
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+++.+|+.++.+++|+|++++++.+.+.+..+++|||+++++|.+++.. .....+++..+..++.|++.||.|||.
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lh~ 120 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEE 120 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457789999999999999999999999989999999999999999999975 222368999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS- 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t- 178 (238)
+ +.||+++.++.++|+|||.++....... ....+..|+|||.+.+..++.++|+||||+++|++++
T Consensus 121 ~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~ 195 (256)
T cd05039 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred CCccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhc
Confidence 4 6789999999999999999876532221 2334567999999888888999999999999999997
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHh
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQ 235 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~ 235 (238)
|..||..... ......+........+...+..+.+++.+||+.+|++| ++.+.++.
T Consensus 196 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 252 (256)
T cd05039 196 GRVPYPRIPL-KDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQ 252 (256)
T ss_pred CCCCCCCCCH-HHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 7766543211 11111222222223334456678889999999999999 44443333
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=215.89 Aligned_cols=198 Identities=21% Similarity=0.275 Sum_probs=145.1
Q ss_pred HHHHHHHHhcCC---CCCcccceeeeee-----cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 31 QIRSEIVTLGQI---RHRNILPLLAHLA-----RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 31 ~~~~E~~~l~~l---~h~~iv~~~~~~~-----~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
.+.+|+.+++.+ +||||+++++++. .....++++||++ ++|.+++.. .....+++..+..++.|++.||
T Consensus 47 ~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL 123 (290)
T cd07862 47 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGL 123 (290)
T ss_pred HHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHH
Confidence 445666665554 6999999999885 3456899999996 589999865 2334589999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
.|||.+ |.||+++.++.+||+|||.++...... ......|++.|+|||.+.+..++.++|+|||||++|
T Consensus 124 ~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 200 (290)
T cd07862 124 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 200 (290)
T ss_pred HHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHH
Confidence 999955 667999999999999999987654331 223457899999999998888999999999999999
Q ss_pred hhcchHHHHHHhhccCCCccccc------------------ccc---cC----CChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 175 EEMSLVKWMRNVMTSENPKRAID------------------SKL---LG----NGYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~------------------~~~---~~----~~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
+|++|..||...........+.+ ... .. ......+..+.+++.+||+.||++| +
T Consensus 201 el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 280 (290)
T cd07862 201 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280 (290)
T ss_pred HHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC
Confidence 99999888754321111111100 000 00 0011234556789999999999999 6
Q ss_pred HHHHHH
Q 041655 229 VRCMLS 234 (238)
Q Consensus 229 v~~~L~ 234 (238)
+.+.|+
T Consensus 281 ~~~~l~ 286 (290)
T cd07862 281 AYSALS 286 (290)
T ss_pred HHHHhc
Confidence 555553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=213.25 Aligned_cols=201 Identities=20% Similarity=0.236 Sum_probs=143.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++..++|||++++++.+......+++|||+++|+|.+++..........++..+..++.|+++||+||
T Consensus 36 ~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~l 115 (268)
T cd05086 36 SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115 (268)
T ss_pred hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999999975322334567778889999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-------cCCCccCCeeehh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-------LSITYMCDIYSFG 170 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-------~~~~~~~DvwslG 170 (238)
|.+ +.||+++.++.++|+|||.+................++..|+|||++.. ..++.++|+||||
T Consensus 116 H~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG 195 (268)
T cd05086 116 HKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALG 195 (268)
T ss_pred HHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHH
Confidence 944 6789999999999999998754322111111234567889999998743 2356789999999
Q ss_pred HHHHhhcch-HHHHHHhhccCCCccccccc----ccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 171 VLLAEEMSL-VKWMRNVMTSENPKRAIDSK----LLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 171 ~~l~~~~t~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+++|+|+++ ..||................ ..+.........+.+++.+|| .+|++|
T Consensus 196 ~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~R 256 (268)
T cd05086 196 VTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKR 256 (268)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccC
Confidence 999999874 55553221111111111110 111111223345666777899 679999
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=214.21 Aligned_cols=205 Identities=23% Similarity=0.278 Sum_probs=155.4
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecC---C--eeEEEEEeCCCCCHHHH
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP---G--CHLLVYEFMKNGSLQDI 75 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~--~~~~v~e~~~~~~L~~~ 75 (238)
.||||+..++..- -.+|+.+|.+++|||||++.-+|... + ...+||||+|. +|.++
T Consensus 51 ~vAIKKv~~d~r~------------------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~ 111 (364)
T KOG0658|consen 51 EVAIKKVLQDKRY------------------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRV 111 (364)
T ss_pred eeEEEEecCCCCc------------------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHH
Confidence 4899988765432 23799999999999999998887532 2 33589999986 89999
Q ss_pred HhhhcCCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCC-CceEEcccccccccCCcccccccccccCC
Q 041655 76 LNDVSRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHD-MEARISEFGLAKVFPEAHTHITTSDVVGT 146 (238)
Q Consensus 76 l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 146 (238)
++.....+..++...++-+..|+.+||.||| .||.|+|+|.+ |.+||+|||.|+.+.....+ .+...+
T Consensus 112 ~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicS 188 (364)
T KOG0658|consen 112 IRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICS 188 (364)
T ss_pred HHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEe
Confidence 9865555678888899999999999999999 56889999987 89999999999987655543 335678
Q ss_pred CcccCcccccc-cCCCccCCeeehhHHHHhhcchHHHHHHhhcc--------------------CCCc-------ccccc
Q 041655 147 AGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTS--------------------ENPK-------RAIDS 198 (238)
Q Consensus 147 ~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~--------------------~~~~-------~~~~~ 198 (238)
..|.|||.+.+ ..|+.+.||||.||++.||+-|.+-|.+.... .++. .+...
T Consensus 189 RyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~ 268 (364)
T KOG0658|consen 189 RYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAH 268 (364)
T ss_pred ccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccc
Confidence 89999997655 56899999999999999999876666332111 0111 11111
Q ss_pred cccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 199 KLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 199 ~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
....-.....+.+..+++.+++..+|.+|
T Consensus 269 ~~~~~~~~~~~~d~~dll~~~L~Y~P~~R 297 (364)
T KOG0658|consen 269 PWHKVFFKRLPPDALDLLSKLLQYSPSKR 297 (364)
T ss_pred cceeecccCCCHHHHHHHHHHhccChhhc
Confidence 11111344567778899999999999999
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=212.09 Aligned_cols=201 Identities=20% Similarity=0.247 Sum_probs=150.0
Q ss_pred HHHHHHHHHHhcCC-CCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 29 MMQIRSEIVTLGQI-RHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 29 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
...+.+|+.++.++ +|||++++.+.+... +..++++||+++++|.+++.. .....+++..+..++.|++.|
T Consensus 46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~ 123 (272)
T cd06637 46 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRG 123 (272)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHH
Confidence 35678899999998 699999999998653 457899999999999999875 223468899999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-----ccCCCccCCeee
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-----TLSITYMCDIYS 168 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~Dvws 168 (238)
|.|||++ +.||+++.++.++|+|||++........ ......|++.|+|||++. +..++.++|+||
T Consensus 124 l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 201 (272)
T cd06637 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 201 (272)
T ss_pred HHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence 9999966 5569999999999999999876533211 123457889999999875 335788999999
Q ss_pred hhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 169 FGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 169 lG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+||++|+|++|..||.........................+..+.+++.+||..||.+| .+.+.+
T Consensus 202 lGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 202 LGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred HHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999999999988854322221111111111111122344567888999999999999 444443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=212.71 Aligned_cols=200 Identities=23% Similarity=0.237 Sum_probs=144.1
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC-CCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR-GRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.....+.+|+.++++++||||+++++.+.+....++||||+++|+|.+++..... .....++..+..++.|++.|+.||
T Consensus 37 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l 116 (269)
T cd05087 37 QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116 (269)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH
Confidence 3445788999999999999999999999988889999999999999999865221 223466778888999999999999
Q ss_pred hc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-------CCCccCCeeehh
Q 041655 106 HM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-------SITYMCDIYSFG 170 (238)
Q Consensus 106 H~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-------~~~~~~DvwslG 170 (238)
|+ ++.||+++.++.++|+|||.+................++..|+|||++.+. .++.++|+||||
T Consensus 117 H~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG 196 (269)
T cd05087 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLG 196 (269)
T ss_pred HHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHH
Confidence 94 467899999999999999998654332221122234567889999987532 357899999999
Q ss_pred HHHHhhcc-hHHHHHHhhccCCCccccc---ccc-cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 171 VLLAEEMS-LVKWMRNVMTSENPKRAID---SKL-LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 171 ~~l~~~~t-~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+++|+|++ |..||.............. ... .+.........+.+++.+|| .+|++|
T Consensus 197 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~R 257 (269)
T cd05087 197 VTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQR 257 (269)
T ss_pred HHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccC
Confidence 99999996 8877743221111111010 000 11111123344667777899 589999
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=217.16 Aligned_cols=198 Identities=20% Similarity=0.221 Sum_probs=155.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++..++||||+++++.+..++..++++||+.+++|.+++.. .....+++..+..++.|++.||+|||.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~ 121 (316)
T cd05574 44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL 121 (316)
T ss_pred HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH
Confidence 556788999999999999999999999999999999999999999999875 234568999999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccc---------------------------cccccccCCCcccCc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTH---------------------------ITTSDVVGTAGYIAP 152 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~---------------------------~~~~~~~~~~~~~ap 152 (238)
. +.||+++.++.++|+|||.+......... .......|+..|+||
T Consensus 122 ~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aP 201 (316)
T cd05574 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP 201 (316)
T ss_pred CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCH
Confidence 4 66799999999999999998654321110 011234678899999
Q ss_pred ccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 153 EYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 153 E~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|++.+..++.++|+||||+++|+|++|..||.........................+..+.+++.+||..||++|
T Consensus 202 E~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (316)
T cd05574 202 EVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276 (316)
T ss_pred HHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHC
Confidence 999888889999999999999999999998854332222222222222222222246678889999999999999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=220.88 Aligned_cols=193 Identities=19% Similarity=0.188 Sum_probs=151.6
Q ss_pred HHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...+.+..|..++..+. |++|+++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~l 117 (323)
T cd05615 42 DDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFL 117 (323)
T ss_pred hHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567788999988886 57888899999999999999999999999999865 45689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.++|+|||+++....... ......|++.|+|||++.+..++.++|+||+|+++|+|+
T Consensus 118 H~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell 195 (323)
T cd05615 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195 (323)
T ss_pred HHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHH
Confidence 955 5679999999999999999875322211 123456899999999998888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||...........+..... ..+.....++.+++.+||+.+|.+|
T Consensus 196 tG~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~~p~~R 243 (323)
T cd05615 196 AGQPPFDGEDEDELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPSKR 243 (323)
T ss_pred hCCCCCCCCCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHcccCHhhC
Confidence 99998864332222222222111 1223344567788889999999999
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=209.45 Aligned_cols=202 Identities=19% Similarity=0.228 Sum_probs=151.3
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
+....+.+|+.++++++||||+++++.+.. ++..++++||+++++|.+++.. ...+++.....++.|++.||+|
T Consensus 46 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~ 121 (266)
T cd06651 46 KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSY 121 (266)
T ss_pred HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Confidence 456778999999999999999999998865 3567899999999999999875 3457889999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCccc-ccccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHT-HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
||.+ +.||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++|+||+|+++|+
T Consensus 122 LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~e 201 (266)
T cd06651 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVE 201 (266)
T ss_pred HHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHH
Confidence 9955 4569999999999999999875432111 111123457889999999988888999999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+++|..||..................+..+......+.+++ .||..+|++| .+.+.|
T Consensus 202 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 202 MLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred HHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 99999988643322222222222222233333444555565 6888999999 444443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=215.32 Aligned_cols=151 Identities=23% Similarity=0.292 Sum_probs=131.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.....++.+|++++.+++||||+++++.+..++..++++||+++++|.+++.. ...+++..+..++.|+++||.||
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l 115 (308)
T cd06615 40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYL 115 (308)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34556788999999999999999999999999999999999999999999975 35688999999999999999999
Q ss_pred hcc---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|++ +.||+++.++.++++|||.+....... .....+++.|+|||.+.+..++.++|+||||+++|+|
T Consensus 116 H~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l 191 (308)
T cd06615 116 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191 (308)
T ss_pred HhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHH
Confidence 953 557999999999999999986543221 1335678999999998888889999999999999999
Q ss_pred cchHHHHH
Q 041655 177 MSLVKWMR 184 (238)
Q Consensus 177 ~t~~~~~~ 184 (238)
++|..||.
T Consensus 192 ~~g~~p~~ 199 (308)
T cd06615 192 AIGRYPIP 199 (308)
T ss_pred HhCCCCCC
Confidence 99988764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=212.74 Aligned_cols=193 Identities=19% Similarity=0.216 Sum_probs=152.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++..++||||+++++.+...+..++|+||+++++|.+++.. ...+++..+..++.+++.||.|||
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH 120 (284)
T cd06620 45 SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLY 120 (284)
T ss_pred hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999999999999999999999999998865 346899999999999999999999
Q ss_pred cc---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MH---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
.. +.||++++++.++|+|||++....... .....|+..|+|||++.+..++.++|+|||||++|+++
T Consensus 121 ~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 196 (284)
T cd06620 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA 196 (284)
T ss_pred HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHH
Confidence 52 567999999999999999976542221 12356889999999988888899999999999999999
Q ss_pred chHHHHHHhhccC-----------CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSE-----------NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||....... ..................+.++.+++.+||+.||++|
T Consensus 197 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 257 (284)
T cd06620 197 LGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257 (284)
T ss_pred hCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccC
Confidence 9999886433210 0111111111111122355678889999999999999
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=215.72 Aligned_cols=204 Identities=18% Similarity=0.169 Sum_probs=154.3
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.+++.++||||+++++.+..++..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH 118 (305)
T cd05609 43 NQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLH 118 (305)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999975 356899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcc-------------cccccccccCCCcccCcccccccCCCccCC
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAH-------------THITTSDVVGTAGYIAPEYQQTLSITYMCD 165 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~-------------~~~~~~~~~~~~~~~apE~~~~~~~~~~~D 165 (238)
.+ +.||+++.++.++++|||.++...... .........++..|+|||.+.+..++.++|
T Consensus 119 ~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 198 (305)
T cd05609 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVD 198 (305)
T ss_pred HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhh
Confidence 55 667999999999999999886321100 000112245778899999988888999999
Q ss_pred eeehhHHHHhhcchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-h---HHHHHH
Q 041655 166 IYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-H---VRCMLS 234 (238)
Q Consensus 166 vwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~---v~~~L~ 234 (238)
+||||+++|++++|..||................. .+......+..+.+++.+||+.||++| . +.+.|+
T Consensus 199 i~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 199 WWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 99999999999999988753221111111111111 111112345667889999999999999 3 455554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=208.96 Aligned_cols=195 Identities=22% Similarity=0.279 Sum_probs=150.7
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++|+|++++++.+.. ...+++|||+++++|.+++.. .....+++..+..++.|++.||.|||.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH~ 120 (260)
T cd05073 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQ 120 (260)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHHh
Confidence 45678999999999999999999999887 678999999999999999965 223457888899999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS- 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t- 178 (238)
+ +.|++++.++.++|+|||.+......... ......++..|+|||++....++.++|+||||+++|++++
T Consensus 121 ~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~ 199 (260)
T cd05073 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 199 (260)
T ss_pred CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence 4 67899999999999999998765432211 1122345677999999988888999999999999999998
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||...... .....+........+...+..+.+++.+||+.+|++|
T Consensus 200 g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 247 (260)
T cd05073 200 GRIPYPGMSNP-EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 247 (260)
T ss_pred CCCCCCCCCHH-HHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccC
Confidence 77777532211 1111122222222334455678889999999999999
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=213.18 Aligned_cols=202 Identities=22% Similarity=0.287 Sum_probs=153.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++|||++++++.+..++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh 120 (280)
T cd06611 44 EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLH 120 (280)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4557789999999999999999999999999999999999999999999865 2356899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-----ccCCCccCCeeehhHHH
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-----TLSITYMCDIYSFGVLL 173 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~DvwslG~~l 173 (238)
.+ +.||+++.++.++|+|||.+........ ......+++.|++||.+. +..++.++|+||||+++
T Consensus 121 ~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il 198 (280)
T cd06611 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITL 198 (280)
T ss_pred HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHH
Confidence 54 6679999999999999998765432211 123356788999999874 34567899999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|+|++|..||................. ....+...+..+.+++..||+.+|.+| ...+.|
T Consensus 199 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 199 IELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred HHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 999999988754322111111111111 111223344567888889999999999 444444
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=209.70 Aligned_cols=201 Identities=23% Similarity=0.249 Sum_probs=156.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+..+.+.+|+.++++++|||++++++.+..++..++++||+++++|.+++.. ...+++..+..++.|++.||.||
T Consensus 43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l 118 (258)
T cd06632 43 QEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYL 118 (258)
T ss_pred hHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999999999999999999999999875 34588999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC-CCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS-ITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~-~~~~~DvwslG~~l~~~ 176 (238)
|+. +.||+++.++.+||+|||.+....... ......++..|++||...... ++.++|+||||+++|++
T Consensus 119 H~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l 195 (258)
T cd06632 119 HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195 (258)
T ss_pred HHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHH
Confidence 955 567999999999999999987653322 123456788999999887666 88999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++|..||..................+..+......+.+++.+||+.+|.+| .+.+.|
T Consensus 196 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 253 (258)
T cd06632 196 ATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELL 253 (258)
T ss_pred HhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 999988754332111111111111222233445667888999999999999 554444
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=209.08 Aligned_cols=199 Identities=26% Similarity=0.318 Sum_probs=154.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++|||++++++.+..++..+++|||+++++|.+++.. ....+++..+..++.|++.||.|||.
T Consensus 43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~ 119 (262)
T cd06613 43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE 119 (262)
T ss_pred hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457888999999999999999999999999999999999999999999875 23568899999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc---CCCccCCeeehhHHHHhh
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL---SITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~---~~~~~~DvwslG~~l~~~ 176 (238)
+ +.||+++.++.++++|||.+........ ......++..|+|||...+. .++.++|+||||+++|+|
T Consensus 120 ~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197 (262)
T ss_pred CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHH
Confidence 4 6679999999999999999876533211 11335678889999998766 788899999999999999
Q ss_pred cchHHHHHHhhccCCCcccccc---cccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDS---KLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
++|..|+............... ..........+..+.+++.+||..+|.+| ++-+
T Consensus 198 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (262)
T cd06613 198 AELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256 (262)
T ss_pred HhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHH
Confidence 9999887543211111111111 11111233445678899999999999999 4433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=209.18 Aligned_cols=200 Identities=22% Similarity=0.262 Sum_probs=156.4
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++|||++++++.+..+...|+++||+++++|.+++.. ....+++..+..++.|++.||.|||..
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~ 118 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN 118 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 57889999999999999999999999999999999999999999999864 245689999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||++++++.++|+|||.+........ ......++..|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 119 ~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~ 196 (256)
T cd06612 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196 (256)
T ss_pred CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCC
Confidence 6679999999999999999876543321 123345788999999998888999999999999999999998
Q ss_pred HHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 181 KWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
.|+................. ....+......+.+++.+||+.||++| .+.+.|
T Consensus 197 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il 251 (256)
T cd06612 197 PPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL 251 (256)
T ss_pred CCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHh
Confidence 88754322211111111111 111223344568888999999999999 544444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=209.67 Aligned_cols=193 Identities=20% Similarity=0.283 Sum_probs=149.1
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+++.+|+.++++++|||++++++.+. .+..++++||+++++|.+++.. .....+++..+..++.|++.||+|||.+
T Consensus 46 ~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~ 122 (260)
T cd05067 46 EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN 122 (260)
T ss_pred HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 57889999999999999999998874 4568999999999999999864 2345688999999999999999999944
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
+.|++++.++.++++|||.+......... ......++..|+|||.+.+..++.++|+||||+++|++++ |.
T Consensus 123 i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~ 201 (260)
T cd05067 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201 (260)
T ss_pred eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCC
Confidence 66799999999999999998765422211 1122345678999999988889999999999999999998 88
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||...... .....+........+...+..+.+++.+||+.+|++|
T Consensus 202 ~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (260)
T cd05067 202 IPYPGMTNP-EVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEER 247 (260)
T ss_pred CCCCCCChH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 877532211 1111222222223334445678889999999999999
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=238.58 Aligned_cols=203 Identities=18% Similarity=0.173 Sum_probs=151.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+.+|+.++.+++||||++++++|.. .+.+|+||||+++++|.+++.........+++..++.++.||+.||.|
T Consensus 54 ~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaY 133 (1021)
T PTZ00266 54 REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133 (1021)
T ss_pred HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 445778999999999999999999998854 456899999999999999987533334579999999999999999999
Q ss_pred hhc---------------cCceeeecC-----------------CCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 105 LHM---------------HQALVLLDH-----------------DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 105 lH~---------------~~~~il~~~-----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
||. +|.|||++. .+.+||+|||++..+..... .....|++.|+||
T Consensus 134 LHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAP 210 (1021)
T PTZ00266 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSP 210 (1021)
T ss_pred HHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCH
Confidence 995 255688854 34589999999976543221 2345789999999
Q ss_pred ccccc--cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hH
Q 041655 153 EYQQT--LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HV 229 (238)
Q Consensus 153 E~~~~--~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v 229 (238)
|++.+ ..++.++|||||||++|+|++|..||............+..... ......+.++.+++..||+.+|.+| .+
T Consensus 211 EvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa 289 (1021)
T PTZ00266 211 ELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSA 289 (1021)
T ss_pred HHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCH
Confidence 98854 45788999999999999999999998532211111111111111 1112234567888888999999999 55
Q ss_pred HHHH
Q 041655 230 RCML 233 (238)
Q Consensus 230 ~~~L 233 (238)
.+.|
T Consensus 290 ~QlL 293 (1021)
T PTZ00266 290 LQCL 293 (1021)
T ss_pred HHHh
Confidence 5555
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=211.38 Aligned_cols=215 Identities=19% Similarity=0.196 Sum_probs=159.4
Q ss_pred HHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHH
Q 041655 17 LVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVR 96 (238)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 96 (238)
++........+..+.+.+|+.++++++|||++++++++.++ ..+++|||+++++|.+++.. ....+++..+..++.
T Consensus 39 ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~ 114 (270)
T cd05056 39 VKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSY 114 (270)
T ss_pred EEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHH
Confidence 33333333345667899999999999999999999988764 56899999999999999975 234589999999999
Q ss_pred HHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeee
Q 041655 97 GIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYS 168 (238)
Q Consensus 97 ~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvws 168 (238)
|++.||.|||.+ +.||+++.++.++++|||.++.......... +...++..|+|||.+....++.++|+||
T Consensus 115 ~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~s 193 (270)
T cd05056 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWM 193 (270)
T ss_pred HHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceec-CCCCccccccChhhhccCCCCchhhhHH
Confidence 999999999954 6789999999999999999876543322111 2233456799999988888899999999
Q ss_pred hhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 169 FGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 169 lG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
||+++|++++ |..||.......... .+........+...+..+.+++.+||..+|.+| ++.+.|++++
T Consensus 194 lG~il~el~~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 194 FGVCMWEILMLGVKPFQGVKNNDVIG-RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHH-HHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999999886 888774432221111 111111122234455678889999999999999 5555555543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=214.31 Aligned_cols=193 Identities=23% Similarity=0.235 Sum_probs=150.6
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.++.+++|+|++.+.+.+..++..++++||+++++|.+++.. .....+++..+..++.|++.||.|||++
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~ 121 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE 121 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45678899999999999999999999999999999999999999988864 2234689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||++++++.++|+|||.+........ .....|+..|+|||.+.+..++.++|+||+|+++|++++|.
T Consensus 122 ~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 198 (285)
T cd05632 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198 (285)
T ss_pred CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 5569999999999999999875433221 12356899999999998888999999999999999999999
Q ss_pred HHHHHhhccCCC---cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSENP---KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||......... ...+... ....+...+..+.+++..||+.||++|
T Consensus 199 ~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05632 199 SPFRGRKEKVKREEVDRRVLET-EEVYSAKFSEEAKSICKMLLTKDPKQR 247 (285)
T ss_pred CCCCCCCHHHHHHHHHHhhhcc-ccccCccCCHHHHHHHHHHccCCHhHc
Confidence 988543211111 1111110 112223344456778888999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=214.79 Aligned_cols=207 Identities=22% Similarity=0.240 Sum_probs=154.8
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLARY 92 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~ 92 (238)
....+.+.+|+.++.++ +||||+++++.+...+..++++||+++++|.+++..... ....+++..+.
T Consensus 43 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 122 (297)
T cd05089 43 ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122 (297)
T ss_pred HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHH
Confidence 34456789999999999 699999999999999999999999999999999864211 11358889999
Q ss_pred HHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.|++.||+|||.+ +.||+++.++.+||+|||++........ ......+..|+|||...+..++.++
T Consensus 123 ~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~ 199 (297)
T cd05089 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKS 199 (297)
T ss_pred HHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchh
Confidence 9999999999999944 6789999999999999999864321111 1112234579999999888899999
Q ss_pred CeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 165 DIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 165 DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
||||||+++|+|++ |..||....... .............+...+..+.+++.+||+.+|.+| ++++.|+++
T Consensus 200 DvwSlG~il~el~t~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 200 DVWSFGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999997 877764322111 111122222222333455668889999999999999 555555544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=209.02 Aligned_cols=198 Identities=19% Similarity=0.272 Sum_probs=148.1
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+....+.+|+.++..++||||+++++++..+...+++|||+++++|..++.. ....+++..+..++.|+++||+|||
T Consensus 46 ~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH 122 (262)
T cd05077 46 DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLE 122 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhh
Confidence 3445788899999999999999999999998889999999999999988764 2356899999999999999999999
Q ss_pred cc--------CceeeecCCCc-------eEEcccccccccCCcccccccccccCCCcccCccccc-ccCCCccCCeeehh
Q 041655 107 MH--------QALVLLDHDME-------ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-TLSITYMCDIYSFG 170 (238)
Q Consensus 107 ~~--------~~~il~~~~~~-------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-~~~~~~~~DvwslG 170 (238)
++ |.||+++.++. ++++|||.+...... ....++..|+|||.+. +..++.++||||||
T Consensus 123 ~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (262)
T cd05077 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFG 196 (262)
T ss_pred hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHH
Confidence 54 66799987664 899999998654222 2245678899999876 45688899999999
Q ss_pred HHHHhhc-chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 171 VLLAEEM-SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 171 ~~l~~~~-t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
+++|+|+ +|..|+...... .......... ........++.+++.+||+.||++| ...+.|+.|
T Consensus 197 ~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 197 TTLWEICYNGEIPLKDKTLA-EKERFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHHHHhCCCCCCCCcchh-HHHHHHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 9999997 466665322110 0001111111 1112234567888999999999999 555555554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-33 Score=244.21 Aligned_cols=203 Identities=21% Similarity=0.209 Sum_probs=167.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|..+|+.++|||+|+++|+-..++..+|.||||++|+|.+.+.. ....++....-+..|++.|++|||.
T Consensus 1277 ~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~ 1352 (1509)
T KOG4645|consen 1277 TFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE 1352 (1509)
T ss_pred cCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh
Confidence 345577899999999999999999999999999999999999999999975 5567777777888999999999994
Q ss_pred --------cCceeeecCCCceEEcccccccccCCccc--ccccccccCCCcccCcccccccC---CCccCCeeehhHHHH
Q 041655 108 --------HQALVLLDHDMEARISEFGLAKVFPEAHT--HITTSDVVGTAGYIAPEYQQTLS---ITYMCDIYSFGVLLA 174 (238)
Q Consensus 108 --------~~~~il~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~apE~~~~~~---~~~~~DvwslG~~l~ 174 (238)
|+.||+++.+|.+|++|||.|..+..... ........||+.|||||++.+.. -..+.||||+||++.
T Consensus 1353 ~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVl 1432 (1509)
T KOG4645|consen 1353 HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVL 1432 (1509)
T ss_pred cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEE
Confidence 46779999999999999999987654321 12234578999999999886543 456899999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcchHH-HHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKERHVR-CMLS 234 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R~v~-~~L~ 234 (238)
||+||+.||-....+..+...+..+..+..|......-.+++..||..||++|-++ +.|+
T Consensus 1433 EM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1433 EMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred EeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 99999999999888888877777777666666555555666777999999999444 4443
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=209.76 Aligned_cols=195 Identities=22% Similarity=0.278 Sum_probs=150.9
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+++.+|+.++++++|||++++++.+......+++|||+++++|.+++.. .....+++..+..++.|++.|+.|||.+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~~ 122 (261)
T cd05034 45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR 122 (261)
T ss_pred HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 35688999999999999999999999988889999999999999999975 2334689999999999999999999944
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||++++++.++++|||.+.......... .....++..|+|||...+..++.++|+||+|+++|++++ |
T Consensus 123 ~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g 201 (261)
T cd05034 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred CcccCCcchheEEEcCCCCEEECccccceeccchhhhh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCC
Confidence 667999999999999999987654321111 112234568999999988889999999999999999998 7
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||....... .............+...+..+.+++.+||+.+|++|
T Consensus 202 ~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 248 (261)
T cd05034 202 RVPYPGMTNRE-VLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEER 248 (261)
T ss_pred CCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 87764322111 111122222222233345678889999999999999
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=208.94 Aligned_cols=202 Identities=21% Similarity=0.258 Sum_probs=155.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...+.+.+|+.++++++|+|++++.+.+.. ++..++++||+++++|.+++.. .....+++..+..++.|++.|+++|
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~l 118 (257)
T cd08223 41 RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYL 118 (257)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999998764 4467899999999999999875 2234689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.++|+|||.+........ ......+++.|+|||+..+..++.++|+||+|+++++++
T Consensus 119 H~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 196 (257)
T cd08223 119 HEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196 (257)
T ss_pred HhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHH
Confidence 954 6779999999999999999876533221 123456789999999999888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..||......... ........+..+...+..+.+++.+||+.||++| ++.+.|
T Consensus 197 ~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 252 (257)
T cd08223 197 TLKHAFNAKDMNSLV-YRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252 (257)
T ss_pred cCCCCCCCCCHHHHH-HHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 998877532211111 1111122223334555678889999999999999 554444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=214.19 Aligned_cols=192 Identities=21% Similarity=0.256 Sum_probs=151.7
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.+++.++|||++++++.+...+..++++||+++++|..++.. ..+++..+..++.|++.|+.|||++
T Consensus 60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~ 134 (296)
T cd06655 60 KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN 134 (296)
T ss_pred HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999998864 3588999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|++++|.
T Consensus 135 ~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~ 212 (296)
T cd06655 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (296)
T ss_pred CcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 56799999999999999998765433211 12346788999999998888999999999999999999999
Q ss_pred HHHHHhhccCCCccccccc-ccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSENPKRAIDSK-LLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||................ .....+...+..+.+++.+||..||.+|
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 260 (296)
T cd06655 213 PPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKR 260 (296)
T ss_pred CCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhC
Confidence 8875432211111111111 1112233445567788899999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=202.51 Aligned_cols=201 Identities=18% Similarity=0.239 Sum_probs=160.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.+-..|+||||+++.+...+....|+|+|+++|++|-.-+-. +.-+++..+..+++|++++|.|+
T Consensus 51 ~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yC 126 (355)
T KOG0033|consen 51 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYC 126 (355)
T ss_pred cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH
Confidence 33567788999999999999999999999999999999999999998655544 36789999999999999999999
Q ss_pred hccCc--------eeeecCCC---ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 106 HMHQA--------LVLLDHDM---EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H~~~~--------~il~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
|.+++ |.++.+.. -+||+|||++..+..... ...+.|||.|+|||+++..+|+..+|||+-|++||
T Consensus 127 H~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLf 203 (355)
T KOG0033|consen 127 HSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 203 (355)
T ss_pred HhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHH
Confidence 97644 46665443 489999999987763322 24578999999999999999999999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
-++.|..||+..........+....+ .+...++..++..+++.+||..||.+| ++.+.|
T Consensus 204 iLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 204 ILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred HHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 99999999986444333333433332 333455556667778888999999999 666555
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=231.67 Aligned_cols=210 Identities=23% Similarity=0.248 Sum_probs=167.8
Q ss_pred hHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc---CC-------C--cccCHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS---RG-------R--RQLDWLAR 91 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~-------~--~~~~~~~~ 91 (238)
...+.+.+..|+.+|..+. |+|++.+.|+|..++..++|+||+..|+|.+|+.... .. . ..++....
T Consensus 341 ~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dL 420 (609)
T KOG0200|consen 341 SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDL 420 (609)
T ss_pred CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHH
Confidence 3356788999999999996 9999999999999999999999999999999998643 00 0 24889999
Q ss_pred HHHHHHHHHHhchhhccC--------ceeeecCCCceEEcccccccccCCccccccc-ccccCCCcccCcccccccCCCc
Q 041655 92 YRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHITT-SDVVGTAGYIAPEYQQTLSITY 162 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~~~--------~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~apE~~~~~~~~~ 162 (238)
..++.|++.|++||++++ .||++..+..+|++|||+++........... +...-+..|||||.+....|+.
T Consensus 421 lsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~ 500 (609)
T KOG0200|consen 421 LSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTS 500 (609)
T ss_pred HHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccc
Confidence 999999999999999876 3599999999999999999865443322211 1111356699999999999999
Q ss_pred cCCeeehhHHHHhhcch-HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHH
Q 041655 163 MCDIYSFGVLLAEEMSL-VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLS 234 (238)
Q Consensus 163 ~~DvwslG~~l~~~~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~ 234 (238)
++||||||++|||++|. ..|+........+.+.+..+.+.+.|..+..++.++|+.||+.+|++| ++.+.+.
T Consensus 501 kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 501 KSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred cchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 99999999999999995 555543221233345677777778888889999999999999999999 4444444
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=208.14 Aligned_cols=200 Identities=16% Similarity=0.205 Sum_probs=151.1
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+.+.+|+.+++.++|||++++++.+..++..++||||+++|+|.+++.. ....+++..+..++.|++.||+|
T Consensus 39 ~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~ 115 (258)
T cd05078 39 HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHF 115 (258)
T ss_pred hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHH
Confidence 344567788999999999999999999999998899999999999999999875 23468899999999999999999
Q ss_pred hhcc--------CceeeecCCCc--------eEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCee
Q 041655 105 LHMH--------QALVLLDHDME--------ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIY 167 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~Dvw 167 (238)
||.+ +.||+++.++. ++++|||.+...... ....+++.|+|||.+.+. .++.++|+|
T Consensus 116 lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Diw 189 (258)
T cd05078 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKW 189 (258)
T ss_pred HHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHH
Confidence 9955 66799987765 689999987644221 234677889999988764 478899999
Q ss_pred ehhHHHHhhcchH-HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 168 SFGVLLAEEMSLV-KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 168 slG~~l~~~~t~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
|||+++|++++|. .|+....... ........ ...+.....++.+++.+||+.||++| ++.+.++.|
T Consensus 190 slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 190 SFGTTLWEIFSGGDKPLSALDSQK-KLQFYEDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHHcCCCCChhhccHHH-HHHHHHcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 9999999999984 4443322111 11111111 12222333567888899999999999 555555554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=216.29 Aligned_cols=156 Identities=21% Similarity=0.239 Sum_probs=126.3
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+..+.+.+|+.+++.++||||+++++++..++..++|+||+++|+|.+++.. .....+++..+..++.|++.||.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH 118 (327)
T cd08227 41 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMSELAIAYILQGVLKALDYIH 118 (327)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3445677899999999999999999999999999999999999999999864 22345899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCccc-----ccccccccCCCcccCcccccc--cCCCccCCeeehhH
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHT-----HITTSDVVGTAGYIAPEYQQT--LSITYMCDIYSFGV 171 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~apE~~~~--~~~~~~~DvwslG~ 171 (238)
++ +.||+++.++.++++||+.......... ........++..|+|||++.+ ..++.++|+|||||
T Consensus 119 ~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (327)
T cd08227 119 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 198 (327)
T ss_pred HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHH
Confidence 44 6779999999999999986543221110 001122346678999999875 35889999999999
Q ss_pred HHHhhcchHHHHH
Q 041655 172 LLAEEMSLVKWMR 184 (238)
Q Consensus 172 ~l~~~~t~~~~~~ 184 (238)
++|+|++|..||.
T Consensus 199 il~el~~g~~pf~ 211 (327)
T cd08227 199 TACELANGHVPFK 211 (327)
T ss_pred HHHHHHHCCCCCC
Confidence 9999999998874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=212.35 Aligned_cols=198 Identities=20% Similarity=0.227 Sum_probs=154.9
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.+++.++|||++++++.+..++..++|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++
T Consensus 60 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~ 134 (297)
T cd06656 60 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN 134 (297)
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46688999999999999999999999999999999999999999999864 4578889999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++++|||.+......... .....+++.|+|||.+.+..++.++|+||||+++|++++|.
T Consensus 135 ~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~ 212 (297)
T cd06656 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (297)
T ss_pred CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 56799999999999999998765332211 13356788999999998888899999999999999999999
Q ss_pred HHHHHhhccCCCccccc-ccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 181 KWMRNVMTSENPKRAID-SKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
.||.............. .......+...+..+.+++.+||+.+|++| .+.+.|
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 267 (297)
T cd06656 213 PPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELL 267 (297)
T ss_pred CCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 98854322221111111 111112334445567888899999999999 444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=209.50 Aligned_cols=202 Identities=21% Similarity=0.258 Sum_probs=154.3
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++.+++|||++++++.+...+..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 51 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~ 126 (272)
T cd06629 51 MVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS 126 (272)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 456788999999999999999999999999999999999999999999875 3568889999999999999999996
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC--CCccCCeeehhHHHHhhc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS--ITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~--~~~~~DvwslG~~l~~~~ 177 (238)
+ +.||+++.++.++++|||.+................++..|+|||.+.+.. ++.++|+||||+++|+++
T Consensus 127 ~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~ 206 (272)
T cd06629 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF 206 (272)
T ss_pred CCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH
Confidence 5 466999999999999999987654332222223456788999999887654 788999999999999999
Q ss_pred chHHHHHHhhccCCCcccccc----cccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDS----KLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..|+............... ..........+..+.+++.+||+.+|.+| ..-+.|
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 267 (272)
T cd06629 207 AGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267 (272)
T ss_pred hCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 998887432211111111111 11111122345678889999999999999 544443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=214.24 Aligned_cols=205 Identities=19% Similarity=0.233 Sum_probs=153.0
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++.+++||||++++|.+... ..++++||+++|+|.+++.. ....+++..+..++.|++.||.|||
T Consensus 51 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH 126 (303)
T cd05110 51 KANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLE 126 (303)
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHh
Confidence 3345688999999999999999999998765 45799999999999999865 2345889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.+||+|||.++...............++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 127 ~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t 206 (303)
T cd05110 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206 (303)
T ss_pred hcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHh
Confidence 44 6779999999999999999986543322222223445678999999988889999999999999999987
Q ss_pred -hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 179 -LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 179 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|..||...... .....+........+...+.++.+++..||..+|++| +++..|+++
T Consensus 207 ~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 207 FGGKPYDGIPTR-EIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCCCCCCCCCHH-HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 66666432111 1111122111122223344567888999999999999 555555554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=211.60 Aligned_cols=193 Identities=23% Similarity=0.284 Sum_probs=153.5
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++++++|||++++.+.+.++...++++||+++++|.+++.. ..+++..+..++.|++.|+.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh 115 (274)
T cd06609 41 DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLH 115 (274)
T ss_pred hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999875 27899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.|+++++++.++++|||+++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 116 ~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~t 193 (274)
T cd06609 116 EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193 (274)
T ss_pred hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 55 5579999999999999999877643321 1233567889999999988889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHH-HHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEE-QMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||........... +.....+..... .+..+.+++.+||..+|++|
T Consensus 194 g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~R 242 (274)
T cd06609 194 GEPPLSDLHPMRVLFL-IPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKER 242 (274)
T ss_pred CCCCcccCchHHHHHH-hhhcCCCCCcccccCHHHHHHHHHHhhCChhhC
Confidence 9998864322111111 111111111112 45567888999999999999
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=210.41 Aligned_cols=202 Identities=22% Similarity=0.244 Sum_probs=151.0
Q ss_pred HHHHHHHHHHHhcCC-CCCcccceeeeeec------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQI-RHRNILPLLAHLAR------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
...++.+|+.++.++ +|||++++++.+.. .+..+++|||+++|+|.+++.. .....+++..+..++.|+++
T Consensus 55 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~ 132 (282)
T cd06636 55 EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN--TKGNALKEDWIAYICREILR 132 (282)
T ss_pred HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHH--ccCCCCCHHHHHHHHHHHHH
Confidence 346678899999998 69999999999853 4578999999999999999875 22345788889999999999
Q ss_pred Hhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-----ccCCCccCCee
Q 041655 101 GLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-----TLSITYMCDIY 167 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~Dvw 167 (238)
||.|||.+ +.||+++.++.++|+|||.+........ ......|++.|+|||.+. +..++.++|+|
T Consensus 133 al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw 210 (282)
T cd06636 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW 210 (282)
T ss_pred HHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchh
Confidence 99999955 5569999999999999999875432211 123356888999999875 34577899999
Q ss_pred ehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 168 SFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 168 slG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|||+++|+|++|..||.........................+.++.+++.+||+.||.+| ++.+.|
T Consensus 211 slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 211 SLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred HHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 999999999999988864332222222211111111223345678889999999999999 544443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=207.87 Aligned_cols=202 Identities=20% Similarity=0.188 Sum_probs=152.3
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
...+.+.+|+.++++++||||+++++.+.+. ..+++++||+++++|.+++.. ...+++.....++.|++.||.|
T Consensus 46 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~ 121 (265)
T cd06652 46 KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSY 121 (265)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999988663 467899999999999999875 3457888899999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
||++ +.||+++.++.++|+|||.+......... .......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 122 lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 201 (265)
T cd06652 122 LHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVE 201 (265)
T ss_pred HHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHH
Confidence 9955 55699999999999999998754321111 11223467889999999988888999999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+++|..||..................+..+......+.+++.+||. +|++| .+-+.+
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il 259 (265)
T cd06652 202 MLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELL 259 (265)
T ss_pred HhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHh
Confidence 9999988754322222222222222223344445567778888985 89999 444433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=216.91 Aligned_cols=197 Identities=19% Similarity=0.148 Sum_probs=148.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|..++..++|+||+++++++.+++..|+||||+++|+|.+++.. ....+++..+..++.|++.||.||
T Consensus 42 ~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~l 118 (331)
T cd05624 42 RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSI 118 (331)
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 34456688899999999999999999999999999999999999999999975 234688999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-----cCCCccCCeeehhHH
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-----LSITYMCDIYSFGVL 172 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-----~~~~~~~DvwslG~~ 172 (238)
|.+ +.||+++.++.+||+|||++......... ......|++.|+|||++.+ ..++.++|+||+|++
T Consensus 119 H~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvi 197 (331)
T cd05624 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVC 197 (331)
T ss_pred HHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehh
Confidence 944 66799999999999999998765433221 1133568999999998865 457889999999999
Q ss_pred HHhhcchHHHHHHhhccCCCcccccccc---cCCChHHHHHHHHHHhhhhcCCCCCc
Q 041655 173 LAEEMSLVKWMRNVMTSENPKRAIDSKL---LGNGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
+|+|++|..||...........+..... .+....+.+..+.+++.+|+..++..
T Consensus 198 l~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~ 254 (331)
T cd05624 198 MYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERR 254 (331)
T ss_pred hhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhh
Confidence 9999999999864322111112221111 11112233456777777788865544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=217.93 Aligned_cols=205 Identities=22% Similarity=0.288 Sum_probs=167.5
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.|++..... ..+..+.+|+++|+.++||||++++.+......+|+||||+.+|.+.+++..
T Consensus 84 VaiK~idkt~ln~------------~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~--- 148 (596)
T KOG0586|consen 84 VAIKIIDKTQLNP------------SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVK--- 148 (596)
T ss_pred EEEEEehhcccCh------------HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHh---
Confidence 7888888776543 3445588999999999999999999999999999999999999999999986
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
.....+..+..++.|+.++++|+|.+ ..|++++.+-++||+|||++..+..... ..+.+|++.|+|||
T Consensus 149 -~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~---lqt~cgsppyAaPE 224 (596)
T KOG0586|consen 149 -HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM---LQTFCGSPPYAAPE 224 (596)
T ss_pred -cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc---ccccCCCCCccChH
Confidence 34456688899999999999999966 4569999999999999999998764432 35689999999999
Q ss_pred cccccCC-CccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 154 YQQTLSI-TYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 154 ~~~~~~~-~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+..+..| ++.+|+||+|+++|.++.|..||+...-.+.-...+...++...+.. .++.+++.+.+-.+|.+|
T Consensus 225 l~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms--~dce~lLrk~lvl~Pskr 297 (596)
T KOG0586|consen 225 LFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMS--CDCEDLLRKFLVLNPSKR 297 (596)
T ss_pred hhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceee--chhHHHHHHhhccCcccc
Confidence 9988877 57899999999999999999999865444444444444444443322 235667777999999999
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=209.89 Aligned_cols=195 Identities=19% Similarity=0.198 Sum_probs=156.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++||||+++++.+.+++..++++||+++++|.+++.. ...+++..+..++.|+++||.|||
T Consensus 42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh 117 (258)
T cd05578 42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLH 117 (258)
T ss_pred hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999999999999999999999999999976 357889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|+++|++++
T Consensus 118 ~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~ 194 (258)
T cd05578 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR 194 (258)
T ss_pred hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHh
Confidence 55 5569999999999999999876543321 133567889999999988889999999999999999999
Q ss_pred hHHHHHHhhcc--CCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hH
Q 041655 179 LVKWMRNVMTS--ENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HV 229 (238)
Q Consensus 179 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v 229 (238)
|..||...... ......... .....+...+..+.+++.+||+.||.+| ..
T Consensus 195 g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 195 GKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred CCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCc
Confidence 99887643321 111111111 2223344556778889999999999999 44
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=211.45 Aligned_cols=203 Identities=21% Similarity=0.232 Sum_probs=152.9
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
..+..+.+.+|+.+++.++|||++++++.+..++..+++|||+++++|..++.. ....+++..+..++.|++.||.|
T Consensus 49 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~ 125 (292)
T cd06644 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQY 125 (292)
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHH
Confidence 345567889999999999999999999999999999999999999999888754 23568999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-----ccCCCccCCeeehhH
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-----TLSITYMCDIYSFGV 171 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~DvwslG~ 171 (238)
||.+ +.||+++.++.++|+|||.+........ ......+++.|+|||++. ...++.++|+||||+
T Consensus 126 lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~ 203 (292)
T cd06644 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 203 (292)
T ss_pred HhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHH
Confidence 9954 6789999999999999998765322211 123356788999999874 344678999999999
Q ss_pred HHHhhcchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHH
Q 041655 172 LLAEEMSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCM 232 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~ 232 (238)
++|+|++|..||................. ....+.....++.+++.+||+.||++| .+-+.
T Consensus 204 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 266 (292)
T cd06644 204 TLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266 (292)
T ss_pred HHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 99999999988754221111111111111 111223344567888999999999999 44333
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=211.92 Aligned_cols=192 Identities=23% Similarity=0.273 Sum_probs=147.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+....+.+|+.++..++|||++++.+++.+.+..++|+||++ |++.+++.. ....+++..+..++.|++.||.||
T Consensus 56 ~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~L 131 (307)
T cd06607 56 NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYL 131 (307)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHH
Confidence 3455678899999999999999999999999999999999996 578777754 234689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhHHHH
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l~ 174 (238)
|.. +.||+++.++.++|+|||.+...... ....+++.|+|||++. ...++.++|+||||+++|
T Consensus 132 H~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~ 205 (307)
T cd06607 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205 (307)
T ss_pred HHCCceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHH
Confidence 954 66799999999999999998754322 2346788999999874 355788999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|++|..||.........................+..+.+++.+||+.+|++|
T Consensus 206 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 258 (307)
T cd06607 206 ELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDR 258 (307)
T ss_pred HHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhC
Confidence 99999887643221111111111111111223345678889999999999999
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=210.93 Aligned_cols=201 Identities=22% Similarity=0.215 Sum_probs=144.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCC-CcccCHHHHHHHHHHHHHHhch
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG-RRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
......+.+|+.+++.++||||+++++.+...+..+++|||+++|+|.+++...... ....++.....++.|++.||+|
T Consensus 36 ~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 115 (269)
T cd05042 36 PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115 (269)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHH
Confidence 444567899999999999999999999999999999999999999999999762211 2334677888999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-------cCCCccCCeeeh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-------LSITYMCDIYSF 169 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-------~~~~~~~Dvwsl 169 (238)
||++ +.||+++.++.+|++|||.+................+++.|+|||+... ..++.++|+|||
T Consensus 116 lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diwsl 195 (269)
T cd05042 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSL 195 (269)
T ss_pred HHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHH
Confidence 9954 6679999999999999999865432211111122345677999998643 346779999999
Q ss_pred hHHHHhhcc-hHHHHHHhhccCCCccccccc----ccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 170 GVLLAEEMS-LVKWMRNVMTSENPKRAIDSK----LLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 170 G~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|+++|+|++ |..||................ ..+......+..+.+++..|| .||++|
T Consensus 196 G~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~R 257 (269)
T cd05042 196 GVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETR 257 (269)
T ss_pred HHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccc
Confidence 999999998 566654322111111111111 111122334455666777899 599999
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=207.70 Aligned_cols=203 Identities=18% Similarity=0.255 Sum_probs=157.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+++.+|+.++++++|||++++.+.+.+.+..++++||+++++|.+++.. .....+++..+..++.|++.|+.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh 118 (256)
T cd08218 41 KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVH 118 (256)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999998865 22345789999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.++.++++|||.+......... .....|++.|+|||.+.+...+.++|+||||++++++++
T Consensus 119 ~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc
Confidence 55 56799999999999999998765432211 123457888999999988888999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|..|+................ ....+...+.++.+++.+||+.+|.+| .+.+.|+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 197 LKHAFEAGNMKNLVLKIIRGS-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCCccCCCHHHHHHHHhcCC-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 988875322111111111111 122334456678889999999999999 5555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=209.86 Aligned_cols=195 Identities=22% Similarity=0.215 Sum_probs=151.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++.+++|||++++++.+...+..|+++||+++++|.+++.. .....+++..+..++.|++.||.|||.
T Consensus 36 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~ 113 (277)
T cd05577 36 GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYN--VGEPGFPEARAIFYAAQIICGLEHLHQ 113 (277)
T ss_pred hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHH--cCcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345677899999999999999999999999999999999999999999875 222468999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|+++|+|++|
T Consensus 114 ~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g 190 (277)
T cd05577 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG 190 (277)
T ss_pred CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC
Confidence 5 556999999999999999987653321 11234677889999998888899999999999999999999
Q ss_pred HHHHHHhhccCCCcccccc--cccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDS--KLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||............... ......+......+.+++.+||+.||.+|
T Consensus 191 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 240 (277)
T cd05577 191 RSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240 (277)
T ss_pred CCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence 9888543221111111000 01112233345667888999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=207.63 Aligned_cols=197 Identities=20% Similarity=0.229 Sum_probs=147.5
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....|.+|+.++..++||||+++++++.+++..++||||+++|+|..++.. ....+++..+..++.|+++||+|||+
T Consensus 59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (274)
T cd05076 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLED 135 (274)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHc
Confidence 446788899999999999999999999999999999999999999998864 23467888999999999999999995
Q ss_pred c--------CceeeecCCC-------ceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhH
Q 041655 108 H--------QALVLLDHDM-------EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGV 171 (238)
Q Consensus 108 ~--------~~~il~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~ 171 (238)
+ +.||+++..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+
T Consensus 136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~ 209 (274)
T cd05076 136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGT 209 (274)
T ss_pred CCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHH
Confidence 5 5679987654 3899999987543221 22356788999998765 55789999999999
Q ss_pred HHHhhc-chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 172 LLAEEM-SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 172 ~l~~~~-t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
++||++ +|..||........ ........ ..+......+.+++.+||+.+|++| ...+.|+++
T Consensus 210 ~l~el~~~g~~p~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 210 TLLEICFDGEVPLKERTPSEK-ERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHhCCCCCccccChHHH-HHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 999985 67777754322111 11111111 1111223457888999999999999 666666554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=226.96 Aligned_cols=197 Identities=18% Similarity=0.197 Sum_probs=142.9
Q ss_pred HHHHHHhcCCCCCcccceeeeeecC--------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 33 RSEIVTLGQIRHRNILPLLAHLARP--------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 33 ~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.+|+.+|+.++||||+++++++... ..+++||||+++ +|.+++.........+++..++.++.|++.||.|
T Consensus 107 ~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~y 185 (440)
T PTZ00036 107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185 (440)
T ss_pred HHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 4799999999999999998876432 246799999974 7888776433345678999999999999999999
Q ss_pred hhcc--------CceeeecCCC-ceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHH
Q 041655 105 LHMH--------QALVLLDHDM-EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLA 174 (238)
Q Consensus 105 lH~~--------~~~il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~ 174 (238)
||++ |.||+++.++ .+||+|||+++.+..... .....|++.|+|||++.+ ..++.++|+||+||++|
T Consensus 186 LH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 262 (440)
T PTZ00036 186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIA 262 (440)
T ss_pred HHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHH
Confidence 9954 6679998665 699999999986543221 123567899999998765 46899999999999999
Q ss_pred hhcchHHHHHHhhccCCCccccc----------------------cc-----ccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 175 EEMSLVKWMRNVMTSENPKRAID----------------------SK-----LLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~----------------------~~-----~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|++|..||.............. .. .....+...+.++.+++.+||+.||.+|
T Consensus 263 elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R 342 (440)
T PTZ00036 263 EMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342 (440)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHC
Confidence 99999888753211110000000 00 0000112234578889999999999999
Q ss_pred -hHHHHH
Q 041655 228 -HVRCML 233 (238)
Q Consensus 228 -~v~~~L 233 (238)
.+.+.|
T Consensus 343 ~ta~e~l 349 (440)
T PTZ00036 343 LNPIEAL 349 (440)
T ss_pred cCHHHHh
Confidence 554444
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=205.66 Aligned_cols=202 Identities=21% Similarity=0.290 Sum_probs=155.1
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++++++|||++++++.+..++..++|+||+++++|.+++.. .....+++..+..++.|++.||+|||
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh 118 (256)
T cd08220 41 DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVH 118 (256)
T ss_pred HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999999975 22345899999999999999999999
Q ss_pred cc--------CceeeecCC-CceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHD-MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
++ +.||+++.+ +.++++|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 119 ~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~ 195 (256)
T cd08220 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195 (256)
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHH
Confidence 55 556888755 4579999999876543322 12346788999999998888899999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||.............. ......+...+..+.+++..||+.+|++| ++.+.|+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 196 SLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred hCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 99888754221111111111 11112233345568888999999999999 5555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=206.97 Aligned_cols=205 Identities=21% Similarity=0.275 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+++.+|+.++++++|||++++++.+.. +...++++||+++++|.+++.........+++..++.++.|++.||.
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~ 119 (265)
T cd08217 40 EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119 (265)
T ss_pred HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHH
Confidence 4456778899999999999999999998753 45678999999999999999764444567899999999999999999
Q ss_pred hhh-----cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 104 YLH-----MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 104 ~lH-----~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
||| .. +.||+++.++.++++|||.+......... .....+++.|+|||.+.+..++.++|+||||
T Consensus 120 ~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG 197 (265)
T cd08217 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLG 197 (265)
T ss_pred HHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHH
Confidence 999 44 45699999999999999998876443321 1235678999999999888889999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+++|+|++|..||..... ......+........+...+..+.+++.+||+.+|++| ++.+.|
T Consensus 198 ~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il 260 (265)
T cd08217 198 CLIYELCALSPPFTARNQ-LQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260 (265)
T ss_pred HHHHHHHHCCCcccCcCH-HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 999999999888764321 11112222222233444556778889999999999999 444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=215.31 Aligned_cols=196 Identities=19% Similarity=0.153 Sum_probs=147.2
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++..++|+||+++++.+.+.+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH 119 (332)
T cd05623 43 AETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVH 119 (332)
T ss_pred hHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3445688899999999999999999999999999999999999999999975 2346889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-----ccCCCccCCeeehhHHH
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-----TLSITYMCDIYSFGVLL 173 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~DvwslG~~l 173 (238)
.+ +.||+++.++.+||+|||++........ .......|++.|+|||++. ...++.++|+|||||++
T Consensus 120 ~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil 198 (332)
T cd05623 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCM 198 (332)
T ss_pred HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHH
Confidence 44 6679999999999999999865432221 1123357899999999875 34578899999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccccccc---cCCChHHHHHHHHHHhhhhcCCCCCc
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAIDSKL---LGNGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
|+|++|..||................. .+......+..+.+++.+|+..++..
T Consensus 199 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r 254 (332)
T cd05623 199 YEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHR 254 (332)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhh
Confidence 999999999864332222222222111 11112234556677777788654443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=206.33 Aligned_cols=202 Identities=21% Similarity=0.279 Sum_probs=156.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++|+|++++++.+.+++..++++||+++++|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 46 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~ 121 (268)
T cd06630 46 VVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHE 121 (268)
T ss_pred HHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 467889999999999999999999999999999999999999999999875 3468899999999999999999996
Q ss_pred c--------CceeeecCCC-ceEEcccccccccCCcccc--cccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 108 H--------QALVLLDHDM-EARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ~--------~~~il~~~~~-~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
+ +.||+++.++ .++|+|||.+......... .......++..|+|||.+.+..++.++|+||+|+++|++
T Consensus 122 ~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 201 (268)
T cd06630 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201 (268)
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHH
Confidence 6 4568988776 5999999998765432111 111234678899999999888889999999999999999
Q ss_pred cchHHHHHHhhccCCCccc---ccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRA---IDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++|..||............ .........+.....++.+++.+||+.+|.+| +..+.|
T Consensus 202 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 202 ATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred HhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 9999887532211111111 11112233444556778889999999999999 555444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=206.61 Aligned_cols=202 Identities=20% Similarity=0.273 Sum_probs=152.3
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-- 107 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~-- 107 (238)
..+.+|++++++++|||++++++.+......++++||+++++|.+++.. ....+++..+..++.|++.|++|||.
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 120 (256)
T cd05112 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN 120 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4688899999999999999999999999999999999999999999864 23457899999999999999999994
Q ss_pred ------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 108 ------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 108 ------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
++.||+++.++.++|+|||.+......... ......++..|+|||...+..++.++|+||+|+++|++++ |.
T Consensus 121 i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 199 (256)
T cd05112 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred ccccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence 477899999999999999998755332211 1112334578999999988889999999999999999998 77
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
.||....... ....+........+...+..+.+++.+||+.+|++| .+.+.++.+
T Consensus 200 ~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 200 TPYENRSNSE-VVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCcCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 7764322111 111111111111122234567888999999999999 555555544
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=206.27 Aligned_cols=204 Identities=22% Similarity=0.272 Sum_probs=156.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+..+..++|+|++++++.+.+.+..+++|||+++++|.+++... ....+++..+..++.|++.||+|||.
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~ 121 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLES 121 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhc
Confidence 5678899999999999999999999999999999999999999999998751 11228999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS- 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t- 178 (238)
+ +.||++++++.++++|||.+........... ....+++.|+|||...+..++.++|+||+|+++|+|++
T Consensus 122 ~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~ 200 (258)
T smart00219 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200 (258)
T ss_pred CCeeecccccceEEEccCCeEEEcccCCceeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence 4 6789999999999999999876543322111 12236788999999888888999999999999999998
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHh
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQ 235 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~ 235 (238)
|..||..... ......+........+...+..+.+++.+||..||++| ++.+.++.
T Consensus 201 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 201 GESPYPGMSN-EEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred CCCCCCCCCH-HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhh
Confidence 5666543211 11111111122222333456678889999999999999 55555543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=208.24 Aligned_cols=193 Identities=20% Similarity=0.286 Sum_probs=149.8
Q ss_pred HHHHHHHHHHHHhcCCC---CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 27 EEMMQIRSEIVTLGQIR---HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....++.+|+.++++++ |||++++++.+..++..+++|||+++++|.+++.. ..+++..+..++.|++.||.
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~ 115 (277)
T cd06917 41 DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALK 115 (277)
T ss_pred hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHH
Confidence 44567888999988886 99999999999999999999999999999999864 36889999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLA 174 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~ 174 (238)
|||.. +.||+++.++.++++|||.+........ ......|+..|+|||.+.+ ..++.++|+||||+++|
T Consensus 116 ~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~ 193 (277)
T cd06917 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIY 193 (277)
T ss_pred HHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHH
Confidence 99955 5679999999999999999876644321 1233568889999998765 34688999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCCChH-HHHHHHHHHhhhhcCCCCCcc
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYE-EQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|++|..||.......... .......+.... ..+.++.+++..||+.||++|
T Consensus 194 ~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 246 (277)
T cd06917 194 EMATGNPPYSDVDAFRAMM-LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKER 246 (277)
T ss_pred HHHhCCCCCCCCChhhhhh-ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccC
Confidence 9999998885432211111 111111111111 245678889999999999999
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=205.48 Aligned_cols=199 Identities=24% Similarity=0.326 Sum_probs=151.2
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++.+++|||++++++.+..++ .+++|||+++++|.+++.. .....+++..+..++.|++.||.|||.+
T Consensus 43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~ 119 (254)
T cd05083 43 AQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLESK 119 (254)
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 357889999999999999999999987654 6899999999999999975 2334578999999999999999999944
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||+++.++.++|+|||.+....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 120 ~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g 194 (254)
T cd05083 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYG 194 (254)
T ss_pred CeeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCC
Confidence 678999999999999999986543221 12234567999999988889999999999999999997 7
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
..||...... ..............+...+..+.+++.+||+.+|++| ...+.++.+
T Consensus 195 ~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 195 RAPYPKMSLK-EVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred CCCCccCCHH-HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 7776433211 1112222222222333445677888999999999999 444444443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=219.76 Aligned_cols=151 Identities=26% Similarity=0.328 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCC-----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPG-----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
..+++.+|+.++..++||||+++++++...+ ..|+++||+. ++|.+++.. ...+++..+..++.|++.||
T Consensus 42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL 116 (372)
T cd07853 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGL 116 (372)
T ss_pred HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHH
Confidence 3467889999999999999999999998776 7899999995 588888754 45689999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHH
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLL 173 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l 173 (238)
.|||++ +.||+++.++.+||+|||+++........ ......+++.|+|||.+.+. .++.++||||+||++
T Consensus 117 ~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 195 (372)
T cd07853 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIF 195 (372)
T ss_pred HHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHH
Confidence 999955 66799999999999999998765332211 11234678899999988764 478899999999999
Q ss_pred HhhcchHHHHH
Q 041655 174 AEEMSLVKWMR 184 (238)
Q Consensus 174 ~~~~t~~~~~~ 184 (238)
|+|++|..||.
T Consensus 196 ~el~~g~~pf~ 206 (372)
T cd07853 196 AELLGRRILFQ 206 (372)
T ss_pred HHHHcCCCCCC
Confidence 99999988774
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=209.12 Aligned_cols=200 Identities=21% Similarity=0.264 Sum_probs=155.5
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+++.+|+..+++++||||+++++.+..++..++++||+++++|.+++.. ....+++..+..++.|+++||+|+|
T Consensus 41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH 117 (265)
T cd06605 41 AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH 117 (265)
T ss_pred HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHc
Confidence 4567789999999999999999999999999999999999998999999976 2267889999999999999999999
Q ss_pred c-c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 M-H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~-~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
+ . +.||+++.++.++|+|||.+........ ....++..|+|||.+.+..++.++|+||||+++|+++
T Consensus 118 ~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 193 (265)
T cd06605 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELA 193 (265)
T ss_pred CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 7 4 5569999999999999999875532211 1256788999999998888999999999999999999
Q ss_pred chHHHHHHhhcc-CCCccccc---ccccCCChHH-HHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMTS-ENPKRAID---SKLLGNGYEE-QMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~-~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..||...... ........ ....+..+.. ....+.+++..||..||++| ++.+.+
T Consensus 194 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 194 TGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred hCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 998887543211 11111111 1111122222 55668888999999999999 544443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=205.40 Aligned_cols=202 Identities=21% Similarity=0.259 Sum_probs=154.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++++++|+||+++++.+...+..++++||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh 116 (264)
T cd06626 41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLH 116 (264)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999999999999999999999999875 345788899999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccc--cccccCCCcccCcccccccC---CCccCCeeehhHHH
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHIT--TSDVVGTAGYIAPEYQQTLS---ITYMCDIYSFGVLL 173 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~~apE~~~~~~---~~~~~DvwslG~~l 173 (238)
++ +.||+++.++.+||+|||.+........... .....+++.|+|||++.+.. .+.++|+||||+++
T Consensus 117 ~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il 196 (264)
T cd06626 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVV 196 (264)
T ss_pred HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHH
Confidence 65 4579999999999999999876643322111 11346788999999987766 78899999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccccccccCCChH--HHHHHHHHHhhhhcCCCCCcc-hHHHH
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYE--EQMLLVLKTACFCTLDDPKER-HVRCM 232 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~cl~~~p~~R-~v~~~ 232 (238)
|++++|..||............+........+. .....+.+++..||+.+|++| .+.+.
T Consensus 197 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i 258 (264)
T cd06626 197 LEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258 (264)
T ss_pred HHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 999999998864321111111111111111122 225567788999999999999 44443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=206.45 Aligned_cols=201 Identities=26% Similarity=0.291 Sum_probs=158.1
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+..+.+++|+|++++++.+..++..++++||+++++|.+++.. ...+++..+..++.|+++|+.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh 116 (264)
T cd06623 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLH 116 (264)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999999999999999999999999999999999999976 367899999999999999999999
Q ss_pred c-c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 M-H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~-~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
. + +.||+++.++.++|+|||.+......... .....++..|+|||...+..++.++|+||||+++|+|+
T Consensus 117 ~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 194 (264)
T cd06623 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECA 194 (264)
T ss_pred ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHH
Confidence 8 5 45699999999999999998765433221 12356788999999998888899999999999999999
Q ss_pred chHHHHHHhhc--cCCCcccccccccCCChHH-HHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMT--SENPKRAIDSKLLGNGYEE-QMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..|+..... .......+........+.. .+..+.+++..||+.+|++| .+.+.|
T Consensus 195 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll 254 (264)
T cd06623 195 LGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELL 254 (264)
T ss_pred hCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 99988755421 1111111111111222223 55678888999999999999 444333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=204.65 Aligned_cols=195 Identities=21% Similarity=0.266 Sum_probs=148.7
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.++++++|||++++++.+.. +..++++||+++|+|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~ 120 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLEDK 120 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 5788999999999999999999999988 778999999999999999975 122688999999999999999999954
Q ss_pred --------CceeeecCCC-------ceEEcccccccccCCcccccccccccCCCcccCccccccc--CCCccCCeeehhH
Q 041655 109 --------QALVLLDHDM-------EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL--SITYMCDIYSFGV 171 (238)
Q Consensus 109 --------~~~il~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~--~~~~~~DvwslG~ 171 (238)
+.||+++.++ .++++|||.+...... ....++..|+|||++.+. .++.++|+||||+
T Consensus 121 ~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGT 194 (259)
T ss_pred CeecccCccceEEEecCccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHH
Confidence 6789999888 7999999998764331 224566789999998776 6889999999999
Q ss_pred HHHhhcch-HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 172 LLAEEMSL-VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 172 ~l~~~~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
++|+++++ ..|+................. .+......+.+++.+||+.+|.+| .+.+.|+.+
T Consensus 195 ~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 195 TLLEICSNGEEPLSTLSSSEKERFYQDQHR---LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHHHhCCCCCcccCCchhHHHHHhcCCC---CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 99999985 555543321111111111111 111112567888899999999999 555555554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=204.80 Aligned_cols=205 Identities=22% Similarity=0.358 Sum_probs=157.5
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+..++.++|+|++++++.+..++..++++|++++++|.+++.... ....+++..+..++.|++.||.|||.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~ 120 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHS 120 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 56778999999999999999999999999999999999999999999987521 12468999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCccccc--ccccccCCCcccCccccccc-CCCccCCeeehhHHHHhh
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHI--TTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~ 176 (238)
. +.||++++++.++|+|||.+..+....... ......++..|++||.+... ..+.++|+||||+++|+|
T Consensus 121 ~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l 200 (267)
T cd06610 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL 200 (267)
T ss_pred CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHH
Confidence 5 556999999999999999987664432221 12334678899999988766 678999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccc---cCC-ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKL---LGN-GYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++|..||................. ... .....+..+.+++.+||..||++| .+.+.|
T Consensus 201 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll 262 (267)
T cd06610 201 ATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262 (267)
T ss_pred HhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 999998864432222222222111 011 112445667889999999999999 544444
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=212.39 Aligned_cols=192 Identities=20% Similarity=0.261 Sum_probs=149.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++..++|||++++++.+..++..++++||+++++|..++.. ..+++..+..++.|++.||.|||.+
T Consensus 62 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~ 136 (297)
T cd06659 62 RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ 136 (297)
T ss_pred HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45688999999999999999999999999999999999999999988754 4578999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 137 ~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~ 214 (297)
T cd06659 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214 (297)
T ss_pred CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 5579999999999999999875433221 123356889999999998888999999999999999999999
Q ss_pred HHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||................. ........+..+.+++..||+.+|++|
T Consensus 215 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~R 262 (297)
T cd06659 215 PPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER 262 (297)
T ss_pred CCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccC
Confidence 88753221111111101000 111122334557788888999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=208.67 Aligned_cols=203 Identities=19% Similarity=0.211 Sum_probs=152.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
....++.+|++++++++||||+++++.+.. ++.++++|||+++++|.+++.........+++..+..++.|++.||.|
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 120 (287)
T cd06621 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120 (287)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 446778999999999999999999998864 346899999999999999876543445668899999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||.. +.||+++.++.++|+|||++........ ....++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus 121 lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l 196 (287)
T cd06621 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196 (287)
T ss_pred HHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 9955 5569999999999999999865432221 234567889999999888899999999999999999
Q ss_pred cchHHHHHHhhcc-CC---Ccc-ccc---ccccCCCh--HHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 177 MSLVKWMRNVMTS-EN---PKR-AID---SKLLGNGY--EEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 177 ~t~~~~~~~~~~~-~~---~~~-~~~---~~~~~~~~--~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++|..||...... .. ... ... ........ ...+..+.+++.+||+.+|.+| ++.+.+
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil 264 (287)
T cd06621 197 AQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264 (287)
T ss_pred HhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 9998887643110 00 000 001 00000101 1234568889999999999999 444444
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=210.12 Aligned_cols=198 Identities=23% Similarity=0.264 Sum_probs=151.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+....+.+|+.++++++|||++++++++.+++..++++||++ |+|.+.+.. ....+++..+..++.|++.||.||
T Consensus 66 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~l 141 (317)
T cd06635 66 NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYL 141 (317)
T ss_pred hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3455678999999999999999999999999999999999996 478777754 245589999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhHHHH
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l~ 174 (238)
|.+ +.||+++.++.++|+|||.+...... ....+++.|+|||.+. +..++.++|+||||+++|
T Consensus 142 H~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~ 215 (317)
T cd06635 142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 215 (317)
T ss_pred HHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHH
Confidence 955 66799999999999999987654322 2346788999999873 456788999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|++|..||.........................+..+.+++.+||+.+|.+| .+.+.+
T Consensus 216 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 216 ELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred HHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHH
Confidence 99999988754322111222222222222233445567888999999999999 444333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=209.14 Aligned_cols=157 Identities=24% Similarity=0.295 Sum_probs=129.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++... ....+++..+..++.|++.||+||
T Consensus 40 ~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~L 117 (314)
T cd08216 40 KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYI 117 (314)
T ss_pred hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999998752 234588999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCccc-----ccccccccCCCcccCccccccc--CCCccCCeeehh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHT-----HITTSDVVGTAGYIAPEYQQTL--SITYMCDIYSFG 170 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~apE~~~~~--~~~~~~DvwslG 170 (238)
|.+ +.||+++.++.++++|||.+........ ........++..|+|||++.+. .++.++|+||+|
T Consensus 118 H~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G 197 (314)
T cd08216 118 HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG 197 (314)
T ss_pred HHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHH
Confidence 955 6679999999999999998865432111 1112234567789999988653 478899999999
Q ss_pred HHHHhhcchHHHHH
Q 041655 171 VLLAEEMSLVKWMR 184 (238)
Q Consensus 171 ~~l~~~~t~~~~~~ 184 (238)
+++|+|++|..||.
T Consensus 198 ~il~el~~g~~pf~ 211 (314)
T cd08216 198 ITACELANGHVPFK 211 (314)
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999988875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=213.83 Aligned_cols=155 Identities=23% Similarity=0.224 Sum_probs=130.2
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++..++|+||+++++++.+++..|+||||+++|+|.+++.. ....+++..+..++.|++.||+|||
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH 119 (331)
T cd05597 43 AETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVH 119 (331)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456688999999999999999999999999999999999999999999965 2456889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-----cCCCccCCeeehhHHH
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-----LSITYMCDIYSFGVLL 173 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-----~~~~~~~DvwslG~~l 173 (238)
.+ +.||+++.++.+||+|||++......... ......|++.|+|||++.. ..++.++|+||+||++
T Consensus 120 ~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l 198 (331)
T cd05597 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCM 198 (331)
T ss_pred hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHH
Confidence 55 56799999999999999998755332211 1123468999999998863 3567899999999999
Q ss_pred HhhcchHHHHHH
Q 041655 174 AEEMSLVKWMRN 185 (238)
Q Consensus 174 ~~~~t~~~~~~~ 185 (238)
|+|++|..||..
T Consensus 199 ~el~~g~~Pf~~ 210 (331)
T cd05597 199 YEMLYGETPFYA 210 (331)
T ss_pred HHHhhCCCCCCC
Confidence 999999998854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=209.49 Aligned_cols=198 Identities=17% Similarity=0.163 Sum_probs=152.5
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.......+.+|+.++.+++||||+++++.+..++..++++||+++++|..++... .....+++..+..++.|++.||.|
T Consensus 39 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~ 117 (286)
T cd06622 39 DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKF 117 (286)
T ss_pred CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHH
Confidence 3445678899999999999999999999999999999999999999999988651 113468999999999999999999
Q ss_pred hhcc---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC------CCccCCeeeh
Q 041655 105 LHMH---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS------ITYMCDIYSF 169 (238)
Q Consensus 105 lH~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~------~~~~~Dvwsl 169 (238)
||.+ +.||+++.++.++|+|||.+..+.... .....+++.|+|||.+.+.. ++.++|+||+
T Consensus 118 LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 193 (286)
T cd06622 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSL 193 (286)
T ss_pred HHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhH
Confidence 9953 557999999999999999987553322 12345788899999875443 4789999999
Q ss_pred hHHHHhhcchHHHHHHhhccCCCcc--cccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 170 GVLLAEEMSLVKWMRNVMTSENPKR--AIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 170 G~~l~~~~t~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
||++|+|++|..||........... ..........+.....++.+++.+||+.+|++|
T Consensus 194 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (286)
T cd06622 194 GLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR 253 (286)
T ss_pred HHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccC
Confidence 9999999999988753221111100 011112223344566778889999999999999
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=206.91 Aligned_cols=203 Identities=19% Similarity=0.237 Sum_probs=151.7
Q ss_pred HHHHHHHHHHhcCC-CCCcccceeeeeecCC------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 29 MMQIRSEIVTLGQI-RHRNILPLLAHLARPG------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 29 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
.+.+.+|+.+++++ +|+|++++++.+.... ..+++|||+++++|.+++......+..+++..+..++.|++.|
T Consensus 46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~a 125 (275)
T cd06608 46 EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125 (275)
T ss_pred HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHH
Confidence 46788999999999 6999999999996544 4899999999999999987533234678999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-----cCCCccCCeee
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-----LSITYMCDIYS 168 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-----~~~~~~~Dvws 168 (238)
|.|||++ +.||+++.++.++|+|||.+........ ......++..|+|||++.. ..++.++|+||
T Consensus 126 l~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 203 (275)
T cd06608 126 LAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWS 203 (275)
T ss_pred HHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHH
Confidence 9999955 5569999999999999999876533221 1234568889999998753 34677899999
Q ss_pred hhHHHHhhcchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 169 FGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 169 lG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
||+++|++++|..||................. ....+......+.+++.+||+.||++| ++.+.+
T Consensus 204 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll 270 (275)
T cd06608 204 LGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELL 270 (275)
T ss_pred hHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 99999999999998864322111111111111 111223345578889999999999999 444433
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=214.67 Aligned_cols=147 Identities=24% Similarity=0.309 Sum_probs=122.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCC------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPG------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
....+.+|+.+++.++||||+++++++...+ ..|++|||+++ +|.+.+. ..+++..+..++.|++.|
T Consensus 63 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~ 135 (359)
T cd07876 63 HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCG 135 (359)
T ss_pred HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHH
Confidence 4567789999999999999999999986443 46899999965 6776663 247888899999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|.|||.+ +.||+++.++.+||+|||+++...... ......+++.|+|||++.+..++.++|+||+||++
T Consensus 136 L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 212 (359)
T cd07876 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212 (359)
T ss_pred HHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHH
Confidence 9999955 667999999999999999987543221 12335778999999999998999999999999999
Q ss_pred HhhcchHHHHH
Q 041655 174 AEEMSLVKWMR 184 (238)
Q Consensus 174 ~~~~t~~~~~~ 184 (238)
|+|++|..||.
T Consensus 213 ~el~tg~~pf~ 223 (359)
T cd07876 213 GELVKGSVIFQ 223 (359)
T ss_pred HHHHhCCCCCC
Confidence 99999988774
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=212.17 Aligned_cols=199 Identities=20% Similarity=0.297 Sum_probs=151.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+..+.+++|||++++++.+..++..++++||+++++|.+++.. ..+++..+..++.|++.||.|||
T Consensus 61 ~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH 135 (292)
T cd06658 61 QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLH 135 (292)
T ss_pred HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999998854 35889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.++.++|+|||++........ ......++..|+|||...+..++.++|+||||+++|++++
T Consensus 136 ~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~ 213 (292)
T cd06658 136 NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID 213 (292)
T ss_pred HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 55 5569999999999999999875433221 1133567899999999988889999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccC--CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLG--NGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||........... ....... .........+.+++.+||..||.+| +..+.|
T Consensus 214 g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 270 (292)
T cd06658 214 GEPPYFNEPPLQAMRR-IRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELL 270 (292)
T ss_pred CCCCCCCCCHHHHHHH-HHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 9888753221111111 1011101 1111233456778888999999999 444444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=204.84 Aligned_cols=207 Identities=23% Similarity=0.184 Sum_probs=165.8
Q ss_pred ChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHH
Q 041655 13 DATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92 (238)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 92 (238)
-+.+|.++.....++...+-..|-++|+..+||++..+.-.|+.++++|+||||+.||.|.-.+.. ...+++...+
T Consensus 196 YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr----er~FsE~RtR 271 (516)
T KOG0690|consen 196 YAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR----ERVFSEDRTR 271 (516)
T ss_pred eehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh----hhcccchhhh
Confidence 344455555555666777788999999999999999999999999999999999999998777754 6779999999
Q ss_pred HHHHHHHHHhchhhccCc--------eeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMHQA--------LVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~~~--------~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.+-..|.++|.|||++++ |.++|.+|++|+.|||+++.- ........+++|||.|+|||++.++.|+...
T Consensus 272 FYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraV 349 (516)
T KOG0690|consen 272 FYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAV 349 (516)
T ss_pred hhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc--ccccceeccccCChhhcCchhhcccccccee
Confidence 999999999999998765 489999999999999998742 1222234678999999999999999999999
Q ss_pred CeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|+|.+|+++|||+.|..||++...+....-++-..+ ..|.....+...++...|.+||.+|
T Consensus 350 DWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~--kFPr~ls~eAktLLsGLL~kdP~kR 410 (516)
T KOG0690|consen 350 DWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDL--KFPRTLSPEAKTLLSGLLKKDPKKR 410 (516)
T ss_pred ehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhc--cCCccCCHHHHHHHHHHhhcChHhh
Confidence 999999999999999999987555444433443333 1233333334555666899999999
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=203.97 Aligned_cols=202 Identities=23% Similarity=0.245 Sum_probs=151.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCccc--CHHHHHHHHHHHHHHhch
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL--DWLARYRTVRGIASGLEY 104 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~--~~~~~~~~~~~l~~gl~~ 104 (238)
...+.+.+|+.++++++|+||+++++++..++..++++||+++++|.+++... ...+ ++..+..++.|++.||+|
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~ 123 (268)
T cd06624 47 RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKY 123 (268)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999999999999999999999999998751 1234 788888899999999999
Q ss_pred hhcc--------CceeeecC-CCceEEcccccccccCCcccccccccccCCCcccCcccccccC--CCccCCeeehhHHH
Q 041655 105 LHMH--------QALVLLDH-DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS--ITYMCDIYSFGVLL 173 (238)
Q Consensus 105 lH~~--------~~~il~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~--~~~~~DvwslG~~l 173 (238)
||.+ +.||+++. .+.++|+|||.+........ ......+++.|+|||.+.+.. ++.++|+||+|+++
T Consensus 124 lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl 201 (268)
T cd06624 124 LHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTI 201 (268)
T ss_pred HHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHH
Confidence 9955 55699976 67899999999875533221 122345788999999876544 78899999999999
Q ss_pred HhhcchHHHHHHhhccCC-CcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 174 AEEMSLVKWMRNVMTSEN-PKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|++++|..||........ ..........+..+......+.+++.+||+.+|.+| ++.+.+
T Consensus 202 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 263 (268)
T cd06624 202 VEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263 (268)
T ss_pred HHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence 999999988754221111 111111111222344455668888999999999999 444433
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=205.10 Aligned_cols=210 Identities=22% Similarity=0.255 Sum_probs=151.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCC------eeEEEEEeCCCCCHHHHHhhhcC--CCcccCHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPG------CHLLVYEFMKNGSLQDILNDVSR--GRRQLDWLARYRTVRG 97 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~ 97 (238)
....+++.+|+.++++++|||++++++++...+ ..+++++|.++|+|.+++..... ....+++..+..++.|
T Consensus 42 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~ 121 (273)
T cd05074 42 SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121 (273)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHH
Confidence 345677899999999999999999999875432 24688999999999988753221 2235788999999999
Q ss_pred HHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 98 IASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 98 l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
++.||+|||++ |.||++++++.++++|||.++...............+++.|++||.+.+..++.++|+|||
T Consensus 122 i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~sl 201 (273)
T cd05074 122 IASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAF 201 (273)
T ss_pred HHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHH
Confidence 99999999955 6679999999999999999876533221111122345678999999988888999999999
Q ss_pred hHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 170 GVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 170 G~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|+++|+|++ |..||...... ..............+...+..+.+++.+||+.+|++| ++...|+++
T Consensus 202 G~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 202 GVTMWEIMTRGQTPYAGVENS-EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHHHhhCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999998 66665432211 1111111111111223445678889999999999999 555555443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=207.76 Aligned_cols=199 Identities=21% Similarity=0.263 Sum_probs=153.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++..++|||++++++.+..++..++++||+++++|.+++.. ..+++..+..++.|++.||+|||+
T Consensus 59 ~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~ 133 (285)
T cd06648 59 RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA 133 (285)
T ss_pred HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346688999999999999999999999999999999999999999999864 458889999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.++++|||.+........ ......|++.|+|||...+..++.++|+||||+++|+|++|
T Consensus 134 ~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g 211 (285)
T cd06648 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211 (285)
T ss_pred CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhC
Confidence 5 5679999999999999998765433211 11234678999999999888899999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 180 VKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
..||................. ........+..+.+++.+||+.+|++| ++.+.|
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 212 EPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred CCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHc
Confidence 888753221111111111100 111122244568889999999999999 444444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=206.74 Aligned_cols=197 Identities=23% Similarity=0.268 Sum_probs=152.7
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++.+++|||++++++.+..++..++++||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH 110 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLH 110 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567788999999999999999999999999999999999999999999975 236899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCccc------ccccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHT------HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
.+ +.||+++.++.++|+|||++........ ........++..|++||...+...+.++|+||||++
T Consensus 111 ~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~ 190 (265)
T cd05579 111 SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCI 190 (265)
T ss_pred HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHH
Confidence 55 5579999999999999999875432211 111233567888999999888888999999999999
Q ss_pred HHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 173 LAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|++++|..||.........................+..+.+++.+||+.+|.+|
T Consensus 191 ~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 245 (265)
T cd05579 191 LYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKR 245 (265)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhc
Confidence 9999999888753322211111111111111111125667888899999999999
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=211.90 Aligned_cols=199 Identities=18% Similarity=0.186 Sum_probs=147.4
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++.. ....+++..+..++.|++.||+|||++
T Consensus 49 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~ 124 (309)
T cd07872 49 CTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK 124 (309)
T ss_pred hhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567899999999999999999999999999999999964 88888765 234578899999999999999999955
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcchH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.+||+|||.+........ ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.
T Consensus 125 ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~ 202 (309)
T cd07872 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202 (309)
T ss_pred eecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 5679999999999999999875432221 1123467889999998754 45788999999999999999998
Q ss_pred HHHHHhhccCCCccc------------------------ccccccC----CChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 181 KWMRNVMTSENPKRA------------------------IDSKLLG----NGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~------------------------~~~~~~~----~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
.||............ ....... ........++.+++.+||+.||.+| ++.+
T Consensus 203 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 282 (309)
T cd07872 203 PLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282 (309)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH
Confidence 877422110000000 0000000 0011234567789999999999999 6555
Q ss_pred HHH
Q 041655 232 MLS 234 (238)
Q Consensus 232 ~L~ 234 (238)
.|+
T Consensus 283 ~l~ 285 (309)
T cd07872 283 AMK 285 (309)
T ss_pred Hhc
Confidence 543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=206.26 Aligned_cols=203 Identities=18% Similarity=0.201 Sum_probs=149.8
Q ss_pred HHHHHHHHHhcCC-CCCcccceeeeee-----cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 30 MQIRSEIVTLGQI-RHRNILPLLAHLA-----RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 30 ~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
..+.+|+.++.++ +|||++++++++. .++..+++|||+++++|.+++.........+++..+..++.|++.||.
T Consensus 59 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ 138 (286)
T cd06638 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138 (286)
T ss_pred HHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHH
Confidence 5677899999999 6999999999874 345689999999999999988643333456889999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-----cCCCccCCeeehh
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-----LSITYMCDIYSFG 170 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-----~~~~~~~DvwslG 170 (238)
|||.+ +.||+++.++.++|+|||.+........ ......|++.|+|||.+.. ..++.++|+||+|
T Consensus 139 ~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 216 (286)
T cd06638 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG 216 (286)
T ss_pred HHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHH
Confidence 99954 6679999999999999999876543221 1233568899999998753 4478899999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCccccccc-ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAIDSK-LLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|++|+|++|..|+................ .....+......+.+++.+||+.||++| .+-+.|+
T Consensus 217 vi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 217 ITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred HHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 99999999988875432211111111111 0111122234568888999999999999 5444443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=206.74 Aligned_cols=201 Identities=22% Similarity=0.270 Sum_probs=155.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+..+..++|+|++++++.+...+..++++||+++++|.+++... ...+++..+..++.|++.||.|||.
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~ 134 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS 134 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3567889999999999999999999999999999999999999999999861 2378999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.++|+|||.+........ ......++..|++||.+.+..++.++|+||||+++|+|++|
T Consensus 135 ~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g 212 (286)
T cd06614 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212 (286)
T ss_pred CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhC
Confidence 4 5679999999999999998765433221 11234577899999998888889999999999999999999
Q ss_pred HHHHHHhhccCCCccccccccc-CCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 180 VKWMRNVMTSENPKRAIDSKLL-GNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
..|+.................. .......+..+.+++..||+.+|.+| +..+.|
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 213 EPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 8876432211111111111111 11222355678889999999999999 444444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=214.18 Aligned_cols=150 Identities=22% Similarity=0.187 Sum_probs=129.1
Q ss_pred HHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--
Q 041655 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH-- 108 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~-- 108 (238)
...+|+.++++++||||+++++.+...+..+++||++. ++|.+++.. ...+++..+..++.|++.||.|||.+
T Consensus 132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~gi 206 (392)
T PHA03207 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRGI 206 (392)
T ss_pred cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34689999999999999999999999999999999995 689888854 45689999999999999999999955
Q ss_pred ------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHH
Q 041655 109 ------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKW 182 (238)
Q Consensus 109 ------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~ 182 (238)
+.||+++.++.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 207 vHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p 286 (392)
T PHA03207 207 IHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286 (392)
T ss_pred cccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 56799999999999999998765443332222346789999999999988999999999999999999999888
Q ss_pred HHH
Q 041655 183 MRN 185 (238)
Q Consensus 183 ~~~ 185 (238)
|..
T Consensus 287 f~~ 289 (392)
T PHA03207 287 LFG 289 (392)
T ss_pred CCC
Confidence 754
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=206.18 Aligned_cols=193 Identities=21% Similarity=0.240 Sum_probs=151.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++|||++++++.+...+..|+|+||+++++|.+++.. ..+++..+..++.|++.||.|||.
T Consensus 59 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~ 133 (293)
T cd06647 59 KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS 133 (293)
T ss_pred HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh
Confidence 346788999999999999999999999999999999999999999999864 357888999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.++|+|||.+......... .....+++.|++||.+....++.++|+||||+++|++++|
T Consensus 134 ~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g 211 (293)
T cd06647 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (293)
T ss_pred CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 5 55699999999999999988755433221 1334678899999998888889999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||................. ....+...+..+.+++..||+.+|++|
T Consensus 212 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 260 (293)
T cd06647 212 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 260 (293)
T ss_pred CCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence 998864332222211111111 111223344567888999999999999
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=214.83 Aligned_cols=147 Identities=22% Similarity=0.298 Sum_probs=122.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
....+.+|+.+++.++||||+++++++... ...|+||||+++ +|.+++.. .+++..+..++.|++.|
T Consensus 66 ~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~a 138 (364)
T cd07875 66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCG 138 (364)
T ss_pred hHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHH
Confidence 456678999999999999999999987543 357999999964 78777742 47888899999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|.|||++ |.||+++.++.+||+|||+++....... .....+++.|+|||++.+..++.++|+|||||++
T Consensus 139 L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 215 (364)
T cd07875 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215 (364)
T ss_pred HHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHH
Confidence 9999955 6679999999999999999976533221 2335788999999999998999999999999999
Q ss_pred HhhcchHHHHH
Q 041655 174 AEEMSLVKWMR 184 (238)
Q Consensus 174 ~~~~t~~~~~~ 184 (238)
|+|++|..||.
T Consensus 216 ~ell~g~~pf~ 226 (364)
T cd07875 216 GEMIKGGVLFP 226 (364)
T ss_pred HHHHhCCCCCC
Confidence 99999987774
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-30 Score=207.31 Aligned_cols=155 Identities=23% Similarity=0.306 Sum_probs=122.5
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhc-----CCCcccCHHHHHHHHHHHHHHh
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVS-----RGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~~~l~~gl 102 (238)
..+.+|+.++++++||||+++++++.. +...++++||+. ++|.+++.... .....+++..+..++.|++.||
T Consensus 43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 121 (317)
T cd07868 43 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121 (317)
T ss_pred HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHH
Confidence 346789999999999999999999854 456789999995 58888875321 1123588999999999999999
Q ss_pred chhhcc--------Cceeee----cCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccc-cCCCccCCeee
Q 041655 103 EYLHMH--------QALVLL----DHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQT-LSITYMCDIYS 168 (238)
Q Consensus 103 ~~lH~~--------~~~il~----~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~-~~~~~~~Dvws 168 (238)
.|||++ |.||++ +.++.+||+|||.++........ .......+|+.|+|||++.+ ..++.++|+||
T Consensus 122 ~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 201 (317)
T cd07868 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201 (317)
T ss_pred HHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHH
Confidence 999955 667998 45678999999999865432211 12234578999999998876 45789999999
Q ss_pred hhHHHHhhcchHHHHHH
Q 041655 169 FGVLLAEEMSLVKWMRN 185 (238)
Q Consensus 169 lG~~l~~~~t~~~~~~~ 185 (238)
+||++|+|++|..||..
T Consensus 202 lG~il~el~~g~~~f~~ 218 (317)
T cd07868 202 IGCIFAELLTSEPIFHC 218 (317)
T ss_pred HHHHHHHHHhCCCCccC
Confidence 99999999999988853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=200.06 Aligned_cols=146 Identities=23% Similarity=0.301 Sum_probs=123.9
Q ss_pred HHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh---
Q 041655 32 IRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH--- 106 (238)
Q Consensus 32 ~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH--- 106 (238)
.+||+.+|.+.+|||||.+-.+... -+.+|+||||++. +|...+.. -..++...+++.++.|+++|++|||
T Consensus 122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~w 197 (419)
T KOG0663|consen 122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDNW 197 (419)
T ss_pred hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhce
Confidence 4799999999999999999998754 3679999999975 99999986 3467999999999999999999999
Q ss_pred -----ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcchH
Q 041655 107 -----MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 107 -----~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~ 180 (238)
.|++|+|+++.|.+|++|||+|+.++.... ..+...-|..|.|||.+.+. .|++..|+||+||++.|++++.
T Consensus 198 ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k 275 (419)
T KOG0663|consen 198 ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK 275 (419)
T ss_pred eEecccchhheeeccCCcEEecccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC
Confidence 448889999999999999999998765422 12445668999999987664 5899999999999999998855
Q ss_pred HHH
Q 041655 181 KWM 183 (238)
Q Consensus 181 ~~~ 183 (238)
+-|
T Consensus 276 Plf 278 (419)
T KOG0663|consen 276 PLF 278 (419)
T ss_pred CCC
Confidence 444
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=201.09 Aligned_cols=205 Identities=24% Similarity=0.258 Sum_probs=160.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+.+.+|+..+++++|||++++++.+... +..++++||+++++|.+++.. ...+++..+..++.|++.||.
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~ 115 (260)
T cd06606 40 EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLA 115 (260)
T ss_pred hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999999888 889999999999999999976 237899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
|||++ +.||+++.++.++|+|||.+................++..|.+||...+...+.++|+||||+++|+
T Consensus 116 ~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~ 195 (260)
T cd06606 116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIE 195 (260)
T ss_pred HHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHH
Confidence 99955 5569999999999999999887654432111233567889999999988888999999999999999
Q ss_pred hcchHHHHHHhhccC-CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 176 EMSLVKWMRNVMTSE-NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+++|..||....... ..............+...+..+.+++.+||+.||.+| ++.+.|+
T Consensus 196 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 196 MATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 999988875432100 1111111122223344446778889999999999999 5555443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=217.65 Aligned_cols=150 Identities=22% Similarity=0.229 Sum_probs=126.2
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.++++++|+||+++++++..++..++++|++. ++|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g 280 (461)
T PHA03211 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG 280 (461)
T ss_pred cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345689999999999999999999999999999999994 689888864 234689999999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
+.||+++.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 281 IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 6679999999999999999986543322222234568999999999999889999999999999999987654
Q ss_pred HH
Q 041655 182 WM 183 (238)
Q Consensus 182 ~~ 183 (238)
++
T Consensus 361 ~l 362 (461)
T PHA03211 361 SL 362 (461)
T ss_pred Cc
Confidence 43
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=206.06 Aligned_cols=203 Identities=20% Similarity=0.232 Sum_probs=149.1
Q ss_pred HHHHHHHHHHhcCC-CCCcccceeeeeecC-----CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 29 MMQIRSEIVTLGQI-RHRNILPLLAHLARP-----GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 29 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
...+.+|+.++.++ +|||++++++++... +..++++||+++++|.+++.........+++..+..++.|++.||
T Consensus 62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 141 (291)
T cd06639 62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence 35567899999998 799999999998643 357999999999999998865333446689999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-----CCCccCCeeeh
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-----SITYMCDIYSF 169 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-----~~~~~~Dvwsl 169 (238)
.|||.+ +.||+++.++.++|+|||.+......... .....++..|+|||.+... .++.++|+|||
T Consensus 142 ~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 219 (291)
T cd06639 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219 (291)
T ss_pred HHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHH
Confidence 999955 55699999999999999998765432211 1234678899999987543 25789999999
Q ss_pred hHHHHhhcchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 170 GVLLAEEMSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 170 G~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|+++|+|++|..||................. ....+......+.+++.+||+.+|++| .+-+.|
T Consensus 220 Gvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 285 (291)
T cd06639 220 GITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285 (291)
T ss_pred HHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 9999999999888754322111111111100 111123344568888999999999999 444443
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=206.74 Aligned_cols=152 Identities=24% Similarity=0.299 Sum_probs=125.4
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++.+++|||++++++++..++..++|+||++ ++|.+++.... ....+++..+..++.|+++||.|||.+
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~ 120 (285)
T cd07861 43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR 120 (285)
T ss_pred hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4567889999999999999999999999999999999996 68988886422 235689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~ 179 (238)
+.||+++.++.++|+|||.+........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|
T Consensus 121 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 198 (285)
T cd07861 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK 198 (285)
T ss_pred CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHC
Confidence 5579999999999999999875432211 11234568889999987654 468899999999999999999
Q ss_pred HHHHH
Q 041655 180 VKWMR 184 (238)
Q Consensus 180 ~~~~~ 184 (238)
..||.
T Consensus 199 ~~~~~ 203 (285)
T cd07861 199 KPLFH 203 (285)
T ss_pred CCCCC
Confidence 87774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-30 Score=218.51 Aligned_cols=201 Identities=19% Similarity=0.221 Sum_probs=164.5
Q ss_pred HHHHHHHHHhcCCC-CCcccceeeeee-----cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 30 MQIRSEIVTLGQIR-HRNILPLLAHLA-----RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 30 ~~~~~E~~~l~~l~-h~~iv~~~~~~~-----~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
+++.-|.++++.+. |||++.++|++. .++.+|+|||||.+|+..|..+.+. +..+.|..+..+++.++.|+.
T Consensus 60 eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~ 137 (953)
T KOG0587|consen 60 EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLA 137 (953)
T ss_pred HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHH
Confidence 44566888888885 999999999984 4678999999999999999998865 567899999999999999999
Q ss_pred hhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-----CCCccCCeeehh
Q 041655 104 YLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-----SITYMCDIYSFG 170 (238)
Q Consensus 104 ~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-----~~~~~~DvwslG 170 (238)
+|| .++.|||++.++.+||.|||++..++... ....+..|||+|||||++.+. .|+..+|+||||
T Consensus 138 HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLG 215 (953)
T KOG0587|consen 138 HLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLG 215 (953)
T ss_pred HHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhcc
Confidence 999 44788999999999999999998764322 233567999999999998754 366789999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCccccc-ccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAID-SKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
++..||..|.+|+..+........+.. +++....+.....++.++|..||.+|-+.| .+.++|+
T Consensus 216 ITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 216 ITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 999999999999876665444443332 333445578888899999999999999999 6666653
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=202.44 Aligned_cols=202 Identities=21% Similarity=0.247 Sum_probs=160.7
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++++++|+||+++.+.+..++..++++||+++++|.+++.........+++..+..++.|++.||+|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh 120 (256)
T cd08530 41 KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120 (256)
T ss_pred HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh
Confidence 44567789999999999999999999999999999999999999999998764344567899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.++.++|+|||.+....... .....+++.|++||.+.+..++.++|+||+|+++|++++
T Consensus 121 ~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh
Confidence 65 567999999999999999987664431 123467889999999988888999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||...... ...........+..+...+.++.+++.+||+.+|++| .+.+.|
T Consensus 197 g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 197 FAPPFEARSMQ-DLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251 (256)
T ss_pred CCCCCCCCCHH-HHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 99887532211 1111222222233344566778999999999999999 544444
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=206.28 Aligned_cols=150 Identities=25% Similarity=0.353 Sum_probs=125.7
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++..++||||+++++++..++..++++||+++++|..+... ...+++..+..++.|++.||.|||.
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~ 118 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHS 118 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456688999999999999999999999999999999999998888877653 3458999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t 178 (238)
+ +.||++++++.++|+|||++........ ......++..|+|||...+ ..++.++|+||||+++|+|++
T Consensus 119 ~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~ 196 (286)
T cd07846 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196 (286)
T ss_pred CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc
Confidence 5 5579999999999999999876533221 1233567889999998765 346789999999999999999
Q ss_pred hHHHH
Q 041655 179 LVKWM 183 (238)
Q Consensus 179 ~~~~~ 183 (238)
|..||
T Consensus 197 g~~~~ 201 (286)
T cd07846 197 GEPLF 201 (286)
T ss_pred CCCCC
Confidence 97666
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=214.11 Aligned_cols=147 Identities=23% Similarity=0.311 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
....+.+|+.+++.++||||+++++++... ...+++|||+++ ++.+.+.. .+++..+..++.|+++|
T Consensus 59 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~a 131 (355)
T cd07874 59 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCG 131 (355)
T ss_pred HHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHH
Confidence 456778999999999999999999988643 346899999964 77777642 47888899999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|.|||.+ |.||+++.++.+||+|||+++...... ......+++.|+|||++.+..++.++|+|||||++
T Consensus 132 L~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il 208 (355)
T cd07874 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208 (355)
T ss_pred HHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHH
Confidence 9999954 667999999999999999997643322 12335789999999999888899999999999999
Q ss_pred HhhcchHHHHH
Q 041655 174 AEEMSLVKWMR 184 (238)
Q Consensus 174 ~~~~t~~~~~~ 184 (238)
|+|++|..||.
T Consensus 209 ~el~~g~~pf~ 219 (355)
T cd07874 209 GEMVRHKILFP 219 (355)
T ss_pred HHHHhCCCCCC
Confidence 99999887763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=204.60 Aligned_cols=199 Identities=22% Similarity=0.268 Sum_probs=154.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++.+++|||++++++.+..++..++|+||+++++|.+++.. ..+++..+..++.|++.|+.|||
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh 118 (277)
T cd06641 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH 118 (277)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHc
Confidence 4456788999999999999999999999999999999999999999999864 45789999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||++++++.++++|||.+........ ......++..|+|||.+.+...+.++|+||||+++|+|++
T Consensus 119 ~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (277)
T cd06641 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 196 (277)
T ss_pred cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHc
Confidence 55 5679999999999999999876533221 1233567889999999988888999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..|+......... ..+............+..+.+++.+||+.+|.+| .+.+.+
T Consensus 197 g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 251 (277)
T cd06641 197 GEPPHSELHPMKVL-FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 251 (277)
T ss_pred CCCCCCccchHHHH-HHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 98887532211111 1111111122223345567788888999999999 443333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=205.61 Aligned_cols=191 Identities=23% Similarity=0.267 Sum_probs=146.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
....++.+|+.+++.++|+|++++.+++...+..++|+||+. |++.+.+.. ....+++..+..++.|++.|+.|||
T Consensus 57 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH 132 (308)
T cd06634 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH 132 (308)
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999996 588877754 2345889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhHHHHh
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l~~ 175 (238)
.+ +.||+++.++.++++|||.+...... ....+++.|+|||.+. ...++.++|+||||+++|+
T Consensus 133 ~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e 206 (308)
T cd06634 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206 (308)
T ss_pred hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHH
Confidence 55 56799999999999999998754332 2245788999999864 3457889999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|++|..|+............................+.+++.+||+.+|++|
T Consensus 207 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R 258 (308)
T cd06634 207 LAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258 (308)
T ss_pred HHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccC
Confidence 9999988754322111111111111111122445567888899999999999
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=203.84 Aligned_cols=197 Identities=20% Similarity=0.220 Sum_probs=142.3
Q ss_pred HHHHHHHHhcCC---CCCcccceeeeeec-----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 31 QIRSEIVTLGQI---RHRNILPLLAHLAR-----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 31 ~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
.+.+|+.+++.+ +||||+++++++.. ....++++||++ ++|.+++.. .....+++..+..++.|++.||
T Consensus 45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~al 121 (288)
T cd07863 45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDK--VPPPGLPAETIKDLMRQFLRGL 121 (288)
T ss_pred HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHH
Confidence 344566666555 79999999998854 345789999996 489888865 2234589999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
.|||++ |.||+++.++.+||+|||.++....... .....++..|+|||++.+..++.++|+||+||++|
T Consensus 122 ~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 198 (288)
T cd07863 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 198 (288)
T ss_pred HHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHH
Confidence 999944 6679999999999999999876543221 13356789999999998888999999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccc------------------ccccc---C----CChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 175 EEMSLVKWMRNVMTSENPKRAI------------------DSKLL---G----NGYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~------------------~~~~~---~----~~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
+|++|.+||............. ..... . ....+....+.+++.+||+.||++| .
T Consensus 199 ~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (288)
T cd07863 199 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278 (288)
T ss_pred HHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC
Confidence 9999988773221110000000 00000 0 0111234557788999999999999 5
Q ss_pred HHHHH
Q 041655 229 VRCML 233 (238)
Q Consensus 229 v~~~L 233 (238)
+.+.|
T Consensus 279 ~~~~l 283 (288)
T cd07863 279 AFRAL 283 (288)
T ss_pred HHHHh
Confidence 55544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=206.16 Aligned_cols=155 Identities=23% Similarity=0.311 Sum_probs=122.1
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeee--cCCeeEEEEEeCCCCCHHHHHhhhc-----CCCcccCHHHHHHHHHHHHHHh
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLA--RPGCHLLVYEFMKNGSLQDILNDVS-----RGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~~~l~~gl 102 (238)
..+.+|+.++++++||||+++++++. .+...++++||++ ++|.+++.... .....+++..+..++.|++.||
T Consensus 43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 121 (317)
T cd07867 43 MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121 (317)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHH
Confidence 35678999999999999999999985 3567889999996 58888775311 1223588999999999999999
Q ss_pred chhhcc--------Cceeee----cCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccc-cCCCccCCeee
Q 041655 103 EYLHMH--------QALVLL----DHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQT-LSITYMCDIYS 168 (238)
Q Consensus 103 ~~lH~~--------~~~il~----~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~-~~~~~~~Dvws 168 (238)
.|||++ |.||++ +.++.+||+|||+++........ .......+++.|+|||++.+ ..++.++||||
T Consensus 122 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 201 (317)
T cd07867 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201 (317)
T ss_pred HHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHh
Confidence 999955 667888 56678999999999865432211 11234567899999998866 45788999999
Q ss_pred hhHHHHhhcchHHHHHH
Q 041655 169 FGVLLAEEMSLVKWMRN 185 (238)
Q Consensus 169 lG~~l~~~~t~~~~~~~ 185 (238)
+||++|+|+||..||..
T Consensus 202 lG~il~el~tg~~~f~~ 218 (317)
T cd07867 202 IGCIFAELLTSEPIFHC 218 (317)
T ss_pred HHHHHHHHHhCCCCccc
Confidence 99999999999988753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-30 Score=202.04 Aligned_cols=188 Identities=18% Similarity=0.191 Sum_probs=144.2
Q ss_pred HHHHHHHHH-hcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIVT-LGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
..+..|..+ ....+|||++++++.+..++..++++||+++++|.+++.. ...+++..+..++.|++.||.|||++
T Consensus 41 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~ 116 (260)
T cd05611 41 TNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR 116 (260)
T ss_pred HHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344555554 4455899999999999999999999999999999999975 35688999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.+..... .....+++.|++||.+.+..++.++|+||+|+++|++++|.
T Consensus 117 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~ 190 (260)
T cd05611 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGY 190 (260)
T ss_pred CeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCC
Confidence 5569999999999999998865432 12346788999999988888899999999999999999999
Q ss_pred HHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||................. ........+..+.+++.+||+.||++|
T Consensus 191 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 239 (260)
T cd05611 191 PPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239 (260)
T ss_pred CCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHc
Confidence 88743221111111111111 111122345668889999999999999
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=204.54 Aligned_cols=150 Identities=20% Similarity=0.305 Sum_probs=126.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++|||++++++.+...+..++++||+++++|..+... ...+++..+..++.|++.||+|||..
T Consensus 44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~ 119 (286)
T cd07847 44 KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH 119 (286)
T ss_pred cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35678999999999999999999999999999999999998877777653 34689999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+.||+++.++.++|+|||.+......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|
T Consensus 120 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g 197 (286)
T cd07847 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197 (286)
T ss_pred CceecCCChhhEEEcCCCcEEECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhC
Confidence 66799999999999999998866443211 123457788999998765 4578899999999999999999
Q ss_pred HHHHH
Q 041655 180 VKWMR 184 (238)
Q Consensus 180 ~~~~~ 184 (238)
..||.
T Consensus 198 ~~p~~ 202 (286)
T cd07847 198 QPLWP 202 (286)
T ss_pred CCCCC
Confidence 87764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=200.83 Aligned_cols=197 Identities=20% Similarity=0.204 Sum_probs=150.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
......+.+|+.++++++||||+++++.+.+. +.+++++||+++++|.+++.. ...+++..+..++.|++.||.
T Consensus 45 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~ 120 (264)
T cd06653 45 SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVS 120 (264)
T ss_pred hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHH
Confidence 34567889999999999999999999998664 467899999999999999865 345788999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCccc-ccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHT-HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
|||++ +.||+++.++.++|+|||.++....... ........++..|+|||.+.+..++.++|+||||+++|
T Consensus 121 ~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 200 (264)
T cd06653 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVV 200 (264)
T ss_pred HHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHH
Confidence 99955 5569999999999999999876432111 11112356888999999998888899999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++++|..||..........+.......+..+......+.+++.+||+ +|..|
T Consensus 201 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r 252 (264)
T cd06653 201 EMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRR 252 (264)
T ss_pred HHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccC
Confidence 99999988854322222222222222233344455667788888999 56788
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=212.09 Aligned_cols=146 Identities=25% Similarity=0.355 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
..+.+.+|+.++++++||||+++++++... ...+++++++ +++|.+++.. ..+++..+..++.|++.|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~a 130 (343)
T cd07878 57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRG 130 (343)
T ss_pred HHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHH
Confidence 345677999999999999999999988543 3468999988 7799888753 458999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVL 172 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~ 172 (238)
|.|||.+ +.||+++.++.+||+|||+++...... ....|++.|+|||++.+ ..++.++||||+||+
T Consensus 131 L~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 205 (343)
T cd07878 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205 (343)
T ss_pred HHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHH
Confidence 9999944 678999999999999999987653321 33568899999998876 567899999999999
Q ss_pred HHhhcchHHHHH
Q 041655 173 LAEEMSLVKWMR 184 (238)
Q Consensus 173 l~~~~t~~~~~~ 184 (238)
+|+|++|..||.
T Consensus 206 l~el~~g~~pf~ 217 (343)
T cd07878 206 MAELLKGKALFP 217 (343)
T ss_pred HHHHHHCCCCCC
Confidence 999999987764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=205.72 Aligned_cols=197 Identities=22% Similarity=0.257 Sum_probs=148.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.+++.++|||++++++++.+.+..|+++||+. +++.+++.. ....+++..+..++.|++.|+.|||
T Consensus 63 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH 138 (313)
T cd06633 63 EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH 138 (313)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 445678899999999999999999999999999999999995 578887754 2456899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhHHHHh
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l~~ 175 (238)
.+ +.||+++.++.++|+|||.+..... .....++..|+|||.+. ...++.++|+||||+++|+
T Consensus 139 ~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~e 212 (313)
T cd06633 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 212 (313)
T ss_pred HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHH
Confidence 55 5679999999999999998754321 12356788999999874 4567889999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|++|..|+.........................+..+.+++.+||+.+|++| .+.+.|
T Consensus 213 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 213 LAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred HHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 9999988754321111111111111111112233457788888999999999 444444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=205.97 Aligned_cols=198 Identities=20% Similarity=0.267 Sum_probs=151.8
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++++++|+|++++++.+..++..+++|||+++++|.+++.. ..+++..+..++.|++.|++|||+
T Consensus 60 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~ 134 (292)
T cd06657 60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHA 134 (292)
T ss_pred HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999998753 357889999999999999999996
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.++++|||.+........ ......+++.|++||.+.+..++.++|+||+|+++|+|++|
T Consensus 135 ~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg 212 (292)
T cd06657 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212 (292)
T ss_pred CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 5 5579999999999999998865533221 11335678899999998888889999999999999999999
Q ss_pred HHHHHHhhccCCCccccccccc--CCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 180 VKWMRNVMTSENPKRAIDSKLL--GNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
..||......... ........ .......+..+.+++.+||+.+|.+| ++.+.|
T Consensus 213 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll 268 (292)
T cd06657 213 EPPYFNEPPLKAM-KMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 268 (292)
T ss_pred CCCCCCCCHHHHH-HHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHh
Confidence 8876432111100 11111111 01112334557788889999999999 444444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=202.96 Aligned_cols=182 Identities=21% Similarity=0.191 Sum_probs=140.2
Q ss_pred HhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------C
Q 041655 38 TLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------Q 109 (238)
Q Consensus 38 ~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~ 109 (238)
++...+|||++.+++.+..++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||++ +
T Consensus 50 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp 125 (279)
T cd05633 50 LVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKP 125 (279)
T ss_pred HHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCH
Confidence 44455799999999999999999999999999999998865 35689999999999999999999955 6
Q ss_pred ceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-ccCCCccCCeeehhHHHHhhcchHHHHHHhhc
Q 041655 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-TLSITYMCDIYSFGVLLAEEMSLVKWMRNVMT 188 (238)
Q Consensus 110 ~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~ 188 (238)
.||+++.++.++++|||++........ ....|++.|+|||... +..++.++|+||+|+++|+|++|..||.....
T Consensus 126 ~Nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 126 ANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred HHEEECCCCCEEEccCCcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 679999999999999999875433221 2346889999999876 45578999999999999999999998864321
Q ss_pred cCCC-cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 189 SENP-KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 189 ~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.... ............+...+.++.+++.+||+.||.+|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 241 (279)
T cd05633 202 KDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241 (279)
T ss_pred cCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHh
Confidence 1100 00001111122233445667888889999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=203.80 Aligned_cols=202 Identities=23% Similarity=0.261 Sum_probs=150.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++++++|||++++++++..++..++|+||+ +++|.+++.. ....+++..+..++.|++.||+|||+
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~ 117 (286)
T cd07832 42 IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA 117 (286)
T ss_pred hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999 9999999865 23568999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++.++.++++|||.+........ .......++..|+|||.+.+. .++.++|+||+|+++|+|++
T Consensus 118 ~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc
Confidence 5 5579999999999999999876543321 112335688899999987654 46889999999999999999
Q ss_pred hHHHHHHhhccCCCc------------------------cccccccc----CCChHHHHHHHHHHhhhhcCCCCCcc-hH
Q 041655 179 LVKWMRNVMTSENPK------------------------RAIDSKLL----GNGYEEQMLLVLKTACFCTLDDPKER-HV 229 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~------------------------~~~~~~~~----~~~~~~~~~~l~~~~~~cl~~~p~~R-~v 229 (238)
|..+|.......... ........ .....+....+.+++.+||+.+|++| .+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 197 GSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred CCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 966553211100000 00000000 00112334678889999999999999 55
Q ss_pred HHHHH
Q 041655 230 RCMLS 234 (238)
Q Consensus 230 ~~~L~ 234 (238)
-+.|+
T Consensus 277 ~~~l~ 281 (286)
T cd07832 277 AEALR 281 (286)
T ss_pred HHHhh
Confidence 55443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=199.49 Aligned_cols=205 Identities=20% Similarity=0.274 Sum_probs=160.1
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+++++.++|||++++.+.+...+..++++||+++++|.+++.........+++..+..++.+++.||.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 120 (258)
T cd08215 41 KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120 (258)
T ss_pred HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999999999999999999999999999763323467899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.++|+|||.+....... .......+++.|+|||...+..++.++|+||+|+++++|++
T Consensus 121 ~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred hCCEecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc
Confidence 55 567999999999999999987654432 12233567889999999888888999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|..||............. .......+...+..+.+++..||+.+|.+| ++.+.|+
T Consensus 199 g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 199 LKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 988874322111111111 111222233455678889999999999999 5555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=208.12 Aligned_cols=143 Identities=21% Similarity=0.252 Sum_probs=121.4
Q ss_pred HHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc---
Q 041655 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--- 108 (238)
Q Consensus 32 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--- 108 (238)
...|+.++.+++||||+++++++...+..++|+|++. ++|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 104 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 179 (357)
T PHA03209 104 TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQRII 179 (357)
T ss_pred cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3568999999999999999999999999999999994 689888864 345689999999999999999999955
Q ss_pred -----CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 109 -----QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 109 -----~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
+.||+++.++.++|+|||.++....... .....|++.|+|||++.+..++.++|+|||||++|||+++..
T Consensus 180 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~ 254 (357)
T PHA03209 180 HRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPS 254 (357)
T ss_pred cCCCCHHHEEECCCCCEEEecCccccccccCcc---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCC
Confidence 5679999999999999999875322111 123568999999999998899999999999999999997533
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=205.22 Aligned_cols=149 Identities=20% Similarity=0.287 Sum_probs=124.3
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.++++++||||+++++++...+..++++||++ ++|.+++.. ....+++..+..++.|++.||.|||++
T Consensus 49 ~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~ 124 (301)
T cd07873 49 CTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK 124 (301)
T ss_pred hHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456789999999999999999999999999999999996 589888865 244678999999999999999999955
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcchH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.+......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 125 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~ 202 (301)
T cd07873 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202 (301)
T ss_pred eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCC
Confidence 56799999999999999998754322211 123456889999998765 34788999999999999999998
Q ss_pred HHHH
Q 041655 181 KWMR 184 (238)
Q Consensus 181 ~~~~ 184 (238)
.||.
T Consensus 203 ~~f~ 206 (301)
T cd07873 203 PLFP 206 (301)
T ss_pred CCCC
Confidence 8774
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=204.42 Aligned_cols=153 Identities=22% Similarity=0.300 Sum_probs=127.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++|+||+++++.+..++..++++||++++.+..+... ...+++..+..++.|++.||.|||
T Consensus 42 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH 117 (288)
T cd07833 42 DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCH 117 (288)
T ss_pred cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3457789999999999999999999999999999999999987666655543 355899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~ 177 (238)
.+ +.||+++.++.++|+|||.+......... ......++..|+|||++.+. .++.++|+||||+++|+|+
T Consensus 118 ~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~ 196 (288)
T cd07833 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196 (288)
T ss_pred HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHH
Confidence 65 45699999999999999998766443321 12335678889999998887 7889999999999999999
Q ss_pred chHHHHH
Q 041655 178 SLVKWMR 184 (238)
Q Consensus 178 t~~~~~~ 184 (238)
+|..||.
T Consensus 197 ~g~~~~~ 203 (288)
T cd07833 197 DGEPLFP 203 (288)
T ss_pred hCCCCCC
Confidence 9987664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=201.49 Aligned_cols=183 Identities=22% Similarity=0.199 Sum_probs=141.4
Q ss_pred HHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-------
Q 041655 36 IVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH------- 108 (238)
Q Consensus 36 ~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~------- 108 (238)
+..+...+|||++++.+.+.+++..++|+||+++++|.+++.. ...+++..+..++.|+++|+.|||++
T Consensus 48 ~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di 123 (278)
T cd05606 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDL 123 (278)
T ss_pred HHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCC
Confidence 3445556899999999999999999999999999999998865 35689999999999999999999954
Q ss_pred -CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcchHHHHHHh
Q 041655 109 -QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLVKWMRNV 186 (238)
Q Consensus 109 -~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~~~~ 186 (238)
+.||+++.++.++|+|||.+........ ....|+..|+|||.+.+. .++.++|+||+|+++|+|++|..||...
T Consensus 124 ~p~nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 124 KPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CHHHEEECCCCCEEEccCcCccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 5679999999999999999875533221 234688999999998754 5789999999999999999999888643
Q ss_pred hccC--CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 187 MTSE--NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 187 ~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.... ...... .......+...+.++.+++.+||..+|.+|
T Consensus 200 ~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R 241 (278)
T cd05606 200 KTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEGLLQRDVNRR 241 (278)
T ss_pred CccchHHHHHHh-hccCCCCCCcCCHHHHHHHHHHhhcCHHhc
Confidence 2111 111111 111122233345667888888999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=201.11 Aligned_cols=201 Identities=19% Similarity=0.259 Sum_probs=153.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.+++.++|+|++++++.+..++..++++||+++++|.+++.. .....+++..+..++.|++.||.|||.
T Consensus 42 ~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (257)
T cd08225 42 EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHD 119 (257)
T ss_pred hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999865 233457899999999999999999995
Q ss_pred c--------CceeeecCCCc-eEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDME-ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
+ +.||++++++. ++++|||.+......... .....|++.|+|||...+..++.++|+||||++++++++
T Consensus 120 ~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08225 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197 (257)
T ss_pred CCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 5 55699988864 699999998765432221 123467889999999888888999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||................. .......+.++.+++.+||+.+|++| .+-+.|
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll 252 (257)
T cd08225 198 LKHPFEGNNLHQLVLKICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSIL 252 (257)
T ss_pred CCCCCCCccHHHHHHHHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 9887643221111111111111 11222334568888899999999999 444433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=204.20 Aligned_cols=149 Identities=23% Similarity=0.290 Sum_probs=123.8
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.++++++|||++++++.+.+.+..++++||++ ++|.+++.. ....+++..+..++.|+++||.|||.+
T Consensus 44 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~ 119 (284)
T cd07839 44 SSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN 119 (284)
T ss_pred cchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 457789999999999999999999999999999999996 588888764 235689999999999999999999955
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcchH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.+......... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.
T Consensus 120 i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 55799999999999999998765332211 1234568899999987664 4688999999999999999987
Q ss_pred HHHH
Q 041655 181 KWMR 184 (238)
Q Consensus 181 ~~~~ 184 (238)
.|+.
T Consensus 198 ~p~~ 201 (284)
T cd07839 198 RPLF 201 (284)
T ss_pred CCCc
Confidence 7753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=205.60 Aligned_cols=198 Identities=26% Similarity=0.324 Sum_probs=152.1
Q ss_pred HHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--
Q 041655 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH-- 108 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~-- 108 (238)
...+|+.++++++||||+++++++...+..+++|||+++++|.+++.. ...+++..+..++.|+++||.+||++
T Consensus 44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~i 119 (260)
T PF00069_consen 44 ENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKGI 119 (260)
T ss_dssp HHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhhhccccccccccccccccccccccccccccccccccccccccc----cccccccccccccccccccccccccccc
Confidence 445699999999999999999999999999999999998899999973 46689999999999999999999944
Q ss_pred ------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-ccCCCccCCeeehhHHHHhhcchHH
Q 041655 109 ------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-TLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 109 ------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
+.||+++.++.++|+|||.+....... .......++..|.|||+.. +...+.++|+||+|+++|+|++|..
T Consensus 120 ~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~ 197 (260)
T PF00069_consen 120 VHRDIKPENILLDENGEVKLIDFGSSVKLSENN--ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKL 197 (260)
T ss_dssp EESSBSGGGEEESTTSEEEESSGTTTEESTSTT--SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSS
T ss_pred ccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 678999999999999999987542111 1224467789999999988 7788999999999999999999988
Q ss_pred HHHHhh---ccCCCccccccccc--CCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 182 WMRNVM---TSENPKRAIDSKLL--GNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 182 ~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|+.... .............. ..........+.+++..||+.||++| ++.+.++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 198 PFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 776430 00111111111110 01111123678889999999999999 5555443
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-31 Score=199.38 Aligned_cols=214 Identities=16% Similarity=0.182 Sum_probs=162.4
Q ss_pred eccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcc
Q 041655 7 IVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85 (238)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~ 85 (238)
.......-.+|+......++++.++++..++++.+-+ .|+||+.+|+|..+...++.||.+ ...+..++.. ...+
T Consensus 112 ~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr---ik~p 187 (391)
T KOG0983|consen 112 RFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR---IKGP 187 (391)
T ss_pred EEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH---hcCC
Confidence 3333333444455555566788899999999866654 899999999999999999999998 4466666654 4567
Q ss_pred cCHHHHHHHHHHHHHHhchhh---------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc
Q 041655 86 LDWLARYRTVRGIASGLEYLH---------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ 156 (238)
Q Consensus 86 ~~~~~~~~~~~~l~~gl~~lH---------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~ 156 (238)
+++..+-++...+..||.||- .||.|||+|..|++|++|||++..+.++..+ +...|.+.|||||-+.
T Consensus 188 iPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trsAGC~~YMaPERid 264 (391)
T KOG0983|consen 188 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRSAGCAAYMAPERID 264 (391)
T ss_pred chHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc---ccccCCccccCccccC
Confidence 899999999999999999995 5689999999999999999999877665443 4467899999999775
Q ss_pred c---cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCC-cccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 157 T---LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENP-KRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 157 ~---~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
- ..|+..+||||||++++|+.||..||.....+... ..+++... ..........++.+++..||++|+.+|
T Consensus 265 p~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~R 340 (391)
T KOG0983|consen 265 PPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKR 340 (391)
T ss_pred CCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccC
Confidence 3 46889999999999999999999999764433322 22332221 112222255667777778999999999
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=198.17 Aligned_cols=201 Identities=24% Similarity=0.301 Sum_probs=156.0
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+..+.+++|||++++.+.+..++..++++||+++++|.+++.. ....+++..+..++.|++.||.+||
T Consensus 39 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh 115 (253)
T cd05122 39 EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLH 115 (253)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhh
Confidence 3567889999999999999999999999999999999999999999999875 2257899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.+ +.||+++.++.++|+|||.+........ .....++..|++||.+.+...+.++|+||||+++|+|++
T Consensus 116 ~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~ 192 (253)
T cd05122 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE 192 (253)
T ss_pred cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHh
Confidence 54 5679999999999999999876544321 234567889999999888888999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCC--hHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNG--YEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|..|+.............. ...... ....+..+.+++..||+.||++| ++.+.|+
T Consensus 193 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 193 GKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9887754311111111111 111111 11124567888889999999999 5555443
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=203.58 Aligned_cols=193 Identities=18% Similarity=0.205 Sum_probs=143.7
Q ss_pred HHHHHHHHH-hcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIVT-LGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
..+..|+.. ++.++|||++++++.+..++..++++||++ |+|.+++.........+++..+..++.|++.||+|||.+
T Consensus 44 ~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 122 (283)
T cd06617 44 KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK 122 (283)
T ss_pred HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 445566664 566789999999999999999999999996 689888865433446789999999999999999999965
Q ss_pred ---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc----cCCCccCCeeehhHHHHh
Q 041655 109 ---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT----LSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 109 ---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~----~~~~~~~DvwslG~~l~~ 175 (238)
+.||+++.++.+||+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus 123 ~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred CCeecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 4569999999999999999876532211 122467888999998764 446889999999999999
Q ss_pred hcchHHHHHHhhcc-CCCcccccccccCCC-hHHHHHHHHHHhhhhcCCCCCcc
Q 041655 176 EMSLVKWMRNVMTS-ENPKRAIDSKLLGNG-YEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 176 ~~t~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|++|..||...... ........ ...... ....+.++.+++.+||..+|++|
T Consensus 200 l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 252 (283)
T cd06617 200 LATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAEKFSPEFQDFVNKCLKKNYKER 252 (283)
T ss_pred HHhCCCCCCccccCHHHHHHHHh-cCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence 99999887532111 11111111 111111 12235568888999999999999
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=205.21 Aligned_cols=157 Identities=18% Similarity=0.207 Sum_probs=125.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+..+.+.+|+.+++.++||||++++++|..++..++++||+++++|.+++... ....+++..+..++.|++.||+|||
T Consensus 41 ~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH 118 (328)
T cd08226 41 EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLH 118 (328)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 34578889999999999999999999999999999999999999999998752 2345889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccc-----cccccccCCCcccCccccccc--CCCccCCeeehhH
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-----ITTSDVVGTAGYIAPEYQQTL--SITYMCDIYSFGV 171 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~apE~~~~~--~~~~~~DvwslG~ 171 (238)
++ +.||+++.++.++++||+........... .......++..|++||++.+. .++.++|+||+||
T Consensus 119 ~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~ 198 (328)
T cd08226 119 QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198 (328)
T ss_pred hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHH
Confidence 55 56799999999999999765332111000 001112346679999998763 4678999999999
Q ss_pred HHHhhcchHHHHHH
Q 041655 172 LLAEEMSLVKWMRN 185 (238)
Q Consensus 172 ~l~~~~t~~~~~~~ 185 (238)
++|+|++|..||..
T Consensus 199 ~l~el~~g~~p~~~ 212 (328)
T cd08226 199 TACELATGRVPFQD 212 (328)
T ss_pred HHHHHHhCCCCCCC
Confidence 99999999988753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=197.32 Aligned_cols=168 Identities=25% Similarity=0.332 Sum_probs=134.3
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCc-ccceeeeeecCC------eeEEEEEeCCCCCHH
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRN-ILPLLAHLARPG------CHLLVYEFMKNGSLQ 73 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~------~~~~v~e~~~~~~L~ 73 (238)
.||+|++...... +..-....+|+.+|++|+|+| |+++++++.+.+ ..++|+||.. .+|.
T Consensus 38 ~VALKkirl~~~~------------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~ 104 (323)
T KOG0594|consen 38 FVALKKIRLEFEE------------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLK 104 (323)
T ss_pred EEEEEEEeccccc------------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHH
Confidence 3777777655431 001234579999999999999 999999998776 7899999995 5999
Q ss_pred HHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccC
Q 041655 74 DILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145 (238)
Q Consensus 74 ~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 145 (238)
.++...+.....++...++.++.|++.||+|||++ |.|++++++|.+||+|||+++...-... ..+....
T Consensus 105 ~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evv 182 (323)
T KOG0594|consen 105 KYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVV 182 (323)
T ss_pred HHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcc--cccccEE
Confidence 99987443324677788999999999999999954 7889999999999999999986542211 1345677
Q ss_pred CCcccCccccccc-CCCccCCeeehhHHHHhhcchHHHH
Q 041655 146 TAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLVKWM 183 (238)
Q Consensus 146 ~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~ 183 (238)
|..|.|||++.+. .|++..||||+||+++||+++.+-|
T Consensus 183 TlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF 221 (323)
T KOG0594|consen 183 TLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF 221 (323)
T ss_pred EeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence 8899999987766 6899999999999999999865544
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=201.92 Aligned_cols=200 Identities=24% Similarity=0.267 Sum_probs=148.6
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+..|+.++++++|+|++++++++.+.+..++||||+ +++|.+++.. ....+++..+..++.|+++||.|||.+
T Consensus 46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~ 121 (298)
T cd07841 46 NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSN 121 (298)
T ss_pred hHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 355678999999999999999999999999999999999 8899999975 123689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+.||+++.++.++|+|||.+......... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|
T Consensus 122 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g 199 (298)
T cd07841 122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR 199 (298)
T ss_pred CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcC
Confidence 56799999999999999998765433211 123356788999998754 4578899999999999999999
Q ss_pred HHHHHHhhccCC---------------------CcccccccccCC-----ChHHHHHHHHHHhhhhcCCCCCcc-hHHHH
Q 041655 180 VKWMRNVMTSEN---------------------PKRAIDSKLLGN-----GYEEQMLLVLKTACFCTLDDPKER-HVRCM 232 (238)
Q Consensus 180 ~~~~~~~~~~~~---------------------~~~~~~~~~~~~-----~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~ 232 (238)
..||........ ............ ........+.+++.+||+.+|++| .+.+.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~ 279 (298)
T cd07841 200 VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA 279 (298)
T ss_pred CccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHH
Confidence 665532111000 000000000000 112335678889999999999999 55444
Q ss_pred HH
Q 041655 233 LS 234 (238)
Q Consensus 233 L~ 234 (238)
|+
T Consensus 280 l~ 281 (298)
T cd07841 280 LE 281 (298)
T ss_pred hh
Confidence 43
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=202.74 Aligned_cols=151 Identities=23% Similarity=0.325 Sum_probs=125.1
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|++++++++||||+++++++.+++..+++|||+. ++|.+++.. .....+++..+..++.|++.||+|||.+
T Consensus 43 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~ 119 (284)
T cd07860 43 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSH 119 (284)
T ss_pred chHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4578899999999999999999999999999999999995 589888865 2345689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC-CCccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS-ITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~-~~~~~DvwslG~~l~~~~t~ 179 (238)
+.||+++.++.++|+|||.+......... .....++..|+|||...+.. ++.++|+||||+++|+|+||
T Consensus 120 ~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 55699999999999999998755332111 12235678899999876544 58889999999999999999
Q ss_pred HHHHH
Q 041655 180 VKWMR 184 (238)
Q Consensus 180 ~~~~~ 184 (238)
..||.
T Consensus 198 ~~p~~ 202 (284)
T cd07860 198 RALFP 202 (284)
T ss_pred CCCCC
Confidence 87763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=202.90 Aligned_cols=195 Identities=21% Similarity=0.212 Sum_probs=148.4
Q ss_pred HHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+++.+|+.++.++ +|+||+++++.+..++..++++||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH 122 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLH 122 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456778899999999 599999999999999999999999999999999875 346788999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc--CCCccCCeeehhHHHHhh
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL--SITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~--~~~~~~DvwslG~~l~~~ 176 (238)
.+ +.||+++.++.++|+|||++......... ......|+..|+|||.+.+. .++.++|+||||+++|+|
T Consensus 123 ~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~l 201 (290)
T cd05613 123 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201 (290)
T ss_pred hCCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHH
Confidence 55 55799999999999999998765332211 11235678899999988653 467899999999999999
Q ss_pred cchHHHHHHhhccCCCccccccc--ccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSK--LLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++|..|+................ .....+......+.+++.+||+.||++|
T Consensus 202 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R 254 (290)
T cd05613 202 LTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254 (290)
T ss_pred hcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHh
Confidence 99998874211111111111110 0112233345567888899999999999
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=208.55 Aligned_cols=151 Identities=22% Similarity=0.286 Sum_probs=127.7
Q ss_pred hHHHHHHHHHHHHHhcCCC-CC-----cccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQIR-HR-----NILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGI 98 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l 98 (238)
.+....+...|+.+|..|+ |. |+|+++++|.-.++.|+|+|.+. .+|.++++. +....++...++.++.|+
T Consensus 222 ~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~--n~f~Glsl~~ir~~~~Qi 298 (586)
T KOG0667|consen 222 KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKN--NKFRGLSLPLVRKFAQQI 298 (586)
T ss_pred ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHh--cCCCCCCHHHHHHHHHHH
Confidence 3445667778999999997 42 89999999999999999999994 599999987 455668999999999999
Q ss_pred HHHhchhh--------ccCceeeecCCC--ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeee
Q 041655 99 ASGLEYLH--------MHQALVLLDHDM--EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYS 168 (238)
Q Consensus 99 ~~gl~~lH--------~~~~~il~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvws 168 (238)
+.||.+|| .||+|||+.+-+ .+||+|||.|+....... +..-+..|.|||++.+.+|+.+.||||
T Consensus 299 l~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWS 373 (586)
T KOG0667|consen 299 LTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWS 373 (586)
T ss_pred HHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceee
Confidence 99999999 558889987654 599999999987654432 345577899999999999999999999
Q ss_pred hhHHHHhhcchHHHH
Q 041655 169 FGVLLAEEMSLVKWM 183 (238)
Q Consensus 169 lG~~l~~~~t~~~~~ 183 (238)
|||+++||++|.+-|
T Consensus 374 LGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 374 LGCILAELFTGEPLF 388 (586)
T ss_pred hhhhHHhHhcCcccc
Confidence 999999999975444
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=201.61 Aligned_cols=149 Identities=20% Similarity=0.270 Sum_probs=123.4
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.++++++||||+++++++.+++..++||||++ ++|.+++.. ....+++..+..++.|+++||.|||.+
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~~ 123 (291)
T cd07844 48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRR 123 (291)
T ss_pred hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 346789999999999999999999999999999999997 489998865 234688999999999999999999955
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcchH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.++........ .....++..|+|||++.+ ..++.++|+||+|+++|+|++|.
T Consensus 124 i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~ 201 (291)
T cd07844 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201 (291)
T ss_pred eecccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCC
Confidence 55699999999999999998654322111 122346788999998765 45788999999999999999998
Q ss_pred HHHH
Q 041655 181 KWMR 184 (238)
Q Consensus 181 ~~~~ 184 (238)
.||.
T Consensus 202 ~~~~ 205 (291)
T cd07844 202 PLFP 205 (291)
T ss_pred CCCC
Confidence 7774
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=198.68 Aligned_cols=193 Identities=24% Similarity=0.225 Sum_probs=153.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++++++|||++++++.+..++..+++|||+++++|.+++.. ...+++..+..++.|++.||.|+|
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh 110 (250)
T cd05123 35 KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLH 110 (250)
T ss_pred HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999999975 346899999999999999999999
Q ss_pred c--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 M--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
. ++.||+++.++.++++|||.+........ ......++..|++||...+...+.++|+||||+++|++++
T Consensus 111 ~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~ 188 (250)
T cd05123 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT 188 (250)
T ss_pred HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHH
Confidence 4 46789999999999999999876543321 1233567889999999988888899999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||............... ....+...+..+.+++.+||..||++|
T Consensus 189 g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 189 GKPPFYAEDRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred CCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 99887533221111111111 112233335667889999999999999
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=194.49 Aligned_cols=180 Identities=18% Similarity=0.103 Sum_probs=140.6
Q ss_pred HHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc----
Q 041655 33 RSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH---- 108 (238)
Q Consensus 33 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~---- 108 (238)
.+|...+....|||++++++.+.+.+..+++|||+++|+|.+++.. ...+++..+..++.|+++||.|||.+
T Consensus 33 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H 108 (237)
T cd05576 33 SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDALHREGIVC 108 (237)
T ss_pred hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 3455555666799999999999999999999999999999999865 34589999999999999999999954
Q ss_pred ----CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHH
Q 041655 109 ----QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 109 ----~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~ 184 (238)
|.||+++.++.++++|||.+....... ....++..|+|||...+..++.++|+||+|+++|+|++|..|+.
T Consensus 109 ~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 109 RDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred cCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 667999999999999999876543321 22345677999999988888999999999999999999988765
Q ss_pred HhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 185 NVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
....... .......+......+.+++.+||+.||++|
T Consensus 184 ~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 184 CHPSGIN------THTTLNIPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred cCchhcc------cccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence 3221111 001111222344567788888999999999
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=227.81 Aligned_cols=189 Identities=26% Similarity=0.439 Sum_probs=145.9
Q ss_pred HHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc------
Q 041655 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM------ 107 (238)
Q Consensus 34 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~------ 107 (238)
.|+..+++++||||++++|++.+++..++||||+++|+|.+++.. +++..+..++.|+++||+|||.
T Consensus 732 ~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~i 804 (968)
T PLN00113 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAV 804 (968)
T ss_pred HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 458889999999999999999999999999999999999999953 7899999999999999999993
Q ss_pred -----cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHH
Q 041655 108 -----HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKW 182 (238)
Q Consensus 108 -----~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~ 182 (238)
++.||+++.++..++. ||........ ....+++.|+|||++.+..++.++|||||||++|||+||..|
T Consensus 805 iH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred ecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 2456899988887765 5554332111 223678999999999998999999999999999999999988
Q ss_pred HHHhhcc--------------CCCcccccccccC--CChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 183 MRNVMTS--------------ENPKRAIDSKLLG--NGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 183 ~~~~~~~--------------~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+...... .......++.... ....++...+.+++.+||+.||++| ++++.|+++
T Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 7422111 0111112222211 2334566678899999999999999 777777665
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=196.14 Aligned_cols=200 Identities=23% Similarity=0.293 Sum_probs=156.7
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|++++.+++|||++++.+++...+..++++||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH 116 (254)
T cd06627 41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLH 116 (254)
T ss_pred HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999999999999999999999999999999999999875 356899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.++.++|+|||.+......... .....++..|+|||...+...+.++|+||+|+++|++++
T Consensus 117 ~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~ 194 (254)
T cd06627 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT 194 (254)
T ss_pred hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHh
Confidence 55 55799999999999999998866443321 233567889999999887778899999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..|+.............. ......+...+..+.+++.+||+.+|++| ++.+.|
T Consensus 195 g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 195 GNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred CCCCCCCccHHHHHHHHhc-cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence 9887753221111111111 11122233445667888899999999999 554444
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=201.24 Aligned_cols=195 Identities=21% Similarity=0.179 Sum_probs=148.7
Q ss_pred HHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+.+.+|+.++.++ +|||++++.+.+..++..++|+||+++++|.+++.. ...+++..+..++.|+++||.|||
T Consensus 47 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH 122 (288)
T cd05583 47 TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLH 122 (288)
T ss_pred HHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999 599999999999999999999999999999999864 356889999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC--CCccCCeeehhHHHHhh
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS--ITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~--~~~~~DvwslG~~l~~~ 176 (238)
.+ +.||+++.++.++++|||+++........ ......++..|++||...+.. .+.++|+||||+++|+|
T Consensus 123 ~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el 201 (288)
T cd05583 123 QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201 (288)
T ss_pred HCCeeccCCCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHH
Confidence 55 56799999999999999998765333211 122346788999999887654 67899999999999999
Q ss_pred cchHHHHHHhhccCCCcccccc--cccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 177 MSLVKWMRNVMTSENPKRAIDS--KLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++|..||............... ......+......+.+++.+||+.||++|
T Consensus 202 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 254 (288)
T cd05583 202 LTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254 (288)
T ss_pred HhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhc
Confidence 9999887421111110010000 00112223344567888899999999999
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=214.72 Aligned_cols=155 Identities=21% Similarity=0.290 Sum_probs=125.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc-CCCcccCHHHHHHHHHHHHHHhch
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS-RGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
......+.+|+.+|.+++||||+++++++...+..|++++++. ++|.+++.... ..........+..++.|++.||.|
T Consensus 204 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~y 282 (501)
T PHA03210 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEY 282 (501)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHH
Confidence 3455678899999999999999999999999999999999994 57888775311 112233456677899999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||++ +.||+++.++.+||+|||+++.+....... .....|+..|+|||++.+..++.++|||||||++|||
T Consensus 283 LH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 283 IHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred HHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 9955 567999999999999999998664432211 1235789999999999998999999999999999999
Q ss_pred cchHHH
Q 041655 177 MSLVKW 182 (238)
Q Consensus 177 ~t~~~~ 182 (238)
++|..+
T Consensus 362 l~~~~~ 367 (501)
T PHA03210 362 LSHDFC 367 (501)
T ss_pred HHCCCC
Confidence 987543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=199.47 Aligned_cols=196 Identities=20% Similarity=0.237 Sum_probs=143.7
Q ss_pred HHHHHHHHhcCCC-CCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 31 QIRSEIVTLGQIR-HRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 31 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
...+|+..+.++. |||++++++++.++ +..++++||++ ++|.+++.. ....+++..+..++.|++.||.|||.
T Consensus 43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~ 118 (282)
T cd07831 43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR 118 (282)
T ss_pred hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3457899999996 99999999999877 88999999996 588888764 23468999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-ccCCCccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-TLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-~~~~~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++. +.+||+|||.+......... ....++..|+|||... +..++.++|+||+||++|+|++
T Consensus 119 ~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 119 NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred CCceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 5 55699999 99999999998765433221 2245788999999764 4456889999999999999999
Q ss_pred hHHHHHHhhccC----------CCcc----------cccccccC-------CChHHHHHHHHHHhhhhcCCCCCcc-hHH
Q 041655 179 LVKWMRNVMTSE----------NPKR----------AIDSKLLG-------NGYEEQMLLVLKTACFCTLDDPKER-HVR 230 (238)
Q Consensus 179 ~~~~~~~~~~~~----------~~~~----------~~~~~~~~-------~~~~~~~~~l~~~~~~cl~~~p~~R-~v~ 230 (238)
|..||......+ .... ........ ......+..+.+++.+||+.+|++| .+.
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 274 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK 274 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence 987774321100 0000 00000000 0012345778999999999999999 555
Q ss_pred HHHH
Q 041655 231 CMLS 234 (238)
Q Consensus 231 ~~L~ 234 (238)
+.|+
T Consensus 275 ~~l~ 278 (282)
T cd07831 275 QALR 278 (282)
T ss_pred HHhh
Confidence 5443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=199.35 Aligned_cols=149 Identities=21% Similarity=0.279 Sum_probs=123.6
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+|+.++.+++||||+++.+++... +..++++||++ ++|.+++.. ....+++..+..++.|++.||+|||+
T Consensus 49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~ 124 (293)
T cd07843 49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD 124 (293)
T ss_pred hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999998777 88999999996 589998865 23468999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++.++.++|+|||.+........ ......+++.|+|||.+.+. .++.++|+||+|+++|+|++
T Consensus 125 ~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 202 (293)
T cd07843 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202 (293)
T ss_pred CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHh
Confidence 5 5679999999999999999876544321 11234568889999987654 36889999999999999999
Q ss_pred hHHHHH
Q 041655 179 LVKWMR 184 (238)
Q Consensus 179 ~~~~~~ 184 (238)
|..||.
T Consensus 203 g~~~f~ 208 (293)
T cd07843 203 KKPLFP 208 (293)
T ss_pred CCCCCC
Confidence 977663
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=197.90 Aligned_cols=180 Identities=19% Similarity=0.191 Sum_probs=140.7
Q ss_pred CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------Cceeee
Q 041655 43 RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLL 114 (238)
Q Consensus 43 ~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~ 114 (238)
+|||++++++.+..++..++||||+++++|.+++.. ...+++..+..++.|+++||.|||++ +.||++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 142 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY 142 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 699999999999999999999999999999999975 34789999999999999999999955 556999
Q ss_pred cCCC-ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCC-C
Q 041655 115 DHDM-EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSEN-P 192 (238)
Q Consensus 115 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~-~ 192 (238)
+.++ .++++|||.+...... ....++..|+|||++.+..++.++|+||+|+++|+|++|..||........ .
T Consensus 143 ~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 216 (267)
T PHA03390 143 DRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL 216 (267)
T ss_pred eCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH
Confidence 9988 9999999998765332 224678899999999888899999999999999999999988863221110 0
Q ss_pred cccccc-cccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHH
Q 041655 193 KRAIDS-KLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCM 232 (238)
Q Consensus 193 ~~~~~~-~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~ 232 (238)
...... ......+...+..+.+++.+||+.+|.+| ..++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 258 (267)
T PHA03390 217 ESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNE 258 (267)
T ss_pred HHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHH
Confidence 011000 11112233455667888889999999999 44343
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=201.69 Aligned_cols=197 Identities=22% Similarity=0.266 Sum_probs=154.5
Q ss_pred HHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...+.+.+|..++.+++ ||||+++++.+..++..+++||++++++|.+++.. ...+++..+..++.|++.||.||
T Consensus 43 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~L 118 (280)
T cd05581 43 KKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYL 118 (280)
T ss_pred HHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567889999999998 99999999999999999999999999999999976 34699999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccc------------------cccccccCCCcccCcccccccC
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH------------------ITTSDVVGTAGYIAPEYQQTLS 159 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~------------------~~~~~~~~~~~~~apE~~~~~~ 159 (238)
|.+ +.||+++.++.++++|||.+......... .......++..|+|||...+..
T Consensus 119 h~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 198 (280)
T cd05581 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP 198 (280)
T ss_pred HHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC
Confidence 955 45699999999999999998765432211 1223345788999999988888
Q ss_pred CCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hH
Q 041655 160 ITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HV 229 (238)
Q Consensus 160 ~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v 229 (238)
.+.++|+||+|++++++++|..||.............. .....+...+..+.+++..||+.+|.+| ++
T Consensus 199 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 199 AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 89999999999999999999888754322111111111 1112233345667888889999999999 55
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=201.56 Aligned_cols=156 Identities=23% Similarity=0.326 Sum_probs=125.7
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCC-CcccCHHHHHHHHHHHHHHhchh
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRG-RRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+.+.+|+.++.+++||||+++++++.+. +..++|+||+++ +|.+++...... ...+++..++.++.|++.||.||
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 124 (316)
T cd07842 46 SQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124 (316)
T ss_pred cHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999887 789999999964 787777543222 23789999999999999999999
Q ss_pred hcc--------CceeeecC----CCceEEcccccccccCCccc-ccccccccCCCcccCcccccc-cCCCccCCeeehhH
Q 041655 106 HMH--------QALVLLDH----DMEARISEFGLAKVFPEAHT-HITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGV 171 (238)
Q Consensus 106 H~~--------~~~il~~~----~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~ 171 (238)
|++ +.||+++. ++.+|++|||.+........ ........+++.|+|||+..+ ..++.++|+||||+
T Consensus 125 H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 204 (316)
T cd07842 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGC 204 (316)
T ss_pred HhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHH
Confidence 955 55799999 99999999999876543222 112233467888999998765 45788999999999
Q ss_pred HHHhhcchHHHHHH
Q 041655 172 LLAEEMSLVKWMRN 185 (238)
Q Consensus 172 ~l~~~~t~~~~~~~ 185 (238)
++|+|++|..||..
T Consensus 205 ~l~~l~~~~~~~~~ 218 (316)
T cd07842 205 IFAELLTLEPIFKG 218 (316)
T ss_pred HHHHHHhcCCCCcC
Confidence 99999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=189.61 Aligned_cols=195 Identities=19% Similarity=0.250 Sum_probs=154.8
Q ss_pred HHHHHHHHhcCCC-CCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 31 QIRSEIVTLGQIR-HRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 31 ~~~~E~~~l~~l~-h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...+|+++.-+.. |||||+++++|.+ ...+.+|||.++||.|.+.+.+ .+...+++.++..+++||..++.||
T Consensus 100 KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~l 177 (400)
T KOG0604|consen 100 KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYL 177 (400)
T ss_pred HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHH
Confidence 4568999766664 9999999999853 4567899999999999999987 5678899999999999999999999
Q ss_pred h--------ccCceeeecCC---CceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 106 H--------MHQALVLLDHD---MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H--------~~~~~il~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
| .|+.|+|...+ -.+||+|||+++...... ...+.+-||+|.|||++....|+..+|+||+|+++|
T Consensus 178 H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimY 254 (400)
T KOG0604|consen 178 HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 254 (400)
T ss_pred HhcchhhccCChhheeeecCCCCcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHH
Confidence 9 45778887654 458999999998654322 235578899999999999999999999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccc-------cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKL-------LGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
-|+.|.+||++..... +......++ .....++......++|...|.-+|.+| ++-+
T Consensus 255 IlLCGyPPFYS~hg~a-ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~ 318 (400)
T KOG0604|consen 255 ILLCGYPPFYSNHGLA-ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEE 318 (400)
T ss_pred HhhcCCCcccccCCcc-CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHH
Confidence 9999999999866422 222222222 223345667778889999999999999 4433
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=197.88 Aligned_cols=151 Identities=25% Similarity=0.322 Sum_probs=125.0
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++|||++++++.+.+++..++++||++ ++|.+++.. .....+++..+..++.|+++||+|||.+
T Consensus 42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~~L~~lH~~ 118 (283)
T cd07835 42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDS--SPLTGLDPPLIKSYLYQLLQGIAYCHSH 118 (283)
T ss_pred hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhh--CCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3567889999999999999999999999999999999995 689999865 2224689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~ 179 (238)
+.||+++.++.++|+|||.+......... .....++..|+|||++.+. .++.++|+||||+++|+|++|
T Consensus 119 ~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC
Confidence 55699999999999999998755332211 1223567889999987654 468899999999999999999
Q ss_pred HHHHH
Q 041655 180 VKWMR 184 (238)
Q Consensus 180 ~~~~~ 184 (238)
..||.
T Consensus 197 ~~pf~ 201 (283)
T cd07835 197 RPLFP 201 (283)
T ss_pred CCCCC
Confidence 87763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=201.86 Aligned_cols=147 Identities=23% Similarity=0.309 Sum_probs=122.7
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
....+.+|+.++++++||||+++++++... ...|+|+||+. ++|.+.+.. .++...+..++.|++.|
T Consensus 58 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~a 130 (353)
T cd07850 58 HAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCG 130 (353)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHH
Confidence 345677899999999999999999988643 34689999995 588888754 28888999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|+|||.+ +.||+++.++.+||+|||.++....... .....++..|+|||.+.+..++.++|+|||||++
T Consensus 131 L~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 207 (353)
T cd07850 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207 (353)
T ss_pred HHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHH
Confidence 9999955 5679999999999999999976543221 1234678899999999988899999999999999
Q ss_pred HhhcchHHHHH
Q 041655 174 AEEMSLVKWMR 184 (238)
Q Consensus 174 ~~~~t~~~~~~ 184 (238)
|+|++|..||.
T Consensus 208 ~~l~~g~~pf~ 218 (353)
T cd07850 208 GEMIRGTVLFP 218 (353)
T ss_pred HHHHHCCCCCC
Confidence 99999987663
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=197.81 Aligned_cols=197 Identities=17% Similarity=0.209 Sum_probs=146.8
Q ss_pred HHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhh-cCCCcccCHHHHHHHHHHHHHHhch
Q 041655 27 EEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDV-SRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+.+|+.++.++. ||||+++++++..++..+++|||+. +++.++.... ......+++..+..++.|++.||+|
T Consensus 44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 122 (288)
T cd06616 44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 44567889999999996 9999999999999889999999985 4666554321 1123568999999999999999999
Q ss_pred hhcc---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc---CCCccCCeeehhHH
Q 041655 105 LHMH---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL---SITYMCDIYSFGVL 172 (238)
Q Consensus 105 lH~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~---~~~~~~DvwslG~~ 172 (238)
||++ +.||+++.++.++|+|||+++.+..... .....+++.|+|||++.+. .++.++|+||+|++
T Consensus 123 lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i 199 (288)
T cd06616 123 LKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT 199 (288)
T ss_pred HhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence 9853 5569999999999999999875533221 1234678899999998766 58889999999999
Q ss_pred HHhhcchHHHHHHhhcc-CCCccccc---ccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 173 LAEEMSLVKWMRNVMTS-ENPKRAID---SKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|+|++|..||...... ........ .........+.+..+.+++.+||+.+|++|
T Consensus 200 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 258 (288)
T cd06616 200 LYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKR 258 (288)
T ss_pred HHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhC
Confidence 99999999988643210 01111111 111111222345668889999999999999
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=198.96 Aligned_cols=193 Identities=17% Similarity=0.196 Sum_probs=142.3
Q ss_pred HHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
....+.+|+.++.+.. ||||+++++++.+....+++|||++ +++.++... ....+++..+..++.|++.||+|||
T Consensus 56 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH 131 (296)
T cd06618 56 ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLK 131 (296)
T ss_pred HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456677887666665 9999999999999999999999985 578777754 2347899999999999999999999
Q ss_pred cc---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC----CCccCCeeehhHHH
Q 041655 107 MH---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS----ITYMCDIYSFGVLL 173 (238)
Q Consensus 107 ~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~----~~~~~DvwslG~~l 173 (238)
++ +.||++++++.++|+|||.+..+...... ....++..|+|||.+.+.. ++.++|+||||+++
T Consensus 132 ~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 208 (296)
T cd06618 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISL 208 (296)
T ss_pred hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHH
Confidence 63 45699999999999999998765332221 2235678899999886553 78899999999999
Q ss_pred HhhcchHHHHHHhhccCC-Ccccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 174 AEEMSLVKWMRNVMTSEN-PKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|+|++|..||........ ......... ........+..+.+++.+||+.||++|
T Consensus 209 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 264 (296)
T cd06618 209 VELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR 264 (296)
T ss_pred HHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999988754211111 111111111 111111245567888889999999999
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=198.37 Aligned_cols=201 Identities=20% Similarity=0.238 Sum_probs=147.7
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.++++++|||++++++.+...+..++++||+++ +|.+++... .....+++..+..++.|++.||.|||++
T Consensus 42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (284)
T cd07836 42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTH-GVRGALDPNTVKSFTYQLLKGIAFCHEN 119 (284)
T ss_pred hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhc-CCCCCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 35667899999999999999999999999999999999975 898888652 1235689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+.||++++++.++++|||.+........ ......++..|++||.+.+ ..++.++|+||+|+++|++++|
T Consensus 120 ~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g 197 (284)
T cd07836 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197 (284)
T ss_pred CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 5669999999999999999875433211 1123456788999998765 3568899999999999999999
Q ss_pred HHHHHHhhccCCCccc--------------------cccccc-------CCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 180 VKWMRNVMTSENPKRA--------------------IDSKLL-------GNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~--------------------~~~~~~-------~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
..||......+..... ...... .......+..+.+++.+||+.||.+| .+.+
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 198 RPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 8876422111000000 000000 00112234567789999999999999 5544
Q ss_pred HH
Q 041655 232 ML 233 (238)
Q Consensus 232 ~L 233 (238)
.|
T Consensus 278 ~l 279 (284)
T cd07836 278 AL 279 (284)
T ss_pred Hh
Confidence 44
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=203.33 Aligned_cols=209 Identities=22% Similarity=0.309 Sum_probs=170.6
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||+|++-.+.. ++.+++.+|+.+|..+.||.||.+--.|++.+..++|||-+ +|+..+.+.+ .
T Consensus 592 VAvKvIdKlrFp~------------kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILS--s 656 (888)
T KOG4236|consen 592 VAVKVIDKLRFPT------------KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILS--S 656 (888)
T ss_pred eeeeeeecccCCC------------chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHH--h
Confidence 7999998876643 34477889999999999999999999999999999999999 5677777654 2
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCC---CceEEcccccccccCCcccccccccccCCCccc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHD---MEARISEFGLAKVFPEAHTHITTSDVVGTAGYI 150 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 150 (238)
....+++...+.+..||+.+|.|||. ||.|+|+.+. ..+||+|||.++.++.+... .+..|||.|+
T Consensus 657 EkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR---rsVVGTPAYL 733 (888)
T KOG4236|consen 657 EKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR---RSVVGTPAYL 733 (888)
T ss_pred hcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh---hhhcCCcccc
Confidence 34568888889999999999999994 4777888654 46999999999998776643 5579999999
Q ss_pred CcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccc-cc--cccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 151 APEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAI-DS--KLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 151 apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|||++++..|+..-|+||.|+++|--++|..||.. ++++...+ .. -+.++..++.....+++|...|+.+-.+|
T Consensus 734 aPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE---dEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kR 810 (888)
T KOG4236|consen 734 APEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE---DEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKR 810 (888)
T ss_pred CHHHHhhccccccccceeeeEEEEEEecccccCCC---ccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999999864 33333322 22 22556677888888999999999999999
Q ss_pred -hHHH
Q 041655 228 -HVRC 231 (238)
Q Consensus 228 -~v~~ 231 (238)
.|-+
T Consensus 811 ysvdk 815 (888)
T KOG4236|consen 811 YSVDK 815 (888)
T ss_pred cchHh
Confidence 4433
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=214.13 Aligned_cols=209 Identities=21% Similarity=0.251 Sum_probs=174.0
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
+||||++..... .+.-.+++.|.-.|.+++|||+++++|++.... +-+|++|+|.|+|.+|...
T Consensus 727 pVaiKvl~~~t~-------------~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~-- 790 (1177)
T KOG1025|consen 727 PVAIKVLIEFTS-------------PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE-- 790 (1177)
T ss_pred eeEEEEeeccCC-------------chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH--
Confidence 578887754433 234577899999999999999999999998776 6799999999999999986
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
.+..+-.+..+.|+.||++||.|||.+ ..|+|+..-.++|+.|||+++.+.............-.+.|+|-
T Consensus 791 -hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmal 869 (1177)
T KOG1025|consen 791 -HRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMAL 869 (1177)
T ss_pred -hhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHH
Confidence 456788888999999999999999954 45699999999999999999988766554444445567889999
Q ss_pred ccccccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 153 EYQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 153 E~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|.++...|+.++|||||||++||++| |..|++.... ..+.+.+..+.+...|..+..++..++.+||..|++.|
T Consensus 870 e~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~r 944 (1177)
T KOG1025|consen 870 ESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSR 944 (1177)
T ss_pred HHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccC
Confidence 99999999999999999999999999 4777765443 34445666666677788889999999999999999999
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=201.40 Aligned_cols=201 Identities=22% Similarity=0.282 Sum_probs=147.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+.+|+.++++++||||+++++++.. ....++++||+. ++|.+++.. ...+++..+..++.|++.||.
T Consensus 47 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~ 121 (334)
T cd07855 47 LAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLK 121 (334)
T ss_pred chHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHH
Confidence 34667789999999999999999998753 346799999995 689888864 355899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCcccccc-cCCCccCCeeehhHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVL 172 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~ 172 (238)
|||.+ +.||+++.++.+||+|||.+......... .......++..|+|||.+.+ ..++.++|+||||++
T Consensus 122 ~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~ 201 (334)
T cd07855 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201 (334)
T ss_pred HHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHH
Confidence 99955 55799999999999999998765332211 11133568889999998765 457889999999999
Q ss_pred HHhhcchHHHHHHhhcc----------CCC-------------cccccc-cccCCC-----hHHHHHHHHHHhhhhcCCC
Q 041655 173 LAEEMSLVKWMRNVMTS----------ENP-------------KRAIDS-KLLGNG-----YEEQMLLVLKTACFCTLDD 223 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~----------~~~-------------~~~~~~-~~~~~~-----~~~~~~~l~~~~~~cl~~~ 223 (238)
+|+|++|..||...... +.. ...... ...... ....+.++.+++.+||+.+
T Consensus 202 l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 281 (334)
T cd07855 202 FAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD 281 (334)
T ss_pred HHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCC
Confidence 99999999887432110 000 000000 000001 1234567889999999999
Q ss_pred CCcc-hHHHHH
Q 041655 224 PKER-HVRCML 233 (238)
Q Consensus 224 p~~R-~v~~~L 233 (238)
|++| ++.+.|
T Consensus 282 P~~Rpt~~~~l 292 (334)
T cd07855 282 PEERITVEQAL 292 (334)
T ss_pred hhhCcCHHHHH
Confidence 9999 554444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=196.35 Aligned_cols=151 Identities=23% Similarity=0.343 Sum_probs=120.5
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCC--------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPG--------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
..+.+|+.++++++||||+++++++...+ ..++++||+. ++|.+++.. ....+++..+..++.|+++|
T Consensus 56 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~a 131 (310)
T cd07865 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNG 131 (310)
T ss_pred hHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHH
Confidence 34568999999999999999999886543 4599999995 588888764 23468999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCcccccccC-CCccCCeeehh
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQTLS-ITYMCDIYSFG 170 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~~~-~~~~~DvwslG 170 (238)
|+|||.+ +.||+++.++.++|+|||.+......... .......++..|+|||.+.+.. ++.++|+||||
T Consensus 132 l~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 211 (310)
T cd07865 132 LYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211 (310)
T ss_pred HHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence 9999965 45699999999999999998765332211 1112345678899999876543 68899999999
Q ss_pred HHHHhhcchHHHHH
Q 041655 171 VLLAEEMSLVKWMR 184 (238)
Q Consensus 171 ~~l~~~~t~~~~~~ 184 (238)
+++|+|++|..||.
T Consensus 212 ~~l~el~t~~~~~~ 225 (310)
T cd07865 212 CIMAEMWTRSPIMQ 225 (310)
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999877663
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=198.60 Aligned_cols=152 Identities=24% Similarity=0.278 Sum_probs=122.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++|||++++++++...+..++|+||++ ++|.+++.. .....+++..+..++.|++.||+|||.
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH~ 120 (294)
T PLN00009 44 VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCHS 120 (294)
T ss_pred chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence 34668899999999999999999999999999999999995 588888754 233446888888999999999999995
Q ss_pred c--------CceeeecC-CCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhc
Q 041655 108 H--------QALVLLDH-DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 ~--------~~~il~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~ 177 (238)
+ +.||+++. ++.+|++|||.+........ ......+++.|+|||.+.+ ..++.++|+||+|+++|+|+
T Consensus 121 ~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~ 198 (294)
T PLN00009 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198 (294)
T ss_pred CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 5 66799985 45799999999875433211 1123456789999998765 45788999999999999999
Q ss_pred chHHHHH
Q 041655 178 SLVKWMR 184 (238)
Q Consensus 178 t~~~~~~ 184 (238)
||..||.
T Consensus 199 tg~~pf~ 205 (294)
T PLN00009 199 NQKPLFP 205 (294)
T ss_pred hCCCCCC
Confidence 9988774
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=194.67 Aligned_cols=149 Identities=20% Similarity=0.221 Sum_probs=122.4
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.+++.++|+||+++++++..++..++++||+. +++.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~ 123 (291)
T cd07870 48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH 123 (291)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 356789999999999999999999999999999999995 688777654 234577888889999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcchH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.++........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.
T Consensus 124 i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 201 (291)
T cd07870 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201 (291)
T ss_pred cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 66799999999999999998754322211 1234568899999988653 4788999999999999999998
Q ss_pred HHHH
Q 041655 181 KWMR 184 (238)
Q Consensus 181 ~~~~ 184 (238)
.||.
T Consensus 202 ~~f~ 205 (291)
T cd07870 202 PAFP 205 (291)
T ss_pred CCCC
Confidence 8774
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=210.68 Aligned_cols=143 Identities=17% Similarity=0.229 Sum_probs=114.6
Q ss_pred HHHHHHHhcCC------CCCcccceeeeeecC-CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 32 IRSEIVTLGQI------RHRNILPLLAHLARP-GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 32 ~~~E~~~l~~l------~h~~iv~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
+..|+.+++.+ +|.+++++.+++... +..++|||++ +++|.+++.. ...+++..+..++.|++.||.|
T Consensus 172 ~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~y 246 (467)
T PTZ00284 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDY 246 (467)
T ss_pred HHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Confidence 34455555554 455688888888654 5788999988 7789998865 3568999999999999999999
Q ss_pred hhcc---------CceeeecCCC----------------ceEEcccccccccCCcccccccccccCCCcccCcccccccC
Q 041655 105 LHMH---------QALVLLDHDM----------------EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS 159 (238)
Q Consensus 105 lH~~---------~~~il~~~~~----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~ 159 (238)
||.+ +.||+++.++ .+||+|||.+...... .....||+.|+|||++.+..
T Consensus 247 LH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~ 321 (467)
T PTZ00284 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLG 321 (467)
T ss_pred HHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCC
Confidence 9953 5679998765 4999999987542211 23467899999999999999
Q ss_pred CCccCCeeehhHHHHhhcchHHHHH
Q 041655 160 ITYMCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 160 ~~~~~DvwslG~~l~~~~t~~~~~~ 184 (238)
++.++|||||||++|||++|..||.
T Consensus 322 ~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 322 WMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999998884
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=199.09 Aligned_cols=200 Identities=22% Similarity=0.282 Sum_probs=145.2
Q ss_pred HHHHHHHHHHHhcCC-CCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 28 EMMQIRSEIVTLGQI-RHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
....+.+|+.++.++ +||||+++++++... ...++|+||++ ++|..++.. ..+++..+..++.|++.||.|
T Consensus 49 ~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~ 122 (337)
T cd07852 49 DAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKY 122 (337)
T ss_pred hhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHH
Confidence 345677899999999 999999999998643 36799999996 599988864 267888899999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccc---cccccccCCCcccCcccccc-cCCCccCCeeehhHH
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH---ITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVL 172 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~ 172 (238)
||.+ +.||+++.++.+||+|||.+......... .......++..|+|||.+.+ ..++.++|+||||++
T Consensus 123 LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~ 202 (337)
T cd07852 123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI 202 (337)
T ss_pred HHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHH
Confidence 9965 55799999999999999998765432211 12233567889999997754 457889999999999
Q ss_pred HHhhcchHHHHHHhhccCCCc-----------------------ccc---c-ccc--cCCChHHHHHHHHHHhhhhcCCC
Q 041655 173 LAEEMSLVKWMRNVMTSENPK-----------------------RAI---D-SKL--LGNGYEEQMLLVLKTACFCTLDD 223 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~~-----------------------~~~---~-~~~--~~~~~~~~~~~l~~~~~~cl~~~ 223 (238)
+|+|++|..||.......... ... . ... ......+.+..+.+++.+||+.|
T Consensus 203 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 282 (337)
T cd07852 203 LGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFN 282 (337)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCC
Confidence 999999987763211000000 000 0 000 00111123566888999999999
Q ss_pred CCcc-hHHHHH
Q 041655 224 PKER-HVRCML 233 (238)
Q Consensus 224 p~~R-~v~~~L 233 (238)
|.+| .+.+.|
T Consensus 283 P~~Rps~~~il 293 (337)
T cd07852 283 PNKRLTAEEAL 293 (337)
T ss_pred cccccCHHHHh
Confidence 9999 544444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=194.51 Aligned_cols=203 Identities=18% Similarity=0.203 Sum_probs=154.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
...++.+|+.++++++|||++++++.+.+.+..++++||+++++|.+++.........+++..+..++.|++.||.|||.
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999999989999999999999999886533345678999999999999999999996
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.|++++. +.++++|||.+........ ......+++.|+|||...+..++.++|+||||+++|++++|
T Consensus 125 ~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~ 201 (260)
T cd08222 125 RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCL 201 (260)
T ss_pred cCccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 5 45688865 5699999999876533221 12335678899999998888888999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
..||............ .....+..+...+.++.+++.+||+.||++| .+.+.|+
T Consensus 202 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 202 AHAFEGQNFLSVVLRI-VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCccHHHHHHHH-HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 8877432111111111 1111222334555678889999999999999 5555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-30 Score=208.88 Aligned_cols=208 Identities=21% Similarity=0.189 Sum_probs=178.5
Q ss_pred ChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHH
Q 041655 13 DATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92 (238)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 92 (238)
-+.++.++......++.+++..|-.+|...++|+||++|..|.++...|+.||-|-||.|...+.. +..|.....+
T Consensus 448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tar 523 (732)
T KOG0614|consen 448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD----RGSFDDYTAR 523 (732)
T ss_pred HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh----cCCcccchhh
Confidence 345666777777888999999999999999999999999999999999999999999999999976 5678888999
Q ss_pred HHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.-+++|++|||++ |.|.+++.+|-+||.|||.++.+..... +.+++|||.|.|||++.+...+..+
T Consensus 524 F~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~av 600 (732)
T KOG0614|consen 524 FYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAV 600 (732)
T ss_pred hhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhh
Confidence 9999999999999966 6679999999999999999998755443 4679999999999999999999999
Q ss_pred CeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|.||||+++||+++|.+||.........+.++..--....|......-.+++++....+|.+|
T Consensus 601 DyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ER 663 (732)
T KOG0614|consen 601 DYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTER 663 (732)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhh
Confidence 999999999999999999976554444444444433445666777777888888999999999
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=196.94 Aligned_cols=200 Identities=24% Similarity=0.284 Sum_probs=150.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++++++|+|++++++.+..++..++++||+++ +|.+++.. ....+++..+..++.|++.||.|||.
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~ 116 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHS 116 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788899999999999999999999999999999999965 88888765 23578999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++.++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++|++++
T Consensus 117 ~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~t 194 (283)
T cd05118 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194 (283)
T ss_pred CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence 5 5579999999999999999876644321 11234577889999988766 67889999999999999999
Q ss_pred hHHHHHHhhccCCC---------------ccccc---------ccc----cCCChHHHHHHHHHHhhhhcCCCCCcc-hH
Q 041655 179 LVKWMRNVMTSENP---------------KRAID---------SKL----LGNGYEEQMLLVLKTACFCTLDDPKER-HV 229 (238)
Q Consensus 179 ~~~~~~~~~~~~~~---------------~~~~~---------~~~----~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v 229 (238)
|..||......... ..... ... ......+.+.++.+++..||+.||.+| .+
T Consensus 195 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 274 (283)
T cd05118 195 RRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA 274 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH
Confidence 98766321110000 00000 000 001122345678899999999999999 44
Q ss_pred HHHH
Q 041655 230 RCML 233 (238)
Q Consensus 230 ~~~L 233 (238)
.+.|
T Consensus 275 ~~ll 278 (283)
T cd05118 275 EQAL 278 (283)
T ss_pred HHHh
Confidence 4443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=194.17 Aligned_cols=198 Identities=24% Similarity=0.269 Sum_probs=145.1
Q ss_pred HHHHHHHHHhcCC---CCCcccceeeeeecCCe-----eEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 30 MQIRSEIVTLGQI---RHRNILPLLAHLARPGC-----HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 30 ~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~-----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
..+.+|+.++.++ +|||++++++.+...+. .++++||++ ++|.+++.. .....+++..+..++.|++.|
T Consensus 43 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~--~~~~~l~~~~~~~~~~~i~~a 119 (287)
T cd07838 43 LSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSK--CPKPGLPPETIKDLMRQLLRG 119 (287)
T ss_pred hhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHH--ccCCCCCHHHHHHHHHHHHHH
Confidence 4456677766555 69999999999987776 899999996 489888865 223458999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|.|||.+ +.||+++.++.++|+|||.+..+..... .....++..|+|||.+.+..++.++|+||||+++
T Consensus 120 l~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred HHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 9999955 5679999999999999999876643321 1223568889999999888899999999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccc----------------------ccccc---CCChHHHHHHHHHHhhhhcCCCCCcc-
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAI----------------------DSKLL---GNGYEEQMLLVLKTACFCTLDDPKER- 227 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~----------------------~~~~~---~~~~~~~~~~l~~~~~~cl~~~p~~R- 227 (238)
|+|++|..||............. ..... ..........+.+++..||+.||.+|
T Consensus 197 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 197 AELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred HHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 99999987765322111000000 00000 01112334667889999999999999
Q ss_pred hHHHHH
Q 041655 228 HVRCML 233 (238)
Q Consensus 228 ~v~~~L 233 (238)
.+.+.|
T Consensus 277 ~~~~il 282 (287)
T cd07838 277 SAFEAL 282 (287)
T ss_pred CHHHHh
Confidence 544444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=194.79 Aligned_cols=152 Identities=24% Similarity=0.352 Sum_probs=125.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+|+.++++++|||++++++++... +..++++||+++ +|.+++.. ....+++..+..++.|+++||+||
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~L 116 (287)
T cd07840 41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYL 116 (287)
T ss_pred chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999999887 789999999964 89888865 235789999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~ 176 (238)
|.+ +.||++++++.++++|||.+......... ......++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus 117 H~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el 195 (287)
T cd07840 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAEL 195 (287)
T ss_pred HHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHH
Confidence 955 55799999999999999998765443211 1123456788999997654 4578899999999999999
Q ss_pred cchHHHHH
Q 041655 177 MSLVKWMR 184 (238)
Q Consensus 177 ~t~~~~~~ 184 (238)
++|..||.
T Consensus 196 ~t~~~p~~ 203 (287)
T cd07840 196 FLGKPIFQ 203 (287)
T ss_pred HhCCCCCC
Confidence 99988774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=201.68 Aligned_cols=198 Identities=20% Similarity=0.237 Sum_probs=145.8
Q ss_pred HHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--
Q 041655 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH-- 108 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~-- 108 (238)
.+.+|+.++.+++||||+++++++...+..+++|||++ ++|.+++.. ...+++.....++.|++.||+|||.+
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~i 140 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWYF 140 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 57789999999999999999999999999999999996 689998865 45689999999999999999999966
Q ss_pred ------CceeeecCCCceEEcccccccccCCcc------------cccccccccCCCcccCccccccc-CCCccCCeeeh
Q 041655 109 ------QALVLLDHDMEARISEFGLAKVFPEAH------------THITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSF 169 (238)
Q Consensus 109 ------~~~il~~~~~~~kl~dfg~~~~~~~~~------------~~~~~~~~~~~~~~~apE~~~~~-~~~~~~Dvwsl 169 (238)
+.||+++.++.++|+|||.+....... .........+++.|+|||.+.+. .++.++|+||+
T Consensus 141 ~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 220 (335)
T PTZ00024 141 MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220 (335)
T ss_pred ecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHH
Confidence 456999999999999999987654111 00111223467889999987654 46889999999
Q ss_pred hHHHHhhcchHHHHHHhhccCCCcccc-----------------------cccc---cCCChHHHHHHHHHHhhhhcCCC
Q 041655 170 GVLLAEEMSLVKWMRNVMTSENPKRAI-----------------------DSKL---LGNGYEEQMLLVLKTACFCTLDD 223 (238)
Q Consensus 170 G~~l~~~~t~~~~~~~~~~~~~~~~~~-----------------------~~~~---~~~~~~~~~~~l~~~~~~cl~~~ 223 (238)
|+++|+|++|..||...........+. .... ...........+.+++.+||+.+
T Consensus 221 G~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 300 (335)
T PTZ00024 221 GCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLN 300 (335)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCC
Confidence 999999999987764221100000000 0000 00011223456788999999999
Q ss_pred CCcc-hHHHHH
Q 041655 224 PKER-HVRCML 233 (238)
Q Consensus 224 p~~R-~v~~~L 233 (238)
|++| .+.+.|
T Consensus 301 P~~R~s~~~~l 311 (335)
T PTZ00024 301 PLERISAKEAL 311 (335)
T ss_pred chhccCHHHHh
Confidence 9999 554444
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=194.83 Aligned_cols=204 Identities=21% Similarity=0.231 Sum_probs=157.6
Q ss_pred hhhHHHHHHHHHHHHHhcCCC-C-C----cccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHH
Q 041655 23 KLLTEEMMQIRSEIVTLGQIR-H-R----NILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVR 96 (238)
Q Consensus 23 ~~~~~~~~~~~~E~~~l~~l~-h-~----~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ 96 (238)
+..++.+++..-|+++|.++. + | -++.+.++|.-+++.|+|+|.+ |.++.+|+.+ ++..+++...++.++.
T Consensus 123 k~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~ 199 (415)
T KOG0671|consen 123 KNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGY 199 (415)
T ss_pred HHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHH
Confidence 456677888889999999994 2 3 3788889999999999999999 7799999976 6678899999999999
Q ss_pred HHHHHhchhh--------ccCceeeecC--------------------CCceEEcccccccccCCcccccccccccCCCc
Q 041655 97 GIASGLEYLH--------MHQALVLLDH--------------------DMEARISEFGLAKVFPEAHTHITTSDVVGTAG 148 (238)
Q Consensus 97 ~l~~gl~~lH--------~~~~~il~~~--------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 148 (238)
|+++++++|| .||.||++.+ +..++++|||.+....... +....|..
T Consensus 200 QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRH 274 (415)
T KOG0671|consen 200 QLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRH 274 (415)
T ss_pred HHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccc
Confidence 9999999999 4578876543 2348999999998754433 45788999
Q ss_pred ccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCC-----------Ccccccc-------------------
Q 041655 149 YIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSEN-----------PKRAIDS------------------- 198 (238)
Q Consensus 149 ~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~-----------~~~~~~~------------------- 198 (238)
|.|||++.+..++.++||||+||+|+|++||...|+...+.+. +...+..
T Consensus 275 YRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~ 354 (415)
T KOG0671|consen 275 YRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSS 354 (415)
T ss_pred cCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccc
Confidence 9999999999999999999999999999998877755432210 0000000
Q ss_pred ---------cccC-----CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 199 ---------KLLG-----NGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 199 ---------~~~~-----~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
...+ ...+.+...|.+++.++|..||.+| +..++|+
T Consensus 355 ~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 355 KGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred cccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 0000 1234667779999999999999999 6666654
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=200.07 Aligned_cols=202 Identities=24% Similarity=0.269 Sum_probs=150.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCC-----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPG-----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
...+.+.+|+.+++.++||||+++.+++...+ ..|++|||++ ++|.+++.. ...+++..+..++.|++.|
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~ 115 (330)
T cd07834 41 IDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRG 115 (330)
T ss_pred hhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHH
Confidence 34567889999999999999999999987765 7899999996 588888865 3478999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCccc-ccccccccCCCcccCccccccc-CCCccCCeeehhH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHT-HITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGV 171 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~ 171 (238)
|+|||++ +.||+++.++.++|+|||.+........ ........++..|+|||.+.+. .++.++|+||+|+
T Consensus 116 l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~ 195 (330)
T cd07834 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGC 195 (330)
T ss_pred HHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHH
Confidence 9999955 5569999999999999999886644321 0112335678899999998877 7899999999999
Q ss_pred HHHhhcchHHHHHHhhccC-----------------------CCcccccc-cccC-----CChHHHHHHHHHHhhhhcCC
Q 041655 172 LLAEEMSLVKWMRNVMTSE-----------------------NPKRAIDS-KLLG-----NGYEEQMLLVLKTACFCTLD 222 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~-----------------------~~~~~~~~-~~~~-----~~~~~~~~~l~~~~~~cl~~ 222 (238)
++|+|++|..||....... .....+.. .... ......+..+.+++..||+.
T Consensus 196 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 275 (330)
T cd07834 196 IFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVF 275 (330)
T ss_pred HHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccC
Confidence 9999999988874321100 00000000 0000 01122355678899999999
Q ss_pred CCCcc-hHHHHH
Q 041655 223 DPKER-HVRCML 233 (238)
Q Consensus 223 ~p~~R-~v~~~L 233 (238)
+|++| .+.+.|
T Consensus 276 ~P~~Rpt~~~ll 287 (330)
T cd07834 276 DPKKRITADEAL 287 (330)
T ss_pred ChhhCCCHHHHH
Confidence 99999 444443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=198.13 Aligned_cols=148 Identities=25% Similarity=0.315 Sum_probs=121.4
Q ss_pred HHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 31 QIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+|+.++.+++|+|++++++++... +..++|+||+. ++|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~ 127 (309)
T cd07845 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHEN 127 (309)
T ss_pred hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 456799999999999999999998654 56899999996 589888865 235689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+.||+++.++.++|+|||.+......... .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|
T Consensus 128 ~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 205 (309)
T cd07845 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205 (309)
T ss_pred CeecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhC
Confidence 55799999999999999998765432211 122345778999998765 4578899999999999999999
Q ss_pred HHHHH
Q 041655 180 VKWMR 184 (238)
Q Consensus 180 ~~~~~ 184 (238)
..||.
T Consensus 206 ~~~f~ 210 (309)
T cd07845 206 KPLLP 210 (309)
T ss_pred CCCCC
Confidence 87764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=196.68 Aligned_cols=202 Identities=19% Similarity=0.185 Sum_probs=144.9
Q ss_pred HHHHHHHHHHhcCCC-CCcccceeeeeecCCe-----eEEEEEeCCCCCHHHHHhhhcCC-CcccCHHHHHHHHHHHHHH
Q 041655 29 MMQIRSEIVTLGQIR-HRNILPLLAHLARPGC-----HLLVYEFMKNGSLQDILNDVSRG-RRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~-----~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~g 101 (238)
...+.+|+.++.+++ |||++++++++...+. .|++|||+++ +|.+++...... ...+++..+..++.|++.|
T Consensus 44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~ 122 (295)
T cd07837 44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122 (295)
T ss_pred chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence 356788999999996 6999999999876655 7999999975 898888653222 3568999999999999999
Q ss_pred hchhhcc--------CceeeecC-CCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhH
Q 041655 102 LEYLHMH--------QALVLLDH-DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGV 171 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~ 171 (238)
|.|||.+ +.||+++. ++.++|+|||.+..+..... ......+++.|+|||.+.+ ..++.++|+||||+
T Consensus 123 L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 200 (295)
T cd07837 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200 (295)
T ss_pred HHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence 9999955 55699998 88999999999875432211 1122356788999998754 45688999999999
Q ss_pred HHHhhcchHHHHHHhhccCCC----------ccccc------------ccccC----CChHHHHHHHHHHhhhhcCCCCC
Q 041655 172 LLAEEMSLVKWMRNVMTSENP----------KRAID------------SKLLG----NGYEEQMLLVLKTACFCTLDDPK 225 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~~~----------~~~~~------------~~~~~----~~~~~~~~~l~~~~~~cl~~~p~ 225 (238)
++|+|++|..||......... ..... ..... .........+.+++.+||+.||.
T Consensus 201 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 999999998777432110000 00000 00000 00122455678899999999999
Q ss_pred cc-hHHHHH
Q 041655 226 ER-HVRCML 233 (238)
Q Consensus 226 ~R-~v~~~L 233 (238)
+| .+-+.|
T Consensus 281 ~R~~~~eil 289 (295)
T cd07837 281 KRISAKAAL 289 (295)
T ss_pred hcCCHHHHh
Confidence 99 554444
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=201.39 Aligned_cols=198 Identities=23% Similarity=0.295 Sum_probs=145.2
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecC-----CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARP-----GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
...+.+|+.+++.++||||+++++++... ...++++||+. ++|.+++.. ...+++..+..++.|++.||.
T Consensus 48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~ 122 (337)
T cd07858 48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLK 122 (337)
T ss_pred hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHH
Confidence 45667899999999999999999988644 34799999995 689888865 356899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLA 174 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~ 174 (238)
|||++ +.||+++.++.+||+|||++........ ......++..|+|||.+.+ ..++.++|+||||+++|
T Consensus 123 ~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (337)
T cd07858 123 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200 (337)
T ss_pred HHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHH
Confidence 99955 5579999999999999999876543221 1233467889999998754 45889999999999999
Q ss_pred hhcchHHHHHHhhcc-----------------------CCCccccc---cccc---CCChHHHHHHHHHHhhhhcCCCCC
Q 041655 175 EEMSLVKWMRNVMTS-----------------------ENPKRAID---SKLL---GNGYEEQMLLVLKTACFCTLDDPK 225 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~-----------------------~~~~~~~~---~~~~---~~~~~~~~~~l~~~~~~cl~~~p~ 225 (238)
+|++|..||...... ........ .... .......+.++.+++.+||+.+|+
T Consensus 201 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 280 (337)
T cd07858 201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPS 280 (337)
T ss_pred HHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChh
Confidence 999998877321100 00000000 0000 001123456678999999999999
Q ss_pred cc-hHHHHH
Q 041655 226 ER-HVRCML 233 (238)
Q Consensus 226 ~R-~v~~~L 233 (238)
+| .+.+.|
T Consensus 281 ~Rps~~ell 289 (337)
T cd07858 281 KRITVEEAL 289 (337)
T ss_pred hccCHHHHH
Confidence 99 444444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=191.21 Aligned_cols=147 Identities=25% Similarity=0.368 Sum_probs=123.3
Q ss_pred HHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 31 QIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 31 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
...+|+..+.+++ |||++++++.+..++..++||||+ +|+|.+++... ....+++..+..++.|++++|.|||++
T Consensus 43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~ 119 (283)
T cd07830 43 MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG 119 (283)
T ss_pred HHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3457999999999 999999999999999999999999 77999988651 234689999999999999999999955
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-ccCCCccCCeeehhHHHHhhcchH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-TLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.+........ .....++..|+|||++. +..++.++|+||||+++++|++|.
T Consensus 120 i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~ 196 (283)
T cd07830 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196 (283)
T ss_pred cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC
Confidence 5679999999999999999876543221 12345788999999774 445788999999999999999998
Q ss_pred HHH
Q 041655 181 KWM 183 (238)
Q Consensus 181 ~~~ 183 (238)
.||
T Consensus 197 ~~~ 199 (283)
T cd07830 197 PLF 199 (283)
T ss_pred Ccc
Confidence 766
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=191.96 Aligned_cols=196 Identities=26% Similarity=0.330 Sum_probs=148.0
Q ss_pred HHHHHHHHHHHHhcCC--CCCcccceeeeeecCC----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQI--RHRNILPLLAHLARPG----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
.....|.+|-++++-. .|+||+++++.-.... .+++|++|.+.|+|.+|+.. ..++|....+++..+++
T Consensus 244 ~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~Smar 318 (534)
T KOG3653|consen 244 QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMAR 318 (534)
T ss_pred HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHH
Confidence 3456788888876655 6999999999876655 78999999999999999985 67899999999999999
Q ss_pred Hhchhh-----------------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC----
Q 041655 101 GLEYLH-----------------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS---- 159 (238)
Q Consensus 101 gl~~lH-----------------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~---- 159 (238)
||+||| .|..|||+.+++++-|+|||+|..+.............||.+|||||++-+..
T Consensus 319 GLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d 398 (534)
T KOG3653|consen 319 GLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD 398 (534)
T ss_pred HHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc
Confidence 999999 23457999999999999999998876554444445589999999999986532
Q ss_pred -CC-ccCCeeehhHHHHhhcchHH------------HHHHhhccCC----Ccc-cccccccCCChH-----HHHHHHHHH
Q 041655 160 -IT-YMCDIYSFGVLLAEEMSLVK------------WMRNVMTSEN----PKR-AIDSKLLGNGYE-----EQMLLVLKT 215 (238)
Q Consensus 160 -~~-~~~DvwslG~~l~~~~t~~~------------~~~~~~~~~~----~~~-~~~~~~~~~~~~-----~~~~~l~~~ 215 (238)
-+ .+.||||+|.++|||++... ||........ .+. ++.++.++..++ ..+.-+.+.
T Consensus 399 ~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et 478 (534)
T KOG3653|consen 399 RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCET 478 (534)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHH
Confidence 12 25899999999999987432 3332222221 111 223333443332 335567788
Q ss_pred hhhhcCCCCCcc
Q 041655 216 ACFCTLDDPKER 227 (238)
Q Consensus 216 ~~~cl~~~p~~R 227 (238)
+..||+.||+-|
T Consensus 479 ~EeCWDhDaeAR 490 (534)
T KOG3653|consen 479 IEECWDHDAEAR 490 (534)
T ss_pred HHHHcCCchhhh
Confidence 888999999999
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=190.75 Aligned_cols=203 Identities=18% Similarity=0.211 Sum_probs=153.4
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCcccceeeeee-cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLA-RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 23 ~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
....+..+...+|-++.+.|+||.||++|++|. +.+.+|-|+|||+|.+|.-|++. ...+++++++.|+.|++.+
T Consensus 505 EKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnA 580 (775)
T KOG1151|consen 505 EKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNA 580 (775)
T ss_pred HhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHH
Confidence 444556777889999999999999999999995 56778999999999999988986 6789999999999999999
Q ss_pred hchhh----------ccCceeeecCC---CceEEcccccccccCCcccc-----cccccccCCCcccCccccc----ccC
Q 041655 102 LEYLH----------MHQALVLLDHD---MEARISEFGLAKVFPEAHTH-----ITTSDVVGTAGYIAPEYQQ----TLS 159 (238)
Q Consensus 102 l~~lH----------~~~~~il~~~~---~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~apE~~~----~~~ 159 (238)
|.||. .||.|||+.+. |.+||.|||+++.+++.... ..++...||..|++||.+. ...
T Consensus 581 L~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPK 660 (775)
T KOG1151|consen 581 LKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPK 660 (775)
T ss_pred HHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCc
Confidence 99997 44677877543 67999999999988654332 2345578999999999543 234
Q ss_pred CCccCCeeehhHHHHhhcchHHHHHHhhccC------CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 160 ITYMCDIYSFGVLLAEEMSLVKWMRNVMTSE------NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 160 ~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
++.++||||+|+++|..+.|..||-...... .+.+.....+++.. ........+|.+||+..-++| +|.+
T Consensus 661 IsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KP--vVsseAkaFIRRCLaYRKeDR~DV~q 737 (775)
T KOG1151|consen 661 ISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKP--VVSSEAKAFIRRCLAYRKEDRIDVQQ 737 (775)
T ss_pred cccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCC--ccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence 7889999999999999999999995433222 22222222222221 112224567777999999999 6554
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-29 Score=199.98 Aligned_cols=203 Identities=20% Similarity=0.201 Sum_probs=163.1
Q ss_pred HHHhhhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHH
Q 041655 17 LVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTV 95 (238)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 95 (238)
|.+++.....+..+--+.|-++|.-.. -|++++++.+|++-+++|+||||+.||+|.-.+.+ -..+.+..+..++
T Consensus 381 iLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYA 456 (683)
T KOG0696|consen 381 ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYA 456 (683)
T ss_pred hhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHH----hcccCCchhhhhh
Confidence 333343444444555566777777664 68999999999999999999999999999887765 4567788888999
Q ss_pred HHHHHHhchhhccCc--------eeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCee
Q 041655 96 RGIASGLEYLHMHQA--------LVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIY 167 (238)
Q Consensus 96 ~~l~~gl~~lH~~~~--------~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvw 167 (238)
..|+-||-+||++++ |++++.+|++||.|||+++.- ......+.+++|||-|+|||++...+|+..+|+|
T Consensus 457 aEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn--i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWW 534 (683)
T KOG0696|consen 457 AEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN--IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 534 (683)
T ss_pred HHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc--ccCCcceeeecCCCcccccceEEecccccchhHH
Confidence 999999999998876 499999999999999998632 1112234678999999999999999999999999
Q ss_pred ehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 168 SFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 168 slG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|+|++||||+.|.+||+...+++....+.+... .+|.....+..++++..+.+.|.+|
T Consensus 535 a~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kR 592 (683)
T KOG0696|consen 535 AFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKR 592 (683)
T ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--cCcccccHHHHHHHHHHhhcCCccc
Confidence 999999999999999998777766666666554 3344445556778888999999999
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=195.02 Aligned_cols=150 Identities=24% Similarity=0.371 Sum_probs=121.6
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCC----------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHH
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPG----------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIA 99 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~ 99 (238)
..+.+|+.++..++|||++++++++.+.+ ..++++||+++ ++.+++.. ....+++..+..++.|++
T Consensus 51 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~ 126 (302)
T cd07864 51 ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLL 126 (302)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHH
Confidence 45678999999999999999999987654 78999999975 78777764 234689999999999999
Q ss_pred HHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehh
Q 041655 100 SGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFG 170 (238)
Q Consensus 100 ~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG 170 (238)
.||.|||.+ +.||++++++.+||+|||.+......... ......++..|+|||.+.+ ..++.++|+||+|
T Consensus 127 ~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 205 (302)
T cd07864 127 EGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 205 (302)
T ss_pred HHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHH
Confidence 999999955 45699999999999999998765433221 1122345778999997754 3468899999999
Q ss_pred HHHHhhcchHHHHH
Q 041655 171 VLLAEEMSLVKWMR 184 (238)
Q Consensus 171 ~~l~~~~t~~~~~~ 184 (238)
+++|+|++|..||.
T Consensus 206 ~~~~el~~g~~~~~ 219 (302)
T cd07864 206 CILGELFTKKPIFQ 219 (302)
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999987775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=198.18 Aligned_cols=152 Identities=28% Similarity=0.374 Sum_probs=122.5
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecC-----CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARP-----GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
.....+.+|+.++++++||||+++++++... ...++++||++ ++|.+.+.. ..+++..+..++.|++.|
T Consensus 45 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~a 118 (336)
T cd07849 45 TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRG 118 (336)
T ss_pred hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHH
Confidence 3456678899999999999999999987543 35789999996 488887753 468999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccc-cCCCccCCeeehhH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGV 171 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~ 171 (238)
|.|||++ +.||+++.++.++|+|||++......... .......+++.|+|||.+.+ ..++.++|+||+|+
T Consensus 119 L~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv 198 (336)
T cd07849 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGC 198 (336)
T ss_pred HHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHH
Confidence 9999955 55699999999999999998765432211 11123567889999997654 46788999999999
Q ss_pred HHHhhcchHHHHH
Q 041655 172 LLAEEMSLVKWMR 184 (238)
Q Consensus 172 ~l~~~~t~~~~~~ 184 (238)
++|+|++|..||.
T Consensus 199 il~el~~G~~~f~ 211 (336)
T cd07849 199 ILAEMLSNRPLFP 211 (336)
T ss_pred HHHHHHhCCCCCC
Confidence 9999999987773
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=195.10 Aligned_cols=146 Identities=25% Similarity=0.339 Sum_probs=120.8
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+.+.+|+.++.+++|||++++.+++.. ++..++++||+ +++|.+++.. ..+++..+..++.|+++||.|||
T Consensus 52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH 125 (328)
T cd07856 52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVH 125 (328)
T ss_pred hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH
Confidence 34667889999999999999999999865 55788999998 5689888753 35778888889999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~ 177 (238)
++ +.|++++.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+||||+++|+|+
T Consensus 126 ~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 200 (328)
T cd07856 126 SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200 (328)
T ss_pred hCCcccCCCCHHHEeECCCCCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence 55 557999999999999999987543221 23456788999998765 56789999999999999999
Q ss_pred chHHHHH
Q 041655 178 SLVKWMR 184 (238)
Q Consensus 178 t~~~~~~ 184 (238)
+|..||.
T Consensus 201 tg~~~f~ 207 (328)
T cd07856 201 EGKPLFP 207 (328)
T ss_pred hCCCCCC
Confidence 9987763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=197.17 Aligned_cols=205 Identities=20% Similarity=0.314 Sum_probs=158.4
Q ss_pred hhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHH
Q 041655 14 ATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93 (238)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 93 (238)
+++-.++.+-+..++......|.++|..-+++.||+||-.|++.+.+|+||+|++||++..+|-. -..|.+..++.
T Consensus 658 AmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARF 733 (1034)
T KOG0608|consen 658 AMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARF 733 (1034)
T ss_pred HHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHH
Confidence 33444444555666777888999999999999999999999999999999999999999999875 46788899999
Q ss_pred HHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCC--------ccccc-------------------
Q 041655 94 TVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPE--------AHTHI------------------- 138 (238)
Q Consensus 94 ~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~--------~~~~~------------------- 138 (238)
++.++..++++.| .||.|||||.+|++||.|||++..+.. ...+.
T Consensus 734 YIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lk 813 (1034)
T KOG0608|consen 734 YIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLK 813 (1034)
T ss_pred HHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccch
Confidence 9999999999998 789999999999999999999864410 00000
Q ss_pred -------------ccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcc------ccccc
Q 041655 139 -------------TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKR------AIDSK 199 (238)
Q Consensus 139 -------------~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~------~~~~~ 199 (238)
...+..||+.|+|||++....++.-+|+||.|++||||+-|..||-.....+.-.+ .++-.
T Consensus 814 vL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~ 893 (1034)
T KOG0608|consen 814 VLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIP 893 (1034)
T ss_pred HHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccc
Confidence 01234799999999999999999999999999999999999999976554443322 22333
Q ss_pred ccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 200 LLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 200 ~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
...+...++..-+..+ |. +++.|
T Consensus 894 ~~~~ls~e~~~li~kL---c~--sad~R 916 (1034)
T KOG0608|consen 894 YQGNLSKEALDLIQKL---CC--SADSR 916 (1034)
T ss_pred cccccCHHHHHHHHHH---hc--Chhhh
Confidence 3334444555444555 76 45556
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=190.27 Aligned_cols=199 Identities=21% Similarity=0.216 Sum_probs=148.4
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++|+|++++++++...+..++++||++ ++|.+++.. ....+++..+..++.|++.||+|||.+
T Consensus 42 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~ 117 (282)
T cd07829 42 PSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLAYCHSH 117 (282)
T ss_pred cHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4567789999999999999999999999999999999997 589999976 224689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~ 179 (238)
+.||++++++.++|+|||.+......... .....++..|+|||.+.+. .++.++|+||||+++|++++|
T Consensus 118 ~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~ 195 (282)
T cd07829 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195 (282)
T ss_pred CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhC
Confidence 56799999999999999998765433211 1223456789999988766 788999999999999999999
Q ss_pred HHHHHHhhccCC---------------------C--cccccccccC----CChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 180 VKWMRNVMTSEN---------------------P--KRAIDSKLLG----NGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 180 ~~~~~~~~~~~~---------------------~--~~~~~~~~~~----~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
..||........ . .......... .........+.+++..||+.||++| .+.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 776632110000 0 0000000000 0111225568899999999999999 4444
Q ss_pred HH
Q 041655 232 ML 233 (238)
Q Consensus 232 ~L 233 (238)
.+
T Consensus 276 ~l 277 (282)
T cd07829 276 AL 277 (282)
T ss_pred Hh
Confidence 33
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=188.73 Aligned_cols=202 Identities=22% Similarity=0.296 Sum_probs=150.8
Q ss_pred HHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.+.+..+|++++...+ |+||+.++.+|+++..+|+|||-+.||+|.+.+.. ...+++.++..+.++++.||.|||
T Consensus 118 sR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH 193 (463)
T KOG0607|consen 118 SRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLH 193 (463)
T ss_pred HHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHh
Confidence 4678899999999997 99999999999999999999999999999998876 577999999999999999999999
Q ss_pred cc--------CceeeecCCC---ceEEcccccccccCCcc-----cccccccccCCCcccCccccc-----ccCCCccCC
Q 041655 107 MH--------QALVLLDHDM---EARISEFGLAKVFPEAH-----THITTSDVVGTAGYIAPEYQQ-----TLSITYMCD 165 (238)
Q Consensus 107 ~~--------~~~il~~~~~---~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~D 165 (238)
.+ |.|||-.+-. -+||+||.+...+.... ......+.+|+..|||||+.. ...|+.++|
T Consensus 194 ~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCD 273 (463)
T KOG0607|consen 194 TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCD 273 (463)
T ss_pred hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcccccccccccc
Confidence 55 6788865544 37999998876542211 111224578999999999753 335788999
Q ss_pred eeehhHHHHhhcchHHHHHHhhccC--------------CCcccccccc---cCCChHHHHHHHHHHhhhhcCCCCCcc-
Q 041655 166 IYSFGVLLAEEMSLVKWMRNVMTSE--------------NPKRAIDSKL---LGNGYEEQMLLVLKTACFCTLDDPKER- 227 (238)
Q Consensus 166 vwslG~~l~~~~t~~~~~~~~~~~~--------------~~~~~~~~~~---~~~~~~~~~~~l~~~~~~cl~~~p~~R- 227 (238)
.||||++||-|++|.+||...-... .....+.++. +..........-.+++...+-.++.+|
T Consensus 274 lwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rl 353 (463)
T KOG0607|consen 274 LWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL 353 (463)
T ss_pred HHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh
Confidence 9999999999999999997653211 1122222222 111223334445566666888999999
Q ss_pred hHHHHH
Q 041655 228 HVRCML 233 (238)
Q Consensus 228 ~v~~~L 233 (238)
..++.|
T Consensus 354 sa~~vl 359 (463)
T KOG0607|consen 354 SAAQVL 359 (463)
T ss_pred hhhhcc
Confidence 444433
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-28 Score=197.22 Aligned_cols=146 Identities=25% Similarity=0.347 Sum_probs=120.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
..+.+.+|+.++.+++||||+++++++... +..+++++++ +++|.+++.. ..+++..+..++.|+++|
T Consensus 59 ~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~a 132 (345)
T cd07877 59 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRG 132 (345)
T ss_pred HHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHH
Confidence 345678899999999999999999987543 3467888877 7799888753 358899999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVL 172 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~ 172 (238)
|.|||.+ +.||+++.++.++|+|||++....... ....++..|+|||.+.+ ..++.++|+||+|++
T Consensus 133 L~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~i 207 (345)
T cd07877 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 207 (345)
T ss_pred HHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHH
Confidence 9999955 567999999999999999987543221 23467888999998765 457889999999999
Q ss_pred HHhhcchHHHHH
Q 041655 173 LAEEMSLVKWMR 184 (238)
Q Consensus 173 l~~~~t~~~~~~ 184 (238)
+|+|++|..||.
T Consensus 208 l~el~~g~~pf~ 219 (345)
T cd07877 208 MAELLTGRTLFP 219 (345)
T ss_pred HHHHHhCCCCCC
Confidence 999999987763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-28 Score=197.37 Aligned_cols=151 Identities=23% Similarity=0.337 Sum_probs=119.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecC--------------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARP--------------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 93 (238)
..+.+.+|+.++++++||||+++++.+... ...++++||++ ++|.+++.. ..+++..+..
T Consensus 45 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~ 118 (342)
T cd07854 45 SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARL 118 (342)
T ss_pred hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHH
Confidence 456788999999999999999999876543 35789999996 589888853 3588999999
Q ss_pred HHHHHHHHhchhhcc--------CceeeecC-CCceEEcccccccccCCccccc-ccccccCCCcccCcccccc-cCCCc
Q 041655 94 TVRGIASGLEYLHMH--------QALVLLDH-DMEARISEFGLAKVFPEAHTHI-TTSDVVGTAGYIAPEYQQT-LSITY 162 (238)
Q Consensus 94 ~~~~l~~gl~~lH~~--------~~~il~~~-~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~apE~~~~-~~~~~ 162 (238)
++.|+++||.|||.+ +.||+++. ++.++++|||.+.......... ......++..|+|||.+.+ ..++.
T Consensus 119 ~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 198 (342)
T cd07854 119 FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198 (342)
T ss_pred HHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCc
Confidence 999999999999955 45688874 5578999999987653321111 1122356888999997654 45788
Q ss_pred cCCeeehhHHHHhhcchHHHHH
Q 041655 163 MCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 163 ~~DvwslG~~l~~~~t~~~~~~ 184 (238)
++|+|||||++|+|++|..||.
T Consensus 199 ~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 199 AIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred hhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999998884
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-28 Score=210.30 Aligned_cols=194 Identities=21% Similarity=0.154 Sum_probs=153.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH- 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH- 106 (238)
.-.-|..|.++|.--+.+.|+.++-.|++++.+|+||||++||+|...+.. ...+++..++.|+..|..||.-||
T Consensus 118 ~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~ 193 (1317)
T KOG0612|consen 118 ETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHS 193 (1317)
T ss_pred hHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHh
Confidence 345688899999999999999999999999999999999999999999976 236999999999999999998888
Q ss_pred -------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc----c-cCCCccCCeeehhHHHH
Q 041655 107 -------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ----T-LSITYMCDIYSFGVLLA 174 (238)
Q Consensus 107 -------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~----~-~~~~~~~DvwslG~~l~ 174 (238)
.||.|+|+|..|++||+|||.+-.+.... .......+|||-|.+||++. + +.|+.-+|+||+|+++|
T Consensus 194 mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~Y 272 (1317)
T KOG0612|consen 194 MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMY 272 (1317)
T ss_pred ccceeccCCcceeEecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHH
Confidence 78999999999999999999986654322 22346689999999999875 3 56899999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCCCh--HHHHHHHHHHhhhhcCCCCCcc
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGY--EEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~~cl~~~p~~R 227 (238)
||+.|..||+...--+...++.+..-...+| ...+....++|...+ .+|+.|
T Consensus 273 EMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~R 326 (1317)
T KOG0612|consen 273 EMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVR 326 (1317)
T ss_pred HHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhh
Confidence 9999999998876555555555553322222 223333344444333 467777
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=197.34 Aligned_cols=146 Identities=25% Similarity=0.334 Sum_probs=121.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCC------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPG------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
....+.+|+.++++++||||+++.+++..++ .+++|+||+ +++|.+++.. ..+++..+..++.|+++|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~a 130 (343)
T cd07880 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKG 130 (343)
T ss_pred HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHH
Confidence 4456889999999999999999999987553 358999999 6799888753 458899999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVL 172 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~ 172 (238)
|.|||.+ +.||+++.++.++++|||.+....... ....+++.|++||.+.+ ..++.++|+||+|++
T Consensus 131 l~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~l 205 (343)
T cd07880 131 LKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCI 205 (343)
T ss_pred HHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHH
Confidence 9999954 567999999999999999987643321 23456889999998765 357889999999999
Q ss_pred HHhhcchHHHHH
Q 041655 173 LAEEMSLVKWMR 184 (238)
Q Consensus 173 l~~~~t~~~~~~ 184 (238)
+|++++|..||.
T Consensus 206 l~~l~~g~~pf~ 217 (343)
T cd07880 206 MAEMLTGKPLFK 217 (343)
T ss_pred HHHHHhCCCCCC
Confidence 999999988774
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=185.12 Aligned_cols=198 Identities=26% Similarity=0.281 Sum_probs=154.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+..+.+++|+|++++++.+......++++||+++++|.+++.. ...+++..+..++.+++.++.+||..
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~ 106 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLHSN 106 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 57889999999999999999999999998999999999998899999875 22388999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++++|||.+....... ......++..|++||...+..++.++|+||+|++++++++|.
T Consensus 107 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~ 183 (244)
T smart00220 107 GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGK 183 (244)
T ss_pred CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 456999999999999999988764432 113356788899999988888899999999999999999998
Q ss_pred HHHHHhhccCCCcccccccccCCChH--HHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYE--EQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
.|+....................... ..+..+.+++.+||..+|++| ...+.+
T Consensus 184 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 184 PPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEAL 239 (244)
T ss_pred CCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHh
Confidence 87754222122222222211111111 145678889999999999999 555444
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-28 Score=197.97 Aligned_cols=144 Identities=26% Similarity=0.363 Sum_probs=118.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
...+.+|+.++++++||||+++++++... ..+++++||+. .+|..+.. ..+++..+..++.|++.||
T Consensus 58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL 130 (342)
T cd07879 58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGL 130 (342)
T ss_pred hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHH
Confidence 45678999999999999999999998654 24689999995 47776652 3578899999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHH
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLL 173 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l 173 (238)
+|||.+ +.||+++.++.++|+|||+++...... ....++..|+|||.+.+ ..++.++|+||||+++
T Consensus 131 ~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil 205 (342)
T cd07879 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIM 205 (342)
T ss_pred HHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHH
Confidence 999955 567999999999999999987543221 23456788999998765 4578899999999999
Q ss_pred HhhcchHHHHH
Q 041655 174 AEEMSLVKWMR 184 (238)
Q Consensus 174 ~~~~t~~~~~~ 184 (238)
|+|++|..||.
T Consensus 206 ~el~~g~~pf~ 216 (342)
T cd07879 206 AEMLTGKTLFK 216 (342)
T ss_pred HHHHhCCCCCC
Confidence 99999988774
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=187.64 Aligned_cols=223 Identities=16% Similarity=0.151 Sum_probs=181.4
Q ss_pred hhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeee-cCCeeEEEEEeCCCCCHHHHHhh----hcCCCcccCH
Q 041655 14 ATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLA-RPGCHLLVYEFMKNGSLQDILND----VSRGRRQLDW 88 (238)
Q Consensus 14 ~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~ 88 (238)
.+-+|......+.-+...+++|.-.+..+.|||+.++.+++. +.+..++++.+..-|+|..|+.. .+...+.++.
T Consensus 316 ~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt 395 (563)
T KOG1024|consen 316 EVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTT 395 (563)
T ss_pred HHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhH
Confidence 344555666677778889999999999999999999999974 55678899999988999999972 1233466888
Q ss_pred HHHHHHHHHHHHHhchhhccC--------ceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCC
Q 041655 89 LARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI 160 (238)
Q Consensus 89 ~~~~~~~~~l~~gl~~lH~~~--------~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~ 160 (238)
.+...++.|++.|++|||.++ .|+++|+..++||+|=.+++.+-+..-+........+..||+||.+.+..|
T Consensus 396 ~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y 475 (563)
T KOG1024|consen 396 IQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY 475 (563)
T ss_pred HHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh
Confidence 889999999999999999664 358999999999999999997765555544444556788999999999999
Q ss_pred CccCCeeehhHHHHhhcch-HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 161 TYMCDIYSFGVLLAEEMSL-VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 161 ~~~~DvwslG~~l~~~~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
+..+|+||||+++|||+|. ..|+- ..+.......+..+++...|.++|.++..+|.-||...|++| +++..|.+
T Consensus 476 ssasDvWsfGVllWELmtlg~~Pya-eIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 476 SSASDVWSFGVLLWELMTLGKLPYA-EIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred cchhhhHHHHHHHHHHHhcCCCCcc-ccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 9999999999999999984 45443 333444556777788888899999999999999999999999 66666665
Q ss_pred hh
Q 041655 236 IQ 237 (238)
Q Consensus 236 ~~ 237 (238)
+.
T Consensus 555 F~ 556 (563)
T KOG1024|consen 555 FH 556 (563)
T ss_pred HH
Confidence 53
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=193.74 Aligned_cols=151 Identities=24% Similarity=0.376 Sum_probs=119.5
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecC--------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARP--------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
..+.+|+.++++++||||+++++.+.+. ...++++||+.+ ++...+.. ....+++..+..++.|+++|
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~a 127 (311)
T cd07866 52 ITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEG 127 (311)
T ss_pred hhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHH
Confidence 3467899999999999999999987543 346899999964 77777653 24568999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccc---------cccccccCCCcccCcccccc-cCCCcc
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH---------ITTSDVVGTAGYIAPEYQQT-LSITYM 163 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~---------~~~~~~~~~~~~~apE~~~~-~~~~~~ 163 (238)
|+|||++ +.||++++++.++|+|||+++........ .......+++.|+|||.+.+ ..++.+
T Consensus 128 l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (311)
T cd07866 128 INYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207 (311)
T ss_pred HHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCch
Confidence 9999955 56799999999999999998765332111 11122456788999998755 357889
Q ss_pred CCeeehhHHHHhhcchHHHHH
Q 041655 164 CDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 164 ~DvwslG~~l~~~~t~~~~~~ 184 (238)
+|+||||+++|+|++|..||.
T Consensus 208 ~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 208 VDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred hHhHHHHHHHHHHHhCCCCCC
Confidence 999999999999999987763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=200.15 Aligned_cols=177 Identities=22% Similarity=0.261 Sum_probs=148.4
Q ss_pred cCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCC
Q 041655 9 QPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRG 82 (238)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~ 82 (238)
+.....+|+|..+...+....++..+|+++|++++|||||+++++-.+. +...++||||.+|+|...+.+ +.+
T Consensus 35 ketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~-PEN 113 (732)
T KOG4250|consen 35 KETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNS-PEN 113 (732)
T ss_pred cccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcC-ccc
Confidence 4455667888888888888899999999999999999999999986543 356799999999999999986 334
Q ss_pred CcccCHHHHHHHHHHHHHHhchhhcc--------Cceeeec--CCCc--eEEcccccccccCCcccccccccccCCCccc
Q 041655 83 RRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLD--HDME--ARISEFGLAKVFPEAHTHITTSDVVGTAGYI 150 (238)
Q Consensus 83 ~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~--~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 150 (238)
...+++.+.+.+..++..||.|||.+ |.||++. .+|+ -||+|||.|+.+++... -.+..||..|.
T Consensus 114 ~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~---~~S~vGT~~YL 190 (732)
T KOG4250|consen 114 AYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSL---FTSLVGTEEYL 190 (732)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCe---eeeecCchhhc
Confidence 56799999999999999999999954 5666643 3343 69999999998876653 35689999999
Q ss_pred Cccccc-ccCCCccCCeeehhHHHHhhcchHHHHHHhhcc
Q 041655 151 APEYQQ-TLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTS 189 (238)
Q Consensus 151 apE~~~-~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~ 189 (238)
+||+.. ...|+..+|.|||||++|+.+||..||......
T Consensus 191 hPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 191 HPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999988 488899999999999999999999999766544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-29 Score=189.19 Aligned_cols=226 Identities=18% Similarity=0.206 Sum_probs=156.8
Q ss_pred EeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhh-cCC
Q 041655 5 RKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDV-SRG 82 (238)
Q Consensus 5 K~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~ 82 (238)
|..+++...-.++++.+.......+.+++.|.++..+- +.||||++||+++.++..|+.||.+ ..+|..+.... .-.
T Consensus 82 KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq 160 (361)
T KOG1006|consen 82 KMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQ 160 (361)
T ss_pred hhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHH
Confidence 34445555555555556666667788999999975555 6899999999999999999999999 45777665421 012
Q ss_pred CcccCHHHHHHHHHHHHHHhchh-------h--ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 83 RRQLDWLARYRTVRGIASGLEYL-------H--MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 83 ~~~~~~~~~~~~~~~l~~gl~~l-------H--~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
...+++...-.+.--...||.|| | .||+|||++..|.+||+|||++..+..+.. .+...|...|||||
T Consensus 161 ~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA---kT~daGCrpYmAPE 237 (361)
T KOG1006|consen 161 KSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA---KTVDAGCRPYMAPE 237 (361)
T ss_pred hccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH---hhhccCCccccChh
Confidence 34466666655555556667766 4 779999999999999999999977644332 23457899999999
Q ss_pred cccc--cCCCccCCeeehhHHHHhhcchHHHHHHhhccC-CCcccccccc---cCC-ChHHHHHHHHHHhhhhcCCCCCc
Q 041655 154 YQQT--LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSE-NPKRAIDSKL---LGN-GYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 154 ~~~~--~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~-~~~~~~~~~~---~~~-~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
-+.. ..|+.+||+||||++|||+.||..|++.-..-. .+..++.... ..+ .-.+....+..++..|+.+|-..
T Consensus 238 Ri~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~ 317 (361)
T KOG1006|consen 238 RIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSD 317 (361)
T ss_pred ccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhccccc
Confidence 7653 348899999999999999999998876543211 1111111111 111 11234556777788899999999
Q ss_pred chHHHHHH
Q 041655 227 RHVRCMLS 234 (238)
Q Consensus 227 R~v~~~L~ 234 (238)
|.-.+.|.
T Consensus 318 Rpky~~Lk 325 (361)
T KOG1006|consen 318 RPKYDDLK 325 (361)
T ss_pred Ccchhhhh
Confidence 94444443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=196.44 Aligned_cols=146 Identities=25% Similarity=0.354 Sum_probs=122.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCe------eEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGC------HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
..+.+.+|+.++++++|||++++.+++...+. .++++||+ +++|.+++.. ..+++..+..++.|+++|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~a 130 (343)
T cd07851 57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRG 130 (343)
T ss_pred HHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHH
Confidence 44667889999999999999999998866554 89999999 6799998864 468999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVL 172 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~ 172 (238)
|.|||.+ +.||+++.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|++
T Consensus 131 L~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~ 205 (343)
T cd07851 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205 (343)
T ss_pred HHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHH
Confidence 9999965 55799999999999999998765332 133467888999998765 357889999999999
Q ss_pred HHhhcchHHHHH
Q 041655 173 LAEEMSLVKWMR 184 (238)
Q Consensus 173 l~~~~t~~~~~~ 184 (238)
+|++++|..||.
T Consensus 206 l~elltg~~pf~ 217 (343)
T cd07851 206 MAELLTGKTLFP 217 (343)
T ss_pred HHHHHhCCCCCC
Confidence 999999988774
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=199.05 Aligned_cols=183 Identities=20% Similarity=0.211 Sum_probs=143.9
Q ss_pred HHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--
Q 041655 32 IRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH-- 108 (238)
Q Consensus 32 ~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~-- 108 (238)
-.+|+.++... +|||++++.+++.++...|+|||.+.++-+.+.+.. ...++ ..+..|+.+|+.++.|||.+
T Consensus 362 ~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~gv 436 (612)
T KOG0603|consen 362 NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQGV 436 (612)
T ss_pred cccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhcCe
Confidence 34577666666 599999999999999999999999999888877754 23333 77788999999999999955
Q ss_pred ------Cceeee-cCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 109 ------QALVLL-DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 109 ------~~~il~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
|.|||+ ++.++++|+|||.++...... .+.+-|..|.|||++....|+..+|+||||++||+|++|..
T Consensus 437 vhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~-----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~t 511 (612)
T KOG0603|consen 437 VHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC-----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRT 511 (612)
T ss_pred eecCCChhheeecCCCCcEEEEEechhhhCchhh-----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCC
Confidence 778999 689999999999998765542 23455788999999999999999999999999999999999
Q ss_pred HHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 182 WMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
||........+...+..+......++. ..+++.+||+.||.+|
T Consensus 512 p~~~~P~~~ei~~~i~~~~~s~~vS~~---AKdLl~~LL~~dP~~R 554 (612)
T KOG0603|consen 512 LFAAHPAGIEIHTRIQMPKFSECVSDE---AKDLLQQLLQVDPALR 554 (612)
T ss_pred ccccCCchHHHHHhhcCCccccccCHH---HHHHHHHhccCChhhC
Confidence 998876653333333322222333444 4556666999999999
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=186.08 Aligned_cols=193 Identities=27% Similarity=0.337 Sum_probs=144.5
Q ss_pred HHHHHHHHHhc--CCCCCcccceeeeeecC----CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 30 MQIRSEIVTLG--QIRHRNILPLLAHLARP----GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 30 ~~~~~E~~~l~--~l~h~~iv~~~~~~~~~----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
+.+.+|.++.. .|+|+||+.+++.-..+ ..+|+|++|-+.|+|.||+.. ..++.....+++..++.||+
T Consensus 248 ~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLa 322 (513)
T KOG2052|consen 248 RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLA 322 (513)
T ss_pred hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHH
Confidence 55667666654 55899999999876433 357999999999999999975 67899999999999999999
Q ss_pred hhh----------------ccCceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCcccccccC----C-
Q 041655 104 YLH----------------MHQALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQTLS----I- 160 (238)
Q Consensus 104 ~lH----------------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~~~----~- 160 (238)
||| .|.-||++.+++.+-|+|+|+|......... ......+||-+|||||++...- +
T Consensus 323 HLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fe 402 (513)
T KOG2052|consen 323 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFE 402 (513)
T ss_pred HHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhh
Confidence 999 3345799999999999999999765443222 2335579999999999986532 1
Q ss_pred Cc-cCCeeehhHHHHhhcc----------hHHHHHHhhccCCCcc----cc-cccccCCC-----hHHHHHHHHHHhhhh
Q 041655 161 TY-MCDIYSFGVLLAEEMS----------LVKWMRNVMTSENPKR----AI-DSKLLGNG-----YEEQMLLVLKTACFC 219 (238)
Q Consensus 161 ~~-~~DvwslG~~l~~~~t----------~~~~~~~~~~~~~~~~----~~-~~~~~~~~-----~~~~~~~l~~~~~~c 219 (238)
++ .+||||||.++||+.- ...||+.........+ .+ ..++++.. ..+....+.++|+.|
T Consensus 403 syk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeC 482 (513)
T KOG2052|consen 403 SYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKEC 482 (513)
T ss_pred hhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHh
Confidence 23 5899999999999864 2345554443332211 11 22333332 356677889999999
Q ss_pred cCCCCCcc
Q 041655 220 TLDDPKER 227 (238)
Q Consensus 220 l~~~p~~R 227 (238)
|..||.-|
T Consensus 483 W~~Np~aR 490 (513)
T KOG2052|consen 483 WYANPAAR 490 (513)
T ss_pred hcCCchhh
Confidence 99999999
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=191.71 Aligned_cols=151 Identities=28% Similarity=0.330 Sum_probs=121.0
Q ss_pred HHHHHHHHHHhcCCC-CCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 29 MMQIRSEIVTLGQIR-HRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
...+.+|+.++.+++ ||||+++++.+.. ....+++++|+. ++|.+++.. ...+++..+..++.|++.||.
T Consensus 45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~ 119 (332)
T cd07857 45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLK 119 (332)
T ss_pred HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHH
Confidence 456788999999994 9999999987532 245688999985 689998864 456899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCcccccc-cCCCccCCeeehhHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVL 172 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~ 172 (238)
|||.+ +.||+++.++.++|+|||.+..+...... .......|+..|+|||...+ ..++.++|+||+|++
T Consensus 120 ~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~ 199 (332)
T cd07857 120 YIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199 (332)
T ss_pred HHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence 99955 56799999999999999999765432211 11133568899999998765 467899999999999
Q ss_pred HHhhcchHHHHH
Q 041655 173 LAEEMSLVKWMR 184 (238)
Q Consensus 173 l~~~~t~~~~~~ 184 (238)
+|++++|..||.
T Consensus 200 l~~l~~g~~pf~ 211 (332)
T cd07857 200 LAELLGRKPVFK 211 (332)
T ss_pred HHHHHhCCcCCC
Confidence 999999987764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-27 Score=188.46 Aligned_cols=196 Identities=15% Similarity=0.119 Sum_probs=139.3
Q ss_pred HHHHHHhcCCCCCcccceeeeeecCC----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 33 RSEIVTLGQIRHRNILPLLAHLARPG----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 33 ~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
..+...+..++|+|++++++++.... ..+++++++. .++.+.+.. ....++..+..++.|+++||+|||++
T Consensus 71 ~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~ 145 (294)
T PHA02882 71 IALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH 145 (294)
T ss_pred HHHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 44556677889999999998765443 3467888774 467776654 23357788889999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccc-----cccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTH-----ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
|.||+++.++.++|+|||+++........ .......||+.|+|||+..+..++.++|||||||++|+
T Consensus 146 ~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 146 GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 67899999999999999999765322111 11123468999999999999899999999999999999
Q ss_pred hcchHHHHHHhhccCCCccccc----ccc-cC-CChHHHHHHHHHHhhhhcCCCCCcchHHHHH
Q 041655 176 EMSLVKWMRNVMTSENPKRAID----SKL-LG-NGYEEQMLLVLKTACFCTLDDPKERHVRCML 233 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~----~~~-~~-~~~~~~~~~l~~~~~~cl~~~p~~R~v~~~L 233 (238)
|++|..||.............. ..+ .. ....+.+..+.+++..||..+|++|+-.+.|
T Consensus 226 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l 289 (294)
T PHA02882 226 WAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDAL 289 (294)
T ss_pred HHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHH
Confidence 9999999865422221111000 011 00 1123345667888888999999999333333
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=205.06 Aligned_cols=225 Identities=20% Similarity=0.269 Sum_probs=159.5
Q ss_pred EEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeec---------------------------
Q 041655 4 IRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR--------------------------- 56 (238)
Q Consensus 4 iK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------------------------- 56 (238)
||+-.+=+...+|||+...+.+......+.+|+.+|++|+|||||+||..|.+
T Consensus 496 vkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~ 575 (1351)
T KOG1035|consen 496 VKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNG 575 (1351)
T ss_pred EEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCccc
Confidence 44444555667778887777777788889999999999999999999976521
Q ss_pred --------------------------------------------------------------------------------
Q 041655 57 -------------------------------------------------------------------------------- 56 (238)
Q Consensus 57 -------------------------------------------------------------------------------- 56 (238)
T Consensus 576 ~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~ 655 (1351)
T KOG1035|consen 576 VDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKT 655 (1351)
T ss_pred ceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhcccc
Confidence
Q ss_pred ----C--------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecC
Q 041655 57 ----P--------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDH 116 (238)
Q Consensus 57 ----~--------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~ 116 (238)
. ..+||-||||+..++.+++.. + ...-.....++++++|++||.|+| .||.||+++.
T Consensus 656 ~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~--N-~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~ 732 (1351)
T KOG1035|consen 656 ENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR--N-HFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDS 732 (1351)
T ss_pred CCccccccccccceEEEEEHhhhhhhHHHHHHHh--c-ccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcC
Confidence 0 124789999988777777765 1 111146778999999999999999 5588999999
Q ss_pred CCceEEcccccccccC----------------CcccccccccccCCCcccCcccccccC---CCccCCeeehhHHHHhhc
Q 041655 117 DMEARISEFGLAKVFP----------------EAHTHITTSDVVGTAGYIAPEYQQTLS---ITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 117 ~~~~kl~dfg~~~~~~----------------~~~~~~~~~~~~~~~~~~apE~~~~~~---~~~~~DvwslG~~l~~~~ 177 (238)
++.+||+|||++.... ........+...||.-|+|||++.+.. |+.|+|+||+|++++||+
T Consensus 733 ~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~ 812 (1351)
T KOG1035|consen 733 RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML 812 (1351)
T ss_pred CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh
Confidence 9999999999997621 001111235578999999999887554 899999999999999998
Q ss_pred chHHHHHHhhccCCCcccccccccC---CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLG---NGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.- |...++.......+..+..+ +.+.+....=.++|..+++.||.+| ...+.|.
T Consensus 813 yP---F~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 813 YP---FGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cc---CCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 73 32222222222222222212 2244444444678888999999999 4444443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=175.06 Aligned_cols=153 Identities=21% Similarity=0.161 Sum_probs=113.8
Q ss_pred CCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--cCceeeecCCCceEEcccccccccCCcccccccccccCCC
Q 041655 70 GSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM--HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTA 147 (238)
Q Consensus 70 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~--~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 147 (238)
|+|.+++.. ....+++..++.++.|+++||.|||. |+.||+++.++.+++ ||.+....... ..|++
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~g~~ 68 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQAKSGNILLTWDGLLKL--DGSVAFKTPEQ-------SRVDP 68 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccEeEcCccceee--ccceEeecccc-------CCCcc
Confidence 689999875 24569999999999999999999997 689999999999999 99987653321 25789
Q ss_pred cccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccC------CChHHHHH--HHHHHhhhh
Q 041655 148 GYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLG------NGYEEQML--LVLKTACFC 219 (238)
Q Consensus 148 ~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~--~l~~~~~~c 219 (238)
.|+|||++.+..++.++|||||||++|||++|..||............+...... ..+..... .+.+++.+|
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 148 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC 148 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence 9999999999999999999999999999999998875432211111111111100 11222222 588899999
Q ss_pred cCCCCCcc-hHHHHHH
Q 041655 220 TLDDPKER-HVRCMLS 234 (238)
Q Consensus 220 l~~~p~~R-~v~~~L~ 234 (238)
|+.+|++| .+.+.++
T Consensus 149 l~~~p~~Rp~~~~ll~ 164 (176)
T smart00750 149 ASRLPQRREAANHYLA 164 (176)
T ss_pred HhcccccccCHHHHHH
Confidence 99999999 4444443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=184.31 Aligned_cols=195 Identities=22% Similarity=0.229 Sum_probs=150.1
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
..+.++=...|-.++++- +||++|-+..+|++..++++|.||.+||+|.-.+.+ ...++++.++.+...+..+|.
T Consensus 290 ddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~ 365 (593)
T KOG0695|consen 290 DDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALN 365 (593)
T ss_pred CcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHH
Confidence 344455566777787777 599999999999999999999999999998766654 577999999999999999999
Q ss_pred hhhccCc--------eeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 104 YLHMHQA--------LVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 104 ~lH~~~~--------~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
|||++++ |+++|.+|++||.|+|..+.-- .....+++++|||.|.|||++++..|++..|+|++|++++|
T Consensus 366 flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfe 443 (593)
T KOG0695|consen 366 FLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFE 443 (593)
T ss_pred HHhhcCeeeeeccccceEEccCCceeecccchhhcCC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHH
Confidence 9998765 5999999999999999986421 11223577999999999999999999999999999999999
Q ss_pred hcchHHHHHHhhccC---C----Ccc-cccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 176 EMSLVKWMRNVMTSE---N----PKR-AIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~---~----~~~-~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|+.|..||+-.-.+. + ... ++...++. |....-....+++..|++||.+|
T Consensus 444 mmagrspfdivgm~n~d~ntedylfqvilekqiri--prslsvkas~vlkgflnkdp~er 501 (593)
T KOG0695|consen 444 MMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI--PRSLSVKASHVLKGFLNKDPKER 501 (593)
T ss_pred HHcCCCCcceecCCCcccchhHHHHHHHhhhcccc--cceeehhhHHHHHHhhcCCcHHh
Confidence 999999996321111 1 111 22222211 11112223456667899999999
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=184.35 Aligned_cols=153 Identities=25% Similarity=0.371 Sum_probs=126.2
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcC-CCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSR-GRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....||+.+++.++|||++++..+|.. +...++++||++. +|.+.+...+. ....++...++.++.|++.|+.|||+
T Consensus 72 ~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~ 150 (438)
T KOG0666|consen 72 MSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS 150 (438)
T ss_pred HHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh
Confidence 456799999999999999999999977 6789999999976 89998864322 23578999999999999999999995
Q ss_pred c--------CceeeecCC----CceEEcccccccccCCccccc-ccccccCCCcccCcccccccC-CCccCCeeehhHHH
Q 041655 108 H--------QALVLLDHD----MEARISEFGLAKVFPEAHTHI-TTSDVVGTAGYIAPEYQQTLS-ITYMCDIYSFGVLL 173 (238)
Q Consensus 108 ~--------~~~il~~~~----~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~apE~~~~~~-~~~~~DvwslG~~l 173 (238)
+ |.||++..+ |.+||+|||+++.+....... ......-|..|.|||.+.+.. |+.+.|+|++||++
T Consensus 151 NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIf 230 (438)
T KOG0666|consen 151 NWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIF 230 (438)
T ss_pred hheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHH
Confidence 4 899999988 899999999999875543322 223345688999999887765 78899999999999
Q ss_pred HhhcchHHHH
Q 041655 174 AEEMSLVKWM 183 (238)
Q Consensus 174 ~~~~t~~~~~ 183 (238)
.||+|..+-|
T Consensus 231 aElLtl~PlF 240 (438)
T KOG0666|consen 231 AELLTLEPLF 240 (438)
T ss_pred HHHHccCccc
Confidence 9999855544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=203.01 Aligned_cols=99 Identities=23% Similarity=0.373 Sum_probs=88.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.....+.+|+.++..++||||+++++.+...+..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||
T Consensus 46 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH 121 (669)
T cd05610 46 NMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLH 121 (669)
T ss_pred HHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999999999999999999999999999975 345788899999999999999999
Q ss_pred cc--------CceeeecCCCceEEccccccc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAK 129 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~ 129 (238)
.+ |.||+++.++.++|+|||+++
T Consensus 122 ~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 54 667999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-27 Score=170.96 Aligned_cols=166 Identities=17% Similarity=0.259 Sum_probs=137.5
Q ss_pred hHHHhhhhhhHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHH
Q 041655 16 ALVEADSKLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94 (238)
Q Consensus 16 ~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 94 (238)
++++.+....+..+++..+|+++..+- ..|++|.+||...+.+..|+.||.+ ..+|..|..+....+..+++..+-++
T Consensus 75 AvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkI 153 (282)
T KOG0984|consen 75 AVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKI 153 (282)
T ss_pred EEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHh
Confidence 333334445566788889999975554 6999999999999999999999999 56999988765556788999999999
Q ss_pred HHHHHHHhchhh---------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc----ccCCC
Q 041655 95 VRGIASGLEYLH---------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ----TLSIT 161 (238)
Q Consensus 95 ~~~l~~gl~~lH---------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~----~~~~~ 161 (238)
+..+.+||.||| .||.|||++.+|++|++|||.+..+.++-. .+...|...|+|||.+. ...|+
T Consensus 154 a~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~ 230 (282)
T KOG0984|consen 154 AVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYS 230 (282)
T ss_pred HHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccce
Confidence 999999999999 459999999999999999999987655432 13357889999999654 44689
Q ss_pred ccCCeeehhHHHHhhcchHHHHHH
Q 041655 162 YMCDIYSFGVLLAEEMSLVKWMRN 185 (238)
Q Consensus 162 ~~~DvwslG~~l~~~~t~~~~~~~ 185 (238)
.++||||||+++.||.++..|+.+
T Consensus 231 vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 231 VKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhhhhhhhhhhhhhccccccc
Confidence 999999999999999999888764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-25 Score=189.64 Aligned_cols=192 Identities=21% Similarity=0.255 Sum_probs=141.9
Q ss_pred HHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCH-HHHHHHHHHHHHHhchhh-
Q 041655 30 MQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDW-LARYRTVRGIASGLEYLH- 106 (238)
Q Consensus 30 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~-~~~~~~~~~l~~gl~~lH- 106 (238)
.-..+|+..|..-+ |||||++|+.-.++.+.|+..|.|. .+|.+++... ........ ...+....|+++||++||
T Consensus 547 ~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHs 624 (903)
T KOG1027|consen 547 DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHS 624 (903)
T ss_pred HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHh
Confidence 44578999998886 9999999999999999999999995 5999999862 11111111 334567799999999999
Q ss_pred -------ccCceeeecC---C--CceEEcccccccccCCccc-ccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 107 -------MHQALVLLDH---D--MEARISEFGLAKVFPEAHT-HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 107 -------~~~~~il~~~---~--~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
.||.|||++. + .+++|+|||+++.+..... ....+...||-.|.|||++....-..++||+|+||++
T Consensus 625 l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvf 704 (903)
T KOG1027|consen 625 LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVF 704 (903)
T ss_pred cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceE
Confidence 4688999877 3 4689999999998765432 2334667899999999999988888899999999999
Q ss_pred Hhhcch-HHHHHHhhccCCCcccccccc---cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 174 AEEMSL-VKWMRNVMTSENPKRAIDSKL---LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 174 ~~~~t~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|+.++| ..||-..... -.+++.... ......++ ...++|..+++.+|..|
T Consensus 705 yYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~R 758 (903)
T KOG1027|consen 705 YYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLR 758 (903)
T ss_pred EEEecCCccCCCchHHh--hhhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccC
Confidence 999997 7887544322 112222211 11111111 45667777999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=187.69 Aligned_cols=192 Identities=23% Similarity=0.302 Sum_probs=147.9
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-- 107 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~-- 107 (238)
.-..+|+-+++..+||||+.|+|.+..++..|+.||||.+|+|.+.... -.++++.++...++..+.||+|||+
T Consensus 57 ~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g 132 (829)
T KOG0576|consen 57 SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG 132 (829)
T ss_pred cccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC
Confidence 4556899999999999999999999999999999999999999987753 4679999999999999999999994
Q ss_pred ------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccc---cccCCCccCCeeehhHHHHhhcc
Q 041655 108 ------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQ---QTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~---~~~~~~~~~DvwslG~~l~~~~t 178 (238)
|+.||++++.|.+|+.|||.+..++.-.. ...++.||++|||||+. +.+.|...+|+|++|++..|+-.
T Consensus 133 k~hRdiKGanilltd~gDvklaDfgvsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e 210 (829)
T KOG0576|consen 133 KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE 210 (829)
T ss_pred cccccccccceeecccCceeecccCchhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh
Confidence 46789999999999999999987654322 12457899999999964 45678899999999999988776
Q ss_pred hHHHHHHhhccCCCcccccccccC---CChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLG---NGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..+|...........-.....+.+ +........+-++++.|+.++|++|
T Consensus 211 Lqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkR 262 (829)
T KOG0576|consen 211 LQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKR 262 (829)
T ss_pred cCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccC
Confidence 655544333222222222222211 2223333444555666999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=179.23 Aligned_cols=146 Identities=25% Similarity=0.284 Sum_probs=127.2
Q ss_pred HHHHHHHhcCCC---CCcccceeeeeecCCeeEEEEEeC-CCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 32 IRSEIVTLGQIR---HRNILPLLAHLARPGCHLLVYEFM-KNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 32 ~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~v~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
+..|+++|..++ |+||++++++|++++.+|++||-- ++-+|.+++.. ...+++..+..+++|++.|+++||+
T Consensus 613 Vp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~ 688 (772)
T KOG1152|consen 613 VPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHD 688 (772)
T ss_pred cchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccc
Confidence 456999999997 999999999999999999999974 56689999986 5679999999999999999999994
Q ss_pred --------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCC-CccCCeeehhHHHHhhcc
Q 041655 108 --------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 --------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~-~~~~DvwslG~~l~~~~t 178 (238)
|..|++++++|.+||+|||.+........ ..+.||..|+|||++.+..| +..-|||++|++||.++.
T Consensus 689 ~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy 764 (772)
T KOG1152|consen 689 QGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY 764 (772)
T ss_pred cCceecccccccEEEecCCeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe
Confidence 45679999999999999999987544332 34789999999999999887 778999999999999998
Q ss_pred hHHHHHH
Q 041655 179 LVKWMRN 185 (238)
Q Consensus 179 ~~~~~~~ 185 (238)
...||++
T Consensus 765 kenpyyn 771 (772)
T KOG1152|consen 765 KENPYYN 771 (772)
T ss_pred ccCCCcC
Confidence 8777653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-24 Score=173.49 Aligned_cols=147 Identities=20% Similarity=0.232 Sum_probs=119.8
Q ss_pred HHHHHHHHhcCCC------CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 31 QIRSEIVTLGQIR------HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 31 ~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.=+.|+++|++|+ --|+++++..|...+++|+|+|.+ ..+|.+.++.. +.+-.|....+..++.|+..||.+
T Consensus 474 tGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKy-G~nvGL~ikaVRsYaqQLflALkl 551 (752)
T KOG0670|consen 474 TGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKL 551 (752)
T ss_pred hhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHh-CcccceeehHHHHHHHHHHHHHHH
Confidence 3468999999995 238999999999999999999998 56999999862 334568888899999999888887
Q ss_pred hh--------ccCceeeecCCC-ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 105 LH--------MHQALVLLDHDM-EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 105 lH--------~~~~~il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
|- +||.|||++... .+||+|||.|........ +-..-+..|.|||++.+.+|+...|+||.||+|||
T Consensus 552 LK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYE 627 (752)
T KOG0670|consen 552 LKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYE 627 (752)
T ss_pred HHhcCeeecccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEE
Confidence 64 779999998764 579999999876544332 11233556999999999999999999999999999
Q ss_pred hcchHHHH
Q 041655 176 EMSLVKWM 183 (238)
Q Consensus 176 ~~t~~~~~ 183 (238)
+.||+--|
T Consensus 628 lYtGkIlF 635 (752)
T KOG0670|consen 628 LYTGKILF 635 (752)
T ss_pred eeccceec
Confidence 99976555
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-24 Score=192.50 Aligned_cols=187 Identities=16% Similarity=0.153 Sum_probs=125.9
Q ss_pred hcCCCC-Ccccceeeee-------ecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc---
Q 041655 39 LGQIRH-RNILPLLAHL-------ARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM--- 107 (238)
Q Consensus 39 l~~l~h-~~iv~~~~~~-------~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~--- 107 (238)
.+.++| +||.++++.| ..++.++.++|+. +++|.+++.. +...+++..+..++.||++||.|||+
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~gI 101 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQGI 101 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 345566 6888888887 2334667888888 5699999974 34569999999999999999999994
Q ss_pred -----cCceeeecCC-------------------CceEEcccccccccCCccc--------------ccccccccCCCcc
Q 041655 108 -----HQALVLLDHD-------------------MEARISEFGLAKVFPEAHT--------------HITTSDVVGTAGY 149 (238)
Q Consensus 108 -----~~~~il~~~~-------------------~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~~ 149 (238)
||.|||++.. +.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 4778999654 4456666666543211000 0000123578889
Q ss_pred cCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 150 ~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
+|||++.+..++.++|||||||++|||+++..|+...... ...+.....+............++..||+.+|.+| .
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT---MSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH---HHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence 9999999989999999999999999999987776532110 01111111111111223345677888999999999 4
Q ss_pred HHHH
Q 041655 229 VRCM 232 (238)
Q Consensus 229 v~~~ 232 (238)
+.+.
T Consensus 259 ~~ei 262 (793)
T PLN00181 259 MSEL 262 (793)
T ss_pred hHHH
Confidence 4333
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=151.69 Aligned_cols=169 Identities=29% Similarity=0.441 Sum_probs=142.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+..++.++|++++++++.+...+..++++|++++++|.+++.. ....+++..+..++.++++++.+||.
T Consensus 34 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~ 110 (215)
T cd00180 34 LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE---NEGKLSEDEILRILLQILEGLEYLHS 110 (215)
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 357789999999999999999999999998999999999998999999875 11468899999999999999999995
Q ss_pred c--------CceeeecC-CCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhc
Q 041655 108 H--------QALVLLDH-DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 ~--------~~~il~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~ 177 (238)
+ +.||+++. ++.++++|||.+........ ......+...|.+||..... ..+.++|+|++|++++++
T Consensus 111 ~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l- 187 (215)
T cd00180 111 NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL- 187 (215)
T ss_pred CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-
Confidence 5 55699998 89999999999876544321 11334577889999988776 778899999999999998
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
..+.+++..|++.+|++| ++.+.++
T Consensus 188 --------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 188 --------------------------------PELKDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred --------------------------------HHHHHHHHHHhhCCcccCcCHHHHhh
Confidence 557788888999999999 6555554
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=158.56 Aligned_cols=149 Identities=24% Similarity=0.378 Sum_probs=121.0
Q ss_pred HHHHHHHHhcCCCCCcccceeeeeec--------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 31 QIRSEIVTLGQIRHRNILPLLAHLAR--------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
..++|+.+|..|.|+|++.+...|.. ...+|+|+.+|+. +|...+.+ ....++..++.+++.+++.||
T Consensus 62 talreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL 137 (376)
T KOG0669|consen 62 TALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGL 137 (376)
T ss_pred HHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHH
Confidence 35789999999999999999888742 2358999999965 89998865 446788999999999999999
Q ss_pred chhhc--------cCceeeecCCCceEEcccccccccCCc--ccccccccccCCCcccCcccccc-cCCCccCCeeehhH
Q 041655 103 EYLHM--------HQALVLLDHDMEARISEFGLAKVFPEA--HTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGV 171 (238)
Q Consensus 103 ~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~ 171 (238)
.|+|. |+.|++++.+|.+||+|||+++.+... ......+.+.-|..|.+||.+.+ ..|+++.|+|..||
T Consensus 138 ~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgC 217 (376)
T KOG0669|consen 138 YYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGC 217 (376)
T ss_pred HHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHH
Confidence 99994 477899999999999999999765432 22223345566899999996654 56899999999999
Q ss_pred HHHhhcchHHHH
Q 041655 172 LLAEEMSLVKWM 183 (238)
Q Consensus 172 ~l~~~~t~~~~~ 183 (238)
++.||.|+.+-+
T Consensus 218 imaeMwtrspim 229 (376)
T KOG0669|consen 218 IMAEMWTRSPIM 229 (376)
T ss_pred HHHHHHccCccc
Confidence 999999865544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-23 Score=161.35 Aligned_cols=157 Identities=24% Similarity=0.325 Sum_probs=127.0
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHH
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQD 74 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~ 74 (238)
+||||++..+... ....++..+|..++..++|+|+++++.+|.-. ...|+|||++. ++|.+
T Consensus 43 ~v~ikk~~~pf~n------------~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~ 109 (369)
T KOG0665|consen 43 PVAIKKLSRPFQN------------QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQ 109 (369)
T ss_pred ceehhhhcCcccc------------CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHH
Confidence 4677777766322 12346678999999999999999999999644 34689999994 58888
Q ss_pred HHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCC
Q 041655 75 ILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGT 146 (238)
Q Consensus 75 ~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 146 (238)
.+.. .++=..+..++.|++.|++|+|+ ||.||++..+..+|+.|||.++.-... ...+....+
T Consensus 110 vi~~------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvt 180 (369)
T KOG0665|consen 110 VILM------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVT 180 (369)
T ss_pred HHHH------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc---cccCchhhe
Confidence 8753 35667788999999999999994 478899999999999999999753322 233556778
Q ss_pred CcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 147 AGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 147 ~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
..|.|||++.+..+..++||||+||++.||++|
T Consensus 181 Ryyrapevil~~~~ke~vdiwSvGci~gEli~~ 213 (369)
T KOG0665|consen 181 RYYRAPEVILGMGYKENVDIWSVGCIMGELILG 213 (369)
T ss_pred eeccCchheeccCCcccchhhhhhhHHHHHhhc
Confidence 899999999998899999999999999999874
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-23 Score=149.04 Aligned_cols=160 Identities=24% Similarity=0.311 Sum_probs=132.1
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
+||.|.+..++.+. ..-....+|+.+++.+.|.||++++++...+...-+|+|||.. +|..|.++
T Consensus 29 ivalkrvrldddde------------gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfds-- 93 (292)
T KOG0662|consen 29 IVALKRVRLDDDDE------------GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS-- 93 (292)
T ss_pred eEEEEEEeccCCCC------------CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHh--
Confidence 47888877665432 1235678999999999999999999999999999999999954 89999887
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
-+..++.+.++.++.|+++||.++|++ |.|.+++.+|.+|+.|||+++-++-.. ...+...-|..|.+|
T Consensus 94 -lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rcysaevvtlwyrpp 170 (292)
T KOG0662|consen 94 -LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPP 170 (292)
T ss_pred -cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--EeeeceeeeeeccCc
Confidence 355688999999999999999999954 788999999999999999998654322 123345568889999
Q ss_pred ccccccC-CCccCCeeehhHHHHhhcc
Q 041655 153 EYQQTLS-ITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 153 E~~~~~~-~~~~~DvwslG~~l~~~~t 178 (238)
.++-+.. |++..|+||.||++.|+..
T Consensus 171 dvlfgakly~tsidmwsagcifaelan 197 (292)
T KOG0662|consen 171 DVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_pred ceeeeeehhccchHhhhcchHHHHHhh
Confidence 9876654 7999999999999999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=154.01 Aligned_cols=153 Identities=29% Similarity=0.358 Sum_probs=129.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcc-cCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ-LDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+.+.+|+..+.+++|+|++++++.+...+..++++|++++++|.+++.. ... +++..+..++.+++.++.+||
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh 115 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLH 115 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 467888999999999999999999999988999999999999899999976 222 789999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccc-cccCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQ-QTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~-~~~~~~~~~DvwslG~~l~~~~ 177 (238)
.+ +.|++++.++.++++|||.+......... ......++..|++||.. ....++.++|+||||+++++|+
T Consensus 116 ~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~ 194 (225)
T smart00221 116 SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELL 194 (225)
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHH
Confidence 55 45699999999999999998876443211 11334667889999988 6667788999999999999999
Q ss_pred chHHHHHH
Q 041655 178 SLVKWMRN 185 (238)
Q Consensus 178 t~~~~~~~ 185 (238)
+|..||..
T Consensus 195 ~g~~pf~~ 202 (225)
T smart00221 195 WGPEPFSG 202 (225)
T ss_pred HCCCCccc
Confidence 99999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=168.43 Aligned_cols=204 Identities=19% Similarity=0.148 Sum_probs=130.4
Q ss_pred HHHHHHHHHhcCCCCCc-----ccceeeeeec--------CCeeEEEEEeCCCCCHHHHHhhhcC---------------
Q 041655 30 MQIRSEIVTLGQIRHRN-----ILPLLAHLAR--------PGCHLLVYEFMKNGSLQDILNDVSR--------------- 81 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~-----iv~~~~~~~~--------~~~~~~v~e~~~~~~L~~~l~~~~~--------------- 81 (238)
+.+..|+..+.+++|.+ ++++.++|.. .+..++|+||+++++|.+++.....
T Consensus 217 e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~ 296 (507)
T PLN03224 217 ETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKK 296 (507)
T ss_pred chhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCc
Confidence 34556777777776654 4677777643 3567999999999999999864211
Q ss_pred -----CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCc
Q 041655 82 -----GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAG 148 (238)
Q Consensus 82 -----~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 148 (238)
....+++..+..++.|++.||.|+|.+ +.||+++.++.+||+|||++......... ......+++.
T Consensus 297 l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~ 375 (507)
T PLN03224 297 IPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPR 375 (507)
T ss_pred hhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcc
Confidence 012346777889999999999999944 67899999999999999998654322111 1112234789
Q ss_pred ccCcccccccC--------------------CC--ccCCeeehhHHHHhhcchHH-HHHHhh------cc--CCCc---c
Q 041655 149 YIAPEYQQTLS--------------------IT--YMCDIYSFGVLLAEEMSLVK-WMRNVM------TS--ENPK---R 194 (238)
Q Consensus 149 ~~apE~~~~~~--------------------~~--~~~DvwslG~~l~~~~t~~~-~~~~~~------~~--~~~~---~ 194 (238)
|+|||.+.... ++ ...|+||+||++|+|+++.. |+.... .. .... .
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 99999865322 12 24699999999999998753 432111 00 0000 0
Q ss_pred cccccccCCChHHHHHHHHHHhhhhcCCCC---Ccc-hHHHHHH
Q 041655 195 AIDSKLLGNGYEEQMLLVLKTACFCTLDDP---KER-HVRCMLS 234 (238)
Q Consensus 195 ~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p---~~R-~v~~~L~ 234 (238)
...................+++.+++..+| .+| .+.+.|+
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 000111111122334556777777888766 578 7666664
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=154.56 Aligned_cols=200 Identities=23% Similarity=0.296 Sum_probs=151.7
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..-+.|..|.-.|+-+.||||+.++|.|.....+.++..|+|.|+|...+.+ ......+..++.+++.++++|++|||
T Consensus 229 risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflh 306 (448)
T KOG0195|consen 229 RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLH 306 (448)
T ss_pred hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHh
Confidence 3446788899899999999999999999999999999999999999999976 33455677888899999999999999
Q ss_pred ccCce----------eeecCCCceEEc--ccccccccCCcccccccccccCCCcccCcccccccCCC---ccCCeeehhH
Q 041655 107 MHQAL----------VLLDHDMEARIS--EFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSIT---YMCDIYSFGV 171 (238)
Q Consensus 107 ~~~~~----------il~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~---~~~DvwslG~ 171 (238)
+-... +++|.+.+.+++ |--.+ +......-.|.|++||.+...+-+ ..+|+|||.+
T Consensus 307 slep~ipr~~lns~hvmidedltarismad~kfs---------fqe~gr~y~pawmspealqrkped~n~raadmwsfai 377 (448)
T KOG0195|consen 307 SLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS---------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAI 377 (448)
T ss_pred hcchhhhhhhcccceEEecchhhhheecccceee---------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHH
Confidence 55322 677777666554 22111 111223457899999988776654 3699999999
Q ss_pred HHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 172 LLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
++||+.|...||......+--.++-.++++...|......+-+++.-|++.||.+| .++..|+.++
T Consensus 378 llwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 378 LLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999977665554455555666555555555555556666999999999 7777887764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=169.75 Aligned_cols=125 Identities=17% Similarity=0.179 Sum_probs=90.1
Q ss_pred ecCCeeEEEEEeCCCCCHHHHHhhhcCC----------------CcccCHHHHHHHHHHHHHHhchhhcc--------Cc
Q 041655 55 ARPGCHLLVYEFMKNGSLQDILNDVSRG----------------RRQLDWLARYRTVRGIASGLEYLHMH--------QA 110 (238)
Q Consensus 55 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~----------------~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~ 110 (238)
..++..++++||+++++|.+++...... ........+..++.|++.||.|||++ |.
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 3556789999999999999998642110 01112344667899999999999944 67
Q ss_pred eeeecC-CCceEEcccccccccCCcccccccccccCCCcccCccccccc----------------------CCCccCCee
Q 041655 111 LVLLDH-DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL----------------------SITYMCDIY 167 (238)
Q Consensus 111 ~il~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~----------------------~~~~~~Dvw 167 (238)
|||++. ++.+||+|||+++.+...... ......+++.|+|||.+... .++.++|||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 799985 589999999999765332211 22446788999999965322 233456999
Q ss_pred ehhHHHHhhcchH
Q 041655 168 SFGVLLAEEMSLV 180 (238)
Q Consensus 168 slG~~l~~~~t~~ 180 (238)
|+||++|||+++.
T Consensus 364 SlGviL~el~~~~ 376 (566)
T PLN03225 364 SAGLIFLQMAFPN 376 (566)
T ss_pred HHHHHHHHHHhCc
Confidence 9999999999754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-22 Score=152.40 Aligned_cols=151 Identities=27% Similarity=0.342 Sum_probs=122.2
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCC-----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPG-----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
...+++.+|+.+|..++|.|+++.++...-.. ..|+++|.+ ..+|...+-+ ...++...++-+..||++|
T Consensus 94 ~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVS----PQ~Ls~DHvKVFlYQILRG 168 (449)
T KOG0664|consen 94 ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVS----PQALTPDHVKVFVYQILRG 168 (449)
T ss_pred HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-Hhhhhheecc----CCCCCcchhhhhHHHHHhh
Confidence 35677899999999999999999999886542 357888888 4588888765 6789999999999999999
Q ss_pred hchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC-CCccCCeeehhHH
Q 041655 102 LEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS-ITYMCDIYSFGVL 172 (238)
Q Consensus 102 l~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~-~~~~~DvwslG~~ 172 (238)
|.||| .||.|.+++++..+|++|||+++.-+......- +...-|.+|.|||++.+.. |+...||||.||+
T Consensus 169 LKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCI 247 (449)
T KOG0664|consen 169 LKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCI 247 (449)
T ss_pred hHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHH
Confidence 99999 557789999999999999999987544322211 2234578999999988754 7899999999999
Q ss_pred HHhhcchHHHH
Q 041655 173 LAEEMSLVKWM 183 (238)
Q Consensus 173 l~~~~t~~~~~ 183 (238)
+.|++..+-.|
T Consensus 248 FaELLgRrILF 258 (449)
T KOG0664|consen 248 FAELLQRKILF 258 (449)
T ss_pred HHHHHhhhhhh
Confidence 99988655444
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=142.18 Aligned_cols=189 Identities=16% Similarity=0.204 Sum_probs=135.5
Q ss_pred HHHHHHHHHHHhcCCC-CCcccceeee-eecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 28 EMMQIRSEIVTLGQIR-HRNILPLLAH-LARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~-h~~iv~~~~~-~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...+|.+|...=-.|. |.||+.-|++ |++.+.+.+++||+|.|+|.+-+.. ..+-+..-+.++.|+++++.|+
T Consensus 63 t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fM 137 (378)
T KOG1345|consen 63 TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFM 137 (378)
T ss_pred hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHh
Confidence 4678999998766665 8999988775 7788888899999999999887753 4577888889999999999999
Q ss_pred hccCc--------eeee-c-CCCceEEcccccccccCCcccccccccccCCCcccCccccccc---C--CCccCCeeehh
Q 041655 106 HMHQA--------LVLL-D-HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL---S--ITYMCDIYSFG 170 (238)
Q Consensus 106 H~~~~--------~il~-~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~---~--~~~~~DvwslG 170 (238)
|+++. |||+ + +.-++||+|||.++..+.-. .....+..|.+||.+... . ..+.+|+|.||
T Consensus 138 HsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfG 212 (378)
T KOG1345|consen 138 HSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFG 212 (378)
T ss_pred hccchhhcccccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchhee
Confidence 98743 4554 3 33479999999987543221 123345678899865432 2 35679999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCcc-------cccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKR-------AIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+++|.++||..||+.......... .... ..++.........+.+-++-+..+|++|
T Consensus 213 Ii~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 213 IIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-ALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred eeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-cCchhhcccCHHHHHHHHHhcCCccccc
Confidence 999999999999986554333211 1111 1222333444456667777899999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-20 Score=137.69 Aligned_cols=148 Identities=22% Similarity=0.365 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHHhcCCC-CCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 27 EEMMQIRSEIVTLGQIR-HRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
...+.+.+|+.+|..|. ||||++++++..+. ....+++||..+.+..... ..++...+..++.+++.||.
T Consensus 74 VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALd 146 (338)
T KOG0668|consen 74 VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALD 146 (338)
T ss_pred HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHh
Confidence 34577889999999998 99999999999765 4567999999887766655 34777888999999999999
Q ss_pred hhhcc--------CceeeecCCC-ceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHH
Q 041655 104 YLHMH--------QALVLLDHDM-EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLL 173 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l 173 (238)
|+|+. |-|+++|... .++|+|+|++.++..... .+-+..+..|-.||.+.+. .|+..-|+|||||++
T Consensus 147 yCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~Gcml 223 (338)
T KOG0668|consen 147 YCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 223 (338)
T ss_pred HHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHH
Confidence 99955 6678888764 589999999988765543 2445678889999987654 478899999999999
Q ss_pred HhhcchHHHHH
Q 041655 174 AEEMSLVKWMR 184 (238)
Q Consensus 174 ~~~~t~~~~~~ 184 (238)
..|+-.+.||.
T Consensus 224 A~miFrkepFF 234 (338)
T KOG0668|consen 224 ASMIFRKEPFF 234 (338)
T ss_pred HHHHhccCccc
Confidence 99988777763
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5e-20 Score=153.45 Aligned_cols=186 Identities=24% Similarity=0.336 Sum_probs=141.2
Q ss_pred hcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhccC---------
Q 041655 39 LGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ--------- 109 (238)
Q Consensus 39 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~~--------- 109 (238)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.-...+.++++.||.|+|..+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecc
Confidence 4678999999999999999999999999999999999975 5677888888889999999999999664
Q ss_pred ceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC-------CCccCCeeehhHHHHhhcchHHH
Q 041655 110 ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS-------ITYMCDIYSFGVLLAEEMSLVKW 182 (238)
Q Consensus 110 ~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~-------~~~~~DvwslG~~l~~~~t~~~~ 182 (238)
.|++++..+.+|++|||+.................-...|.|||.++... .+.+.|+||||++++|+++...|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 46899999999999999988764311111111122345699999887642 35579999999999999999998
Q ss_pred HHHhhccCCCcccc-------cccccCCCh-H-HHHHHHHHHhhhhcCCCCCcc
Q 041655 183 MRNVMTSENPKRAI-------DSKLLGNGY-E-EQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 183 ~~~~~~~~~~~~~~-------~~~~~~~~~-~-~~~~~l~~~~~~cl~~~p~~R 227 (238)
|...........++ ....++... . +.+..++.++..||..+|++|
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~r 211 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKR 211 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhC
Confidence 87655444321211 111222222 1 444568999999999999999
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=147.17 Aligned_cols=76 Identities=25% Similarity=0.367 Sum_probs=63.7
Q ss_pred HHHHHHHHHHHhcCCC-----CC---cccceeeeee----cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIR-----HR---NILPLLAHLA----RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTV 95 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~-----h~---~iv~~~~~~~----~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 95 (238)
..+..+-|+.+|++++ |+ +||++++.|. .+.++|+|+|++ |.+|..++.. ...+.++...+++|+
T Consensus 117 YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~ 193 (590)
T KOG1290|consen 117 YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEIC 193 (590)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHH
Confidence 4566778999999984 32 6999999995 456789999999 7799999976 445678899999999
Q ss_pred HHHHHHhchhh
Q 041655 96 RGIASGLEYLH 106 (238)
Q Consensus 96 ~~l~~gl~~lH 106 (238)
+|++.||.|||
T Consensus 194 ~qvL~GLdYLH 204 (590)
T KOG1290|consen 194 RQVLTGLDYLH 204 (590)
T ss_pred HHHHHHHHHHH
Confidence 99999999999
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.8e-19 Score=151.89 Aligned_cols=197 Identities=20% Similarity=0.215 Sum_probs=150.1
Q ss_pred HHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-----
Q 041655 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----- 106 (238)
Q Consensus 32 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH----- 106 (238)
+..|..+-..+.|||++.....+.+.....-.||||++ +|..++.. ...++...+..++.|++.|++|+|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~Gia 442 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMGLA 442 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcCce
Confidence 66788888899999998888888777666666999998 99999975 346788888999999999999999
Q ss_pred ---ccCceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCcccccccCCCc-cCCeeehhHHHHhhcchH
Q 041655 107 ---MHQALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQTLSITY-MCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 107 ---~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~~~~~~-~~DvwslG~~l~~~~t~~ 180 (238)
.|+.|++++.+|.+|++|||.+......... .......|+-.|+|||++.+..|+. ..||||.|+++..|++|.
T Consensus 443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 4467899999999999999998765332221 3345678999999999999999876 699999999999999998
Q ss_pred HHHHHhhccCCC--cccccccc-c----CCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 181 KWMRNVMTSENP--KRAIDSKL-L----GNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 181 ~~~~~~~~~~~~--~~~~~~~~-~----~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
.||......... ........ . .......+.....++.++|+.||.+| ++-+.|
T Consensus 523 ~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred CccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 888654433221 11111111 1 11234456667888889999999999 554444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.6e-17 Score=130.42 Aligned_cols=161 Identities=22% Similarity=0.287 Sum_probs=126.5
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
||+|.|..... ..++.+|+++|..+. +.||+++.+++..++...+|+||.+.....+++..
T Consensus 67 valk~i~~ts~----------------p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-- 128 (418)
T KOG1167|consen 67 VALKAIYRTSS----------------PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-- 128 (418)
T ss_pred EeeeecccccC----------------chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc--
Confidence 67777766544 355889999999996 89999999999999999999999999889998865
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCC-CceEEcccccccccCCc-------c------cc-
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHD-MEARISEFGLAKVFPEA-------H------TH- 137 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~-~~~kl~dfg~~~~~~~~-------~------~~- 137 (238)
++...+..+++.++.||+++|.+ |.|++.+.. +.-.|.|||++...... . ..
T Consensus 129 -----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~ 203 (418)
T KOG1167|consen 129 -----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPA 203 (418)
T ss_pred -----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCcc
Confidence 66788889999999999999955 566777654 56789999998721100 0 00
Q ss_pred ----------------------------cccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcchHHHHHH
Q 041655 138 ----------------------------ITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLVKWMRN 185 (238)
Q Consensus 138 ----------------------------~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~~~ 185 (238)
.......||++|.|||++... ..+++.||||.|+++..++++..||..
T Consensus 204 ~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 204 MGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred ccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccccccc
Confidence 001124699999999987644 468899999999999999998888743
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=128.50 Aligned_cols=200 Identities=28% Similarity=0.360 Sum_probs=148.3
Q ss_pred HHHHHHHHHHHHhcCCCCC-cccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQIRHR-NILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.....+.+|..++..+.|+ +++++.+.+......+++++++.++++.+++...... ..++......++.|++.++.|+
T Consensus 39 ~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~ 117 (384)
T COG0515 39 KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYL 117 (384)
T ss_pred hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHH
Confidence 3567899999999999988 7999999998887789999999999999777651111 3688999999999999999999
Q ss_pred hcc--------CceeeecCCC-ceEEcccccccccCCccccc----ccccccCCCcccCcccccc---cCCCccCCeeeh
Q 041655 106 HMH--------QALVLLDHDM-EARISEFGLAKVFPEAHTHI----TTSDVVGTAGYIAPEYQQT---LSITYMCDIYSF 169 (238)
Q Consensus 106 H~~--------~~~il~~~~~-~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~apE~~~~---~~~~~~~Dvwsl 169 (238)
|.. |.|++++..+ .+++.|||.++......... ......|+..|++||...+ ...+...|+||+
T Consensus 118 H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~ 197 (384)
T COG0515 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197 (384)
T ss_pred HhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHH
Confidence 944 5779999998 79999999998654433221 2356789999999999887 577889999999
Q ss_pred hHHHHhhcchHHHHHHhhc---cCCCccccccccc----CCChH----HHHHHHHHHhhhhcCCCCCcc
Q 041655 170 GVLLAEEMSLVKWMRNVMT---SENPKRAIDSKLL----GNGYE----EQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 170 G~~l~~~~t~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~----~~~~~l~~~~~~cl~~~p~~R 227 (238)
|++++++.++..|+..... .......+..... ..... .....+.+++..|+..+|..|
T Consensus 198 g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r 266 (384)
T COG0515 198 GITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNR 266 (384)
T ss_pred HHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhc
Confidence 9999999998877443221 0111111111111 11111 112456777788999999999
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2e-17 Score=138.71 Aligned_cols=179 Identities=22% Similarity=0.240 Sum_probs=142.4
Q ss_pred HHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh---
Q 041655 31 QIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH--- 106 (238)
Q Consensus 31 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH--- 106 (238)
....|..++...+ ||.++++.-.++.+...+++++|..+|.|...+.. ...+.+.....+...++.+++++|
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~ 117 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG 117 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH
Confidence 4566888899997 99999999999999999999999999888877754 566777888888889999999999
Q ss_pred -----ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 107 -----MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 107 -----~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
.|+.||+++.+|++++.|||+++..-.... .+|+..|+|||+.. .....+|+||||++.++|+||..
T Consensus 118 iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~ 189 (612)
T KOG0603|consen 118 IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTL 189 (612)
T ss_pred HHHhcccccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCC
Confidence 557889999999999999999986433221 28899999999998 45678999999999999999999
Q ss_pred HHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 182 WMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
||.. +....++... ...+.+......+++...+..+|.+|
T Consensus 190 pf~~----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 190 PFGG----DTMKRILKAE--LEMPRELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred CCch----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhCHHHH
Confidence 9986 2222222212 22344444455666667899999999
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=120.84 Aligned_cols=179 Identities=18% Similarity=0.202 Sum_probs=125.0
Q ss_pred CCCcccceeeeeec---------------------------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHH
Q 041655 43 RHRNILPLLAHLAR---------------------------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTV 95 (238)
Q Consensus 43 ~h~~iv~~~~~~~~---------------------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 95 (238)
.|||||++++.|.+ +..+|+||.-.+. +|.+++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 59999999998854 2356899998855 89999975 345666677788
Q ss_pred HHHHHHhchhhcc--------Cceeee--cCCC--ceEEcccccccccCCccc----ccccccccCCCcccCcccccccC
Q 041655 96 RGIASGLEYLHMH--------QALVLL--DHDM--EARISEFGLAKVFPEAHT----HITTSDVVGTAGYIAPEYQQTLS 159 (238)
Q Consensus 96 ~~l~~gl~~lH~~--------~~~il~--~~~~--~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~~~apE~~~~~~ 159 (238)
.|+++|+.|||.+ .+||++ |+++ .+.++|||++---..... ....-...|....||||+....+
T Consensus 348 aQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999944 567775 4443 378999998632111000 01123467888899999865432
Q ss_pred -----CC-ccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 160 -----IT-YMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 160 -----~~-~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.+ .++|.|+.|.+.||+++...||++.-+.........+...+..++..+..+.+++-..|+.||.+|
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskR 501 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKR 501 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCcccc
Confidence 22 379999999999999999999987211111111122223345567777888889999999999999
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=118.35 Aligned_cols=132 Identities=22% Similarity=0.205 Sum_probs=93.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccc-eeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQIRHRNILP-LLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+.|.+|+.+|++++|+|++. +++. +..|+||||+++++|.. .. ... ...++.|++++|.|||
T Consensus 64 ~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH 128 (365)
T PRK09188 64 ARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLH 128 (365)
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHH
Confidence 4567899999999999999985 4432 45799999999998863 21 011 1357789999999999
Q ss_pred c---------cCceeeecCCCceEEcccccccccCCcccccc------cccccCCCcccCcccccccC------CCccCC
Q 041655 107 M---------HQALVLLDHDMEARISEFGLAKVFPEAHTHIT------TSDVVGTAGYIAPEYQQTLS------ITYMCD 165 (238)
Q Consensus 107 ~---------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~~~apE~~~~~~------~~~~~D 165 (238)
+ ||.||+++.++.++|+|||+++.+........ .....+++.|.+||.+.... .+..+|
T Consensus 129 ~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~d 208 (365)
T PRK09188 129 RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSR 208 (365)
T ss_pred HCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccC
Confidence 3 78899999999999999999987654332111 13456788899999875432 223356
Q ss_pred ee-ehhHHHH
Q 041655 166 IY-SFGVLLA 174 (238)
Q Consensus 166 vw-slG~~l~ 174 (238)
-| ..|=+.+
T Consensus 209 gW~~TGDlg~ 218 (365)
T PRK09188 209 IWLATGKKVY 218 (365)
T ss_pred cEEeCCCEEE
Confidence 66 5554444
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-15 Score=125.66 Aligned_cols=164 Identities=19% Similarity=0.280 Sum_probs=117.8
Q ss_pred eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch---hh--ccCceeeecCCCceEEcccccccccCC
Q 041655 59 CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY---LH--MHQALVLLDHDMEARISEFGLAKVFPE 133 (238)
Q Consensus 59 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~---lH--~~~~~il~~~~~~~kl~dfg~~~~~~~ 133 (238)
.+|+.|++|...+|.+|+.... .....++.....++.|++.|+.| +| .+|.||+...+..+||+|||+......
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~yk~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~ 408 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEYKGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDK 408 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhhccchhhhccccccccccchhhhhhhhhheeeccc
Confidence 4789999999999999997532 33456778888999999988874 34 668899999999999999999765433
Q ss_pred cc----cccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHH
Q 041655 134 AH----THITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQ 208 (238)
Q Consensus 134 ~~----~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (238)
.. .....+...||..||+||.+.+..|+.++||||||.+|+|+.. ..-.+...-...++. +..+.+....+.
T Consensus 409 ~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r---~g~ip~~~~~d~ 485 (516)
T KOG1033|consen 409 DETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIR---DGIIPPEFLQDY 485 (516)
T ss_pred CCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhh---cCCCChHHhhcC
Confidence 32 1112345789999999999999999999999999999999987 344443322222221 222222222222
Q ss_pred HHHHHHHhhhhcCCCCCcc
Q 041655 209 MLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 209 ~~~l~~~~~~cl~~~p~~R 227 (238)
+.+ ..++..++.+.|.+|
T Consensus 486 p~e-~~ll~~lls~~p~~R 503 (516)
T KOG1033|consen 486 PEE-YTLLQQLLSPSPEER 503 (516)
T ss_pred cHH-HHHHHHhcCCCcccC
Confidence 222 456667899999999
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=111.86 Aligned_cols=154 Identities=17% Similarity=0.168 Sum_probs=121.4
Q ss_pred HHHHHHHHhcCCCC----Ccccceeeee-ecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 31 QIRSEIVTLGQIRH----RNILPLLAHL-ARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 31 ~~~~E~~~l~~l~h----~~iv~~~~~~-~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+..|+.++..+.. +++..+.+.. ..++..|+||+.+ |.+|.++.... +...++..++..++.|++.+|+++
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~--~~~~fs~~T~l~ia~q~l~~l~~l 138 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRN--PPGRFSRKTVLRIAIQNLNALEDL 138 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhC--CCCCcCHhHHHHHHHHHHHHHHHH
Confidence 56678888888862 5788888888 5777889999998 78999988652 257799999999999999999999
Q ss_pred h--------ccCceeeecCC-----CceEEccccccc--ccCCccc----ccc--cccccCCCcccCcccccccCCCccC
Q 041655 106 H--------MHQALVLLDHD-----MEARISEFGLAK--VFPEAHT----HIT--TSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 106 H--------~~~~~il~~~~-----~~~kl~dfg~~~--~~~~~~~----~~~--~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
| .||.|+++... ..+.+.|||+++ .+..... ... .....||..|+++....+...+.+.
T Consensus 139 H~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~D 218 (322)
T KOG1164|consen 139 HSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRD 218 (322)
T ss_pred HhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCch
Confidence 9 44777888765 468999999998 3322211 111 1234599999999999999999999
Q ss_pred CeeehhHHHHhhcchHHHHHHhh
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVM 187 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~ 187 (238)
|+||++.++.++..|..||....
T Consensus 219 Dles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 219 DLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred hhhhHHHHHHHHhcCCCCCcccc
Confidence 99999999999999987775433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.2e-13 Score=105.79 Aligned_cols=121 Identities=14% Similarity=0.172 Sum_probs=89.4
Q ss_pred HHHHHHHHhcCCCCCcccceeeeeecC--------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 31 QIRSEIVTLGQIRHRNILPLLAHLARP--------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
.+.+|+..+.+++||+|..+..++... +..+++|||++|.+|.++.. +++. ...+++.++
T Consensus 81 ~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~~----~~~~i~~~l 148 (232)
T PRK10359 81 YYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISED----VKAKIKASI 148 (232)
T ss_pred HHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccHH----HHHHHHHHH
Confidence 368999999999999999998886533 35789999999999988742 2222 345888899
Q ss_pred chhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 103 EYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 103 ~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
..+|. +|.|++++++| ++++|||.......... .........++.++|+||||+++.
T Consensus 149 ~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~ 213 (232)
T PRK10359 149 ESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLL 213 (232)
T ss_pred HHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeeh
Confidence 99994 47789999988 99999998765422110 011333445678999999999887
Q ss_pred hhcc
Q 041655 175 EEMS 178 (238)
Q Consensus 175 ~~~t 178 (238)
....
T Consensus 214 ~~~~ 217 (232)
T PRK10359 214 IYKK 217 (232)
T ss_pred HHHH
Confidence 6554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.3e-14 Score=121.88 Aligned_cols=201 Identities=19% Similarity=0.226 Sum_probs=149.3
Q ss_pred HHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...++...|..+-+.+. |+|++++++.....+..++.++|..++++.+.+.. ......+......++.|+..|+.|+
T Consensus 62 ~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~ 139 (601)
T KOG0590|consen 62 DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYL 139 (601)
T ss_pred chhhhcCccccccccccccccccccCCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCcccc
Confidence 34455666888888887 99999999999999999999999999999888832 1222455566677899999999999
Q ss_pred h---------ccCceeeecCCC-ceEEcccccccccCC-cccccccccccC-CCcccCccccccc-CCCccCCeeehhHH
Q 041655 106 H---------MHQALVLLDHDM-EARISEFGLAKVFPE-AHTHITTSDVVG-TAGYIAPEYQQTL-SITYMCDIYSFGVL 172 (238)
Q Consensus 106 H---------~~~~~il~~~~~-~~kl~dfg~~~~~~~-~~~~~~~~~~~~-~~~~~apE~~~~~-~~~~~~DvwslG~~ 172 (238)
| .+|.|.+++..+ .++..|||++..+.. ...........| ++.|+|||...+. ..+...|+||.|++
T Consensus 140 H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~ 219 (601)
T KOG0590|consen 140 HPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIV 219 (601)
T ss_pred CcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccc
Confidence 9 347789999999 999999999987655 333333345677 9999999988874 45788999999999
Q ss_pred HHhhcchHHHHHHhhccCCC-ccccccc--ccCCChHHHHHHHHHHhhhhcCCCCCcchH
Q 041655 173 LAEEMSLVKWMRNVMTSENP-KRAIDSK--LLGNGYEEQMLLVLKTACFCTLDDPKERHV 229 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~l~~~~~~cl~~~p~~R~v 229 (238)
+..+.+|..|+......... ....... ..............+++.+++..+|..|-.
T Consensus 220 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s 279 (601)
T KOG0590|consen 220 LSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS 279 (601)
T ss_pred ccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccc
Confidence 99999998777654433322 2222211 122334444455677777888899999933
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.4e-12 Score=102.50 Aligned_cols=169 Identities=17% Similarity=0.207 Sum_probs=132.7
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhh
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDV 79 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~ 79 (238)
+||||.-..+.- ..++.-|....+.|. .++|..++-+-.++-.-.+|+|.+ |.+|.|+.+-
T Consensus 55 ~VAIKfEPrkS~----------------APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~- 116 (449)
T KOG1165|consen 55 PVAIKFEPRKSE----------------APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL- 116 (449)
T ss_pred eEEEEeccccCC----------------cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH-
Confidence 488886654433 245566777777775 678888876666776778999999 7899998764
Q ss_pred cCCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCC-----ceEEcccccccccCCcccc-----cccc
Q 041655 80 SRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDM-----EARISEFGLAKVFPEAHTH-----ITTS 141 (238)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~-----~~kl~dfg~~~~~~~~~~~-----~~~~ 141 (238)
-+..|+.+++..++.|++.-++|+| .||.|+||..-+ .+-++|||+++.+-+.... ....
T Consensus 117 --CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~K 194 (449)
T KOG1165|consen 117 --CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHK 194 (449)
T ss_pred --hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccc
Confidence 4567999999999999999999999 558889986543 4789999999977443221 1224
Q ss_pred cccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhcc
Q 041655 142 DVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTS 189 (238)
Q Consensus 142 ~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~ 189 (238)
+..||..||+.-...+...+...|+=|+|-++.+.+.|..||+..-..
T Consensus 195 SLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 195 SLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred ccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 578999999999988999999999999999999999999999876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=7e-12 Score=95.46 Aligned_cols=93 Identities=12% Similarity=0.125 Sum_probs=71.4
Q ss_pred HHHHHHHHHHhcCC-----CCCcccceeeeeecCC---eeE-EEEEe--CCCCCHHHHHhhhcCCCcccCHHHHHHHHHH
Q 041655 29 MMQIRSEIVTLGQI-----RHRNILPLLAHLARPG---CHL-LVYEF--MKNGSLQDILNDVSRGRRQLDWLARYRTVRG 97 (238)
Q Consensus 29 ~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~~~-~v~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 97 (238)
.+.+.+|+.++..+ +||||++++|++.++. ..+ +|+|| +++++|.+++.+ ..+++. ..++.|
T Consensus 40 ~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~ 112 (210)
T PRK10345 40 DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQ 112 (210)
T ss_pred HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHH
Confidence 46789999999999 5799999999998763 333 78999 557899999965 235554 245678
Q ss_pred HHHHh-chhhcc--------CceeeecC----CCceEEcccccc
Q 041655 98 IASGL-EYLHMH--------QALVLLDH----DMEARISEFGLA 128 (238)
Q Consensus 98 l~~gl-~~lH~~--------~~~il~~~----~~~~kl~dfg~~ 128 (238)
++.++ +|||++ |.||+++. ++.++|+|++.+
T Consensus 113 ~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 113 LLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 88888 899954 67899974 347999995443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.5e-12 Score=94.52 Aligned_cols=93 Identities=15% Similarity=0.071 Sum_probs=69.8
Q ss_pred HHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh-hc---
Q 041655 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL-HM--- 107 (238)
Q Consensus 32 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l-H~--- 107 (238)
..+|...+.++.++++........ .+ .++||||++++++...... ...++...+..++.|++.+|.++ |.
T Consensus 66 ~~~E~~~l~~l~~~~v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~gi 139 (190)
T cd05147 66 AEKEMRNLKRLVTAGIPCPEPILL-KS-HVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCRL 139 (190)
T ss_pred HHHHHHHHHHHHHCCCCCCcEEEe-cC-CEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCc
Confidence 356999999998777644333222 22 3899999988776655332 34688899999999999999999 64
Q ss_pred -----cCceeeecCCCceEEccccccccc
Q 041655 108 -----HQALVLLDHDMEARISEFGLAKVF 131 (238)
Q Consensus 108 -----~~~~il~~~~~~~kl~dfg~~~~~ 131 (238)
||.||+++ ++.++|+|||++...
T Consensus 140 iHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 140 VHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred ccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 47789998 478999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-13 Score=122.71 Aligned_cols=212 Identities=20% Similarity=0.209 Sum_probs=136.2
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
|.||++.++.... +=....+-+.|++ +..+++||++.+..+...+...|+|=+|..+ +|.|.+..
T Consensus 49 vVvKVFvk~~p~~----------sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlST--- 113 (1431)
T KOG1240|consen 49 VVVKVFVKQDPTI----------SLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLST--- 113 (1431)
T ss_pred EEEEEEeccCCCC----------CchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhcc---
Confidence 6778777665321 1111222334555 5666899999999888877777888888854 89999865
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccc--cCCccc-----ccccccccCC
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKV--FPEAHT-----HITTSDVVGT 146 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~--~~~~~~-----~~~~~~~~~~ 146 (238)
+.-+...+.+=++.|++.|+..+| .|..|||+++-+=+.|+||.--+. ++..+. .+.+ ....
T Consensus 114 -RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDT--SrRR 190 (1431)
T KOG1240|consen 114 -RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDT--SRRR 190 (1431)
T ss_pred -chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEec--CCce
Confidence 333566777778999999999999 456789999998899999977653 222111 1111 2234
Q ss_pred CcccCcccccc----------cC-CCccCCeeehhHHHHhhcch-HHHHHHhhccCCCccc--ccc-cccCCChHHHHHH
Q 041655 147 AGYIAPEYQQT----------LS-ITYMCDIYSFGVLLAEEMSL-VKWMRNVMTSENPKRA--IDS-KLLGNGYEEQMLL 211 (238)
Q Consensus 147 ~~~~apE~~~~----------~~-~~~~~DvwslG~~l~~~~t~-~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~ 211 (238)
.+|.|||-... .. .+++.||+|+||++.|+++- .++|.- ......... .+. ......... .
T Consensus 191 tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-SQL~aYr~~~~~~~e~~Le~Ied~---~ 266 (1431)
T KOG1240|consen 191 TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-SQLLAYRSGNADDPEQLLEKIEDV---S 266 (1431)
T ss_pred eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-HHHHhHhccCccCHHHHHHhCcCc---c
Confidence 67999995432 12 45688999999999999874 555532 211111110 000 000011111 4
Q ss_pred HHHHhhhhcCCCCCcc-hHHHHHHh
Q 041655 212 VLKTACFCTLDDPKER-HVRCMLSQ 235 (238)
Q Consensus 212 l~~~~~~cl~~~p~~R-~v~~~L~~ 235 (238)
+..++..|++.||++| ..-+-|++
T Consensus 267 ~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 267 LRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHHHHccCchhccCHHHHHHh
Confidence 6678888999999999 65555554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-12 Score=97.63 Aligned_cols=158 Identities=18% Similarity=0.187 Sum_probs=125.3
Q ss_pred HHHHHHHHHHhcCCCC-CcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-
Q 041655 29 MMQIRSEIVTLGQIRH-RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH- 106 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH- 106 (238)
..+...|..+...|++ ..|..+..+..+...-.+||+.+ |.+|.+..+- -...++..+++.++.|++.-++|+|
T Consensus 54 hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~ 129 (341)
T KOG1163|consen 54 HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHL 129 (341)
T ss_pred CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHh
Confidence 4567889999999985 56777777777777788999999 7899998764 3466899999999999999999999
Q ss_pred -------ccCceeeecCCC---ceEEcccccccccCCccc-----ccccccccCCCcccCcccccccCCCccCCeeehhH
Q 041655 107 -------MHQALVLLDHDM---EARISEFGLAKVFPEAHT-----HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171 (238)
Q Consensus 107 -------~~~~~il~~~~~---~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~ 171 (238)
.||.|+++.-.. .+-++|||+|+.+-+... ........||..|++.-...+...+...|+=|+|.
T Consensus 130 r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgY 209 (341)
T KOG1163|consen 130 RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGY 209 (341)
T ss_pred hccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcc
Confidence 568888876543 478999999986643221 12334578999999988887778889999999999
Q ss_pred HHHhhcchHHHHHHhhccC
Q 041655 172 LLAEEMSLVKWMRNVMTSE 190 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~ 190 (238)
+|.+.-.|..||+......
T Consensus 210 vLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 210 VLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred eeeeeecCCCcccccchhh
Confidence 9998888999987665443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.2e-12 Score=102.72 Aligned_cols=142 Identities=25% Similarity=0.334 Sum_probs=104.5
Q ss_pred HhcCCCCCcccceeeeeec-----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhccC--c
Q 041655 38 TLGQIRHRNILPLLAHLAR-----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ--A 110 (238)
Q Consensus 38 ~l~~l~h~~iv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~~--~ 110 (238)
-|..+.|.||++++.++.+ ..+..++.||+..|++.+|+.+.......+....-.+|+.|++.||.|||+.. +
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 3455679999999999854 34578999999999999999987777788899999999999999999999652 1
Q ss_pred --------eeeecCCCceEEcccccccccCC--cccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 111 --------LVLLDHDMEARISEFGLAKVFPE--AHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 111 --------~il~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
-+++..+|-+|++.-.-...-.. .......+...+.++|.+||.-....-+..+|||+||+...+|..+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 16777888888753211111000 0111111234567889999987776777899999999999988765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.6e-12 Score=95.31 Aligned_cols=140 Identities=14% Similarity=0.070 Sum_probs=99.1
Q ss_pred HHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--
Q 041655 31 QIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-- 107 (238)
Q Consensus 31 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~-- 107 (238)
.+.+|+++|++|. |+++.+++++ +..+++|||++|.+|.+.... . ...++.|++.+|.++|.
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~G 111 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRCG 111 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHCc
Confidence 5789999999996 5789999886 346899999998888654321 1 12467889999999993
Q ss_pred -------cCceeeecCCCceEEcccccccccCCcccc----c-------ccccccCCCcccCccccccc-CCC-ccCCee
Q 041655 108 -------HQALVLLDHDMEARISEFGLAKVFPEAHTH----I-------TTSDVVGTAGYIAPEYQQTL-SIT-YMCDIY 167 (238)
Q Consensus 108 -------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~----~-------~~~~~~~~~~~~apE~~~~~-~~~-~~~Dvw 167 (238)
++.||+++.++.++|+|||++......... . .......++.+++|+...-. ..+ ...+++
T Consensus 112 IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~ 191 (218)
T PRK12274 112 VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF 191 (218)
T ss_pred CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence 578999999999999999999854332210 0 01112356677777643221 223 345667
Q ss_pred ehhHHHHhhcchHHHHHH
Q 041655 168 SFGVLLAEEMSLVKWMRN 185 (238)
Q Consensus 168 slG~~l~~~~t~~~~~~~ 185 (238)
+.|.-+|.++|+.-+.++
T Consensus 192 ~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 192 ATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HhcchHHHHHhccCCccc
Confidence 999999999998776654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.4e-11 Score=90.75 Aligned_cols=94 Identities=15% Similarity=0.112 Sum_probs=72.0
Q ss_pred HHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHH-HhhhcCCCcccCHHHHHHHHHHHHHHhchhhc-c
Q 041655 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDI-LNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-H 108 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~-~ 108 (238)
.+.+|...+.++.|+++.....+.... .++||||++++++... +. ...++......++.|++.++.++|. +
T Consensus 65 ~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~ 137 (190)
T cd05145 65 WAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA 137 (190)
T ss_pred HHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 446799999999998875444443332 3799999988755433 33 2456788889999999999999996 4
Q ss_pred --------CceeeecCCCceEEcccccccccC
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFP 132 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~ 132 (238)
|.||+++ ++.++|+|||++....
T Consensus 138 givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 138 GLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 6789998 8899999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.4e-12 Score=102.89 Aligned_cols=155 Identities=16% Similarity=0.137 Sum_probs=97.3
Q ss_pred EEEEEeCCCCCHHHHHhhh---cCCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEccccccc
Q 041655 61 LLVYEFMKNGSLQDILNDV---SRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAK 129 (238)
Q Consensus 61 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~ 129 (238)
+++|+-+ .++|.+++... ......+....+..+..|+.+.+++||.. +.|++++.+|.+.|+||+...
T Consensus 115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~ 193 (288)
T PF14531_consen 115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLV 193 (288)
T ss_dssp EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEE
T ss_pred hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHe
Confidence 5677766 56888875421 12223455556667779999999999954 667999999999999998765
Q ss_pred ccCCcccccccccccCCCcccCcccccc--------cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccccccc
Q 041655 130 VFPEAHTHITTSDVVGTAGYIAPEYQQT--------LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLL 201 (238)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~apE~~~~--------~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~ 201 (238)
..+.... ....+..|.|||.... ..++.+.|.|++|+++|.+..+..||........... ..
T Consensus 194 r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----~f 263 (288)
T PF14531_consen 194 RAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----DF 263 (288)
T ss_dssp ETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----GG
T ss_pred ecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----cc
Confidence 5433221 1234577999997644 2467889999999999999999888864433332221 12
Q ss_pred CCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 202 GNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 202 ~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..+. +.+..+..+|..+|+.||++|
T Consensus 264 ~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 264 SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 2233 667778888999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.5e-13 Score=116.65 Aligned_cols=129 Identities=20% Similarity=0.191 Sum_probs=97.3
Q ss_pred HHHhchhh--------ccCceeeecCCCceEEcccccccccCCc-------------ccccccccccCCCcccCcccccc
Q 041655 99 ASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEA-------------HTHITTSDVVGTAGYIAPEYQQT 157 (238)
Q Consensus 99 ~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~-------------~~~~~~~~~~~~~~~~apE~~~~ 157 (238)
+.+++|+| .++.|.+++.-|++|+.|||+++..... ..++.....+||+.|.|||++.-
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 67899999 4567799999999999999998742110 11112233589999999999999
Q ss_pred cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 158 LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 158 ~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..|+..+|+|++|+++|+..-|..||.....++.+...+...+ -++.....+.+..+++...|+.+|-.|
T Consensus 233 qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 233 QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 8999999999999999999999999987655444444443322 233345555667778888999999999
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7e-10 Score=94.78 Aligned_cols=140 Identities=19% Similarity=0.243 Sum_probs=100.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+......+.+.-|+.++||||++++..+...+..|+|+|-+. .|..++++ +....+.--+.||+.||.|||
T Consensus 51 ~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~ 121 (690)
T KOG1243|consen 51 EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEEVCLGLFQILAALSFLN 121 (690)
T ss_pred hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHHHHHHHHHHHHHHHHHh
Confidence 345567788899999999999999999999999999999983 68888876 224444555789999999998
Q ss_pred ccCc----e-----eeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MHQA----L-----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~~~----~-----il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
.+.. | ++++..|..||++|......+.-.. .......-..|..|+...... ...|.|.|||++++++
T Consensus 122 ~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ 197 (690)
T KOG1243|consen 122 DDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELF 197 (690)
T ss_pred ccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHh
Confidence 4422 1 7899999999999987654322111 001111122345555443222 3469999999999999
Q ss_pred ch
Q 041655 178 SL 179 (238)
Q Consensus 178 t~ 179 (238)
.|
T Consensus 198 ng 199 (690)
T KOG1243|consen 198 NG 199 (690)
T ss_pred Cc
Confidence 98
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.7e-10 Score=84.09 Aligned_cols=93 Identities=19% Similarity=0.314 Sum_probs=77.9
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.++..+.|+++.....++...+..+++|||++|++|.+++.. . .+ ....++.+++.+|.++|.+
T Consensus 43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH~~ 114 (211)
T PRK14879 43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLHSA 114 (211)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHHhC
Confidence 45678999999999999988777777777788999999999999999864 1 12 6778899999999999955
Q ss_pred --------CceeeecCCCceEEcccccccc
Q 041655 109 --------QALVLLDHDMEARISEFGLAKV 130 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~ 130 (238)
+.||+++ ++.++++|||.+..
T Consensus 115 ~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 115 GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 6679998 78899999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.2e-10 Score=100.08 Aligned_cols=132 Identities=17% Similarity=0.141 Sum_probs=104.1
Q ss_pred cccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCC
Q 041655 46 NILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHD 117 (238)
Q Consensus 46 ~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~ 117 (238)
.|..+..+..-.+..++|+||.+.|+|.++++. ...+++..+..+..|++.-++.|| .||.|+++...
T Consensus 755 ~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~ 830 (974)
T KOG1166|consen 755 SIMHISSAHVFQNASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRRE 830 (974)
T ss_pred chHHHHHHHccCCcceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecc
Confidence 455555555556667899999999999999973 677899999999999999999999 55777766433
Q ss_pred -------CceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 118 -------MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 118 -------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
.-++|+|||.+..+..-.....-....+|-.+-.+|+..+.+++++.|-|.++.+++-|+-|..
T Consensus 831 ~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 831 ICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 3489999999965432111111133567788899999999999999999999999999999876
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.2e-09 Score=81.33 Aligned_cols=90 Identities=20% Similarity=0.334 Sum_probs=71.9
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+++.+|+.++..++|+++.....++...+..+++|||++|++|.+++.. ... .++.+++.+|.++|..
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~ 109 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKA 109 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHC
Confidence 46778999999999988765555555566667899999999999998754 111 6788999999999954
Q ss_pred --------CceeeecCCCceEEcccccccc
Q 041655 109 --------QALVLLDHDMEARISEFGLAKV 130 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~ 130 (238)
+.|++++ ++.++++|||.+..
T Consensus 110 gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 110 GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 6679998 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.7e-09 Score=92.89 Aligned_cols=89 Identities=21% Similarity=0.306 Sum_probs=75.7
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+++.+|+.++.+++|++++....++...+..++||||+++++|.+++. ....++.+++++|.+||.+
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~ 447 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA 447 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC
Confidence 4678899999999999999887777777777889999999999999884 2356789999999999944
Q ss_pred --------CceeeecCCCceEEcccccccc
Q 041655 109 --------QALVLLDHDMEARISEFGLAKV 130 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~ 130 (238)
|.||++ .++.++++|||+++.
T Consensus 448 giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 448 GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 677999 678999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.9e-09 Score=81.61 Aligned_cols=95 Identities=15% Similarity=0.135 Sum_probs=68.3
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhccC
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ 109 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~~ 109 (238)
..+.+|...+.++.+. .+.+...+... ..++||||+++.+|..+... ...+.......++.|++.++.+||.++
T Consensus 95 ~~~~~E~~~L~~L~~~-~i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 95 LWAEKEFRNLQRLYEA-GVPVPKPIAWR-RNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred HHHHHHHHHHHHHHhc-CCCCCeeeEec-CceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcC
Confidence 3467899999999753 22322222222 34799999988787665422 234556667789999999999999654
Q ss_pred ---------ceeeecCCCceEEccccccccc
Q 041655 110 ---------ALVLLDHDMEARISEFGLAKVF 131 (238)
Q Consensus 110 ---------~~il~~~~~~~kl~dfg~~~~~ 131 (238)
.||+++ ++.++++|||.+...
T Consensus 169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 578998 889999999998653
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.5e-09 Score=80.43 Aligned_cols=96 Identities=18% Similarity=0.151 Sum_probs=72.5
Q ss_pred HHHHHHHHHHHHhcCCCCCcc--cceeeeeecC-C---eeEEEEEeCCC-CCHHHHHhhhcCCCcccCHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNI--LPLLAHLARP-G---CHLLVYEFMKN-GSLQDILNDVSRGRRQLDWLARYRTVRGIA 99 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~-~---~~~~v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~ 99 (238)
.....+.+|+.++..++|+++ +..+++.... . ..++|+|++++ .+|.+++.. ..++... +.+++
T Consensus 82 ~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~ 152 (239)
T PRK01723 82 LERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIG 152 (239)
T ss_pred hhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHH
Confidence 445678899999999998774 6666654332 2 23599999987 689888854 2345443 46899
Q ss_pred HHhchhhcc--------CceeeecCCCceEEccccccccc
Q 041655 100 SGLEYLHMH--------QALVLLDHDMEARISEFGLAKVF 131 (238)
Q Consensus 100 ~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~ 131 (238)
.++.++|.+ |.||+++.++.++|+|||.+...
T Consensus 153 ~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 153 QLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 999999955 67899999999999999988653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.4e-09 Score=90.34 Aligned_cols=194 Identities=18% Similarity=0.168 Sum_probs=133.6
Q ss_pred HHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH----Hhchhh
Q 041655 32 IRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS----GLEYLH 106 (238)
Q Consensus 32 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~----gl~~lH 106 (238)
=.+|....++++ |+|.++.+..+.+.+..|+-+|++ +.+|.++... ....++....+....+... |+.++|
T Consensus 164 k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~h 239 (524)
T KOG0601|consen 164 KLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLH 239 (524)
T ss_pred ccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccC
Confidence 357888888886 999999999999999999999999 5688888765 3344667777778888888 999999
Q ss_pred cc--------CceeeecCC-CceEEcccccccccCCccccc---ccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 107 MH--------QALVLLDHD-MEARISEFGLAKVFPEAHTHI---TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 107 ~~--------~~~il~~~~-~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
+. +.||++..+ ..++++|||+...+....... ..-...|...|++||.+.+ .++...|+|++|.+..
T Consensus 240 s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l 318 (524)
T KOG0601|consen 240 SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVIL 318 (524)
T ss_pred CCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhH
Confidence 55 556888888 889999999987765433211 1112367788999999865 5788999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCC-ChHHHHHHHHHHhhhhcCCCCCcchHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGN-GYEEQMLLVLKTACFCTLDDPKERHVRCM 232 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~~cl~~~p~~R~v~~~ 232 (238)
+...+...+... .......++..+.+. +-......+...+..+++.+|..|...+.
T Consensus 319 ~~~l~~~~~~~g--~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~ 375 (524)
T KOG0601|consen 319 EAILGSHLPSVG--KNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQI 375 (524)
T ss_pred hhHhhcccccCC--CCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHH
Confidence 988765543321 112222223222221 11111222333566689999988833333
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.5e-08 Score=74.83 Aligned_cols=90 Identities=12% Similarity=0.092 Sum_probs=66.0
Q ss_pred HHHHHHHHHhcCCCCCc--ccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 30 MQIRSEIVTLGQIRHRN--ILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+|...+.++.|++ +...++ ....+++|||+++++|...... .....++.++++++.++|.
T Consensus 78 ~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~ 143 (198)
T cd05144 78 LAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK 143 (198)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH
Confidence 34678899998887764 333333 2345899999999888665421 2234677889999999984
Q ss_pred --------cCceeeecCCCceEEcccccccccCC
Q 041655 108 --------HQALVLLDHDMEARISEFGLAKVFPE 133 (238)
Q Consensus 108 --------~~~~il~~~~~~~kl~dfg~~~~~~~ 133 (238)
+|.||+++.++.++|+|||.+.....
T Consensus 144 ~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 144 HGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 47789999999999999999865433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2e-09 Score=96.13 Aligned_cols=199 Identities=20% Similarity=0.175 Sum_probs=140.2
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+...++-.++-...+|.++..+--+......+++++|..+++|...+.. ....+..-.+.....+..+++|
T Consensus 844 ~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~ 919 (1205)
T KOG0606|consen 844 RTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLES 919 (1205)
T ss_pred ccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhc
Confidence 333344444555555555667777666666677788999999988899888865 2245555555566778889999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCc------------------------ccc-----cccccccCCC
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEA------------------------HTH-----ITTSDVVGTA 147 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~------------------------~~~-----~~~~~~~~~~ 147 (238)
||+. +.+.+....++.++.+||........ ... .......+|+
T Consensus 920 L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~ 999 (1205)
T KOG0606|consen 920 LHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTP 999 (1205)
T ss_pred cccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCC
Confidence 9965 44577888899999999843221100 000 0012356899
Q ss_pred cccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccC-CChHHHHHHHHHHhhhhcCCCCCc
Q 041655 148 GYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLG-NGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 148 ~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
-|.+||...+...+..+|+|++|+++++..+|..||........+.++....... ..+........+++...+..+|.+
T Consensus 1000 ~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1000 DYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred cccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchh
Confidence 9999999999999999999999999999999999998766666666666555433 345555556667777789999999
Q ss_pred c
Q 041655 227 R 227 (238)
Q Consensus 227 R 227 (238)
|
T Consensus 1080 r 1080 (1205)
T KOG0606|consen 1080 R 1080 (1205)
T ss_pred c
Confidence 9
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.70 E-value=8.2e-08 Score=68.84 Aligned_cols=91 Identities=19% Similarity=0.226 Sum_probs=72.8
Q ss_pred HHHHHHHHHHhcCCCC--CcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 29 MMQIRSEIVTLGQIRH--RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+|...+..++| .++.++++.....+..++++||++++.+..+ +......++.++++++.++|
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh 103 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLH 103 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHh
Confidence 3568889999999976 5888998888877889999999987655443 33445567788899999888
Q ss_pred c-----------cCceeeecCCCceEEcccccccc
Q 041655 107 M-----------HQALVLLDHDMEARISEFGLAKV 130 (238)
Q Consensus 107 ~-----------~~~~il~~~~~~~kl~dfg~~~~ 130 (238)
. ++.|++++..+.+++.|||.+..
T Consensus 104 ~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 104 QLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 4 46789999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.6e-07 Score=75.50 Aligned_cols=185 Identities=17% Similarity=0.105 Sum_probs=123.5
Q ss_pred HHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc---
Q 041655 33 RSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--- 108 (238)
Q Consensus 33 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--- 108 (238)
..|+.+...+. |.+++.++..|...+..|+-.|||+++++.....- ...+.+...+.+..|++.++.++|++
T Consensus 313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~ 388 (524)
T KOG0601|consen 313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKLFV 388 (524)
T ss_pred hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchhhh
Confidence 46777777775 88899998888888888899999998887665532 34577788888999999999999944
Q ss_pred -----CceeeecCC-CceEEcccccccccCCcccccccccccCCCcc-cCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 109 -----QALVLLDHD-MEARISEFGLAKVFPEAHTHITTSDVVGTAGY-IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 109 -----~~~il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~-~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
+.||++.++ +..+++|||.+..+.-... ........| .++.......+..+.|++|||....+..++..
T Consensus 389 ~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 389 HLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccccccceeeccchhhhhccccccccccceecc----cccccccccccchhhccccccccccccccccccccccccCcc
Confidence 678888886 7889999999864322211 111122233 24445556667789999999999999988765
Q ss_pred HHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcchHH
Q 041655 182 WMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKERHVR 230 (238)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R~v~ 230 (238)
..++... ...+..+..+..+... ..+..+.+.....++.-|...
T Consensus 465 ls~~~~~----~~~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~ 508 (524)
T KOG0601|consen 465 LSESGVQ----SLTIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSA 508 (524)
T ss_pred cCccccc----ceeeecccccCCCchH-HhhhhhhhhhcCCccccchhh
Confidence 4333222 2222222222222222 445555555888888777333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.6e-06 Score=63.76 Aligned_cols=88 Identities=19% Similarity=0.171 Sum_probs=58.0
Q ss_pred HHHHHHhcCCCCCc--ccceeeeeecCCeeEEEEEeCCCCCHHH-HHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--
Q 041655 33 RSEIVTLGQIRHRN--ILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-- 107 (238)
Q Consensus 33 ~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~v~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~-- 107 (238)
..|...+.++.+.. +.+.++. ...+++|||++++.+.. .+.. .... .....++.+++.++.++|.
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-----~~~~-~~~~~~~~~~~~~l~~lh~~~ 134 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-----VRLL-EDPEELYDQILELMRKLYREA 134 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhh-----hhhc-ccHHHHHHHHHHHHHHHhhcc
Confidence 34555555554332 3333332 23589999998854322 1211 0011 5567888999999999997
Q ss_pred -------cCceeeecCCCceEEccccccccc
Q 041655 108 -------HQALVLLDHDMEARISEFGLAKVF 131 (238)
Q Consensus 108 -------~~~~il~~~~~~~kl~dfg~~~~~ 131 (238)
+|.||+++ ++.++++|||.+...
T Consensus 135 ~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 135 GLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 47789999 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.6e-06 Score=74.90 Aligned_cols=74 Identities=15% Similarity=0.136 Sum_probs=54.7
Q ss_pred eeEEEEEeCCCCCHHHHHhhhcC--CCcccCHHHHHHHHHHHHHHhchhh--ccCceeeecCCC----ceEEcccccccc
Q 041655 59 CHLLVYEFMKNGSLQDILNDVSR--GRRQLDWLARYRTVRGIASGLEYLH--MHQALVLLDHDM----EARISEFGLAKV 130 (238)
Q Consensus 59 ~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~gl~~lH--~~~~~il~~~~~----~~kl~dfg~~~~ 130 (238)
..++||||++|+++.+...-... ....+....+..++.|+.+ -.+.| -||.||+++.++ .+++.|||+...
T Consensus 235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 44699999999999875321111 1124667777778888875 56677 779999999988 999999999887
Q ss_pred cCC
Q 041655 131 FPE 133 (238)
Q Consensus 131 ~~~ 133 (238)
++.
T Consensus 314 l~~ 316 (537)
T PRK04750 314 LNK 316 (537)
T ss_pred CCH
Confidence 643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=6.7e-07 Score=76.82 Aligned_cols=144 Identities=17% Similarity=0.142 Sum_probs=103.3
Q ss_pred HHHHHHHhcCCCCCc-ccceeeeeecCCeeEEEEEeCCCC-CHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 32 IRSEIVTLGQIRHRN-ILPLLAHLARPGCHLLVYEFMKNG-SLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 32 ~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~v~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..-++++|.+++||| .+..++-+..++..++.++++.++ +-..-.. .....+-.-+.....+.-.++++++|+.
T Consensus 280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~ 356 (829)
T KOG0576|consen 280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY 356 (829)
T ss_pred hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc
Confidence 345888999999999 777777788888889999999765 1111111 0122233333444566678899999976
Q ss_pred ---CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHH
Q 041655 109 ---QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKW 182 (238)
Q Consensus 109 ---~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~ 182 (238)
+.||+. .++..+.++|+....++... ..+...+++.|+|||+...+.+....|.|+.|.-..++.-|.+|
T Consensus 357 ~~~~d~~l~-s~~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 357 KVHRDNILG-SEEEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred ccCcccccc-cccccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 334444 44678999999987766543 23567889999999999999999999999999877776655444
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.8e-05 Score=66.78 Aligned_cols=129 Identities=19% Similarity=0.254 Sum_probs=91.4
Q ss_pred HHHHHhcCCCCCcccceeeeee----cCCeeEEEEEeCCC-CCHHHHHhhhc-----------CCCcccCHHHHHHHHHH
Q 041655 34 SEIVTLGQIRHRNILPLLAHLA----RPGCHLLVYEFMKN-GSLQDILNDVS-----------RGRRQLDWLARYRTVRG 97 (238)
Q Consensus 34 ~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~v~e~~~~-~~L~~~l~~~~-----------~~~~~~~~~~~~~~~~~ 97 (238)
.-++.++++.|+|+|.+..+|. .+..+++|++|.|+ ++|.++.-... ..+...++..+|.++.|
T Consensus 322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q 401 (655)
T KOG3741|consen 322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ 401 (655)
T ss_pred HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence 3477899999999999999886 34567899999875 47877653211 12345778999999999
Q ss_pred HHHHhchhhccCc--------eeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 98 IASGLEYLHMHQA--------LVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 98 l~~gl~~lH~~~~--------~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
+..||.++|+.+- .|+++.+-+++++.-|..-.+.... .+| + ....+-|.=.|
T Consensus 402 LtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------~~~--l---e~~Qq~D~~~l 462 (655)
T KOG3741|consen 402 LTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------TEP--L---ESQQQNDLRDL 462 (655)
T ss_pred HHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC--------------Ccc--h---hHHhhhhHHHH
Confidence 9999999997643 3888888888887666544332111 000 0 11234677889
Q ss_pred hHHHHhhcchHH
Q 041655 170 GVLLAEEMSLVK 181 (238)
Q Consensus 170 G~~l~~~~t~~~ 181 (238)
|.++..+.+|..
T Consensus 463 G~ll~aLAt~~~ 474 (655)
T KOG3741|consen 463 GLLLLALATGTE 474 (655)
T ss_pred HHHHHHHhhccc
Confidence 999999999743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.4e-05 Score=65.59 Aligned_cols=101 Identities=16% Similarity=0.187 Sum_probs=57.8
Q ss_pred HHHHHHHhcCCC----CCcccceeeeee-cCCeeEEEEEeCCCCCHHHHHhhhcCCC--cccCHHHHHHHHHHHHHHhch
Q 041655 32 IRSEIVTLGQIR----HRNILPLLAHLA-RPGCHLLVYEFMKNGSLQDILNDVSRGR--RQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 32 ~~~E~~~l~~l~----h~~iv~~~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~l~~gl~~ 104 (238)
|.+|...+.++. |.+-+.+..++. ..+..++||||++|++|.++......+. ..+....+..++.|+. .-.+
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~-~~g~ 278 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVL-RDGF 278 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHH-hCCc
Confidence 555666555552 333344444432 1234589999999999988765311110 0111111111222221 1233
Q ss_pred hh--ccCceeeecCCCceEEcccccccccCC
Q 041655 105 LH--MHQALVLLDHDMEARISEFGLAKVFPE 133 (238)
Q Consensus 105 lH--~~~~~il~~~~~~~kl~dfg~~~~~~~ 133 (238)
+| -+|.||+++.++.+++.|||++..++.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 44 568899999999999999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.91 E-value=7.3e-06 Score=71.02 Aligned_cols=134 Identities=15% Similarity=0.100 Sum_probs=84.5
Q ss_pred HHHHHHHhchhhcc---------CceeeecCCCceEEcccccccccCCccccc-------ccccccCCCcccCccccccc
Q 041655 95 VRGIASGLEYLHMH---------QALVLLDHDMEARISEFGLAKVFPEAHTHI-------TTSDVVGTAGYIAPEYQQTL 158 (238)
Q Consensus 95 ~~~l~~gl~~lH~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~apE~~~~~ 158 (238)
+.+++.|+.|+|.. |..|+++..+..|+..|+.+.-........ ......-...|.|||.+...
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 45667899999955 344889999999999998865433211111 11112234569999999887
Q ss_pred CCCccCCeeehhHHHHhhcchHHHHHHhhccCCC---cccccccccCCChHHHHHHHHHHhhhhcCCCCCcch
Q 041655 159 SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENP---KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKERH 228 (238)
Q Consensus 159 ~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R~ 228 (238)
.-+.++|++|+|+.+|.+..+..|-......-.. ......-....+..+.+.++.+-+.+.+..++.-|.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp 257 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP 257 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence 7788999999999999999554443221111110 001111111123355566677777778999998884
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0005 Score=51.82 Aligned_cols=89 Identities=15% Similarity=0.125 Sum_probs=60.4
Q ss_pred HHHHHHhcCCCC--CcccceeeeeecCCeeEEEEEeCCCCCHH-HHHhhhcCCCcccCHHHHHHHHHHHHHHhchh-hcc
Q 041655 33 RSEIVTLGQIRH--RNILPLLAHLARPGCHLLVYEFMKNGSLQ-DILNDVSRGRRQLDWLARYRTVRGIASGLEYL-HMH 108 (238)
Q Consensus 33 ~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~v~e~~~~~~L~-~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l-H~~ 108 (238)
.+|...|.++.. -++.+.+++ ...++||||+.+..+. ..+.+ ..++......+..+++.+|..+ |..
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~ 144 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC 144 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC
Confidence 379999999863 355666654 3457999999654332 22222 2344555667778999999988 644
Q ss_pred --------CceeeecCCCceEEccccccccc
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVF 131 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~ 131 (238)
+.||+++ ++.+.++|||.+...
T Consensus 145 glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 145 NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 4468886 468999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00011 Score=53.89 Aligned_cols=85 Identities=20% Similarity=0.126 Sum_probs=55.7
Q ss_pred HHHHHHHHhcCCCCCc-ccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 31 QIRSEIVTLGQIRHRN-ILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
.+.+|...+..+.+.+ +.+++.... +..++|||++++.++.+.. ... ...+.+++++|..||..
T Consensus 38 ~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~--------~~~----~~~~~~l~~~l~~LH~~~ 103 (170)
T cd05151 38 NRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED--------FSD----PENLEKIAKLLKKLHSSP 103 (170)
T ss_pred CHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc--------ccC----HHHHHHHHHHHHHHhCCC
Confidence 3567888888776444 344554433 2347999999987765431 011 22356788888888854
Q ss_pred ------------CceeeecCCCceEEcccccccc
Q 041655 109 ------------QALVLLDHDMEARISEFGLAKV 130 (238)
Q Consensus 109 ------------~~~il~~~~~~~kl~dfg~~~~ 130 (238)
+.|++++ ++.++++||+.+..
T Consensus 104 ~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 104 LPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 4478888 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0011 Score=49.79 Aligned_cols=94 Identities=20% Similarity=0.194 Sum_probs=68.8
Q ss_pred HHHHHHhcCCCC-CcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc---
Q 041655 33 RSEIVTLGQIRH-RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--- 108 (238)
Q Consensus 33 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--- 108 (238)
.+|.-+|..+++ +++.+++|.|-+ +++.||.+.+++....... ..-...+|..+.+++.++++.+.+++..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888875 689999999932 5899999766553210000 0113468999999999999999999853
Q ss_pred --------CceeeecCCCceEEccccccccc
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVF 131 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~ 131 (238)
+.|+-++++|++|+.|.......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 55678888999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00022 Score=65.73 Aligned_cols=178 Identities=18% Similarity=0.156 Sum_probs=113.6
Q ss_pred HHHHHHHhcCCCCCcccceeeeeecCCe----eEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 32 IRSEIVTLGQIRHRNILPLLAHLARPGC----HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 32 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
-.-|...+.++.|+|++.++.+-...-. ..+..+++..-++.+.+.+ -...+....+.+..++.+|+.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3457778888999999999998754422 2355578877778777765 4557788888999999999999996
Q ss_pred cCc-e----------eeecCCCceEEc--ccccccccCCcccccccccccCCCcccCcccccccCCCc--cCCeeehhHH
Q 041655 108 HQA-L----------VLLDHDMEARIS--EFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY--MCDIYSFGVL 172 (238)
Q Consensus 108 ~~~-~----------il~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~--~~DvwslG~~ 172 (238)
..- + .-.+..+....+ ||+.++.++..... ........|.++|....+.+.. ..|+|.+|..
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 521 1 123344455555 88777665443322 1223345577888776665544 4799999999
Q ss_pred HHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 173 LAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+..+..+..+..... .+...++ ..... .+.+...+|+..++++|
T Consensus 382 ~~~~~~~~~i~~~~~---~~~~~l~----~~~~~----~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA---VPVSLLD----VLSTS----ELLDALPKCLDEDSEER 425 (1351)
T ss_pred HhhhhhcCccccccc---chhhhhc----cccch----hhhhhhhhhcchhhhhc
Confidence 888776544321110 1111111 11111 34556677999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00068 Score=50.14 Aligned_cols=100 Identities=18% Similarity=0.178 Sum_probs=66.6
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCC-CCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKN-GSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+..+|...|.++.--.|.--.-++.+...-.+.|||+++ .++.+++.+. ............++.++-+-+.-||.
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~--~~~~~~d~~~~~~~~~iG~~igklH~ 131 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILST--MEDESEDEGLAELARRIGELIGKLHD 131 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHH--ccCcccchhHHHHHHHHHHHHHHhhh
Confidence 45667888888887633332222234455556799999976 3788888652 22233333446788899999999996
Q ss_pred c--------CceeeecCCCc---eEEcccccccc
Q 041655 108 H--------QALVLLDHDME---ARISEFGLAKV 130 (238)
Q Consensus 108 ~--------~~~il~~~~~~---~kl~dfg~~~~ 130 (238)
+ .+||++.+++. +.++|||++..
T Consensus 132 ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 132 NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 6 45677766553 47999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00059 Score=50.46 Aligned_cols=91 Identities=20% Similarity=0.286 Sum_probs=62.3
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..++-.+|..++.++.--.|..-.=+..+.+...++|||++|..|.+.+... . ..++..+-.-+.-||.
T Consensus 42 rr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~----~~~~r~vG~~vg~lH~ 110 (204)
T COG3642 42 RRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------R----PDLLREVGRLVGKLHK 110 (204)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------c----hHHHHHHHHHHHHHHh
Confidence 3456678999988876433333233344566667999999998899899761 1 3345666666778885
Q ss_pred c--------CceeeecCCCceEEcccccccc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKV 130 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~ 130 (238)
+ +.|+++.+.+ +-++|||++..
T Consensus 111 ~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 111 AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 5 4457766664 89999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.002 Score=51.13 Aligned_cols=98 Identities=15% Similarity=0.171 Sum_probs=67.8
Q ss_pred HHHHHHHHhcCCCCCc--ccceeeeeec-----CCeeEEEEEeCCCC-CHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 31 QIRSEIVTLGQIRHRN--ILPLLAHLAR-----PGCHLLVYEFMKNG-SLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~--iv~~~~~~~~-----~~~~~~v~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
.+.+|...+.++..-+ +....++... ....++|+|++++. +|.+++... .....+......++.+++..+
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~--~~~~~~~~~~~~ll~~la~~i 151 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADW--ATNPPDPRLKRMLIKRVATMV 151 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhh--cccCCCHHHHHHHHHHHHHHH
Confidence 4678888777774222 3444444332 23468999999876 799988641 123445667778899999999
Q ss_pred chhhccC--------ceeeecC-------CCceEEcccccccc
Q 041655 103 EYLHMHQ--------ALVLLDH-------DMEARISEFGLAKV 130 (238)
Q Consensus 103 ~~lH~~~--------~~il~~~-------~~~~kl~dfg~~~~ 130 (238)
.-||.++ .||+++. ++.+.++||+.++.
T Consensus 152 ~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 152 RDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999664 4688875 46789999998753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.00053 Score=56.93 Aligned_cols=124 Identities=17% Similarity=0.183 Sum_probs=84.7
Q ss_pred eEEEEEeCCCC-CHHHHHhh--hcCCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccc
Q 041655 60 HLLVYEFMKNG-SLQDILND--VSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLA 128 (238)
Q Consensus 60 ~~~v~e~~~~~-~L~~~l~~--~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~ 128 (238)
.-+.|+.+++. .+..++.- +..+.....|.-..+.++.++.+.+-||.+ +.++++.+++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 45777777653 34444432 122345678999999999999999999944 55689999988888864332
Q ss_pred cccCCcccccccccccCCCcccCccccc-----ccCCCccCCeeehhHHHHhhcch-HHHHHHh
Q 041655 129 KVFPEAHTHITTSDVVGTAGYIAPEYQQ-----TLSITYMCDIYSFGVLLAEEMSL-VKWMRNV 186 (238)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~DvwslG~~l~~~~t~-~~~~~~~ 186 (238)
..-.... ......|...|.+||.-. +..-+...|.+.+|+++++++-| ..||...
T Consensus 165 qi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 165 QINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 2211111 123367889999999543 33445679999999999998876 7777543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0036 Score=46.90 Aligned_cols=93 Identities=15% Similarity=0.143 Sum_probs=51.4
Q ss_pred HHHHHHHHHHHhcCCCCC--cccceeeeeecCCeeEEEEEeCC--CCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 28 EMMQIRSEIVTLGQIRHR--NILPLLAHLARPGCHLLVYEFMK--NGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~~v~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
......+|...|.++..- ++.+.+++. ...+||||++ |..+..+... .++......++.+++..+.
T Consensus 51 ~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~ 120 (188)
T PF01163_consen 51 IREWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEII 120 (188)
T ss_dssp HHHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHH
Confidence 345567899999999754 456665442 2369999997 5444443322 1112223344455555433
Q ss_pred hh-h--------ccCceeeecCCCceEEccccccccc
Q 041655 104 YL-H--------MHQALVLLDHDMEARISEFGLAKVF 131 (238)
Q Consensus 104 ~l-H--------~~~~~il~~~~~~~kl~dfg~~~~~ 131 (238)
.+ | ..+.||+++.+ .+.++|||.+...
T Consensus 121 ~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 121 KMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence 32 3 23457888887 9999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0075 Score=45.89 Aligned_cols=101 Identities=13% Similarity=0.129 Sum_probs=70.0
Q ss_pred HHHHHHHHHHHhcCCCCCc--cccee-eeee-cC--CeeEEEEEeCCC-CCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIRHRN--ILPLL-AHLA-RP--GCHLLVYEFMKN-GSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~--iv~~~-~~~~-~~--~~~~~v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
....|.+|...+.+|..-+ +.+.. +-.. .+ ..-++|+|-+++ -+|.+++.+ ..-.+.+......+..+++.
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~--~~~~~~~~~~k~~il~~va~ 139 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQ--HAVSPYSDEVRQAMLKAVAL 139 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhc--CCcCCcchHHHHHHHHHHHH
Confidence 3467899999998886332 33333 1111 11 235699998754 478888854 12234577777889999999
Q ss_pred HhchhhccCce--------eeecCCCc--eEEcccccccc
Q 041655 101 GLEYLHMHQAL--------VLLDHDME--ARISEFGLAKV 130 (238)
Q Consensus 101 gl~~lH~~~~~--------il~~~~~~--~kl~dfg~~~~ 130 (238)
.+.-||..+.+ |+++..+. +.++||.-++.
T Consensus 140 ~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 140 AFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99999977654 88886777 99999977653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0083 Score=45.71 Aligned_cols=97 Identities=22% Similarity=0.223 Sum_probs=69.3
Q ss_pred HHHHHHHHHhcCCCCC--cccceeeeeecC----CeeEEEEEeCCCC-CHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 30 MQIRSEIVTLGQIRHR--NILPLLAHLARP----GCHLLVYEFMKNG-SLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~--~iv~~~~~~~~~----~~~~~v~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
....+|...+..|..- .+.+..++.... ...++++|++++. +|.+++.. ....+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHHH
Confidence 4566777766666422 245555554432 2457999999874 79998875 12256667778899999999
Q ss_pred chhhcc--------CceeeecCCC---ceEEcccccccc
Q 041655 103 EYLHMH--------QALVLLDHDM---EARISEFGLAKV 130 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~---~~kl~dfg~~~~ 130 (238)
.-||.+ +.|||++.++ .+.++||+.++.
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999965 5579999887 899999988765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.0029 Score=48.31 Aligned_cols=76 Identities=24% Similarity=0.232 Sum_probs=57.8
Q ss_pred HHHHHHHHHHhcCCCC--CcccceeeeeecC---CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 29 MMQIRSEIVTLGQIRH--RNILPLLAHLARP---GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
...+.+|..+++.+.+ .++.+++.+.... +..+++|||++|.++.+.+.. ..+++.....++.++++.|.
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~ 113 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLA 113 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHH
Confidence 4567889999999875 3467777776553 356899999998877765531 34677788889999999999
Q ss_pred hhhccC
Q 041655 104 YLHMHQ 109 (238)
Q Consensus 104 ~lH~~~ 109 (238)
.||.-+
T Consensus 114 ~lH~~~ 119 (223)
T cd05154 114 ALHSVD 119 (223)
T ss_pred HHhCCC
Confidence 999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.0014 Score=62.50 Aligned_cols=160 Identities=11% Similarity=0.007 Sum_probs=106.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeee--cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLA--RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
+...+-...|++.++...|+++...+.-.. ++...|..++|+.+|.+.+.+..-......+...-+.....+......
T Consensus 1270 ePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1270 EPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred hHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccc
Confidence 334444566777777778998877765543 334567899999999998887642222223333333333233355555
Q ss_pred hhhcc-------------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 104 YLHMH-------------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 104 ~lH~~-------------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
-+|+. ..|-++..+-+++++++|+.+....... ..+...+++.|+.|++...-.++.++|+|+.|
T Consensus 1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRS 1427 (2724)
T ss_pred hhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHH
Confidence 55522 2335778888899999999884332221 12446788889999988777788889999999
Q ss_pred HHHHhhcchHHHHHHhh
Q 041655 171 VLLAEEMSLVKWMRNVM 187 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~ 187 (238)
+.+|+...|..++....
T Consensus 1428 ~~ly~rs~~n~~fi~fl 1444 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIFFL 1444 (2724)
T ss_pred HHHHHHhcccHHHHHHH
Confidence 99999999888875544
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.036 Score=47.68 Aligned_cols=148 Identities=21% Similarity=0.169 Sum_probs=85.5
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.++......++.+.|+|...+..+-.. ..+..+|+|++ +.+|.+.+... . +.... +. |=.++|.+
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~----~-l~~~s-------~~-~~~~~~~~ 92 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG----N-LKDES-------LL-AHGVLHLN 92 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc----c-cchhh-------hc-ccccceeh
Confidence 445667788999999999998887643 35578999999 67999998751 1 11111 00 11111111
Q ss_pred CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhc
Q 041655 109 QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMT 188 (238)
Q Consensus 109 ~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~ 188 (238)
....+| .+... | | .+.++++||||+|.++.++.-|..-+.....
T Consensus 93 ----------~~~~td-----~~~t~--------------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~ 136 (725)
T KOG1093|consen 93 ----------IIYITD-----HFLTK--------------Y--P-----SPIGPKSDVWSLGFIILELYLGISLEAELTE 136 (725)
T ss_pred ----------hhhccc-----ccccc--------------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHHHHHH
Confidence 111222 00000 0 0 1122599999999999999887766654433
Q ss_pred cCCCcccccccccC----------CChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 189 SENPKRAIDSKLLG----------NGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 189 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.+.......-.... ....+....+....++|+-..|..|
T Consensus 137 s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir 185 (725)
T KOG1093|consen 137 SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIR 185 (725)
T ss_pred HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccc
Confidence 22211111100000 2234556677888889999999988
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.063 Score=42.42 Aligned_cols=120 Identities=12% Similarity=0.084 Sum_probs=69.5
Q ss_pred eeEEeeccCCCChhhHHHhhhh--------hhHHHHHHHHHHHHHhcCCCCC--cccceeeeeecCCeeEEEEEeCCCCC
Q 041655 2 IAIRKIVQPPMDATALVEADSK--------LLTEEMMQIRSEIVTLGQIRHR--NILPLLAHLARPGCHLLVYEFMKNGS 71 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~~v~e~~~~~~ 71 (238)
+|||.=..+..+-.+++..+.. +....+....+|...|.+|... .+.+.++ .+...+||||++|-.
T Consensus 118 ~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~----~nRHaVvMe~ieG~e 193 (304)
T COG0478 118 VAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIA----WNRHAVVMEYIEGVE 193 (304)
T ss_pred EEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCccc----cccceeeeehcccce
Confidence 5677655555555555554433 1133455678899999988643 4444443 345579999998755
Q ss_pred HHHHHhhhcCCCcccCHHHHHHHHHHHHHH--hchhh--ccCceeeecCCCceEEcccccccc
Q 041655 72 LQDILNDVSRGRRQLDWLARYRTVRGIASG--LEYLH--MHQALVLLDHDMEARISEFGLAKV 130 (238)
Q Consensus 72 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g--l~~lH--~~~~~il~~~~~~~kl~dfg~~~~ 130 (238)
|...-.. ..-+......++.++..+ .-+.| -++-||+++.+|.+.++||..+..
T Consensus 194 L~~~r~~-----~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 194 LYRLRLD-----VENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred eecccCc-----ccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeCccccc
Confidence 4443211 001111122233333322 23344 446789999999999999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.032 Score=48.40 Aligned_cols=101 Identities=19% Similarity=0.226 Sum_probs=66.4
Q ss_pred HHHHHHHhcCCC----CCcccceeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcCC--CcccCHHHHHHHHHHHHHHhch
Q 041655 32 IRSEIVTLGQIR----HRNILPLLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSRG--RRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 32 ~~~E~~~l~~l~----h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
+.+|..-+.+++ +.--+++-.++.+ .+.-.++|||++|-.+.+...-...+ ...++..-...++.|+.. -.+
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~-dgf 286 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR-DGF 286 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh-cCc
Confidence 455665555552 2223444444432 23447999999998888874321122 124555666666777766 777
Q ss_pred hh--ccCceeeecCCCceEEcccccccccCC
Q 041655 105 LH--MHQALVLLDHDMEARISEFGLAKVFPE 133 (238)
Q Consensus 105 lH--~~~~~il~~~~~~~kl~dfg~~~~~~~ 133 (238)
.| =+|.|++++.+|.+.+.|||+...++.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 88 668999999999999999999876643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.29 Score=37.09 Aligned_cols=90 Identities=16% Similarity=0.144 Sum_probs=58.0
Q ss_pred HHHHHHHHHHhcCCC------CCcccceeeeeecCCeeEEEEEeCCC------CCHHHHHhhhcCCCcccCHHHHHHHHH
Q 041655 29 MMQIRSEIVTLGQIR------HRNILPLLAHLARPGCHLLVYEFMKN------GSLQDILNDVSRGRRQLDWLARYRTVR 96 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~~v~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~~~~~ 96 (238)
.++..+|+.....+. +.+|.+++|+..++-...+|+|.+.+ .+|.+++.+ ..++. ...+.+.
T Consensus 55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~ 128 (199)
T PF10707_consen 55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQALD 128 (199)
T ss_pred hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHHH
Confidence 345556666544444 78899999999999888999997532 368888854 34555 5555556
Q ss_pred HHHHHhchhh-----ccCceeeecCCC----ceEEcc
Q 041655 97 GIASGLEYLH-----MHQALVLLDHDM----EARISE 124 (238)
Q Consensus 97 ~l~~gl~~lH-----~~~~~il~~~~~----~~kl~d 124 (238)
++.+-|.-.| .++.||++.... .+.++|
T Consensus 129 ~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 129 EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 6665554444 446677664332 355555
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.11 Score=48.08 Aligned_cols=73 Identities=16% Similarity=0.187 Sum_probs=52.1
Q ss_pred HHHHHHHHHhcCCC-CCcc--cceeeeeecC---CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 30 MQIRSEIVTLGQIR-HRNI--LPLLAHLARP---GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 30 ~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
..+.+|..+|+.+. |+++ .+++.++.+. +..|+||||++|..+.+- ....++......++.++++.|.
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~------~~~~~~~~~r~~l~~~l~~~La 156 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDP------KLPGVAPERRRAIYRATAKVLA 156 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCc------cCCCCCHHHHHHHHHHHHHHHH
Confidence 56789999999995 6654 7777777654 467899999987543221 1123566677788899999999
Q ss_pred hhhcc
Q 041655 104 YLHMH 108 (238)
Q Consensus 104 ~lH~~ 108 (238)
.||.-
T Consensus 157 ~LH~v 161 (822)
T PLN02876 157 ALHSA 161 (822)
T ss_pred HHhCC
Confidence 99953
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.43 Score=36.76 Aligned_cols=59 Identities=22% Similarity=0.309 Sum_probs=39.2
Q ss_pred eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccc
Q 041655 59 CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKV 130 (238)
Q Consensus 59 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~ 130 (238)
..+++|||++|..|.+... +++. +...+.+++.-+| .+|.|+++++++ +++.||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~--------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED--------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccchh--------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccccc
Confidence 4468999999987776543 2221 2234445566666 557888888655 89999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.35 Score=37.41 Aligned_cols=41 Identities=15% Similarity=0.126 Sum_probs=30.1
Q ss_pred HHHHHHHHHhcCCCCCc--ccceeeeeecCCeeEEEEEeCCCC
Q 041655 30 MQIRSEIVTLGQIRHRN--ILPLLAHLARPGCHLLVYEFMKNG 70 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~v~e~~~~~ 70 (238)
....+|.+++..+..-. +.+.+++...++...++||+++|.
T Consensus 37 ~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 37 ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 34577888888775332 467777777777788999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.54 E-value=0.28 Score=42.84 Aligned_cols=74 Identities=16% Similarity=0.215 Sum_probs=46.8
Q ss_pred eeEEEEEeCCCCCHHHH--HhhhcCCCcccCHHHHHHHHHHHHHHhchhh--ccCceeeecC----CCceEEcccccccc
Q 041655 59 CHLLVYEFMKNGSLQDI--LNDVSRGRRQLDWLARYRTVRGIASGLEYLH--MHQALVLLDH----DMEARISEFGLAKV 130 (238)
Q Consensus 59 ~~~~v~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH--~~~~~il~~~----~~~~kl~dfg~~~~ 130 (238)
.-.++|||++|..+.+. +.+..-....+.......++.||+..- ++| =+|.||+++. ++.+.+.|||+...
T Consensus 276 ~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~G-ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKTG-FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhcC-CccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 34799999998876555 433111122233333344455555433 677 4688999984 56799999999876
Q ss_pred cCC
Q 041655 131 FPE 133 (238)
Q Consensus 131 ~~~ 133 (238)
+..
T Consensus 355 is~ 357 (538)
T KOG1235|consen 355 ISH 357 (538)
T ss_pred ccH
Confidence 544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.35 E-value=2.1 Score=31.87 Aligned_cols=91 Identities=14% Similarity=0.093 Sum_probs=55.0
Q ss_pred HHHHHHHHHHhcCCCCCcc-cceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHH--HHHHhchh
Q 041655 29 MMQIRSEIVTLGQIRHRNI-LPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRG--IASGLEYL 105 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~--l~~gl~~l 105 (238)
+..+..|.++|..+..-++ .+++.+-.+ ++.|||+.|..|.+.... .+..++..++.. .+..+--.
T Consensus 59 r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~-------~~rk~l~~vlE~a~~LD~~GI~ 127 (201)
T COG2112 59 RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIG-------GDRKHLLRVLEKAYKLDRLGIE 127 (201)
T ss_pred hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhc-------ccHHHHHHHHHHHHHHHHhccc
Confidence 5778889999988874433 344433322 355999988888877652 123333333221 22222333
Q ss_pred h---ccCceeeecCCCceEEcccccccc
Q 041655 106 H---MHQALVLLDHDMEARISEFGLAKV 130 (238)
Q Consensus 106 H---~~~~~il~~~~~~~kl~dfg~~~~ 130 (238)
| +++.-+++.+++.+-|+||..++.
T Consensus 128 H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 128 HGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcCCceeEEecCCcEEEEEccchhh
Confidence 4 445557777777999999988763
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=86.70 E-value=1.6 Score=35.22 Aligned_cols=71 Identities=15% Similarity=0.117 Sum_probs=50.2
Q ss_pred HHHHHHHHHhcCCCC---Ccccceeeeeec---CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 30 MQIRSEIVTLGQIRH---RNILPLLAHLAR---PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h---~~iv~~~~~~~~---~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
..+.+|...|+.+.. -.+.++++++.. .+..++|||++++.++.+. ..+......+..+++++|.
T Consensus 52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~---------~~~~~~~~~l~~~l~~~La 122 (297)
T PRK10593 52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP---------ARTPERWEQLKDQIVEGLL 122 (297)
T ss_pred hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC---------CCCHHHHHHHHHHHHHHHH
Confidence 567889998888853 357788877654 3668999999998776651 1223344556678889999
Q ss_pred hhhccC
Q 041655 104 YLHMHQ 109 (238)
Q Consensus 104 ~lH~~~ 109 (238)
-||..+
T Consensus 123 ~LH~~~ 128 (297)
T PRK10593 123 AWHRID 128 (297)
T ss_pred HHhCCC
Confidence 999753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=84.73 E-value=2.1 Score=33.30 Aligned_cols=69 Identities=16% Similarity=0.173 Sum_probs=46.7
Q ss_pred HHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhccC
Q 041655 31 QIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ 109 (238)
Q Consensus 31 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~~ 109 (238)
...+|+.++..+. +--+.++++....++..++|||+++|.++..... ... ...++.++++.+.-||+-+
T Consensus 37 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-------~~~---~~~~~~~l~~~l~~lH~i~ 106 (244)
T cd05150 37 ELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWE-------ELE---PERLVDALAEALRRLHALP 106 (244)
T ss_pred chHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhc-------ccC---HHHHHHHHHHHHHHHhcCC
Confidence 4556787777764 3345677777766667789999999877754331 111 2345688888999999754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=81.38 E-value=4.2 Score=34.08 Aligned_cols=62 Identities=15% Similarity=0.118 Sum_probs=38.8
Q ss_pred eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc---------CceeeecCCCceEEccccccc
Q 041655 59 CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH---------QALVLLDHDMEARISEFGLAK 129 (238)
Q Consensus 59 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~---------~~~il~~~~~~~kl~dfg~~~ 129 (238)
..|+++++- |+++...- .-.+.++..++.+.+.-+.-+..+ -.||+++ +|++.|+||.+++
T Consensus 300 y~yl~~kdh-gt~is~ik--------~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR 369 (488)
T COG5072 300 YLYLHFKDH-GTPISIIK--------ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR 369 (488)
T ss_pred EEEEEEecC-Cceeeeee--------cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence 345666655 44433221 124556666766666555444422 3469999 9999999999998
Q ss_pred c
Q 041655 130 V 130 (238)
Q Consensus 130 ~ 130 (238)
.
T Consensus 370 l 370 (488)
T COG5072 370 L 370 (488)
T ss_pred c
Confidence 4
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 238 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-25 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-13 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-08 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-04 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-62
Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 29/226 (12%)
Query: 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWL 89
+Q ++E+ + HRN+L L P LLVY +M NGS+ L + + LDW
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 90 ARYRTVRGIASGLEYLHMHQAL-----------VLLDHDMEARISEFGLAKVFPEAHTHI 138
R R G A GL YLH H +LLD + EA + +FGLAK+ TH+
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV 191
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE-----------------EMSLVK 181
TT V GT G+IAPEY T + D++ +GV+L E ++ L+
Sbjct: 192 TT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 182 WMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
W++ ++ + + +D L GN +E++ +++ A CT P ER
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMER 296
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-57
Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 33 RSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
EI + + +H N++ LL + LVY +M NGSL D L+ G L W R
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRC 136
Query: 93 RTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPE-AHTHITTSDV 143
+ +G A+G+ +LH + + +LLD A+IS+FGLA+ + A T +T+ +
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR-I 195
Query: 144 VGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE-------------EMSLVKWMRNVMTSE 190
VGT Y+APE IT DIYSFGV+L E L+ + E
Sbjct: 196 VGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE 254
Query: 191 NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237
K + + + + A C + +R V+ +L ++
Sbjct: 255 KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-55
Identities = 68/248 (27%), Positives = 107/248 (43%), Gaps = 33/248 (13%)
Query: 23 KLLTEEMMQ----IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILND 78
K T E Q +EI TL RH +++ L+ +L+Y++M+NG+L+ L
Sbjct: 69 KRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128
Query: 79 VSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKV 130
+ W R G A GL YLH +H+ + +LLD + +I++FG++K
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 131 FPEA-HTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL---------------A 174
E TH++T V GT GYI PEY +T D+YSFGV+L
Sbjct: 189 GTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247
Query: 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVR 230
E ++L +W + ++ +D L E + TA C ++R V
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 231 CMLSQIQQ 238
L +
Sbjct: 308 WKLEYALR 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-39
Identities = 56/264 (21%), Positives = 95/264 (35%), Gaps = 57/264 (21%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH----LLVYEFMKNGSLQDILNDVSRG 82
++ Q E+ +L ++H NIL + R L+ F + GSL D L
Sbjct: 60 KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK----- 114
Query: 83 RRQLDWLARYRTVRGIASGLEYLHMHQAL------------------VLLDHDMEARISE 124
+ W +A GL YLH VLL +++ A I++
Sbjct: 115 ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 125 FGLAKVFPEAHTHITTSDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAE---- 175
FGLA F + T VGT Y+APE D+Y+ G++L E
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 176 -----------EMSLVKWMRNVMTSENPKRAIDSKL----LGNGY--EEQMLLVLKTACF 218
+ + + + E+ + + K L + + M ++ +T
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294
Query: 219 CTLDDPKER----HVRCMLSQIQQ 238
C D + R V ++Q+Q+
Sbjct: 295 CWDHDAEARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-29
Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 13/165 (7%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
+ E + + E+ + ++RH NI+ + + +P +V E++ GSL +L+ S
Sbjct: 70 EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-S 128
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH------MHQAL----VLLDHDMEARISEFGLAKV 130
R QLD R +A G+ YLH +H+ L +L+D ++ +FGL+++
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188
Query: 131 FPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+A T +++ GT ++APE + D+YSFGV+L E
Sbjct: 189 --KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWE 231
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-27
Identities = 41/166 (24%), Positives = 73/166 (43%), Gaps = 21/166 (12%)
Query: 23 KLLTEEMM-QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
++ +E E+ L ++ H NI+ L P C LV E+ + GSL ++L+ +
Sbjct: 38 QIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHG-AE 94
Query: 82 GRRQLDWLARYRTVRGIASGLEYLHMHQAL-----------VLLDHDME-ARISEFGLAK 129
+ G+ YLH Q +LL +I +FG A
Sbjct: 95 PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ TH+T + G+A ++APE + + + CD++S+G++L E
Sbjct: 155 ---DIQTHMTNN--KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWE 195
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-27
Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 23/179 (12%)
Query: 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG 82
+ E E+ + + H N+L + L + + E++K G+L+ I+
Sbjct: 45 RFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---M 101
Query: 83 RRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEA 134
Q W R + IASG+ YLH +H+ L L+ + +++FGLA++ +
Sbjct: 102 DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161
Query: 135 HTHITTSD------------VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181
T VVG ++APE S D++SFG++L E + V
Sbjct: 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 43/174 (24%), Positives = 62/174 (35%), Gaps = 40/174 (22%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCH-----LLVYEFMKNGSLQDILNDVSRGRRQLDWL 89
I + + H NI + R LLV E+ NGSL L+ DW+
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWV 111
Query: 90 ARYRTVRGIASGLEYLHM-------------HQAL----VLLDHDMEARISEFGLAKVF- 131
+ R + GL YLH H+ L VL+ +D IS+FGL+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 132 -----PEAHTHITTSDVVGTAGYIAPEY-------QQTLSITYMCDIYSFGVLL 173
VGT Y+APE + S D+Y+ G++
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-26
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 25/167 (14%)
Query: 25 LTEEMMQ-IRSEIVTLGQIRHRNILPLL-AHLARPGCHL-LVYEFMKNGSLQDILNDVSR 81
+ + E L H N+LP+L A + P H L+ +M GSL ++L++
Sbjct: 46 WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--G 103
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH------MHQAL----VLLDHDMEARISEFGLAKVF 131
+D + +A G+ +LH AL V++D DM ARIS + F
Sbjct: 104 TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163
Query: 132 PEAHTHITTSDVVGTAGYIAPE---YQQTLSITYMCDIYSFGVLLAE 175
+ + ++APE + + D++SF VLL E
Sbjct: 164 -------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 45/177 (25%), Positives = 68/177 (38%), Gaps = 33/177 (18%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGC----HLLVYEFMKNGSLQDILNDVSRG 82
E +EI +RH NIL +A + L+ ++ +NGSL D L
Sbjct: 73 EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----- 127
Query: 83 RRQLDWLARYRTVRGIASGLEYLHM------------HQAL----VLLDHDMEARISEFG 126
LD + + SGL +LH H+ L +L+ + I++ G
Sbjct: 128 STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187
Query: 127 LAKVFPEAHTHITTSD--VVGTAGYIAPE------YQQTLSITYMCDIYSFGVLLAE 175
LA F + VGT Y+ PE + M D+YSFG++L E
Sbjct: 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE 244
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 45/175 (25%), Positives = 68/175 (38%), Gaps = 33/175 (18%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPG----CHLLVYEFMKNGSLQDILNDVSRG 82
E +EI +RH NIL +A + LV ++ ++GSL D LN
Sbjct: 78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----- 132
Query: 83 RRQLDWLARYRTVRGIASGLEYLHM------------HQAL----VLLDHDMEARISEFG 126
R + + ASGL +LHM H+ L +L+ + I++ G
Sbjct: 133 RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192
Query: 127 LAKVFPEAHTHITTSD--VVGTAGYIAPE------YQQTLSITYMCDIYSFGVLL 173
LA A I + VGT Y+APE + DIY+ G++
Sbjct: 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-25
Identities = 41/190 (21%), Positives = 79/190 (41%), Gaps = 34/190 (17%)
Query: 3 AIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLL 62
AI+ ++ + + E+ + + E+ + + H NI+ L + P +
Sbjct: 48 AIKSLILGDSE-------GETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--M 98
Query: 63 VYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH------MHQAL----V 112
V EF+ G L L D + W + R + IA G+EY+ +H+ L +
Sbjct: 99 VMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNI 155
Query: 113 LLD-----HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY--MCD 165
L + A++++FGL++ + S ++G ++APE +Y D
Sbjct: 156 FLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKAD 210
Query: 166 IYSFGVLLAE 175
YSF ++L
Sbjct: 211 TYSFAMILYT 220
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-25
Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 33/175 (18%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLA----HLARPGCHLLVYEFMKNGSLQDILNDVSRG 82
E+ +E+ +RH NIL +A L+ + + GSL D L
Sbjct: 44 EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----- 98
Query: 83 RRQLDWLARYRTVRGIASGLEYLHMHQAL----------------VLLDHDMEARISEFG 126
LD ++ R V IASGL +LH+ +L+ + + I++ G
Sbjct: 99 LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158
Query: 127 LAKVFPEAHTHITTSD--VVGTAGYIAPE------YQQTLSITYMCDIYSFGVLL 173
LA + ++ + + VGT Y+APE DI++FG++L
Sbjct: 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-24
Identities = 39/179 (21%), Positives = 72/179 (40%), Gaps = 28/179 (15%)
Query: 16 ALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDI 75
A + +++ + +R E ++H NI+ L + LV EF + G L +
Sbjct: 37 AARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV 96
Query: 76 LNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL-----------VLLDHDMEAR--- 121
L+ +++ IA G+ YLH + +L+ +E
Sbjct: 97 LS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151
Query: 122 -----ISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
I++FGLA+ T ++ G ++APE + + D++S+GVLL E
Sbjct: 152 NKILKITDFGLARE--WHRTTKMSA--AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWE 206
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-24
Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 16/163 (9%)
Query: 25 LTEEMMQI-RSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGR 83
T + +Q ++E+ L + RH NIL + + P +V ++ + SL L+
Sbjct: 59 PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH---ASE 114
Query: 84 RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAH 135
+ + R A G++YLH +H+ L + L D +I +FGLA
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 136 THITTSDVVGTAGYIAPE---YQQTLSITYMCDIYSFGVLLAE 175
+ G+ ++APE Q + ++ D+Y+FG++L E
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-22
Identities = 33/172 (19%), Positives = 66/172 (38%), Gaps = 25/172 (14%)
Query: 25 LTEEMMQ-IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGR 83
E+ ++ + E++ Q RH N++ + P ++ K +L ++ D +
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AK 124
Query: 84 RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVF---P 132
LD + + I G+ YLH +H+ L V D + + I++FGL +
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183
Query: 133 EAHTHITTSDVVGTAGYIAPE---------YQQTLSITYMCDIYSFGVLLAE 175
G ++APE + L + D+++ G + E
Sbjct: 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-21
Identities = 38/162 (23%), Positives = 66/162 (40%), Gaps = 17/162 (10%)
Query: 22 SKLLTEEMM-QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
S LL ++ EI + H++++ +V E + SL ++
Sbjct: 51 SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KR 108
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLA-KVF 131
R Y +R I G +YLH ++ + + L+ D+E +I +FGLA KV
Sbjct: 109 RKALTEPEARYY--LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166
Query: 132 PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ GT YIAPE ++ D++S G ++
Sbjct: 167 YDGERKKVL---CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-21
Identities = 38/162 (23%), Positives = 66/162 (40%), Gaps = 17/162 (10%)
Query: 22 SKLLTEEMM-QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
S LL ++ EI + H++++ +V E + SL ++
Sbjct: 77 SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH--KR 134
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLA-KVF 131
R Y +R I G +YLH ++ + + L+ D+E +I +FGLA KV
Sbjct: 135 RKALTEPEARYY--LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192
Query: 132 PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ GT YIAPE ++ D++S G ++
Sbjct: 193 YDGERKKVL---CGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-20
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 14/161 (8%)
Query: 22 SKLLTEEMM-QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
+ M+ ++++E+ Q++H +IL L + LV E NG + L +
Sbjct: 47 KAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KN 104
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFP 132
R + + AR + I +G+ YLH H L +LL +M +I++FGLA
Sbjct: 105 RVKPFSENEAR-HFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
H T GT YI+PE + D++S G +
Sbjct: 164 MPHEKHYTL--CGTPNYISPEIATRSAHGLESDVWSLGCMF 202
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-19
Identities = 27/187 (14%), Positives = 66/187 (35%), Gaps = 23/187 (12%)
Query: 4 IRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLV 63
K + D + + ++E+ + I++ L + ++
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121
Query: 64 YEFMKNGSLQDIL------NDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQALV----- 112
YE+M+N S+ + + + ++ + + Y+H + +
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI--IKSVLNSFSYIHNEKNICHRDVK 179
Query: 113 ----LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE--YQQTLSITYMCDI 166
L+D + ++S+FG ++ + S GT ++ PE ++ DI
Sbjct: 180 PSNILMDKNGRVKLSDFGESEYMVDKKIK--GS--RGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 167 YSFGVLL 173
+S G+ L
Sbjct: 236 WSLGICL 242
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-18
Identities = 45/242 (18%), Positives = 81/242 (33%), Gaps = 51/242 (21%)
Query: 27 EEMMQIRSEIVTLGQIRHRNI------------LPLLAHLARPGCHL-LVYEFMKNGSLQ 73
E++ I SE++ L + H+ + + L + E+ +NG+L
Sbjct: 44 EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLY 103
Query: 74 DILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEF 125
D++ S Q R R I L Y+H + + +D +I +F
Sbjct: 104 DLI--HSENLNQQRDEYW-RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 126 GLAKVFPEAHTHITTSD------------VVGTAGYIAPE-YQQTLSITYMCDIYSFGVL 172
GLAK + + +GTA Y+A E T D+YS G++
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 173 LAE-------EMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPK 225
E M V ++ + + N + + ++ DP
Sbjct: 221 FFEMIYPFSTGMERVNILKKLR---SVSIEFPPDFDDNKMKVEKKIIRL--LIDH--DPN 273
Query: 226 ER 227
+R
Sbjct: 274 KR 275
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-18
Identities = 38/163 (23%), Positives = 64/163 (39%), Gaps = 17/163 (10%)
Query: 22 SKLLTEEMM-QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
++L + Q+R E+ +RH NIL L + L+ E+ G++ L
Sbjct: 45 AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QK 102
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFP 132
+ A Y + +A+ L Y H + + +LL E +I++FG + P
Sbjct: 103 LSKFDEQRTATY--ITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
GT Y+ PE + D++S GVL E
Sbjct: 161 S-SRRTDL---CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 199
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-18
Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 17/163 (10%)
Query: 22 SKLLTEEMM-QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
S+L E + Q+R EI +RH NIL + + L+ EF G L L
Sbjct: 50 SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL--QK 107
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFP 132
GR A + + +A L Y H +H+ + +L+ + E +I++FG + P
Sbjct: 108 HGRFDEQRSATF--MEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
T GT Y+ PE + + D++ GVL E
Sbjct: 166 SLRRR-TM---CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-17
Identities = 36/170 (21%), Positives = 67/170 (39%), Gaps = 24/170 (14%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLL---AHLARPGCHLLVY-EFMKNGSLQDIL 76
D KL E + + E L ++H NI+ + +++ E M +G+L+ L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQALV----------LLDH-DMEARISEF 125
++ L + R I GL++LH + + +I +
Sbjct: 121 KRF--KVMKIKVLRSW--CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
Query: 126 GLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
GLA + + V+GT ++APE + D+Y+FG+ + E
Sbjct: 177 GLATLKRASFAK----AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLE 221
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-16
Identities = 42/178 (23%), Positives = 80/178 (44%), Gaps = 20/178 (11%)
Query: 9 QPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPG-CHL-LVYEF 66
+PP T + Q+ EI L ++ H N++ L+ L P HL +V+E
Sbjct: 60 RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119
Query: 67 MKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDM 118
+ G + ++ + D AR + + G+EYLH +H+ + +L+ D
Sbjct: 120 VNQGPVMEV---PTLKPLSED-QAR-FYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG 174
Query: 119 EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY---MCDIYSFGVLL 173
+I++FG++ F + ++ + VGT ++APE + D+++ GV L
Sbjct: 175 HIKIADFGVSNEFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 41/170 (24%), Positives = 66/170 (38%), Gaps = 21/170 (12%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLA------HLARPGCHLLVYEFMKNGSLQD 74
+L + + EI + ++ H N++ LA LL E+ + G L+
Sbjct: 48 RQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRK 107
Query: 75 ILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLD---HDMEARIS 123
LN + R + I+S L YLH +H+ L ++L + +I
Sbjct: 108 YLNQFENCCGLKEGPIR-TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166
Query: 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ G AK + VGT Y+APE + T D +SFG L
Sbjct: 167 DLGYAKELDQGELCTE---FVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-16
Identities = 44/239 (18%), Positives = 83/239 (34%), Gaps = 48/239 (20%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNIL---------PLLAHLARPGCHLLVY---EFMKNGSLQ 73
++ E+ L ++ H I+ L + +Y + + +L+
Sbjct: 44 ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLK 103
Query: 74 DILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEF 125
D +N + + IA +E+LH MH+ L + D ++ +F
Sbjct: 104 DWMNG-RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162
Query: 126 GLAKV----------FPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
GL + + VGT Y++PE S ++ DI+S G++L E
Sbjct: 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
Query: 176 -------EMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
+M V+ + +V + P L Y + ++V P ER
Sbjct: 223 LLYPFSTQMERVRTLTDVRNLKFP------PLFTQKYPCEYVMVQD----MLSPSPMER 271
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-16
Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 22/169 (13%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH--LLVYEFMKNGSLQDILNDVSRGR 83
+ ++ EI L + H NI+ G + L+ EF+ +GSL++ L ++ +
Sbjct: 64 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNK 122
Query: 84 RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAH 135
L +Y I G++YL +H+ L VL++ + + +I +FGL K
Sbjct: 123 INLKQQLKY--AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
Query: 136 THITTSDVVGTAGYI-----APEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ T APE D++SFGV L E ++
Sbjct: 181 EYYTVK----DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 8e-16
Identities = 37/170 (21%), Positives = 71/170 (41%), Gaps = 20/170 (11%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
S++ ++E + R E+ L ++H NI+ G +V ++ + G L +N
Sbjct: 60 SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 82 GR----RQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK 129
+ LDW + I L+++H + L + L D ++ +FG+A+
Sbjct: 120 VLFQEDQILDWFVQ------ICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
V +GT Y++PE + DI++ G +L E +L
Sbjct: 174 VLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-15
Identities = 30/172 (17%), Positives = 56/172 (32%), Gaps = 29/172 (16%)
Query: 28 EMMQIRSEIVTLGQIRHRNI---------------LPLLAHLARPGCHL-LVYEFMKNGS 71
+ E+ L ++ H NI L + EF G+
Sbjct: 47 NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGT 106
Query: 72 LQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARIS 123
L+ + + I G++Y+H + + + L + +I
Sbjct: 107 LEQWIEKRRGEKLDKVLALEL--FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164
Query: 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+FGL + GT Y++PE + D+Y+ G++LAE
Sbjct: 165 DFGLVTSLKNDGKRTRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-15
Identities = 46/180 (25%), Positives = 73/180 (40%), Gaps = 37/180 (20%)
Query: 19 EADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILN 77
EA+ L +E++ E + Q+ + I+ ++ A +LV E + G L L
Sbjct: 55 EANDPALKDELLA---EANVMQQLDNPYIVRMIGICEAES--WMLVMEMAELGPLNKYL- 108
Query: 78 DVSRGRRQLDWLARYRTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAK 129
+ R + V ++ G++YL +H+ L VLL A+IS+FGL+K
Sbjct: 109 ---QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165
Query: 130 VFPEAHTHITTSDVVGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ T G APE I Y D++SFGVL+ E S
Sbjct: 166 ALRADENYYKAQ----THGKWPVKWYAPE-----CINYYKFSSKSDVWSFGVLMWEAFSY 216
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-15
Identities = 42/179 (23%), Positives = 74/179 (41%), Gaps = 29/179 (16%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAH-LARPGCHL-LVYEFMKNGSLQDILNDV 79
+ E + SE+ L +++H NI+ + R L +V E+ + G L ++
Sbjct: 42 GSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG 101
Query: 80 SRGRRQL------DWLARYRTVRGIASGLEYLH---------MHQAL----VLLDHDMEA 120
++ R+ L + + + L+ H +H+ L V LD
Sbjct: 102 TKERQYLDEEFVLRVMTQ------LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155
Query: 121 RISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
++ +FGLA++ H VGT Y++PE +S DI+S G LL E +L
Sbjct: 156 KLGDFGLARIL--NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 4e-15
Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 24/166 (14%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
KL + ++ E +++H NI+ L + H LV++ + G L + + V+R
Sbjct: 42 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAR 99
Query: 82 GR---RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFGL 127
A ++ I + Y H +H+ L +LL ++++FGL
Sbjct: 100 EFYSEAD----AS-HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154
Query: 128 AKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
A ++ GT GY++PE + + DI++ GV+L
Sbjct: 155 AIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 4e-15
Identities = 35/162 (21%), Positives = 63/162 (38%), Gaps = 16/162 (9%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+ +R EI T+ +RH ++ L +++YEFM G L + V+
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE---KVAD 247
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARI--SEFGLAKVF 131
++ +R + GL ++H +H L ++ + +FGL
Sbjct: 248 EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
Query: 132 PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ GTA + APE + + Y D++S GVL
Sbjct: 308 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-15
Identities = 39/174 (22%), Positives = 64/174 (36%), Gaps = 24/174 (13%)
Query: 19 EADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILND 78
E L + +Q E L Q H NI+ L+ + +V E ++ G L
Sbjct: 149 ETLPPDLKAKFLQ---EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT 205
Query: 79 VSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKV 130
+L + V A+G+EYL + L+ +IS+FG+++
Sbjct: 206 ---EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262
Query: 131 FPEAHTHITTSDVVGTAGYI-----APEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ G + APE + D++SFG+LL E SL
Sbjct: 263 EAD-----GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSL 311
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-15
Identities = 37/166 (22%), Positives = 70/166 (42%), Gaps = 24/166 (14%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
KL + ++ E +++H NI+ L + H LV++ + G L + + V+R
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI--VAR 122
Query: 82 GR---RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFGL 127
A ++ I + Y H +H+ L +LL ++++FGL
Sbjct: 123 EFYSEAD----AS-HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 128 AKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
A ++ GT GY++PE + + DI++ GV+L
Sbjct: 178 AIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 5e-15
Identities = 31/175 (17%), Positives = 65/175 (37%), Gaps = 26/175 (14%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL--LVYEFMKNGSLQDILND 78
++ + E L ++ H+NI+ L A L+ EF GSL +L +
Sbjct: 43 NNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE 102
Query: 79 VSRGRRQLDWLARYRTVRGIASGLEYLHMH---------QALVLL---DHDMEARISEFG 126
S + +R + G+ +L + ++ + D ++++FG
Sbjct: 103 PSNAYGLPESEFL-IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPE------YQQTLSITY--MCDIYSFGVLL 173
A+ + ++ + GT Y+ P+ ++ Y D++S GV
Sbjct: 162 AARELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 5e-15
Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 22/174 (12%)
Query: 23 KLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
++L E E+ L + H N++ + E +LQ+ + +
Sbjct: 55 RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYV--EQK 111
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL-----DHDMEARISEFGLA 128
L ++ SGL +LH +H+ L +L+ ++A IS+FGL
Sbjct: 112 DFAHLGLEPI-TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170
Query: 129 KVF-PEAHTHITTSDVVGTAGYIAPEY---QQTLSITYMCDIYSFGVLLAEEMS 178
K H+ S V GT G+IAPE + TY DI+S G + +S
Sbjct: 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-15
Identities = 40/162 (24%), Positives = 68/162 (41%), Gaps = 24/162 (14%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVSRGRRQ 85
+ + + +EI L ++ H I+ + ++ V E M+ G L D + V R +
Sbjct: 182 DPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKV---VGNKRLK 237
Query: 86 LDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFGLAKVFPEA 134
Y + ++YLH +H+ L VLL + D +I++FG +K+ E
Sbjct: 238 EATCKLY--FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 135 HTHITTSDVVGTAGYIAPE---YQQTLSITYMCDIYSFGVLL 173
+ GT Y+APE T D +S GV+L
Sbjct: 296 SL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-15
Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 33/165 (20%)
Query: 34 SEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E + Q+ + I+ L+ A +LV E G L L R ++
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVG---KREEIPVSNVA 113
Query: 93 RTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
+ ++ G++YL +H+ L VLL + A+IS+FGL+K ++ T
Sbjct: 114 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--- 170
Query: 145 GTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+AG APE I + D++S+GV + E +S
Sbjct: 171 -SAGKWPLKWYAPE-----CINFRKFSSRSDVWSYGVTMWEALSY 209
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 6e-15
Identities = 32/173 (18%), Positives = 59/173 (34%), Gaps = 27/173 (15%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRH--RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDV 79
+ + + R+EI L +++ I+ L + +V E N L L
Sbjct: 44 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--K 100
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVF 131
+ Y + + + +H H A L+ M ++ +FG+A
Sbjct: 101 KKKSIDPWERKSY--WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQM 157
Query: 132 PEAHTHITTSDVVGTAGYIAPE-----------YQQTLSITYMCDIYSFGVLL 173
T + VGT Y+ PE + I+ D++S G +L
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-15
Identities = 32/173 (18%), Positives = 60/173 (34%), Gaps = 27/173 (15%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRN--ILPLLAHLARPGCHLLVYEFMKNGSLQDILNDV 79
+ + + R+EI L +++ + I+ L + +V E N L L
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL--K 119
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVF 131
+ Y + + + +H H A L+ M ++ +FG+A
Sbjct: 120 KKKSIDPWERKSY--WKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQM 176
Query: 132 PEAHTHITTSDVVGTAGYIAPE-----------YQQTLSITYMCDIYSFGVLL 173
T + VGT Y+ PE + I+ D++S G +L
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-15
Identities = 45/175 (25%), Positives = 71/175 (40%), Gaps = 26/175 (14%)
Query: 23 KLLTEEMMQIR----SEIVTLGQIRHRNILPLLAHLARPGCH--LLVYEFMKNGSLQDIL 76
K L + EI L ++H NI+ G L+ E++ GSL+D L
Sbjct: 45 KKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
Query: 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLA 128
+ R L +Y I G+EYL +H+ L +L++++ +I +FGL
Sbjct: 105 QK-HKERIDHIKLLQY--TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
Query: 129 KVFPEAHTHITTSDVVGTAGYI-----APEYQQTLSITYMCDIYSFGVLLAEEMS 178
KV P+ G APE + D++SFGV+L E +
Sbjct: 162 KVLPQDKEFFKVK----EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 8e-15
Identities = 35/159 (22%), Positives = 63/159 (39%), Gaps = 14/159 (8%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+ EI L Q+ H N++ A +V E G L ++ + +R +
Sbjct: 74 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 133
Query: 87 --DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHT 136
+ +Y + S LE++H + + V + ++ + GL + F T
Sbjct: 134 PERTVWKY--FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191
Query: 137 HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ +VGT Y++PE + DI+S G LL E
Sbjct: 192 AAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-15
Identities = 53/169 (31%), Positives = 74/169 (43%), Gaps = 24/169 (14%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGC--HLLVYEFMKNGSLQDILNDVSRGR 83
+ + EI L + H +I+ G LV E++ GSL+D L S G
Sbjct: 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL 133
Query: 84 RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAH 135
QL A+ I G+ YLH +H+ L VLLD+D +I +FGLAK PE H
Sbjct: 134 AQLLLFAQ-----QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
Query: 136 THITTSDVVGTAGYI-----APEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ V G APE + Y D++SFGV L E ++
Sbjct: 189 EYYR----VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 9e-15
Identities = 37/154 (24%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
E + +I+H N++ LL R ++ EFM G+L D L R+++ +
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLY 322
Query: 94 TVRGIASGLEYLHM----HQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
I+S +EYL H+ L L+ + ++++FGL+++ T+ +
Sbjct: 323 MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKF 381
Query: 146 TAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ APE + D+++FGVLL E +
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 9e-15
Identities = 32/175 (18%), Positives = 67/175 (38%), Gaps = 26/175 (14%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL--LVYEFMKNGSLQDILND 78
++ + E L ++ H+NI+ L A L+ EF GSL +L +
Sbjct: 43 NNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE 102
Query: 79 VSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL----DHDMEARISEFG 126
S + +R + G+ +L +H+ + ++ D ++++FG
Sbjct: 103 PSNAYGLPESEFL-IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPE------YQQTLSITY--MCDIYSFGVLL 173
A+ + ++ + GT Y+ P+ ++ Y D++S GV
Sbjct: 162 AARELEDDEQFVS---LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-14
Identities = 45/175 (25%), Positives = 72/175 (41%), Gaps = 26/175 (14%)
Query: 23 KLLTEEMMQIR----SEIVTLGQIRHRNILPLLAHLARPGCH--LLVYEFMKNGSLQDIL 76
K L + EI L ++H NI+ G L+ E++ GSL+D L
Sbjct: 76 KKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
Query: 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLA 128
+ R L +Y I G+EYL +H+ L +L++++ +I +FGL
Sbjct: 136 QK-HKERIDHIKLLQY--TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
Query: 129 KVFPEAHTHITTSDVVGTAGYI-----APEYQQTLSITYMCDIYSFGVLLAEEMS 178
KV P+ + G APE + D++SFGV+L E +
Sbjct: 193 KVLPQDKEYYKVK----EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-14
Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 23/160 (14%)
Query: 34 SEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E + Q+ + I+ L+ A +LV E G L L R + +A
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVG-KREEIPVSNVAEL 441
Query: 93 RTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
+ ++ G++YL +H+ L VLL + A+IS+FGL+K ++ T
Sbjct: 442 --LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--- 496
Query: 145 GTAGYI-----APEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+AG APE + D++S+GV + E +S
Sbjct: 497 -SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 535
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-14
Identities = 38/169 (22%), Positives = 62/169 (36%), Gaps = 22/169 (13%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH----LLVYEFMKNGSLQDILNDVSRG 82
++ + + E H NIL L+A+ R L+ F K G+L + + +
Sbjct: 68 QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDK 127
Query: 83 RRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKV---- 130
L + GI GLE +H H+ L +LL + + + + G
Sbjct: 128 GNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187
Query: 131 FPEAHTHITTSD---VVGTAGYIAPE---YQQTLSITYMCDIYSFGVLL 173
+ +T D T Y APE Q I D++S G +L
Sbjct: 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-14
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 31/166 (18%)
Query: 34 SEIVTLGQIRH----RNILPLLAHLARPGC-----------HL-LVYEFMKNGSLQDILN 77
I+ ++ + R+++ L H P L + KNG L +
Sbjct: 66 RHIIKENKVPYVTRERDVMSRLDH---PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI- 121
Query: 78 DVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAK 129
+ + R+ T I S LEYLH +H+ L +LL+ DM +I++FG AK
Sbjct: 122 --RKIGSFDETCTRFYTAE-IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 178
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
V + VGTA Y++PE S D+++ G ++ +
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 39/231 (16%), Positives = 77/231 (33%), Gaps = 36/231 (15%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
M +I + +N + L + + + + +L+D +N
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR-RC 156
Query: 82 GRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKV--- 130
+ IA +E+LH + + D ++ +FGL
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 131 -------FPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE-------E 176
+ T + VGT Y++PE + ++ DI+S G++L E +
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
Query: 177 MSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
M V+ + +V + P L Y ++ ++V P ER
Sbjct: 277 MERVRIITDVRNLKFP------LLFTQKYPQEHMMVQD----MLSPSPTER 317
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 30/164 (18%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
SE +GQ H NI+ L + R ++V E+M+NGSL L G+ + L
Sbjct: 99 SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGM- 156
Query: 94 TVRGIASGLEYLHM----HQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
+RG+ +G+ YL H+ L VL+D ++ ++S+FGL++V + T+
Sbjct: 157 -LRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT---- 211
Query: 146 TAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
T G I APE +I + D++SFGV++ E ++
Sbjct: 212 TGGKIPIRWTAPE-----AIAFRTFSSASDVWSFGVVMWEVLAY 250
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 31/169 (18%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVS 80
+ ++ I E+ L ++ H NI+ L L +V E G L D I +
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IK 114
Query: 81 RGR---RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFG 126
R R A R ++ + SG+ Y+H +H+ L +LL + D + +I +FG
Sbjct: 115 RKRFSEHD----AA-RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY--MCDIYSFGVLL 173
L+ F + D +GTA YIAPE L TY CD++S GV+L
Sbjct: 170 LSTCFQQNTKM---KDRIGTAYYIAPE---VLRGTYDEKCDVWSAGVIL 212
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-14
Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 32/174 (18%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH--LLVYEFMKNGSLQDILNDVSRGR 83
++ + EI L + I+ PG LV E++ +G L+D L R R
Sbjct: 65 PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRAR 123
Query: 84 RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAH 135
L Y I G+EYL +H+ L +L++ + +I++FGLAK+ P
Sbjct: 124 LDASRLLLY--SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
Query: 136 THITTSDVVGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ V G APE S++ D++SFGV+L E +
Sbjct: 182 DYYV----VREPGQSPIFWYAPE-----SLSDNIFSRQSDVWSFGVVLYELFTY 226
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 2e-14
Identities = 31/173 (17%), Positives = 58/173 (33%), Gaps = 27/173 (15%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRH--RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDV 79
+ + + R+EI L +++ I+ L + +V E N L L
Sbjct: 91 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--K 147
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVF 131
+ Y + + + +H H A L+ D ++ +FG+A
Sbjct: 148 KKKSIDPWERKSY--WKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204
Query: 132 PEAHTHITTSDVVGTAGYIAPE-----------YQQTLSITYMCDIYSFGVLL 173
T + VG Y+ PE + I+ D++S G +L
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-14
Identities = 43/191 (22%), Positives = 76/191 (39%), Gaps = 39/191 (20%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGC 59
++ + P + EA R E L Q+ H +I+ L+
Sbjct: 126 IMEVTAERLSPEQLEEVREA-----------TRRETHILRQVAGHPHIITLIDSYESSSF 174
Query: 60 HLLVYEFMKNGSLQDILNDVSRGR---RQLDWLARYRTVRGIASGLEYLH----MHQAL- 111
LV++ M+ G L D L + ++ R +R + + +LH +H+ L
Sbjct: 175 MFLVFDLMRKGELFDYL--TEKVALSEKE----TR-SIMRSLLEAVSFLHANNIVHRDLK 227
Query: 112 ---VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE----YQQTLSITY-- 162
+LLD +M+ R+S+FG + ++ GT GY+APE Y
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGK 284
Query: 163 MCDIYSFGVLL 173
D+++ GV+L
Sbjct: 285 EVDLWACGVIL 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-14
Identities = 38/172 (22%), Positives = 67/172 (38%), Gaps = 28/172 (16%)
Query: 22 SKLLTEEMM---QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILND 78
+K + + ++ E ++H +I+ LL + G +V+EFM L +
Sbjct: 60 AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-- 117
Query: 79 VSRGRRQLDWLARY------RTVRGIASGLEYLH----MHQAL----VLL---DHDMEAR 121
V R Y +R I L Y H +H+ + VLL ++ +
Sbjct: 118 VKRADAG----FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVK 173
Query: 122 ISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ FG+A E+ VGT ++APE + D++ GV+L
Sbjct: 174 LGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-14
Identities = 39/160 (24%), Positives = 66/160 (41%), Gaps = 28/160 (17%)
Query: 32 IRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGR---RQLD 87
E+ L ++ H NI+ L LV++ MK G L D L + ++
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKE-- 125
Query: 88 WLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHIT 139
R + +R + + LH +H+ L +LLD DM ++++FG +
Sbjct: 126 --TR-KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--- 179
Query: 140 TSDVVGTAGYIAPE----YQQTLSITYM--CDIYSFGVLL 173
+V GT Y+APE Y D++S GV++
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-14
Identities = 35/164 (21%), Positives = 67/164 (40%), Gaps = 19/164 (11%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+ +I E+ L Q+ H N++ L +L+ E + G L D L +
Sbjct: 52 ASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQK 109
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH----MH-----QALVLLDHDMEA---RISEFGLAK 129
+ + ++ I G+ YLH H + ++LLD ++ ++ +FGLA
Sbjct: 110 ESLSEEEATSF--IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ ++ GT ++APE + D++S GV+
Sbjct: 168 EIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-14
Identities = 40/186 (21%), Positives = 70/186 (37%), Gaps = 39/186 (20%)
Query: 24 LLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG 82
+L + EI L + H N++ + E N +LQD++ S+
Sbjct: 47 MLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLV--ESKN 103
Query: 83 RRQLDWLARY-----RTVRGIASGLEYLH----MHQAL----VLLDH------------- 116
+ + +R IASG+ +LH +H+ L +L+
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163
Query: 117 DMEARISEFGLAKVFPEAHT--HITTSDVVGTAGYIAPE-------YQQTLSITYMCDIY 167
++ IS+FGL K + ++ GT+G+ APE Q +T DI+
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 168 SFGVLL 173
S G +
Sbjct: 224 SMGCVF 229
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 5e-14
Identities = 37/170 (21%), Positives = 67/170 (39%), Gaps = 31/170 (18%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
S +I E+ L +IRH NI+ L +L+ E + G L D L +
Sbjct: 45 SSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEK 102
Query: 82 GRRQLDWLARY------RTVRGIASGLEYLH----MH-----QALVLLDHDMEA---RIS 123
+ ++ I G+ YLH H + ++LLD ++ ++
Sbjct: 103 ES--------LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLI 154
Query: 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+FG+A + ++ GT ++APE + D++S GV+
Sbjct: 155 DFGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-14
Identities = 43/180 (23%), Positives = 67/180 (37%), Gaps = 36/180 (20%)
Query: 20 ADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILN 77
+ E+ L Q + HRN+L L+ LV+E M+ GS+ I
Sbjct: 47 EKQPGHIRSRV--FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI-- 102
Query: 78 DVSRGR---RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARIS 123
R + A V+ +AS L++LH H+ L +L + +I
Sbjct: 103 -HKRRHFNELE----AS-VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKIC 156
Query: 124 EFGLAKVFPEAHTHITTSD-----VVGTAGYIAPE---YQQTLSITY--MCDIYSFGVLL 173
+F L S G+A Y+APE + Y CD++S GV+L
Sbjct: 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 6e-14
Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 14/155 (9%)
Query: 34 SEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E + ++RH ++ L A P +V E+M GSL D L + L
Sbjct: 311 QEAQVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLK--GETGKYLRLPQLV 366
Query: 93 RTVRGIASGLEYLHM----HQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
IASG+ Y+ H+ L +L+ ++ ++++FGLA++ + + +
Sbjct: 367 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAK 425
Query: 145 GTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ APE T D++SFG+LL E +
Sbjct: 426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-14
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 30/164 (18%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
E +GQ H NI+ L + + ++V E+M+NGSL L Q +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVG 151
Query: 94 TVRGIASGLEYLHM----HQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
+RGIASG++YL H+ L +L++ ++ ++S+FGL +V + T+
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT---- 207
Query: 146 TAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
G I +PE +I Y D++S+G++L E MS
Sbjct: 208 RGGKIPIRWTSPE-----AIAYRKFTSASDVWSYGIVLWEVMSY 246
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-14
Identities = 36/164 (21%), Positives = 67/164 (40%), Gaps = 19/164 (11%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+ +I E+ L Q+ H NI+ L +L+ E + G L D L +
Sbjct: 52 ASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQK 109
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH----MH-----QALVLLDHDMEA---RISEFGLAK 129
+ + ++ I G+ YLH H + ++LLD ++ ++ +FGLA
Sbjct: 110 ESLSEEEATSF--IKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ ++ GT ++APE + D++S GV+
Sbjct: 168 EIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 7e-14
Identities = 35/168 (20%), Positives = 60/168 (35%), Gaps = 20/168 (11%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL-LVYEFMKNGSLQDILNDVSRGRR 84
E + ++ E+ H NI+P A L +V FM GS +D++
Sbjct: 67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSFMAYGSAKDLICTHFMDGM 125
Query: 85 QLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHT 136
+A ++G+ L+Y+H + +L+ D + +S
Sbjct: 126 NELAIAYI--LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183
Query: 137 -----HITTSDVVGTAGYIAPEYQQTLSITY--MCDIYSFGVLLAEEM 177
H V +++PE Q Y DIYS G+ A E+
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI-TACEL 230
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-14
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 30/165 (18%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVSRGR-- 83
+ + + +EI L ++ H I+ + ++ V E M+ G L D + V R
Sbjct: 57 DPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKV---VGNKRLK 112
Query: 84 -RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFGLAKVF 131
+ + ++YLH +H+ L VLL + D +I++FG +K+
Sbjct: 113 EAT----CK-LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 132 PEAHTHITTSDVVGTAGYIAPE---YQQTLSITYMCDIYSFGVLL 173
E + GT Y+APE T D +S GV+L
Sbjct: 168 GETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-13
Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVS 80
S + + +EI L +I+H NI+ L + LV + + G L D I +
Sbjct: 45 SPAFRDSS--LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI---LE 99
Query: 81 RGR---RQLDWLARYRTVRGIASGLEYLH----MH-----QALVLLDHDMEAR--ISEFG 126
RG + A ++ + S ++YLH +H + L+ L + ++ I++FG
Sbjct: 100 RGVYTEKD----AS-LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFG 154
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
L+K+ S GT GY+APE + D +S GV+
Sbjct: 155 LSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-13
Identities = 36/165 (21%), Positives = 63/165 (38%), Gaps = 34/165 (20%)
Query: 34 SEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E + + + ++ LL L L+ + M G L D + + + +L +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNW 122
Query: 93 RTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
IA G+ YL +H+ L VL+ +I++FGLAK+
Sbjct: 123 --CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-- 178
Query: 145 GTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
G + A E SI + D++S+GV + E M+
Sbjct: 179 ---GKVPIKWMALE-----SILHRIYTHQSDVWSYGVTVWELMTF 215
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-13
Identities = 36/167 (21%), Positives = 68/167 (40%), Gaps = 25/167 (14%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVS 80
KL + ++ E ++H NI+ L ++ G H L+++ + G L + I V+
Sbjct: 47 KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI---VA 103
Query: 81 RGR---RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFG 126
R A ++ I + + H +H+ L +LL ++++FG
Sbjct: 104 REYYSEAD----AS-HCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG 158
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
LA GT GY++PE + D+++ GV+L
Sbjct: 159 LAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-13
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 25/166 (15%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+ + T ++ E+ L + H NI+ L + LV E K G L D + + R
Sbjct: 73 TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI--IHR 130
Query: 82 GR---RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFGL 127
+ A ++ + SG+ YLH +H+ L +LL + D +I +FGL
Sbjct: 131 MKFNEVD----AA-VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185
Query: 128 AKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ VF + +GTA YIAPE + CD++S GV+L
Sbjct: 186 SAVFENQKKM---KERLGTAYYIAPEVLRK-KYDEKCDVWSIGVIL 227
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 43/164 (26%), Positives = 82/164 (50%), Gaps = 30/164 (18%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
E +GQ H NI+ L +++ +++ E+M+NG+L L + G + L
Sbjct: 95 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGM- 152
Query: 94 TVRGIASGLEYLHM----HQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
+RGIA+G++YL H+ L +L++ ++ ++S+FGL++V + +
Sbjct: 153 -LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED----DPEATYTT 207
Query: 146 TAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ G I APE +I+Y D++SFG+++ E M+
Sbjct: 208 SGGKIPIRWTAPE-----AISYRKFTSASDVWSFGIVMWEVMTY 246
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-13
Identities = 42/204 (20%), Positives = 69/204 (33%), Gaps = 54/204 (26%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
++ +++ +I++E+ + ++ H NI L LV E G L D L
Sbjct: 65 RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL--NVF 122
Query: 82 GRRQLDWLARY--------------------------------------RTVRGIASGLE 103
A +R I S L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 104 YLH----MHQAL----VLLDHDMEAR--ISEFGLAKVFPEAHTH--ITTSDVVGTAGYIA 151
YLH H+ + L + + +FGL+K F + + + GT ++A
Sbjct: 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 152 PEYQQTLSITY--MCDIYSFGVLL 173
PE T + +Y CD +S GVLL
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLL 266
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-13
Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 19/164 (11%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+ EI ++H+NI+ L + G + E + GSL +L +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 87 DWLARYRTVRGIASGLEYLHMHQ--------ALVLLD-HDMEARISEFGLAKVFPEAHTH 137
+ + T + I GL+YLH +Q VL++ + +IS+FG +K +
Sbjct: 121 EQTIGFYT-KQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 138 ITTSDVVGTAGYIAPE--YQQTLSITYMCDIYSFG--VLLAEEM 177
T GT Y+APE + DI+S G ++ EM
Sbjct: 180 TET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII---EM 218
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-13
Identities = 29/162 (17%), Positives = 63/162 (38%), Gaps = 16/162 (9%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+ + +++EI + Q+ H ++ L +L+ EF+ G L D + +
Sbjct: 85 NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--AAE 142
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARI--SEFGLAKVF 131
+ + +R GL+++H +H + ++ + + + +FGLA
Sbjct: 143 DYKMSEAEVI-NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201
Query: 132 PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
TA + APE + + D+++ GVL
Sbjct: 202 NPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-13
Identities = 40/169 (23%), Positives = 64/169 (37%), Gaps = 31/169 (18%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVS 80
K E++ + + EI + + H NI+ L LV E G L + + V
Sbjct: 43 PKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV---VH 99
Query: 81 RGR---RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFG 126
+ A R ++ + S + Y H H+ L L D ++ +FG
Sbjct: 100 KRVFRESD----AA-RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY--MCDIYSFGVLL 173
LA F VGT Y++P+ L Y CD +S GV++
Sbjct: 155 LAARFKPGKMM---RTKVGTPYYVSPQ---VLEGLYGPECDEWSAGVMM 197
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-13
Identities = 36/155 (23%), Positives = 57/155 (36%), Gaps = 16/155 (10%)
Query: 33 RSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E+V + I+PL + + E ++ GSL ++ G D Y
Sbjct: 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK--QMGCLPEDRALYY 155
Query: 93 RTVRGIASGLEYLHMHQAL--------VLLDHD-MEARISEFGLAKVFPE---AHTHITT 140
+ GLEYLH + L VLL D A + +FG A + +T
Sbjct: 156 --LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 141 SDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ GT ++APE DI+S ++
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-13
Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 14/155 (9%)
Query: 34 SEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E + ++RH ++ L A P +V E+M GSL D L + L
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLK--GETGKYLRLPQLV 283
Query: 93 RTVRGIASGLEYLHM----HQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
IASG+ Y+ H+ L +L+ ++ ++++FGLA++ + + +
Sbjct: 284 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAK 342
Query: 145 GTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ APE T D++SFG+LL E +
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-13
Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 16/161 (9%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
++L + ++ E+ + + H NI+ L + L+ E+ G + D L V+
Sbjct: 51 TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL--VAH 108
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPE 133
GR + AR R I S ++Y H +H+ L +LLD DM +I++FG + F
Sbjct: 109 GRMKEK-EAR-SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166
Query: 134 AHTHITTSDVVGTAGYIAPE-YQQTLSITYMCDIYSFGVLL 173
+ G Y APE +Q D++S GV+L
Sbjct: 167 GG-KLDAF--CGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-13
Identities = 33/163 (20%), Positives = 68/163 (41%), Gaps = 18/163 (11%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVS 80
++ ++++EI + Q+ H N++ L +LV E++ G L D I +
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---ID 179
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARI--SEFGLAKV 130
+ ++ I G+ ++H +H L +L + +I +FGLA+
Sbjct: 180 ESYNLTELDTI-LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238
Query: 131 FPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ GT ++APE +++ D++S GV+
Sbjct: 239 YKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-13
Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 34/170 (20%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVS 80
K + +++ +R+EI L ++ H NI+ L P LV E + G L D I V
Sbjct: 87 KKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI---VE 141
Query: 81 RGRRQLDWLARY------RTVRGIASGLEYLH----MHQAL-----VLLDHDMEAR--IS 123
+G Y V+ I + YLH +H+ L + +A I+
Sbjct: 142 KGY--------YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIA 193
Query: 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+FGL+K+ V GT GY APE + + D++S G++
Sbjct: 194 DFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 37/170 (21%), Positives = 66/170 (38%), Gaps = 31/170 (18%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
S I E+ L +I+H N++ L +L+ E + G L D L +
Sbjct: 51 SSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEK 108
Query: 82 GRRQLDWLARY------RTVRGIASGLEYLH----MH-----QALVLLDHDMEA---RIS 123
++ I +G+ YLH H + ++LLD ++ +I
Sbjct: 109 ES--------LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+FGLA + ++ GT ++APE + D++S GV+
Sbjct: 161 DFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 3e-13
Identities = 41/167 (24%), Positives = 66/167 (39%), Gaps = 23/167 (13%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
D K + I+ EI + H N++ H L E+ G L D +
Sbjct: 41 DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EP 98
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFP 132
A+ R + +G+ YLH H+ + +LLD +IS+FGLA VF
Sbjct: 99 DIGMPEP-DAQ-RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 133 EAHTHITTSDVVGTAGYIAPE------YQQTLSITYMCDIYSFGVLL 173
+ + + GT Y+APE + D++S G++L
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPV-----DVWSCGIVL 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-13
Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 26/158 (16%)
Query: 32 IRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVSRGR---RQL 86
+ EI L H NI+ L LV E + G L + I + +
Sbjct: 52 TQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERI---KKKKHFSETE- 107
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFGLAKVFPEAH 135
A +R + S + ++H +H+ L +L + ++E +I +FG A++ P +
Sbjct: 108 ---AS-YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 136 THITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ T T Y APE CD++S GV+L
Sbjct: 164 QPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 4e-13
Identities = 17/187 (9%), Positives = 40/187 (21%), Gaps = 43/187 (22%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHL--------------------------ARPGCH 60
E+ ++ ++ + +
Sbjct: 104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANY 163
Query: 61 LLVYEFMK--NGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL--- 111
LL+ L L+ V R LA + + L +H
Sbjct: 164 LLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPD 223
Query: 112 -VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEY--QQTLSITYMCDIYS 168
+ + D + + Y E+ T + T+ + +
Sbjct: 224 NLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 169 FGVLLAE 175
G+ +
Sbjct: 279 LGLSIYR 285
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-13
Identities = 31/163 (19%), Positives = 59/163 (36%), Gaps = 28/163 (17%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+ + ++ EI L RHRNIL L ++++EF+ + + + +
Sbjct: 43 TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSA---- 96
Query: 87 DWLARY------RTVRGIASGLEYLH----MHQAL----VLLDHDMEA--RISEFGLAKV 130
V + L++LH H + ++ + +I EFG A+
Sbjct: 97 ---FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153
Query: 131 FPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ Y APE Q ++ D++S G L+
Sbjct: 154 LKPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-13
Identities = 40/172 (23%), Positives = 71/172 (41%), Gaps = 30/172 (17%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARP-GCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
E+ Q +E + + H N+L LL R G L+V +MK+G L++ + +
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHN 188
Query: 86 LDWLARYRTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTH 137
+A G+++L +H+ L +LD ++++FGLA+ +
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248
Query: 138 ITTSDVVGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ T + A E S+ D++SFGVLL E M+
Sbjct: 249 SVHN---KTGAKLPVKWMALE-----SLQTQKFTTKSDVWSFGVLLWELMTR 292
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-13
Identities = 46/182 (25%), Positives = 81/182 (44%), Gaps = 25/182 (13%)
Query: 6 KIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYE 65
K+++ D+K + + +I +EI L + H NI+ L LV E
Sbjct: 67 KVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTE 126
Query: 66 FMKNGSLQDILNDVSRGR---RQLDWLARYRTVRGIASGLEYLH----MH-----QALVL 113
F + G L + + ++R + A ++ I SG+ YLH +H + ++L
Sbjct: 127 FYEGGELFEQI--INRHKFDECD----AA-NIMKQILSGICYLHKHNIVHRDIKPENILL 179
Query: 114 LDHDMEARI--SEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171
+ + I +FGL+ F + + D +GTA YIAPE + CD++S GV
Sbjct: 180 ENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGV 235
Query: 172 LL 173
++
Sbjct: 236 IM 237
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-13
Identities = 40/167 (23%), Positives = 63/167 (37%), Gaps = 23/167 (13%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
D K + I+ EI + H N++ H L E+ G L D +
Sbjct: 41 DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EP 98
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFP 132
A+ R + +G+ YLH +LLD +IS+FGLA VF
Sbjct: 99 DIGMPEP-DAQ-RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156
Query: 133 EAHTHITTSDVVGTAGYIAPE------YQQTLSITYMCDIYSFGVLL 173
+ + + GT Y+APE + D++S G++L
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPV-----DVWSCGIVL 198
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-13
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 25/166 (15%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+ ++ I E+ L ++ H NI+ L L +V E G L D + + R
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI--IKR 115
Query: 82 GR---RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFGL 127
R A R ++ + SG+ Y+H +H+ L +LL + D + +I +FGL
Sbjct: 116 KRFSEHD----AA-RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170
Query: 128 AKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ F + D +GTA YIAPE + + CD++S GV+L
Sbjct: 171 STCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-13
Identities = 42/165 (25%), Positives = 72/165 (43%), Gaps = 33/165 (20%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
E + +I+H N++ LL R ++ EFM G+L D L + +R L
Sbjct: 58 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM- 116
Query: 94 TVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
I+S +EYL +H+ L L+ + ++++FGL+++ +T
Sbjct: 117 -ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-------MTGDTYTA 168
Query: 146 TAG------YIAPEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
AG + APE S+ Y D+++FGVLL E +
Sbjct: 169 HAGAKFPIKWTAPE-----SLAYNKFSIKSDVWAFGVLLWEIATY 208
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 6e-13
Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 22 SKLLTEEMM-QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
K+ + +++ +I+ EI L RH +I+ L ++ P +V E++ G L D +
Sbjct: 47 QKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI--CK 104
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFP 132
GR + AR R + I S ++Y H +H+ L VLLD M A+I++FGL+ +
Sbjct: 105 HGRVEEM-EAR-RLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162
Query: 133 EAHTHITTSDVVGTAGYIAPE-YQQTLSITYMCDIYSFGVLL 173
+ T+ G+ Y APE L DI+S GV+L
Sbjct: 163 DGEFLRTS---CGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-13
Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 26/167 (15%)
Query: 22 SKLLTEEMMQ-IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
++ + + + E+ L Q+ H NI+ L G LV E G L D + +S
Sbjct: 62 RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI--IS 119
Query: 81 RGR---RQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFG 126
R R A R +R + SG+ Y+H +H+ L +LL D RI +FG
Sbjct: 120 RKRFSEVD----AA-RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 174
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
L+ F + D +GTA YIAPE + CD++S GV+L
Sbjct: 175 LSTHFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVIL 217
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 7e-13
Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 21/165 (12%)
Query: 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVSR 81
M QI +EI L + H NI+ + +V E + G L + I++ +R
Sbjct: 58 DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQAR 117
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFGLAKV 130
G+ + ++ + + L Y H +H+ L +L +I +FGLA++
Sbjct: 118 GKALSEGYVA-ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 131 FPEAHTHITTSDVVGTAGYIAPEYQQTLSITY--MCDIYSFGVLL 173
F ++ GTA Y+APE CDI+S GV++
Sbjct: 177 FKSDEHS---TNAAGTALYMAPE---VFKRDVTFKCDIWSAGVVM 215
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 8e-13
Identities = 35/165 (21%), Positives = 63/165 (38%), Gaps = 34/165 (20%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
E + ++ H ++ L LV EFM++G L D L RG + L
Sbjct: 52 EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT-QRGLFAAETLLGM- 109
Query: 94 TVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
+ G+ YL +H+ L L+ + ++S+FG+ + +
Sbjct: 110 -CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTS 161
Query: 146 TAG------YIAPEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ G + +PE ++ D++SFGVL+ E S
Sbjct: 162 STGTKFPVKWASPE-----VFSFSRYSSKSDVWSFGVLMWEVFSE 201
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 8e-13
Identities = 19/167 (11%), Positives = 41/167 (24%), Gaps = 22/167 (13%)
Query: 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL- 86
E + L + + +LV E G+L + +N ++
Sbjct: 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169
Query: 87 -DWLARYRTVRGIASGLEYLH-------------------MHQALVLLDHDMEARISEFG 126
L +R + +E +H + D + + G
Sbjct: 170 PQGLVISFAMR-MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
+ + T+G+ E Y D + +
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATV 275
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-13
Identities = 31/164 (18%), Positives = 63/164 (38%), Gaps = 17/164 (10%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHR-NILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
+ + +I EI L + ++ L +L+ E+ G + + +
Sbjct: 65 RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC--LP 122
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH----MH-----QALVLLDHDMEARI--SEFGLAK 129
+ R ++ I G+ YLH +H Q ++L I +FG+++
Sbjct: 123 ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
A +++GT Y+APE IT D+++ G++
Sbjct: 183 KIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 9e-13
Identities = 26/125 (20%), Positives = 57/125 (45%), Gaps = 13/125 (10%)
Query: 60 HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL-------- 111
+V E++ +L+DI++ + + L + H + +
Sbjct: 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPAN 146
Query: 112 VLLDHDMEARISEFGLAKVFPEAHTHIT-TSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170
+++ ++ +FG+A+ ++ +T T+ V+GTA Y++PE + S+ D+YS G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 171 VLLAE 175
+L E
Sbjct: 207 CVLYE 211
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 30/174 (17%)
Query: 23 KLLTEEMMQ--IRSEIVTLGQIRHRNILPLLAHLARPGCHL-LVYEFMKNGSLQDILNDV 79
K + + +E + Q+RH N++ LL + L +V E+M GSL D L
Sbjct: 222 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-- 279
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF 131
SRGR L + + +EYL + + VL+ D A++S+FGL K
Sbjct: 280 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-- 337
Query: 132 PEAHTHITTSDVVG------TAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+++ G T APE + + D++SFG+LL E S
Sbjct: 338 -----EASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSF 382
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-12
Identities = 36/165 (21%), Positives = 66/165 (40%), Gaps = 34/165 (20%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
E + + H ++ L + ++ E+M NG L + L + R R Q L
Sbjct: 68 EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEM- 125
Query: 94 TVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
+ + +EYL +H+ L L++ ++S+FGL++ + +
Sbjct: 126 -CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-------DEYTS 177
Query: 146 TAG------YIAPEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ G + PE + Y DI++FGVL+ E SL
Sbjct: 178 SVGSKFPVRWSPPE-----VLMYSKFSSKSDIWAFGVLMWEIYSL 217
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 27/167 (16%)
Query: 22 SKLLTEEMM-QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
K+ + +++ +IR EI L RH +I+ L ++ P +V E++ G L D +
Sbjct: 52 QKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI--CK 109
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFP 132
GR +R R + I SG++Y H +H+ L VLLD M A+I++FGL+ +
Sbjct: 110 NGRLDEK-ESR-RLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167
Query: 133 EAHTHITTSDVVGTAGYIAPE------YQQTLSITYMCDIYSFGVLL 173
+ T+ G+ Y APE Y DI+S GV+L
Sbjct: 168 DGEFLRTS---CGSPNYAAPEVISGRLYAGPEV-----DIWSSGVIL 206
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 35/160 (21%), Positives = 62/160 (38%), Gaps = 24/160 (15%)
Query: 34 SEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E + + + ++ LL L L+ + M G L D + + + +L +
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNW 122
Query: 93 RTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
IA G+ YL +H+ L VL+ +I++FGLAK+
Sbjct: 123 --CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-- 178
Query: 145 GTAGYI-----APEYQQTLSITYMCDIYSFGVLLAEEMSL 179
G + A E T+ D++S+GV + E M+
Sbjct: 179 ---GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-12
Identities = 33/161 (20%), Positives = 63/161 (39%), Gaps = 27/161 (16%)
Query: 34 SEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E +T+ Q H +I+ L+ P ++ E G L+ L + L L Y
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQV-RKFSLDLASLILY 496
Query: 93 RTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
+++ L YL +H+ + VL+ + ++ +FGL++ + S
Sbjct: 497 --AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYY 547
Query: 145 GTAG------YIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ ++APE T D++ FGV + E +
Sbjct: 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 588
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-12
Identities = 40/190 (21%), Positives = 68/190 (35%), Gaps = 43/190 (22%)
Query: 23 KLLTEEMMQIR----SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDIL-- 76
K L E R E L ++H++I+ L+V+E+M++G L L
Sbjct: 77 KALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRS 136
Query: 77 ---------NDVSRGRRQLDWLARYRTVRGIASGLEYL----HMHQAL----VLLDHDME 119
L +A+G+ YL +H+ L L+ +
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196
Query: 120 ARISEFGLAKVFPEAHTHITTSDVVGTAGYI-----APEYQQTLSITY-----MCDIYSF 169
+I +FG+++ + VG + PE SI Y D++SF
Sbjct: 197 VKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPE-----SILYRKFTTESDVWSF 246
Query: 170 GVLLAEEMSL 179
GV+L E +
Sbjct: 247 GVVLWEIFTY 256
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-12
Identities = 31/126 (24%), Positives = 57/126 (45%), Gaps = 13/126 (10%)
Query: 58 GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL------ 111
C+ LV E+++ +L + + L I G+++ H + +
Sbjct: 84 DCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKP 139
Query: 112 --VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169
+L+D + +I +FG+AK E + T+ V+GT Y +PE + + DIYS
Sbjct: 140 QNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198
Query: 170 GVLLAE 175
G++L E
Sbjct: 199 GIVLYE 204
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 2e-12
Identities = 22/180 (12%), Positives = 56/180 (31%), Gaps = 29/180 (16%)
Query: 17 LVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH--LLVYEFMK--NGSL 72
L ++ + ++ + + + ++ + +Y M+ +
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 73 QDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISE 124
++L S + L AR + + L LH +H L ++LD ++
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 125 FGLAKVFPEAHTHITTSDVVGTAGYIAPEY-----------QQTLSITYMCDIYSFGVLL 173
F + G+ PE + +T+ D ++ G+++
Sbjct: 250 FEHLVRDGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-12
Identities = 46/168 (27%), Positives = 69/168 (41%), Gaps = 27/168 (16%)
Query: 23 KLLTEEMMQIRSEIVTLGQ-IRHRNILPLLAHLARPGCHLLVYEFMKNGSLQD-ILNDVS 80
K++ + EI L + +H NI+ L +V E MK G L D I +
Sbjct: 53 KIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI---LR 109
Query: 81 RGR---RQLDWLARYRTVRGIASGLEYLH----MHQAL-----VLLDHDMEA---RISEF 125
+ R+ A + I +EYLH +H+ L + +D RI +F
Sbjct: 110 QKFFSERE----AS-AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 126 GLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
G AK + + T TA ++APE + CDI+S GVLL
Sbjct: 165 GFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-12
Identities = 48/178 (26%), Positives = 73/178 (41%), Gaps = 38/178 (21%)
Query: 23 KLLTEEMMQ--IRSEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDV 79
K + + +E + Q+RH N++ LL + G +V E+M GSL D L
Sbjct: 50 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-- 107
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVF 131
SRGR L + + +EYL +H+ L VL+ D A++S+FGL K
Sbjct: 108 SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167
Query: 132 PEAHTHITTSDVVGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
G + APE ++ D++SFG+LL E S
Sbjct: 168 SSTQ----------DTGKLPVKWTAPE-----ALREKKFSTKSDVWSFGILLWEIYSF 210
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 3e-12
Identities = 23/200 (11%), Positives = 49/200 (24%), Gaps = 33/200 (16%)
Query: 6 KIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH----- 60
+ + K + +R H + + P
Sbjct: 109 HVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRV 168
Query: 61 ------------LLVYEFMK--NGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106
+Y M+ + ++L S + L AR + + L LH
Sbjct: 169 RLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228
Query: 107 ----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE----- 153
+H L ++LD ++ F + A
Sbjct: 229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGR-GFAPPETTAERMLPFG 287
Query: 154 YQQTLSITYMCDIYSFGVLL 173
+T+ D ++ G+ +
Sbjct: 288 QHHPTLMTFAFDTWTLGLAI 307
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-12
Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 52/181 (28%)
Query: 34 SEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E+ L ++ H NI+ LL G L E+ +G+L D L R R L+ +
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAF 129
Query: 93 RTV----------------RGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLA 128
+A G++YL +H+ L +L+ + A+I++FGL+
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
Query: 129 KVFPEAHTHITTSDVVGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMS 178
+ V T G + A E S+ Y D++S+GVLL E +S
Sbjct: 190 RGQEVY--------VKKTMGRLPVRWMAIE-----SLNYSVYTTNSDVWSYGVLLWEIVS 236
Query: 179 L 179
L
Sbjct: 237 L 237
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-12
Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 22/159 (13%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
+E + ++H ++ L A + + ++ EFM GSL D L S +
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLK--SDEGSKQPLPKLID 288
Query: 94 TVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
IA G+ ++ ++H+ L +L+ + +I++FGLA+V +
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED------NEYTAR 342
Query: 146 TAGYI-----APEYQQTLSITYMCDIYSFGVLLAEEMSL 179
APE S T D++SFG+LL E ++
Sbjct: 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-12
Identities = 34/166 (20%), Positives = 65/166 (39%), Gaps = 37/166 (22%)
Query: 34 SEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E +T+ Q H +I+ L+ P ++ E G L+ L + L L Y
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQV-RKYSLDLASLILY 121
Query: 93 RTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
+++ L YL +H+ + VL+ + ++ +FGL++ + S
Sbjct: 122 --AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYY 172
Query: 145 GTAG------YIAPEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ ++APE SI + D++ FGV + E +
Sbjct: 173 KASKGKLPIKWMAPE-----SINFRRFTSASDVWMFGVCMWEILMH 213
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-12
Identities = 29/161 (18%), Positives = 52/161 (32%), Gaps = 23/161 (14%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG--- 82
++ + +E+ + ++ +H + L G L E SLQ
Sbjct: 98 KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPE 156
Query: 83 RRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEA 134
+ +L L +LH + + L ++ +FGL A
Sbjct: 157 AQVWGYLRD------TLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210
Query: 135 HTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
G Y+APE Q S D++S G+ + E
Sbjct: 211 GAGEV---QEGDPRYMAPELLQG-SYGTAADVFSLGLTILE 247
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-12
Identities = 33/165 (20%), Positives = 65/165 (39%), Gaps = 34/165 (20%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
E T+ ++ H ++ ++ +V E++ NG L + L + L
Sbjct: 52 QEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS-HGKGLEPSQLLEM- 109
Query: 94 TVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVG 145
+ G+ +L +H+ L L+D D+ ++S+FG+ + + V
Sbjct: 110 -CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-------DQYVS 161
Query: 146 TAG------YIAPEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ G + APE Y D+++FG+L+ E SL
Sbjct: 162 SVGTKFPVKWSAPE-----VFHYFKYSSKSDVWAFGILMWEVFSL 201
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-12
Identities = 41/165 (24%), Positives = 62/165 (37%), Gaps = 33/165 (20%)
Query: 34 SEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
E+ + + HRN++ L L P +V E GSL D L +G L L+RY
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLLDRLRK-HQGHFLLGTLSRY 126
Query: 93 RTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
+A G+ YL + + +LL +I +FGL + P+ H
Sbjct: 127 --AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ--- 181
Query: 145 GTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ APE S+ D + FGV L E +
Sbjct: 182 -EHRKVPFAWCAPE-----SLKTRTFSHASDTWMFGVTLWEMFTY 220
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-12
Identities = 40/166 (24%), Positives = 76/166 (45%), Gaps = 36/166 (21%)
Query: 34 SEIVTLGQIRHRNILPLLAH-LARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
+E + Q++H+ ++ L A P ++ E+M+NGSL D L + +L
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVTQEP--IYIITEYMENGSLVDFLK--TPSGIKLTINKLL 112
Query: 93 RTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
IA G+ ++ ++H+ L +L+ + +I++FGLA++ + + T+
Sbjct: 113 DMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED---NEYTAREG 169
Query: 145 G------TAGYIAPEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
T APE +I Y D++SFG+LL E ++
Sbjct: 170 AKFPIKWT----APE-----AINYGTFTIKSDVWSFGILLTEIVTH 206
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 6e-12
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 21/160 (13%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
QI E+ L + I+ G + E M GSL +L GR
Sbjct: 73 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPE 130
Query: 87 DWLARYRTVRGIASGLEYLH-----MHQ----ALVLLDHDMEARISEFGLAKVFPE--AH 135
L + + GL YL MH+ + +L++ E ++ +FG++ + A+
Sbjct: 131 QILGK--VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 188
Query: 136 THITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ VGT Y++PE Q + DI+S G+ L E
Sbjct: 189 SF------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-12
Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 30/172 (17%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARP-GCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
E+ Q +E + + H N+L LL R G L+V +MK+G L++ + +
Sbjct: 68 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHN 124
Query: 86 LDWLARYRTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTH 137
+A G++YL +H+ L +LD ++++FGLA+ +
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDK 181
Query: 138 ITTSDVVGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
S T + A E S+ D++SFGVLL E M+
Sbjct: 182 EYYSVHNKTGAKLPVKWMALE-----SLQTQKFTTKSDVWSFGVLLWELMTR 228
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-12
Identities = 37/180 (20%), Positives = 73/180 (40%), Gaps = 40/180 (22%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
E ++ +E + + +++ LL +++ L++ E M G L+ L R
Sbjct: 70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPAMAN 128
Query: 87 DWLARYRTV-------RGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVF 131
+ + ++ IA G+ YL+ +H+ L ++ D +I +FG+ +
Sbjct: 129 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD- 187
Query: 132 PEAHTHITTSD--VVGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
I +D G G + +PE S+ D++SFGV+L E +L
Sbjct: 188 ------IYETDYYRKGGKGLLPVRWMSPE-----SLKDGVFTTYSDVWSFGVVLWEIATL 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 8e-12
Identities = 31/86 (36%), Positives = 39/86 (45%), Gaps = 10/86 (11%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I SGLE+LH + VLLD D RIS+ GLA T T GT G+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGF 355
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAE 175
+APE + D ++ GV L E
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYE 381
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-12
Identities = 33/127 (25%), Positives = 49/127 (38%), Gaps = 15/127 (11%)
Query: 58 GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL------ 111
G + + L +L +G L VR I S L+ H A
Sbjct: 107 GQLYVDMRLINGVDLAAMLRR--QGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKP 162
Query: 112 --VLLDHDMEARISEFGLAKVFPEAHTHIT-TSDVVGTAGYIAPEYQQTLSITYMCDIYS 168
+L+ D A + +FG+A + +T + VGT Y+APE TY DIY+
Sbjct: 163 ENILVSADDFAYLVDFGIASATTD--EKLTQLGNTVGTLYYMAPERFSESHATYRADIYA 220
Query: 169 FGVLLAE 175
+L E
Sbjct: 221 LTCVLYE 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 24/168 (14%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRR 84
+ + ++ +G + H +I+ LL LV +++ GSL D + RG
Sbjct: 56 RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQ-HRGAL 112
Query: 85 QLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHT 136
L + IA G+ YL +H+ L VLL + ++++FG+A + P
Sbjct: 113 GPQLLLNW--GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
Query: 137 HITTSDVVGTAGYI-----APEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+ S+ A E T+ D++S+GV + E M+
Sbjct: 171 QLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF 213
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 32/86 (37%), Positives = 41/86 (47%), Gaps = 11/86 (12%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I GLE LH + + +LLD RIS+ GLA PE T VGT GY
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGY 351
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAE 175
+APE + T+ D ++ G LL E
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYE 377
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-11
Identities = 41/182 (22%), Positives = 67/182 (36%), Gaps = 41/182 (22%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLA-----HLARPGCHLLVYEFMKNGSLQDILNDVS 80
E+ + SE + H N++ LL +++ FMK G L L S
Sbjct: 77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY-S 135
Query: 81 RGRRQLDWLARYRTV---RGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAK 129
R + + IA G+EYL +H+ L +L DM +++FGL+K
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
Query: 130 VFPEAHTHITTSDV--VGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEM 177
I + D G + A E S+ D+++FGV + E
Sbjct: 196 K-------IYSGDYYRQGRIAKMPVKWIAIE-----SLADRVYTSKSDVWAFGVTMWEIA 243
Query: 178 SL 179
+
Sbjct: 244 TR 245
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-11
Identities = 35/159 (22%), Positives = 62/159 (38%), Gaps = 24/159 (15%)
Query: 32 IRSEIVTLGQI-RHRNILPLLA----HLARPGCHLLVYEFMKNGSLQD-ILNDVSRGRRQ 85
R E+ Q +I+ +L C L++ E M+ G L I RG +
Sbjct: 68 ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI---QERGDQA 124
Query: 86 LDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFGLAKVFPEA 134
+R I + +++LH H+ + +L + D ++++FG AK +
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
Query: 135 HTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
T Y+APE CD++S GV++
Sbjct: 185 ----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-11
Identities = 40/170 (23%), Positives = 63/170 (37%), Gaps = 34/170 (20%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93
E + + + H+NI+ + + ++ E M G L+ L + Q LA
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 94 TV---RGIASGLEYL----HMHQAL----VLLDHDMEAR---ISEFGLAKVFPEAHTHIT 139
+ R IA G +YL +H+ + LL R I +FG+A+ A +
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-- 240
Query: 140 TSDVVGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
G + PE + D +SFGVLL E SL
Sbjct: 241 ---RKGGCAMLPVKWMPPE-----AFMEGIFTSKTDTWSFGVLLWEIFSL 282
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-11
Identities = 38/167 (22%), Positives = 67/167 (40%), Gaps = 20/167 (11%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAH-LARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+++ E + + + H N+L L+ L G ++ +M +G L + +R
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRN 120
Query: 86 LDWLARYRTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTH 137
+A G+EYL +H+ L +LD ++++FGLA+
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI---LDR 177
Query: 138 ITTSDVVGTAGYI-----APEYQQTLSITYMCDIYSFGVLLAEEMSL 179
S + A E QT T D++SFGVLL E ++
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-11
Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRR 84
+ ++ +I EI + Q +++ + +V E+ GS+ DI+ +
Sbjct: 64 VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII-RLRNKTL 122
Query: 85 QLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHT 136
D +A ++ GLEYLH + + +LL+ + A++++FG+A +
Sbjct: 123 TEDEIA--TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180
Query: 137 HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177
T V+GT ++APE Q + + DI+S G+ A EM
Sbjct: 181 KRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGI-TAIEM 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-11
Identities = 28/87 (32%), Positives = 41/87 (47%), Gaps = 13/87 (14%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I GLE++H + +LLD RIS+ GLA F + VGT GY
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGY 356
Query: 150 IAPE-YQQTLSITYMCDIYSFGVLLAE 175
+APE Q+ ++ D +S G +L +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFK 383
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-11
Identities = 32/156 (20%), Positives = 57/156 (36%), Gaps = 27/156 (17%)
Query: 33 RSEIVTLGQIRHRNILPLL---AHLARPGCHL--LVYEFMKNGSLQDILNDVSRGRRQLD 87
+E L ++ H +I+ + H R G + +V E++ SL+ + +
Sbjct: 127 MAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVA 182
Query: 88 WLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHIT 139
Y + I L YLH + ++L + + ++ + G
Sbjct: 183 EAIAY--LLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINS-- 233
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ GT G+ APE T DIY+ G LA
Sbjct: 234 FGYLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAA 268
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-11
Identities = 43/197 (21%), Positives = 74/197 (37%), Gaps = 56/197 (28%)
Query: 23 KLLTEEMMQIR----SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILND 78
K L + + R E L ++H +I+ ++V+E+MK+G L L
Sbjct: 51 KALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL-- 108
Query: 79 VSRGRRQLDWLARYRTVRG----------------IASGLEYL----HMHQAL----VLL 114
R + R IASG+ YL +H+ L L+
Sbjct: 109 --RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 166
Query: 115 DHDMEARISEFGLAKVFPEAHTHITTSD--VVGTAGYI-----APEYQQTLSITY----- 162
++ +I +FG+++ + ++D VG + PE SI Y
Sbjct: 167 GANLLVKIGDFGMSRD-------VYSTDYYRVGGHTMLPIRWMPPE-----SIMYRKFTT 214
Query: 163 MCDIYSFGVLLAEEMSL 179
D++SFGV+L E +
Sbjct: 215 ESDVWSFGVILWEIFTY 231
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-11
Identities = 32/166 (19%), Positives = 63/166 (37%), Gaps = 37/166 (22%)
Query: 34 SEIVTLGQIRHRNILPLLA-HLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92
SE V + + H +I+ L+ P ++ E G L L ++ ++ L Y
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLER-NKNSLKVLTLVLY 118
Query: 93 RTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVV 144
I + YL +H+ + +L+ ++ +FGL++ I D
Sbjct: 119 --SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY-------IEDEDYY 169
Query: 145 GTAG------YIAPEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ +++PE SI + D++ F V + E +S
Sbjct: 170 KASVTRLPIKWMSPE-----SINFRRFTTASDVWMFAVCMWEILSF 210
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-11
Identities = 39/178 (21%), Positives = 73/178 (41%), Gaps = 44/178 (24%)
Query: 34 SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDIL------------NDVSR 81
E + +++H N++ LL + + +++ + +G L + L +D
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 82 GRRQLDWLARYRTVRGIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAKVFPE 133
+ L+ V IA+G+EYL +H+ L VL+ + +IS+ GL +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--- 177
Query: 134 AHTHITTSD--VVGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
+ +D + + APE +I Y DI+S+GV+L E S
Sbjct: 178 ----VYAADYYKLLGNSLLPIRWMAPE-----AIMYGKFSIDSDIWSYGVVLWEVFSY 226
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-11
Identities = 47/190 (24%), Positives = 80/190 (42%), Gaps = 53/190 (27%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+++ + SE+ + I +H+NI+ LL + G ++ E+ G+L++ L R RR
Sbjct: 82 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRP 137
Query: 86 LDWLARYRTVRG----------------IASGLEYL----HMHQAL----VLLDHDMEAR 121
Y R +A G+EYL +H+ L VL+ + +
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 197
Query: 122 ISEFGLAKVFPEAHTHITTSD--VVGTAGYI-----APEYQQTLSITY-----MCDIYSF 169
I++FGLA+ I D T G + APE ++ D++SF
Sbjct: 198 IADFGLARD-------INNIDYYKKTTNGRLPVKWMAPE-----ALFDRVYTHQSDVWSF 245
Query: 170 GVLLAEEMSL 179
GVL+ E +L
Sbjct: 246 GVLMWEIFTL 255
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-11
Identities = 33/159 (20%), Positives = 63/159 (39%), Gaps = 23/159 (14%)
Query: 32 IRSEIVTLGQI-RHRNILPLLA----HLARPGCHLLVYEFMKNGSLQD-ILNDVSRGRRQ 85
R E+ + + +I+ ++ A C L+V E + G L I RG +
Sbjct: 101 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQA 157
Query: 86 LDWLARYRTVRGIASGLEYLH----MHQAL----VLL---DHDMEARISEFGLAKVFPEA 134
++ I ++YLH H+ + +L + ++++FG AK
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 135 HTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173
++ + T Y+APE CD++S GV++
Sbjct: 218 NSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-11
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 19/167 (11%)
Query: 22 SKLLTEEMM--QIRSEIVTLGQIRHRNILPLL--AHLARPGCHLLVYEFMKNGSLQDILN 77
KL ++ EI L ++RH+N++ L+ + +V E+ G +Q++L+
Sbjct: 41 KKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLD 99
Query: 78 DVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAK 129
V R A + GLEYLH +H+ + +LL +IS G+A+
Sbjct: 100 SVPEKRFP-VCQAH-GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY---MCDIYSFGVLL 173
T G+ + PE L T+ DI+S GV L
Sbjct: 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTL 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-11
Identities = 42/169 (24%), Positives = 69/169 (40%), Gaps = 19/169 (11%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL-LVYEFMKNGSLQDILNDVSRGRR 84
M ++ EI + Q H NI+ L LV + + GS+ DI+ +
Sbjct: 54 QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-KDELWLVMKLLSGGSVLDIIKHIVAKGE 112
Query: 85 QLDWLARYRTV----RGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFP 132
+ T+ R + GLEYLH + + +LL D +I++FG++
Sbjct: 113 HKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172
Query: 133 EAHTHITTSD---VVGTAGYIAPE-YQQTLSITYMCDIYSFGVLLAEEM 177
VGT ++APE +Q + DI+SFG+ A E+
Sbjct: 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI-TAIEL 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-11
Identities = 42/182 (23%), Positives = 71/182 (39%), Gaps = 42/182 (23%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLA------HLARPGCHLLVYEFMKNGSLQDILNDVS 80
++ + E + + H ++ L+ R +++ FMK+G L L S
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA-S 125
Query: 81 RGRRQLDWLARYRTVR---GIASGLEYL----HMHQAL----VLLDHDMEARISEFGLAK 129
R L VR IA G+EYL +H+ L +L DM +++FGL++
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 130 VFPEAHTHITTSDV--VGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEM 177
I + D G A + A E S+ D+++FGV + E M
Sbjct: 186 K-------IYSGDYYRQGCASKLPVKWLALE-----SLADNLYTVHSDVWAFGVTMWEIM 233
Query: 178 SL 179
+
Sbjct: 234 TR 235
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-11
Identities = 47/190 (24%), Positives = 80/190 (42%), Gaps = 53/190 (27%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+++ + SE+ + I +H+NI+ LL + G ++ E+ G+L++ L R RR
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRP 183
Query: 86 LDWLARYRTVRG----------------IASGLEYL----HMHQAL----VLLDHDMEAR 121
Y R +A G+EYL +H+ L VL+ + +
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMK 243
Query: 122 ISEFGLAKVFPEAHTHITTSD--VVGTAGYI-----APEYQQTLSITY-----MCDIYSF 169
I++FGLA+ I D T G + APE ++ D++SF
Sbjct: 244 IADFGLARD-------INNIDYYKKTTNGRLPVKWMAPE-----ALFDRVYTHQSDVWSF 291
Query: 170 GVLLAEEMSL 179
GVL+ E +L
Sbjct: 292 GVLMWEIFTL 301
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-10
Identities = 39/194 (20%), Positives = 69/194 (35%), Gaps = 54/194 (27%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+ + E + + + NI+ LL A L++E+M G L + L
Sbjct: 92 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS-MSPHTVC 150
Query: 87 DWLARYRTVRG---------------------IASGLEYL----HMHQAL----VLLDHD 117
+ R +A+G+ YL +H+ L L+ +
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 210
Query: 118 MEARISEFGLAKVFPEAHTHITTSD--VVGTAGYI-----APEYQQTLSITY-----MCD 165
M +I++FGL++ I ++D I PE SI Y D
Sbjct: 211 MVVKIADFGLSRN-------IYSADYYKADGNDAIPIRWMPPE-----SIFYNRYTTESD 258
Query: 166 IYSFGVLLAEEMSL 179
++++GV+L E S
Sbjct: 259 VWAYGVVLWEIFSY 272
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 47/190 (24%), Positives = 79/190 (41%), Gaps = 53/190 (27%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+++ + SE+ + I +H+NI+ LL + G ++ E+ G+L++ L + RR
Sbjct: 116 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----QARRP 171
Query: 86 LDWLARYRTVRG----------------IASGLEYL----HMHQAL----VLLDHDMEAR 121
Y +A G+EYL +H+ L VL+ D +
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK 231
Query: 122 ISEFGLAKVFPEAHTHITTSD--VVGTAGYI-----APEYQQTLSITY-----MCDIYSF 169
I++FGLA+ I D T G + APE ++ D++SF
Sbjct: 232 IADFGLARD-------IHHIDYYKKTTNGRLPVKWMAPE-----ALFDRIYTHQSDVWSF 279
Query: 170 GVLLAEEMSL 179
GVLL E +L
Sbjct: 280 GVLLWEIFTL 289
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-10
Identities = 49/191 (25%), Positives = 71/191 (37%), Gaps = 54/191 (28%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLV-YEFMKNGSLQDILNDVSRGRR 84
E + SE+ L I H N++ LL +PG L+V EF K G+L L R +R
Sbjct: 72 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKR 127
Query: 85 QLDWLARYRTVRG----------------IASGLEYL----HMHQAL----VLLDHDMEA 120
+ +A G+E+L +H+ L +LL
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 187
Query: 121 RISEFGLAKVFPEAHTHITTSDV--VGTAGYI-----APEYQQTLSITY-----MCDIYS 168
+I +FGLA+ I + APE +I D++S
Sbjct: 188 KICDFGLARD-------IYKDPDYVRKGDARLPLKWMAPE-----TIFDRVYTIQSDVWS 235
Query: 169 FGVLLAEEMSL 179
FGVLL E SL
Sbjct: 236 FGVLLWEIFSL 246
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-10
Identities = 40/178 (22%), Positives = 66/178 (37%), Gaps = 34/178 (19%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
++ + E + + + H+NI+ + + ++ E M G L+ L + Q
Sbjct: 74 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQ 133
Query: 86 LDWLARYRTV---RGIASGLEYL----HMHQAL----VLLDHDMEAR---ISEFGLAKVF 131
LA + R IA G +YL +H+ + LL R I +FG+A+
Sbjct: 134 PSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
Query: 132 PEAHTHITTSDVVGTAGYI-----APEYQQTLSITY-----MCDIYSFGVLLAEEMSL 179
A + G + PE + D +SFGVLL E SL
Sbjct: 194 YRASYY-----RKGGCAMLPVKWMPPE-----AFMEGIFTSKTDTWSFGVLLWEIFSL 241
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-10
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 28/160 (17%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHL------LVYEFMKNGSLQDILNDVSRGRRQ 85
I +EI+ + + ++ NI+ L +L +V E++ GSL D+ V+
Sbjct: 64 IINEILVMRENKNPNIVNYL------DSYLVGDELWVVMEYLAGGSLTDV---VTETCMD 114
Query: 86 LDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTH 137
+A R LE+LH +Q + +LL D ++++FG +
Sbjct: 115 EGQIA--AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177
+T +VGT ++APE + DI+S G+ +A EM
Sbjct: 173 RST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGI-MAIEM 209
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-10
Identities = 43/189 (22%), Positives = 74/189 (39%), Gaps = 51/189 (26%)
Query: 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRR 84
+E + SE+ + + +H NI+ LL G L++ E+ G L + L R +
Sbjct: 90 ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFL----RRKS 145
Query: 85 QLDWLARYRTVRG--------------IASGLEYL----HMHQAL----VLLDHDMEARI 122
++ + +A G+ +L +H+ + VLL + A+I
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205
Query: 123 SEFGLAKVFPEAHTHITTSD--VVGTAGYI-----APEYQQTLSITY-----MCDIYSFG 170
+FGLA+ I +V + APE SI D++S+G
Sbjct: 206 GDFGLAR-------DIMNDSNYIVKGNARLPVKWMAPE-----SIFDCVYTVQSDVWSYG 253
Query: 171 VLLAEEMSL 179
+LL E SL
Sbjct: 254 ILLWEIFSL 262
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-10
Identities = 38/168 (22%), Positives = 62/168 (36%), Gaps = 21/168 (12%)
Query: 18 VEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGS-LQDIL 76
V D + ++ ++ EI L ++ H NI+ +L G LV E +G L +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLA 128
R LA R + S + YL + + +++ D ++ +FG A
Sbjct: 122 --DRHPRLDEP-LAS-YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
Query: 129 KVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY---MCDIYSFGVLL 173
T GT Y APE Y +++S GV L
Sbjct: 178 AYLERGKLFYTF---CGTIEYCAPEVLMGNP--YRGPELEMWSLGVTL 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-10
Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 28/160 (17%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHL------LVYEFMKNGSLQDILNDVSRGRRQ 85
+ +E+V + +H N++ + +L ++ EF++ G+L DI VS+ R
Sbjct: 89 LFNEVVIMRDYQHFNVVEMY------KSYLVGEELWVLMEFLQGGALTDI---VSQVRLN 139
Query: 86 LDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTH 137
+ +A + L YLH + +LL D ++S+FG +
Sbjct: 140 EEQIAT--VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177
+ +VGT ++APE DI+S G+ + EM
Sbjct: 198 RKS--LVGTPYWMAPEVISRSLYATEVDIWSLGI-MVIEM 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-10
Identities = 26/183 (14%), Positives = 53/183 (28%), Gaps = 42/183 (22%)
Query: 27 EEMMQIRSEIVTLGQIR-HRNILPLLAH-------LARPGCHLLVYEFMKNGSLQDILND 78
E+ I E+ + ++ H NI+ + L+ + G L + L
Sbjct: 67 EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKK 126
Query: 79 VSRGRR-----QLDWLARYRTVRGIASGLEYLHMHQAL----------VLLDHDMEARIS 123
+ L ++++H + +LL + ++
Sbjct: 127 MESRGPLSCDTVLKIF------YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180
Query: 124 EFGLAKVFPEAHTHITTSD----------VVGTAGYIAPE---YQQTLSITYMCDIYSFG 170
+FG A + ++ T Y PE I DI++ G
Sbjct: 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240
Query: 171 VLL 173
+L
Sbjct: 241 CIL 243
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-10
Identities = 40/159 (25%), Positives = 68/159 (42%), Gaps = 16/159 (10%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+E+ I+ EI L Q + + ++ E++ GS D+L G
Sbjct: 62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDE 118
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
+A +R I GL+YLH + + VLL E ++++FG+A +
Sbjct: 119 TQIAT--ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177
T VGT ++APE + + DI+S G+ A E+
Sbjct: 177 NT--FVGTPFWMAPEVIKQSAYDSKADIWSLGI-TAIEL 212
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-10
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 28/167 (16%)
Query: 22 SKLLTEEMM-QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
L +M ++ EI L +RH +I+ L + P ++V E+ G L D + V
Sbjct: 45 QLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYI--VE 101
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFP 132
+ R D R R + I +EY H +H+ L +LLD ++ +I++FGL+ +
Sbjct: 102 KKRMTED-EGR-RFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159
Query: 133 EAHTHITTSDVVGTAGYIAPE------YQQTLSITYMCDIYSFGVLL 173
+ + + TS G+ Y APE Y D++S G++L
Sbjct: 160 DGN-FLKTS--CGSPNYAAPEVINGKLYAGPEV-----DVWSCGIVL 198
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-10
Identities = 46/197 (23%), Positives = 78/197 (39%), Gaps = 60/197 (30%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
E+ + SE L Q+ H +++ L ++ G LL+ E+ K GSL+ L R R++
Sbjct: 68 SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL----RESRKV 123
Query: 87 DWLARYRTVRG------------------------IASGLEYL----HMHQAL----VLL 114
I+ G++YL +H+ L +L+
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV 183
Query: 115 DHDMEARISEFGLAKVFPEAHTHITTSD--VVGTAGYI-----APEYQQTLSITY----- 162
+ +IS+FGL++ + D V + G I A E S+
Sbjct: 184 AEGRKMKISDFGLSR-------DVYEEDSYVKRSQGRIPVKWMAIE-----SLFDHIYTT 231
Query: 163 MCDIYSFGVLLAEEMSL 179
D++SFGVLL E ++L
Sbjct: 232 QSDVWSFGVLLWEIVTL 248
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-10
Identities = 44/168 (26%), Positives = 67/168 (39%), Gaps = 31/168 (18%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+ E ++ EI+ +RH NI+ + P ++ E+ G L + + +
Sbjct: 56 GAAIDE---NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI--CNA 110
Query: 82 GRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEAR--ISEFGLAKVF 131
GR D AR + + SG+ Y H Q LLD R I +FG +K
Sbjct: 111 GRFSED-EAR-FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
Query: 132 PEAHTHITTSDVVGTAGYIAPE------YQQTLSITYMCDIYSFGVLL 173
+T VGT YIAPE Y ++ D++S GV L
Sbjct: 169 VLHSQPKST---VGTPAYIAPEVLLRQEYDGKIA-----DVWSCGVTL 208
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-10
Identities = 31/186 (16%), Positives = 67/186 (36%), Gaps = 46/186 (24%)
Query: 23 KLLTEEMMQIR----SEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILND 78
K+L + + ++ H++++ ++LV EF+K GSL L
Sbjct: 46 KVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK 105
Query: 79 VSRGRRQLDWLARYRTVRGIASGLEYL----HMHQAL----VLLDHDMEAR--------I 122
++ + W + +A+ + +L +H + +LL + + + +
Sbjct: 106 -NKNCINILWKLEV--AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162
Query: 123 SEFGLAKVFPEAHTHITTSDVVGTAGY------IAPE---YQQTLSITYMCDIYSFGVLL 173
S+ G++ V+ + PE + L++ D +SFG L
Sbjct: 163 SDPGISI------------TVLPKDILQERIPWVPPECIENPKNLNL--ATDKWSFGTTL 208
Query: 174 AEEMSL 179
E S
Sbjct: 209 WEICSG 214
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-10
Identities = 23/180 (12%), Positives = 54/180 (30%), Gaps = 39/180 (21%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+ E+ + +H +++ + A L+ E+ GSL D +++ R
Sbjct: 52 VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY 111
Query: 86 LD--WLARYRTVRGIASGLEYLHMHQAL--------VLLDHD------------------ 117
L + + GL Y+H + + +
Sbjct: 112 FKEAELKDL--LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169
Query: 118 -MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE-YQQTLSITYMCDIYSFGVLLAE 175
+ +I + G G + ++A E Q+ + DI++ + +
Sbjct: 170 KVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-10
Identities = 31/166 (18%), Positives = 65/166 (39%), Gaps = 22/166 (13%)
Query: 26 TEEMMQIRSEI-VTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRR 84
++E ++ ++ +++ + + L R G + E M + SL V +
Sbjct: 46 SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQ 104
Query: 85 QL--DWLARYRTVRGIASGLEYLH-----MHQ----ALVLLDHDMEARISEFGLAKVFPE 133
+ D L + I LE+LH +H+ + VL++ + ++ +FG++
Sbjct: 105 TIPEDILGK--IAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---Y 159
Query: 134 AHTHITTSDVVGTAGYIAPE----YQQTLSITYMCDIYSFGVLLAE 175
+ G Y+APE + DI+S G+ + E
Sbjct: 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-10
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 25/175 (14%)
Query: 23 KLLTEEMMQIRSEIVTLGQI-RHRNILP-----LLAHLARPGCHL-LVYEFMKNGSLQDI 75
+ +E +I+ EI L + HRNI + + L LV EF GS+ D+
Sbjct: 58 DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 76 LNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGL 127
+ + + +W+A R I GL +LH H+ + VLL + E ++ +FG+
Sbjct: 118 IKNTKGNTLKEEWIA--YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 128 AKVFPEAHTHITTSDVVGTAGYIAPE---YQQTLSITY--MCDIYSFGVLLAEEM 177
+ T +GT ++APE + TY D++S G+ A EM
Sbjct: 176 SAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI-TAIEM 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-10
Identities = 37/168 (22%), Positives = 65/168 (38%), Gaps = 25/168 (14%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHR--NILPLLAHLARPGCHLLVYEFMKN-GSLQDILN 77
++ E+V L ++ ++ LL RP +L+ E + L D +
Sbjct: 82 SDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI- 140
Query: 78 DVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHD-MEARISEFGLA 128
RG Q + LAR + + + H L +L+D + E ++ +FG
Sbjct: 141 -TERGALQEE-LAR-SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197
Query: 129 KVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM---CDIYSFGVLL 173
+ + T T D GT Y PE+ + Y ++S G+LL
Sbjct: 198 ALLKD--TVYTDFD--GTRVYSPPEWIRYHR--YHGRSAAVWSLGILL 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-10
Identities = 24/89 (26%), Positives = 38/89 (42%), Gaps = 14/89 (15%)
Query: 98 IASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
+ L+YL +H+ + +LLD I++F +A + P T + GT Y
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGTKPY 180
Query: 150 IAPE-YQQTLSITY--MCDIYSFGVLLAE 175
+APE + Y D +S GV E
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-10
Identities = 44/192 (22%), Positives = 68/192 (35%), Gaps = 55/192 (28%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
E + SE+ L + H NI+ LL G L++ E+ G L + L R +R
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL----RRKRD 123
Query: 86 LDWLARYRTVRG------------------IASGLEYLHM----HQAL----VLLDHDME 119
++ +A G+ +L H+ L +LL H
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
Query: 120 ARISEFGLAKVFPEAHTHITTSDV--VGTAGYI-----APEYQQTLSITY-----MCDIY 167
+I +FGLA+ I V + APE SI D++
Sbjct: 184 TKICDFGLARD-------IKNDSNYVVKGNARLPVKWMAPE-----SIFNCVYTFESDVW 231
Query: 168 SFGVLLAEEMSL 179
S+G+ L E SL
Sbjct: 232 SYGIFLWELFSL 243
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 4e-09
Identities = 37/164 (22%), Positives = 68/164 (41%), Gaps = 19/164 (11%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
EE+ EI L H I+ LL G ++ EF G++ I+ ++ RG +
Sbjct: 58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE- 116
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
+ R + L +LH + + VL+ + + R+++FG++ +
Sbjct: 117 PQIQ--VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174
Query: 139 TTSDVVGTAGYIAPE-----YQQTLSITYMCDIYSFGVLLAEEM 177
+ +GT ++APE + Y DI+S G+ EM
Sbjct: 175 DS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI-TLIEM 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-09
Identities = 45/194 (23%), Positives = 71/194 (36%), Gaps = 54/194 (27%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
E + SE+ + Q+ H NI+ LL G L++E+ G L + L R +
Sbjct: 90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS-KREKFS 148
Query: 86 LDWLARYRTVRG--------------------IASGLEYLHMHQAL--------VLLDHD 117
D + R +A G+E+L + VL+ H
Sbjct: 149 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 208
Query: 118 MEARISEFGLAKVFPEAHTHITTSD--VVGTAGYI-----APEYQQTLSITY-----MCD 165
+I +FGLA+ I + VV + APE S+ D
Sbjct: 209 KVVKICDFGLAR-------DIMSDSNYVVRGNARLPVKWMAPE-----SLFEGIYTIKSD 256
Query: 166 IYSFGVLLAEEMSL 179
++S+G+LL E SL
Sbjct: 257 VWSYGILLWEIFSL 270
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-09
Identities = 30/173 (17%), Positives = 60/173 (34%), Gaps = 31/173 (17%)
Query: 22 SKLLTEEMM----QIRSEIVTLGQIR----HRNILPLLAHLARPGCHLLVYEFMKNGS-L 72
+++L + E+ L ++ H ++ LL +LV E L
Sbjct: 67 NRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL 126
Query: 73 QDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDM-EARIS 123
D + +G +R + + +++ H + +L+D A++
Sbjct: 127 FDYI--TEKGPLGEG-PSR-CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182
Query: 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM---CDIYSFGVLL 173
+FG + + T GT Y PE+ Y ++S G+LL
Sbjct: 183 DFGSGALLHD--EPYTDF--DGTRVYSPPEWISRHQ--YHALPATVWSLGILL 229
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 7e-09
Identities = 41/160 (25%), Positives = 63/160 (39%), Gaps = 15/160 (9%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+E+ +E L RH + L V E+ G ++ +SR R
Sbjct: 190 DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFS 246
Query: 87 DWLARYRTVRGIASGLEYLHMHQALV---------LLDHDMEARISEFGLAKVFPEAHTH 137
+ AR+ I S L+YLH + +V +LD D +I++FGL K
Sbjct: 247 EDRARFYGAE-IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDG 303
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177
T GT Y+APE + D + GV++ E M
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-09
Identities = 23/91 (25%), Positives = 42/91 (46%), Gaps = 14/91 (15%)
Query: 98 IASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
+ ++ +H +H+ + +L+D + R+++FG E T ++ VGT Y
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-AVGTPDY 242
Query: 150 IAPE---YQQTLSITY--MCDIYSFGVLLAE 175
I+PE + Y CD +S GV + E
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-09
Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 37/170 (21%)
Query: 34 SEIVTLGQIRH----RNILPLLAHLARP-----------GCHL-LVYEFMKNGSLQDILN 77
E++ R+I+ P +L +V E+M G D++N
Sbjct: 105 FEMIKRSDSAFFWEERDIMAFANS---PWVVQLFYAFQDDRYLYMVMEYMPGG---DLVN 158
Query: 78 DVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAK 129
+S W AR+ T + L+ +H +H+ + +LLD ++++FG
Sbjct: 159 LMSNYDVPEKW-ARFYTAE-VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216
Query: 130 VFPEAHTHITTSDVVGTAGYIAPE--YQQTLSITY--MCDIYSFGVLLAE 175
+ + VGT YI+PE Q Y CD +S GV L E
Sbjct: 217 KMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 265
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 31/166 (18%), Positives = 58/166 (34%), Gaps = 23/166 (13%)
Query: 27 EEMMQIRSEI-VTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+E Q+ ++ V + I+ L R G + E M + S V
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDD 120
Query: 86 L---DWLARYRTVRGIASGLEYLH-----MHQ----ALVLLDHDMEARISEFGLAKVFPE 133
+ + L + L +L +H+ + +LLD ++ +FG++ +
Sbjct: 121 VIPEEILGK--ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---Q 175
Query: 134 AHTHITTSDVVGTAGYIAPE----YQQTLSITYMCDIYSFGVLLAE 175
I + G Y+APE D++S G+ L E
Sbjct: 176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 41/162 (25%), Positives = 65/162 (40%), Gaps = 22/162 (13%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
E+ I E+ L ++RH N + R LV E+ GS D+L +V + Q
Sbjct: 96 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL-EVHKKPLQE 153
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
+A G GL YLH H + +LL ++ +FG A + A++
Sbjct: 154 VEIA--AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-- 209
Query: 139 TTSDVVGTAGYIAPE---YQQTLSITYMCDIYSFGVLLAEEM 177
VGT ++APE D++S G+ E+
Sbjct: 210 ----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI-TCIEL 246
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 33/152 (21%), Positives = 57/152 (37%), Gaps = 17/152 (11%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
+E L + ++ L +V E++ G + L R R + AR
Sbjct: 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHAR 144
Query: 92 YRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDV 143
+ + I EYLH + +L+D ++++FG AK T +
Sbjct: 145 FYAAQ-IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTL 198
Query: 144 VGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
GT +APE + D ++ GVL+ E
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 5e-08
Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 11/88 (12%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I+ L +LH + ++L+H ++++FGL K T T GT Y
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEY 187
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEM 177
+APE D +S G L+ +M
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALM-YDM 214
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-08
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 12/90 (13%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I LE+LH + +LLD + +++FGL+K F T GT Y
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226
Query: 150 IAPEYQQTLSITY--MCDIYSFGVLLAEEM 177
+AP+ + + D +S GVL+ E+
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLM-YEL 255
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 8e-08
Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 10/86 (11%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
+A L++LH + +LLD + ++++FGL+K + GT Y
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEY 192
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAE 175
+APE T D +SFGVL+ E
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFE 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-08
Identities = 30/88 (34%), Positives = 43/88 (48%), Gaps = 14/88 (15%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTA 147
I GL++LH + +LLD D +I++FG+ K + +A T+ GT
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTP 182
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
YIAPE + D +SFGVLL E
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYE 210
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 16/93 (17%)
Query: 98 IASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
I ++ +H +H+ + +LLD R+++FG T + + VGT Y
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDY 229
Query: 150 IAPE-----YQQTLSITY--MCDIYSFGVLLAE 175
++PE + +Y CD ++ GV E
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 27/88 (30%), Positives = 37/88 (42%), Gaps = 14/88 (15%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTA 147
IAS L YLH + +LLD +++FGL K + + TTS GT
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTP 203
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
Y+APE D + G +L E
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYE 231
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 28/88 (31%), Positives = 40/88 (45%), Gaps = 14/88 (15%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTA 147
IA GL +L + V+LD + +I++FG+ K ++ TT GT
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTP 506
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
YIAPE D ++FGVLL E
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 2e-07
Identities = 29/86 (33%), Positives = 41/86 (47%), Gaps = 13/86 (15%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
+ LEYLH + +LLD + +I++FG AK P+ T + GT Y
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDY 169
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAE 175
IAPE T D +SFG+L+ E
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYE 195
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-07
Identities = 28/88 (31%), Positives = 40/88 (45%), Gaps = 14/88 (15%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTA 147
IA GL +L + V+LD + +I++FG+ K ++ TT GT
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTP 185
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
YIAPE D ++FGVLL E
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYE 213
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-07
Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 14/88 (15%)
Query: 98 IASGLEYLH----MHQAL----VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTA 147
I S LEYLH +++ + ++LD D +I++FGL K + A T GT
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTP 169
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
Y+APE + D + GV++ E
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYE 197
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-07
Identities = 31/164 (18%), Positives = 54/164 (32%), Gaps = 22/164 (13%)
Query: 27 EEMMQIRSEI-VTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
EE +I ++ V L I+ + E M + + +G
Sbjct: 65 EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK--RMQGPIP 122
Query: 86 LDWLARYRTVRGIASGLEYLH-----MHQ----ALVLLDHDMEARISEFGLAKVFPEAHT 136
L + I L YL +H+ + +LLD + ++ +FG++
Sbjct: 123 ERILGK--MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVD 177
Query: 137 HITTSDVVGTAGYIAPEYQQTLSI-----TYMCDIYSFGVLLAE 175
G A Y+APE D++S G+ L E
Sbjct: 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-07
Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 14/88 (15%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTA 147
I S L +LH + VLLDH+ ++++FG+ K + TT+ GT
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV----TTATFCGTP 188
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
YIAPE Q + D ++ GVLL E
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYE 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 5e-07
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 26/156 (16%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHL-------LVYEFMKNGSLQDILNDVSRGRRQLD 87
E+V + + H+NI+ LL ++ P L LV E M Q I ++ R
Sbjct: 111 ELVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY- 168
Query: 88 WLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHIT 139
Y+ + G +++LH +H+ L +++ D +I +FGLA+ +
Sbjct: 169 --LLYQMLCG----IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--- 219
Query: 140 TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ V T Y APE + DI+S G ++ E
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 5e-07
Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 14/88 (15%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTA 147
I+ L YLH + VLLD + +++++G+ K + P TTS GT
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTP 174
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
YIAPE + + D ++ GVL+ E
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFE 202
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 28/157 (17%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHL-------LVYEFMKNGSLQDILN-DVSRGRRQL 86
E+V + + H+NI+ LL ++ P L +V E M + +L ++ ++ R
Sbjct: 74 ELVLMKCVNHKNIIGLL-NVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY 131
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
Y+ + G +++LH +H+ L +++ D +I +FGLA+ +
Sbjct: 132 ---LLYQMLCG----IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-- 182
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ V T Y APE + DI+S G ++ E
Sbjct: 183 -MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 27/88 (30%), Positives = 42/88 (47%), Gaps = 14/88 (15%)
Query: 98 IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAK--VFPEAHTHITTSDVVGTA 147
I+ L YLH + VLLD + +++++G+ K + P TTS GT
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTP 217
Query: 148 GYIAPEYQQTLSITYMCDIYSFGVLLAE 175
YIAPE + + D ++ GVL+ E
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFE 245
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-06
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 36/163 (22%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
+R EI L Q+RH N++ LL + LV+EF+ IL+D+ LD
Sbjct: 72 MR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLD---- 122
Query: 92 YRTVRG----IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF---PEAHT 136
Y+ V+ I +G+ + H H + +L+ ++ +FG A+ E +
Sbjct: 123 YQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 137 HITTSDVVGTAGYIAPEYQQTL--SITYMC--DIYSFGVLLAE 175
+V T Y APE L + Y D+++ G L+ E
Sbjct: 183 D----EVA-TRWYRAPE---LLVGDVKYGKAVDVWAIGCLVTE 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-06
Identities = 39/206 (18%), Positives = 73/206 (35%), Gaps = 62/206 (30%)
Query: 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIR--SEIVTLGQIRHRNILPLLAHLARPG 58
+AI+K++Q P R + L + H NI+ L ++ G
Sbjct: 50 SVAIKKVIQDPRFR-----------------NRELQIMQDLAVLHHPNIVQLQSYFYTLG 92
Query: 59 -------CHLLVYEFMKNGSLQDILNDVSRGRRQLDW----LARYRTVRGIASGLEYLHM 107
+V E++ +L + R + + ++ +R I LH+
Sbjct: 93 ERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG----CLHL 147
Query: 108 HQALV----------LLD-HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE--- 153
V L++ D ++ +FG AK + + + + + Y APE
Sbjct: 148 PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN--VAYIC-SRYYRAPELIF 204
Query: 154 ----YQQTLSITYMCDIYSFGVLLAE 175
Y T ++ DI+S G + AE
Sbjct: 205 GNQHY--TTAV----DIWSVGCIFAE 224
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 5e-06
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 27/161 (16%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
IR EI + +++H NI+ L + LV+EFM + L+ ++ + G
Sbjct: 51 IR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELN 108
Query: 92 YRTVRGIA----SGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHIT 139
V+ GL + H ++ L +L++ + ++ +FGLA+ F +
Sbjct: 109 --LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTF 165
Query: 140 TSDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAE 175
+S+VV T Y AP+ + SI DI+S G +LAE
Sbjct: 166 SSEVV-TLWYRAPDVLMGSRTYSTSI----DIWSCGCILAE 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 7e-06
Identities = 38/167 (22%), Positives = 68/167 (40%), Gaps = 32/167 (19%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
+R EI L +++H+NI+ L L LV+EF L+ + +
Sbjct: 49 LR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP------ 100
Query: 92 YRTVRGIA----SGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHIT 139
V+ GL + H L +L++ + E +++ FGLA+ F
Sbjct: 101 -EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCY 158
Query: 140 TSDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAEEMSLVK 181
+++VV T Y P+ + SI D++S G + AE + +
Sbjct: 159 SAEVV-TLWYRPPDVLFGAKLYSTSI----DMWSAGCIFAELANAGR 200
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 9e-06
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 32/161 (19%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
IR EI L ++ H NI+ L+ + C LV+EFM+ L+ +L++ G +
Sbjct: 67 IR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD------ 118
Query: 92 YRTVRGIA----SGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHIT 139
++ G+ + H H+ L +L++ D ++++FGLA+ F
Sbjct: 119 -SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSY 176
Query: 140 TSDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAE 175
T +VV T Y AP+ + + S+ DI+S G + AE
Sbjct: 177 THEVV-TLWYRAPDVLMGSKKYSTSV----DIWSIGCIFAE 212
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-05
Identities = 35/167 (20%), Positives = 69/167 (41%), Gaps = 36/167 (21%)
Query: 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLD 87
+ + +R EI L Q++H N++ LL R LV+E+ +L+++ R +R +
Sbjct: 46 KKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVP 100
Query: 88 WLARYRTVRGIA----SGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF---P 132
V+ I + + H H + +L+ ++ +FG A++
Sbjct: 101 ----EHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTL--SITYMC--DIYSFGVLLAE 175
+ + +V T Y +PE L Y D+++ G + AE
Sbjct: 157 DYYDD----EVA-TRWYRSPE---LLVGDTQYGPPVDVWAIGCVFAE 195
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-05
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 8/90 (8%)
Query: 98 IASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149
+A G+E+L +H+ L +LL +I +FGLA+ + ++ D +
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+APE T D++SFGVLL E SL
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSL 291
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-05
Identities = 40/164 (24%), Positives = 70/164 (42%), Gaps = 31/164 (18%)
Query: 32 IRSEIVTLGQIR---HRNILPLL-----AHLARPGCHLLVYEFMKNGSLQDILNDVSRGR 83
IR E+ L + H N++ L + R LV+E + L L+ V
Sbjct: 59 IR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116
Query: 84 RQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF--PE 133
+ + + + GL++LH H+ + +L+ + ++++FGLA+++
Sbjct: 117 VPTETIKDM--MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174
Query: 134 AHTHITTSDVVGTAGYIAPEYQQTLSITYMC--DIYSFGVLLAE 175
A T VV T Y APE L +Y D++S G + AE
Sbjct: 175 ALTS-----VVVTLWYRAPEV--LLQSSYATPVDLWSVGCIFAE 211
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 40/163 (24%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHL-------LVYEFMKNGSLQDILNDVSRGRRQLD 87
E+ L ++H N++ LL + P L LV M D LN++ + ++ D
Sbjct: 78 ELRLLKHMKHENVIGLL-DVFTPARSLEEFNDVYLVTHLMGA----D-LNNIVKCQKLTD 131
Query: 88 WLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHIT 139
++ + I GL+Y+H +H+ L + ++ D E +I +FGLA+ + T
Sbjct: 132 DHVQF-LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--- 187
Query: 140 TSDVVGTAGYIAPE-------YQQTLSITYMCDIYSFGVLLAE 175
V T Y APE Y QT+ DI+S G ++AE
Sbjct: 188 --GYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAE 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-05
Identities = 23/142 (16%), Positives = 45/142 (31%), Gaps = 27/142 (19%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
S + L +I + +L + L+V E+++ GSLQ++ +
Sbjct: 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGA 131
Query: 92 YRTVRGIASGLEYLHMHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIA 151
R ++ +A+ + H + +DH R+S G + +
Sbjct: 132 IRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVV--------------LAYPATMP 177
Query: 152 PEYQQTLSITYMCDIYSFGVLL 173
DI G L
Sbjct: 178 DA-------NPQDDIRGIGASL 192
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 4e-05
Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 32/161 (19%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
IR EI L +++H NI+ L + +LV+E + L+ +L+ G
Sbjct: 48 IR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLES------ 99
Query: 92 YRTVRGIA----SGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHIT 139
T + +G+ Y H + L +L++ + E +I++FGLA+ F
Sbjct: 100 -VTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKY 157
Query: 140 TSDVVGTAGYIAPE-----YQQTLSITYMCDIYSFGVLLAE 175
T ++V T Y AP+ + + +I DI+S G + AE
Sbjct: 158 THEIV-TLWYRAPDVLMGSKKYSTTI----DIWSVGCIFAE 193
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-05
Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 31/164 (18%)
Query: 32 IRSEIVTLGQIR---HRNILPLL--AHLARPGCHL---LVYEFMKNGSLQDILNDVSRGR 83
+R E+ L ++ H N++ L+ +R + LV+E + L+ L+
Sbjct: 59 VR-EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG 116
Query: 84 RQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVF--PE 133
+ + +R GL++LH + + +L+ ++++FGLA+++
Sbjct: 117 LPAETIKDL--MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174
Query: 134 AHTHITTSDVVGTAGYIAPEYQQTLSITYMC--DIYSFGVLLAE 175
A T VV T Y APE L TY D++S G + AE
Sbjct: 175 ALTP----VVV-TLWYRAPEV--LLQSTYATPVDMWSVGCIFAE 211
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-05
Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 41/179 (22%)
Query: 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPG-----CHL-LVYEFMKNGSLQDIL 76
K+L ++ + R E+ + ++ H NI+ L G +L LV +++ ++ +
Sbjct: 86 KVLQDKRFKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVA 143
Query: 77 NDVSRGRRQLDW----LARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEA-RIS 123
SR ++ L L Y+ R +A Y+H +LLD D ++
Sbjct: 144 RHYSRAKQTLPVIYVKLYMYQLFRSLA----YIHSFGICHRDIKPQNLLLDPDTAVLKLC 199
Query: 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPE-------YQQTLSITYMCDIYSFGVLLAE 175
+FG AK S + + Y APE Y T SI D++S G +LAE
Sbjct: 200 DFGSAKQL--VRGEPNVSYIC-SRYYRAPELIFGATDY--TSSI----DVWSAGCVLAE 249
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-05
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 40/163 (24%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHL-------LVYEFMKNGSLQDILNDVSRGRRQLD 87
E+ L +RH N++ LL + P L LV FM D L + + + +
Sbjct: 74 ELRLLKHMRHENVIGLL-DVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGE 127
Query: 88 WLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHIT 139
++ V + GL Y+H +H+ L + ++ D E +I +FGLA+ T
Sbjct: 128 DRIQF-LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT--- 183
Query: 140 TSDVVGTAGYIAPE-------YQQTLSITYMCDIYSFGVLLAE 175
V T Y APE Y QT+ DI+S G ++AE
Sbjct: 184 --GYVVTRWYRAPEVILNWMRYTQTV------DIWSVGCIMAE 218
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 9e-05
Identities = 47/166 (28%), Positives = 68/166 (40%), Gaps = 42/166 (25%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGR-------- 83
+R EI L ++ H NI+ LL LV++FM+ L+ I+ D S
Sbjct: 60 LR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY 117
Query: 84 -RQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEA 134
GLEYLH H L +LLD + ++++FGLAK F
Sbjct: 118 MLMT------------LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS- 164
Query: 135 HTHITTSDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAE 175
T VV T Y APE + + D+++ G +LAE
Sbjct: 165 PNRAYTHQVV-TRWYRAPELLFGARMYGVGV----DMWAVGCILAE 205
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 1e-04
Identities = 40/179 (22%), Positives = 73/179 (40%), Gaps = 50/179 (27%)
Query: 29 MMQIRSEIVTLGQIRHRNILPLL--------AHLARPGCHLLVYEFMKN---GSLQDILN 77
+ +R EI L ++H N++ L+ + G LV++F ++ G L ++L
Sbjct: 61 ITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 119
Query: 78 DVSRGR-----RQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISE 124
+ + L +GL Y+H ++ L VL+ D ++++
Sbjct: 120 KFTLSEIKRVMQML------------LNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 167
Query: 125 FGLAKVF---PEAHTHITTSDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAE 175
FGLA+ F + + T+ VV T Y PE I D++ G ++AE
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPI----DLWGAGCIMAE 221
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 39/179 (21%), Positives = 74/179 (41%), Gaps = 41/179 (22%)
Query: 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL------LVYEFMKNGSLQDIL 76
K+L ++ + R E+ + ++H N++ L A G LV E++ ++
Sbjct: 71 KVLQDKRFKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS 128
Query: 77 NDVSRGRRQLDW----LARYRTVRGIASGLEYLHMHQAL--------VLLDHDM-EARIS 123
++ ++ + L Y+ +R +A Y+H +LLD ++
Sbjct: 129 RHYAKLKQTMPMLLIKLYMYQLLRSLA----YIHSIGICHRDIKPQNLLLDPPSGVLKLI 184
Query: 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPE-------YQQTLSITYMCDIYSFGVLLAE 175
+FG AK+ + S + + Y APE Y T +I DI+S G ++AE
Sbjct: 185 DFGSAKILIAGEPN--VSYIC-SRYYRAPELIFGATNY--TTNI----DIWSTGCVMAE 234
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 2e-04
Identities = 36/161 (22%), Positives = 64/161 (39%), Gaps = 32/161 (19%)
Query: 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR 91
IR E+ L ++H NI+ L + LV+E++ L+ L+D
Sbjct: 48 IR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINM------ 99
Query: 92 YRTVRG----IASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHIT 139
V+ + GL Y H + L +L++ E ++++FGLA+ T
Sbjct: 100 -HNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTY 157
Query: 140 TSDVVGTAGYIAPEY-----QQTLSITYMCDIYSFGVLLAE 175
++VV T Y P+ + I D++ G + E
Sbjct: 158 DNEVV-TLWYRPPDILLGSTDYSTQI----DMWGVGCIFYE 193
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 43/164 (26%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHL-------LVYEFMKNGSLQDILN-DVSRGRRQL 86
E++ L ++H N++ LL + P L LV FM LQ I+ S + Q
Sbjct: 73 ELLLLKHMQHENVIGLL-DVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQ- 129
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
Y+ ++ GL+Y+H +H+ L + ++ D E +I +FGLA+ T
Sbjct: 130 --YLVYQMLK----GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-- 181
Query: 139 TTSDVVGTAGYIAPE-------YQQTLSITYMCDIYSFGVLLAE 175
V T Y APE Y QT+ DI+S G ++AE
Sbjct: 182 ---GYVVTRWYRAPEVILSWMHYNQTV------DIWSVGCIMAE 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 3e-04
Identities = 34/169 (20%), Positives = 68/169 (40%), Gaps = 36/169 (21%)
Query: 35 EIVTLGQIRHRNILPLL-AHLARPGCHL-LVYEFMKN--GSLQDILNDVSRGRRQLDWLA 90
EI L +++H N++ L L+ + L++++ ++ + ++ +
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 91 RYRTVRGIA----SGLEYLHMHQAL--------VLLDHDMEAR----ISEFGLAKVF--- 131
V+ + G+ YLH + L +L+ + R I++ G A++F
Sbjct: 128 --GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 132 PEAHTHITTSDVVGTAGYIAPE-----YQQTLSITYMCDIYSFGVLLAE 175
+ + VV T Y APE T +I DI++ G + AE
Sbjct: 186 LKPLADLDP--VVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAE 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 9e-04
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 35/163 (21%)
Query: 35 EIVTLGQIRHRNILPLLAHLARPGCHL------LVYEFMKNGSLQDILNDVSRGRRQLDW 88
EI L + RH NI+ + + R +V + M+ D L + + + +
Sbjct: 75 EIKILLRFRHENIIGIN-DIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQHLSND 128
Query: 89 LARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAK-VFPEAHTHIT 139
Y + I GL+Y+H +H+ L +LL+ + +I +FGLA+ P+
Sbjct: 129 HICY-FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 140 TSDVVGTAGYIAPE-------YQQTLSITYMCDIYSFGVLLAE 175
++ V T Y APE Y +++ DI+S G +LAE
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSI------DIWSVGCILAE 224
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 238 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.98 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.98 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.98 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.98 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.98 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.98 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.8 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.51 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.01 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 98.47 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.99 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 97.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 96.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.47 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.64 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 92.72 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 91.96 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 88.66 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=317.38 Aligned_cols=210 Identities=18% Similarity=0.236 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc---------CCCcccCHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS---------RGRRQLDWLARYRTVRG 97 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~~~ 97 (238)
+..++|.+|+.+|++++|||||+++|+|.+++..++||||+++|+|.+++.... .....+++..+..++.|
T Consensus 57 ~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 136 (299)
T 4asz_A 57 NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHH
Confidence 446789999999999999999999999999999999999999999999997521 23457999999999999
Q ss_pred HHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 98 IASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 98 l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
+++||+|||++ +.|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||
T Consensus 137 ia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~ 216 (299)
T 4asz_A 137 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 216 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHH
Confidence 99999999954 6789999999999999999987654433333344578999999999999999999999999
Q ss_pred hHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 170 GVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 170 G~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
||++|||+| |..||......... ..+..+.....+..++.++.+++.+||+.||++| ++.+.|+++.
T Consensus 217 Gvvl~Ellt~G~~Pf~~~~~~~~~-~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 217 GVVLWEIFTYGKQPWYQLSNNEVI-ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHH-HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHH-HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 999999998 78888653322222 2222233344556677788999999999999999 7777777664
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=316.98 Aligned_cols=210 Identities=18% Similarity=0.224 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC-----------CCcccCHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR-----------GRRQLDWLARYRTV 95 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~~~~ 95 (238)
...++|.+|+.+|++++|||||+++|+|.+++..++||||+++|+|.+++..... ...++++..+..++
T Consensus 85 ~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 164 (329)
T 4aoj_A 85 SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164 (329)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHH
Confidence 4467899999999999999999999999999999999999999999999975211 12469999999999
Q ss_pred HHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCee
Q 041655 96 RGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIY 167 (238)
Q Consensus 96 ~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvw 167 (238)
.|+++||.|||++ +.|||++.++.+||+|||+++...........+...||+.|+|||++.+..++.++|||
T Consensus 165 ~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvw 244 (329)
T 4aoj_A 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVW 244 (329)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcccccc
Confidence 9999999999944 67899999999999999999876444333333456799999999999999999999999
Q ss_pred ehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 168 SFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 168 slG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
||||++|||+| |..||......... ..+........+..++.++.+++.+||+.||++| ++++.|+.+.
T Consensus 245 S~Gvvl~Ellt~G~~Pf~~~~~~~~~-~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 245 SFGVVLWEIFTYGKQPWYQLSNTEAI-DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHHHHHHHTTSCCTTCSSCHHHHH-HHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHcCCCCCCCCCCHHHHH-HHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 99999999999 78888543322212 2222233344556677789999999999999999 7888887764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=311.30 Aligned_cols=208 Identities=21% Similarity=0.334 Sum_probs=161.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+..+.|.+|+.+|++++|||||+++|++.+ +.+++||||+++|+|.+++.. ....+++..+..++.|+++||+||
T Consensus 73 ~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yL 148 (307)
T 3omv_A 73 PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYL 148 (307)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 4557889999999999999999999998765 568999999999999999975 345699999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc---cCCCccCCeeehhHHHH
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT---LSITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~---~~~~~~~DvwslG~~l~ 174 (238)
|++ +.|||++.++++||+|||+|+...............||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 149 H~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~ 228 (307)
T 3omv_A 149 HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLY 228 (307)
T ss_dssp HHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHH
T ss_pred HHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHH
Confidence 944 7789999999999999999987654333333355789999999998863 45899999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccc----cCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKL----LGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
||+||..||............+.... ....+.+++..+.+++.+||+.||++| ++++.|+.|+
T Consensus 229 Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 229 ELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp HHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred HHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 99999999864322222222222211 123445667788999999999999999 7777777665
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=313.35 Aligned_cols=221 Identities=20% Similarity=0.241 Sum_probs=176.7
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+..... ....++|.+|+.+|.+++|||||+++|+|.+++..++||||+++|+|.+++.....
T Consensus 59 VAvK~l~~~~~-------------~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~ 125 (308)
T 4gt4_A 59 VAIKTLKDKAE-------------GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSP 125 (308)
T ss_dssp EEEEECCC-CC-------------C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCS
T ss_pred EEEEEECcccC-------------hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCc
Confidence 77887754322 22357899999999999999999999999999999999999999999999964211
Q ss_pred ------------CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccc
Q 041655 82 ------------GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTS 141 (238)
Q Consensus 82 ------------~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 141 (238)
....+++..+..++.|+++||+|||++ +.|||+++++++||+|||+++...........+
T Consensus 126 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~ 205 (308)
T 4gt4_A 126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205 (308)
T ss_dssp SCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSS
T ss_pred cccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEec
Confidence 124689999999999999999999954 678999999999999999998765443333345
Q ss_pred cccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhc
Q 041655 142 DVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCT 220 (238)
Q Consensus 142 ~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl 220 (238)
...||+.|+|||++.+..++.++|||||||++|||+| |..||...... .....+..+.....+.+++..+.+++.+||
T Consensus 206 ~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~C~ 284 (308)
T 4gt4_A 206 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVVEMIRNRQVLPCPDDCPAWVYALMIECW 284 (308)
T ss_dssp SSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCcccchHHHHHHHHHHc
Confidence 5789999999999999999999999999999999998 78887643322 222233333344456677888999999999
Q ss_pred CCCCCcc----hHHHHHHhh
Q 041655 221 LDDPKER----HVRCMLSQI 236 (238)
Q Consensus 221 ~~~p~~R----~v~~~L~~~ 236 (238)
+.||++| ++++.|+++
T Consensus 285 ~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 285 NEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CSSGGGSCCHHHHHHHHHTS
T ss_pred CCChhHCcCHHHHHHHHHhc
Confidence 9999999 677777654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=310.68 Aligned_cols=216 Identities=19% Similarity=0.256 Sum_probs=172.0
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+.+... .....+.+.+|+.+|++++|||||++++++.+++.+|+|||||+||+|.+++.. .
T Consensus 52 vAiK~i~~~~~------------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~ 117 (350)
T 4b9d_A 52 YVIKEINISRM------------SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA--Q 117 (350)
T ss_dssp EEEEEEECTTS------------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--T
T ss_pred EEEEEEehHHC------------CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH--c
Confidence 78887765433 234567899999999999999999999999999999999999999999999975 2
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
....+++..++.++.|++.||+|||+ ||.|||++.+|++||+|||+++.+..... .....+||+.|+|||
T Consensus 118 ~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE 195 (350)
T 4b9d_A 118 KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPE 195 (350)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH--HHHHHHSCCTTCCHH
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc--cccccCCCccccCHH
Confidence 34567999999999999999999994 47789999999999999999987643221 124468999999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCM 232 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~ 232 (238)
++.+..|+.++||||+||++|||++|..||...........+..... +..+...+.++.+++.+||++||++| ++.+.
T Consensus 196 ~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 274 (350)
T 4b9d_A 196 ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274 (350)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99999999999999999999999999999864322222222222222 22334455678888999999999999 55554
Q ss_pred HH
Q 041655 233 LS 234 (238)
Q Consensus 233 L~ 234 (238)
|+
T Consensus 275 l~ 276 (350)
T 4b9d_A 275 LE 276 (350)
T ss_dssp HT
T ss_pred hc
Confidence 43
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=307.51 Aligned_cols=212 Identities=20% Similarity=0.248 Sum_probs=169.5
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||++...... ..+.+.+|+.+|++++|||||+++++|.+++.+|+||||+++|+|.+++..
T Consensus 102 vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--- 164 (346)
T 4fih_A 102 VAVKKMDLRKQQ--------------RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--- 164 (346)
T ss_dssp EEEEEEEGGGCS--------------SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH---
T ss_pred EEEEEEecCchh--------------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc---
Confidence 788877543221 235678999999999999999999999999999999999999999999975
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
..+++..+..++.|++.||+|||+ ||.|||++.+|++||+|||+++.+..... ...+.+||+.|+|||
T Consensus 165 --~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPE 240 (346)
T 4fih_A 165 --TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPE 240 (346)
T ss_dssp --SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHH
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHH
Confidence 458999999999999999999994 47789999999999999999987644322 234578999999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccccc-ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSK-LLGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
++.+..|+.++||||+||++|||++|..||...........+.... .....+...+.++.+++.+||+.||++| ++.+
T Consensus 241 vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e 320 (346)
T 4fih_A 241 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 320 (346)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999999999999999999999986432222222222111 1223344556678889999999999999 5555
Q ss_pred HHH
Q 041655 232 MLS 234 (238)
Q Consensus 232 ~L~ 234 (238)
.|+
T Consensus 321 ~l~ 323 (346)
T 4fih_A 321 LLK 323 (346)
T ss_dssp HTT
T ss_pred Hhc
Confidence 543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=311.09 Aligned_cols=210 Identities=24% Similarity=0.256 Sum_probs=171.2
Q ss_pred HHHHHHHHHHHHhcCCCC-Ccccceeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRH-RNILPLLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLARY 92 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~ 92 (238)
...+.|.+|+.+|.+++| ||||+++|+|.+ ++.+++|||||++|+|.+++..... ....+++..+.
T Consensus 109 ~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 188 (353)
T 4ase_A 109 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188 (353)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHH
Confidence 456789999999999975 899999999865 4578999999999999999975321 13458999999
Q ss_pred HHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.|+++||+|||++ +.|||++.++.+||+|||+|+.+.........+...||+.|+|||++.+..|+.++
T Consensus 189 ~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ks 268 (353)
T 4ase_A 189 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 268 (353)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcc
Confidence 9999999999999954 67899999999999999999876554443344567889999999999999999999
Q ss_pred CeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 165 DIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 165 DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|||||||++|||+| |..||............+..+.....+...+.++.+++.+||+.||++| ++++.|+++
T Consensus 269 DVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 269 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 99999999999998 7888865433333334444445555566677788999999999999999 777777665
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=297.87 Aligned_cols=200 Identities=21% Similarity=0.316 Sum_probs=157.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
....+.|.+|+.+|++++|||||+++++|.+ ++.+|+||||+++|+|.+++.. ...+++..+..++.|+++|
T Consensus 66 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~a 141 (290)
T 3fpq_A 66 KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKG 141 (290)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999864 3568999999999999999976 4578999999999999999
Q ss_pred hchhhcc----------CceeeecC-CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 102 LEYLHMH----------QALVLLDH-DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 102 l~~lH~~----------~~~il~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
|+|||++ |.|||+++ +|.+||+|||+|+...... ..+..||+.|+|||++.+ .|+.++||||||
T Consensus 142 L~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlG 216 (290)
T 3fpq_A 142 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 216 (290)
T ss_dssp HHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc----cCCcccCccccCHHHcCC-CCCcHHHHHHHH
Confidence 9999954 56799985 7999999999998643322 245689999999998865 699999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCccccccccc-CCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAIDSKLL-GNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|++|||+||..||............+..... ...+...+.++.+++.+||+.||++| ++.+.|+
T Consensus 217 vilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 217 MCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999999998643222222222222221 12233344568888999999999999 6555554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=303.28 Aligned_cols=197 Identities=18% Similarity=0.154 Sum_probs=158.2
Q ss_pred HHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc-----
Q 041655 33 RSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM----- 107 (238)
Q Consensus 33 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~----- 107 (238)
.+|+.+|++++|||||++++++.+++.+|+||||++||+|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 98 ~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~IiH 173 (336)
T 4g3f_A 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRRILH 173 (336)
T ss_dssp THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 3699999999999999999999999999999999999999999976 3569999999999999999999994
Q ss_pred ---cCceeeecCCC-ceEEcccccccccCCccc---ccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 108 ---HQALVLLDHDM-EARISEFGLAKVFPEAHT---HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 108 ---~~~~il~~~~~-~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
||.|||++.+| ++||+|||+|+.+..... .......+||+.|+|||++.+..|+.++||||+||++|||++|.
T Consensus 174 RDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~ 253 (336)
T 4g3f_A 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253 (336)
T ss_dssp SCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCc
Confidence 47789999998 599999999987644321 11224467999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCccccccccc-CCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 181 KWMRNVMTSENPKRAIDSKLL-GNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
.||...........+...... ...+...+..+.+++.+||++||++| ++.+.+
T Consensus 254 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~ 308 (336)
T 4g3f_A 254 HPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELR 308 (336)
T ss_dssp CSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 999764443333333333221 23345566778889999999999999 433333
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=303.83 Aligned_cols=195 Identities=21% Similarity=0.253 Sum_probs=163.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+..+.+.+|+++|++++||||++++++|.+++.+|+||||++||+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 74 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH 149 (311)
T 4aw0_A 74 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH 149 (311)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3457789999999999999999999999999999999999999999999976 456999999999999999999999
Q ss_pred --------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 --------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 --------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.||.|||++.++++||+|||+|+.+..........+.+||+.|+|||++.+..|+.++||||+||++|+|++
T Consensus 150 ~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~ 229 (311)
T 4aw0_A 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229 (311)
T ss_dssp HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence 457889999999999999999998765444444466899999999999999999999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||..........++....+ ..+...+.++.+++.+||+.||++|
T Consensus 230 G~~PF~~~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R 276 (311)
T 4aw0_A 230 GLPPFRAGNEGLIFAKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKR 276 (311)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGS
T ss_pred CCCCCCCCCHHHHHHHHHcCCC--CCCcccCHHHHHHHHHHccCCHhHC
Confidence 9999964332222222332222 2333445567888889999999999
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=308.69 Aligned_cols=212 Identities=20% Similarity=0.253 Sum_probs=169.3
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||++...... ..+.+.+|+.+|++++|||||+++++|.+++.+|+|||||+||+|.+++..
T Consensus 179 vAiK~i~~~~~~--------------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--- 241 (423)
T 4fie_A 179 VAVKKMDLRKQQ--------------RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--- 241 (423)
T ss_dssp EEEEEEESTTCS--------------SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---
T ss_pred EEEEEEeccchh--------------HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc---
Confidence 788888654332 135678999999999999999999999999999999999999999999975
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
..+++..+..++.|++.||+||| .|+.|||++.+|.+||+|||+++.+..... ...+.+||+.|+|||
T Consensus 242 --~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPE 317 (423)
T 4fie_A 242 --TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPE 317 (423)
T ss_dssp --SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHH
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHH
Confidence 45899999999999999999999 447789999999999999999987644322 234578999999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccccc-ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSK-LLGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
++.+..|+.++|||||||++|||++|..||...........+.... .....+...+.++.+++.+||+.||++| .+.+
T Consensus 318 vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e 397 (423)
T 4fie_A 318 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 397 (423)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 9999999999999999999999999999986432222121221111 1112233445667888889999999999 6555
Q ss_pred HHH
Q 041655 232 MLS 234 (238)
Q Consensus 232 ~L~ 234 (238)
.|+
T Consensus 398 ll~ 400 (423)
T 4fie_A 398 LLK 400 (423)
T ss_dssp HTT
T ss_pred Hhc
Confidence 553
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=290.26 Aligned_cols=212 Identities=19% Similarity=0.238 Sum_probs=156.4
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+.+.... ..+..+.+.+|+.+|++++||||+++++++.+++..|+||||+ +|+|.+++..
T Consensus 41 vAiK~i~~~~~~-----------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~--- 105 (275)
T 3hyh_A 41 VALKIINKKVLA-----------KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ--- 105 (275)
T ss_dssp EEEEEEECC-----------------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH---
T ss_pred EEEEEEeHHHcC-----------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH---
Confidence 778877654321 2234567899999999999999999999999999999999999 6799999976
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
...+++..+..++.|++.||+||| .||.||+++.++++||+|||+|+....... ..+..||+.|+|||
T Consensus 106 -~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---~~~~~GT~~Y~APE 181 (275)
T 3hyh_A 106 -RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPE 181 (275)
T ss_dssp -SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHH
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc---cCCeeECcccCChh
Confidence 467999999999999999999999 447889999999999999999986543322 24578999999999
Q ss_pred cccccCC-CccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 154 YQQTLSI-TYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 154 ~~~~~~~-~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
++.+..+ +.++||||+||++|+|++|..||...........+.... ...+...+.++.+++.+||+.||++| ++.+
T Consensus 182 ~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~e 259 (275)
T 3hyh_A 182 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHE 259 (275)
T ss_dssp HHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9988776 579999999999999999999985422111111122211 12233445667888889999999999 5555
Q ss_pred HHH
Q 041655 232 MLS 234 (238)
Q Consensus 232 ~L~ 234 (238)
.|+
T Consensus 260 il~ 262 (275)
T 3hyh_A 260 IMQ 262 (275)
T ss_dssp HHH
T ss_pred HHc
Confidence 554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=299.47 Aligned_cols=190 Identities=22% Similarity=0.244 Sum_probs=151.3
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-- 107 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~-- 107 (238)
.++.+|+.+|++++||||+++++++.+++.+|+||||++||+|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 71 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~ 146 (304)
T 3ubd_A 71 VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG 146 (304)
T ss_dssp C------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3578899999999999999999999999999999999999999999976 4579999999999999999999994
Q ss_pred ------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 108 ------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 108 ------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
||.|||++.+|++||+|||+|+....... ...+..||+.|+|||++.+..|+.++||||+||++|||++|..
T Consensus 147 IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 224 (304)
T 3ubd_A 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224 (304)
T ss_dssp CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCC
Confidence 47789999999999999999986533221 2345789999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 182 WMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
||...........+..... ..+...+.++.+++.+||+.||++|
T Consensus 225 PF~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R 268 (304)
T 3ubd_A 225 PFQGKDRKETMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANR 268 (304)
T ss_dssp SSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCcCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcccCHHHC
Confidence 9864332222222222222 2334455668888999999999999
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=285.31 Aligned_cols=204 Identities=16% Similarity=0.225 Sum_probs=144.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCC------------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPG------------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 94 (238)
...+.+.+|+.+|++++|||||+++++|.+.+ .+|+||||+++|+|.+++... ......++..++.+
T Consensus 45 ~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i 123 (299)
T 4g31_A 45 LAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHI 123 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHH
Confidence 34578899999999999999999999986543 368999999999999999752 12234566778899
Q ss_pred HHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccc----------cccccccCCCcccCccccc
Q 041655 95 VRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTH----------ITTSDVVGTAGYIAPEYQQ 156 (238)
Q Consensus 95 ~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~~~apE~~~ 156 (238)
+.|+++||+|||+ ||.|||++.++.+||+|||+|+........ ...+..+||+.|+|||++.
T Consensus 124 ~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 203 (299)
T 4g31_A 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHT
T ss_pred HHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc
Confidence 9999999999994 477899999999999999999876432211 1123457999999999999
Q ss_pred ccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 157 TLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 157 ~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+..|+.++|||||||++|||++ ||............+.....+..+.+......+++.+||+.||++| ++.+.|+
T Consensus 204 ~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 204 GNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9999999999999999999986 3322111000000111111122233444556788999999999999 5555554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=284.78 Aligned_cols=201 Identities=26% Similarity=0.289 Sum_probs=151.1
Q ss_pred HHHHHHHhcCCCCCcccceeeeeecCC----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 32 IRSEIVTLGQIRHRNILPLLAHLARPG----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 32 ~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
+..|+..+.+++||||++++|++.+++ .+|+||||+++|+|.+++.. ..+++..+..++.|+++||+|||+
T Consensus 44 ~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~ 118 (303)
T 3hmm_A 44 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM 118 (303)
T ss_dssp HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 346777788999999999999997654 57999999999999999975 468999999999999999999995
Q ss_pred ----------------cCceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCccccccc------CCCcc
Q 041655 108 ----------------HQALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQTL------SITYM 163 (238)
Q Consensus 108 ----------------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~~------~~~~~ 163 (238)
|+.|||++.++++||+|||+++........ .......||+.|+|||++.+. .++.+
T Consensus 119 ~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k 198 (303)
T 3hmm_A 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred hhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChh
Confidence 366799999999999999999876443222 122346799999999998654 36678
Q ss_pred CCeeehhHHHHhhcchHHHHHHhhccCCCc---------------ccccccccCCC-----hHHHHHHHHHHhhhhcCCC
Q 041655 164 CDIYSFGVLLAEEMSLVKWMRNVMTSENPK---------------RAIDSKLLGNG-----YEEQMLLVLKTACFCTLDD 223 (238)
Q Consensus 164 ~DvwslG~~l~~~~t~~~~~~~~~~~~~~~---------------~~~~~~~~~~~-----~~~~~~~l~~~~~~cl~~~ 223 (238)
+|||||||++|||+||..|+........+. ........+.. ..+.+..+.+++.+||+.|
T Consensus 199 ~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~d 278 (303)
T 3hmm_A 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278 (303)
T ss_dssp HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSS
T ss_pred HhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccC
Confidence 999999999999999876553221111110 01112222222 2345677899999999999
Q ss_pred CCcc----hHHHHHHhhh
Q 041655 224 PKER----HVRCMLSQIQ 237 (238)
Q Consensus 224 p~~R----~v~~~L~~~~ 237 (238)
|++| ++++.|++|.
T Consensus 279 P~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 279 GAARLTALRIKKTLSQLS 296 (303)
T ss_dssp GGGSCCHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHH
Confidence 9999 7888887765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=276.48 Aligned_cols=216 Identities=20% Similarity=0.261 Sum_probs=159.6
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeec------CCeeEEEEEeCCCCCHHHH
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR------PGCHLLVYEFMKNGSLQDI 75 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~~v~e~~~~~~L~~~ 75 (238)
||||++.+... .....+.+.+|+.+|++++||||+++++++.. .+.+|+||||++ |+|.++
T Consensus 82 vAiK~i~~~~~------------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~ 148 (398)
T 4b99_A 82 VAIKKIPNAFD------------VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQI 148 (398)
T ss_dssp EEEEEETTTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHH
T ss_pred EEEEEECcccc------------chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHH
Confidence 77887754332 22345678899999999999999999998753 367899999995 689999
Q ss_pred HhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcc--cccccccccC
Q 041655 76 LNDVSRGRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAH--THITTSDVVG 145 (238)
Q Consensus 76 l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~ 145 (238)
+.. ...+++..+..++.|++.||.|||+ ||.|||++.++.+|++|||+++.+.... ......+.+|
T Consensus 149 i~~----~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~G 224 (398)
T 4b99_A 149 IHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224 (398)
T ss_dssp HTS----SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCC
T ss_pred HHh----cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcccccccccccee
Confidence 965 5679999999999999999999994 4778999999999999999998764321 1223356789
Q ss_pred CCcccCccccccc-CCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccc----------------------ccc--
Q 041655 146 TAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID----------------------SKL-- 200 (238)
Q Consensus 146 ~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~----------------------~~~-- 200 (238)
|+.|+|||++.+. .++.++||||+||++|||++|..||...........+.. ...
T Consensus 225 T~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 304 (398)
T 4b99_A 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPP 304 (398)
T ss_dssp CCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCC
T ss_pred ChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCC
Confidence 9999999988765 568999999999999999999998843211111000000 000
Q ss_pred -cCCC----hHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 201 -LGNG----YEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 201 -~~~~----~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.+.. ......++.+++.+||..||++| ++.+.|+
T Consensus 305 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 305 RQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 11224567888999999999999 6666654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.25 Aligned_cols=201 Identities=20% Similarity=0.290 Sum_probs=162.1
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.+|+.++||||++++++|.+++.+|+||||++||+|.+++.. ....+++..+..++.|+++||.|||+
T Consensus 197 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~ 273 (573)
T 3uto_A 197 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE 273 (573)
T ss_dssp HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999999999999999999999999999864 24569999999999999999999994
Q ss_pred --------cCceeeecCC--CceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 108 --------HQALVLLDHD--MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 --------~~~~il~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|+.||+++.+ +.+||+|||+++.+..... ....+||+.|+|||++.+..|+.++||||+||++|+|+
T Consensus 274 ~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml 350 (573)
T 3uto_A 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350 (573)
T ss_dssp TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 4778999864 8999999999987654332 23468999999999999999999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||...........+..... ....+...+.++.+++.+||+.||.+| .+.+.|+
T Consensus 351 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 351 SGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999854332222222222221 122233445667888999999999999 6665554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=284.12 Aligned_cols=187 Identities=21% Similarity=0.200 Sum_probs=152.6
Q ss_pred HHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-----
Q 041655 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----- 106 (238)
Q Consensus 32 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH----- 106 (238)
..+++.++..++||||++++++|.+.+.+|+||||++||+|.+++.. ...+++..++.++.||+.||+|||
T Consensus 239 E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~gIi 314 (689)
T 3v5w_A 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRFVV 314 (689)
T ss_dssp HHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34567888999999999999999999999999999999999999976 456999999999999999999999
Q ss_pred ---ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcchHHH
Q 041655 107 ---MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLVKW 182 (238)
Q Consensus 107 ---~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~~~ 182 (238)
.||.|||++.+|++||+|||+|+.+.... ..+.+||+.|+|||++.+ ..|+.++|+||+||++|||++|..|
T Consensus 315 HRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~P 390 (689)
T 3v5w_A 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390 (689)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 44778999999999999999998765433 245789999999999864 5799999999999999999999999
Q ss_pred HHHhhccCCCcccccc--cccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 183 MRNVMTSENPKRAIDS--KLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 183 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|....... ....... ......+...+.++.+++.+||+.||.+|
T Consensus 391 F~~~~~~~-~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~R 436 (689)
T 3v5w_A 391 FRQHKTKD-KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436 (689)
T ss_dssp TCGGGCCC-HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGC
T ss_pred CCCCChHH-HHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHC
Confidence 96533221 1111110 11122344455667888888999999999
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=266.15 Aligned_cols=148 Identities=20% Similarity=0.290 Sum_probs=125.2
Q ss_pred HHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh--
Q 041655 30 MQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH-- 106 (238)
Q Consensus 30 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH-- 106 (238)
.++.+|+.+|..+ +||||++++++|.+++.+|+||||+++|+|.+++.. +++..++.++.|++.||+|||
T Consensus 64 ~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~ 136 (361)
T 4f9c_A 64 IRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF 136 (361)
T ss_dssp HHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC
Confidence 4577899999988 599999999999999999999999999999999843 889999999999999999999
Q ss_pred ------ccCceeeecCC-CceEEcccccccccCCccc--------------------------ccccccccCCCcccCcc
Q 041655 107 ------MHQALVLLDHD-MEARISEFGLAKVFPEAHT--------------------------HITTSDVVGTAGYIAPE 153 (238)
Q Consensus 107 ------~~~~~il~~~~-~~~kl~dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~~~apE 153 (238)
.||.|||++.+ +.+||+|||+|+....... .......+||+.|+|||
T Consensus 137 gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE 216 (361)
T 4f9c_A 137 GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE 216 (361)
T ss_dssp TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 45788999877 7999999999976532211 01123457999999999
Q ss_pred ccccc-CCCccCCeeehhHHHHhhcchHHHHH
Q 041655 154 YQQTL-SITYMCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 154 ~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~~ 184 (238)
++.+. .|+.++||||+||++|||++|..||.
T Consensus 217 ~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 217 VLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred HHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 88765 48999999999999999999998884
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=251.31 Aligned_cols=209 Identities=28% Similarity=0.426 Sum_probs=168.7
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++||||+++++++...+..++||||+++|+|.+++.........+++..+..++.|++.||.|||.
T Consensus 78 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 157 (321)
T 2qkw_B 78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT 157 (321)
T ss_dssp HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC
Confidence 35678999999999999999999999999999999999999999999986533334568999999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.+||+|||.++...............|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 158 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 237 (321)
T 2qkw_B 158 RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237 (321)
T ss_dssp TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHC
T ss_pred CCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhC
Confidence 4 77899999999999999999765433322223445689999999999888999999999999999999999
Q ss_pred HHHHHHhhccC---------------CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 180 VKWMRNVMTSE---------------NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 180 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
..||....... .....++.........+.+..+.+++.+||+.||++| ++++.|+.+
T Consensus 238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 88875332211 1222333334445567788889999999999999999 666666554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=257.69 Aligned_cols=211 Identities=21% Similarity=0.256 Sum_probs=167.2
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLAR 91 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~ 91 (238)
.....+.+.+|+.+++++ +||||+++++++..++..|+||||+++|+|.+++..... ....+++..+
T Consensus 126 ~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (370)
T 2psq_A 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205 (370)
T ss_dssp BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHH
Confidence 345567899999999999 899999999999999999999999999999999976321 1245899999
Q ss_pred HHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCcc
Q 041655 92 YRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM 163 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~ 163 (238)
..++.|++.||.|||.+ +.||+++.++.+||+|||+++...............+++.|+|||++.+..++.+
T Consensus 206 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 285 (370)
T 2psq_A 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 285 (370)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH
T ss_pred HHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH
Confidence 99999999999999944 6789999999999999999986654333222334567889999999999899999
Q ss_pred CCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 164 CDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 164 ~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+|||||||++|||++ |..||..... ......+........+...+..+.+++.+||+.||.+| ++++.|+++
T Consensus 286 ~DvwslG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 286 SDVWSFGVLMWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999 7777754221 12222223333334455566778889999999999999 666666655
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=251.49 Aligned_cols=204 Identities=36% Similarity=0.558 Sum_probs=167.4
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.++.+++||||+++++++...+..++||||+++|+|.+++.........+++..+..++.|++.||.|||.+
T Consensus 72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 151 (326)
T 3uim_A 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151 (326)
T ss_dssp CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3688999999999999999999999999999999999999999999986444456699999999999999999999976
Q ss_pred ----------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 109 ----------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 109 ----------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
+.||+++.++.+||+|||.+.......... .....||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 152 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 230 (326)
T 3uim_A 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230 (326)
T ss_dssp SSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH
T ss_pred CCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh
Confidence 457999999999999999998764433222 234568999999999988889999999999999999999
Q ss_pred hHHHHHHhh-----------------ccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHH
Q 041655 179 LVKWMRNVM-----------------TSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLS 234 (238)
Q Consensus 179 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~ 234 (238)
|..||.... .........+.........+.+..+.+++..||+.||.+| ++++.|+
T Consensus 231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp CCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred CCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 988874221 1122233334444555677888899999999999999999 5555554
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=250.09 Aligned_cols=210 Identities=22% Similarity=0.335 Sum_probs=163.7
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+.+.+|+.++.+++||||+++++++.+++..++||||+++++|.+++.. ....+++..+..++.|+++||+|
T Consensus 47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~ 123 (310)
T 3s95_A 47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAY 123 (310)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHH
Confidence 345667899999999999999999999999999999999999999999999976 34568999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCccccc------------ccccccCCCcccCcccccccCCCccC
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI------------TTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~------------~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
||++ +.||+++.++.+||+|||.++......... ......||+.|+|||++.+..++.++
T Consensus 124 lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (310)
T 3s95_A 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV 203 (310)
T ss_dssp HHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred HHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHH
Confidence 9944 778999999999999999998654322111 11145789999999999999999999
Q ss_pred CeeehhHHHHhhcchHHHHHHhhccCCC-cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVMTSENP-KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
||||||+++|+|++|..|+......... ............+...+..+.+++.+||+.||++| ++.+.|++++
T Consensus 204 Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 204 DVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp HHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999998776543322211 11111111112233445567888999999999999 7777777664
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=262.07 Aligned_cols=208 Identities=20% Similarity=0.210 Sum_probs=163.9
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+..++|.+|+.+|++++||||+++++++..++..++||||+++|+|.+++.. ....+++..+..++.|++.||+||
T Consensus 153 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~L 229 (377)
T 3cbl_A 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYL 229 (377)
T ss_dssp HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 44566789999999999999999999999999999999999999999999975 234689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ +.||+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||+
T Consensus 230 H~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 309 (377)
T 3cbl_A 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309 (377)
T ss_dssp HHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred HHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHH
Confidence 954 678999999999999999997654332211112234567899999998888999999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
+ |..||...... .....+........+...+..+.+++.+||+.||++| ++++.|++++
T Consensus 310 t~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 310 SLGASPYPNLSNQ-QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp TTSCCSSTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 8 77776532211 1122222222333444556678889999999999999 7777777764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=249.64 Aligned_cols=220 Identities=22% Similarity=0.339 Sum_probs=162.1
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+..... ..+..+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++... .
T Consensus 63 vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~ 129 (309)
T 3p86_A 63 VAVKILMEQDF------------HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-G 129 (309)
T ss_dssp EEEEEECCCCC------------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHST-T
T ss_pred EEEEEecCCCC------------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhc-C
Confidence 67777755433 2345677899999999999999999999999999999999999999999999751 1
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhccC----------ceeeecCCCceEEcccccccccCCcccccccccccCCCcccC
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMHQ----------ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIA 151 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~~----------~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~a 151 (238)
....+++..+..++.|++.||+|||+++ .||+++.++.+||+|||+++....... ......||+.|+|
T Consensus 130 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~a 207 (309)
T 3p86_A 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPEWMA 207 (309)
T ss_dssp HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCccccC
Confidence 1234899999999999999999999765 469999999999999999975433211 1234678999999
Q ss_pred cccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----
Q 041655 152 PEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER---- 227 (238)
Q Consensus 152 pE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R---- 227 (238)
||++.+..++.++||||||+++|+|++|..||.....................+...+..+.+++.+||+.||.+|
T Consensus 208 PE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 287 (309)
T 3p86_A 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFA 287 (309)
T ss_dssp HHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9999998999999999999999999999888854322211111111122223344555678889999999999999
Q ss_pred hHHHHHHhh
Q 041655 228 HVRCMLSQI 236 (238)
Q Consensus 228 ~v~~~L~~~ 236 (238)
++++.|+.+
T Consensus 288 ~ll~~L~~~ 296 (309)
T 3p86_A 288 TIMDLLRPL 296 (309)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 666666655
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=248.23 Aligned_cols=210 Identities=22% Similarity=0.319 Sum_probs=158.9
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+..... ......+.+.+|+.++.+++||||+++++++..++..++||||+++++|.+++..
T Consensus 39 vaiK~~~~~~~-----------~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--- 104 (294)
T 4eqm_A 39 VAIKAIFIPPR-----------EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES--- 104 (294)
T ss_dssp EEEEEEECCSS-----------CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---
T ss_pred EEEEEeccCcc-----------ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh---
Confidence 67776654332 2234567899999999999999999999999999999999999999999999976
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
...+++..+..++.|++.||.|||++ |.||+++.++.+||+|||.+......... ......||+.|+|||
T Consensus 105 -~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE 182 (294)
T 4eqm_A 105 -HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPE 182 (294)
T ss_dssp -HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHH
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-ccCccccCccccCHh
Confidence 35689999999999999999999954 67899999999999999999865433221 123457899999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc---cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL---LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++.+..++.++|+||+|+++|+|++|..||................. ........+..+.+++.+||+.||.+|
T Consensus 183 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 259 (294)
T 4eqm_A 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259 (294)
T ss_dssp HHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHc
Confidence 99998899999999999999999999988753221111111111111 111223445678889999999999999
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=248.35 Aligned_cols=199 Identities=21% Similarity=0.234 Sum_probs=159.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++..++..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++
T Consensus 61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~ 135 (297)
T 3fxz_A 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN 135 (297)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 35688999999999999999999999999999999999999999999976 3589999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||+|+++|+|++|.
T Consensus 136 ~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 213 (297)
T 3fxz_A 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (297)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 6789999999999999999876644322 224467999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCccccc-ccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 181 KWMRNVMTSENPKRAID-SKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.||.............. .......+...+..+.+++.+||+.||++| ++.+.|+
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 214 PPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 88854221111111111 111222344556668889999999999999 5555443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=251.27 Aligned_cols=208 Identities=23% Similarity=0.320 Sum_probs=162.8
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+.+.+|+.++.+++||||+++++++.+++..++||||+++++|.+++.. ....+++..+..++.|++.||.|
T Consensus 90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~ 166 (325)
T 3kul_A 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRY 166 (325)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHH
Confidence 344567899999999999999999999999999999999999999999999965 34568999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
||.+ +.||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|+
T Consensus 167 LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 246 (325)
T 3kul_A 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246 (325)
T ss_dssp HHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred HHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHH
Confidence 9944 67899999999999999999876443221 12223456778999999988889999999999999999
Q ss_pred hcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 176 EMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 176 ~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|++ |..||....... ....+........+...+..+.+++..||+.||++| ++++.|+.+
T Consensus 247 ll~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 247 VLAYGERPYWNMTNRD-VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp HHTTSCCTTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCcccCCHHH-HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 998 888875432221 112222222333444556678889999999999999 677777665
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=257.35 Aligned_cols=211 Identities=24% Similarity=0.274 Sum_probs=163.1
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCC-eeEEEEEeCCCCCHHHHHhhhcCC----------------------
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPG-CHLLVYEFMKNGSLQDILNDVSRG---------------------- 82 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~---------------------- 82 (238)
...+.+.+|+.++.++ +||||+++++++...+ ..+++|||+++|+|.+++......
T Consensus 67 ~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (359)
T 3vhe_A 67 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------
T ss_pred HHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccc
Confidence 4467899999999999 6899999999987754 489999999999999999763211
Q ss_pred ----------------------------------------CcccCHHHHHHHHHHHHHHhchhhcc--------Cceeee
Q 041655 83 ----------------------------------------RRQLDWLARYRTVRGIASGLEYLHMH--------QALVLL 114 (238)
Q Consensus 83 ----------------------------------------~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~ 114 (238)
...+++..+..++.|++.||.|||++ +.||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll 226 (359)
T 3vhe_A 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 226 (359)
T ss_dssp -------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred hhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE
Confidence 12289999999999999999999944 678999
Q ss_pred cCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCc
Q 041655 115 DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPK 193 (238)
Q Consensus 115 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~ 193 (238)
+.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 227 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 306 (359)
T 3vhe_A 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 306 (359)
T ss_dssp CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH
Confidence 9999999999999986644433333345678899999999999899999999999999999998 888875432222222
Q ss_pred ccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 194 RAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 194 ~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
..+........+...+..+.+++..||+.||.+| ++++.|+++.
T Consensus 307 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 307 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 2222222333344455668888999999999999 6666666553
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=248.29 Aligned_cols=211 Identities=22% Similarity=0.266 Sum_probs=165.9
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC--------------------CCc
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR--------------------GRR 84 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------------------~~~ 84 (238)
.....+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++..... ...
T Consensus 66 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (314)
T 2ivs_A 66 SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145 (314)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------C
T ss_pred CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccccccccccccccccccc
Confidence 345567899999999999999999999999999999999999999999999976321 123
Q ss_pred ccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc
Q 041655 85 QLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ 156 (238)
Q Consensus 85 ~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~ 156 (238)
.+++..+..++.|+++||.|||.+ +.||+++.++.+||+|||.+................+++.|+|||.+.
T Consensus 146 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence 489999999999999999999954 678999999999999999998665433332334456788899999998
Q ss_pred ccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHH
Q 041655 157 TLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRC 231 (238)
Q Consensus 157 ~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~ 231 (238)
+..++.++||||||+++|+|++ |..||..... ......+........+...+..+.+++.+||+.||++| ++++
T Consensus 226 ~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 226 DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8889999999999999999999 8877754322 11222222222333445556678889999999999999 6666
Q ss_pred HHHhh
Q 041655 232 MLSQI 236 (238)
Q Consensus 232 ~L~~~ 236 (238)
.|+++
T Consensus 305 ~l~~~ 309 (314)
T 2ivs_A 305 DLEKM 309 (314)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 66554
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=252.49 Aligned_cols=211 Identities=21% Similarity=0.270 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC--------------------CCcc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR--------------------GRRQ 85 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------------------~~~~ 85 (238)
....+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++..... ....
T Consensus 91 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T 1luf_A 91 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170 (343)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCC
Confidence 34567899999999999999999999999999999999999999999999976321 1257
Q ss_pred cCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc
Q 041655 86 LDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT 157 (238)
Q Consensus 86 ~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~ 157 (238)
+++..++.++.|+++||.|||++ +.||+++.++.+||+|||.++...............+++.|+|||++.+
T Consensus 171 l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 250 (343)
T 1luf_A 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 250 (343)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence 89999999999999999999954 6679999999999999999976544332222344567899999999988
Q ss_pred cCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHH
Q 041655 158 LSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCM 232 (238)
Q Consensus 158 ~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~ 232 (238)
..++.++|+||||+++|+|++ |..||.............. ......+...+..+.+++.+||+.||.+| ++.+.
T Consensus 251 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhC-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 889999999999999999999 8877754322111111111 11222344555678889999999999999 77777
Q ss_pred HHhhh
Q 041655 233 LSQIQ 237 (238)
Q Consensus 233 L~~~~ 237 (238)
|+++.
T Consensus 330 L~~~~ 334 (343)
T 1luf_A 330 LQRMC 334 (343)
T ss_dssp HHHTT
T ss_pred HHHHH
Confidence 77664
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=254.26 Aligned_cols=207 Identities=23% Similarity=0.336 Sum_probs=154.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.|.+|+.++.+++||||+++++++..++..++||||+++|+|.+++.. ....+++..+..++.|+++||.||
T Consensus 87 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L 163 (373)
T 2qol_A 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYL 163 (373)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999999999999999999999999999999975 345689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCccccc-ccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI-TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|.+ +.||+++.++.+||+|||+++......... ......+++.|+|||++.+..++.++||||||+++||+
T Consensus 164 H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~el 243 (373)
T 2qol_A 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243 (373)
T ss_dssp HHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHH
Confidence 954 667999999999999999998764332111 11223456789999999988999999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++ |..||...... .....+........+...+..+.+++..||+.||++| ++++.|+++
T Consensus 244 lt~g~~P~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 244 MSYGERPYWEMSNQ-DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HTTC-CTTTTCCHH-HHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhCCCCCCCCCCHH-HHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 97 88887543221 1122222333333445566778889999999999999 777777665
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=248.17 Aligned_cols=204 Identities=27% Similarity=0.337 Sum_probs=156.8
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCC----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPG----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
...+.+|+.++.+++||||+++++++.... .+++||||+++|+|.+++.. ..+++..+..++.|++.||.|
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~ 136 (322)
T 3soc_A 62 SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAY 136 (322)
T ss_dssp HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHH
Confidence 345567999999999999999999997644 36999999999999999975 358999999999999999999
Q ss_pred hhcc------------------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-----cCCC
Q 041655 105 LHMH------------------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-----LSIT 161 (238)
Q Consensus 105 lH~~------------------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-----~~~~ 161 (238)
||++ +.||+++.++.+||+|||+++...............||+.|+|||++.+ ..++
T Consensus 137 LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 216 (322)
T 3soc_A 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAF 216 (322)
T ss_dssp HTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHH
T ss_pred HHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCC
Confidence 9964 5679999999999999999987654433333344678999999998876 3456
Q ss_pred ccCCeeehhHHHHhhcchHHHHHHhhccCCCcc----------------cccccccCC-----ChHHHHHHHHHHhhhhc
Q 041655 162 YMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKR----------------AIDSKLLGN-----GYEEQMLLVLKTACFCT 220 (238)
Q Consensus 162 ~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~----------------~~~~~~~~~-----~~~~~~~~l~~~~~~cl 220 (238)
.++|||||||++|+|++|..||........... .......+. .....+..+.+++.+||
T Consensus 217 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (322)
T 3soc_A 217 LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296 (322)
T ss_dssp HHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHT
T ss_pred ccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHc
Confidence 688999999999999999888754322111000 001111111 12244566899999999
Q ss_pred CCCCCcc----hHHHHHHhhh
Q 041655 221 LDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 221 ~~~p~~R----~v~~~L~~~~ 237 (238)
+.||++| ++++.|++|+
T Consensus 297 ~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 297 DHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CSSGGGSCCHHHHHHHHHHHH
T ss_pred cCChhhCcCHHHHHHHHHHHH
Confidence 9999999 7777777765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=253.81 Aligned_cols=210 Identities=22% Similarity=0.257 Sum_probs=164.2
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCC-------------------Cccc
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG-------------------RRQL 86 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-------------------~~~~ 86 (238)
...+.+.+|+.++.++ +||||+++++++..++..++||||+++|+|.+++...... ...+
T Consensus 90 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 169 (344)
T 1rjb_A 90 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169 (344)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccC
Confidence 3457889999999999 8999999999999999999999999999999999752211 1347
Q ss_pred CHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc
Q 041655 87 DWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL 158 (238)
Q Consensus 87 ~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~ 158 (238)
++..+..++.|++.||.|||.+ |.||+++.++.+||+|||.+................+++.|+|||++.+.
T Consensus 170 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 249 (344)
T 1rjb_A 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 249 (344)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC
Confidence 9999999999999999999944 67899999999999999999866443332233445678899999999888
Q ss_pred CCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHH
Q 041655 159 SITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCML 233 (238)
Q Consensus 159 ~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L 233 (238)
.++.++||||||+++|+|+| |..||............+........+...+..+.+++..||+.||.+| ++++.|
T Consensus 250 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 250 IYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99999999999999999998 8888754332222223333333334445556778889999999999999 666666
Q ss_pred Hhh
Q 041655 234 SQI 236 (238)
Q Consensus 234 ~~~ 236 (238)
+.+
T Consensus 330 ~~~ 332 (344)
T 1rjb_A 330 GCQ 332 (344)
T ss_dssp HHH
T ss_pred HHH
Confidence 554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=251.47 Aligned_cols=200 Identities=21% Similarity=0.254 Sum_probs=158.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+++.+|+.+++.++||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 55 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~l 130 (328)
T 3fe3_A 55 PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYC 130 (328)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999999999999999999999999999976 35689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCC-ccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSIT-YMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~-~~~DvwslG~~l~~~ 176 (238)
|++ |.||+++.++.+||+|||++........ .....||+.|+|||++.+..++ .++||||+||++|+|
T Consensus 131 H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 207 (328)
T 3fe3_A 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207 (328)
T ss_dssp HHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHH
T ss_pred HHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHH
Confidence 954 6789999999999999999976543322 2456799999999999887764 789999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
++|..||................. ..+...+.++.+++.+||+.||.+| ++.+.|+
T Consensus 208 l~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 208 VSGSLPFDGQNLKELRERVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 999988853221111111111111 1223345567788888999999999 5555543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=257.68 Aligned_cols=201 Identities=24% Similarity=0.279 Sum_probs=160.8
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCC-eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPG-CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
.+.|.+|+.+|++++||||+++++++...+ ..++||||+++|+|.+++... +...+++..+..++.|++.||+|||+
T Consensus 230 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~ 307 (450)
T 1k9a_A 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG 307 (450)
T ss_dssp SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 367899999999999999999999987654 789999999999999999762 33457899999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS- 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t- 178 (238)
+ +.||+++.++.+||+|||+++...... ....+++.|+|||++.+..++.++||||||+++|||++
T Consensus 308 ~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~ 382 (450)
T 1k9a_A 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 382 (450)
T ss_dssp TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 4 678999999999999999987543221 22356789999999999999999999999999999998
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|..||..... ......+..+.....+...+..+.+++..||+.||++| ++.+.|++++
T Consensus 383 g~~P~~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 383 GRVPYPRIPL-KDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp TCCSSTTSCT-TTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 8888764332 22222333333444556677788999999999999999 6777777664
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=248.85 Aligned_cols=210 Identities=21% Similarity=0.259 Sum_probs=164.9
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC--------------CCcccCHHHH
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR--------------GRRQLDWLAR 91 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~ 91 (238)
...+.+.+|+.++.++ +||||+++++++..++..++||||+++|+|.+++..... ....+++..+
T Consensus 68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (313)
T 1t46_A 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147 (313)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence 3467899999999999 899999999999999999999999999999999976221 1225899999
Q ss_pred HHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCcc
Q 041655 92 YRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM 163 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~ 163 (238)
..++.|++.||.|||++ +.||+++.++.+||+|||.+................+++.|+|||++.+..++.+
T Consensus 148 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 227 (313)
T 1t46_A 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227 (313)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH
Confidence 99999999999999954 6689999999999999999987655433333344567889999999988899999
Q ss_pred CCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 164 CDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 164 ~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+||||||+++|+|++ |..||............+........+...+..+.+++.+||+.||.+| ++++.|+++
T Consensus 228 ~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 228 SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 999999999999998 8877754332222222222232233344456678889999999999999 666666554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=249.08 Aligned_cols=205 Identities=18% Similarity=0.183 Sum_probs=161.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++||||+++++++..++ .++++||+++|+|.+++.. ....+++..+..++.|++.||.|||
T Consensus 59 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH 134 (327)
T 3poz_A 59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE 134 (327)
T ss_dssp -CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 44578999999999999999999999998765 6799999999999999976 3456899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|+|++
T Consensus 135 ~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 214 (327)
T 3poz_A 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHh
Confidence 44 6789999999999999999987654433333334566889999999999999999999999999999999
Q ss_pred -hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 179 -LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 179 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|..||..... ......+........+...+..+.+++.+||+.||++| ++++.|+.+
T Consensus 215 ~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 215 FGSKPYDGIPA-SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp TSCCTTTTCCG-GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred cCCCCccCCCH-HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 8888764322 22223333333333445566678889999999999999 666666654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=240.64 Aligned_cols=216 Identities=24% Similarity=0.280 Sum_probs=167.7
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhh
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDV 79 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~ 79 (238)
||||.+..... .....+.+.+|+.++.+++||||+++++++.+. +..+++|||+++|+|.+++..
T Consensus 36 ~avK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 102 (271)
T 3kmu_A 36 IVVKVLKVRDW------------STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE- 102 (271)
T ss_dssp EEEEEECCTTC------------CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHS-
T ss_pred EEEEEeccccc------------CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhh-
Confidence 67777754432 234457799999999999999999999999876 778999999999999999975
Q ss_pred cCCCcccCHHHHHHHHHHHHHHhchhhcc----------CceeeecCCCceEEcccccccccCCcccccccccccCCCcc
Q 041655 80 SRGRRQLDWLARYRTVRGIASGLEYLHMH----------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149 (238)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~l~~gl~~lH~~----------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 149 (238)
.....+++..+..++.|++.||.|||++ +.||+++.++.+++.|||.+..... ....+|+.|
T Consensus 103 -~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y 174 (271)
T 3kmu_A 103 -GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAW 174 (271)
T ss_dssp -CSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGG
T ss_pred -cccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccc
Confidence 2334689999999999999999999965 4679999999999998888654221 235678999
Q ss_pred cCcccccccCCCc---cCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCc
Q 041655 150 IAPEYQQTLSITY---MCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 150 ~apE~~~~~~~~~---~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
+|||.+.+..++. ++||||||+++|+|++|..||.....................+...+..+.+++.+||+.||++
T Consensus 175 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 254 (271)
T 3kmu_A 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAK 254 (271)
T ss_dssp SCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 9999988765544 7999999999999999998886433222222222233333444555667888999999999999
Q ss_pred c----hHHHHHHhhhC
Q 041655 227 R----HVRCMLSQIQQ 238 (238)
Q Consensus 227 R----~v~~~L~~~~~ 238 (238)
| ++++.|+++++
T Consensus 255 Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 255 RPKFDMIVPILEKMQD 270 (271)
T ss_dssp SCCHHHHHHHHHHHCC
T ss_pred CcCHHHHHHHHHHhhc
Confidence 9 77777777653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=242.11 Aligned_cols=203 Identities=20% Similarity=0.252 Sum_probs=160.0
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+++.+|+.++++++||||+++++++.+++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 50 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 126 (269)
T 4hcu_A 50 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC 126 (269)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5688999999999999999999999999999999999999999999965 345689999999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
+.||+++.++.+||+|||.+......... ......+++.|+|||.+.+..++.++|+||+|+++|+|++ |.
T Consensus 127 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~ 205 (269)
T 4hcu_A 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205 (269)
T ss_dssp CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eecCCcchheEEEcCCCCEEeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCC
Confidence 67899999999999999999865433221 1233456788999999998899999999999999999999 78
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
.||......... ..+........+...+..+.+++..||+.||++| ++++.|+++.
T Consensus 206 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 206 IPYENRSNSEVV-EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CTTTTCCHHHHH-HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHH-HHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 777542221111 1112222222333445667888889999999999 6666666653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=240.98 Aligned_cols=203 Identities=16% Similarity=0.221 Sum_probs=159.5
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+++.+|+.++.+++||||+++++++.+++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 124 (268)
T 3sxs_A 48 DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ 124 (268)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 5688999999999999999999999999999999999999999999976 234689999999999999999999944
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
+.||+++.++.++|+|||.+.......... .....+++.|+|||.+.+..++.++|+||+|+++|+|++ |.
T Consensus 125 i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 203 (268)
T 3sxs_A 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK 203 (268)
T ss_dssp EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTC
T ss_pred eecCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCC
Confidence 678999999999999999998654432221 133456778999999988889999999999999999999 88
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
.||........... .........+...+..+.+++..||+.||.+| ++++.|++++
T Consensus 204 ~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 204 MPYDLYTNSEVVLK-VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CTTTTSCHHHHHHH-HHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCccccChHHHHHH-HHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 77753222111111 11111122223334567888888999999999 7777777665
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=253.04 Aligned_cols=211 Identities=22% Similarity=0.247 Sum_probs=166.3
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLAR 91 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~ 91 (238)
.....+++.+|+.+++++ +||||+++++++..++..++||||+++|+|.+++..... ....+++..+
T Consensus 114 ~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 193 (382)
T 3tt0_A 114 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193 (382)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHH
Confidence 345567899999999999 899999999999999999999999999999999986321 1245899999
Q ss_pred HHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCcc
Q 041655 92 YRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM 163 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~ 163 (238)
..++.|++.||.|||++ +.||+++.++.+||+|||+++...............+++.|+|||++.+..++.+
T Consensus 194 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 273 (382)
T 3tt0_A 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 273 (382)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch
Confidence 99999999999999944 6789999999999999999987654333223344567789999999999899999
Q ss_pred CCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 164 CDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 164 ~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+||||||+++|+|++ |..||...... .....+........+...+..+.+++..||+.||++| ++++.|+++
T Consensus 274 ~DiwslG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 274 SDVWSFGVLLWEIFTLGGSPYPGVPVE-ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999 77776432211 1122222222333344556678889999999999999 666666655
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=261.08 Aligned_cols=204 Identities=19% Similarity=0.271 Sum_probs=164.1
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.|.+|+.+|++++||||+++++++...+..++||||+++|+|.+++.. .....+++..+..++.|++.||+|||.+
T Consensus 260 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 337 (495)
T 1opk_A 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK 337 (495)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999999999999999999999999999999999999999999975 3345689999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |
T Consensus 338 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g 416 (495)
T 1opk_A 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 416 (495)
T ss_dssp TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CcccCCCChhhEEECCCCcEEEeecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCC
Confidence 66899999999999999999876433221 1123456788999999998889999999999999999999 7
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
..||.... .......+........+...+..+.+++.+||+.||++| ++++.|+++
T Consensus 417 ~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 417 MSPYPGID-LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCSSTTCC-GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCC-HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 77775422 122223333343444455667778899999999999999 666666654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=251.09 Aligned_cols=217 Identities=19% Similarity=0.236 Sum_probs=166.5
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+.+...... ......+.+.+|+.+|.+++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 40 ~avK~i~~~~~~~~--------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~--- 108 (361)
T 2yab_A 40 YAAKFIKKRQSRAS--------RRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ--- 108 (361)
T ss_dssp EEEEEEEBCSSTTC--------SSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT---
T ss_pred EEEEEEEccccccc--------cchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh---
Confidence 67887765543210 0011246788999999999999999999999999999999999999999999965
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCC----ceEEcccccccccCCcccccccccccCCCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDM----EARISEFGLAKVFPEAHTHITTSDVVGTAGY 149 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 149 (238)
...+++..+..++.|++.||.|||++ |.||+++.++ .+||+|||++........ .....||+.|
T Consensus 109 -~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y 184 (361)
T 2yab_A 109 -KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEF 184 (361)
T ss_dssp -CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGG
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccE
Confidence 45799999999999999999999954 6789998877 799999999987644322 2346799999
Q ss_pred cCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccccccc--CCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLL--GNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 150 ~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|||++.+..++.++|+||+|+++|+|++|..||...........+...... ...+...+..+.+++.+||..||++|
T Consensus 185 ~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 264 (361)
T 2yab_A 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKR 264 (361)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred ECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHC
Confidence 9999999889999999999999999999999988543222112222221111 11123345567888899999999999
Q ss_pred -hHHHHH
Q 041655 228 -HVRCML 233 (238)
Q Consensus 228 -~v~~~L 233 (238)
.+.+.|
T Consensus 265 ~t~~e~l 271 (361)
T 2yab_A 265 LTIQEAL 271 (361)
T ss_dssp CCHHHHH
T ss_pred cCHHHHh
Confidence 555544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=254.35 Aligned_cols=210 Identities=20% Similarity=0.209 Sum_probs=162.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC---CCcccCHHHHHHHHHHHHHHh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR---GRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~gl 102 (238)
......+.+|+.++.+++||||+++++++...+..++||||+++|+|.+++..... ....+++..+..++.|++.||
T Consensus 115 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL 194 (367)
T 3l9p_A 115 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194 (367)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHH
Confidence 34456789999999999999999999999999999999999999999999976432 224589999999999999999
Q ss_pred chhhcc--------CceeeecCCC---ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhH
Q 041655 103 EYLHMH--------QALVLLDHDM---EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~ 171 (238)
.|||++ +.||+++.++ .+||+|||+++...............+|+.|+|||++.+..++.++|||||||
T Consensus 195 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~ 274 (367)
T 3l9p_A 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 274 (367)
T ss_dssp HHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHH
Confidence 999954 6789999655 49999999997553322222234456789999999999889999999999999
Q ss_pred HHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 172 LLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 172 ~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++|+|++ |..||....... ....+........+...+..+.+++.+||+.||++| ++++.|+.+
T Consensus 275 il~ellt~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 275 LLWEIFSLGYMPYPSKSNQE-VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999998 777775422211 112222222233344556678889999999999999 566665544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=249.67 Aligned_cols=200 Identities=18% Similarity=0.238 Sum_probs=157.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++||||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||
T Consensus 70 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH 145 (362)
T 2bdw_A 70 RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCH 145 (362)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567789999999999999999999999999999999999999999999865 456899999999999999999999
Q ss_pred cc--------CceeeecCCC---ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 107 MH--------QALVLLDHDM---EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 107 ~~--------~~~il~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
.+ |.||+++.++ .+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 146 ~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 222 (362)
T 2bdw_A 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 222 (362)
T ss_dssp HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 54 6779998654 599999999986643322 234679999999999998899999999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|++|..||...........+..... ........+..+.+++.+||+.||++| ++.+.|
T Consensus 223 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 223 LLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred HHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 9999988753221111111111111 112223445678889999999999999 554444
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=252.45 Aligned_cols=211 Identities=21% Similarity=0.269 Sum_probs=164.4
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC----------CCcccCHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR----------GRRQLDWLARYRT 94 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~ 94 (238)
....+.+.+|+.++.++ +||||+++++++..++..++||||+++|+|.+++..... ....+++..+..+
T Consensus 90 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (333)
T 2i1m_A 90 ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169 (333)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHH
Confidence 34567899999999999 899999999999999999999999999999999875321 1345799999999
Q ss_pred HHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCe
Q 041655 95 VRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDI 166 (238)
Q Consensus 95 ~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dv 166 (238)
+.|++.||.|||++ |.||+++.++.+||+|||++................+++.|+|||++.+..++.++||
T Consensus 170 ~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 249 (333)
T 2i1m_A 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249 (333)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHH
Confidence 99999999999954 6689999999999999999986544333222344567889999999988889999999
Q ss_pred eehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 167 YSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 167 wslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
||||+++|+|++ |..||.....................+...+..+.+++..||+.||.+| ++++.|+++
T Consensus 250 ~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 999999999998 7777754322222222222222223334445678889999999999999 666666654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=240.52 Aligned_cols=207 Identities=31% Similarity=0.475 Sum_probs=165.8
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++... .....+++..+..++.|++.||.|||.
T Consensus 73 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~ 151 (307)
T 2nru_A 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE 151 (307)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 4577899999999999999999999999999999999999999999998752 223568999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.+||+|||.+................|++.|+|||.+.+ .++.++|+||||+++|+|++|
T Consensus 152 ~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC
T ss_pred CCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC
Confidence 4 6779999999999999999986654333223344678999999998865 478899999999999999999
Q ss_pred HHHHHHhhccCCCccc--------------ccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 180 VKWMRNVMTSENPKRA--------------IDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
..||............ ++. .....+...+..+.+++..||+.||.+| ++++.|+++.
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 231 LPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDK-KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp CCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCS-SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred CCCcccCcchHHHHHHHHHhhhhhhhhhhhccc-cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 8887643322211111 111 1223456677889999999999999999 7777777765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=240.95 Aligned_cols=209 Identities=20% Similarity=0.194 Sum_probs=163.7
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCee-EEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH-LLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
.....+.+.+|+.++++++||||+++++++.+.+.. ++++||+.+++|.+++.. ....+++..+..++.|++.||.
T Consensus 62 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~ 138 (298)
T 3pls_A 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGME 138 (298)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHH
Confidence 345568899999999999999999999999766554 899999999999999975 3466899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCccc--ccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHT--HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|||.+ +.||+++.++.+||+|||.++....... ........+++.|+|||.+.+..++.++|+||||+++
T Consensus 139 ~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 218 (298)
T 3pls_A 139 YLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLL 218 (298)
T ss_dssp HHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred HHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHH
Confidence 99944 6789999999999999999976543221 1122345678899999999998999999999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|+|++|..|+............+........+...+..+.+++..||+.||.+| ++++.|+++
T Consensus 219 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 219 WELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp HHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999997665544333333333333333333344556678889999999999999 666666655
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=244.30 Aligned_cols=209 Identities=22% Similarity=0.241 Sum_probs=152.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCee------EEEEEeCCCCCHHHHHhhhcC--CCcccCHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH------LLVYEFMKNGSLQDILNDVSR--GRRQLDWLARYRTVRGI 98 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l 98 (238)
...+.+.+|+.++++++||||+++++++...+.. +++|||+++|+|.+++..... ....+++..+..++.|+
T Consensus 67 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi 146 (323)
T 3qup_A 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146 (323)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHH
Confidence 3467899999999999999999999999877654 899999999999999865322 22368999999999999
Q ss_pred HHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 99 ASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 99 ~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
+.||.|||++ +.||+++.++.+||+|||.++...............+++.|+|||.+.+..++.++||||||
T Consensus 147 ~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 226 (323)
T 3qup_A 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFG 226 (323)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHH
Confidence 9999999944 67899999999999999999866443322222345567889999999998999999999999
Q ss_pred HHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 171 VLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 171 ~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+++|+|++ |..||......... ..+........+...+..+.+++.+||+.||++| ++.+.|+++
T Consensus 227 ~il~ell~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 227 VTMWEIMTRGQTPYAGIENAEIY-NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCccccChHHHH-HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999 78877643322222 1122222233344556678889999999999999 666666654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=254.03 Aligned_cols=203 Identities=16% Similarity=0.197 Sum_probs=160.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||.||
T Consensus 51 ~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~l 126 (444)
T 3soa_A 51 ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHC 126 (444)
T ss_dssp HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999999999999999999999999999976 45699999999999999999999
Q ss_pred hcc--------Cceeeec---CCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 106 HMH--------QALVLLD---HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H~~--------~~~il~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
|++ |.||+++ .++.+||+|||++........ ......||+.|+|||++.+..++.++||||+||++|
T Consensus 127 H~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvily 204 (444)
T 3soa_A 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILY 204 (444)
T ss_dssp HHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred HHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHH
Confidence 944 7789998 467899999999976644322 123467999999999999989999999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|++|..||................. ........+..+.+++.+||+.||++| ++.+.|+
T Consensus 205 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 205 ILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999988743222111111221111 111223445667888899999999999 5555554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=244.71 Aligned_cols=209 Identities=20% Similarity=0.300 Sum_probs=156.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+.+.+|+.++.+++||||+++++++.. ....++||||+++++|.+++.. ....+++..+..++.|++.||.
T Consensus 52 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~ 128 (295)
T 3ugc_A 52 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGME 128 (295)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999854 3568999999999999999976 2345899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
|||++ +.||+++.++.+||+|||.+......... .......++..|+|||.+.+..++.++||||||+++|
T Consensus 129 ~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 208 (295)
T 3ugc_A 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208 (295)
T ss_dssp HHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHH
Confidence 99954 67899999999999999999876443221 1223345677899999999989999999999999999
Q ss_pred hhcchHHHHHHhh-------ccCCC--------cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 175 EEMSLVKWMRNVM-------TSENP--------KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 175 ~~~t~~~~~~~~~-------~~~~~--------~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
+|++|..|+.... ..... ...+........+...+..+.+++..||+.||++| ++++.|++
T Consensus 209 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 9999755442211 11100 01111222223344556778889999999999999 77777776
Q ss_pred hh
Q 041655 236 IQ 237 (238)
Q Consensus 236 ~~ 237 (238)
++
T Consensus 289 l~ 290 (295)
T 3ugc_A 289 IR 290 (295)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=249.58 Aligned_cols=206 Identities=21% Similarity=0.235 Sum_probs=150.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeee-cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLA-RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...++|.+|+.++++++||||+++++++. .++..++||||+++|+|.+++.. ....+++..+..++.|+++||.||
T Consensus 132 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L 208 (373)
T 3c1x_A 132 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL 208 (373)
T ss_dssp HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999875 45678999999999999999975 345688999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
|++ +.||+++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|+
T Consensus 209 H~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~e 288 (373)
T 3c1x_A 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 288 (373)
T ss_dssp HHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHH
Confidence 954 66899999999999999999865332211 11233456788999999999899999999999999999
Q ss_pred hcch-HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 176 EMSL-VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 176 ~~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|++| ..||.. .........+........+...+..+.+++.+||+.||++| ++++.|+++
T Consensus 289 llt~~~~p~~~-~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 289 LMTRGAPPYPD-VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp HHTTSCCSCTT-SCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCcCCCCCC-CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9995 555543 22222222222222223344556678889999999999999 666666654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=258.61 Aligned_cols=203 Identities=22% Similarity=0.279 Sum_probs=160.0
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.|.+|+.+|++++||||+++++++. .+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++
T Consensus 227 ~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~ 303 (454)
T 1qcf_A 227 VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR 303 (454)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 467899999999999999999999986 55789999999999999999741 223578899999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |
T Consensus 304 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g 382 (454)
T 1qcf_A 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 382 (454)
T ss_dssp TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCC
Confidence 66899999999999999999876432211 1123456788999999998899999999999999999999 8
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
..||....... ....+........+...+..+.+++.+||+.||++| ++.+.|+++
T Consensus 383 ~~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 383 RIPYPGMSNPE-VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp CCSSTTCCHHH-HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 88775432211 112222233333455667778899999999999999 666777665
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=249.48 Aligned_cols=202 Identities=21% Similarity=0.260 Sum_probs=158.1
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++
T Consensus 49 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~ 124 (323)
T 3tki_A 49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI 124 (323)
T ss_dssp --CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46688999999999999999999999999999999999999999999864 45699999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCC-CccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~-~~~~DvwslG~~l~~~~t~ 179 (238)
+.||+++.++.+||+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++|
T Consensus 125 givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 6789999999999999999986543333223345689999999999887765 7789999999999999999
Q ss_pred HHHHHHhhccCCC-cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 180 VKWMRNVMTSENP-KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 180 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
..||......... ................+..+.+++.+||+.||++| ++.+.|+
T Consensus 205 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 205 ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp SCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 9888542221111 11111111222234456667889999999999999 5555543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=242.74 Aligned_cols=212 Identities=20% Similarity=0.259 Sum_probs=164.3
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+...... ..+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..
T Consensus 73 vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 135 (321)
T 2c30_A 73 VAVKMMDLRKQQ--------------RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--- 135 (321)
T ss_dssp EEEEEEETTTCC--------------SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---
T ss_pred EEEEEEeccchh--------------HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---
Confidence 677777544322 246688999999999999999999999999999999999999999999864
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
..+++..+..++.|++.||.|||.+ +.||+++.++.+||+|||++......... .....||+.|+|||
T Consensus 136 --~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE 211 (321)
T 2c30_A 136 --VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPE 211 (321)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHH
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHh
Confidence 4689999999999999999999954 67899999999999999998766443221 23467899999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
++.+..++.++||||||+++|+|++|..||................. ........+..+.+++.+||+.||++| ++.+
T Consensus 212 ~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99988899999999999999999999988753221111111111111 111223445567888889999999999 5554
Q ss_pred HHH
Q 041655 232 MLS 234 (238)
Q Consensus 232 ~L~ 234 (238)
.|+
T Consensus 292 ll~ 294 (321)
T 2c30_A 292 LLD 294 (321)
T ss_dssp HHT
T ss_pred Hhc
Confidence 443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=241.41 Aligned_cols=208 Identities=19% Similarity=0.292 Sum_probs=149.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++++++||||+++++++ ..+..++||||+++++|.+++.. ....+++..+..++.|++.||.||
T Consensus 61 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~l 136 (289)
T 3og7_A 61 PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYL 136 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999965 45568999999999999999964 346689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhHHHH
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l~ 174 (238)
|++ +.||+++.++.++|+|||.+................|++.|+|||++. +..++.++||||||+++|
T Consensus 137 H~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 216 (289)
T 3og7_A 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216 (289)
T ss_dssp HHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHH
T ss_pred HhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHH
Confidence 954 678999999999999999997654322222234467899999999886 566788999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccc----cCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKL----LGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
+|++|..||............+.... ........+..+.+++..||+.||.+| ++++.|+++.
T Consensus 217 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 217 ELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 99999988854322211111111111 112233556678889999999999999 7777777664
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=262.22 Aligned_cols=204 Identities=20% Similarity=0.207 Sum_probs=158.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.|.+|+.+|++++||||+++++++.. +..++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+
T Consensus 379 ~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~ 454 (613)
T 2ozo_A 379 DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE 454 (613)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35789999999999999999999999976 468999999999999999964 34568999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++
T Consensus 455 ~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 534 (613)
T 2ozo_A 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534 (613)
T ss_dssp TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 4 66799999999999999999876433221 11122345688999999998899999999999999999998
Q ss_pred -hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 179 -LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 179 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|..||...... .....+........+...+..+.+++..||+.||++| ++++.|+++
T Consensus 535 ~G~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 535 YGQKPYKKMKGP-EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp TSCCTTTTCCSH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH-HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 88888643322 1222233333344555677788999999999999999 666666654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=240.77 Aligned_cols=200 Identities=23% Similarity=0.282 Sum_probs=150.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.. ..+++..+..++.|++.||.|||.
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~ 123 (271)
T 3dtc_A 49 TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHD 123 (271)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 356788999999999999999999999999999999999999999999853 568999999999999999999996
Q ss_pred c-----------CceeeecC--------CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeee
Q 041655 108 H-----------QALVLLDH--------DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYS 168 (238)
Q Consensus 108 ~-----------~~~il~~~--------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvws 168 (238)
+ +.||+++. ++.+||+|||.+........ ....|++.|+|||.+.+..++.++|+||
T Consensus 124 ~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~s 199 (271)
T 3dtc_A 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWS 199 (271)
T ss_dssp SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHH
T ss_pred CCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHH
Confidence 5 45799986 77899999999976543322 2357899999999999888999999999
Q ss_pred hhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHhh
Q 041655 169 FGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 169 lG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~~ 236 (238)
||+++|+|++|..||.....................+...+..+.+++.+||+.||.+| ++.+.++.+
T Consensus 200 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 200 YGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp HHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 99999999999988864332222222222222333445556678889999999999999 444444443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=239.02 Aligned_cols=209 Identities=21% Similarity=0.206 Sum_probs=159.1
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeee-ecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHL-ARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
.....+.+.+|+.++++++||||+++++++ ..++..+++|||+++|+|.+++.. ....+++..+..++.|++.||.
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~ 142 (298)
T 3f66_A 66 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 142 (298)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHH
Confidence 345567899999999999999999999986 455678999999999999999975 3456899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCccc--ccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHT--HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|||++ +.||+++.++.+||+|||.+........ ........+++.|+|||.+.+..++.++|+||+|+++
T Consensus 143 ~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 222 (298)
T 3f66_A 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222 (298)
T ss_dssp HHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHH
Confidence 99954 6789999999999999999986643321 1122335677899999999988999999999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|+|++|..|+.....................+...+..+.+++.+||+.||++| ++++.|+++
T Consensus 223 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 223 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp HHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999996544333232222222222222222334445668888999999999999 666666654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=239.00 Aligned_cols=202 Identities=18% Similarity=0.227 Sum_probs=158.7
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+++.+|+.++.+++||||+++++++.+.+..++||||+++++|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 64 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 140 (283)
T 3gen_A 64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ 140 (283)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 5688999999999999999999999999999999999999999999975 235689999999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
+.||+++.++.+||+|||.+......... ......+++.|+|||++.+..++.++|+||+|+++|+|++ |.
T Consensus 141 i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~ 219 (283)
T 3gen_A 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 219 (283)
T ss_dssp CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTC
T ss_pred ccCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 66899999999999999999865433211 1123456788999999998889999999999999999998 88
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
.||......... ..+........+...+..+.+++..||+.||.+| ++++.|+++
T Consensus 220 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 220 MPYERFTNSETA-EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CTTTTSCHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccccChhHHH-HHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 877543222111 1122222222333345567888889999999999 555555554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=242.76 Aligned_cols=205 Identities=18% Similarity=0.177 Sum_probs=155.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++.+++||||+++++++..++ .+++++|+++|+|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 60 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~ 135 (327)
T 3lzb_A 60 ANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED 135 (327)
T ss_dssp CHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3567889999999999999999999998765 7899999999999999976 34568999999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS- 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t- 178 (238)
+ |.||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 136 ~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 215 (327)
T 3lzb_A 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215 (327)
T ss_dssp TTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHC
Confidence 4 6789999999999999999987654333323334556788999999999999999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|..||..... ......+........+...+..+.+++.+||+.||.+| ++++.|+++.
T Consensus 216 g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 216 GSKPYDGIPA-SEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp SCCTTTTCCG-GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCH-HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 8888864322 22222333333333444556678889999999999999 6666666553
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=244.73 Aligned_cols=201 Identities=19% Similarity=0.272 Sum_probs=159.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++..++||||+++++++.+.+..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 44 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~ 120 (321)
T 1tki_A 44 DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS 120 (321)
T ss_dssp HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 346688999999999999999999999999999999999999999999964 34568999999999999999999995
Q ss_pred c--------CceeeecC--CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 108 H--------QALVLLDH--DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 ~--------~~~il~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
+ |.||+++. ++.+||+|||.+........ .....|++.|+|||++.+..++.++|+||+|+++|+|+
T Consensus 121 ~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 197 (321)
T 1tki_A 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 4 67899987 78999999999987644322 23357899999999998888899999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCC--ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGN--GYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||.................... ...+.+..+.+++.+||+.||.+| ++.+.|+
T Consensus 198 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 198 SGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99998854322221222222221111 122345678889999999999999 5555543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=238.97 Aligned_cols=206 Identities=20% Similarity=0.230 Sum_probs=151.0
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++.. ....+++..+..++.|++.||.|
T Consensus 56 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~ 131 (281)
T 1mp8_A 56 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAY 131 (281)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHH
Confidence 4456678999999999999999999999985 4567899999999999999975 24568999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||.+ +.||+++.++.+||+|||.++........ ......+++.|+|||++.+..++.++|+||||+++|+|
T Consensus 132 lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 210 (281)
T 1mp8_A 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 210 (281)
T ss_dssp HHHTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred HHhCCeecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHH
Confidence 9954 67899999999999999999866443221 12334567889999999888899999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++ |..||......... ..+........+...+..+.+++.+||+.||++| ++.+.|+++
T Consensus 211 l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 211 LMHGVKPFQGVKNNDVI-GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCCcCCHHHHH-HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 96 78887643222111 1121222223344556678889999999999999 666666655
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=245.54 Aligned_cols=218 Identities=20% Similarity=0.251 Sum_probs=165.6
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+........ ......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++..
T Consensus 39 ~avK~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 107 (326)
T 2y0a_A 39 YAAKFIKKRRTKSS--------RRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--- 107 (326)
T ss_dssp EEEEEEEBCCSTTC--------SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT---
T ss_pred EEEEEEEccccccc--------cchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh---
Confidence 67777765543210 0001246788999999999999999999999999999999999999999999965
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCC----ceEEcccccccccCCcccccccccccCCCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDM----EARISEFGLAKVFPEAHTHITTSDVVGTAGY 149 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 149 (238)
...+++..+..++.|++.||.|||++ |.||+++.++ .+||+|||+++....... .....||+.|
T Consensus 108 -~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y 183 (326)
T 2y0a_A 108 -KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 183 (326)
T ss_dssp -SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTT
T ss_pred -cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCc
Confidence 46789999999999999999999954 6789999887 799999999987643322 2345789999
Q ss_pred cCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 150 ~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|||++.+..++.++||||||+++|+|++|..||................. ....+...+..+.+++.+||+.||++|
T Consensus 184 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 263 (326)
T 2y0a_A 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263 (326)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhC
Confidence 999999988999999999999999999999888743221111111111111 111123345567888999999999999
Q ss_pred -hHHHHHH
Q 041655 228 -HVRCMLS 234 (238)
Q Consensus 228 -~v~~~L~ 234 (238)
++.+.|+
T Consensus 264 pt~~e~l~ 271 (326)
T 2y0a_A 264 MTIQDSLQ 271 (326)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 5555543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=247.96 Aligned_cols=200 Identities=19% Similarity=0.262 Sum_probs=158.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++.+++||||+++++++.+.+..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 129 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~ 205 (373)
T 2x4f_A 129 DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ 205 (373)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999999999999998865 34568999999999999999999995
Q ss_pred c--------Cceeee--cCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 108 H--------QALVLL--DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 ~--------~~~il~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
+ +.||++ +.++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 206 ~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 282 (373)
T 2x4f_A 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282 (373)
T ss_dssp TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH
T ss_pred CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH
Confidence 4 667988 5678999999999987644322 23357899999999998888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..||...........+..... ........+..+.+++.+||+.||.+| .+.+.|
T Consensus 283 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l 341 (373)
T 2x4f_A 283 SGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEAL 341 (373)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99988854322211222222111 111223445678889999999999999 554444
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=238.66 Aligned_cols=203 Identities=16% Similarity=0.214 Sum_probs=153.8
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCC-------------------------------------------------
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPG------------------------------------------------- 58 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------------------------------------------------- 58 (238)
..+.+.+|+.++++++||||+++++++.+.+
T Consensus 47 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (332)
T 3qd2_B 47 AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126 (332)
T ss_dssp HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------------------------------
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccccc
Confidence 4577899999999999999999999985543
Q ss_pred --------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEE
Q 041655 59 --------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARI 122 (238)
Q Consensus 59 --------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl 122 (238)
..+++|||+++++|.+++... ......++..+..++.|++.||.|||++ +.||+++.++.+||
T Consensus 127 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL 205 (332)
T 3qd2_B 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 205 (332)
T ss_dssp -----CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred ccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEE
Confidence 378999999999999999762 2234456777899999999999999954 67899999999999
Q ss_pred cccccccccCCcccc----------cccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCC
Q 041655 123 SEFGLAKVFPEAHTH----------ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENP 192 (238)
Q Consensus 123 ~dfg~~~~~~~~~~~----------~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~ 192 (238)
+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..|+......
T Consensus 206 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~--- 282 (332)
T 3qd2_B 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI--- 282 (332)
T ss_dssp CCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH---
T ss_pred eecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH---
Confidence 999999876543211 1123457999999999999989999999999999999999986665432211
Q ss_pred cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 193 KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.........+.........+.+++.+||+.||++| ++.+.|+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 283 ITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 01111111122234455667889999999999999 6555554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=245.17 Aligned_cols=210 Identities=24% Similarity=0.278 Sum_probs=161.0
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCC-eeEEEEEeCCCCCHHHHHhhhcCC------------CcccCHHHHH
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPG-CHLLVYEFMKNGSLQDILNDVSRG------------RRQLDWLARY 92 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~ 92 (238)
...+.+.+|+.++.++ +||||+++++++...+ ..+++|||+++++|.+++...... ...+++..+.
T Consensus 72 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (316)
T 2xir_A 72 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151 (316)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHH
T ss_pred HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHH
Confidence 4557889999999999 6999999999987654 589999999999999999762211 1228999999
Q ss_pred HHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccC
Q 041655 93 RTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMC 164 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~ 164 (238)
.++.|++.||.|||++ +.||+++.++.+||+|||.++...............+++.|+|||++.+..++.++
T Consensus 152 ~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 231 (316)
T 2xir_A 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 231 (316)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchh
Confidence 9999999999999955 66799999999999999999866443333333445678899999999988999999
Q ss_pred CeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 165 DIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 165 DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|+||||+++|+|++ |..||............+........+...+..+.+++..||+.||.+| ++++.|+++
T Consensus 232 Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 232 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999999998 8877754222111112222222222333445668888899999999999 666666655
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=246.40 Aligned_cols=158 Identities=21% Similarity=0.243 Sum_probs=133.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+..+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.. .....+++..+..++.|++.||.||
T Consensus 67 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l~~L 144 (389)
T 3gni_B 67 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLKALDYI 144 (389)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhh--hcccCCCHHHHHHHHHHHHHHHHHH
Confidence 34567788999999999999999999999999999999999999999999976 2235689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcc-----cccccccccCCCcccCcccccc--cCCCccCCeeehh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAH-----THITTSDVVGTAGYIAPEYQQT--LSITYMCDIYSFG 170 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~~~apE~~~~--~~~~~~~DvwslG 170 (238)
|++ +.||+++.++.+||+|||.+....... .........||+.|+|||++.+ ..++.++||||||
T Consensus 145 H~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 224 (389)
T 3gni_B 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 224 (389)
T ss_dssp HHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHH
T ss_pred HhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHH
Confidence 944 678999999999999999876442111 1111233578899999999887 5789999999999
Q ss_pred HHHHhhcchHHHHHH
Q 041655 171 VLLAEEMSLVKWMRN 185 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~ 185 (238)
|++|+|++|..||..
T Consensus 225 ~il~el~~g~~pf~~ 239 (389)
T 3gni_B 225 ITACELANGHVPFKD 239 (389)
T ss_dssp HHHHHHHHSSCTTTT
T ss_pred HHHHHHHHCCCCCCC
Confidence 999999999998854
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=244.82 Aligned_cols=195 Identities=20% Similarity=0.279 Sum_probs=156.2
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh--
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH-- 106 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH-- 106 (238)
...+.+|+.+++.++||||+++++++.+.+..++||||+ +|+|.+++.. ...+++..+..++.|++.||.|||
T Consensus 53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~ 127 (336)
T 3h4j_B 53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH 127 (336)
T ss_dssp SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 356889999999999999999999999999999999999 6799999876 356899999999999999999999
Q ss_pred ------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCC-CccCCeeehhHHHHhhcch
Q 041655 107 ------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 107 ------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~-~~~~DvwslG~~l~~~~t~ 179 (238)
.++.||+++.++.+||+|||++........ .....||+.|+|||++.+..+ +.++||||+|+++|+|++|
T Consensus 128 givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (336)
T 3h4j_B 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204 (336)
T ss_dssp TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHS
T ss_pred CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhC
Confidence 447789999999999999999986544322 244679999999999988776 6899999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
..||................ ...+...+..+.+++.+||+.||.+| ++.+.|
T Consensus 205 ~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil 257 (336)
T 3h4j_B 205 RLPFDDEFIPNLFKKVNSCV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIR 257 (336)
T ss_dssp SCSSBCSSSTTCBCCCCSSC--CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHT
T ss_pred CCCCCCccHHHHHHHHHcCC--CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 99886433222222221111 12233445567888999999999999 554444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=245.85 Aligned_cols=192 Identities=23% Similarity=0.189 Sum_probs=155.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.+++.++||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 48 ~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~ 123 (337)
T 1o6l_A 48 EVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS 123 (337)
T ss_dssp CHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999875 3568999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.+|.+||+|||+++....... ......||+.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 124 ~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 201 (337)
T 1o6l_A 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201 (337)
T ss_dssp TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcC
Confidence 4 6789999999999999999875322211 22456899999999999998999999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||...........+..... ..+...+..+.+++.+||+.||++|
T Consensus 202 ~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R 247 (337)
T 1o6l_A 202 RLPFYNQDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp SCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 988753221111111221111 2233445567888888999999999
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=239.41 Aligned_cols=210 Identities=21% Similarity=0.239 Sum_probs=154.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCC-----eeEEEEEeCCCCCHHHHHhhhc--CCCcccCHHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPG-----CHLLVYEFMKNGSLQDILNDVS--RGRRQLDWLARYRTVRGI 98 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~~l 98 (238)
....+.+.+|+.++.+++||||+++++++...+ ..+++|||+++++|.+++.... .....+++..++.++.|+
T Consensus 77 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi 156 (313)
T 3brb_A 77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156 (313)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHH
Confidence 345678899999999999999999999997654 3589999999999999985421 234679999999999999
Q ss_pred HHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 99 ASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 99 ~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
+.||.|||++ +.||+++.++.+||+|||.+................+++.|+|||.+.+..++.++|+||||
T Consensus 157 ~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 236 (313)
T 3brb_A 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 236 (313)
T ss_dssp HHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHH
T ss_pred HHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHH
Confidence 9999999955 66799999999999999999865443322222345678899999999988999999999999
Q ss_pred HHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 171 VLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 171 ~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+++|+|++ |..||....... .............+...+..+.+++.+||+.||.+| ++++.|+++
T Consensus 237 ~il~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 237 VTMWEIATRGMTPYPGVQNHE-MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp HHHHHHHTTSCCSSTTCCGGG-HHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCccCCHHH-HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999999 777765432221 111122222233444556678889999999999999 666666654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=248.83 Aligned_cols=193 Identities=24% Similarity=0.277 Sum_probs=153.5
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
+..+.+.+|..++.++ +||||+++++++.+.+..|+||||+++|+|..++.. ...+++..++.++.|++.||+||
T Consensus 94 ~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~L 169 (396)
T 4dc2_A 94 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYL 169 (396)
T ss_dssp --CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 3445678899998887 799999999999999999999999999999999876 35689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|++ |.||+++.++++||+|||+++...... .......||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 170 H~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell 247 (396)
T 4dc2_A 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 247 (396)
T ss_dssp HHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred HHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 954 678999999999999999997532221 1234578999999999999999999999999999999999
Q ss_pred chHHHHHHhhccCCC---------cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENP---------KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||......... ..+... ....+...+.++.+++.+||+.||.+|
T Consensus 248 ~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R 304 (396)
T 4dc2_A 248 AGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKER 304 (396)
T ss_dssp HSSCSSTTTTC------CCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTS
T ss_pred hCCCCCcccccccccchhhHHHHHHHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHc
Confidence 999998532211111 011111 122334455667888889999999999
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=246.55 Aligned_cols=202 Identities=19% Similarity=0.232 Sum_probs=156.9
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-- 107 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~-- 107 (238)
..+.+|+.++.+++||||+++++++.+ +..++|+||+++|+|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 60 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 135 (325)
T 3kex_A 60 QAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG 135 (325)
T ss_dssp CSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 456789999999999999999998864 568899999999999999875 24578899999999999999999994
Q ss_pred ------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 108 ------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 108 ------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
|+.||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 136 ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~ 215 (325)
T 3kex_A 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 215 (325)
T ss_dssp CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCC
Confidence 47789999999999999999987755443333345677889999999998899999999999999999999 88
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
.||..... ......+........+...+..+.+++.+||+.||.+| ++++.|+++
T Consensus 216 ~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 216 EPYAGLRL-AEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp CTTTTSCT-THHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred CCccccCH-HHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 88864321 11222222222223333445567788889999999999 666666655
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=242.03 Aligned_cols=207 Identities=22% Similarity=0.348 Sum_probs=156.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.++.+++||||+++++++...+..++||||+++++|.+++.. ....+++..+..++.|++.||.||
T Consensus 87 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~L 163 (333)
T 1mqb_A 87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYL 163 (333)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34566789999999999999999999999999999999999999999999975 345689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|.+ +.||+++.++.+||+|||.++........ .......+++.|+|||++.+..++.++||||||+++|+|
T Consensus 164 H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 243 (333)
T 1mqb_A 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243 (333)
T ss_dssp HHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred HhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHH
Confidence 954 66799999999999999999866433211 111223457889999999888899999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++ |..||....... ....+........+...+..+.+++.+||+.||.+| ++++.|+++
T Consensus 244 lt~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 244 MTYGERPYWELSNHE-VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp HTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCCCCcccCCHHH-HHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 98 888875322211 111122222222334556678889999999999999 666666654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=246.45 Aligned_cols=217 Identities=16% Similarity=0.236 Sum_probs=154.8
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCe----eEEEEEeCCCCCHHHHHh
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGC----HLLVYEFMKNGSLQDILN 77 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~~v~e~~~~~~L~~~l~ 77 (238)
||||.+..... ........+.+|+.++.+++||||+++++++...+. .|+||||+++++|.+++.
T Consensus 40 vavK~~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 108 (311)
T 3ork_A 40 VAVKVLRADLA-----------RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH 108 (311)
T ss_dssp EEEEEECTTTT-----------TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHH
T ss_pred EEEEEeCcccc-----------CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHH
Confidence 67777654322 233456788999999999999999999999875543 489999999999999997
Q ss_pred hhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCc
Q 041655 78 DVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAG 148 (238)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~ 148 (238)
. ...+++..+..++.|++.||.|||.+ +.||+++.++.+||+|||.+......... .......|++.
T Consensus 109 ~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~ 184 (311)
T 3ork_A 109 T----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184 (311)
T ss_dssp H----HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCT
T ss_pred h----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcc
Confidence 6 35689999999999999999999954 67899999999999999999865433221 12234578999
Q ss_pred ccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccC--CChHHHHHHHHHHhhhhcCCCCCc
Q 041655 149 YIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLG--NGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 149 ~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
|+|||++.+..++.++||||||+++|+|++|..||................... ......+.++.+++.+||+.||++
T Consensus 185 y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 264 (311)
T 3ork_A 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 264 (311)
T ss_dssp TCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGG
T ss_pred cCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhh
Confidence 999999999899999999999999999999988874322111111111111111 011224556788899999999999
Q ss_pred c-hHHHHH
Q 041655 227 R-HVRCML 233 (238)
Q Consensus 227 R-~v~~~L 233 (238)
| +..+.|
T Consensus 265 R~~~~~~l 272 (311)
T 3ork_A 265 RYQTAAEM 272 (311)
T ss_dssp SCSSHHHH
T ss_pred ChhhHHHH
Confidence 9 333333
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=243.67 Aligned_cols=211 Identities=20% Similarity=0.251 Sum_probs=162.7
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLAR 91 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~ 91 (238)
.....+.+.+|+.+++++ +||||+++++++...+..++||||+++|+|.+++..... ....+++..+
T Consensus 80 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (334)
T 2pvf_A 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159 (334)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHH
T ss_pred cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHH
Confidence 344567899999999999 899999999999999999999999999999999976321 1234899999
Q ss_pred HHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCcc
Q 041655 92 YRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM 163 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~ 163 (238)
..++.|++.||.|||.+ +.||+++.++.+||+|||.++...............+++.|+|||++.+..++.+
T Consensus 160 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 239 (334)
T 2pvf_A 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 239 (334)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH
Confidence 99999999999999954 6789999999999999999987654332222234566788999999988889999
Q ss_pred CCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 164 CDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 164 ~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+||||||+++|+|++ |..||...... .....+........+...+..+.+++.+||+.||.+| ++++.|+++
T Consensus 240 ~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 240 SDVWSFGVLMWEIFTLGGSPYPGIPVE-ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCcCcCCHH-HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999 77776432211 1111122222223344555678889999999999999 666666654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=249.33 Aligned_cols=193 Identities=23% Similarity=0.208 Sum_probs=146.4
Q ss_pred HHHHHHHHHHHH-hcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 27 EEMMQIRSEIVT-LGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 27 ~~~~~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.....+.+|..+ ++.++||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..++.++.|++.||+||
T Consensus 80 ~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L 155 (373)
T 2r5t_A 80 KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYL 155 (373)
T ss_dssp -----------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 345567778887 5778999999999999999999999999999999999976 35688999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.+|++||+|||+++...... .......||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 156 H~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 233 (373)
T 2r5t_A 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233 (373)
T ss_dssp HHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred HHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 954 678999999999999999987532221 1234578999999999999999999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||...........+..... ..+...+..+.+++.+||+.||.+|
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R 281 (373)
T 2r5t_A 234 YGLPPFYSRNTAEMYDNILNKPL--QLKPNITNSARHLLEGLLQKDRTKR 281 (373)
T ss_dssp HSSCTTCCSBHHHHHHHHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGS
T ss_pred cCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHHHHHHHHHHcccCHHhC
Confidence 99998854322222222222221 1223344567788888999999999
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=244.44 Aligned_cols=198 Identities=22% Similarity=0.269 Sum_probs=153.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++.+++||||+++++++.+++..++||||++ |+|.+++.. ....+++..+..++.|++.||.||
T Consensus 95 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~L 170 (348)
T 1u5q_A 95 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYL 170 (348)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999996 688888764 245689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhHHHH
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l~ 174 (238)
|.+ +.||+++.++.+||+|||++...... ....||+.|+|||++. +..++.++||||||+++|
T Consensus 171 H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ 244 (348)
T 1u5q_A 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 244 (348)
T ss_dssp HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHH
T ss_pred HhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHH
Confidence 954 66899999999999999999765432 3357899999999874 567889999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|++|..||.........................+..+.+++.+||+.||++| ++.+.|
T Consensus 245 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 304 (348)
T 1u5q_A 245 ELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 304 (348)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 99999988754222111111111111111223344557788888999999999 444443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=237.79 Aligned_cols=210 Identities=20% Similarity=0.272 Sum_probs=154.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++.........+++..+..++.|++.||.||
T Consensus 73 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 152 (310)
T 2wqm_A 73 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152 (310)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999999999999999999999999999876444456789999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 153 H~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 230 (310)
T 2wqm_A 153 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230 (310)
T ss_dssp HHTTCCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 955 6679999999999999999876543221 123356899999999999888999999999999999999
Q ss_pred chHHHHHHhhccC-CCcc-cccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 178 SLVKWMRNVMTSE-NPKR-AIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 178 t~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
+|..||....... .... ..............+..+.+++.+||+.||.+| ++++.|++++
T Consensus 231 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 231 ALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp HSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 9988875321100 0001 111111111123445567888889999999999 7777777664
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=237.01 Aligned_cols=204 Identities=19% Similarity=0.272 Sum_probs=162.8
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++.. .....+++..+..++.|++.||.|||.+
T Consensus 53 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 130 (288)
T 3kfa_A 53 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK 130 (288)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHC
Confidence 56788999999999999999999999999999999999999999999976 3445689999999999999999999944
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||+++.++.++|+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 131 ~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g 209 (288)
T 3kfa_A 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 209 (288)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 67899999999999999999876543322 1233456788999999998899999999999999999999 7
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
..||..... ......+........+...+..+.+++..||+.||.+| ++++.|+++
T Consensus 210 ~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 210 MSPYPGIDL-SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCSSTTCCG-GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCH-HHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 777753221 12222223333333445556678889999999999999 566665554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=243.09 Aligned_cols=194 Identities=24% Similarity=0.274 Sum_probs=155.0
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
....+.+.+|..++.++ +||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..++.++.|++.||+|
T Consensus 50 ~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~ 125 (345)
T 3a8x_A 50 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNY 125 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Confidence 34567788999999888 799999999999999999999999999999999976 3568999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||++ +.||+++.++++||+|||+++....... ......||+.|+|||++.+..++.++|+||+||++|+|
T Consensus 126 LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 203 (345)
T 3a8x_A 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 203 (345)
T ss_dssp HHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred HHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHH
Confidence 9954 6789999999999999999975322211 23456899999999999998999999999999999999
Q ss_pred cchHHHHHHhhccCC----C-----cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 177 MSLVKWMRNVMTSEN----P-----KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~----~-----~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++|..||........ . ..+.... ...+...+..+.+++.+||+.||.+|
T Consensus 204 l~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R 261 (345)
T 3a8x_A 204 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKER 261 (345)
T ss_dssp HHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHC
Confidence 999999853211110 0 0111111 12233445567888889999999999
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=240.96 Aligned_cols=207 Identities=24% Similarity=0.288 Sum_probs=161.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+.+.+|+.++++++||||+++++++.+ ....++||||+++++|.+++.. ..+++..+..++.|++.||.
T Consensus 74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~ 148 (318)
T 3lxp_A 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMA 148 (318)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999976 4678999999999999999975 34899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
|||.+ +.||+++.++.+||+|||.+......... .......+++.|+|||++.+..++.++||||||+++|
T Consensus 149 ~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 228 (318)
T 3lxp_A 149 YLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228 (318)
T ss_dssp HHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred HHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHH
Confidence 99954 67899999999999999999876543221 1223456788899999999888999999999999999
Q ss_pred hhcchHHHHHHhhcc--------------CCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 175 EEMSLVKWMRNVMTS--------------ENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+|++|..||...... ......+........+...+..+.+++.+||+.||++| ++++.|+++
T Consensus 229 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 229 ELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 999987766432211 00111222222333445556678889999999999999 677777665
Q ss_pred h
Q 041655 237 Q 237 (238)
Q Consensus 237 ~ 237 (238)
.
T Consensus 309 ~ 309 (318)
T 3lxp_A 309 H 309 (318)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=240.34 Aligned_cols=209 Identities=17% Similarity=0.248 Sum_probs=160.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------CCcccCHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------GRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~~l~~ 100 (238)
.....+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++..... ....+++..+..++.|++.
T Consensus 70 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 149 (322)
T 1p4o_A 70 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149 (322)
T ss_dssp HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHH
Confidence 4456789999999999999999999999999999999999999999999875211 1245789999999999999
Q ss_pred Hhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 101 GLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
||.|||.+ +.||+++.++.+||+|||.++...............+++.|+|||++.+..++.++||||||++
T Consensus 150 ~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 229 (322)
T 1p4o_A 150 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229 (322)
T ss_dssp HHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHH
Confidence 99999954 6679999999999999999976544332222334567889999999998889999999999999
Q ss_pred HHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 173 LAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 173 l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+|+|++ |..||......... ..+........+...+..+.+++.+||+.||.+| ++++.|+++
T Consensus 230 l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 230 LWEIATLAEQPYQGLSNEQVL-RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHHHHTSCCTTTTSCHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHhcCCCccccCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 999999 67776432211111 1111111222334556668889999999999999 555555443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=239.37 Aligned_cols=207 Identities=19% Similarity=0.262 Sum_probs=159.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecC--CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
..+.+.+|+.++.+++||||+++++++... +..+++|||+++++|.+++.. ....+++..+..++.|++.||+||
T Consensus 66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~l 142 (302)
T 4e5w_A 66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYL 142 (302)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHh
Confidence 357788999999999999999999999876 668999999999999999965 235689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|++ +.||+++.++.++|+|||.+......... .......++..|+|||++.+..++.++|+||+|+++|+|
T Consensus 143 H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (302)
T 4e5w_A 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222 (302)
T ss_dssp HHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred hcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence 944 67899999999999999999876543221 222446688889999999988899999999999999999
Q ss_pred cchHHHHHHhhc-------cC-------CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 177 MSLVKWMRNVMT-------SE-------NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 177 ~t~~~~~~~~~~-------~~-------~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
++|..|+..... .. ..............+...+..+.+++.+||+.||.+| ++++.|+++.
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 223 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 998765422210 00 0011111222223344556678889999999999999 6777776653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=235.44 Aligned_cols=203 Identities=20% Similarity=0.240 Sum_probs=158.7
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+.+|+.++++++||||+++++++.+++..+++|||+++++|.+++.. ....+++..+..++.|++.||.|||++
T Consensus 48 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 124 (267)
T 3t9t_A 48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC 124 (267)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5688999999999999999999999999999999999999999999976 335689999999999999999999955
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
+.||+++.++.++|+|||.+......... ......+++.|+|||++.+..++.++|+||+|+++|+|++ |.
T Consensus 125 i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 203 (267)
T 3t9t_A 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203 (267)
T ss_dssp CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCchheEEECCCCCEEEccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCC
Confidence 66799999999999999999865432211 1133456788999999988889999999999999999999 77
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
.||......... ..+........+...+..+.+++.+||+.||++| ++++.|+++.
T Consensus 204 ~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 204 IPYENRSNSEVV-EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CTTTTCCHHHHH-HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHH-HHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 777532211111 1111111222233345567888889999999999 6666666653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=237.88 Aligned_cols=204 Identities=18% Similarity=0.225 Sum_probs=157.4
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCC--eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPG--CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.+.+.+|+.++++++||||+++++++...+ ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||
T Consensus 51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH 129 (319)
T 4euu_A 51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLR 129 (319)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 566789999999999999999999987654 7799999999999999997521 2234899999999999999999999
Q ss_pred cc--------Cceeee----cCCCceEEcccccccccCCcccccccccccCCCcccCccccc--------ccCCCccCCe
Q 041655 107 MH--------QALVLL----DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ--------TLSITYMCDI 166 (238)
Q Consensus 107 ~~--------~~~il~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~--------~~~~~~~~Dv 166 (238)
++ +.||++ +.++.+||+|||.++....... .....|++.|+|||++. +..++.++||
T Consensus 130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di 206 (319)
T 4euu_A 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206 (319)
T ss_dssp HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHH
T ss_pred HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHH
Confidence 54 677988 7888899999999987644332 23457899999999876 4678899999
Q ss_pred eehhHHHHhhcchHHHHHHhhccCCCcccc---------------------------cccccCCChHHHHHHHHHHhhhh
Q 041655 167 YSFGVLLAEEMSLVKWMRNVMTSENPKRAI---------------------------DSKLLGNGYEEQMLLVLKTACFC 219 (238)
Q Consensus 167 wslG~~l~~~~t~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~~~~c 219 (238)
|||||++|+|++|..||............. .-.............+.+++.+|
T Consensus 207 wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~ 286 (319)
T 4euu_A 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286 (319)
T ss_dssp HHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHh
Confidence 999999999999998885322111110000 00111133456677889999999
Q ss_pred cCCCCCcc-hHHHHHHhh
Q 041655 220 TLDDPKER-HVRCMLSQI 236 (238)
Q Consensus 220 l~~~p~~R-~v~~~L~~~ 236 (238)
|+.||++| ++.+.|+..
T Consensus 287 L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 287 LEADQEKCWGFDQFFAET 304 (319)
T ss_dssp SCCCTTTSCCHHHHHHHH
T ss_pred ccCChhhhccHHHhhhcc
Confidence 99999999 666666543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=248.40 Aligned_cols=189 Identities=16% Similarity=0.117 Sum_probs=155.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++..++||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 84 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (350)
T 1rdq_E 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS 159 (350)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999976 3468999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ |.||+++.++.+||+|||+++...... ....||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 160 ~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 234 (350)
T 1rdq_E 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234 (350)
T ss_dssp TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCcccccCccceEEECCCCCEEEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhC
Confidence 4 678999999999999999998654332 346789999999999998999999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||...........+.... ...+...+..+.+++.+||+.||.+|
T Consensus 235 ~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R 280 (350)
T 1rdq_E 235 YPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTC
T ss_pred CCCCCCCCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhc
Confidence 98875322111111222221 12233445667888899999999999
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=243.02 Aligned_cols=189 Identities=22% Similarity=0.299 Sum_probs=155.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++..++||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 49 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~ 124 (318)
T 1fot_A 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS 124 (318)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456778999999999999999999999999999999999999999999976 4568999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.+|.+||+|||+++..... .....||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 125 ~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 199 (318)
T 1fot_A 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199 (318)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred CCccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhC
Confidence 4 67899999999999999999865432 2346799999999999998999999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||...........+..... ..+...+.++.+++.+||+.||.+|
T Consensus 200 ~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R 245 (318)
T 1fot_A 200 YTPFYDSNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQR 245 (318)
T ss_dssp SCTTCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTC
T ss_pred CCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHc
Confidence 988853222111222222221 1223344567788888999999999
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=236.94 Aligned_cols=206 Identities=17% Similarity=0.202 Sum_probs=157.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++++++||||+++++++.++ ..+++|||+++++|.+++.. ....+++..+..++.|++.||.||
T Consensus 54 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~l 129 (281)
T 3cc6_A 54 LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYL 129 (281)
T ss_dssp HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999998754 56899999999999999975 235589999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.+||+|||.+......... ......+++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 130 H~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll 208 (281)
T 3cc6_A 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 208 (281)
T ss_dssp HHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred HHCCcccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHH
Confidence 954 66799999999999999999865443221 123345678899999998888999999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
+ |..||....... ....+........+...+..+.+++.+||+.||++| ++++.|+++.
T Consensus 209 t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 209 SFGKQPFFWLENKD-VIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TTTCCTTTTSCGGG-HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hCCCCCcccCChHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 8 888875322221 111111111222333445668888999999999999 6666666553
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=237.30 Aligned_cols=206 Identities=20% Similarity=0.211 Sum_probs=161.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++.+++||||+++++++. .+..++||||+++++|.+++.. ....+++..+..++.|++.||.||
T Consensus 51 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~l 126 (287)
T 1u59_A 51 KADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL 126 (287)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHH
Confidence 455678999999999999999999999994 5568999999999999999964 345689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|.+ +.||+++.++.++|+|||.+......... .......+++.|+|||++.+..++.++|+||||+++|+|
T Consensus 127 H~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 206 (287)
T 1u59_A 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206 (287)
T ss_dssp HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred HHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 954 67899999999999999999876433221 112334568899999999888899999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++ |..||....... ....+........+...+..+.+++..||+.||++| ++.+.|+++
T Consensus 207 lt~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 207 LSYGQKPYKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp HTTSCCTTTTCCTHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCcccCCHHH-HHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 98 888875422211 111222222233445566778889999999999999 666666554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=254.62 Aligned_cols=202 Identities=22% Similarity=0.304 Sum_probs=153.7
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.|.+|+.+|++++||||+++++++.+ +..++||||+++|+|.+++... ....+++..+..++.|++.||+|||++
T Consensus 224 ~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 300 (452)
T 1fmk_A 224 EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN 300 (452)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999999999999876 6789999999999999999641 124589999999999999999999955
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
+.||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 301 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~ 379 (452)
T 1fmk_A 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379 (452)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCC
Confidence 66799999999999999999865432211 1123456788999999988899999999999999999999 77
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
.||....... ....+........+...+..+.+++.+||+.||++| ++.+.|+++
T Consensus 380 ~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 380 VPYPGMVNRE-VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp CSSTTCCHHH-HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 7775322211 112222233333445666778899999999999999 666666654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=240.72 Aligned_cols=207 Identities=20% Similarity=0.246 Sum_probs=161.0
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeee--cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLA--RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
...+.+.+|+.++++++||||+++++++. +.+..++||||+++++|.+++.. ....+++..+..++.|++.||.|
T Consensus 66 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~ 142 (327)
T 3lxl_A 66 DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEY 142 (327)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHH
Confidence 44577899999999999999999999886 45678999999999999999975 23458999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
||++ +.||+++.++.+||+|||.+......... .......+++.|+|||++.+..++.++||||||+++|+
T Consensus 143 lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 222 (327)
T 3lxl_A 143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 222 (327)
T ss_dssp HHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred HHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHH
Confidence 9954 67899999999999999999876443221 12234567888999999998889999999999999999
Q ss_pred hcchHHHHHHhhccC--------------CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 176 EMSLVKWMRNVMTSE--------------NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|++|..||....... .....+........+...+..+.+++.+||+.||++| ++++.|+.+
T Consensus 223 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 223 LFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred HHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 999977764332210 0011112222233344556678889999999999999 666666654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=245.74 Aligned_cols=229 Identities=13% Similarity=0.080 Sum_probs=164.9
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecC----CeeEEEEEeCCCCCHHHHH
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP----GCHLLVYEFMKNGSLQDIL 76 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~~v~e~~~~~~L~~~l 76 (238)
.||||.+..... ................+.+|+..+..++||||+++++++... ...++||||+ +++|.+++
T Consensus 67 ~vavK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~ 142 (364)
T 3op5_A 67 PCVVKVEPSDNG---PLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY 142 (364)
T ss_dssp SEEEEEEETTCH---HHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHH
T ss_pred ceEEEEeeccch---hHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHH
Confidence 378887765432 111111112222234466788889999999999999998664 4579999999 99999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------Cceeeec--CCCceEEcccccccccCCccccc-----ccc
Q 041655 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLD--HDMEARISEFGLAKVFPEAHTHI-----TTS 141 (238)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~--~~~~~kl~dfg~~~~~~~~~~~~-----~~~ 141 (238)
.. ....+++..+..++.|++.||.|||++ +.||+++ .++.+||+|||+++.+....... ...
T Consensus 143 ~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~ 219 (364)
T 3op5_A 143 EA---NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKR 219 (364)
T ss_dssp HH---TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSC
T ss_pred Hh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCccc
Confidence 76 346799999999999999999999944 6789999 88999999999998764432211 113
Q ss_pred cccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCC---------hHHHHHHH
Q 041655 142 DVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNG---------YEEQMLLV 212 (238)
Q Consensus 142 ~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l 212 (238)
...||+.|+|||++.+..++.++||||||+++|+|++|..||..................... ....+..+
T Consensus 220 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (364)
T 3op5_A 220 CHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEI 299 (364)
T ss_dssp CCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHH
T ss_pred ccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHH
Confidence 345999999999999988999999999999999999999998753322111111111100000 02235567
Q ss_pred HHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 213 LKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 213 ~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
.+++..||+.||++| ++.+.|+++
T Consensus 300 ~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 300 AKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 888888999999999 666666554
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=247.52 Aligned_cols=198 Identities=16% Similarity=0.218 Sum_probs=157.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.+|+.++||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 58 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~ 133 (384)
T 4fr4_A 58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQN 133 (384)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999975 4569999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc---cCCCccCCeeehhHHHHhh
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT---LSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~---~~~~~~~DvwslG~~l~~~ 176 (238)
+ +.||+++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 134 ~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~el 210 (384)
T 4fr4_A 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210 (384)
T ss_dssp TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHH
T ss_pred CCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHH
Confidence 4 6789999999999999999987643322 245789999999998864 4588999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccc--cccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDS--KLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++|..||...... ........ ......+...+..+.+++.+||+.||.+| ..++.+
T Consensus 211 ltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l 269 (384)
T 4fr4_A 211 LRGRRPYHIRSST-SSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269 (384)
T ss_dssp HHSSCSSCCCTTS-CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred HhCCCCCCCCCCc-cHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence 9999988532111 11111110 11122344455678888999999999999 434444
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=234.52 Aligned_cols=196 Identities=24% Similarity=0.337 Sum_probs=152.9
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhccC
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ 109 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~~ 109 (238)
+.+.+|+.++.+++||||+++++++.+.. +++|||+++++|.+++.. ....+++..+..++.|++.||.|||.++
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 142 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN 142 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC
Confidence 67889999999999999999999997665 699999999999998865 3457899999999999999999999765
Q ss_pred ----------ceeeecCCCc-----eEEcccccccccCCcccccccccccCCCcccCccccc--ccCCCccCCeeehhHH
Q 041655 110 ----------ALVLLDHDME-----ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ--TLSITYMCDIYSFGVL 172 (238)
Q Consensus 110 ----------~~il~~~~~~-----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~--~~~~~~~~DvwslG~~ 172 (238)
.||+++.++. +||+|||.++..... .....|++.|+|||++. ...++.++||||+|++
T Consensus 143 ~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~ 217 (287)
T 4f0f_A 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217 (287)
T ss_dssp SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHH
T ss_pred CCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHH
Confidence 4699988776 999999998754332 23467899999999883 4557889999999999
Q ss_pred HHhhcchHHHHHHhhccCC--CcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 173 LAEEMSLVKWMRNVMTSEN--PKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
+|+|++|..||........ .............+...+..+.+++.+||+.||++| ++++.|++
T Consensus 218 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 218 LYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 9999999988854221111 111122233333445566778889999999999999 45555443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=245.02 Aligned_cols=192 Identities=20% Similarity=0.176 Sum_probs=155.4
Q ss_pred HHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+.+.+|..++..+ +||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..++.++.|++.||.|||
T Consensus 63 ~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH 138 (353)
T 2i0e_A 63 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ 138 (353)
T ss_dssp CHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456788999999988 799999999999999999999999999999999976 346899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.+|++||+|||+++...... .......||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 139 ~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 216 (353)
T 2i0e_A 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216 (353)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHc
Confidence 54 678999999999999999997532221 12345689999999999999899999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||...........+..... ..+...+..+.+++.+||+.||.+|
T Consensus 217 G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R 263 (353)
T 2i0e_A 217 GQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 263 (353)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSC
T ss_pred CCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHc
Confidence 9988854322211222222221 2233445667888889999999999
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=243.89 Aligned_cols=228 Identities=12% Similarity=0.069 Sum_probs=165.9
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHH
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDIL 76 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l 76 (238)
.||||.+...... ...............+.+|+..+..++||||+++++++.. .+..++||||+ +++|.+++
T Consensus 67 ~~aiK~~~~~~~~---~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l 142 (345)
T 2v62_A 67 RHVVKVEYQENGP---LFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS 142 (345)
T ss_dssp CEEEEEEECC-CH---HHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHC
T ss_pred eEEEEeeecCCcc---hHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHH
Confidence 3788877655331 1111111122233457789999999999999999999877 67889999999 99999998
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCC--ceEEcccccccccCCcccc-----cccc
Q 041655 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDM--EARISEFGLAKVFPEAHTH-----ITTS 141 (238)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~--~~kl~dfg~~~~~~~~~~~-----~~~~ 141 (238)
.. ...+++..+..++.|++.||+|||++ +.||+++.++ .+||+|||+++.+...... ....
T Consensus 143 ~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~ 218 (345)
T 2v62_A 143 GQ----NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218 (345)
T ss_dssp BG----GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGG
T ss_pred Hh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhcccc
Confidence 75 34799999999999999999999954 6679998887 9999999999876432211 1113
Q ss_pred cccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChH---------HHHHHH
Q 041655 142 DVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYE---------EQMLLV 212 (238)
Q Consensus 142 ~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~l 212 (238)
...|++.|+|||++.+..++.++||||||+++|+|++|..||.....................+. ..+..+
T Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (345)
T 2v62_A 219 GHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEI 298 (345)
T ss_dssp CSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHH
T ss_pred ccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHH
Confidence 45789999999999998899999999999999999999999854322111111111111111111 344578
Q ss_pred HHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 213 LKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 213 ~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
.+++..||+.||++| ++++.|+++
T Consensus 299 ~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 299 AQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 888999999999999 555555543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=236.74 Aligned_cols=204 Identities=21% Similarity=0.231 Sum_probs=158.2
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++.+++||||+++++++ ..+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 60 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH 134 (291)
T 1xbb_A 60 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE 134 (291)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999999 55678899999999999999976 456899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCccccc-ccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI-TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
++ +.||+++.++.+||+|||.+.......... ......+++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 135 ~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 214 (291)
T 1xbb_A 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214 (291)
T ss_dssp HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHH
Confidence 55 667999999999999999998664432211 112345678899999998888899999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+ |..||...... .....+........+...+..+.+++.+||+.||.+| ++++.|+++
T Consensus 215 ~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 215 SYGQKPYRGMKGS-EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TTTCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred hcCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 9 88887542211 1112222222233344556678889999999999999 666666554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=241.96 Aligned_cols=197 Identities=20% Similarity=0.221 Sum_probs=145.2
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||.+
T Consensus 61 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~ 136 (361)
T 3uc3_A 61 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ 136 (361)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4577999999999999999999999999999999999999999999875 34689999999999999999999954
Q ss_pred -------CceeeecCCCc--eEEcccccccccCCcccccccccccCCCcccCcccccccCCCcc-CCeeehhHHHHhhcc
Q 041655 109 -------QALVLLDHDME--ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM-CDIYSFGVLLAEEMS 178 (238)
Q Consensus 109 -------~~~il~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~-~DvwslG~~l~~~~t 178 (238)
+.||+++.++. +||+|||+++...... ......||+.|+|||++.+..++.+ +||||+||++|+|++
T Consensus 137 ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 213 (361)
T 3uc3_A 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV 213 (361)
T ss_dssp CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred cccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh
Confidence 67899987765 9999999987432221 1234578999999999888777655 899999999999999
Q ss_pred hHHHHHHhhccCCCcccc----cccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAI----DSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||............+ ............+..+.+++.+||+.||++| ++.+.|
T Consensus 214 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell 273 (361)
T 3uc3_A 214 GAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIK 273 (361)
T ss_dssp SSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 999886544333222221 1111111222344567888889999999999 555444
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=233.55 Aligned_cols=198 Identities=20% Similarity=0.231 Sum_probs=155.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||.+
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~ 125 (277)
T 3f3z_A 50 VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL 125 (277)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999999876 35689999999999999999999954
Q ss_pred --------Cceeee---cCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 109 --------QALVLL---DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 109 --------~~~il~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
+.||++ +.++.++|+|||.+........ .....|++.|+|||++.+. ++.++|+||||+++|+|+
T Consensus 126 ~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~ 201 (277)
T 3f3z_A 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLL 201 (277)
T ss_dssp TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHH
T ss_pred CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHH
Confidence 667999 7889999999999976543322 2345789999999988654 899999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCC--ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGN--GYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||.................... .....+..+.+++.+||+.||++| ++.+.|+
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 202 CGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99888753222111111111111111 111345678889999999999999 5555553
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=237.38 Aligned_cols=196 Identities=19% Similarity=0.207 Sum_probs=144.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++.+++||||+++++++..++..++++||+++++|.+++.. ...+++..+..++.|++.||.||
T Consensus 75 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~l 150 (309)
T 2h34_A 75 PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAA 150 (309)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999999999999999999999999999999976 35689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.+||+|||.+......... ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 151 H~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 229 (309)
T 2h34_A 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229 (309)
T ss_dssp HHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHH
T ss_pred HHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHH
Confidence 955 66799999999999999998765433211 123457899999999999888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||...... .....+.... ....+...+..+.+++.+||+.||++|
T Consensus 230 ~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 280 (309)
T 2h34_A 230 TGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280 (309)
T ss_dssp HSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGS
T ss_pred HCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHH
Confidence 998887432211 0111111111 111223445567888889999999999
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=238.56 Aligned_cols=198 Identities=16% Similarity=0.204 Sum_probs=151.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++.+++||||+++++++.+++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 55 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~ 131 (289)
T 4fvq_A 55 YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE 131 (289)
T ss_dssp GHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 346789999999999999999999999999999999999999999999976 33458999999999999999999995
Q ss_pred c--------CceeeecCCCc--------eEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehh
Q 041655 108 H--------QALVLLDHDME--------ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFG 170 (238)
Q Consensus 108 ~--------~~~il~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG 170 (238)
+ +.||+++.++. +||+|||.+...... ....+++.|+|||++.+ ..++.++||||||
T Consensus 132 ~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 205 (289)
T 4fvq_A 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFG 205 (289)
T ss_dssp TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHH
T ss_pred CCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHH
Confidence 4 67899998887 999999998654332 22457888999998877 6789999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+++|+|++|..|+................ ...+...+..+.+++.+||+.||++| ++++.|+++
T Consensus 206 ~il~el~~g~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l 273 (289)
T 4fvq_A 206 TTLWEICSGGDKPLSALDSQRKLQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273 (289)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHTT--CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHcCCCCCccccchHHHHHHhhcc--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 99999999654443222111111111111 11112223457778888999999999 555555544
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=237.42 Aligned_cols=207 Identities=22% Similarity=0.260 Sum_probs=159.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+..+.+.+|+.++.+++||||+++++++..++ .++++||+++++|.+++.. ....+++..+..++.|++.||.|||
T Consensus 63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH 138 (291)
T 1u46_A 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE 138 (291)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999998765 7899999999999999975 2356899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
.+ +.||+++.++.+||+|||.+......... .......+++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 139 ~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 218 (291)
T 1u46_A 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218 (291)
T ss_dssp HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred hCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 54 67799999999999999999876443221 1223456778899999998888899999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
+ |..||.....................+...+..+.+++.+||+.||++| ++.+.|++++
T Consensus 219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 219 TYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred hCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 9 8888754322211112222222222334556678889999999999999 6666666654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=260.34 Aligned_cols=203 Identities=21% Similarity=0.228 Sum_probs=158.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+++.+|+.+|.+++||||+++++++..+ ..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 413 ~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~ 487 (635)
T 4fl3_A 413 LKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE 487 (635)
T ss_dssp GHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 457799999999999999999999999654 57899999999999999975 4568999999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++.++.+||+|||+++.+...... .......+++.|+|||++.+..++.++||||||+++|||++
T Consensus 488 ~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 567 (635)
T 4fl3_A 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567 (635)
T ss_dssp TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 4 67899999999999999999876443221 12233456788999999999899999999999999999998
Q ss_pred -hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 179 -LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 179 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|..||...... .....+........+...+..+.+++..||+.||++| ++.+.|+++
T Consensus 568 ~G~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 568 YGQKPYRGMKGS-EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TTCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 88887543222 1222233333344455667778899999999999999 666666654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=243.04 Aligned_cols=199 Identities=23% Similarity=0.293 Sum_probs=143.6
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||.+
T Consensus 92 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~ 167 (349)
T 2w4o_A 92 KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN 167 (349)
T ss_dssp -------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35678899999999999999999999999999999999999999999975 45689999999999999999999954
Q ss_pred --------CceeeecC---CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 109 --------QALVLLDH---DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 109 --------~~~il~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
+.||+++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 168 ~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 244 (349)
T 2w4o_A 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILL 244 (349)
T ss_dssp TCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHH
Confidence 66799975 88999999999876543221 23467899999999999988999999999999999999
Q ss_pred chHHHHHHhhccC-CCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSE-NPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||....... .......... ......+.+..+.+++.+||+.||++| ++.+.|+
T Consensus 245 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 245 CGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9988875322211 0111111111 111223455678889999999999999 6555554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=241.76 Aligned_cols=192 Identities=19% Similarity=0.210 Sum_probs=146.0
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++++++||||+++++++..++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||.
T Consensus 64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~ 139 (327)
T 3a62_A 64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ 139 (327)
T ss_dssp -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 446678999999999999999999999999999999999999999999975 3568899999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 140 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 217 (327)
T 3a62_A 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217 (327)
T ss_dssp TTCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHC
Confidence 4 6789999999999999999875432211 12346789999999999888899999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||...........+..... ..+...+..+.+++.+||+.||.+|
T Consensus 218 ~~pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R 263 (327)
T 3a62_A 218 APPFTGENRKKTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASR 263 (327)
T ss_dssp SCSCCCSSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGS
T ss_pred CCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhc
Confidence 988753222111112222111 2223345567888888999999999
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=245.79 Aligned_cols=201 Identities=18% Similarity=0.249 Sum_probs=157.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.+|.+++||||+++++++.+.+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 91 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~ 167 (387)
T 1kob_A 91 DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE 167 (387)
T ss_dssp HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 345788999999999999999999999999999999999999999999864 34568999999999999999999995
Q ss_pred c--------CceeeecC--CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 108 H--------QALVLLDH--DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 ~--------~~~il~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
+ +.||+++. .+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 168 ~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 4 67799974 57799999999987644322 12357899999999999888999999999999999999
Q ss_pred chHHHHHHhhccCCCccccccc--ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSK--LLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||................ .........+..+.+++.+||+.||++| ++.+.|+
T Consensus 245 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 245 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 9998875322111111111111 1122233455678889999999999999 5555554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=234.79 Aligned_cols=201 Identities=25% Similarity=0.323 Sum_probs=149.6
Q ss_pred HHHHHHHHhc--CCCCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 31 QIRSEIVTLG--QIRHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 31 ~~~~E~~~l~--~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.+.+|.+++. +++||||+++++++.. .+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|
T Consensus 46 ~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~ 120 (301)
T 3q4u_A 46 SWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAH 120 (301)
T ss_dssp HHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHH
Confidence 3444555544 4899999999998643 3568899999999999999964 468999999999999999999
Q ss_pred hh--------c--------cCceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCccccccc------CC
Q 041655 105 LH--------M--------HQALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQTL------SI 160 (238)
Q Consensus 105 lH--------~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~~------~~ 160 (238)
|| . |+.||+++.++.+||+|||+++........ .......||+.|+|||++.+. .+
T Consensus 121 lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 200 (301)
T 3q4u_A 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS 200 (301)
T ss_dssp HHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHH
T ss_pred HHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccC
Confidence 99 3 367899999999999999999765433221 112345789999999998776 44
Q ss_pred CccCCeeehhHHHHhhcch----------HHHHHHhhccCCCccccc-----ccccCC-----ChHHHHHHHHHHhhhhc
Q 041655 161 TYMCDIYSFGVLLAEEMSL----------VKWMRNVMTSENPKRAID-----SKLLGN-----GYEEQMLLVLKTACFCT 220 (238)
Q Consensus 161 ~~~~DvwslG~~l~~~~t~----------~~~~~~~~~~~~~~~~~~-----~~~~~~-----~~~~~~~~l~~~~~~cl 220 (238)
+.++||||||+++|+|++| ..||.............. ....+. .....+..+.+++..||
T Consensus 201 ~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 280 (301)
T 3q4u_A 201 YKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW 280 (301)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHC
T ss_pred CchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHh
Confidence 5789999999999999999 667654333222211110 111111 23446778999999999
Q ss_pred CCCCCcc----hHHHHHHhh
Q 041655 221 LDDPKER----HVRCMLSQI 236 (238)
Q Consensus 221 ~~~p~~R----~v~~~L~~~ 236 (238)
+.||++| ++++.|++|
T Consensus 281 ~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 281 YQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSSGGGSCCHHHHHHHHHHH
T ss_pred hcChhhCCCHHHHHHHHhcc
Confidence 9999999 677777665
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=244.85 Aligned_cols=192 Identities=21% Similarity=0.199 Sum_probs=153.5
Q ss_pred HHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+.+.+|..++..+ +||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 60 ~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH 135 (345)
T 1xjd_A 60 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH 135 (345)
T ss_dssp CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345677899988876 899999999999999999999999999999999976 356899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.+|.+||+|||+++....... ......||+.|+|||++.+..++.++|+||+||++|+|++
T Consensus 136 ~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 213 (345)
T 1xjd_A 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213 (345)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc
Confidence 54 6789999999999999999875432211 2345689999999999999899999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||...........+.... ...+...+..+.+++.+||+.||++|
T Consensus 214 g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R 260 (345)
T 1xjd_A 214 GQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKR 260 (345)
T ss_dssp SSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCCCCCCCCHHHHHHHHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHc
Confidence 998885322211111111111 12233345567888888999999999
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=235.03 Aligned_cols=211 Identities=20% Similarity=0.160 Sum_probs=161.1
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeee----cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLA----RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
...+.+.+|+.++++++||||+++++++. .....++|+||+++++|.+++.........+++..+..++.|++.||
T Consensus 68 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L 147 (317)
T 2buj_A 68 QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147 (317)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 45678899999999999999999999986 34578899999999999999986545567799999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCccccc-------ccccccCCCcccCcccccccC---CCccC
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI-------TTSDVVGTAGYIAPEYQQTLS---ITYMC 164 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~-------~~~~~~~~~~~~apE~~~~~~---~~~~~ 164 (238)
.|||.+ +.||+++.++.++|+|||.+.......... ......|++.|+|||++.+.. ++.++
T Consensus 148 ~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 227 (317)
T 2buj_A 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227 (317)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHH
T ss_pred HHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchh
Confidence 999954 667999999999999999987543211100 012245789999999887543 68899
Q ss_pred CeeehhHHHHhhcchHHHHHHhhccCC-CcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVMTSEN-PKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
||||||+++|+|++|..||........ .................+..+.+++.+||+.||.+| ++++.|++++
T Consensus 228 Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 999999999999999988876443222 212222222222233445668889999999999999 6677776654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=238.38 Aligned_cols=208 Identities=21% Similarity=0.320 Sum_probs=158.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCC--eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPG--CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
...+.+.+|+.++++++||||+++++++...+ ..++||||+++++|.+++.. ....+++..+..++.|++.||.|
T Consensus 84 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~ 160 (326)
T 2w1i_A 84 EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEY 160 (326)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999999986543 78999999999999999976 23468999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
||.+ +.||+++.++.+||+|||.+......... .......++..|+|||.+.+..++.++||||||+++|+
T Consensus 161 LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 240 (326)
T 2w1i_A 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 240 (326)
T ss_dssp HHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred HHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHH
Confidence 9954 67899999999999999999876543221 11233456788999999988888999999999999999
Q ss_pred hcchHHHHHHh-------hccCCC--------cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 176 EMSLVKWMRNV-------MTSENP--------KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 176 ~~t~~~~~~~~-------~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|++|..|+... ...... ...+........+...+..+.+++.+||+.||++| ++++.|+++
T Consensus 241 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 241 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99986554321 111110 01111111222344556678889999999999999 777777766
Q ss_pred h
Q 041655 237 Q 237 (238)
Q Consensus 237 ~ 237 (238)
+
T Consensus 321 ~ 321 (326)
T 2w1i_A 321 R 321 (326)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=238.11 Aligned_cols=200 Identities=19% Similarity=0.227 Sum_probs=150.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
..+.+.+|+.++++++||||+++++++.+ .+..++||||+++++|.++.. ...+++..+..++.|++.||.||
T Consensus 79 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~l 153 (298)
T 2zv2_A 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYL 153 (298)
T ss_dssp --CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 35678999999999999999999999986 567899999999999887653 35689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC---CCccCCeeehhHHHH
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS---ITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~---~~~~~DvwslG~~l~ 174 (238)
|.+ +.||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|
T Consensus 154 H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~ 231 (298)
T 2zv2_A 154 HYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231 (298)
T ss_dssp HHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHH
T ss_pred HHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHH
Confidence 954 6789999999999999999986643322 123467899999999987655 367899999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|++|..||.........................+..+.+++.+||+.||++| .+.+.|+
T Consensus 232 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 232 CFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99999888743211100011111111111122344567888889999999999 5555443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=244.17 Aligned_cols=202 Identities=20% Similarity=0.261 Sum_probs=150.5
Q ss_pred HHHHHHHHHHHHHhcCCC--CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIR--HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+.+.+|+.+|.+++ ||||+++++++..++..++||| +.+++|.+++.. ...+++..+..++.|++.||.
T Consensus 95 ~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~ 169 (390)
T 2zmd_A 95 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 169 (390)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Confidence 345678999999999997 5999999999999999999999 457899999986 357889999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-----------cCCCccC
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-----------LSITYMC 164 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-----------~~~~~~~ 164 (238)
|||++ |.||+++ ++.+||+|||+++...............||+.|+|||++.+ ..++.++
T Consensus 170 ~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 248 (390)
T 2zmd_A 170 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248 (390)
T ss_dssp HHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred HHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence 99954 6679995 58999999999987654333222345679999999998865 3678899
Q ss_pred CeeehhHHHHhhcchHHHHHHhhcc-CCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVMTS-ENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|||||||++|+|++|..||...... ......+........+...+..+.+++.+||+.||++| .+.+.|
T Consensus 249 DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 9999999999999999988642211 11112222222222223334567888888999999999 544444
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.02 Aligned_cols=197 Identities=26% Similarity=0.329 Sum_probs=156.8
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 59 ~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~ 134 (476)
T 2y94_A 59 VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHR 134 (476)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999999999999999999999999999864 4568999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCC-CccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~-~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++.++.+||+|||++........ .....||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 135 ~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 211 (476)
T 2y94_A 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211 (476)
T ss_dssp TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh
Confidence 4 6789999999999999999987644322 234679999999999988765 679999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||...........+..... ..+...+..+.+++.+||+.||++| ++.+.+
T Consensus 212 G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil 265 (476)
T 2y94_A 212 GTLPFDDDHVPTLFKKICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIR 265 (476)
T ss_dssp SSCSSCCSSSHHHHHHHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 9988753221111111222111 1223344567888889999999999 544444
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=245.16 Aligned_cols=194 Identities=22% Similarity=0.230 Sum_probs=152.7
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
....+.+.+|..++..+ +||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..++.++.|++.||+|
T Consensus 64 ~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~ 139 (353)
T 3txo_A 64 DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMF 139 (353)
T ss_dssp HTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHH
Confidence 34556788999999988 699999999999999999999999999999999976 3568999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||++ +.||+++.++++||+|||+++...... .......||+.|+|||++.+..++.++|+||+||++|+|
T Consensus 140 LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 217 (353)
T 3txo_A 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEM 217 (353)
T ss_dssp HHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHH
T ss_pred HHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHH
Confidence 9954 678999999999999999987532221 123456899999999999998999999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++|..||...........+..... ..+......+.+++.+||+.||.+|
T Consensus 218 l~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R 266 (353)
T 3txo_A 218 LCGHAPFEAENEDDLFEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMR 266 (353)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHc
Confidence 999998854332222222222221 2233345567788888999999999
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=240.96 Aligned_cols=203 Identities=20% Similarity=0.262 Sum_probs=150.2
Q ss_pred HHHHHHHHHHHHHhcCCCC--CcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIRH--RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+.+.+|+.++.+++| |||+++++++..++..++|||+ .+++|.+++.. ...+++..+..++.|++.||.
T Consensus 48 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~ 122 (343)
T 3dbq_A 48 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 122 (343)
T ss_dssp HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Confidence 3456788999999999986 9999999999999999999995 47899999986 457899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-----------cCCCccC
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-----------LSITYMC 164 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-----------~~~~~~~ 164 (238)
|||.+ +.||+++ ++.+||+|||+++...............||+.|+|||++.+ ..++.++
T Consensus 123 ~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 201 (343)
T 3dbq_A 123 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201 (343)
T ss_dssp HHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred HHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence 99944 6679997 67899999999987654433323345679999999998864 6678899
Q ss_pred CeeehhHHHHhhcchHHHHHHhhccC-CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVMTSE-NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|||||||++|+|++|..||....... ..............+...+..+.+++.+||+.||.+| ++.+.|+
T Consensus 202 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 202 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 99999999999999999885422110 1112222222223333334567788888999999999 5555443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=238.20 Aligned_cols=206 Identities=21% Similarity=0.229 Sum_probs=157.2
Q ss_pred HHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc------------CCCcccCHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS------------RGRRQLDWLARYR 93 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~ 93 (238)
...+.+.+|+.++.++ +||||+++++++.+.+..++||||+++++|.+++.... .....+++..++.
T Consensus 67 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (327)
T 1fvr_A 67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146 (327)
T ss_dssp ---CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHH
Confidence 4456789999999999 89999999999999999999999999999999997521 1234689999999
Q ss_pred HHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCC
Q 041655 94 TVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCD 165 (238)
Q Consensus 94 ~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~D 165 (238)
++.|++.||.|||.+ |.||+++.++.+||+|||+++....... .....+++.|+|||++.+..++.++|
T Consensus 147 i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~D 223 (327)
T 1fvr_A 147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSD 223 (327)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhc
Confidence 999999999999954 6789999999999999999874332211 12345678899999998888899999
Q ss_pred eeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 166 IYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 166 vwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|||||+++|+|++ |..||....... ....+........+...+..+.+++.+||+.||.+| ++++.|+++
T Consensus 224 i~slG~il~ellt~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 224 VWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCCCCCCCcHHH-HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999998 888875322111 111222222233344555678889999999999999 555555544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=236.47 Aligned_cols=202 Identities=20% Similarity=0.265 Sum_probs=149.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++||||+++++++.+ ..++||||+++++|.+++... .....+++..+..++.|+++||.|||.
T Consensus 44 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~ 120 (307)
T 2eva_A 44 ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHS 120 (307)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHh
Confidence 35678999999999999999999999874 478999999999999999751 112347889999999999999999997
Q ss_pred ---c--------CceeeecCCCc-eEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHh
Q 041655 108 ---H--------QALVLLDHDME-ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 108 ---~--------~~~il~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~ 175 (238)
+ +.||+++.++. +||+|||.+....... ....|++.|+|||++.+..++.++||||||+++|+
T Consensus 121 ~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 195 (307)
T 2eva_A 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWE 195 (307)
T ss_dssp CSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHH
T ss_pred CCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHH
Confidence 3 55799988886 7999999987543321 23468999999999998899999999999999999
Q ss_pred hcchHHHHHHhhccC-CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 176 EMSLVKWMRNVMTSE-NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|++|..||....... ..............+...+..+.+++.+||+.||++| ++++.|+++.
T Consensus 196 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 196 VITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp HHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred HHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 999998875321110 0000111112222334455668889999999999999 7777776654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=233.01 Aligned_cols=199 Identities=20% Similarity=0.297 Sum_probs=137.5
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++.+++||||+++++++.+.+..+++|||+++++|.+++.. ....+++..+..++.|+++||.|||.+
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~ 131 (278)
T 3cok_A 55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH 131 (278)
T ss_dssp HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999999975 346789999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.+......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 132 ~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 209 (278)
T 3cok_A 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209 (278)
T ss_dssp TEECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSS
T ss_pred CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 66799999999999999998765432211 12356899999999998888999999999999999999999
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.||................. ..+...+..+.+++.+||+.||++| .+.+.|+
T Consensus 210 ~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 210 PPFDTDTVKNTLNKVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CSSCCCSCC-----CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCChhHHHHHHHHhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 88754332222222222111 1233345567888899999999999 5555443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=232.25 Aligned_cols=202 Identities=21% Similarity=0.255 Sum_probs=157.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~ 123 (276)
T 2yex_A 48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHG 123 (276)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 457788999999999999999999999999999999999999999998864 4568999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCC-CccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~-~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++.++.++|+|||.+................|++.|+|||.+.+..+ +.++|+||||+++|+|++
T Consensus 124 ~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 203 (276)
T 2yex_A 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203 (276)
T ss_dssp TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh
Confidence 5 6679999999999999999876543322222345678999999999887665 678999999999999999
Q ss_pred hHHHHHHhhccCCC-cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 179 LVKWMRNVMTSENP-KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 179 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|..||......... ................+..+.+++.+||+.||++| ++.+.|
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (276)
T 2yex_A 204 GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (276)
T ss_dssp SSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHh
Confidence 98887542211110 01111111112233455667888999999999999 555444
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=256.45 Aligned_cols=202 Identities=22% Similarity=0.304 Sum_probs=158.2
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.|.+|+.+|++++||||+++++++.+ +..++||||+++|+|.+++... ....+++..+..++.|++.||.|||.+
T Consensus 307 ~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 383 (535)
T 2h8h_A 307 EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN 383 (535)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999999999999876 6789999999999999999641 124588999999999999999999955
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-hH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-LV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~~ 180 (238)
+.||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |.
T Consensus 384 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~ 462 (535)
T 2h8h_A 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462 (535)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTC
T ss_pred eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 66799999999999999999866432211 1123456788999999988899999999999999999999 77
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
.||....... ....+........+...+..+.+++.+||+.||++| ++.+.|+++
T Consensus 463 ~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 463 VPYPGMVNRE-VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp CSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 7775322211 112222222333345566778899999999999999 666666654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=241.47 Aligned_cols=202 Identities=21% Similarity=0.212 Sum_probs=157.2
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.+++.++||||+++++++.+++..|+||||+++++|.+++.........+++..+..++.|++.||.|||++
T Consensus 70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 149 (351)
T 3c0i_A 70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149 (351)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999988865433445689999999999999999999954
Q ss_pred --------CceeeecCCCc---eEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 109 --------QALVLLDHDME---ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 109 --------~~~il~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.||+++.++. +||+|||++........ ......||+.|+|||++.+..++.++||||+||++|+|+
T Consensus 150 ~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 227 (351)
T 3c0i_A 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILL 227 (351)
T ss_dssp TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHH
Confidence 67899987655 99999999987644321 124467999999999999888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccC--CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLG--NGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..||..... ............. ......+..+.+++.+||+.||++| ++.+.|
T Consensus 228 ~g~~pf~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 285 (351)
T 3c0i_A 228 SGCLPFYGTKE-RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285 (351)
T ss_dssp HSSCSSCSSHH-HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HCCCCCCCcHH-HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 99888753211 0111111111111 1112345668889999999999999 554444
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=227.58 Aligned_cols=215 Identities=20% Similarity=0.176 Sum_probs=158.4
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+...... ....+.+.+|+.++++++||||+++++++.+++..++||||+++ ++.+++..
T Consensus 30 vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--- 93 (292)
T 3o0g_A 30 VALKRVRLDDDD------------EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS--- 93 (292)
T ss_dssp EEEEEEESSCSS------------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH---
T ss_pred EEEEeeeccCCc------------CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh---
Confidence 677777544322 22346788999999999999999999999999999999999965 67766654
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
....+++..+..++.|++.||+|||++ +.||+++.++.+||+|||.+........ ......||+.|+|||
T Consensus 94 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE 171 (292)
T 3o0g_A 94 CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPD 171 (292)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHH
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChH
Confidence 246699999999999999999999954 6789999999999999999986543221 123457899999999
Q ss_pred cccccC-CCccCCeeehhHHHHhhcchHHHHHHhhccC----------------CCcccc------------cccccCCC
Q 041655 154 YQQTLS-ITYMCDIYSFGVLLAEEMSLVKWMRNVMTSE----------------NPKRAI------------DSKLLGNG 204 (238)
Q Consensus 154 ~~~~~~-~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~----------------~~~~~~------------~~~~~~~~ 204 (238)
++.+.. ++.++||||+|+++|+|++|..|+....... ...... ........
T Consensus 172 ~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (292)
T 3o0g_A 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251 (292)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred HHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhc
Confidence 887665 7999999999999999998876642111000 000000 00000111
Q ss_pred hHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 205 YEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 205 ~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.......+.+++.+||+.||++| ++.+.|+
T Consensus 252 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 22345567788889999999999 6555554
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=251.44 Aligned_cols=194 Identities=22% Similarity=0.185 Sum_probs=146.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
......+.+|+.++..++||||+++++++..++..++||||+++|+|.+++.. ...+++..+..++.|++.||+||
T Consensus 189 ~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~L 264 (446)
T 4ejn_A 189 KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYL 264 (446)
T ss_dssp ------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34456788999999999999999999999999999999999999999999876 45689999999999999999999
Q ss_pred hc-c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HM-H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~-~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|+ + |.||+++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 265 H~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 342 (446)
T 4ejn_A 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 342 (446)
T ss_dssp HHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHH
T ss_pred hhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHH
Confidence 96 4 5679999999999999999875432221 12446899999999999999999999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++|..||...........+..... ..+...+..+.+++.+||+.||.+|
T Consensus 343 l~g~~Pf~~~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R 391 (446)
T 4ejn_A 343 MCGRLPFYNQDHEKLFELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQR 391 (446)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred hhCCCCCCCCCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHcccCHHHh
Confidence 999988853222111111111111 1233345567888889999999999
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=235.73 Aligned_cols=192 Identities=8% Similarity=-0.024 Sum_probs=149.9
Q ss_pred HHHHHHHHHhcCCC---CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC-CCcccCHHHHHHHHHHHHHHhchh
Q 041655 30 MQIRSEIVTLGQIR---HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR-GRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 30 ~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
..+.+|+.++..++ |+|++++++++..++..++||||+++|+|.+++..... ....+++..+..++.|++.||+||
T Consensus 109 ~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l 188 (365)
T 3e7e_A 109 WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188 (365)
T ss_dssp HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 45667777777776 99999999999999999999999999999999975322 356799999999999999999999
Q ss_pred hc--------cCceeeecC-----------CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCe
Q 041655 106 HM--------HQALVLLDH-----------DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDI 166 (238)
Q Consensus 106 H~--------~~~~il~~~-----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dv 166 (238)
|. |+.||+++. ++.+||+|||+++.+.............||+.|+|||++.+..++.++||
T Consensus 189 H~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 268 (365)
T 3e7e_A 189 HDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268 (365)
T ss_dssp HTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHH
T ss_pred hhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccH
Confidence 94 477899998 89999999999976543222223355689999999999999899999999
Q ss_pred eehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 167 YSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 167 wslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|||||++|+|++|..||..... .............. ...+.+++..|++.+|.+|
T Consensus 269 wslG~il~elltg~~pf~~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r 323 (365)
T 3e7e_A 269 FGVAATVYCMLFGTYMKVKNEG---GECKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHH 323 (365)
T ss_dssp HHHHHHHHHHHHSSCCCEEEET---TEEEECSCCTTCSS---HHHHHHHHHHHHCCCCTTC
T ss_pred HHHHHHHHHHHhCCCccccCCC---CceeechhccccCc---HHHHHHHHHHHcCCCCCCc
Confidence 9999999999999988753221 11112222222222 3334556667999999999
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=239.31 Aligned_cols=210 Identities=20% Similarity=0.211 Sum_probs=158.1
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC---CCcccCHHHHHHHHHHHHHHh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR---GRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~gl 102 (238)
.....++.+|+.++.+++||||+++++++...+..++||||+++++|.+++..... ....+++..+..++.|++.||
T Consensus 74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al 153 (327)
T 2yfx_A 74 EQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153 (327)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHH
Confidence 34456789999999999999999999999999999999999999999999986321 124589999999999999999
Q ss_pred chhhcc--------CceeeecC---CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhH
Q 041655 103 EYLHMH--------QALVLLDH---DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~ 171 (238)
.|||.+ +.||+++. +..++|+|||.+................+++.|+|||++.+..++.++||||||+
T Consensus 154 ~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 233 (327)
T 2yfx_A 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 233 (327)
T ss_dssp HHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHH
Confidence 999955 66799984 4469999999987543332222223456788999999998888999999999999
Q ss_pred HHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 172 LLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 172 ~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++|+|++ |..||...... .....+........+...+..+.+++.+||+.||.+| ++++.|+.+
T Consensus 234 il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 234 LLWEIFSLGYMPYPSKSNQ-EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHHTTSCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCcCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 9999998 77776432211 1111122222223334455678889999999999999 555555544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=250.84 Aligned_cols=213 Identities=25% Similarity=0.332 Sum_probs=164.7
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+....... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 54 ~avK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--- 119 (484)
T 3nyv_A 54 CAVKVISKRQVKQ-----------KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--- 119 (484)
T ss_dssp EEEEEEETTTCCB-----------SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT---
T ss_pred EEEEEEEhhhccc-----------chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh---
Confidence 6778776543321 12356788999999999999999999999999999999999999999999875
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------Cceeee---cCCCceEEcccccccccCCcccccccccccCCCccc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLL---DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYI 150 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 150 (238)
...+++..+..++.|++.||.|||++ |.||++ +.++.+||+|||+++....... .....||+.|+
T Consensus 120 -~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~ 195 (484)
T 3nyv_A 120 -RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYI 195 (484)
T ss_dssp -CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCcccc
Confidence 45689999999999999999999954 678999 5678999999999986644322 23357899999
Q ss_pred CcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccccccc--CCChHHHHHHHHHHhhhhcCCCCCcc-
Q 041655 151 APEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLL--GNGYEEQMLLVLKTACFCTLDDPKER- 227 (238)
Q Consensus 151 apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~cl~~~p~~R- 227 (238)
|||++.+ .++.++||||+||++|+|++|..||...........+...... .......+..+.+++.+||+.||.+|
T Consensus 196 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~ 274 (484)
T 3nyv_A 196 APEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274 (484)
T ss_dssp CHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSC
T ss_pred CceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCc
Confidence 9999876 6899999999999999999999988543222212222222211 12234456678889999999999999
Q ss_pred hHHHHH
Q 041655 228 HVRCML 233 (238)
Q Consensus 228 ~v~~~L 233 (238)
++.+.|
T Consensus 275 s~~e~l 280 (484)
T 3nyv_A 275 SARDAL 280 (484)
T ss_dssp CHHHHH
T ss_pred CHHHHh
Confidence 555544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=233.18 Aligned_cols=201 Identities=24% Similarity=0.288 Sum_probs=151.7
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecC-CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARP-GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
.+.+.+|+.++++++||||+++++++... +..+++|||+++++|.+++... ....+++..+..++.|++.||.|||.
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~ 135 (278)
T 1byg_A 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG 135 (278)
T ss_dssp -HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 46788999999999999999999997544 5789999999999999999752 22347899999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS- 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t- 178 (238)
+ +.||+++.++.++|+|||.+....... ....+++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 136 ~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 210 (278)
T 1byg_A 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 210 (278)
T ss_dssp TTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhC
Confidence 5 667999999999999999987543322 22456889999999988889999999999999999998
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|..||...... .....+........+...+..+.+++.+||+.||.+| ++++.|++++
T Consensus 211 g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 211 GRVPYPRIPLK-DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp SCCSCTTSCGG-GHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHH-HHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 88777542211 1112222222233344556678889999999999999 6777777664
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=237.33 Aligned_cols=218 Identities=19% Similarity=0.239 Sum_probs=165.2
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+........ ......+.+.+|+.++.+++||||+++++++.+.+..++||||+++++|.+++..
T Consensus 40 vavK~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--- 108 (321)
T 2a2a_A 40 YAAKFIKKRQSRAS--------RRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ--- 108 (321)
T ss_dssp EEEEEEEBCSSSSC--------SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT---
T ss_pred EEEEEEeccccccc--------ccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh---
Confidence 67777765443210 0001246788999999999999999999999999999999999999999999975
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCC----ceEEcccccccccCCcccccccccccCCCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDM----EARISEFGLAKVFPEAHTHITTSDVVGTAGY 149 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 149 (238)
...+++..+..++.|++.||.|||++ +.||+++.++ .+||+|||.+........ .....|++.|
T Consensus 109 -~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y 184 (321)
T 2a2a_A 109 -KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEF 184 (321)
T ss_dssp -CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGG
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCc
Confidence 45689999999999999999999954 6679999888 799999999986644322 2345789999
Q ss_pred cCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 150 ~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|||++.+..++.++|+||||+++|+|++|..||................. ....+...+..+.+++.+||+.||++|
T Consensus 185 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 264 (321)
T 2a2a_A 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKR 264 (321)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTS
T ss_pred cCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhC
Confidence 999999988899999999999999999999888743221111111111111 111123345568889999999999999
Q ss_pred -hHHHHHH
Q 041655 228 -HVRCMLS 234 (238)
Q Consensus 228 -~v~~~L~ 234 (238)
++.+.|+
T Consensus 265 ps~~e~l~ 272 (321)
T 2a2a_A 265 LTIQEALR 272 (321)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHhc
Confidence 5555443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=242.92 Aligned_cols=209 Identities=24% Similarity=0.248 Sum_probs=154.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc-------------------------
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS------------------------- 80 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------------------- 80 (238)
....+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.+++....
T Consensus 69 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (345)
T 3hko_A 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148 (345)
T ss_dssp -CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccc
Confidence 3456789999999999999999999999999999999999999999999885210
Q ss_pred -----------CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCC--ceEEcccccccccCCccc--c
Q 041655 81 -----------RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDM--EARISEFGLAKVFPEAHT--H 137 (238)
Q Consensus 81 -----------~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~--~~kl~dfg~~~~~~~~~~--~ 137 (238)
.....+++..+..++.|++.||.|||++ +.||+++.++ .+||+|||.+..+..... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 228 (345)
T 3hko_A 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228 (345)
T ss_dssp HHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--
T ss_pred ccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc
Confidence 0123356788889999999999999954 6789998776 899999999986533211 1
Q ss_pred cccccccCCCcccCcccccc--cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccC--CChHHHHHHHH
Q 041655 138 ITTSDVVGTAGYIAPEYQQT--LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLG--NGYEEQMLLVL 213 (238)
Q Consensus 138 ~~~~~~~~~~~~~apE~~~~--~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 213 (238)
.......|++.|+|||++.+ ..++.++||||||+++|+|++|..||................... ......+..+.
T Consensus 229 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (345)
T 3hko_A 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLAR 308 (345)
T ss_dssp ------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHH
T ss_pred ccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHH
Confidence 12245678999999998865 678899999999999999999998875433222222222222211 12223456788
Q ss_pred HHhhhhcCCCCCcc-hHHHHHH
Q 041655 214 KTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 214 ~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+++.+||+.||.+| ++.+.|+
T Consensus 309 ~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 309 DLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCCCHHHHhc
Confidence 89999999999999 5555554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=231.39 Aligned_cols=202 Identities=17% Similarity=0.239 Sum_probs=157.4
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++++++||||+++++++..++..+++|||+++++|.+++.. ...+++..+..++.|++.||.||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l 121 (284)
T 3kk8_A 46 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYC 121 (284)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567788999999999999999999999999999999999999999998876 35689999999999999999999
Q ss_pred hcc--------CceeeecCCCc---eEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 106 HMH--------QALVLLDHDME---ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H~~--------~~~il~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
|.+ +.||+++.++. +||+|||.+........ .....|++.|+|||++.+..++.++||||+|+++|
T Consensus 122 H~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 198 (284)
T 3kk8_A 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILY 198 (284)
T ss_dssp HHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred HHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHH
Confidence 955 66799987665 99999999976544322 13457899999999999989999999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|++|..||................. ........+..+.+++.+||+.||++| ++.+.|+
T Consensus 199 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 199 ILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99999888743221111111111111 111223445567888889999999999 5555443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-35 Score=235.28 Aligned_cols=153 Identities=24% Similarity=0.307 Sum_probs=129.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC--CCcccCHHHHHHHHHHHHHHhchhh
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR--GRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.+.+.+|+.++++++||||+++++++..++..++||||++ ++|.+++..... ....+++..+..++.|++.||.|||
T Consensus 47 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH 125 (317)
T 2pmi_A 47 PSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125 (317)
T ss_dssp CHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3567889999999999999999999999999999999997 599999875332 2245899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~ 177 (238)
.+ +.||+++.++.+||+|||.++........ .....+|+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 126 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 203 (317)
T 2pmi_A 126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203 (317)
T ss_dssp HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHH
Confidence 54 67899999999999999999865432211 234578999999998876 46899999999999999999
Q ss_pred chHHHHH
Q 041655 178 SLVKWMR 184 (238)
Q Consensus 178 t~~~~~~ 184 (238)
+|..||.
T Consensus 204 ~g~~pf~ 210 (317)
T 2pmi_A 204 TGKPLFP 210 (317)
T ss_dssp HSSCSCC
T ss_pred hCCCCCC
Confidence 9988773
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=251.96 Aligned_cols=198 Identities=23% Similarity=0.225 Sum_probs=158.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++++++||||+++++++.+.+..|+||||+++|+|.+++.........+++..+..++.|++.||.|||+
T Consensus 228 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~ 307 (543)
T 3c4z_A 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307 (543)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 34678899999999999999999999999999999999999999999987633334579999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ |.||+++.+|++||+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 308 ~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG 385 (543)
T 3c4z_A 308 RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385 (543)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhC
Confidence 4 6789999999999999999987543322 12345899999999999998999999999999999999999
Q ss_pred HHHHHHhhccCCCccccccc--ccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSK--LLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||................ .....+...+..+.+++.+||+.||++|
T Consensus 386 ~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 435 (543)
T 3c4z_A 386 RGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435 (543)
T ss_dssp SCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHC
Confidence 99986432211111111100 0122334455667888889999999999
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=234.14 Aligned_cols=201 Identities=21% Similarity=0.267 Sum_probs=152.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++++++||||+++++++.+++..++||||++ ++|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~ 137 (311)
T 3niz_A 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ 137 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35678899999999999999999999999999999999997 488888865 34568999999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++.++.+||+|||.++........ .....+|+.|+|||++.+ ..++.++||||+||++|+|++
T Consensus 138 ~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 215 (311)
T 3niz_A 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215 (311)
T ss_dssp TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh
Confidence 4 67899999999999999999865432221 233578999999998876 568999999999999999999
Q ss_pred hHHHHHHhhccCCCccccc---cc---------------------ccC----CChHHHHHHHHHHhhhhcCCCCCcc-hH
Q 041655 179 LVKWMRNVMTSENPKRAID---SK---------------------LLG----NGYEEQMLLVLKTACFCTLDDPKER-HV 229 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~---~~---------------------~~~----~~~~~~~~~l~~~~~~cl~~~p~~R-~v 229 (238)
|..||.............. .. ... ........++.+++.+||+.||++| ++
T Consensus 216 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 295 (311)
T 3niz_A 216 GKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295 (311)
T ss_dssp SSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH
T ss_pred CCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH
Confidence 9988753222211111100 00 000 0011223467888999999999999 55
Q ss_pred HHHHH
Q 041655 230 RCMLS 234 (238)
Q Consensus 230 ~~~L~ 234 (238)
.+.|+
T Consensus 296 ~ell~ 300 (311)
T 3niz_A 296 RDAMN 300 (311)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 55553
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=232.88 Aligned_cols=203 Identities=22% Similarity=0.292 Sum_probs=149.8
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.........+++..+..++.|++.||.|||.
T Consensus 63 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 142 (285)
T 3is5_A 63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142 (285)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 35778899999999999999999999999999999999999999999986533334679999999999999999999995
Q ss_pred c--------Cceeee---cCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 108 H--------QALVLL---DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ~--------~~~il~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
+ +.||++ +.++.+||+|||.+........ .....|++.|+|||++. ..++.++|+||||+++|+|
T Consensus 143 ~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~l 218 (285)
T 3is5_A 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFL 218 (285)
T ss_dssp TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHH
T ss_pred CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHH
Confidence 4 667999 5567899999999976543322 23457899999999876 4678999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
++|..||................. ........+..+.+++.+||+.||++| ++.+.|+
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 219 LTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999888743211111101100000 001111134557788888999999999 6555554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=233.48 Aligned_cols=197 Identities=22% Similarity=0.274 Sum_probs=154.2
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||.+
T Consensus 50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~ 125 (304)
T 2jam_A 50 DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN 125 (304)
T ss_dssp --HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35688999999999999999999999999999999999999999999875 34689999999999999999999955
Q ss_pred --------Cceeee---cCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 109 --------QALVLL---DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 109 --------~~~il~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
+.||++ +.++.++|+|||.+....... .....|++.|+|||++.+..++.++|+||+|+++|+|+
T Consensus 126 ~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 201 (304)
T 2jam_A 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201 (304)
T ss_dssp TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHH
T ss_pred CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHH
Confidence 667998 788999999999987543321 13346899999999999988999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..||................. ........+..+.+++.+||+.||++| ++.+.|
T Consensus 202 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 260 (304)
T 2jam_A 202 CGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKAL 260 (304)
T ss_dssp HSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 99988754222111111111111 112223445668888999999999999 555544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=236.72 Aligned_cols=202 Identities=16% Similarity=0.140 Sum_probs=157.0
Q ss_pred HHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
+.+.+|+.+++++ +||||+++++++..++..++||||+ +++|.+++.. ....+++..+..++.|++.||+|||++
T Consensus 49 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~ 124 (330)
T 2izr_A 49 PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSK 124 (330)
T ss_dssp CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3577899999999 8999999999999999999999999 8999999976 245799999999999999999999944
Q ss_pred --------CceeeecCCCc-----eEEcccccccccCCccccc-----ccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 109 --------QALVLLDHDME-----ARISEFGLAKVFPEAHTHI-----TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 109 --------~~~il~~~~~~-----~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
+.||+++.++. +||+|||+++......... ......||+.|+|||++.+..++.++||||||
T Consensus 125 ~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 204 (330)
T 2izr_A 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALG 204 (330)
T ss_dssp TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHH
Confidence 67899999887 9999999998654322111 12456899999999999999999999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCC---cccccccccCCC---hHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 171 VLLAEEMSLVKWMRNVMTSENP---KRAIDSKLLGNG---YEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~---~~~~~~~~~~~~---~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+++|+|++|..||......... ............ ....+ .+.+++..||+.||.+| ++.+.|+++
T Consensus 205 ~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 205 HMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 9999999999998653211110 111111110000 01123 78889999999999999 566666654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=247.17 Aligned_cols=197 Identities=24% Similarity=0.309 Sum_probs=154.1
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++
T Consensus 80 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~ 155 (494)
T 3lij_A 80 NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH 155 (494)
T ss_dssp THHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999998876 35689999999999999999999944
Q ss_pred --------CceeeecCC---CceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 109 --------QALVLLDHD---MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 109 --------~~~il~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.||+++.. +.+||+|||++........ .....||+.|+|||++. ..++.++||||+||++|+|+
T Consensus 156 ~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll 231 (494)
T 3lij_A 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL 231 (494)
T ss_dssp TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHH
T ss_pred CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHH
Confidence 678999764 4599999999987644322 24467999999999886 46899999999999999999
Q ss_pred chHHHHHHhhccCCCccccccccc--CCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLL--GNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..||.................. .......+..+.+++.+||+.||.+| ++.+.|
T Consensus 232 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 290 (494)
T 3lij_A 232 AGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290 (494)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHh
Confidence 999888543222111122221111 11123445667888899999999999 544444
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=242.64 Aligned_cols=204 Identities=18% Similarity=0.213 Sum_probs=156.4
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCC--eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPG--CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.+.+.+|+.++++++||||+++++++...+ ..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||
T Consensus 51 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH 129 (396)
T 4eut_A 51 VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLR 129 (396)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 566789999999999999999999997654 6799999999999999997521 1234899999999999999999999
Q ss_pred cc--------Cceeee----cCCCceEEcccccccccCCcccccccccccCCCcccCcccccc--------cCCCccCCe
Q 041655 107 MH--------QALVLL----DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT--------LSITYMCDI 166 (238)
Q Consensus 107 ~~--------~~~il~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~--------~~~~~~~Dv 166 (238)
++ +.||++ +.++.+||+|||.++....... .....|++.|+|||++.+ ..++.++||
T Consensus 130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di 206 (396)
T 4eut_A 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206 (396)
T ss_dssp HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHH
T ss_pred HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHH
Confidence 54 677988 7788899999999987644332 234678999999998764 567789999
Q ss_pred eehhHHHHhhcchHHHHHHhhccCCCccccc---------------------------ccccCCChHHHHHHHHHHhhhh
Q 041655 167 YSFGVLLAEEMSLVKWMRNVMTSENPKRAID---------------------------SKLLGNGYEEQMLLVLKTACFC 219 (238)
Q Consensus 167 wslG~~l~~~~t~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~l~~~~~~c 219 (238)
|||||++|+|++|..||.............. ..............+.+++..|
T Consensus 207 wSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~ 286 (396)
T 4eut_A 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286 (396)
T ss_dssp HHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHh
Confidence 9999999999999988854322111111100 0011123356677888999999
Q ss_pred cCCCCCcc----hHHHHHHhh
Q 041655 220 TLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 220 l~~~p~~R----~v~~~L~~~ 236 (238)
|+.||++| ++++.++++
T Consensus 287 L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 287 LEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp SCCCTTTSCCHHHHHHHHHHH
T ss_pred hccChhhhccHHHHHHHHHHH
Confidence 99999999 555555544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.27 Aligned_cols=199 Identities=18% Similarity=0.237 Sum_probs=145.0
Q ss_pred HHHHHHHHhc-CCCCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 31 QIRSEIVTLG-QIRHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 31 ~~~~E~~~l~-~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
.+.+|+.++. ..+||||+++++++.. .+..|+||||+++|+|.+++.. .....+++..+..++.|++.||.||
T Consensus 100 ~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~L 177 (400)
T 1nxk_A 100 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYL 177 (400)
T ss_dssp HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567888764 4579999999999865 5678999999999999999975 2345699999999999999999999
Q ss_pred hcc--------CceeeecC---CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 106 HMH--------QALVLLDH---DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 106 H~~--------~~~il~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
|.+ +.||+++. ++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 178 H~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 254 (400)
T 1nxk_A 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 254 (400)
T ss_dssp HHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHH
T ss_pred HHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHH
Confidence 944 67899998 78999999999986543221 23467899999999999989999999999999999
Q ss_pred hhcchHHHHHHhhccCCCc----ccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPK----RAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|++|..||.......... .+..... ........+..+.+++.+||+.||++| ++.+.|+
T Consensus 255 ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 255 ILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp HHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999886433221110 1111111 111123455678889999999999999 5544443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=232.62 Aligned_cols=203 Identities=14% Similarity=0.126 Sum_probs=156.8
Q ss_pred HHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
+.+.+|+.++.++ +|+|++++++++..+...+++|||+ +++|.+++.. ....+++..+..++.|++.||.|||++
T Consensus 50 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~ 125 (298)
T 1csn_A 50 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK 125 (298)
T ss_dssp CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4567899999999 6999999999999999999999999 8999999976 234689999999999999999999954
Q ss_pred --------CceeeecCCCc-----eEEcccccccccCCcccc-----cccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 109 --------QALVLLDHDME-----ARISEFGLAKVFPEAHTH-----ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 109 --------~~~il~~~~~~-----~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
+.||+++.++. +||+|||.++........ .......||+.|+|||++.+..++.++||||||
T Consensus 126 ~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 205 (298)
T 1csn_A 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 205 (298)
T ss_dssp TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHH
Confidence 67799987776 999999999876443221 122456799999999999998899999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCC---cccccccccCC---ChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 171 VLLAEEMSLVKWMRNVMTSENP---KRAIDSKLLGN---GYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+++|+|++|..||......... ........... .....+..+.+++..||+.||++| ++.+.|+++
T Consensus 206 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 206 HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 9999999999988642211100 01111111111 112345678889999999999999 666666654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=231.62 Aligned_cols=203 Identities=20% Similarity=0.297 Sum_probs=155.8
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++.. +..+++|||+++++|.+++... ....+++..+..++.|++.||.|||++
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (279)
T 1qpc_A 52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER 128 (279)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3578899999999999999999999864 4578999999999999998641 123689999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-h
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS-L 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t-~ 179 (238)
+.||+++.++.+||+|||.+......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 129 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 207 (279)
T 1qpc_A 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207 (279)
T ss_dssp TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTT
T ss_pred CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCC
Confidence 66799999999999999999876543221 1133456788999999988889999999999999999999 7
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
..||....... ....+........+...+..+.+++..||+.||++| ++.+.|+++
T Consensus 208 ~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 208 RIPYPGMTNPE-VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CCSSTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCHHH-HHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 77764322111 111111122222334455678888899999999999 666666654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=248.07 Aligned_cols=195 Identities=23% Similarity=0.181 Sum_probs=152.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|..++..++||||+++++++.+.+..|+||||+++|+|.+++... ...+++..++.++.|++.||+|||+
T Consensus 104 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~ 180 (412)
T 2vd5_A 104 EVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR 180 (412)
T ss_dssp GGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999999999999999999999999999752 3468999999999999999999994
Q ss_pred --------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-------ccCCCccCCeeehhHH
Q 041655 108 --------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-------TLSITYMCDIYSFGVL 172 (238)
Q Consensus 108 --------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-------~~~~~~~~DvwslG~~ 172 (238)
|+.||+++.++++||+|||+++........ ......||+.|+|||++. +..++.++|+|||||+
T Consensus 181 ~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvi 259 (412)
T 2vd5_A 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVF 259 (412)
T ss_dssp TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHH
T ss_pred CCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHH
Confidence 477899999999999999999866443221 223468999999999886 3568899999999999
Q ss_pred HHhhcchHHHHHHhhccCCCccccccc--c-cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 173 LAEEMSLVKWMRNVMTSENPKRAIDSK--L-LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|||++|..||...........+.... . .+......+.++.+++.+||. +|++|
T Consensus 260 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~R 316 (412)
T 2vd5_A 260 AYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETR 316 (412)
T ss_dssp HHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGC
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-Chhhc
Confidence 999999999985433222222222211 1 111123445667888889999 99999
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=249.33 Aligned_cols=197 Identities=17% Similarity=0.173 Sum_probs=153.9
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+.+|+.++..++||||+++++++.+++..|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++
T Consensus 114 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g 188 (410)
T 3v8s_A 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG 188 (410)
T ss_dssp STHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4578899999999999999999999999999999999999999999875 3589999999999999999999944
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC----CCccCCeeehhHHHHhhc
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS----ITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~----~~~~~DvwslG~~l~~~~ 177 (238)
+.||+++.++++||+|||+++........ ......||+.|+|||++.+.. ++.++|+|||||++|+|+
T Consensus 189 ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell 267 (410)
T 3v8s_A 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267 (410)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHH
T ss_pred eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHH
Confidence 67899999999999999999865443221 224578999999999987655 788999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCc--c-hHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKE--R-HVRCM 232 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~--R-~v~~~ 232 (238)
+|..||...........+..... ........+..+.+++.+||..+|.+ | .+.+.
T Consensus 268 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei 327 (410)
T 3v8s_A 268 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEI 327 (410)
T ss_dssp HSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHH
T ss_pred hCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHH
Confidence 99999864332222223332211 11111234456777888899988877 7 44333
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=241.87 Aligned_cols=208 Identities=13% Similarity=0.091 Sum_probs=150.8
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHH---HHhcCCCCCccccee-------eeeecCC-------------
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEI---VTLGQIRHRNILPLL-------AHLARPG------------- 58 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~~iv~~~-------~~~~~~~------------- 58 (238)
||||.+...... .....+.+.+|+ ..+.+++||||++++ +++.+++
T Consensus 101 vavK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (377)
T 3byv_A 101 FEVHVPYFTERP-----------PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 169 (377)
T ss_dssp EEEEEEEECC-C-----------CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------
T ss_pred EEEEEEeecccc-----------chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCc
Confidence 677777643221 123457788999 566667899999998 5555443
Q ss_pred ----eeEEEEEeCCCCCHHHHHhhhcC---CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEc
Q 041655 59 ----CHLLVYEFMKNGSLQDILNDVSR---GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARIS 123 (238)
Q Consensus 59 ----~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~ 123 (238)
..|++|||+ +|+|.+++..... ....+++..+..++.|++.||+|||++ |.||+++.++.+||+
T Consensus 170 ~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~ 248 (377)
T 3byv_A 170 MWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 248 (377)
T ss_dssp CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEEC
T ss_pred eEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEE
Confidence 278999999 6799999975211 123455688889999999999999944 778999999999999
Q ss_pred ccccccccCCcccccccccccCCCcccCccccccc-----------CCCccCCeeehhHHHHhhcchHHHHHHhhccCCC
Q 041655 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-----------SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENP 192 (238)
Q Consensus 124 dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-----------~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~ 192 (238)
|||+++..... .....| +.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 249 DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~ 322 (377)
T 3byv_A 249 GFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS 322 (377)
T ss_dssp CGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS
T ss_pred echhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch
Confidence 99999854332 234567 999999999887 7999999999999999999999998765443333
Q ss_pred cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 193 KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
...... ....+..+.+++.+||+.||++| ++.+.|
T Consensus 323 ~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 323 EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp GGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred hhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 332221 12334567888889999999999 444443
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=227.53 Aligned_cols=201 Identities=21% Similarity=0.316 Sum_probs=154.8
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
.....+.+.+|+.++++++||||+++++++.. ....++||||+++++|.+++.. ...+++..+..++.|++.
T Consensus 65 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~ 140 (290)
T 1t4h_A 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILK 140 (290)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHH
Confidence 34557789999999999999999999998864 4568999999999999999976 356899999999999999
Q ss_pred HhchhhccC----------ceeeec-CCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 101 GLEYLHMHQ----------ALVLLD-HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 101 gl~~lH~~~----------~~il~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
||.|||+++ .||+++ .++.+||+|||.+....... .....|++.|+|||++.+ .++.++|+||+
T Consensus 141 ~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~sl 215 (290)
T 1t4h_A 141 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAF 215 (290)
T ss_dssp HHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHH
T ss_pred HHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHH
Confidence 999999664 469997 78999999999997543332 133568999999998864 58999999999
Q ss_pred hHHHHhhcchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 170 GVLLAEEMSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 170 G~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|+++|+|++|..||................. ....+...+..+.+++.+||+.||.+| ++.+.|+
T Consensus 216 G~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 216 GMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 9999999999988854322211111122111 112223334568888999999999999 5555554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=227.51 Aligned_cols=196 Identities=18% Similarity=0.281 Sum_probs=152.6
Q ss_pred HHHHHHHHhcCCCCCcccceeeeeec----------------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHH
Q 041655 31 QIRSEIVTLGQIRHRNILPLLAHLAR----------------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRT 94 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 94 (238)
.+.+|+.++.+++||||+++++++.. ....+++|||+++++|.+++... ....+++..+..+
T Consensus 50 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i 127 (284)
T 2a19_B 50 KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALEL 127 (284)
T ss_dssp GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHH
Confidence 45689999999999999999998854 34578999999999999999752 2356899999999
Q ss_pred HHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCe
Q 041655 95 VRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDI 166 (238)
Q Consensus 95 ~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dv 166 (238)
+.|++.||.|||.+ +.||+++.++.+||+|||.+........ .....|++.|+|||.+.+..++.++|+
T Consensus 128 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di 204 (284)
T 2a19_B 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDL 204 (284)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHH
T ss_pred HHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhh
Confidence 99999999999954 6679999999999999999886644322 233568999999999998889999999
Q ss_pred eehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 167 YSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 167 wslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
||||+++|+|++|..|+...... ...+.... .+...+..+.+++.+||+.||.+| ++++.|..++
T Consensus 205 ~slG~il~~l~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 205 YALGLILAELLHVCDTAFETSKF---FTDLRDGI---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHHHHHSCCSSHHHHHHH---HHHHHTTC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCCcchhHHHH---HHHhhccc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 99999999999987766543211 01111111 112233456778888999999999 6666666554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=236.13 Aligned_cols=212 Identities=17% Similarity=0.227 Sum_probs=162.1
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCC-CHHHHHhhhc
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNG-SLQDILNDVS 80 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~-~L~~~l~~~~ 80 (238)
||||.+......... .........+.+|+.++++++||||+++++++.+.+..++||||+.+| +|.+++..
T Consensus 52 vavK~~~~~~~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-- 123 (335)
T 3dls_A 52 VVVKFIKKEKVLEDC------WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-- 123 (335)
T ss_dssp EEEEEEESTTSCTTS------EEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT--
T ss_pred EEEEEEehhhccccc------ccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh--
Confidence 788877665432110 000112345678999999999999999999999999999999998766 99999975
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
...+++..+..++.|++.||.|||.+ +.||+++.++.+||+|||.+........ .....||+.|+||
T Consensus 124 --~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aP 198 (335)
T 3dls_A 124 --HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAP 198 (335)
T ss_dssp --CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCH
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccCh
Confidence 45699999999999999999999944 6789999999999999999987644322 2335789999999
Q ss_pred ccccccCC-CccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHH
Q 041655 153 EYQQTLSI-TYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVR 230 (238)
Q Consensus 153 E~~~~~~~-~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~ 230 (238)
|++.+..+ +.++||||||+++|+|++|..||..... ...... ..+...+..+.+++.+||+.||++| ++.
T Consensus 199 E~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ 270 (335)
T 3dls_A 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLE 270 (335)
T ss_dssp HHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHH
Confidence 99888776 7889999999999999999998854222 111111 1122234557788888999999999 555
Q ss_pred HHHH
Q 041655 231 CMLS 234 (238)
Q Consensus 231 ~~L~ 234 (238)
+.|+
T Consensus 271 ell~ 274 (335)
T 3dls_A 271 KLVT 274 (335)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 5554
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=238.29 Aligned_cols=166 Identities=22% Similarity=0.265 Sum_probs=131.7
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecC-----CeeEEEEEeCCCCCHHHHH
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP-----GCHLLVYEFMKNGSLQDIL 76 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l 76 (238)
||||++..... .....+++.+|+.+|++++||||+++++++... +..|+||||+. ++|.+++
T Consensus 54 vAiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~ 120 (432)
T 3n9x_A 54 VAIKKVNRMFE------------DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLF 120 (432)
T ss_dssp EEEEEECSTTT------------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHH
T ss_pred EEEEEeCchhc------------ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHH
Confidence 67777754322 233457889999999999999999999999765 56899999995 6999999
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccc-----------
Q 041655 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH----------- 137 (238)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~----------- 137 (238)
.. ...+++..+..++.|+++||.|||++ |.||+++.++.+||+|||+++........
T Consensus 121 ~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 196 (432)
T 3n9x_A 121 KT----PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196 (432)
T ss_dssp HS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----------------
T ss_pred hc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccccccc
Confidence 75 46699999999999999999999944 77899999999999999999876432211
Q ss_pred ---------cccccccCCCcccCcccc-cccCCCccCCeeehhHHHHhhcchHHHHH
Q 041655 138 ---------ITTSDVVGTAGYIAPEYQ-QTLSITYMCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 138 ---------~~~~~~~~~~~~~apE~~-~~~~~~~~~DvwslG~~l~~~~t~~~~~~ 184 (238)
.......||+.|+|||++ .+..++.++||||+||++|||++|..|+.
T Consensus 197 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp --------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 112456889999999975 56678999999999999999998655543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=247.24 Aligned_cols=198 Identities=25% Similarity=0.321 Sum_probs=156.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 89 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~ 164 (504)
T 3q5i_A 89 FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK 164 (504)
T ss_dssp THHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356789999999999999999999999999999999999999999999876 3568999999999999999999995
Q ss_pred c--------CceeeecCCC---ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 108 H--------QALVLLDHDM---EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ~--------~~~il~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
+ |.||+++.++ .+||+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|
T Consensus 165 ~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l 240 (504)
T 3q5i_A 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYIL 240 (504)
T ss_dssp TTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHH
T ss_pred CCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHH
Confidence 4 6789998876 699999999987644322 234679999999999864 689999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccCC--ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLGN--GYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++|..||...........+........ .....+..+.+++.+||+.||.+| ++.+.|
T Consensus 241 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l 300 (504)
T 3q5i_A 241 LCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300 (504)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 999988854322211222222211111 112345668888999999999999 555444
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=237.12 Aligned_cols=202 Identities=21% Similarity=0.328 Sum_probs=156.5
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
....+.+.+|+.++.++ +||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|
T Consensus 140 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~ 215 (365)
T 2y7j_A 140 EEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSF 215 (365)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Confidence 34467788999999999 799999999999999999999999999999999976 3568999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc------cCCCccCCeeehh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT------LSITYMCDIYSFG 170 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~------~~~~~~~DvwslG 170 (238)
||.+ |.||+++.++.++|+|||++..+..... .....||+.|+|||++.+ ..++.++||||||
T Consensus 216 LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 292 (365)
T 2y7j_A 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292 (365)
T ss_dssp HHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHH
T ss_pred HHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHH
Confidence 9954 6789999999999999999886644322 234678999999998763 3578899999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCcccccccccCC--ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGN--GYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+++|+|++|..||.................... .....+..+.+++.+||+.||++| ++.+.|+
T Consensus 293 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 293 VILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999999888743211111111111111111 112334568889999999999999 5555554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=236.45 Aligned_cols=192 Identities=21% Similarity=0.262 Sum_probs=134.1
Q ss_pred HHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
..+.+|+.+++.+. ||||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++
T Consensus 50 ~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~ 125 (325)
T 3kn6_A 50 ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV 125 (325)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 55678999999997 99999999999999999999999999999999976 46799999999999999999999954
Q ss_pred --------CceeeecCCC---ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 109 --------QALVLLDHDM---EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 109 --------~~~il~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
+.||+++.++ .+||+|||.++....... ......||+.|+|||++.+..++.++||||+|+++|+|+
T Consensus 126 ~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 203 (325)
T 3kn6_A 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTML 203 (325)
T ss_dssp TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 6789997766 899999999986543322 123457899999999999989999999999999999999
Q ss_pred chHHHHHHhhccCCC-------ccccccccc--CCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENP-------KRAIDSKLL--GNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~-------~~~~~~~~~--~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||......... ......... .......+..+.+++.+||+.||.+|
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 262 (325)
T 3kn6_A 204 SGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKR 262 (325)
T ss_dssp HSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTC
T ss_pred hCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHC
Confidence 999988643321110 111111111 11123446678889999999999999
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=231.70 Aligned_cols=195 Identities=21% Similarity=0.227 Sum_probs=155.7
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||.+
T Consensus 58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (284)
T 2vgo_A 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER 133 (284)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999999976 34689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.+....... .....|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 134 ~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 209 (284)
T 2vgo_A 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209 (284)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred CceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCC
Confidence 667999999999999999987553322 23457899999999999888999999999999999999998
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
.||................ ...+...+..+.+++.+||+.||.+| ++.+.|
T Consensus 210 ~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 261 (284)
T 2vgo_A 210 PPFDSPSHTETHRRIVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVM 261 (284)
T ss_dssp CTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCCCCHhHHHHHHhccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHh
Confidence 8875322111111111111 11223344567888888999999999 554444
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=230.29 Aligned_cols=198 Identities=22% Similarity=0.264 Sum_probs=156.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++.+++||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||.
T Consensus 63 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~ 137 (303)
T 3a7i_A 63 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS 137 (303)
T ss_dssp THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 357788999999999999999999999999999999999999999999864 468999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.++|+|||.+........ ......|++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 138 ~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 215 (303)
T 3a7i_A 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215 (303)
T ss_dssp TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccC
Confidence 4 6679999999999999999976543321 12346789999999999988899999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
..||......... ..+............+..+.+++.+||+.||++| ++.+.|
T Consensus 216 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 269 (303)
T 3a7i_A 216 EPPHSELHPMKVL-FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELL 269 (303)
T ss_dssp SCTTTTSCHHHHH-HHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred CCCCCCcCHHHHH-HHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 8887532211111 1111111122223344567888889999999999 444444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=249.27 Aligned_cols=193 Identities=19% Similarity=0.149 Sum_probs=151.9
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-- 107 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~-- 107 (238)
..+.+|+.++..++||||++++++|.+++..|+||||+++|+|.+++.. ....+++..++.++.|++.||.|||.
T Consensus 119 ~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g 195 (437)
T 4aw2_A 119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH 195 (437)
T ss_dssp CCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3478899999999999999999999999999999999999999999975 24569999999999999999999994
Q ss_pred ------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-----ccCCCccCCeeehhHHHHhh
Q 041655 108 ------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-----TLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~DvwslG~~l~~~ 176 (238)
|+.||+++.++.+||+|||+++........ ......||+.|+|||++. ...++.++|||||||++|||
T Consensus 196 iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~el 274 (437)
T 4aw2_A 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEM 274 (437)
T ss_dssp EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHH
T ss_pred eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHH
Confidence 477899999999999999999765433221 224468999999999886 45689999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccc---cCCChHHHHHHHHHHhhhhcCCCCCc
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKL---LGNGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
++|..||...........+..... .+......+.++.+++.+||..+|+.
T Consensus 275 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r 327 (437)
T 4aw2_A 275 LYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHR 327 (437)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGC
T ss_pred HhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccc
Confidence 999999854332222222222111 11122234556778888899888777
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=239.83 Aligned_cols=161 Identities=22% Similarity=0.318 Sum_probs=127.6
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeec-----CCeeEEEEEeCCCCCHHHHH
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR-----PGCHLLVYEFMKNGSLQDIL 76 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l 76 (238)
||||++..... .....+++.+|+.+|.+++||||+++++++.. .+..|+||||+ +++|.+++
T Consensus 81 vaiK~i~~~~~------------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~ 147 (458)
T 3rp9_A 81 VAIKKILRVFE------------DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLF 147 (458)
T ss_dssp EEEEEECSTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHH
T ss_pred EEEEEechhhc------------CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhc
Confidence 67777754322 23346778999999999999999999999843 35689999998 57999998
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccc-----------
Q 041655 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTH----------- 137 (238)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~----------- 137 (238)
.. ...+++..+..++.|++.||.|||+ |+.||+++.++.+||+|||+++........
T Consensus 148 ~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 223 (458)
T 3rp9_A 148 RT----PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223 (458)
T ss_dssp HS----SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC------
T ss_pred cc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccc
Confidence 75 4669999999999999999999994 467899999999999999999875422110
Q ss_pred --------------cccccccCCCcccCcccc-cccCCCccCCeeehhHHHHhhcch
Q 041655 138 --------------ITTSDVVGTAGYIAPEYQ-QTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 138 --------------~~~~~~~~~~~~~apE~~-~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
.......||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp ---------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 112345789999999975 566789999999999999999984
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=247.24 Aligned_cols=198 Identities=25% Similarity=0.318 Sum_probs=154.6
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++
T Consensus 65 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~ 140 (486)
T 3mwu_A 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH 140 (486)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999999876 35689999999999999999999954
Q ss_pred --------Cceeeec---CCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 109 --------QALVLLD---HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 109 --------~~~il~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.||+++ .++.+||+|||+++....... .....||+.|+|||++.+ .++.++||||+||++|+|+
T Consensus 141 ~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (486)
T ss_dssp TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHH
T ss_pred CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHH
Confidence 6789995 456799999999976543322 234678999999999876 5899999999999999999
Q ss_pred chHHHHHHhhccCCCccccccccc--CCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLL--GNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||...........+...... .......+..+.+++.+||+.||.+| ++.+.|+
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 999888543222111222222211 12223445678889999999999999 5555543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=230.54 Aligned_cols=199 Identities=20% Similarity=0.251 Sum_probs=156.1
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+.+|+.++.+++||||+++++++...+..+++|||+++++|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 69 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 145 (314)
T 3com_A 69 QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR 145 (314)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5688999999999999999999999999999999999999999999874 245689999999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
+.||+++.++.++|+|||.+........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 146 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (314)
T 3com_A 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223 (314)
T ss_dssp EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 6679999999999999999976543221 1234578999999999998889999999999999999999988
Q ss_pred HHHHhhccCCCcccccc-cccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 182 WMRNVMTSENPKRAIDS-KLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 182 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
||............... ......+...+..+.+++.+||+.||.+| ++.+.|
T Consensus 224 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll 277 (314)
T 3com_A 224 PYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLL 277 (314)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 87532211111000000 11112233445668889999999999999 544444
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=229.25 Aligned_cols=200 Identities=20% Similarity=0.261 Sum_probs=157.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++++++||||+++++++.+++..+++|||+++++|.+++.. ...+++..+..++.|++.||.||
T Consensus 56 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~l 131 (294)
T 2rku_A 56 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYL 131 (294)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999999999999999999999999999875 35689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.+||+|||.+........ ......|++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus 132 H~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 209 (294)
T 2rku_A 132 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 209 (294)
T ss_dssp HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHH
T ss_pred HHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHH
Confidence 955 6679999999999999999986543221 123457899999999998888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..||................ ...+...+..+.+++.+||+.||++| ++.+.|
T Consensus 210 ~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 264 (294)
T 2rku_A 210 VGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELL 264 (294)
T ss_dssp HSSCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred hCCCCCCCCCHHHHHHHHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 9988874322111111111111 11222334567788888999999999 443333
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=238.58 Aligned_cols=151 Identities=22% Similarity=0.298 Sum_probs=131.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.||
T Consensus 72 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~l 147 (360)
T 3eqc_A 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYL 147 (360)
T ss_dssp HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999999999999999999999999999999976 34689999999999999999999
Q ss_pred hcc---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|++ +.||+++.++.++|+|||.+....... .....|++.|+|||++.+..++.++||||||+++|+|
T Consensus 148 h~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 223 (360)
T 3eqc_A 148 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223 (360)
T ss_dssp HHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHH
T ss_pred HHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHH
Confidence 953 567999999999999999987543221 2345789999999999998999999999999999999
Q ss_pred cchHHHHH
Q 041655 177 MSLVKWMR 184 (238)
Q Consensus 177 ~t~~~~~~ 184 (238)
++|..||.
T Consensus 224 ~~g~~pf~ 231 (360)
T 3eqc_A 224 AVGRYPIP 231 (360)
T ss_dssp HHTSCCSS
T ss_pred HhCCCCCC
Confidence 99987763
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=233.02 Aligned_cols=215 Identities=23% Similarity=0.291 Sum_probs=155.7
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
||||.+...... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+++++|.+++..
T Consensus 41 vavK~~~~~~~~--------------~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-- 104 (316)
T 2ac3_A 41 YAVKIIEKQPGH--------------IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-- 104 (316)
T ss_dssp EEEEEEECCSSC--------------CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--
T ss_pred EEEEEEeeCcch--------------hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc--
Confidence 677777544321 246788999999885 699999999999999999999999999999999976
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCc---eEEcccccccccCCccc-----cccccccc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDME---ARISEFGLAKVFPEAHT-----HITTSDVV 144 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~---~kl~dfg~~~~~~~~~~-----~~~~~~~~ 144 (238)
...+++..+..++.|++.||+|||.+ +.||+++.++. +||+|||++........ ........
T Consensus 105 --~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 182 (316)
T 2ac3_A 105 --RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182 (316)
T ss_dssp --HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------C
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccccccccc
Confidence 35689999999999999999999954 66799988776 99999999876532111 11112356
Q ss_pred CCCcccCcccccc-----cCCCccCCeeehhHHHHhhcchHHHHHHhhccCC---------------CcccccccccCC-
Q 041655 145 GTAGYIAPEYQQT-----LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSEN---------------PKRAIDSKLLGN- 203 (238)
Q Consensus 145 ~~~~~~apE~~~~-----~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~---------------~~~~~~~~~~~~- 203 (238)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ............
T Consensus 183 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 262 (316)
T 2ac3_A 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPD 262 (316)
T ss_dssp CSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCH
T ss_pred CCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCc
Confidence 8999999998865 5578999999999999999999988754321110 000011111000
Q ss_pred -ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 204 -GYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 204 -~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.....+..+.+++.+||+.||.+| ++.+.|+
T Consensus 263 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 263 KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 012345568889999999999999 5555554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=230.97 Aligned_cols=198 Identities=24% Similarity=0.289 Sum_probs=144.4
Q ss_pred HHHHHhcCCCCCcccceeeeee-----cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 34 SEIVTLGQIRHRNILPLLAHLA-----RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 34 ~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.|+..+..++||||+++++.+. ....+++||||+++|+|.+++.. ...++..+..++.|++.||.|||++
T Consensus 56 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~ 130 (336)
T 3g2f_A 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTE 130 (336)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhh
Confidence 4455566689999999998543 23467899999999999999975 3458889999999999999999965
Q ss_pred -----------------CceeeecCCCceEEcccccccccCCccc------ccccccccCCCcccCcccccc-------c
Q 041655 109 -----------------QALVLLDHDMEARISEFGLAKVFPEAHT------HITTSDVVGTAGYIAPEYQQT-------L 158 (238)
Q Consensus 109 -----------------~~~il~~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~~~apE~~~~-------~ 158 (238)
+.||+++.++.+||+|||+++.+..... ........||+.|+|||++.+ .
T Consensus 131 ~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 210 (336)
T 3g2f_A 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE 210 (336)
T ss_dssp BCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHH
T ss_pred hccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccc
Confidence 4579999999999999999986643211 111234579999999999876 4
Q ss_pred CCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccc------------------cccccC------CChHHHHHHHHH
Q 041655 159 SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAI------------------DSKLLG------NGYEEQMLLVLK 214 (238)
Q Consensus 159 ~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~------------------~~~~~~------~~~~~~~~~l~~ 214 (238)
.++.++|||||||++|+|++|..|+............. .....+ ......+..+.+
T Consensus 211 ~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 290 (336)
T 3g2f_A 211 SALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHH
Confidence 56678999999999999999976664433221111110 000011 112345667899
Q ss_pred HhhhhcCCCCCcc----hHHHHHHhh
Q 041655 215 TACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 215 ~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++.+||+.||++| ++++.|+++
T Consensus 291 li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 291 TIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcCChhhCcchHHHHHHHHHH
Confidence 9999999999999 666666655
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=227.42 Aligned_cols=211 Identities=15% Similarity=0.178 Sum_probs=158.1
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
||||.+...... ......+.+|+..+.++ +||||+++++++.+++..++||||+++++|.+++....
T Consensus 39 vaiK~~~~~~~~------------~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 106 (289)
T 1x8b_A 39 YAIKRSKKPLAG------------SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENY 106 (289)
T ss_dssp EEEEEEECCCTT------------SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHH
T ss_pred EEEEEecccccc------------cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhc
Confidence 677776544322 12356778999999999 89999999999999999999999999999999997633
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCC-------------------CceEEcccccccccCC
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHD-------------------MEARISEFGLAKVFPE 133 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~-------------------~~~kl~dfg~~~~~~~ 133 (238)
.....+++..+..++.|++.||.|||.+ |.||+++.+ ..++|+|||.+.....
T Consensus 107 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~ 186 (289)
T 1x8b_A 107 RIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186 (289)
T ss_dssp HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTC
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCC
Confidence 3335689999999999999999999954 677999844 4799999999876543
Q ss_pred cccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHH
Q 041655 134 AHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLV 212 (238)
Q Consensus 134 ~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 212 (238)
. ....|++.|+|||++.+. .++.++||||||+++|+|++|..|+.... ....+........+...+..+
T Consensus 187 ~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 256 (289)
T 1x8b_A 187 P------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWHEIRQGRLPRIPQVLSQEF 256 (289)
T ss_dssp S------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----HHHHHHTTCCCCCSSCCCHHH
T ss_pred c------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----HHHHHHcCCCCCCCcccCHHH
Confidence 2 224589999999998765 55679999999999999999876542211 111111111222333445567
Q ss_pred HHHhhhhcCCCCCcc-hHHHHHH
Q 041655 213 LKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 213 ~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.+++.+||+.||++| ++.+.|+
T Consensus 257 ~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 257 TELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCcccCCCHHHHhh
Confidence 888889999999999 6555554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=231.29 Aligned_cols=196 Identities=22% Similarity=0.241 Sum_probs=152.9
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||.+
T Consensus 53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~ 128 (279)
T 3fdn_A 53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK 128 (279)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56788999999999999999999999999999999999999999999976 35689999999999999999999955
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.++|+|||.+....... .....|++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 129 ~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 204 (279)
T 3fdn_A 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204 (279)
T ss_dssp TCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CEecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCC
Confidence 667999999999999999986543322 23457899999999999888999999999999999999998
Q ss_pred HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 181 KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.||.............. .....+...+..+.+++.+||+.||++| ++.+.|+
T Consensus 205 ~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 205 PPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCCCcHHHHHHHHHh--CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 88753221111111111 1112233345567788888999999999 5555443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=234.66 Aligned_cols=200 Identities=20% Similarity=0.261 Sum_probs=157.3
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++.. ...+++..+..++.|++.||.||
T Consensus 82 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~L 157 (335)
T 2owb_A 82 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYL 157 (335)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999999999999999999999999999876 35689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
|.+ +.||+++.++.+||+|||.+........ ......|++.|+|||++.+..++.++|+||||+++|+|+
T Consensus 158 H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 235 (335)
T 2owb_A 158 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 235 (335)
T ss_dssp HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHH
T ss_pred HHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 955 6679999999999999999986543221 123457899999999999888999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|..||................ ...+......+.+++.+||+.||++| .+.+.|
T Consensus 236 ~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 290 (335)
T 2owb_A 236 VGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELL 290 (335)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred HCcCCCCCCCHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 9988874321111111111111 11222334557788888999999999 444433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=229.88 Aligned_cols=198 Identities=21% Similarity=0.292 Sum_probs=153.1
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||.+
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~ 127 (283)
T 3bhy_A 52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK 127 (283)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46788999999999999999999999999999999999999999999975 35689999999999999999999954
Q ss_pred --------CceeeecCCC----ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 109 --------QALVLLDHDM----EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 109 --------~~~il~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
+.||+++.++ .++|+|||.+........ .....+++.|+|||++.+..++.++|+||||+++|+|
T Consensus 128 ~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 204 (283)
T 3bhy_A 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 204 (283)
T ss_dssp TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHH
Confidence 6679998877 899999999976543322 1335689999999999888899999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
++|..||................. ........+..+.+++.+||+.||++| ++.+.|
T Consensus 205 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 264 (283)
T 3bhy_A 205 LSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264 (283)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 999888753221111111111111 111123345568889999999999999 444444
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=232.22 Aligned_cols=200 Identities=21% Similarity=0.263 Sum_probs=148.5
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.++++++||||+++++++...+..++||||+++ +|.+++.. ....+++..+..++.|+++||.|||++
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (288)
T 1ob3_A 44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR 119 (288)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35678999999999999999999999999999999999975 89998875 345689999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+.||+++.++.+||+|||.+........ ......+|+.|+|||++.+ ..++.++|+||+|+++|+|++|
T Consensus 120 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (288)
T 1ob3_A 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (288)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 6689999999999999999876543211 1233578999999998865 4589999999999999999999
Q ss_pred HHHHHHhhccCCCccc--------------------cccccc-------CCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 180 VKWMRNVMTSENPKRA--------------------IDSKLL-------GNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~--------------------~~~~~~-------~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
..||............ .+.... .......+..+.+++.+||+.||++| ++.+
T Consensus 198 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 277 (288)
T 1ob3_A 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (288)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 8877432110000000 000000 00112235567888999999999999 6655
Q ss_pred HHH
Q 041655 232 MLS 234 (238)
Q Consensus 232 ~L~ 234 (238)
.|+
T Consensus 278 ~l~ 280 (288)
T 1ob3_A 278 ALE 280 (288)
T ss_dssp HHT
T ss_pred Hhc
Confidence 554
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=230.73 Aligned_cols=195 Identities=19% Similarity=0.165 Sum_probs=145.7
Q ss_pred HHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
...+.+|+..+.++ +||||+++++++.+++..++||||+ +++|.+++... ...+++..+..++.|++.||+|||+
T Consensus 100 ~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~ 175 (311)
T 3p1a_A 100 RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS 175 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34555666665555 8999999999999999999999999 67999988762 4569999999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+ +.||+++.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|
T Consensus 176 ~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g 251 (311)
T 3p1a_A 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACN 251 (311)
T ss_dssp TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHT
T ss_pred CCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhC
Confidence 4 6789999999999999999876543322 234568999999998876 789999999999999999998
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
..++...... ............+...+..+.+++.+||+.||++| ++.+.|+
T Consensus 252 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 252 MELPHGGEGW---QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCCCSSHHHH---HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCccHH---HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 5443221111 11111111112233445668889999999999999 5555443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=231.08 Aligned_cols=207 Identities=22% Similarity=0.264 Sum_probs=157.6
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeee--cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLA--RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+.+.+|+.++++++||||+++++++. .++..++||||+++++|.+++.........+++..++.++.|++.||.
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~ 125 (279)
T 2w5a_A 46 EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125 (279)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999874 467889999999999999999764334456999999999999999999
Q ss_pred hhhccC-------------ceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehh
Q 041655 104 YLHMHQ-------------ALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFG 170 (238)
Q Consensus 104 ~lH~~~-------------~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG 170 (238)
|||.++ .||+++.++.+||+|||.+........ ......|++.|+|||++.+..++.++|+||||
T Consensus 126 ~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 203 (279)
T 2w5a_A 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203 (279)
T ss_dssp HHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHH
T ss_pred HHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHH
Confidence 999654 469999999999999999876543221 11235689999999999888899999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHHh
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLSQ 235 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~~ 235 (238)
+++|+|++|..||....... ....+........+...+..+.+++.+||+.||++| ++.+.|+.
T Consensus 204 ~il~~l~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 204 CLLYELCALMPPFTAFSQKE-LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp HHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHCCCCCcccCHHH-HHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 99999999988764322111 111111111122333445668888899999999999 66555554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=249.59 Aligned_cols=194 Identities=24% Similarity=0.257 Sum_probs=156.2
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.+|.+++||||+++++++.+.+..|+||||+++|+|.+++.. .+...+++..+..++.|++.||.|||.+
T Consensus 228 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH~~ 305 (576)
T 2acx_A 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLHRE 305 (576)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45678999999999999999999999999999999999999999999875 2334589999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.+|.+||+|||+++....... .....||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 306 gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~ 382 (576)
T 2acx_A 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382 (576)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSS
T ss_pred CEeccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence 6789999999999999999987643322 23458999999999999888999999999999999999999
Q ss_pred HHHHHhhccCCCccccc--ccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 181 KWMRNVMTSENPKRAID--SKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.||.............. .......+...+..+.+++.+||+.||.+|
T Consensus 383 ~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R 431 (576)
T 2acx_A 383 SPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431 (576)
T ss_dssp CSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHc
Confidence 99864322111111110 011122334455667888889999999999
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=240.14 Aligned_cols=152 Identities=24% Similarity=0.384 Sum_probs=125.4
Q ss_pred HHHHHHHHHHHHhcCCC-CCcccceeeeeecCC--eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 27 EEMMQIRSEIVTLGQIR-HRNILPLLAHLARPG--CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....++.+|+.++.++. ||||+++++++...+ ..|+||||++ ++|.+++.. ..+++..+..++.|++.||+
T Consensus 50 ~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~ 123 (388)
T 3oz6_A 50 TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIK 123 (388)
T ss_dssp HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHH
Confidence 44567889999999997 999999999997544 6899999996 589999875 46889999999999999999
Q ss_pred hhhc--------cCceeeecCCCceEEcccccccccCCcc-------------------cccccccccCCCcccCccccc
Q 041655 104 YLHM--------HQALVLLDHDMEARISEFGLAKVFPEAH-------------------THITTSDVVGTAGYIAPEYQQ 156 (238)
Q Consensus 104 ~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~-------------------~~~~~~~~~~~~~~~apE~~~ 156 (238)
|||+ ||.||+++.++.+||+|||+++...... .........||+.|+|||++.
T Consensus 124 ~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 203 (388)
T 3oz6_A 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILL 203 (388)
T ss_dssp HHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHT
T ss_pred HHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhc
Confidence 9994 4778999999999999999998653210 011123467999999999887
Q ss_pred c-cCCCccCCeeehhHHHHhhcchHHHHH
Q 041655 157 T-LSITYMCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 157 ~-~~~~~~~DvwslG~~l~~~~t~~~~~~ 184 (238)
+ ..++.++||||+||++|+|++|..||.
T Consensus 204 ~~~~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 204 GSTKYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 6 678999999999999999999988774
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=228.50 Aligned_cols=204 Identities=22% Similarity=0.230 Sum_probs=154.6
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++... .....+++..+..++.|++.||.|||.
T Consensus 62 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~ 140 (295)
T 2clq_A 62 YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD 140 (295)
T ss_dssp --HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh
Confidence 3467889999999999999999999999999999999999999999999762 223456789999999999999999995
Q ss_pred c--------CceeeecC-CCceEEcccccccccCCcccccccccccCCCcccCcccccccC--CCccCCeeehhHHHHhh
Q 041655 108 H--------QALVLLDH-DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS--ITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ~--------~~~il~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~--~~~~~DvwslG~~l~~~ 176 (238)
+ +.||+++. ++.+||+|||.+........ ......|++.|+|||++.+.. ++.++|+||||+++|+|
T Consensus 141 ~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 218 (295)
T 2clq_A 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218 (295)
T ss_dssp TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHH
T ss_pred CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHH
Confidence 5 66799987 89999999999976543221 123457899999999987644 78899999999999999
Q ss_pred cchHHHHHHhhccCC-CcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 177 MSLVKWMRNVMTSEN-PKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
++|..||........ .............+...+..+.+++.+||+.||++| .+.+.|+
T Consensus 219 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 219 ATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999988854321110 000001111223334455667888899999999999 5555543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=252.43 Aligned_cols=206 Identities=20% Similarity=0.229 Sum_probs=157.9
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
.....+.+.+|+.++.+++||||+++++++.+ +..++||||+++|+|.+++.. ....+++..+..++.|++.||.|
T Consensus 431 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~ 506 (656)
T 2j0j_A 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAY 506 (656)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHH
Confidence 44556789999999999999999999999854 568999999999999999975 34568999999999999999999
Q ss_pred hhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 105 LHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 105 lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
||++ |.||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||
T Consensus 507 LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 585 (656)
T 2j0j_A 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 585 (656)
T ss_dssp HHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 9954 67899999999999999999876443221 12334567899999999888999999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++ |..||......... ..+........+...+..+.+++.+||+.||.+| ++++.|+++
T Consensus 586 lt~g~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 586 LMHGVKPFQGVKNNDVI-GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp HTTSCCTTTTCCHHHHH-HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCHHHHH-HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 97 77777542221111 1111122223344556778889999999999999 666666655
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=230.53 Aligned_cols=203 Identities=25% Similarity=0.277 Sum_probs=154.0
Q ss_pred HHHHHHHHHhcC--CCCCcccceeeeeecCC----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 30 MQIRSEIVTLGQ--IRHRNILPLLAHLARPG----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 30 ~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
..+.+|..++.. ++||||+++++++...+ ..++||||+++|+|.+++.. ..+++..+..++.|++.||.
T Consensus 79 ~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~ 153 (342)
T 1b6c_B 79 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLA 153 (342)
T ss_dssp HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHH
Confidence 456678887766 78999999999998775 78999999999999999975 35899999999999999999
Q ss_pred hhh--------cc--------CceeeecCCCceEEcccccccccCCccccc--ccccccCCCcccCcccccccC------
Q 041655 104 YLH--------MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI--TTSDVVGTAGYIAPEYQQTLS------ 159 (238)
Q Consensus 104 ~lH--------~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~apE~~~~~~------ 159 (238)
||| .+ +.||+++.++.+||+|||++.......... ......|++.|+|||++.+..
T Consensus 154 ~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 233 (342)
T 1b6c_B 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 233 (342)
T ss_dssp HHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHH
T ss_pred HHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccc
Confidence 999 43 667999999999999999997654332211 224457899999999887652
Q ss_pred CCccCCeeehhHHHHhhcch----------HHHHHHhhccCCCcc-----cccccccCCC-----hHHHHHHHHHHhhhh
Q 041655 160 ITYMCDIYSFGVLLAEEMSL----------VKWMRNVMTSENPKR-----AIDSKLLGNG-----YEEQMLLVLKTACFC 219 (238)
Q Consensus 160 ~~~~~DvwslG~~l~~~~t~----------~~~~~~~~~~~~~~~-----~~~~~~~~~~-----~~~~~~~l~~~~~~c 219 (238)
++.++||||||+++|+|++| ..||........... .......+.. ..+.+..+.+++.+|
T Consensus 234 ~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 313 (342)
T 1b6c_B 234 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 313 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHH
T ss_pred cCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHH
Confidence 33689999999999999998 556654322111111 1111112221 235667889999999
Q ss_pred cCCCCCcc----hHHHHHHhhh
Q 041655 220 TLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 220 l~~~p~~R----~v~~~L~~~~ 237 (238)
|+.||++| ++++.|+++.
T Consensus 314 l~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 314 WYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccChhhCCCHHHHHHHHHHHH
Confidence 99999999 7777777664
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=228.25 Aligned_cols=220 Identities=20% Similarity=0.251 Sum_probs=164.8
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
||||.+........ .........+.+.+|+.++.++. ||||+++++++..++..++||||+++++|.+++..
T Consensus 45 vavK~~~~~~~~~~-----~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-- 117 (298)
T 1phk_A 45 YAVKIIDVTGGGSF-----SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-- 117 (298)
T ss_dssp EEEEEEETTCSTTC-----CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--
T ss_pred EEEEEEeccccccc-----CHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc--
Confidence 67787765442211 11122345677889999999996 99999999999999999999999999999999976
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
...+++..+..++.|++.||.|||.+ +.||+++.++.+||+|||.+........ .....+++.|+||
T Consensus 118 --~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aP 192 (298)
T 1phk_A 118 --KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAP 192 (298)
T ss_dssp --HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCH
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCH
Confidence 35689999999999999999999955 6679999999999999999976543322 2345789999999
Q ss_pred cccc------ccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCC
Q 041655 153 EYQQ------TLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDP 224 (238)
Q Consensus 153 E~~~------~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p 224 (238)
|++. ...++.++|+||||+++|+|++|..||................. ........+..+.+++.+||+.||
T Consensus 193 E~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 272 (298)
T 1phk_A 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272 (298)
T ss_dssp HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSG
T ss_pred HHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCc
Confidence 9875 44578899999999999999999887743211111111111111 112223456678889999999999
Q ss_pred Ccc-hHHHHH
Q 041655 225 KER-HVRCML 233 (238)
Q Consensus 225 ~~R-~v~~~L 233 (238)
++| ++.+.|
T Consensus 273 ~~Rps~~~ll 282 (298)
T 1phk_A 273 QKRYTAEEAL 282 (298)
T ss_dssp GGSCCHHHHT
T ss_pred ccCCCHHHHH
Confidence 999 555554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=241.80 Aligned_cols=198 Identities=24% Similarity=0.274 Sum_probs=146.1
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
...+.+|+.+|++++||||+++++++..+ ..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||++
T Consensus 184 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~ 258 (419)
T 3i6u_A 184 ALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN 258 (419)
T ss_dssp -CCHHHHHHHHHHCCCTTBCCCCEEEESS-EEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecC-ceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34588999999999999999999998654 57899999999999998864 46789999999999999999999944
Q ss_pred --------CceeeecCCC---ceEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhHHHH
Q 041655 109 --------QALVLLDHDM---EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 109 --------~~~il~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l~ 174 (238)
+.||+++.++ .+||+|||+++....... .....||+.|+|||++. ...++.++||||||+++|
T Consensus 259 ~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ 335 (419)
T 3i6u_A 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335 (419)
T ss_dssp TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHH
T ss_pred CccccCCChHhEEEecCCCcceEEEeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHH
Confidence 6789997654 599999999987643321 23467899999999875 356788999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccC---CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLG---NGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|++|..||............+...... ......+..+.+++.+||+.||++| ++.+.|+
T Consensus 336 ~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 336 ICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 9999999886433222222222222111 1122345678889999999999999 5555553
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=226.73 Aligned_cols=201 Identities=25% Similarity=0.307 Sum_probs=148.5
Q ss_pred HHHHHHHhcC--CCCCcccceeeeeecC----CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 32 IRSEIVTLGQ--IRHRNILPLLAHLARP----GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 32 ~~~E~~~l~~--l~h~~iv~~~~~~~~~----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
+.+|.+++.. ++||||+++++++... +..++||||+++|+|.+++.. ..+++..+..++.|++.||.||
T Consensus 76 ~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~l 150 (337)
T 3mdy_A 76 WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHL 150 (337)
T ss_dssp HHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHH
Confidence 3445555444 4899999999999876 678999999999999999975 4689999999999999999999
Q ss_pred hcc----------------CceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCcccccccCCCcc----
Q 041655 106 HMH----------------QALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQTLSITYM---- 163 (238)
Q Consensus 106 H~~----------------~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~~~~~~~---- 163 (238)
|.+ +.||+++.++.+||+|||++......... .......||+.|+|||++.+...+..
T Consensus 151 H~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 230 (337)
T 3mdy_A 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230 (337)
T ss_dssp HSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHH
T ss_pred HHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCc
Confidence 964 55799999999999999999765433221 11234679999999999887766655
Q ss_pred --CCeeehhHHHHhhcch----------HHHHHHhhccCCCcccc-----cccccCCC-----hHHHHHHHHHHhhhhcC
Q 041655 164 --CDIYSFGVLLAEEMSL----------VKWMRNVMTSENPKRAI-----DSKLLGNG-----YEEQMLLVLKTACFCTL 221 (238)
Q Consensus 164 --~DvwslG~~l~~~~t~----------~~~~~~~~~~~~~~~~~-----~~~~~~~~-----~~~~~~~l~~~~~~cl~ 221 (238)
+|||||||++|+|++| ..||............. ........ ..+.+..+.+++.+||+
T Consensus 231 ~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 310 (337)
T 3mdy_A 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310 (337)
T ss_dssp HHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSC
T ss_pred cccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhh
Confidence 8999999999999999 44443322211111100 11111111 23677889999999999
Q ss_pred CCCCcc----hHHHHHHhhh
Q 041655 222 DDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 222 ~~p~~R----~v~~~L~~~~ 237 (238)
.||.+| ++++.|+++.
T Consensus 311 ~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 311 HNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp SSGGGSCCHHHHHHHHHHHH
T ss_pred hChhhCCCHHHHHHHHHHHH
Confidence 999999 6777776654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=229.33 Aligned_cols=208 Identities=22% Similarity=0.318 Sum_probs=144.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc----CCCcccCHHHHHHHHHHHHHHh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS----RGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~~~l~~gl 102 (238)
...+.+.+|+.++.+++||||+++++++...+..++||||+++++|.+++.... .....+++..+..++.|++.||
T Consensus 55 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 134 (303)
T 2vwi_A 55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134 (303)
T ss_dssp -----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHH
Confidence 345678899999999999999999999999999999999999999999986421 1235689999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCccc---ccccccccCCCcccCcccccc-cCCCccCCeeehh
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHT---HITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFG 170 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG 170 (238)
.|||.+ +.||+++.++.+||+|||.+........ ........|++.|+|||++.+ ..++.++|+||||
T Consensus 135 ~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 214 (303)
T 2vwi_A 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214 (303)
T ss_dssp HHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHH
T ss_pred HHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHH
Confidence 999955 6679999999999999999876543211 111234578999999998865 5688999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCccccccc--------ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAIDSK--------LLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+++|+|++|..||................ .........+..+.+++.+||+.||.+| ++.+.|+
T Consensus 215 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 215 ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp HHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 99999999998885432211110010000 0011122334567888889999999999 5555443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=234.78 Aligned_cols=197 Identities=22% Similarity=0.254 Sum_probs=151.5
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCC------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPG------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
...+++.+|+.+++.++||||+++++++...+ .+|+||||+ +++|.+++.. ..+++..+..++.|+++
T Consensus 66 ~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~ 139 (367)
T 1cm8_A 66 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLK 139 (367)
T ss_dssp HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHH
Confidence 44577899999999999999999999997653 469999999 7899999875 45899999999999999
Q ss_pred Hhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhH
Q 041655 101 GLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGV 171 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~ 171 (238)
||.|||++ +.||+++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|+||+||
T Consensus 140 ~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 214 (367)
T 1cm8_A 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 214 (367)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHH
T ss_pred HHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHH
Confidence 99999954 67899999999999999999865432 234578999999998876 67899999999999
Q ss_pred HHHhhcchHHHHHHhhccCCCcccc--------------------------cc---cccCCChHHHHHHHHHHhhhhcCC
Q 041655 172 LLAEEMSLVKWMRNVMTSENPKRAI--------------------------DS---KLLGNGYEEQMLLVLKTACFCTLD 222 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~~~~~~~--------------------------~~---~~~~~~~~~~~~~l~~~~~~cl~~ 222 (238)
++|+|++|..||...........+. .. ..........+..+.+++.+||..
T Consensus 215 il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~ 294 (367)
T 1cm8_A 215 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 294 (367)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCS
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccC
Confidence 9999999988874321110000000 00 000011223355678889999999
Q ss_pred CCCcc-hHHHHHH
Q 041655 223 DPKER-HVRCMLS 234 (238)
Q Consensus 223 ~p~~R-~v~~~L~ 234 (238)
||++| ++.+.|+
T Consensus 295 dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 295 DAEQRVTAGEALA 307 (367)
T ss_dssp STTTSCCHHHHHH
T ss_pred ChhHCCCHHHHhc
Confidence 99999 6555554
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=232.74 Aligned_cols=149 Identities=23% Similarity=0.295 Sum_probs=128.5
Q ss_pred HHHHHHHHHHHhcCCC-----CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 28 EMMQIRSEIVTLGQIR-----HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
..+.+.+|+.+++.++ ||||+++++++...+..++||||+ +++|.+++.. .....+++..+..++.|++.||
T Consensus 74 ~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~aL 150 (360)
T 3llt_A 74 YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITR--NNYNGFHIEDIKLYCIEILKAL 150 (360)
T ss_dssp HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHH
Confidence 4456677888888886 999999999999999999999999 8899999976 2334589999999999999999
Q ss_pred chhhcc--------CceeeecC-------------------------CCceEEcccccccccCCcccccccccccCCCcc
Q 041655 103 EYLHMH--------QALVLLDH-------------------------DMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~-------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 149 (238)
+|||++ +.||+++. ++.+||+|||++....... ....||+.|
T Consensus 151 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y 225 (360)
T 3llt_A 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQY 225 (360)
T ss_dssp HHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGG
T ss_pred HHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccc
Confidence 999944 67899975 7899999999997643322 346789999
Q ss_pred cCcccccccCCCccCCeeehhHHHHhhcchHHHHH
Q 041655 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 150 ~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~ 184 (238)
+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 226 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 226 RAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp CCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999999999988774
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=227.87 Aligned_cols=201 Identities=20% Similarity=0.226 Sum_probs=147.9
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH 119 (311)
T 4agu_A 44 VIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCH 119 (311)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999888888764 456899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~ 177 (238)
++ +.||+++.++.+||+|||.+......... .....|++.|+|||++.+ ..++.++|+||+|+++|+|+
T Consensus 120 ~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 197 (311)
T 4agu_A 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197 (311)
T ss_dssp HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHH
T ss_pred HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence 54 67899999999999999999876433221 234578999999998875 56799999999999999999
Q ss_pred chHHHHHHhhccCCCcc--------------------cc-ccccc--C------CChHHHHHHHHHHhhhhcCCCCCcc-
Q 041655 178 SLVKWMRNVMTSENPKR--------------------AI-DSKLL--G------NGYEEQMLLVLKTACFCTLDDPKER- 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~--------------------~~-~~~~~--~------~~~~~~~~~l~~~~~~cl~~~p~~R- 227 (238)
+|..||........... .. ..... . ....+.+..+.+++.+||+.||++|
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 277 (311)
T 4agu_A 198 SGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL 277 (311)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcC
Confidence 99777632211000000 00 00000 0 0012345567889999999999999
Q ss_pred hHHHHH
Q 041655 228 HVRCML 233 (238)
Q Consensus 228 ~v~~~L 233 (238)
++.+.|
T Consensus 278 t~~ell 283 (311)
T 4agu_A 278 TCEQLL 283 (311)
T ss_dssp CHHHHH
T ss_pred CHHHHh
Confidence 554444
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=232.12 Aligned_cols=208 Identities=22% Similarity=0.279 Sum_probs=152.1
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+..... .....+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.++...
T Consensus 53 vavK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--- 117 (331)
T 4aaa_A 53 VAIKKFLESDD------------DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--- 117 (331)
T ss_dssp EEEEEEESCSS------------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS---
T ss_pred EEEEEEecCCC------------chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh---
Confidence 67776654432 223456788999999999999999999999999999999999998888887654
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
...+++..+..++.|++.||.|||.+ +.||+++.++.+||+|||.+........ ......|++.|+|||
T Consensus 118 -~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE 194 (331)
T 4aaa_A 118 -PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPE 194 (331)
T ss_dssp -TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHH
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcc
Confidence 45689999999999999999999954 6689999999999999999976543221 123457899999999
Q ss_pred ccccc-CCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccc------------------------ccccccC-----C
Q 041655 154 YQQTL-SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRA------------------------IDSKLLG-----N 203 (238)
Q Consensus 154 ~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~------------------------~~~~~~~-----~ 203 (238)
++.+. .++.++||||+|+++|+|++|..||............ ....... .
T Consensus 195 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (331)
T 4aaa_A 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLER 274 (331)
T ss_dssp HHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHH
T ss_pred cccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhh
Confidence 88765 6789999999999999999998776322111000000 0000000 0
Q ss_pred ChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 204 GYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 204 ~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
.....+..+.+++.+||+.||++|
T Consensus 275 ~~~~~~~~l~~li~~~L~~dP~~R 298 (331)
T 4aaa_A 275 RYPKLSEVVIDLAKKCLHIDPDKR 298 (331)
T ss_dssp HSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred cccchhHHHHHHHHHHhccCcccC
Confidence 112345668889999999999999
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=224.42 Aligned_cols=203 Identities=22% Similarity=0.329 Sum_probs=145.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeec-------------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLAR-------------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 93 (238)
...+.+.+|+.++++++||||+++++++.+ .+..++||||+++++|.+++.. ....+++..++.
T Consensus 44 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~ 120 (303)
T 1zy4_A 44 EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120 (303)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHH
Confidence 456788999999999999999999998754 3567899999999999999975 345678899999
Q ss_pred HHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCccc------------ccccccccCCCcccCcc
Q 041655 94 TVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHT------------HITTSDVVGTAGYIAPE 153 (238)
Q Consensus 94 ~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~apE 153 (238)
++.|++.||.|||.+ +.||+++.++.+||+|||.+........ ........|++.|+|||
T Consensus 121 i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE 200 (303)
T 1zy4_A 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE 200 (303)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHH
T ss_pred HHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcc
Confidence 999999999999955 5679999999999999999876542210 11123456899999999
Q ss_pred ccccc-CCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccc--ccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hH
Q 041655 154 YQQTL-SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRA--IDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HV 229 (238)
Q Consensus 154 ~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v 229 (238)
++.+. .++.++|+||||+++|+|+++..+...... ..... .............+..+.+++.+||+.||.+| ++
T Consensus 201 ~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 278 (303)
T 1zy4_A 201 VLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN--ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA 278 (303)
T ss_dssp HHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH
T ss_pred cccCCCCCcchhhHHHHHHHHHHHHhccCCchhHHH--HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCH
Confidence 98754 688999999999999999973211111000 00000 11112223344555667888999999999999 55
Q ss_pred HHHHH
Q 041655 230 RCMLS 234 (238)
Q Consensus 230 ~~~L~ 234 (238)
.+.|+
T Consensus 279 ~~ll~ 283 (303)
T 1zy4_A 279 RTLLN 283 (303)
T ss_dssp HHHHH
T ss_pred HHHhC
Confidence 55443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=240.09 Aligned_cols=193 Identities=22% Similarity=0.230 Sum_probs=150.1
Q ss_pred HHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
+.+.+|+.++.++ +||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||.+
T Consensus 103 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~ 178 (355)
T 1vzo_A 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL 178 (355)
T ss_dssp GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4566799999999 699999999999999999999999999999999976 34689999999999999999999954
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc--cCCCccCCeeehhHHHHhhcc
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT--LSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~--~~~~~~~DvwslG~~l~~~~t 178 (238)
+.||+++.++.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 179 ~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~ 257 (355)
T 1vzo_A 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257 (355)
T ss_dssp TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH
Confidence 67899999999999999999865433222 2234678999999999875 346889999999999999999
Q ss_pred hHHHHHHhhccCCCccccccc--ccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSK--LLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||................ .....+.+.+..+.+++.+||+.||++|
T Consensus 258 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 308 (355)
T 1vzo_A 258 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308 (355)
T ss_dssp SSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHh
Confidence 998885332222211111110 1122334455667888899999999999
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=230.82 Aligned_cols=200 Identities=20% Similarity=0.250 Sum_probs=144.7
Q ss_pred HHHHHHHHHhcCC-CCCcccceeeeeec------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 30 MQIRSEIVTLGQI-RHRNILPLLAHLAR------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 30 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
+.+.+|+.++.++ +||||+++++++.. .+..++||||+++++|.+++.. .....+++..+..++.|++.||
T Consensus 65 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l 142 (326)
T 2x7f_A 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGL 142 (326)
T ss_dssp HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHH--SGGGCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHh--cccCCCCHHHHHHHHHHHHHHH
Confidence 5678899999998 79999999999976 4678999999999999999976 2235689999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-----ccCCCccCCeeeh
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-----TLSITYMCDIYSF 169 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~Dvwsl 169 (238)
.|||.+ +.||+++.++.+||+|||.+........ ......|++.|+|||++. +..++.++|||||
T Consensus 143 ~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 220 (326)
T 2x7f_A 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220 (326)
T ss_dssp HHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHH
T ss_pred HHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHH
Confidence 999954 6679999999999999999876543211 123457899999999886 5568899999999
Q ss_pred hHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 170 GVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 170 G~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|+++|+|++|..||.........................+..+.+++.+||+.||.+| .+.+.|
T Consensus 221 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 285 (326)
T 2x7f_A 221 GITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285 (326)
T ss_dssp HHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 9999999999888743221111111111111111122334567788888999999999 444444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=240.68 Aligned_cols=149 Identities=23% Similarity=0.309 Sum_probs=121.7
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIA 99 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~ 99 (238)
....+++.+|+.+|+.++||||+++++++... ...|+||||+++ +|.+.+.. .+++..+..++.|++
T Consensus 102 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil 174 (464)
T 3ttj_A 102 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQML 174 (464)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHH
Confidence 34567788999999999999999999999654 356999999965 67777742 489999999999999
Q ss_pred HHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhH
Q 041655 100 SGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171 (238)
Q Consensus 100 ~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~ 171 (238)
.||.|||+ |+.||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||
T Consensus 175 ~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 251 (464)
T 3ttj_A 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 251 (464)
T ss_dssp HHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHH
T ss_pred HHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHH
Confidence 99999994 4678999999999999999998654332 124468899999999999999999999999999
Q ss_pred HHHhhcchHHHHH
Q 041655 172 LLAEEMSLVKWMR 184 (238)
Q Consensus 172 ~l~~~~t~~~~~~ 184 (238)
++|+|++|..||.
T Consensus 252 il~ell~g~~pF~ 264 (464)
T 3ttj_A 252 IMGEMVRHKILFP 264 (464)
T ss_dssp HHHHHHHSSCSSC
T ss_pred HHHHHHhCCCCCC
Confidence 9999999988774
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=229.40 Aligned_cols=201 Identities=20% Similarity=0.233 Sum_probs=151.3
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++.+++||||+++++++..++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||.
T Consensus 59 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~ 135 (302)
T 2j7t_A 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS 135 (302)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc
Confidence 357788999999999999999999999999999999999999999999865 23568999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccc-----cccCCCccCCeeehhHHHH
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQ-----QTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~-----~~~~~~~~~DvwslG~~l~ 174 (238)
+ +.||+++.++.+||+|||.+....... .......|++.|+|||++ .+..++.++|+||||+++|
T Consensus 136 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~ 213 (302)
T 2j7t_A 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 213 (302)
T ss_dssp TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHH
T ss_pred CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHH
Confidence 4 667999999999999999875432111 111335789999999987 3567888999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|++|..||................. ....+...+..+.+++..||+.||++| ++.+.|
T Consensus 214 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 274 (302)
T 2j7t_A 214 EMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274 (302)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHT
T ss_pred HHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 99999888754221111111111111 112234455678888999999999999 544444
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=226.50 Aligned_cols=201 Identities=17% Similarity=0.183 Sum_probs=142.0
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.++...++.++||||+++++++.+++..++||||++ |+|.+++.........+++..+..++.|++.||.|||++
T Consensus 50 ~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (290)
T 3fme_A 50 KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128 (290)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 3445556666888999999999999999999999999996 589888765444467799999999999999999999965
Q ss_pred ---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccc----cccCCCccCCeeehhHHHHh
Q 041655 109 ---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQ----QTLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 109 ---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~----~~~~~~~~~DvwslG~~l~~ 175 (238)
+.||+++.++.+||+|||.+........ .....|++.|+|||++ .+..++.++|+||+|+++|+
T Consensus 129 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~ 205 (290)
T 3fme_A 129 LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE 205 (290)
T ss_dssp SCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHH
T ss_pred CCeecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHH
Confidence 4579999999999999999976544322 1334789999999985 56678889999999999999
Q ss_pred hcchHHHHHHhhcc-CCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 176 EMSLVKWMRNVMTS-ENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 176 ~~t~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|++|..||...... ...................+..+.+++.+||+.||++| ++.+.|
T Consensus 206 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l 265 (290)
T 3fme_A 206 LAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265 (290)
T ss_dssp HHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHH
Confidence 99998887431110 01111111111122223445567888889999999999 544444
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=234.27 Aligned_cols=194 Identities=24% Similarity=0.287 Sum_probs=149.1
Q ss_pred HHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc---
Q 041655 33 RSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--- 108 (238)
Q Consensus 33 ~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--- 108 (238)
.+|+.++.++ +||||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++
T Consensus 63 ~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~giv 138 (342)
T 2qr7_A 63 TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQGVV 138 (342)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence 4677778777 699999999999999999999999999999999975 45689999999999999999999955
Q ss_pred -----CceeeecCC----CceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 109 -----QALVLLDHD----MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 -----~~~il~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
+.||++.+. +.+||+|||++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 139 HrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 216 (342)
T 2qr7_A 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216 (342)
T ss_dssp CSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred eccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcC
Confidence 667887443 3599999999986543321 12446789999999999888889999999999999999999
Q ss_pred HHHHHHhhccCCCcc----cccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 180 VKWMRNVMTSENPKR----AIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
..||..... ..... +..... ....+...+..+.+++.+||+.||++| .+.+.|
T Consensus 217 ~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il 276 (342)
T 2qr7_A 217 YTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276 (342)
T ss_dssp SCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 988853211 11111 111111 112233455667888889999999999 554444
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=233.08 Aligned_cols=200 Identities=18% Similarity=0.196 Sum_probs=142.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++||||+++++++.+++..++||||++ |+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 76 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~ 150 (329)
T 3gbz_A 76 VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS 150 (329)
T ss_dssp ----CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45667899999999999999999999999999999999997 599999976 4568999999999999999999995
Q ss_pred c--------Cceeee-----cCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHH
Q 041655 108 H--------QALVLL-----DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLL 173 (238)
Q Consensus 108 ~--------~~~il~-----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l 173 (238)
+ +.||++ +.++.+||+|||.++........ .....+|+.|+|||++.+. .++.++|||||||++
T Consensus 151 ~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIW 228 (329)
T ss_dssp TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence 4 678999 44556999999999865432211 2335679999999988764 479999999999999
Q ss_pred HhhcchHHHHHHhhccCCCccccc-----------------------ccccCC-----ChHHHHHHHHHHhhhhcCCCCC
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAID-----------------------SKLLGN-----GYEEQMLLVLKTACFCTLDDPK 225 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~-----~~~~~~~~l~~~~~~cl~~~p~ 225 (238)
|+|++|..||.............. ...... ........+.+++.+||+.||+
T Consensus 229 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 308 (329)
T 3gbz_A 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV 308 (329)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChh
Confidence 999999887743211100000000 000000 0111345678899999999999
Q ss_pred cc-hHHHHHH
Q 041655 226 ER-HVRCMLS 234 (238)
Q Consensus 226 ~R-~v~~~L~ 234 (238)
+| ++.+.|+
T Consensus 309 ~R~t~~e~l~ 318 (329)
T 3gbz_A 309 KRISAKNALE 318 (329)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhC
Confidence 99 6655554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=230.28 Aligned_cols=198 Identities=20% Similarity=0.230 Sum_probs=147.4
Q ss_pred HHHHHHHHhcCC---CCCcccceeeeeecCC-----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 31 QIRSEIVTLGQI---RHRNILPLLAHLARPG-----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 31 ~~~~E~~~l~~l---~h~~iv~~~~~~~~~~-----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
.+.+|+.+++++ +||||+++++++.... ..+++|||+. ++|.+++.. .....+++..+..++.|++.||
T Consensus 57 ~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~i~~qi~~al 133 (308)
T 3g33_A 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDK--APPPGLPAETIKDLMRQFLRGL 133 (308)
T ss_dssp HHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHT--CCTTCSCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhh--ccCCCCCHHHHHHHHHHHHHHH
Confidence 345666666555 5999999999997654 4789999996 599999976 2334489999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
+|||++ +.||+++.++.+||+|||.++....... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 134 ~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 210 (308)
T 3g33_A 134 DFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 210 (308)
T ss_dssp HHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHH
T ss_pred HHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHH
Confidence 999944 7789999999999999999986543322 23467899999999999889999999999999999
Q ss_pred hhcchHHHHHHhhccCCCccccc------------------cccc---C----CChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 175 EEMSLVKWMRNVMTSENPKRAID------------------SKLL---G----NGYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~------------------~~~~---~----~~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
+|++|..||.............. .... . ....+.+..+.+++.+||+.||++| +
T Consensus 211 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 290 (308)
T 3g33_A 211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290 (308)
T ss_dssp HTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC
Confidence 99999888732211110000000 0000 0 0112334567888899999999999 6
Q ss_pred HHHHHH
Q 041655 229 VRCMLS 234 (238)
Q Consensus 229 v~~~L~ 234 (238)
+.+.|+
T Consensus 291 ~~e~l~ 296 (308)
T 3g33_A 291 AFRALQ 296 (308)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 666664
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=235.50 Aligned_cols=204 Identities=14% Similarity=0.128 Sum_probs=153.6
Q ss_pred HHHHHHHHHhcCCCCCcccc---------------eeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHH
Q 041655 30 MQIRSEIVTLGQIRHRNILP---------------LLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYR 93 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~---------------~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 93 (238)
+.+.+|+.++.+++||||++ +++++.. ++..++||||+ +++|.+++.. .....+++..+..
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~ 163 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV--SPKHVLSERSVLQ 163 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHH--SGGGCCCHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHh--CCcCCCCHHHHHH
Confidence 35778999999999999988 4556554 67889999999 9999999986 2236799999999
Q ss_pred HHHHHHHHhchhhcc--------CceeeecCCC--ceEEcccccccccCCcccc-----cccccccCCCcccCccccccc
Q 041655 94 TVRGIASGLEYLHMH--------QALVLLDHDM--EARISEFGLAKVFPEAHTH-----ITTSDVVGTAGYIAPEYQQTL 158 (238)
Q Consensus 94 ~~~~l~~gl~~lH~~--------~~~il~~~~~--~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~apE~~~~~ 158 (238)
++.|++.||.|||++ +.||+++.++ .+||+|||+++.+...... .......|++.|+|||++.+.
T Consensus 164 i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 243 (352)
T 2jii_A 164 VACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC 243 (352)
T ss_dssp HHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC
T ss_pred HHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC
Confidence 999999999999955 6679999998 8999999999876433221 111335789999999999998
Q ss_pred CCCccCCeeehhHHHHhhcchHHHHHHhhccC-CCccccc---cc---cc--CCChHHHHHHHHHHhhhhcCCCCCcc--
Q 041655 159 SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSE-NPKRAID---SK---LL--GNGYEEQMLLVLKTACFCTLDDPKER-- 227 (238)
Q Consensus 159 ~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~-~~~~~~~---~~---~~--~~~~~~~~~~l~~~~~~cl~~~p~~R-- 227 (238)
.++.++||||||+++|+|++|..||....... ....... .. .. .......+..+.+++..||+.||++|
T Consensus 244 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 323 (352)
T 2jii_A 244 GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP 323 (352)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC
Confidence 99999999999999999999998886543111 1111000 00 00 00011234667888888999999999
Q ss_pred --hHHHHHHhh
Q 041655 228 --HVRCMLSQI 236 (238)
Q Consensus 228 --~v~~~L~~~ 236 (238)
++++.|+++
T Consensus 324 ~~~l~~~L~~~ 334 (352)
T 2jii_A 324 YAMLRNNLEAL 334 (352)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 666666655
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-34 Score=232.83 Aligned_cols=201 Identities=18% Similarity=0.240 Sum_probs=153.8
Q ss_pred HHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
...+.+|+.++.++. ||||+++++++...+..++||||+++|+|.+++.. .....+++..+..++.|++.||+|||.
T Consensus 72 ~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~ 149 (327)
T 3lm5_A 72 RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ 149 (327)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 467889999999995 69999999999999999999999999999999854 234678999999999999999999995
Q ss_pred c--------CceeeecC---CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 108 H--------QALVLLDH---DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ~--------~~~il~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
+ +.||+++. ++.+||+|||.++....... .....|++.|+|||++.+..++.++|+||||+++|+|
T Consensus 150 ~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 226 (327)
T 3lm5_A 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 226 (327)
T ss_dssp TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHH
Confidence 4 67799988 78999999999987643322 2345789999999999988999999999999999999
Q ss_pred cchHHHHHHhhccCCCcccc--cccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAI--DSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
++|..||............. ............+..+.+++.+||+.||.+| .+.+.|+
T Consensus 227 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 227 LTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 99988874322111111111 1112222334455668888999999999999 5555443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.9e-34 Score=226.08 Aligned_cols=198 Identities=24% Similarity=0.293 Sum_probs=146.5
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+..++.++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||.
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~ 129 (276)
T 2h6d_A 54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR 129 (276)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999999999999999999999999999976 3468999999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCC-CccCCeeehhHHHHhhcc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~-~~~~DvwslG~~l~~~~t 178 (238)
+ +.||+++.++.++|+|||.+........ .....+++.|+|||.+.+..+ +.++|+||||+++|+|++
T Consensus 130 ~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 206 (276)
T 2h6d_A 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206 (276)
T ss_dssp HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh
Confidence 4 6679999999999999999876543321 133568899999999887765 679999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|..||................ ...+...+..+.+++.+||+.||++| ++.+.|+
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 207 GTLPFDDEHVPTLFKKIRGGV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp SSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCcHHHHHHHhhcCc--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 988774321111111111111 11222334567788888999999999 5544443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-34 Score=250.50 Aligned_cols=192 Identities=20% Similarity=0.171 Sum_probs=157.4
Q ss_pred HHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+.+.+|..++..+ +||||+++++++.+.+.+|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 384 ~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH 459 (674)
T 3pfq_A 384 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ 459 (674)
T ss_dssp TTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456778899999988 699999999999999999999999999999999976 356899999999999999999999
Q ss_pred c--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 M--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
+ |+.|||++.++++||+|||+++....... ......||+.|+|||++.+..++.++|+||||+++|||++
T Consensus 460 ~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt 537 (674)
T 3pfq_A 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537 (674)
T ss_dssp HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH
T ss_pred hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc
Confidence 4 47789999999999999999985332221 2345789999999999999999999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||...........+..... ..+...+.++.+++.+||+.||++|
T Consensus 538 G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R 584 (674)
T 3pfq_A 538 GQAPFEGEDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKR 584 (674)
T ss_dssp SSCSSCCSSHHHHHHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTC
T ss_pred CCCCCCCCCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHC
Confidence 9999864332222223333222 2334455667888889999999999
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.1e-34 Score=229.54 Aligned_cols=198 Identities=24% Similarity=0.290 Sum_probs=151.2
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
....+.+|+.++++++||||+++++++..++ .++||||+++++|.+++.. ...+++..+..++.|++.||.|||.
T Consensus 58 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~ 132 (322)
T 2ycf_A 58 PALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHE 132 (322)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456889999999999999999999987665 7999999999999999864 4678999999999999999999995
Q ss_pred c--------CceeeecCCCc---eEEcccccccccCCcccccccccccCCCcccCccccc---ccCCCccCCeeehhHHH
Q 041655 108 H--------QALVLLDHDME---ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLL 173 (238)
Q Consensus 108 ~--------~~~il~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l 173 (238)
+ +.||+++.++. +||+|||.+........ .....|++.|+|||++. +..++.++|+||||+++
T Consensus 133 ~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 209 (322)
T 2ycf_A 133 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209 (322)
T ss_dssp TTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHH
T ss_pred CCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHH
Confidence 4 66799987665 99999999986543321 12356899999999863 55688999999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccccccccC---CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAIDSKLLG---NGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|+|++|..||............+...... ......+..+.+++.+||+.||++| ++.+.|
T Consensus 210 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 210 FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp HHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 99999998886433322222222211111 1123345678889999999999999 555544
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-35 Score=236.67 Aligned_cols=204 Identities=18% Similarity=0.204 Sum_probs=148.6
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 74 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~ 150 (319)
T 2y4i_B 74 KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG 150 (319)
T ss_dssp CCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4567899999999999999999999999999999999999999999965 345689999999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcc---cccccccccCCCcccCcccccc---------cCCCccCCeeeh
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAH---THITTSDVVGTAGYIAPEYQQT---------LSITYMCDIYSF 169 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~~~~apE~~~~---------~~~~~~~Dvwsl 169 (238)
+.||+++ ++.++|+|||.+....... .........|++.|+|||++.+ ..++.++|||||
T Consensus 151 i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~sl 229 (319)
T 2y4i_B 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229 (319)
T ss_dssp CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHH
T ss_pred ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHH
Confidence 6779998 6899999999987543211 1111233568899999998764 347889999999
Q ss_pred hHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 170 GVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 170 G~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|+++|+|++|..||.........................+..+.+++..||+.||++| +++++|+++.
T Consensus 230 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 230 GTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 9999999999888753221111111111111111111234457788888999999999 6666666553
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-34 Score=233.44 Aligned_cols=199 Identities=26% Similarity=0.272 Sum_probs=150.8
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+.+|+.++.+++||||+++++++...+..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||.+
T Consensus 57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 132 (346)
T 1ua2_A 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW 132 (346)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4678999999999999999999999999999999999975 89888865 345688889999999999999999954
Q ss_pred -------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhcchH
Q 041655 109 -------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 -------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~ 180 (238)
+.||+++.++.+||+|||+++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 133 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 210 (346)
T 1ua2_A 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210 (346)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSS
T ss_pred EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 6789999999999999999986643321 12346789999999988654 4788999999999999999987
Q ss_pred HHHHHhhccCCCcccc---------------------cccccCCC-----hHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 181 KWMRNVMTSENPKRAI---------------------DSKLLGNG-----YEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~---------------------~~~~~~~~-----~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
.||...........+. .....+.. ....+..+.+++.+||+.||++| ++.+.|
T Consensus 211 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 211 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 7653221100000000 00000000 12334668889999999999999 555555
Q ss_pred H
Q 041655 234 S 234 (238)
Q Consensus 234 ~ 234 (238)
+
T Consensus 291 ~ 291 (346)
T 1ua2_A 291 K 291 (346)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.7e-33 Score=231.08 Aligned_cols=148 Identities=22% Similarity=0.297 Sum_probs=118.4
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCC------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPG------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
...+.+.+|+.+++.++||||+++++++...+ ..++||||++ ++|.+++.. .+++..+..++.|++.
T Consensus 66 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~ 138 (371)
T 2xrw_A 66 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLC 138 (371)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHH
Confidence 45577889999999999999999999997654 6799999996 578888852 4889999999999999
Q ss_pred Hhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 101 GLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
||.|||.+ +.||+++.++.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||+
T Consensus 139 al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 215 (371)
T 2xrw_A 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 215 (371)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred HHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHH
Confidence 99999954 678999999999999999997654322 1234578999999999999889999999999999
Q ss_pred HHhhcchHHHHH
Q 041655 173 LAEEMSLVKWMR 184 (238)
Q Consensus 173 l~~~~t~~~~~~ 184 (238)
+|+|++|..||.
T Consensus 216 l~el~~g~~pf~ 227 (371)
T 2xrw_A 216 MGEMIKGGVLFP 227 (371)
T ss_dssp HHHHHHSSCSSC
T ss_pred HHHHHhCCCCCC
Confidence 999999988774
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-33 Score=231.14 Aligned_cols=203 Identities=24% Similarity=0.261 Sum_probs=152.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecC-----CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARP-----GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
....+.+.+|+.++.+++||||+++++++... ...+++|||+. ++|.+++.. ..+++..+..++.|++.
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~ 139 (364)
T 3qyz_A 66 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILR 139 (364)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHH
Confidence 34557789999999999999999999998654 46899999996 599999875 45899999999999999
Q ss_pred Hhchhhcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccc-cCCCccCCeeehh
Q 041655 101 GLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFG 170 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG 170 (238)
||.|||++ +.||+++.++.+||+|||.+......... .......||+.|+|||++.+ ..++.++||||+|
T Consensus 140 aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 219 (364)
T 3qyz_A 140 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219 (364)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHH
T ss_pred HHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHH
Confidence 99999954 67899999999999999999876543221 11244688999999997654 4589999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCccccc-----------------------cc-ccC-----CChHHHHHHHHHHhhhhcC
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAID-----------------------SK-LLG-----NGYEEQMLLVLKTACFCTL 221 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~-----------------------~~-~~~-----~~~~~~~~~l~~~~~~cl~ 221 (238)
+++|+|++|..||...........+.. .. ... ......+.++.+++.+||+
T Consensus 220 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 299 (364)
T 3qyz_A 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 299 (364)
T ss_dssp HHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcC
Confidence 999999999888743221111111100 00 000 0012234567889999999
Q ss_pred CCCCcc-hHHHHHH
Q 041655 222 DDPKER-HVRCMLS 234 (238)
Q Consensus 222 ~~p~~R-~v~~~L~ 234 (238)
.||++| ++.+.|+
T Consensus 300 ~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 300 FNPHKRIEVEQALA 313 (364)
T ss_dssp SSTTTSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 999999 6666554
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-33 Score=223.93 Aligned_cols=203 Identities=19% Similarity=0.208 Sum_probs=154.1
Q ss_pred HHHHHHHHHhcCCCCCcccceeeee-ecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHL-ARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
+.+.+|+.++..++|++++..++.+ ..++..+++|||+ +++|.+++.. ....+++..+..++.|++.||.|||++
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~ 124 (296)
T 3uzp_A 49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK 124 (296)
T ss_dssp CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3578899999999988876666655 5677889999999 8899999974 245689999999999999999999954
Q ss_pred --------Cceeee---cCCCceEEcccccccccCCcccc-----cccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 109 --------QALVLL---DHDMEARISEFGLAKVFPEAHTH-----ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 109 --------~~~il~---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
+.||++ +.++.+||+|||.+......... .......|++.|+|||.+.+..++.++||||||++
T Consensus 125 ~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 204 (296)
T 3uzp_A 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 204 (296)
T ss_dssp TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHH
Confidence 667999 48889999999999876443221 11244678999999999999899999999999999
Q ss_pred HHhhcchHHHHHHhhccCCCc---ccccccccCC---ChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 173 LAEEMSLVKWMRNVMTSENPK---RAIDSKLLGN---GYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+|+|++|..||.......... .......... .....+..+.+++..||+.||++| ++.+.|+++
T Consensus 205 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 205 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 999999999886432211111 1111111111 112335668889999999999999 677776665
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-33 Score=224.15 Aligned_cols=203 Identities=18% Similarity=0.202 Sum_probs=154.9
Q ss_pred HHHHHHHHHhcCCCCCcccceeeee-ecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHL-ARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
..+.+|+.++..++|++++..++.+ ..++..+++|||+ +++|.+++.. ....+++..+..++.|++.||.|||++
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~ 124 (296)
T 4hgt_A 49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK 124 (296)
T ss_dssp CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4578899999999988877776665 6677889999999 8899999975 245689999999999999999999944
Q ss_pred --------Cceeee---cCCCceEEcccccccccCCcccc-----cccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 109 --------QALVLL---DHDMEARISEFGLAKVFPEAHTH-----ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 109 --------~~~il~---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
+.||++ +.++.+||+|||.++........ .......|++.|+|||.+.+..++.++||||||++
T Consensus 125 ~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 204 (296)
T 4hgt_A 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 204 (296)
T ss_dssp TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHH
Confidence 678999 78899999999999876443221 12235678999999999999899999999999999
Q ss_pred HHhhcchHHHHHHhhccCCCccc---ccccccCCC---hHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 173 LAEEMSLVKWMRNVMTSENPKRA---IDSKLLGNG---YEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+|+|++|..||............ ......... ....+..+.+++..||+.||++| ++++.|+++
T Consensus 205 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 205 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 99999999998653322221111 111111110 12235678889999999999999 666666654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-33 Score=226.80 Aligned_cols=202 Identities=19% Similarity=0.207 Sum_probs=150.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeee--cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLA--RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
..+.+.+|+.++++++||||+++++++. +.+..++||||++++ |.+++.. .....+++..+..++.|++.||.||
T Consensus 49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~L 125 (305)
T 2wtk_C 49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDS--VPEKRFPVCQAHGYFCQLIDGLEYL 125 (305)
T ss_dssp HHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHH--STTCSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHh--CcccccCHHHHHHHHHHHHHHHHHH
Confidence 4577899999999999999999999984 456789999999765 8787765 2345689999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC--CCccCCeeehhHHHHh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS--ITYMCDIYSFGVLLAE 175 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~--~~~~~DvwslG~~l~~ 175 (238)
|++ +.||+++.++.++|+|||.+................|++.|+|||++.+.. ++.++|+||||+++|+
T Consensus 126 H~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 205 (305)
T 2wtk_C 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYN 205 (305)
T ss_dssp HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHH
T ss_pred HHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHH
Confidence 955 667999999999999999998764332222234567899999999887644 3779999999999999
Q ss_pred hcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 176 EMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|++|..||................ ...+...+..+.+++.+||+.||.+| ++.+.|+
T Consensus 206 l~~g~~p~~~~~~~~~~~~i~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 206 ITTGLYPFEGDNIYKLFENIGKGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCCchHHHHHHHHhcCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999988774321111111111111 11223445567888889999999999 5555443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-33 Score=232.23 Aligned_cols=211 Identities=10% Similarity=-0.023 Sum_probs=141.2
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHH---HHHhcCCCCCccccee-------eeeecC--------------
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSE---IVTLGQIRHRNILPLL-------AHLARP-------------- 57 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~~iv~~~-------~~~~~~-------------- 57 (238)
||||.+...... .....+.+.+| +..|.. +||||++++ +++...
T Consensus 90 vavK~~~~~~~~-----------~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~ 157 (371)
T 3q60_A 90 FALKVFTMGAEN-----------SRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDD 157 (371)
T ss_dssp EEEEEEECCSTT-----------HHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC---
T ss_pred eEEEEEEecccc-----------cccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCccc
Confidence 677877665432 23445667777 456666 799988755 344322
Q ss_pred ---CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHH------HHHHHHHHHHhchhhc--------cCceeeecCCCce
Q 041655 58 ---GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLAR------YRTVRGIASGLEYLHM--------HQALVLLDHDMEA 120 (238)
Q Consensus 58 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~------~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~ 120 (238)
...|+||||++ |+|.+++... ...+.+..+ ..++.|+++||+|||+ ||.||+++.++.+
T Consensus 158 ~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~ 233 (371)
T 3q60_A 158 YAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL 233 (371)
T ss_dssp CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCE
T ss_pred ceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCE
Confidence 33799999998 8999999763 223344444 6777999999999994 4778999999999
Q ss_pred EEcccccccccCCcccccccccccCCCcccCcccccc--cCCCccCCeeehhHHHHhhcchHHHHHHhhccCC--Ccc--
Q 041655 121 RISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT--LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSEN--PKR-- 194 (238)
Q Consensus 121 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~--~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~--~~~-- 194 (238)
||+|||+++...... ....+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...
T Consensus 234 kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~ 308 (371)
T 3q60_A 234 MLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308 (371)
T ss_dssp EECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCC
T ss_pred EEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhh
Confidence 999999998654322 13456699999999987 6789999999999999999999999875432211 110
Q ss_pred ---cccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 195 ---AIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 195 ---~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
..............+..+.+++.+||+.||++| ++.+.|
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 309 LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 001111111223456678889999999999999 444443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.6e-33 Score=224.61 Aligned_cols=204 Identities=19% Similarity=0.206 Sum_probs=137.0
Q ss_pred HHHHHHHHHHHHhcCCC-CCcccceeeeee--------cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIR-HRNILPLLAHLA--------RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRG 97 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~--------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~ 97 (238)
...+.+.+|+.++.++. ||||+++++++. .....+++|||+. |+|.+++.... ....+++..+..++.|
T Consensus 67 ~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~q 144 (337)
T 3ll6_A 67 EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQ 144 (337)
T ss_dssp HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHH
Confidence 44567889999999996 999999999983 3445789999995 69999886532 2356899999999999
Q ss_pred HHHHhchhhccC----------ceeeecCCCceEEcccccccccCCccccc----------ccccccCCCcccCcccc--
Q 041655 98 IASGLEYLHMHQ----------ALVLLDHDMEARISEFGLAKVFPEAHTHI----------TTSDVVGTAGYIAPEYQ-- 155 (238)
Q Consensus 98 l~~gl~~lH~~~----------~~il~~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~~~apE~~-- 155 (238)
++.||.|||.++ .||+++.++.+||+|||.+.......... ......|++.|+|||++
T Consensus 145 i~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 224 (337)
T 3ll6_A 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL 224 (337)
T ss_dssp HHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------C
T ss_pred HHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhc
Confidence 999999999654 56999999999999999998764322111 11235689999999988
Q ss_pred -cccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHH
Q 041655 156 -QTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVR 230 (238)
Q Consensus 156 -~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~ 230 (238)
.+..++.++||||||+++|+|++|..||....... ..............+..+.+++.+||+.||++| +++
T Consensus 225 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 300 (337)
T 3ll6_A 225 YSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300 (337)
T ss_dssp CTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHH
Confidence 56678889999999999999999998886533222 222222122222223346778888999999999 666
Q ss_pred HHHHhh
Q 041655 231 CMLSQI 236 (238)
Q Consensus 231 ~~L~~~ 236 (238)
+.|+++
T Consensus 301 ~~l~~~ 306 (337)
T 3ll6_A 301 HQLQEI 306 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 666554
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=221.99 Aligned_cols=195 Identities=19% Similarity=0.232 Sum_probs=149.4
Q ss_pred HHHHHHHHHhcCCC-CCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 30 MQIRSEIVTLGQIR-HRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 30 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+.+.+|+.++++++ ||||+++++++.+ ....+++|||+++++|.+++.. +++..+..++.|++.||+|||
T Consensus 75 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH 147 (330)
T 3nsz_A 75 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCH 147 (330)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHH
Confidence 56889999999997 9999999999987 6678999999999999998853 888999999999999999999
Q ss_pred cc--------CceeeecCCC-ceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhh
Q 041655 107 MH--------QALVLLDHDM-EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 107 ~~--------~~~il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~ 176 (238)
.+ +.||+++.++ .+||+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|+|
T Consensus 148 ~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 224 (330)
T 3nsz_A 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 224 (330)
T ss_dssp HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHH
Confidence 44 6789999777 899999999986544322 234578999999998876 6689999999999999999
Q ss_pred cchHHHHHHhhcc----------------------CC--------------CcccccccccCCChHHHHHHHHHHhhhhc
Q 041655 177 MSLVKWMRNVMTS----------------------EN--------------PKRAIDSKLLGNGYEEQMLLVLKTACFCT 220 (238)
Q Consensus 177 ~t~~~~~~~~~~~----------------------~~--------------~~~~~~~~~~~~~~~~~~~~l~~~~~~cl 220 (238)
++|..||...... .. .................+..+.+++.+||
T Consensus 225 l~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 304 (330)
T 3nsz_A 225 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 304 (330)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTS
T ss_pred HhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHh
Confidence 9998777211000 00 00000000111122234567888999999
Q ss_pred CCCCCcc-hHHHHHH
Q 041655 221 LDDPKER-HVRCMLS 234 (238)
Q Consensus 221 ~~~p~~R-~v~~~L~ 234 (238)
+.||++| ++.+.|+
T Consensus 305 ~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 305 RYDHQSRLTAREAME 319 (330)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCCcccCCCHHHHhc
Confidence 9999999 6655554
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-33 Score=230.21 Aligned_cols=197 Identities=16% Similarity=0.178 Sum_probs=146.8
Q ss_pred HHHHHHhcCCCCCcccceeeeeec--------------------------------------CCeeEEEEEeCCCCCHHH
Q 041655 33 RSEIVTLGQIRHRNILPLLAHLAR--------------------------------------PGCHLLVYEFMKNGSLQD 74 (238)
Q Consensus 33 ~~E~~~l~~l~h~~iv~~~~~~~~--------------------------------------~~~~~~v~e~~~~~~L~~ 74 (238)
.+|+.+++.++||||+++++++.. +...++||||++ ++|.+
T Consensus 48 ~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 126 (383)
T 3eb0_A 48 NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHK 126 (383)
T ss_dssp CHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHH
T ss_pred HHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHH
Confidence 379999999999999999999843 334789999997 58888
Q ss_pred HHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------Cceeeec-CCCceEEcccccccccCCcccccccccccC
Q 041655 75 ILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLD-HDMEARISEFGLAKVFPEAHTHITTSDVVG 145 (238)
Q Consensus 75 ~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 145 (238)
.+.........+++..+..++.|+++||.|||++ +.||+++ .++.+||+|||.++....... .....+
T Consensus 127 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~ 203 (383)
T 3eb0_A 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYIC 203 (383)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCccc
Confidence 8765444467799999999999999999999954 6679997 688999999999986544322 234578
Q ss_pred CCcccCccccccc-CCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccc---------------------------c
Q 041655 146 TAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAI---------------------------D 197 (238)
Q Consensus 146 ~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~---------------------------~ 197 (238)
++.|+|||++.+. .++.++||||+||++|+|++|..||...........++ .
T Consensus 204 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 283 (383)
T 3eb0_A 204 SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA 283 (383)
T ss_dssp CSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCC
T ss_pred CCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCc
Confidence 9999999987764 48999999999999999999988774322111110000 0
Q ss_pred ccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 198 SKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 198 ~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
.......+...+..+.+++.+||+.||++| ++.+.|
T Consensus 284 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM 320 (383)
T ss_dssp CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 000001122345568889999999999999 555554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-33 Score=226.07 Aligned_cols=203 Identities=20% Similarity=0.253 Sum_probs=147.9
Q ss_pred HHHHHHHHHHHHHhcCCC--CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 26 TEEMMQIRSEIVTLGQIR--HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+.+.+|+.++.+++ ||||+++++++..++..+++|| +.+++|.+++.. ...+++..+..++.|+++||.
T Consensus 67 ~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~ 141 (313)
T 3cek_A 67 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 141 (313)
T ss_dssp HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Confidence 345678899999999997 5999999999999999999999 457899999986 457899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-----------cCCCccC
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-----------LSITYMC 164 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-----------~~~~~~~ 164 (238)
|||.+ +.||++++ +.+||+|||.+................|++.|+|||.+.+ ..++.++
T Consensus 142 ~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 220 (313)
T 3cek_A 142 TIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220 (313)
T ss_dssp HHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHH
T ss_pred HHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchH
Confidence 99955 66799964 8999999999987644332222244578999999998865 4678899
Q ss_pred CeeehhHHHHhhcchHHHHHHhhccC-CCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVMTSE-NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
||||||+++|+|++|..||....... ..............+...+..+.+++.+||+.||.+| .+.+.|+
T Consensus 221 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 221 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 99999999999999998885422111 1111222222222233334567888888999999999 5555443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-34 Score=233.42 Aligned_cols=198 Identities=17% Similarity=0.182 Sum_probs=145.1
Q ss_pred HHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--
Q 041655 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH-- 108 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~-- 108 (238)
.+.+|+.++++++||||+++++++..++..++||||++ |+|.+++.. ....+++..+..++.|++.||.|||++
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 121 (324)
T 3mtl_A 46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQKV 121 (324)
T ss_dssp CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 45679999999999999999999999999999999996 599999876 345689999999999999999999944
Q ss_pred ------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcchHH
Q 041655 109 ------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 109 ------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
+.||+++.++.+||+|||.+........ ......+|+.|+|||++.+ ..++.++||||+|+++|+|++|..
T Consensus 122 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 199 (324)
T 3mtl_A 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199 (324)
T ss_dssp EESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 6789999999999999999876543221 1233577999999998876 568999999999999999999988
Q ss_pred HHHHhhccCCCccc---------------cc---------ccccC----CChHHHHHHHHHHhhhhcCCCCCcc-hHHHH
Q 041655 182 WMRNVMTSENPKRA---------------ID---------SKLLG----NGYEEQMLLVLKTACFCTLDDPKER-HVRCM 232 (238)
Q Consensus 182 ~~~~~~~~~~~~~~---------------~~---------~~~~~----~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~ 232 (238)
||............ .. ..... ........++.+++.+||+.||.+| ++.+.
T Consensus 200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 279 (324)
T 3mtl_A 200 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279 (324)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence 77432111000000 00 00000 0011234567888999999999999 55555
Q ss_pred HH
Q 041655 233 LS 234 (238)
Q Consensus 233 L~ 234 (238)
|+
T Consensus 280 l~ 281 (324)
T 3mtl_A 280 MK 281 (324)
T ss_dssp TT
T ss_pred hc
Confidence 43
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-34 Score=232.00 Aligned_cols=199 Identities=16% Similarity=0.196 Sum_probs=154.0
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHH------HhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDI------LNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
+.+.+|+.++.+++||||+++++++.+++..++||||+++++|.++ +.. .....+++..+..++.|++.||.
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~ 165 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFS 165 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHH
Confidence 7789999999999999999999999999999999999999999998 432 22567899999999999999999
Q ss_pred hhhc-c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCc-cCCeeehhHH
Q 041655 104 YLHM-H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITY-MCDIYSFGVL 172 (238)
Q Consensus 104 ~lH~-~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~-~~DvwslG~~ 172 (238)
|||. + +.||+++.++.++|+|||.+...... ......|++.|+|||++.+. .++. ++|+||||++
T Consensus 166 ~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~i 241 (348)
T 2pml_X 166 YIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241 (348)
T ss_dssp HHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHH
T ss_pred HHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHH
Confidence 9997 5 56799999999999999999865433 12446789999999998877 5666 9999999999
Q ss_pred HHhhcchHHHHHHhhccCCCc-ccccccccCC-----------------ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 173 LAEEMSLVKWMRNVMTSENPK-RAIDSKLLGN-----------------GYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~~-~~~~~~~~~~-----------------~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
+|+|++|..||.......... .......... .....+..+.+++.+||+.||.+| .+.+.|
T Consensus 242 l~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l 321 (348)
T 2pml_X 242 LYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321 (348)
T ss_dssp HHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 999999988875322200000 0111100000 013445678889999999999999 555544
Q ss_pred H
Q 041655 234 S 234 (238)
Q Consensus 234 ~ 234 (238)
+
T Consensus 322 ~ 322 (348)
T 2pml_X 322 K 322 (348)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-33 Score=223.21 Aligned_cols=199 Identities=25% Similarity=0.311 Sum_probs=151.7
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++||||+++++++...+..++++||+++++|.+++.. ...+++..+..++.|++.||.|||.
T Consensus 64 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~ 139 (287)
T 2wei_A 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK 139 (287)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999999999999999999999999999999998875 3468999999999999999999995
Q ss_pred c--------CceeeecCC---CceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 108 H--------QALVLLDHD---MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 108 ~--------~~~il~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
+ +.||+++.+ +.+||+|||.+........ .....+++.|+|||.+.+ .++.++|+||||+++|+|
T Consensus 140 ~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l 215 (287)
T 2wei_A 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYIL 215 (287)
T ss_dssp TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHH
T ss_pred CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHH
Confidence 5 567999764 4699999999876543321 123457889999998876 488999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccC--CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLG--NGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
++|..||................... ......+..+.+++.+||+.||++| ++.+.|+
T Consensus 216 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 216 LSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 99988874322111111111111111 1123345568888999999999999 5544443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-33 Score=228.11 Aligned_cols=151 Identities=25% Similarity=0.353 Sum_probs=125.0
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeec--------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLAR--------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
..+.+|+.++++++||||+++++++.. .+..++||||+++ +|.+.+.. ....+++..+..++.|++.|
T Consensus 61 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~ 136 (351)
T 3mi9_A 61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNG 136 (351)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHH
Confidence 457789999999999999999999876 4468999999964 88887764 34568999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcc--cccccccccCCCcccCcccccc-cCCCccCCeeehh
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAH--THITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFG 170 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG 170 (238)
|.|||++ +.||+++.++.+||+|||.++...... .........||+.|+|||++.+ ..++.++||||||
T Consensus 137 l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 216 (351)
T 3mi9_A 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216 (351)
T ss_dssp HHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHH
T ss_pred HHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHH
Confidence 9999944 678999999999999999998654221 1122244678999999998865 4579999999999
Q ss_pred HHHHhhcchHHHHH
Q 041655 171 VLLAEEMSLVKWMR 184 (238)
Q Consensus 171 ~~l~~~~t~~~~~~ 184 (238)
|++|+|++|..||.
T Consensus 217 ~il~ell~g~~pf~ 230 (351)
T 3mi9_A 217 CIMAEMWTRSPIMQ 230 (351)
T ss_dssp HHHHHHHHSSCSCC
T ss_pred HHHHHHHhCCCCCC
Confidence 99999999987764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-33 Score=232.60 Aligned_cols=197 Identities=21% Similarity=0.255 Sum_probs=137.3
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
...+.+.+|+.+++.++||||+++++++... ...++++|++ +++|.+++.. ..+++..+..++.|+++
T Consensus 70 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~ 143 (367)
T 2fst_X 70 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILR 143 (367)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHH
Confidence 3457788999999999999999999998654 5679999999 6799988864 46899999999999999
Q ss_pred Hhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhH
Q 041655 101 GLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGV 171 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~ 171 (238)
||.|||++ +.||+++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++||||+||
T Consensus 144 aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 218 (367)
T 2fst_X 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 218 (367)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHH
T ss_pred HHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHH
Confidence 99999954 67899999999999999999765432 134578999999998876 67899999999999
Q ss_pred HHHhhcchHHHHHHhhccCCCccccc-----------------------c--cccCC----ChHHHHHHHHHHhhhhcCC
Q 041655 172 LLAEEMSLVKWMRNVMTSENPKRAID-----------------------S--KLLGN----GYEEQMLLVLKTACFCTLD 222 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~~~~~~~~-----------------------~--~~~~~----~~~~~~~~l~~~~~~cl~~ 222 (238)
++|+|++|..||...........+.. . ..... ........+.+++.+||+.
T Consensus 219 il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~ 298 (367)
T 2fst_X 219 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 298 (367)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCS
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCC
Confidence 99999999887743211100000000 0 00000 0112345678899999999
Q ss_pred CCCcc-hHHHHHH
Q 041655 223 DPKER-HVRCMLS 234 (238)
Q Consensus 223 ~p~~R-~v~~~L~ 234 (238)
||.+| ++.+.|+
T Consensus 299 dP~~R~t~~e~L~ 311 (367)
T 2fst_X 299 DSDKRITAAQALA 311 (367)
T ss_dssp SGGGSCCHHHHHT
T ss_pred CcccCcCHHHHhc
Confidence 99999 6666654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-33 Score=232.29 Aligned_cols=148 Identities=18% Similarity=0.244 Sum_probs=124.5
Q ss_pred HHHHHHHHHHhcCC------CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 29 MMQIRSEIVTLGQI------RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 29 ~~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
.+.+.+|+.+++.+ +|+||+++++.+...+..++||||+. ++|.+++.. .....+++..+..++.|++.||
T Consensus 137 ~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~aL 213 (429)
T 3kvw_A 137 HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKK--NKFQGFSLPLVRKFAHSILQCL 213 (429)
T ss_dssp HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHh--ccCCCCCHHHHHHHHHHHHHHH
Confidence 34556666666555 67899999999999999999999995 699999876 2334589999999999999999
Q ss_pred chhh--------ccCceeeecCCCc--eEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 103 EYLH--------MHQALVLLDHDME--ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 103 ~~lH--------~~~~~il~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
+||| .|+.||+++.++. +||+|||++...... .....||+.|+|||++.+..++.++|||||||+
T Consensus 214 ~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 288 (429)
T 3kvw_A 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCI 288 (429)
T ss_dssp HHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHH
T ss_pred HHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHH
Confidence 9999 4477899999987 999999999764332 234678999999999999999999999999999
Q ss_pred HHhhcchHHHHH
Q 041655 173 LAEEMSLVKWMR 184 (238)
Q Consensus 173 l~~~~t~~~~~~ 184 (238)
+|+|++|..||.
T Consensus 289 l~elltG~~pf~ 300 (429)
T 3kvw_A 289 LAELLTGYPLLP 300 (429)
T ss_dssp HHHHHHSSCSSC
T ss_pred HHHHHhCCCCCC
Confidence 999999987763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-33 Score=232.49 Aligned_cols=154 Identities=23% Similarity=0.311 Sum_probs=118.3
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeee--cCCeeEEEEEeCCCCCHHHHHhhhc-----CCCcccCHHHHHHHHHHHHHHh
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLA--RPGCHLLVYEFMKNGSLQDILNDVS-----RGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~~~l~~gl 102 (238)
..+.+|+.+|++++||||+++++++. .+...++||||++ ++|.+++.... .....+++..++.++.|++.||
T Consensus 63 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 141 (405)
T 3rgf_A 63 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141 (405)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHH
Confidence 35778999999999999999999994 4678899999996 58888875321 1123589999999999999999
Q ss_pred chhhcc--------Cceeee----cCCCceEEcccccccccCCccc-ccccccccCCCcccCccccccc-CCCccCCeee
Q 041655 103 EYLHMH--------QALVLL----DHDMEARISEFGLAKVFPEAHT-HITTSDVVGTAGYIAPEYQQTL-SITYMCDIYS 168 (238)
Q Consensus 103 ~~lH~~--------~~~il~----~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~apE~~~~~-~~~~~~Dvws 168 (238)
.|||++ +.||++ +.++.+||+|||+++....... ........||+.|+|||++.+. .++.++||||
T Consensus 142 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 221 (405)
T 3rgf_A 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 221 (405)
T ss_dssp HHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHH
T ss_pred HHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHH
Confidence 999954 678999 7788999999999987643211 1222446789999999988774 5899999999
Q ss_pred hhHHHHhhcchHHHHH
Q 041655 169 FGVLLAEEMSLVKWMR 184 (238)
Q Consensus 169 lG~~l~~~~t~~~~~~ 184 (238)
|||++|+|++|..||.
T Consensus 222 lG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 222 IGCIFAELLTSEPIFH 237 (405)
T ss_dssp HHHHHHHHHHSSCTTC
T ss_pred HHHHHHHHHhCCCCCC
Confidence 9999999999998884
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-33 Score=228.38 Aligned_cols=223 Identities=20% Similarity=0.214 Sum_probs=153.3
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeec-----CCeeEEEEEeCCCCCHHHHH
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR-----PGCHLLVYEFMKNGSLQDIL 76 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l 76 (238)
||||.+.......... .........+.+.+|+.++++++||||+++++++.. ....++||||++ |+|.+++
T Consensus 49 vavK~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~ 124 (362)
T 3pg1_A 49 VAIKRVFNTVSDGRTV---NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVI 124 (362)
T ss_dssp EEEEEECEECCTTSCE---EGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHH
T ss_pred EEEEeccccCCccchh---hhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHH
Confidence 7888776544322111 112234456789999999999999999999999843 346799999996 6888888
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCc
Q 041655 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAG 148 (238)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 148 (238)
.. ....+++..+..++.|++.||.|||.+ +.||+++.++.+||+|||.+........ .....+++.
T Consensus 125 ~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~ 198 (362)
T 3pg1_A 125 HD---QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRW 198 (362)
T ss_dssp HC---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC------------------CGG
T ss_pred Hh---cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccce
Confidence 64 345789999999999999999999954 6789999999999999999975433221 234578899
Q ss_pred ccCcccccc-cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccc-----------------------cc---ccc
Q 041655 149 YIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAI-----------------------DS---KLL 201 (238)
Q Consensus 149 ~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~-----------------------~~---~~~ 201 (238)
|+|||++.+ ..++.++|+||+|+++|+|++|..||............. .. ...
T Consensus 199 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
T 3pg1_A 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278 (362)
T ss_dssp GCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCC
T ss_pred ecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCC
Confidence 999998876 678999999999999999999987774321100000000 00 000
Q ss_pred C----CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 202 G----NGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 202 ~----~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
. .........+.+++.+||+.||++| ++.+.|+
T Consensus 279 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 279 ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 0 0112234567889999999999999 6555553
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=229.13 Aligned_cols=197 Identities=18% Similarity=0.185 Sum_probs=144.4
Q ss_pred HHHHHhcCCCCCcccceeeeeecCC------eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 34 SEIVTLGQIRHRNILPLLAHLARPG------CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 34 ~E~~~l~~l~h~~iv~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
+|+.+++.++||||+++++++...+ ..++||||+++ ++.+.+.........+++..+..++.|+++||.|||+
T Consensus 81 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~ 159 (394)
T 4e7w_A 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159 (394)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 6999999999999999999985433 37899999976 5555443322335678999999999999999999995
Q ss_pred c--------Cceeeec-CCCceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhhc
Q 041655 108 H--------QALVLLD-HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 ~--------~~~il~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~~ 177 (238)
+ +.||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|+|+
T Consensus 160 ~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 236 (394)
T 4e7w_A 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236 (394)
T ss_dssp TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHH
Confidence 4 6789999 799999999999987643322 2345789999999988654 5899999999999999999
Q ss_pred chHHHHHHhhccCCCcccc-------------------c---ccccCC-----ChHHHHHHHHHHhhhhcCCCCCcc-hH
Q 041655 178 SLVKWMRNVMTSENPKRAI-------------------D---SKLLGN-----GYEEQMLLVLKTACFCTLDDPKER-HV 229 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~-------------------~---~~~~~~-----~~~~~~~~l~~~~~~cl~~~p~~R-~v 229 (238)
+|..||...........+. . ...... .....+.++.+++.+||+.||.+| ++
T Consensus 237 ~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (394)
T 4e7w_A 237 QGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA 316 (394)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH
Confidence 9988874321110000000 0 000000 112245578889999999999999 66
Q ss_pred HHHHH
Q 041655 230 RCMLS 234 (238)
Q Consensus 230 ~~~L~ 234 (238)
.+.|+
T Consensus 317 ~e~l~ 321 (394)
T 4e7w_A 317 IEALC 321 (394)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 65553
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=227.65 Aligned_cols=209 Identities=21% Similarity=0.248 Sum_probs=152.8
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCee------EEEEEeCCCCCHHHH
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH------LLVYEFMKNGSLQDI 75 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------~~v~e~~~~~~L~~~ 75 (238)
||||.+..... .....+.+.+|+.+++.++||||+++++++...+.. ++||||+. ++|.++
T Consensus 70 vaiK~~~~~~~------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~ 136 (371)
T 4exu_A 70 VAIKKLSRPFQ------------SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKI 136 (371)
T ss_dssp EEEEEECSTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHH
T ss_pred EEEEEeccccc------------chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHH
Confidence 67777654332 233467788999999999999999999999877654 99999996 588887
Q ss_pred HhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCC
Q 041655 76 LNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTA 147 (238)
Q Consensus 76 l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 147 (238)
+. ..+++..+..++.|++.||.|||.+ +.||+++.++.+||+|||.++...... ....||+
T Consensus 137 ~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~~~~~t~ 205 (371)
T 4exu_A 137 MG------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTR 205 (371)
T ss_dssp TT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCC
T ss_pred hh------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCc-----CCcccCc
Confidence 74 3489999999999999999999954 678999999999999999997653322 3457899
Q ss_pred cccCcccccc-cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccc--------------------------ccc
Q 041655 148 GYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID--------------------------SKL 200 (238)
Q Consensus 148 ~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~--------------------------~~~ 200 (238)
.|+|||++.+ ..++.++||||||+++|+|++|..||.............. ...
T Consensus 206 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (371)
T 4exu_A 206 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTP 285 (371)
T ss_dssp TTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCC
T ss_pred cccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCc
Confidence 9999998876 6789999999999999999999888743211100000000 000
Q ss_pred cC---CChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 201 LG---NGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 201 ~~---~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.. ..+...+..+.+++.+||+.||++| ++.+.|+
T Consensus 286 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 286 RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 00 0112235668889999999999999 6655553
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=229.76 Aligned_cols=197 Identities=18% Similarity=0.164 Sum_probs=143.8
Q ss_pred HHHHHHhcCCCCCcccceeeeeecC------CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 33 RSEIVTLGQIRHRNILPLLAHLARP------GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 33 ~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.+|+.+|++++||||+++++++... ...++||||+++ ++.+.+.........+++..+..++.|+++||.|||
T Consensus 95 ~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 173 (420)
T 1j1b_A 95 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173 (420)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3699999999999999999988432 236799999975 777776543334567999999999999999999999
Q ss_pred cc--------CceeeecCC-CceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhh
Q 041655 107 MH--------QALVLLDHD-MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 107 ~~--------~~~il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~ 176 (238)
++ +.||+++.+ +.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||
T Consensus 174 ~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 250 (420)
T 1j1b_A 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 250 (420)
T ss_dssp TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHH
Confidence 44 678999965 5689999999986543322 1345789999999988664 689999999999999999
Q ss_pred cchHHHHHHhhccCCCcccc----------------------cccccCC-----ChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 177 MSLVKWMRNVMTSENPKRAI----------------------DSKLLGN-----GYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~----------------------~~~~~~~-----~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
++|..||...........++ ....... .....+.++.+++.+||..||.+| .
T Consensus 251 l~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t 330 (420)
T 1j1b_A 251 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330 (420)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC
Confidence 99988874321110000000 0000000 112334668889999999999999 5
Q ss_pred HHHHH
Q 041655 229 VRCML 233 (238)
Q Consensus 229 v~~~L 233 (238)
+.+.|
T Consensus 331 ~~e~l 335 (420)
T 1j1b_A 331 PLEAC 335 (420)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 55554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=221.17 Aligned_cols=201 Identities=16% Similarity=0.187 Sum_probs=132.2
Q ss_pred HHHHHHHHHH-HhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc-CCCcccCHHHHHHHHHHHHHHhchh
Q 041655 28 EMMQIRSEIV-TLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS-RGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 28 ~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
...++.+|.. +++.++||||+++++++..++..++||||+++ +|.+++.... .....+++..+..++.|++.||.||
T Consensus 63 ~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 141 (327)
T 3aln_A 63 EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141 (327)
T ss_dssp HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHH
Confidence 3455566666 78888999999999999999999999999975 8888876321 2346789999999999999999999
Q ss_pred hcc---------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccc----cccCCCccCCeeehhHH
Q 041655 106 HMH---------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQ----QTLSITYMCDIYSFGVL 172 (238)
Q Consensus 106 H~~---------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~----~~~~~~~~~DvwslG~~ 172 (238)
|.+ +.||+++.++.+||+|||.++....... .....|++.|+|||++ .+..++.++|+||||++
T Consensus 142 H~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 218 (327)
T 3aln_A 142 KENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 218 (327)
T ss_dssp HHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHH
T ss_pred hccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence 965 5679999999999999999976543321 1234689999999998 45668899999999999
Q ss_pred HHhhcchHHHHHHhhcc-CCCccccccc---ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHH
Q 041655 173 LAEEMSLVKWMRNVMTS-ENPKRAIDSK---LLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCM 232 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~ 232 (238)
+|+|++|..||...... .......... .........+..+.+++.+||+.||.+| .+.+.
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 283 (327)
T 3aln_A 219 LYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283 (327)
T ss_dssp HHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 99999998887532211 1111111111 1111123345668888899999999999 44443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=231.51 Aligned_cols=197 Identities=21% Similarity=0.266 Sum_probs=138.0
Q ss_pred HHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--
Q 041655 32 IRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH-- 108 (238)
Q Consensus 32 ~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~-- 108 (238)
+.+|+.+|+++ +||||+++++++.+.+..|+||||++ |+|.+++.. ....+++..+..++.|+++||.|||++
T Consensus 64 ~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 139 (432)
T 3p23_A 64 ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSLNI 139 (432)
T ss_dssp CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHCcC
Confidence 45799999999 79999999999999999999999995 699999975 233344555678999999999999944
Q ss_pred ------CceeeecC-----CCceEEcccccccccCCccc-ccccccccCCCcccCccccc---ccCCCccCCeeehhHHH
Q 041655 109 ------QALVLLDH-----DMEARISEFGLAKVFPEAHT-HITTSDVVGTAGYIAPEYQQ---TLSITYMCDIYSFGVLL 173 (238)
Q Consensus 109 ------~~~il~~~-----~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~apE~~~---~~~~~~~~DvwslG~~l 173 (238)
+.||+++. ...+||+|||+++....... ........||+.|+|||++. ...++.++|||||||++
T Consensus 140 vHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il 219 (432)
T 3p23_A 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219 (432)
T ss_dssp CCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHH
T ss_pred EeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHH
Confidence 77899943 33588999999987643321 12224467999999999987 45667899999999999
Q ss_pred Hhhcc-hHHHHHHhhccCCCcccccc-cc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 174 AEEMS-LVKWMRNVMTSENPKRAIDS-KL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 174 ~~~~t-~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|+|++ |..||....... ....... .. ...........+.+++.+||+.||.+| ++.+.|
T Consensus 220 ~ellt~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 220 YYVISEGSHPFGKSLQRQ-ANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp HHHHTTSCBTTBSTTTHH-HHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHcCCCCCcchhhHHH-HHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 99999 777763211110 0001110 00 111223344557788999999999999 444444
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=222.74 Aligned_cols=150 Identities=23% Similarity=0.336 Sum_probs=126.9
Q ss_pred HHHHHHHHHHHHhcCCCCC------cccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHR------NILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
...+.+.+|+.+++.++|+ +++++++++..++..++||||+ +++|.+++.. .....+++..+..++.|++.
T Consensus 53 ~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~~~~qi~~ 129 (339)
T 1z57_A 53 RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKE--NGFLPFRLDHIRKMAYQICK 129 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHh--cCCCCCcHHHHHHHHHHHHH
Confidence 3456778888888888654 5999999999999999999999 8899999976 33346899999999999999
Q ss_pred Hhchhhcc--------CceeeecC-------------------CCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 101 GLEYLHMH--------QALVLLDH-------------------DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~-------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
||.|||.+ +.||+++. ++.+||+|||.+....... ....||+.|+|||
T Consensus 130 ~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE 204 (339)
T 1z57_A 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPE 204 (339)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHH
T ss_pred HHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChH
Confidence 99999944 67799987 6689999999997643322 3457899999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~ 184 (238)
++.+..++.++||||||+++|+|++|..||.
T Consensus 205 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 205 VILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp HHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred HhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 9998899999999999999999999977763
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=225.44 Aligned_cols=201 Identities=18% Similarity=0.161 Sum_probs=146.6
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCe-------eEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGC-------HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
..+.+|+..+..++||||+++++++...+. .++||||+++ +|...+.........+++..+..++.|++.||
T Consensus 64 ~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 142 (360)
T 3e3p_A 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142 (360)
T ss_dssp CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence 345677888888899999999999865332 7899999975 66666554334567789999999999999999
Q ss_pred chhh--cc--------CceeeecC-CCceEEcccccccccCCcccccccccccCCCcccCcccccccC-CCccCCeeehh
Q 041655 103 EYLH--MH--------QALVLLDH-DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS-ITYMCDIYSFG 170 (238)
Q Consensus 103 ~~lH--~~--------~~~il~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~-~~~~~DvwslG 170 (238)
.||| .+ +.||+++. ++.+||+|||+++....... .....||+.|+|||++.+.. ++.++||||||
T Consensus 143 ~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG 219 (360)
T 3e3p_A 143 GCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVG 219 (360)
T ss_dssp HHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHH
Confidence 9999 44 66799996 89999999999987654332 23457899999999886544 89999999999
Q ss_pred HHHHhhcchHHHHHHhhccCCCccccc------------------------------ccccCCChHHHHHHHHHHhhhhc
Q 041655 171 VLLAEEMSLVKWMRNVMTSENPKRAID------------------------------SKLLGNGYEEQMLLVLKTACFCT 220 (238)
Q Consensus 171 ~~l~~~~t~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~l~~~~~~cl 220 (238)
+++|+|++|..||.............. ...........+..+.+++.+||
T Consensus 220 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 299 (360)
T 3e3p_A 220 CIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALL 299 (360)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHT
T ss_pred HHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHh
Confidence 999999999887743211110000000 00001111224567889999999
Q ss_pred CCCCCcc-hHHHHHH
Q 041655 221 LDDPKER-HVRCMLS 234 (238)
Q Consensus 221 ~~~p~~R-~v~~~L~ 234 (238)
+.||.+| ++.+.|+
T Consensus 300 ~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 300 QYLPEERMKPYEALC 314 (360)
T ss_dssp CSSGGGSCCHHHHTT
T ss_pred ccCccccCCHHHHhc
Confidence 9999999 5555553
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-33 Score=224.31 Aligned_cols=198 Identities=21% Similarity=0.271 Sum_probs=147.3
Q ss_pred HHHHHHHHhcCC---CCCcccceeeeee-----cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 31 QIRSEIVTLGQI---RHRNILPLLAHLA-----RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 31 ~~~~E~~~l~~l---~h~~iv~~~~~~~-----~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
.+.+|+.+++.+ +||||+++++++. .....++||||++ |+|.+++.. .....+++..+..++.|++.||
T Consensus 57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~~~qi~~~l 133 (326)
T 1blx_A 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDK--VPEPGVPTETIKDMMFQLLRGL 133 (326)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHh--cccCCCCHHHHHHHHHHHHHHH
Confidence 345666666555 8999999999987 5567899999997 699999976 2334589999999999999999
Q ss_pred chhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 103 EYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 103 ~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
.|||.+ +.||+++.++.+||+|||.++...... ......|++.|+|||++.+..++.++||||||+++|
T Consensus 134 ~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (326)
T 1blx_A 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210 (326)
T ss_dssp HHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHH
Confidence 999954 667999999999999999997654322 123467899999999999888999999999999999
Q ss_pred hhcchHHHHHHhhccCCCcccc----------------------c---ccccCCChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 175 EEMSLVKWMRNVMTSENPKRAI----------------------D---SKLLGNGYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~----------------------~---~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
+|++|..||............. . ...........+..+.+++.+||+.||++| +
T Consensus 211 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 290 (326)
T 1blx_A 211 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290 (326)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC
Confidence 9999988774321110000000 0 000011123345567888899999999999 5
Q ss_pred HHHHHH
Q 041655 229 VRCMLS 234 (238)
Q Consensus 229 v~~~L~ 234 (238)
+.+.|+
T Consensus 291 ~~e~l~ 296 (326)
T 1blx_A 291 AYSALS 296 (326)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 555553
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=224.42 Aligned_cols=196 Identities=20% Similarity=0.236 Sum_probs=145.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCe------eEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGC------HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
...+.+.+|+.++++++||||+++++++...+. .+++|||+. ++|.+++. ..+++..+..++.|++.
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~ 137 (353)
T 3coi_A 65 IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLK 137 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHH
Confidence 456778899999999999999999999987654 499999996 58887764 34899999999999999
Q ss_pred Hhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhH
Q 041655 101 GLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGV 171 (238)
Q Consensus 101 gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~ 171 (238)
||.|||.+ +.||+++.++.+||+|||.++..... .....+++.|+|||++.+ ..++.++|+||||+
T Consensus 138 al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~ 212 (353)
T 3coi_A 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGC 212 (353)
T ss_dssp HHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHH
T ss_pred HHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHH
Confidence 99999955 66799999999999999998764332 133578999999998876 67889999999999
Q ss_pred HHHhhcchHHHHHHhhccCCCccc--------------------------cccc---ccCCChHHHHHHHHHHhhhhcCC
Q 041655 172 LLAEEMSLVKWMRNVMTSENPKRA--------------------------IDSK---LLGNGYEEQMLLVLKTACFCTLD 222 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~~~l~~~~~~cl~~ 222 (238)
++|+|++|..||............ .... .........+..+.+++.+||+.
T Consensus 213 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 292 (353)
T 3coi_A 213 IMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 292 (353)
T ss_dssp HHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCC
Confidence 999999998877432110000000 0000 00111234456788899999999
Q ss_pred CCCcc-hHHHHHH
Q 041655 223 DPKER-HVRCMLS 234 (238)
Q Consensus 223 ~p~~R-~v~~~L~ 234 (238)
||++| ++.+.|+
T Consensus 293 dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 293 DVDKRLTAAQALT 305 (353)
T ss_dssp CTTTSCCHHHHHT
T ss_pred CcccCCCHHHHhc
Confidence 99999 5555553
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=219.90 Aligned_cols=202 Identities=19% Similarity=0.231 Sum_probs=147.1
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeee--------------cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLA--------------RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--------------~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 92 (238)
...+.+.+|+.++++++||||+++++++. ..+..++||||++ |+|.+++.. ..+++..+.
T Consensus 50 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~ 123 (320)
T 2i6l_A 50 QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHAR 123 (320)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHH
Confidence 45678899999999999999999998873 3467899999997 699999864 468999999
Q ss_pred HHHHHHHHHhchhhcc--------Cceeeec-CCCceEEcccccccccCCccc-ccccccccCCCcccCcccccc-cCCC
Q 041655 93 RTVRGIASGLEYLHMH--------QALVLLD-HDMEARISEFGLAKVFPEAHT-HITTSDVVGTAGYIAPEYQQT-LSIT 161 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~--------~~~il~~-~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~apE~~~~-~~~~ 161 (238)
.++.|++.||+|||.+ +.||+++ .++.+||+|||.++....... ........++..|+|||.+.+ ..++
T Consensus 124 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (320)
T 2i6l_A 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203 (320)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred HHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence 9999999999999954 6679997 567999999999986543211 111233567899999998765 6788
Q ss_pred ccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccc----------------------ccc-C-----CChHHHHHHHH
Q 041655 162 YMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDS----------------------KLL-G-----NGYEEQMLLVL 213 (238)
Q Consensus 162 ~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~----------------------~~~-~-----~~~~~~~~~l~ 213 (238)
.++|+||||+++|+|++|..||............... ... . ......+..+.
T Consensus 204 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (320)
T 2i6l_A 204 KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV 283 (320)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHH
T ss_pred chhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHH
Confidence 9999999999999999998877432211110000000 000 0 00122356688
Q ss_pred HHhhhhcCCCCCcc-hHHHHHH
Q 041655 214 KTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 214 ~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+++.+||+.||++| ++.+.|+
T Consensus 284 ~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 284 DFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCccccCCHHHHhC
Confidence 89999999999999 5555543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=232.46 Aligned_cols=199 Identities=19% Similarity=0.191 Sum_probs=152.4
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeec------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGI 98 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l 98 (238)
.....+.+.+|+.++.+++||||+++++++.. ++..++||||+++|+|.+++... .....+++..+..++.|+
T Consensus 52 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QL 130 (676)
T 3qa8_A 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDI 130 (676)
T ss_dssp CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHH
Confidence 34556789999999999999999999998755 67789999999999999999752 223358889999999999
Q ss_pred HHHhchhhcc--------CceeeecCCCc---eEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCee
Q 041655 99 ASGLEYLHMH--------QALVLLDHDME---ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIY 167 (238)
Q Consensus 99 ~~gl~~lH~~--------~~~il~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvw 167 (238)
+.||.|||++ +.||+++.++. +||+|||.+........ .....|++.|+|||.+.+..++.++|+|
T Consensus 131 l~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIw 207 (676)
T 3qa8_A 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYW 207 (676)
T ss_dssp HHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHH
T ss_pred HHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHH
Confidence 9999999954 67899997765 89999999987644322 2346789999999999999999999999
Q ss_pred ehhHHHHhhcchHHHHHHhhcc--------------CCCcccccc--------cccCCChHHHHHHHHHHhhhhcCCCCC
Q 041655 168 SFGVLLAEEMSLVKWMRNVMTS--------------ENPKRAIDS--------KLLGNGYEEQMLLVLKTACFCTLDDPK 225 (238)
Q Consensus 168 slG~~l~~~~t~~~~~~~~~~~--------------~~~~~~~~~--------~~~~~~~~~~~~~l~~~~~~cl~~~p~ 225 (238)
|+|+++|+|++|..||...... ......... ..........+..+.+++..||+.||+
T Consensus 208 SLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~ 287 (676)
T 3qa8_A 208 SFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR 287 (676)
T ss_dssp HHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC
T ss_pred HHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHh
Confidence 9999999999998887431000 000000000 001123345677889999999999999
Q ss_pred cc
Q 041655 226 ER 227 (238)
Q Consensus 226 ~R 227 (238)
+|
T Consensus 288 kR 289 (676)
T 3qa8_A 288 QR 289 (676)
T ss_dssp --
T ss_pred hC
Confidence 99
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=231.15 Aligned_cols=203 Identities=16% Similarity=0.183 Sum_probs=153.4
Q ss_pred HHHHHHHHHhcCCCC-CcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 30 MQIRSEIVTLGQIRH-RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.++.+|+.++..++| +++..+..++...+..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||.+
T Consensus 47 ~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~ 122 (483)
T 3sv0_A 47 PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK 122 (483)
T ss_dssp CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 347789999999987 55556666667788889999999 8899999975 245699999999999999999999944
Q ss_pred --------Cceeee---cCCCceEEcccccccccCCcccc-----cccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 109 --------QALVLL---DHDMEARISEFGLAKVFPEAHTH-----ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 109 --------~~~il~---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
+.||++ +.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+
T Consensus 123 gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvi 202 (483)
T 3sv0_A 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYV 202 (483)
T ss_dssp TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHH
Confidence 678999 68899999999999876443221 11235679999999999999999999999999999
Q ss_pred HHhhcchHHHHHHhhccCCC---cccccccccC---CChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 173 LAEEMSLVKWMRNVMTSENP---KRAIDSKLLG---NGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 173 l~~~~t~~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+|+|++|..||......... .......... ......+.++.+++..||+.||++| ++.+.|+++
T Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 99999999988643221110 1111111100 0112335678889999999999999 677777665
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=225.70 Aligned_cols=199 Identities=17% Similarity=0.128 Sum_probs=152.3
Q ss_pred HHHHHHHHHHHhcCCC--------CCcccceeeeee----cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIR--------HRNILPLLAHLA----RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTV 95 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~--------h~~iv~~~~~~~----~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 95 (238)
..+.+.+|+.+++.++ |+||+++++++. .+...++||||+ +++|.+++.. .....+++..+..++
T Consensus 76 ~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~ 152 (397)
T 1wak_A 76 YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKII 152 (397)
T ss_dssp HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHH
Confidence 4567889999999885 788999999987 566789999999 6678777764 233568999999999
Q ss_pred HHHHHHhchhhcc---------CceeeecCCC------------------------------------------------
Q 041655 96 RGIASGLEYLHMH---------QALVLLDHDM------------------------------------------------ 118 (238)
Q Consensus 96 ~~l~~gl~~lH~~---------~~~il~~~~~------------------------------------------------ 118 (238)
.|++.||.|||++ +.||+++.++
T Consensus 153 ~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (397)
T 1wak_A 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEK 232 (397)
T ss_dssp HHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGG
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccc
Confidence 9999999999965 4579998775
Q ss_pred -ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCc----
Q 041655 119 -EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPK---- 193 (238)
Q Consensus 119 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~---- 193 (238)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 233 ~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 307 (397)
T 1wak_A 233 LKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307 (397)
T ss_dssp CCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHH
T ss_pred cceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHH
Confidence 7999999999865432 234578999999999999899999999999999999999988875322111000
Q ss_pred -------------cc----------c---------cc-c---------ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHH
Q 041655 194 -------------RA----------I---------DS-K---------LLGNGYEEQMLLVLKTACFCTLDDPKER-HVR 230 (238)
Q Consensus 194 -------------~~----------~---------~~-~---------~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~ 230 (238)
.. . .. . .....+.+....+.+++.+||+.||++| ++.
T Consensus 308 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 387 (397)
T 1wak_A 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387 (397)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHH
T ss_pred HHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHH
Confidence 00 0 00 0 0012245667789999999999999999 666
Q ss_pred HHHH
Q 041655 231 CMLS 234 (238)
Q Consensus 231 ~~L~ 234 (238)
+.|+
T Consensus 388 e~l~ 391 (397)
T 1wak_A 388 ECLR 391 (397)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 6554
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=223.65 Aligned_cols=202 Identities=18% Similarity=0.208 Sum_probs=148.6
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecC-----CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARP-----GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
.....+.+|+.++++++||||+++++++... ...+++|||+. ++|.+++.. ..+++..+..++.|++.|
T Consensus 51 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~ 124 (353)
T 2b9h_A 51 LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRA 124 (353)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHH
Confidence 4456788999999999999999999987653 67899999996 689999875 468999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCccccc--------ccccccCCCcccCcccccc-cCCCccC
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI--------TTSDVVGTAGYIAPEYQQT-LSITYMC 164 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~~~apE~~~~-~~~~~~~ 164 (238)
|.|||++ +.||+++.++.+||+|||.+.......... ......||+.|+|||++.+ ..++.++
T Consensus 125 L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 204 (353)
T 2b9h_A 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204 (353)
T ss_dssp HHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHH
T ss_pred HHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchh
Confidence 9999954 678999999999999999998664321110 1123578999999998654 6789999
Q ss_pred CeeehhHHHHhhcchHHHHHHhhccC----------------CCccc--------ccc--cccC----CChHHHHHHHHH
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVMTSE----------------NPKRA--------IDS--KLLG----NGYEEQMLLVLK 214 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~~~~----------------~~~~~--------~~~--~~~~----~~~~~~~~~l~~ 214 (238)
|+||||+++|+|++|..||....... ..... ... .... ......+..+.+
T Consensus 205 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
T 2b9h_A 205 DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGID 284 (353)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHH
Confidence 99999999999999988774321100 00000 000 0000 011234566788
Q ss_pred HhhhhcCCCCCcc-hHHHHHH
Q 041655 215 TACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 215 ~~~~cl~~~p~~R-~v~~~L~ 234 (238)
++.+||+.||++| ++.+.|+
T Consensus 285 li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 285 LLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCcCcccCCCHHHHhc
Confidence 9999999999999 5555543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=229.66 Aligned_cols=201 Identities=20% Similarity=0.227 Sum_probs=139.5
Q ss_pred HHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcc---cCHHHHHHHHHHHHHHhchh
Q 041655 30 MQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ---LDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 30 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~---~~~~~~~~~~~~l~~gl~~l 105 (238)
+.+.+|+.++.++ +||||+++++++.+++..++||||+. |+|.+++......... .++..+..++.|++.||+||
T Consensus 53 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 131 (434)
T 2rio_A 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131 (434)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH
Confidence 4567899999876 79999999999999999999999995 6999999752211111 12334567999999999999
Q ss_pred hcc--------CceeeecCC-------------CceEEcccccccccCCccccc--ccccccCCCcccCcccccc-----
Q 041655 106 HMH--------QALVLLDHD-------------MEARISEFGLAKVFPEAHTHI--TTSDVVGTAGYIAPEYQQT----- 157 (238)
Q Consensus 106 H~~--------~~~il~~~~-------------~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~apE~~~~----- 157 (238)
|++ |.||+++.+ +.+||+|||+++......... ......||+.|+|||++.+
T Consensus 132 H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 211 (434)
T 2rio_A 132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ 211 (434)
T ss_dssp HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTS
T ss_pred HHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccc
Confidence 954 667999754 489999999998765432211 1234579999999998865
Q ss_pred --cCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccc-----cccCCChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 158 --LSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDS-----KLLGNGYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 158 --~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
..++.++|||||||++|+|++ |..||....... ...... ..........+.++.+++.+||+.||.+| .
T Consensus 212 ~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 289 (434)
T 2rio_A 212 TKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289 (434)
T ss_dssp CCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred cccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC
Confidence 568899999999999999998 788774321110 011111 11111234556778899999999999999 5
Q ss_pred HHHHH
Q 041655 229 VRCML 233 (238)
Q Consensus 229 v~~~L 233 (238)
+.+.|
T Consensus 290 ~~eil 294 (434)
T 2rio_A 290 AMKVL 294 (434)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 44444
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=219.61 Aligned_cols=191 Identities=19% Similarity=0.268 Sum_probs=125.0
Q ss_pred HhcCCCCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-----
Q 041655 38 TLGQIRHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH----- 108 (238)
Q Consensus 38 ~l~~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~----- 108 (238)
.+..++||||+++++++.. ++..++||||+++|+|.+++.. .....+++..+..++.|++.||.|||.+
T Consensus 75 ~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~ 152 (336)
T 3fhr_A 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR 152 (336)
T ss_dssp HHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 3556689999999999865 4558999999999999999976 3335799999999999999999999954
Q ss_pred ---CceeeecC---CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHHH
Q 041655 109 ---QALVLLDH---DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKW 182 (238)
Q Consensus 109 ---~~~il~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~ 182 (238)
+.||+++. ++.+||+|||.+....... .....+++.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 153 dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (336)
T 3fhr_A 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228 (336)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 67799976 4559999999997654322 2345779999999999888889999999999999999999988
Q ss_pred HHHhhccCCCc---c-cccc--cccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 183 MRNVMTSENPK---R-AIDS--KLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 183 ~~~~~~~~~~~---~-~~~~--~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|.......... . .... ..........+..+.+++.+||+.||++| ++.+.|+
T Consensus 229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 229 FYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp C---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 86544322111 1 1111 11111223456678889999999999999 5555443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=216.78 Aligned_cols=196 Identities=16% Similarity=0.165 Sum_probs=136.3
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
+.+..+..++..++||||+++++++..++..++||||+ ++.+..+... ....+++..+..++.|++.||.|||.+
T Consensus 69 ~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 144 (318)
T 2dyl_A 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH 144 (318)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 34445556788889999999999999999999999999 5566666543 235689999999999999999999963
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc-----ccCCCccCCeeehhHHHHh
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ-----TLSITYMCDIYSFGVLLAE 175 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~DvwslG~~l~~ 175 (238)
+.||+++.++.+||+|||.+........ .....+++.|+|||++. +..++.++||||||+++|+
T Consensus 145 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 221 (318)
T 2dyl_A 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221 (318)
T ss_dssp CCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHH
T ss_pred CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHH
Confidence 5579999999999999999876543221 13356899999999884 4567889999999999999
Q ss_pred hcchHHHHHHhhccCC-Ccccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHH
Q 041655 176 EMSLVKWMRNVMTSEN-PKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCM 232 (238)
Q Consensus 176 ~~t~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~ 232 (238)
|++|..||........ ......... ........+..+.+++.+||+.||.+| ++.+.
T Consensus 222 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (318)
T 2dyl_A 222 LATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281 (318)
T ss_dssp HHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred HHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 9999888754221111 111111111 111112345567888889999999999 44433
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=219.60 Aligned_cols=150 Identities=20% Similarity=0.313 Sum_probs=126.1
Q ss_pred HHHHHHHHHHHHhcCCCCCc------ccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRN------ILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
...+.+.+|+.++++++|++ ++.+.+++...+..++||||+ ++++.+++.. .....+++..+..++.|++.
T Consensus 58 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~ 134 (355)
T 2eu9_A 58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCH 134 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHH
Confidence 34567788999888887655 899999999999999999999 6688888765 23356899999999999999
Q ss_pred Hhchhhcc--------Cceeee-------------------cCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 101 GLEYLHMH--------QALVLL-------------------DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 101 gl~~lH~~--------~~~il~-------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
||.|||++ +.||++ +.++.+||+|||.++...... ....||+.|+|||
T Consensus 135 ~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE 209 (355)
T 2eu9_A 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPE 209 (355)
T ss_dssp HHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHH
T ss_pred HHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCe
Confidence 99999955 667999 567899999999997643322 3457899999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~ 184 (238)
++.+..++.++||||||+++|+|++|..||.
T Consensus 210 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 210 VILELGWAQPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 9998899999999999999999999988774
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=235.57 Aligned_cols=179 Identities=19% Similarity=0.203 Sum_probs=141.2
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCe-----eEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGC-----HLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
...+.+.+|+.++.+++||||+++++++...+. .|+||||+++++|.+++.. .+++..+..++.|+++|
T Consensus 121 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~a 194 (681)
T 2pzi_A 121 EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPA 194 (681)
T ss_dssp HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHH
Confidence 456778999999999999999999999976655 6999999999999887742 68999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|.|||++ |.||+++.+ .+||+|||+++..... ....||+.|+|||++.+.. +.++||||||+++
T Consensus 195 L~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l 266 (681)
T 2pzi_A 195 LSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTL 266 (681)
T ss_dssp HHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHH
T ss_pred HHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHH
Confidence 9999944 678999885 8999999999765432 3457899999999987654 8899999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|+|++|..|+........ .........+..+.+++.+||+.||++|
T Consensus 267 ~~l~~g~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~R 312 (681)
T 2pzi_A 267 AALTLDLPTRNGRYVDGL--------PEDDPVLKTYDSYGRLLRRAIDPDPRQR 312 (681)
T ss_dssp HHHHSCCCEETTEECSSC--------CTTCHHHHHCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhCCCCCcccccccc--------cccccccccCHHHHHHHhhhccCChhhC
Confidence 999998766543211111 0111223344678889999999999999
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=221.12 Aligned_cols=149 Identities=19% Similarity=0.254 Sum_probs=124.4
Q ss_pred HHHHHHHHHHHhcCCC-CC-----cccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 28 EMMQIRSEIVTLGQIR-HR-----NILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
....+.+|+.+++.++ |+ +++++++++...+..++||||++ ++|.+++.. .....+++..+..++.|++.|
T Consensus 93 ~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~a 169 (382)
T 2vx3_A 93 FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRN--TNFRGVSLNLTRKFAQQMCTA 169 (382)
T ss_dssp HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHH--TTTSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhh--cCcCCCCHHHHHHHHHHHHHH
Confidence 3456677888877775 44 59999999999999999999995 599999976 223458999999999999999
Q ss_pred hchhhc----------cCceeeec--CCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 102 LEYLHM----------HQALVLLD--HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 102 l~~lH~----------~~~~il~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
|.|||+ ||.||+++ .++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||
T Consensus 170 l~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 244 (382)
T 2vx3_A 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSL 244 (382)
T ss_dssp HHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHH
Confidence 999994 36779994 47889999999998764322 34678999999999999899999999999
Q ss_pred hHHHHhhcchHHHHH
Q 041655 170 GVLLAEEMSLVKWMR 184 (238)
Q Consensus 170 G~~l~~~~t~~~~~~ 184 (238)
||++|+|++|..||.
T Consensus 245 G~il~elltg~~pf~ 259 (382)
T 2vx3_A 245 GCILVEMHTGEPLFS 259 (382)
T ss_dssp HHHHHHHHHSSCSSC
T ss_pred HHHHHHHHhCCCCCC
Confidence 999999999988874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-32 Score=217.63 Aligned_cols=189 Identities=16% Similarity=0.203 Sum_probs=144.8
Q ss_pred HHHHHHHHHhcCC----CCCcccceeeeeecCCeeEEEEEe-CCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 30 MQIRSEIVTLGQI----RHRNILPLLAHLARPGCHLLVYEF-MKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 30 ~~~~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~v~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
..+.+|+.++.++ +||||+++++++...+..++++|+ +++++|.+++.. ...+++..+..++.|++.||.|
T Consensus 79 ~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~ 154 (312)
T 2iwi_A 79 VTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQH 154 (312)
T ss_dssp CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Confidence 3456788888888 899999999999999999999999 788999999976 3468999999999999999999
Q ss_pred hhcc--------Cceeeec-CCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCC-ccCCeeehhHHHH
Q 041655 105 LHMH--------QALVLLD-HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSIT-YMCDIYSFGVLLA 174 (238)
Q Consensus 105 lH~~--------~~~il~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~-~~~DvwslG~~l~ 174 (238)
||.+ +.||+++ .++.+||+|||.+....... .....|++.|+|||++.+..+. .++|+||||+++|
T Consensus 155 lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 230 (312)
T 2iwi_A 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLY 230 (312)
T ss_dssp HHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHH
T ss_pred HHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHH
Confidence 9944 6679998 88999999999998764432 2345689999999988776664 5899999999999
Q ss_pred hhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 175 EEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|++|..||..... ..... ...+...+..+.+++.+||+.||++| .+.+.|+
T Consensus 231 ~l~~g~~pf~~~~~------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 231 DMVCGDIPFERDQE------ILEAE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHSSCSCCSHHH------HHHTC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCCChHH------Hhhhc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999887743221 11111 11223344567888889999999999 5555554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=216.92 Aligned_cols=199 Identities=18% Similarity=0.222 Sum_probs=149.5
Q ss_pred HHHHHHHHHHHhcCCC-----------CCcccceeeeeecCC----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHH
Q 041655 28 EMMQIRSEIVTLGQIR-----------HRNILPLLAHLARPG----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARY 92 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 92 (238)
..+.+.+|+.++.+++ ||||+++++++...+ ..+++|||+ +++|.+++.. .....+++..+.
T Consensus 58 ~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~ 134 (373)
T 1q8y_A 58 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKK--YEHRGIPLIYVK 134 (373)
T ss_dssp HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHH--TTTSCCCHHHHH
T ss_pred chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHH--hhccCCcHHHHH
Confidence 3466778898888876 889999999987543 788999999 8899999976 233558999999
Q ss_pred HHHHHHHHHhchhhcc---------Cceeeec------CCCceEEcccccccccCCcccccccccccCCCcccCcccccc
Q 041655 93 RTVRGIASGLEYLHMH---------QALVLLD------HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT 157 (238)
Q Consensus 93 ~~~~~l~~gl~~lH~~---------~~~il~~------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~ 157 (238)
.++.|++.||.|||.+ +.||+++ ..+.+||+|||++....... ....||+.|+|||++.+
T Consensus 135 ~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLG 209 (373)
T ss_dssp HHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhC
Confidence 9999999999999975 4569984 44589999999997654322 33578999999999999
Q ss_pred cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCC-------------------------------------cccccc--
Q 041655 158 LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENP-------------------------------------KRAIDS-- 198 (238)
Q Consensus 158 ~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~-------------------------------------~~~~~~-- 198 (238)
..++.++||||||+++|+|++|..||......... ......
T Consensus 210 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (373)
T 1q8y_A 210 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 289 (373)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccc
Confidence 89999999999999999999998887643211000 000000
Q ss_pred -------cccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 199 -------KLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 199 -------~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
......+...+..+.+++.+||+.||++| ++.+.|+
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 290 WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp CCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 00112345667889999999999999999 5555553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-32 Score=217.49 Aligned_cols=189 Identities=17% Similarity=0.240 Sum_probs=148.5
Q ss_pred HHHHHHHHHhcCCC--CCcccceeeeeecCCeeEEEEEeCCC-CCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 30 MQIRSEIVTLGQIR--HRNILPLLAHLARPGCHLLVYEFMKN-GSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 30 ~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+.+.+|+.++++++ ||||+++++++..++..++++|++.+ ++|.+++.. ...+++..+..++.|++.||.|||
T Consensus 91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH 166 (320)
T 3a99_A 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCH 166 (320)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44667899999986 59999999999999999999999975 899999976 456899999999999999999999
Q ss_pred cc--------Cceeeec-CCCceEEcccccccccCCcccccccccccCCCcccCcccccccCC-CccCCeeehhHHHHhh
Q 041655 107 MH--------QALVLLD-HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEE 176 (238)
Q Consensus 107 ~~--------~~~il~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~-~~~~DvwslG~~l~~~ 176 (238)
++ +.||+++ .++.+||+|||.+....... .....|++.|+|||++.+..+ +.++||||||+++|+|
T Consensus 167 ~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el 242 (320)
T 3a99_A 167 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242 (320)
T ss_dssp HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred HCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHH
Confidence 54 6679998 78999999999998764332 234578999999999877665 6789999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
++|..||..... ...... ..+...+..+.+++.+||+.||++| ++.+.|+
T Consensus 243 ~~g~~pf~~~~~------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 243 VCGDIPFEHDEE------IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHSSCSCCSHHH------HHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCChhh------hhcccc--cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999888743221 111110 1112234557788888999999999 5544443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=203.81 Aligned_cols=190 Identities=14% Similarity=0.118 Sum_probs=143.2
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+...... ..+..+.+.+|+..+.+++||||+++++++..++..|+||||+++++|.+++..
T Consensus 59 vavK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--- 124 (286)
T 3uqc_A 59 VALTFVDPQGVL-----------PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT--- 124 (286)
T ss_dssp EEEEESCTTCCS-----------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT---
T ss_pred EEEEEECccccc-----------CHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc---
Confidence 677777654332 234567899999999999999999999999999999999999999999999954
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
. .....+..++.|++.||+|||.+ +.||+++.++.+||++++ |++
T Consensus 125 --~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------------------~~~-- 177 (286)
T 3uqc_A 125 --S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP-- 177 (286)
T ss_dssp --C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------------------CCT--
T ss_pred --C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------------------ccC--
Confidence 1 35557788999999999999944 678999999999987443 222
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCc---ccccccccC--CChHHHHHHHHHHhhhhcCCCCCcc-
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPK---RAIDSKLLG--NGYEEQMLLVLKTACFCTLDDPKER- 227 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~l~~~~~~cl~~~p~~R- 227 (238)
.++.++||||||+++|+|++|..||.......... ......... ......+..+.+++.+||+.||++|
T Consensus 178 -----~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rs 252 (286)
T 3uqc_A 178 -----DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRS 252 (286)
T ss_dssp -----TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCCC
T ss_pred -----CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccCC
Confidence 36889999999999999999999887544322221 111111110 1123445668889999999999999
Q ss_pred --hHHHHHHhhh
Q 041655 228 --HVRCMLSQIQ 237 (238)
Q Consensus 228 --~v~~~L~~~~ 237 (238)
++++.|+++.
T Consensus 253 ~~el~~~L~~~~ 264 (286)
T 3uqc_A 253 ASTLLNLMQQAT 264 (286)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 6666666543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=202.14 Aligned_cols=179 Identities=17% Similarity=0.231 Sum_probs=132.9
Q ss_pred HHHHHHHHHh-cCCCCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 30 MQIRSEIVTL-GQIRHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 30 ~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
..+.+|+.++ +..+||||+++++++.. ++..++||||+++++|.+++.. .....+++..+..++.|++.||.|
T Consensus 55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~ 132 (299)
T 3m2w_A 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQY 132 (299)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHH
Confidence 3456788877 55689999999999876 6778999999999999999976 334569999999999999999999
Q ss_pred hhcc--------CceeeecC---CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 105 LHMH--------QALVLLDH---DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 105 lH~~--------~~~il~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
||++ +.||+++. ++.+||+|||++.... +..++.++|+||||+++
T Consensus 133 lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il 188 (299)
T 3m2w_A 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIM 188 (299)
T ss_dssp HHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHH
T ss_pred HHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHH
Confidence 9944 67899998 7889999999986432 23467789999999999
Q ss_pred HhhcchHHHHHHhhccCCCc---ccccccccC-C--ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 174 AEEMSLVKWMRNVMTSENPK---RAIDSKLLG-N--GYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~---~~~~~~~~~-~--~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|+|++|..||.......... ......... . .....+..+.+++.+||+.||++| ++.+.|+
T Consensus 189 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 189 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 99999998885433221111 111111101 0 113446678889999999999999 5555543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=211.89 Aligned_cols=187 Identities=16% Similarity=0.120 Sum_probs=136.0
Q ss_pred HHHHHHHHHHHhcCCCC-Ccccceeee---------------------eec-----CCeeEEEEEeCCCCCHHHHHhhh-
Q 041655 28 EMMQIRSEIVTLGQIRH-RNILPLLAH---------------------LAR-----PGCHLLVYEFMKNGSLQDILNDV- 79 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h-~~iv~~~~~---------------------~~~-----~~~~~~v~e~~~~~~L~~~l~~~- 79 (238)
..+.+.+|+.++..++| +|...+..+ +.. ....+++|+++ +++|.+++...
T Consensus 121 ~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~ 199 (413)
T 3dzo_A 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL 199 (413)
T ss_dssp CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhh
Confidence 35678899999999987 322211111 111 12356777766 67999988532
Q ss_pred --cCCCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcc
Q 041655 80 --SRGRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGY 149 (238)
Q Consensus 80 --~~~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 149 (238)
......+++..+..++.|+++||+|||+ |+.||+++.++.+||+|||+++..... .....| +.|
T Consensus 200 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y 273 (413)
T 3dzo_A 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGF 273 (413)
T ss_dssp HHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTT
T ss_pred cccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-Cce
Confidence 2235668889999999999999999994 477899999999999999998765433 234567 999
Q ss_pred cCcccc----------cccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhh
Q 041655 150 IAPEYQ----------QTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFC 219 (238)
Q Consensus 150 ~apE~~----------~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~c 219 (238)
+|||++ .+..++.++|||||||++|+|++|..||................. ..+..+.+++.+|
T Consensus 274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~ 347 (413)
T 3dzo_A 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCK------NIPQPVRALLEGF 347 (413)
T ss_dssp CCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSCC------CCCHHHHHHHHHH
T ss_pred eCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhcc------cCCHHHHHHHHHH
Confidence 999988 555678899999999999999999998865443333333322111 2335678888899
Q ss_pred cCCCCCcc
Q 041655 220 TLDDPKER 227 (238)
Q Consensus 220 l~~~p~~R 227 (238)
|+.||++|
T Consensus 348 l~~dP~~R 355 (413)
T 3dzo_A 348 LRYPKEDR 355 (413)
T ss_dssp TCSSGGGS
T ss_pred ccCChhhC
Confidence 99999999
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-29 Score=205.40 Aligned_cols=204 Identities=14% Similarity=0.072 Sum_probs=142.3
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCC---------C-----------------Ccccceeeee
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIR---------H-----------------RNILPLLAHL 54 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---------h-----------------~~iv~~~~~~ 54 (238)
.||||.+........ ........+.+.+|+.+++.++ | |||+++++++
T Consensus 45 ~vAvK~~~~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~ 118 (336)
T 2vuw_A 45 PVAIKIIAIEGPDLV------NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHY 118 (336)
T ss_dssp EEEEEEEEESCSSCB------TTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHH
T ss_pred eEEEEEEecCCcccc------ccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHH
Confidence 389998876543210 0001112355677777777665 4 5555555555
Q ss_pred ec-------------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-cc--------Ccee
Q 041655 55 AR-------------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH-MH--------QALV 112 (238)
Q Consensus 55 ~~-------------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH-~~--------~~~i 112 (238)
.+ .+..|+||||+++|++.+.+.. ..+++..++.++.|++.||+||| ++ |.||
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NI 193 (336)
T 2vuw_A 119 NSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193 (336)
T ss_dssp HHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGE
T ss_pred hhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHE
Confidence 43 6789999999999976666632 45899999999999999999999 44 7789
Q ss_pred eecCCC--------------------ceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 113 LLDHDM--------------------EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 113 l~~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
+++.++ .+||+|||+++..... ...||+.|+|||++.+.. +.++||||+|++
T Consensus 194 Ll~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~ 265 (336)
T 2vuw_A 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKK 265 (336)
T ss_dssp EEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHH
T ss_pred EEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCC
Confidence 999887 8999999999865432 347899999999998766 889999998777
Q ss_pred -HHhhcchHHHHHHhhccC-CCccc-----ccccccCCChHHHHHHHHHHhhhhcCCC
Q 041655 173 -LAEEMSLVKWMRNVMTSE-NPKRA-----IDSKLLGNGYEEQMLLVLKTACFCTLDD 223 (238)
Q Consensus 173 -l~~~~t~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~l~~~~~~cl~~~ 223 (238)
.+++.+|..||....... ..... .........+...+.++.+++.+||+.|
T Consensus 266 ~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 266 ENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp HHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred CCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 777888888876421100 00010 1111112234567778999999999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=208.92 Aligned_cols=172 Identities=16% Similarity=0.074 Sum_probs=123.7
Q ss_pred CeeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhh
Q 041655 1 MIAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDV 79 (238)
Q Consensus 1 ~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~ 79 (238)
.+|||.+.+...... ......+...++|.+|+++|+++ .|+||+++++++++++..|+||||++|++|.+.+..
T Consensus 261 ~~~~K~~~~~~~~~~----~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~- 335 (569)
T 4azs_A 261 DYVCKFFYYDMPHGI----LTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA- 335 (569)
T ss_dssp SEEEEEEESSCSTTC----SCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-
T ss_pred eeEEEEEeccccccc----chhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-
Confidence 378898876543322 12233445667899999999999 599999999999999999999999999999999976
Q ss_pred cCCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccC
Q 041655 80 SRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIA 151 (238)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~a 151 (238)
..+++.. +++.||+.||+|+| .||.|||++.+|++||+|||+++....... ...+..||+.|+|
T Consensus 336 ---~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmA 407 (569)
T 4azs_A 336 ---GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFV 407 (569)
T ss_dssp ---TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHH
T ss_pred ---CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhcc
Confidence 4556654 47899999999999 557889999999999999999986644322 2345689999999
Q ss_pred cccccccCCCccCCeeehhHHHHhhcchHHHHHHh
Q 041655 152 PEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNV 186 (238)
Q Consensus 152 pE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~ 186 (238)
||++.+ .+..++|+||+|++++++.++..++...
T Consensus 408 PE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~~~~ 441 (569)
T 4azs_A 408 NELFAE-NKSWNGFWRSAPVHPFNLPQPWSNWLYA 441 (569)
T ss_dssp HHHC------------------CCCCTTHHHHHHH
T ss_pred HHHhCC-CCCCcccccccccchhhhccccchhHHH
Confidence 999876 4677899999999999999987776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=7e-21 Score=163.76 Aligned_cols=135 Identities=14% Similarity=0.141 Sum_probs=109.7
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+++.+|+.++++++||||+++..++...+..|+||||+++++|.+++.. +..++.|+++||.|||+
T Consensus 382 ~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~ 449 (540)
T 3en9_A 382 RKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK 449 (540)
T ss_dssp HHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH
Confidence 456789999999999999999766666677778999999999999999853 45789999999999994
Q ss_pred --------cCceeeecCCCceEEcccccccccCCccccc-----ccccccCCCcccCcccccc--cCCCccCCeeehhHH
Q 041655 108 --------HQALVLLDHDMEARISEFGLAKVFPEAHTHI-----TTSDVVGTAGYIAPEYQQT--LSITYMCDIYSFGVL 172 (238)
Q Consensus 108 --------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~apE~~~~--~~~~~~~DvwslG~~ 172 (238)
||.||+++. .+||+|||+++......... ......||+.|+|||++.. ..|+..+|+||..+-
T Consensus 450 ~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~ 527 (540)
T 3en9_A 450 NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILE 527 (540)
T ss_dssp TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHH
T ss_pred CcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHH
Confidence 578899999 99999999998775432211 1235689999999999876 567778999987766
Q ss_pred HHhh
Q 041655 173 LAEE 176 (238)
Q Consensus 173 l~~~ 176 (238)
..+.
T Consensus 528 ~l~~ 531 (540)
T 3en9_A 528 LMKD 531 (540)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5553
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=2.2e-15 Score=119.44 Aligned_cols=98 Identities=14% Similarity=0.095 Sum_probs=76.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH- 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH- 106 (238)
....+.+|+.++++++ | +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||.|||
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~ 211 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH 211 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH
Confidence 4677899999999999 5 777776544 45699999999999988 421 123368899999999999
Q ss_pred -------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc
Q 041655 107 -------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ 156 (238)
Q Consensus 107 -------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~ 156 (238)
.||.||+++ ++.+||+|||+++. +..+.|||.+.
T Consensus 212 ~giiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 212 RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TTEECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CCCEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 447889999 99999999999863 23467788764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=3.8e-10 Score=88.06 Aligned_cols=90 Identities=12% Similarity=0.158 Sum_probs=66.5
Q ss_pred HHHHHHHHHHhcCCCCCcc--cceeeeeecCCeeEEEEEeCCC-C----CHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 29 MMQIRSEIVTLGQIRHRNI--LPLLAHLARPGCHLLVYEFMKN-G----SLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~v~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
...+.+|+..|.++.|+++ ..+++. +..++||||+.+ | +|.++... .++..+..++.|++.|
T Consensus 114 ~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~ 182 (258)
T 1zth_A 114 FIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVEN 182 (258)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHH
Confidence 3467899999999988764 333332 346899999942 3 66665432 2344567889999999
Q ss_pred hchhh-cc--------CceeeecCCCceEEccccccccc
Q 041655 102 LEYLH-MH--------QALVLLDHDMEARISEFGLAKVF 131 (238)
Q Consensus 102 l~~lH-~~--------~~~il~~~~~~~kl~dfg~~~~~ 131 (238)
|.||| .+ |.||+++. .++|+|||++...
T Consensus 183 l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 183 VKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999 54 77899988 9999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=98.47 E-value=4.9e-09 Score=85.91 Aligned_cols=87 Identities=9% Similarity=0.093 Sum_probs=56.5
Q ss_pred HHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc-----
Q 041655 33 RSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM----- 107 (238)
Q Consensus 33 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~----- 107 (238)
.+|...|.++.+.++. ....+... ..++||||++|++|.++... + ....++.|++.+|.++|.
T Consensus 161 ~kE~~nL~rL~~~gv~-vp~p~~~~-~~~LVME~i~G~~L~~l~~~--------~--~~~~l~~qll~~l~~lH~~gIVH 228 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFP-VPEPIAQS-RHTIVMSLVDALPMRQVSSV--------P--DPASLYADLIALILRLAKHGLIH 228 (397)
T ss_dssp HHHHHHHHHHHHTTCS-CCCEEEEE-TTEEEEECCSCEEGGGCCCC--------S--CHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhcCCC-CCeeeecc-CceEEEEecCCccHhhhccc--------H--HHHHHHHHHHHHHHHHHHCCCcC
Confidence 3566666666433322 21111111 23799999988777654321 1 234577899999999994
Q ss_pred ---cCceeeecCCC----------ceEEccccccccc
Q 041655 108 ---HQALVLLDHDM----------EARISEFGLAKVF 131 (238)
Q Consensus 108 ---~~~~il~~~~~----------~~kl~dfg~~~~~ 131 (238)
||.|||++.++ .+.++||+.+...
T Consensus 229 rDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 229 GDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 47789998887 3889999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=7.5e-06 Score=63.45 Aligned_cols=69 Identities=10% Similarity=0.031 Sum_probs=51.6
Q ss_pred HHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 30 MQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 30 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+|..+++.+. +..+.++++++...+..|++||+++|.+|.+.+.. ......++.+++++|..||.
T Consensus 54 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 54 YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhC
Confidence 35778898888885 66788899998888899999999999888775311 11123456778888888886
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00018 Score=55.19 Aligned_cols=44 Identities=14% Similarity=0.183 Sum_probs=33.5
Q ss_pred HHHHHHHHHhcCCCCCc--ccceeeeeecCCeeEEEEEeCCCCCHH
Q 041655 30 MQIRSEIVTLGQIRHRN--ILPLLAHLARPGCHLLVYEFMKNGSLQ 73 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~v~e~~~~~~L~ 73 (238)
..+.+|..+++.+.+.+ +.+++++...++..+++|||++|.+|.
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 34667888888775433 566888888777889999999987774
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00042 Score=56.18 Aligned_cols=73 Identities=14% Similarity=0.133 Sum_probs=52.4
Q ss_pred HHHHHHHHHHhcCCC--CCcccceeeeeecC---CeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 29 MMQIRSEIVTLGQIR--HRNILPLLAHLARP---GCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
...+.+|..+++.+. +..+.+++..+.+. +..|+||||++|..+.+.. ...++......++.++++.|.
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La 153 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIA 153 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHH
Confidence 356778999988886 44578888888766 4578999999987664311 123567777777888888888
Q ss_pred hhhc
Q 041655 104 YLHM 107 (238)
Q Consensus 104 ~lH~ 107 (238)
.||.
T Consensus 154 ~LH~ 157 (359)
T 3dxp_A 154 AMHT 157 (359)
T ss_dssp HHHH
T ss_pred HHhC
Confidence 8884
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00024 Score=56.29 Aligned_cols=47 Identities=13% Similarity=0.067 Sum_probs=29.8
Q ss_pred HHHHHHHHHHHhcCCC-CCc--ccceeeeeecCC---eeEEEEEeCCCCCHHH
Q 041655 28 EMMQIRSEIVTLGQIR-HRN--ILPLLAHLARPG---CHLLVYEFMKNGSLQD 74 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~-h~~--iv~~~~~~~~~~---~~~~v~e~~~~~~L~~ 74 (238)
....+.+|..+|..+. +.. +.+++......+ ..|+||++++|.++.+
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~ 105 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTP 105 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCc
Confidence 3567888999988774 322 334444433332 3479999999877654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0096 Score=45.89 Aligned_cols=71 Identities=15% Similarity=0.137 Sum_probs=50.6
Q ss_pred HHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
...+.+|...|..+. +--+.++++++.+++..++|||+++|.++.+.... .......+..++...|.-||.
T Consensus 63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~ 134 (272)
T 4gkh_A 63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHS 134 (272)
T ss_dssp HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHT
T ss_pred HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcC
Confidence 456778888887775 32367788888888899999999999888776643 111223456677777777773
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.64 E-value=0.012 Score=44.04 Aligned_cols=89 Identities=13% Similarity=0.083 Sum_probs=56.0
Q ss_pred CCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh----cc-----CceeeecCCCceEEcccccccccCCccccccc
Q 041655 70 GSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MH-----QALVLLDHDMEARISEFGLAKVFPEAHTHITT 140 (238)
Q Consensus 70 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH----~~-----~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~ 140 (238)
-+|.+.+.. .+.++++.++|.++.|.+++|.-+- .. +..+++..+|++-+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 478999876 4678999999999999999987761 11 2226777777776553 1110
Q ss_pred ccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 141 SDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 141 ~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
.....+.|||... ...+.+.=|||+|+++|..+
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~AL 130 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKAL 130 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHH
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHh
Confidence 1123466787653 23356677999999999754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=91.96 E-value=0.4 Score=37.60 Aligned_cols=76 Identities=17% Similarity=0.020 Sum_probs=55.4
Q ss_pred HHHHHHHHHHHhcCCCCC---cccceeeeee-cCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 28 EMMQIRSEIVTLGQIRHR---NILPLLAHLA-RPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
....+.+|..+|..+.+. .+.+++.+.. ..+..+++||+++|.++.+..- ..++......++.++.+.|.
T Consensus 52 ~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La 125 (306)
T 3tdw_A 52 GADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMN 125 (306)
T ss_dssp HHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHH
Confidence 456788999999988742 2455555553 4456789999999887766432 23567777888999999999
Q ss_pred hhhccC
Q 041655 104 YLHMHQ 109 (238)
Q Consensus 104 ~lH~~~ 109 (238)
.||.-+
T Consensus 126 ~LH~~~ 131 (306)
T 3tdw_A 126 ELSAFP 131 (306)
T ss_dssp HHHHSC
T ss_pred HHhcCC
Confidence 999654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 238 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-35 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-31 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-29 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-29 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-28 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-28 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-27 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-27 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-27 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-26 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-26 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-26 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-25 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-25 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-25 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-25 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-24 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-24 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-23 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-23 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-23 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-21 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-21 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-20 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-20 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-19 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-19 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-18 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-18 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-18 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-17 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-17 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-16 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-16 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-16 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-15 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-15 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-14 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-14 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-13 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-12 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-11 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-10 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 7e-35
Identities = 43/241 (17%), Positives = 92/241 (38%), Gaps = 33/241 (13%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+ +++ ++E+ L + RH NIL + + + +V ++ + SL L+
Sbjct: 41 TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLH---I 96
Query: 82 GRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPE 133
+ + + R A G++YLH + + L D+ +I +FGLA V
Sbjct: 97 IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156
Query: 134 AHTHITTSDVVGTAGYIAPEY---QQTLSITYMCDIYSFGVLLAE---------EMSLVK 181
+ G+ ++APE Q ++ D+Y+FG++L E ++
Sbjct: 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216
Query: 182 WMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237
+ ++ SK+ N + L+ + C ER + + +
Sbjct: 217 QIIFMV-GRGYLSPDLSKVRSNCPKAMKRLMAE----CLKKKRDERPLFPQILASIELLA 271
Query: 238 Q 238
+
Sbjct: 272 R 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-31
Identities = 35/164 (21%), Positives = 64/164 (39%), Gaps = 17/164 (10%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
++ QI E+ L + I+ G + E M GSL +L
Sbjct: 40 HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-- 97
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH-----MHQAL----VLLDHDMEARISEFGLAKVF 131
++ + + GL YL MH+ + +L++ E ++ +FG++
Sbjct: 98 --AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
Query: 132 PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
++ + VGT Y++PE Q + DI+S G+ L E
Sbjct: 156 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 113 bits (284), Expect = 6e-31
Identities = 50/238 (21%), Positives = 103/238 (43%), Gaps = 18/238 (7%)
Query: 16 ALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDI 75
A+ S ++ SE +GQ H N++ L + + +++ EFM+NGSL
Sbjct: 58 AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117
Query: 76 LNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGL 127
+ + Q + +RGIA+G++YL + +L++ ++ ++S+FGL
Sbjct: 118 ---LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 128 AKVFPEAHTHITTSDVVG---TAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMR 184
++ + + T + +G + APE Q T D++S+G+++ E MS +
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 185 NVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQQ 238
MT+++ AI+ + + + C D R + L ++ +
Sbjct: 235 WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-30
Identities = 39/205 (19%), Positives = 69/205 (33%), Gaps = 12/205 (5%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
+ E + + H ++ L + ++ E+M NG L + L R +
Sbjct: 45 EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQ 101
Query: 91 RYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSD 142
+ + +EYL Q L L++ ++S+FGL++ + +
Sbjct: 102 LLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG- 160
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLG 202
+ PE + DI++FGVL+ E SL K T+ I L
Sbjct: 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 220
Query: 203 NGYEEQMLLVLKTACFCTLDDPKER 227
V C + ER
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADER 245
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 1e-29
Identities = 39/210 (18%), Positives = 69/210 (32%), Gaps = 14/210 (6%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
++ +E + Q+ + I+ ++ +LV E + G L L R +
Sbjct: 50 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHV 104
Query: 87 DWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHI 138
V ++ G++YL VLL A+IS+FGL+K +
Sbjct: 105 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 139 TTSD-VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID 197
+ APE + D++SFGVL+ E S + M ++
Sbjct: 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224
Query: 198 SKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
+ C D + R
Sbjct: 225 KGERMGCPAGCPREMYDLMNLCWTYDVENR 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 3e-29
Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 35/223 (15%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
EE+ EI L H NI+ LL ++ EF G++ ++ R L
Sbjct: 51 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML---ELERPL 107
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
+ L YLH +H+ L +L D + ++++FG++
Sbjct: 108 TESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167
Query: 139 TTSDVVGTAGYIAPEYQQTLS-----ITYMCDIYSFGVLLAE---------EMSLVKWMR 184
+ +GT ++APE + Y D++S G+ L E E++ ++ +
Sbjct: 168 DS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL 225
Query: 185 NVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
+ SE P A S+ N + + K C + R
Sbjct: 226 KIAKSEPPTLAQPSRWSSNFKD----FLKK----CLEKNVDAR 260
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (273), Expect = 3e-29
Identities = 44/230 (19%), Positives = 84/230 (36%), Gaps = 39/230 (16%)
Query: 18 VEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILN 77
+ K E+ I E+ L ++RH N + R LV E+ + +
Sbjct: 48 MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE- 106
Query: 78 DVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAK 129
++ L + G GL YLH +H+ + +LL ++ +FG A
Sbjct: 107 ---VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163
Query: 130 VFPEAHTHITTSDVVGTAGYIAPEYQQTLS---ITYMCDIYSFGVLLAE---------EM 177
+ A++ VGT ++APE + D++S G+ E M
Sbjct: 164 IMAPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
Query: 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
+ + + ++ +E+P L + E + + C P++R
Sbjct: 218 NAMSALYHIAQNESP------ALQSGHWSEYFRNFVDS---CLQKIPQDR 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 9e-29
Identities = 47/231 (20%), Positives = 103/231 (44%), Gaps = 16/231 (6%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
+ ++ + E +GQ H NI+ L +++ +++ E+M+NG+L L +
Sbjct: 45 KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-- 102
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFP 132
+ L +RGIA+G++YL +H+ L +L++ ++ ++S+FGL++V
Sbjct: 103 -KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161
Query: 133 EAHTHI-TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSEN 191
+ TTS + APE T D++SFG+++ E M+ + +++
Sbjct: 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
Query: 192 PKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQQ 238
+AI+ + + + C + R + +L ++ +
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (268), Expect = 1e-28
Identities = 44/250 (17%), Positives = 87/250 (34%), Gaps = 32/250 (12%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
+ + + E + + + NI+ LL A L++E+M G L + L +S
Sbjct: 52 KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 111
Query: 81 R--------------------GRRQLDWLARYRTVRGIASGLEYLHMHQAL--------V 112
G L + R +A+G+ YL + +
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171
Query: 113 LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172
L+ +M +I++FGL++ A + + ++ PE T D++++GV+
Sbjct: 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 231
Query: 173 LAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----H 228
L E S M E + + E L + C P +R
Sbjct: 232 LWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 229 VRCMLSQIQQ 238
+ +L ++ +
Sbjct: 292 IHRILQRMCE 301
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-28
Identities = 40/191 (20%), Positives = 73/191 (38%), Gaps = 21/191 (10%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDV 79
+ E + SE+ L +++H NI+ + +V E+ + G L ++
Sbjct: 40 GSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG 99
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLHMHQAL-------------VLLDHDMEARISEFG 126
++ R+ LD R + + L+ H V LD ++ +FG
Sbjct: 100 TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 159
Query: 127 LAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNV 186
LA++ + VGT Y++PE +S DI+S G LL E + +
Sbjct: 160 LARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE----LCALMPP 213
Query: 187 MTSENPKRAID 197
T+ + K
Sbjct: 214 FTAFSQKELAG 224
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-28
Identities = 39/172 (22%), Positives = 64/172 (37%), Gaps = 13/172 (7%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80
D K + I+ EI + H N++ H L E+ G L D +
Sbjct: 39 DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---- 94
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFP 132
+ R + +G+ YLH +LLD +IS+FGLA VF
Sbjct: 95 EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 154
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEEMSLVKWM 183
+ + + GT Y+APE + D++S G++L ++
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-28
Identities = 51/225 (22%), Positives = 85/225 (37%), Gaps = 20/225 (8%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL-LVYEFMKNGSLQDILNDVSRGRRQ 85
+E + Q+RH N++ LL + L +V E+M GSL D L SRGR
Sbjct: 42 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSV 99
Query: 86 LDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTH 137
L + + +EYL + + VL+ D A++S+FGL K
Sbjct: 100 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 159
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID 197
+ APE + + D++SFG+LL E S + + ++ ++
Sbjct: 160 -----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 214
Query: 198 SKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQQ 238
+ + V + C D R +R L I+
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (261), Expect = 1e-27
Identities = 42/225 (18%), Positives = 83/225 (36%), Gaps = 15/225 (6%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
T E+ + E + +I+H N++ LL R ++ EFM G+L D L + R++
Sbjct: 54 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQE 111
Query: 86 LDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTH 137
+ + I+S +EYL + L+ + ++++FGL+++
Sbjct: 112 VSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID 197
+ APE + D+++FGVLL E + + ++
Sbjct: 172 AHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
Query: 198 SKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQQ 238
E V + C +P +R + + Q
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (259), Expect = 1e-27
Identities = 44/221 (19%), Positives = 97/221 (43%), Gaps = 22/221 (9%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
+E + Q++H+ ++ L A + + ++ + E+M+NGSL D L +L
Sbjct: 54 AFLAEANLMKQLQHQRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKT--PSGIKLTINK 110
Query: 91 RYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHITTSD 142
IA G+ ++ +H+ L +L+ + +I++FGLA++ +
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG- 169
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL-- 200
+ APE + T D++SFG+LL E ++ + MT+ + ++
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM 229
Query: 201 -LGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236
+ E++ +++ C + P++R ++R +L
Sbjct: 230 VRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-27
Identities = 43/205 (20%), Positives = 81/205 (39%), Gaps = 12/205 (5%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
E + ++RH ++ L A ++ ++ V E+M GSL D L + +L L
Sbjct: 58 AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLV 116
Query: 91 RYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSD 142
IASG+ Y+ + +L+ ++ ++++FGLA++ +
Sbjct: 117 DM--AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG- 173
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLG 202
+ APE T D++SFG+LL E + + M + ++
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 233
Query: 203 NGYEEQMLLVLKTACFCTLDDPKER 227
E + C C +P+ER
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEER 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 3e-27
Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 16/158 (10%)
Query: 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
Q+R E+ +RH NIL L + L+ E+ G++ L +S+
Sbjct: 47 AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---- 102
Query: 86 LDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTH 137
D + +A+ L Y H +H+ + +LL E +I++FG + P +
Sbjct: 103 FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ GT Y+ PE + D++S GVL E
Sbjct: 163 ----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 196
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 5e-27
Identities = 40/210 (19%), Positives = 76/210 (36%), Gaps = 13/210 (6%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+ ++ E + Q+ + I+ L+ +LV E G L L R ++
Sbjct: 51 ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL---VGKREEI 106
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
+ ++ G++YL + VLL + A+IS+FGL+K ++
Sbjct: 107 PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166
Query: 139 T-TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID 197
T S + APE + D++S+GV + E +S + M I+
Sbjct: 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 226
Query: 198 SKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
E + C + ++R
Sbjct: 227 QGKRMECPPECPPELYALMSDCWIYKWEDR 256
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 1e-26
Identities = 38/220 (17%), Positives = 76/220 (34%), Gaps = 16/220 (7%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
E + ++ H ++ L LV+EFM++G L D + R
Sbjct: 46 DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAET 102
Query: 91 RYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHITTSD 142
+ G+ YL + L+ + ++S+FG+ + + +T
Sbjct: 103 LLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG- 161
Query: 143 VVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLG 202
+ +PE + D++SFGVL+ E S K ++ I +
Sbjct: 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 221
Query: 203 NGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQQ 238
V + C + P++R + L++I +
Sbjct: 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-26
Identities = 51/255 (20%), Positives = 90/255 (35%), Gaps = 37/255 (14%)
Query: 16 ALVEADSKLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQD 74
A+ K + E + SE+ + Q+ H NI+ LL G L++E+ G L +
Sbjct: 71 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 130
Query: 75 ILN-------------------DVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL 111
L + L + +A G+E+L +H+ L
Sbjct: 131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190
Query: 112 ----VLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIY 167
VL+ H +I +FGLA+ ++ + ++APE T D++
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250
Query: 168 SFGVLLAEEMSLVK-WMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKE 226
S+G+LL E SL + N + I + + + C D ++
Sbjct: 251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310
Query: 227 R--------HVRCML 233
R + C L
Sbjct: 311 RPSFPNLTSFLGCQL 325
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 3e-26
Identities = 37/224 (16%), Positives = 77/224 (34%), Gaps = 16/224 (7%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+ +I E + + + ++ LL + L+ + M G L L+ V + +
Sbjct: 53 KANKEILDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCL---LDYVREHKDNI 108
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
IA G+ YL + + VL+ +I++FGLAK+
Sbjct: 109 GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 168
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDS 198
++A E T+ D++S+GV + E M+ + + + ++
Sbjct: 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
Query: 199 KLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQQ 238
+ V C + D R + S++ +
Sbjct: 229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.7 bits (248), Expect = 1e-25
Identities = 40/191 (20%), Positives = 79/191 (41%), Gaps = 24/191 (12%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+ I +EI+ + + ++ NI+ L +V E++ GSL D++ +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCM 113
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
D R LE+LH +H+ + +LL D ++++FG +
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE---------EMSLVKWMRNVMTS 189
+T +VGT ++APE + DI+S G++ E + ++ + + T+
Sbjct: 174 ST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 190 ENPKRAIDSKL 200
P+ KL
Sbjct: 232 GTPELQNPEKL 242
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 1e-25
Identities = 38/215 (17%), Positives = 86/215 (40%), Gaps = 14/215 (6%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG---- 82
E ++ +E + + +++ LL +++ L++ E M G L+ L +
Sbjct: 65 RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 124
Query: 83 --RRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFP 132
+ IA G+ YL+ ++ + ++ D +I +FG+ +
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENP 192
E + + +++PE + T D++SFGV+L E +L + +++E
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244
Query: 193 KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
R + L + + ++ + C +PK R
Sbjct: 245 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.9 bits (248), Expect = 1e-25
Identities = 48/250 (19%), Positives = 88/250 (35%), Gaps = 28/250 (11%)
Query: 14 ATALVEADSKLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSL 72
A+ ++ E+ L ++ H NI+ LL G L E+ +G+L
Sbjct: 39 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 98
Query: 73 QDILND------------VSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----V 112
D L + L +A G++YL +H+ L +
Sbjct: 99 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 158
Query: 113 LLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172
L+ + A+I++FGL++ ++ + ++A E T D++S+GVL
Sbjct: 159 LVGENYVAKIADFGLSRGQ---EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 215
Query: 173 LAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----H 228
L E +SL MT + V C + P ER
Sbjct: 216 LWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 229 VRCMLSQIQQ 238
+ L+++ +
Sbjct: 276 ILVSLNRMLE 285
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 99.0 bits (246), Expect = 4e-25
Identities = 34/164 (20%), Positives = 62/164 (37%), Gaps = 16/164 (9%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+ +R EI T+ +RH ++ L +++YEFM G L + +
Sbjct: 60 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---D 116
Query: 82 GRRQLDWLARYRTVRGIASGLEYLHMHQA----------LVLLDHDMEARISEFGLAKVF 131
++ +R + GL ++H + + E ++ +FGL
Sbjct: 117 EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176
Query: 132 PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ T GTA + APE + + Y D++S GVL
Sbjct: 177 DPKQSVKVT---TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 217
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 4e-25
Identities = 47/238 (19%), Positives = 85/238 (35%), Gaps = 28/238 (11%)
Query: 27 EEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILND------- 78
E + SE+ L + H NI+ LL G L++ E+ G L + L
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 79 -------VSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARIS 123
+ LD +A G+ +L +H+ L +LL H +I
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 124 EFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWM 183
+FGLA+ ++ + ++APE T+ D++S+G+ L E SL
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 184 RNVMTSENPKRAIDSKLLGNGYEEQMLLVLKT-ACFCTLDDPKER----HVRCMLSQI 236
M ++ + + E + C DP +R + ++ +
Sbjct: 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 5e-25
Identities = 53/225 (23%), Positives = 86/225 (38%), Gaps = 18/225 (8%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
E M E+ + + HRN++ L + P +V E GSL D L +G L
Sbjct: 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRK-HQGHFLL 110
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
L+RY +A G+ YL +H+ L +LL +I +FGL + P+ H
Sbjct: 111 GTLSRY--AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 139 T-TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAID 197
+ APE +T + ++ D + FGV L E + + + ID
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228
Query: 198 SKLLGNGYEEQMLLVLKT-ACFCTLDDPKER----HVRCMLSQIQ 237
+ E + C P++R +R L + Q
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 6e-25
Identities = 44/223 (19%), Positives = 84/223 (37%), Gaps = 25/223 (11%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQIRHRNILPLL----AHLARPGCHLLVYEFMKNGSLQDIL 76
D KL E + + E L ++H NI+ + + C +LV E M +G+L+ L
Sbjct: 44 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 103
Query: 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQALV-----------LLDHDMEARISEF 125
+ + + R I GL++LH + + +I +
Sbjct: 104 ----KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159
Query: 126 GLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRN 185
GLA + + V+GT ++APE + D+Y+FG+ + E +
Sbjct: 160 GLATLKRASFAK----AVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214
Query: 186 VMTSENPKRAIDSKLLGNGYEEQMLLVLKT-ACFCTLDDPKER 227
+ R + S + +++ + +K C + ER
Sbjct: 215 CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 6e-25
Identities = 55/264 (20%), Positives = 91/264 (34%), Gaps = 57/264 (21%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHL----LVYEFMKNGSLQDILNDVSRG 82
E +EI +RH NIL +A + LV ++ ++GSL D LN
Sbjct: 39 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----- 93
Query: 83 RRQLDWLARYRTVRGIASGLEYLHM------------HQAL----VLLDHDMEARISEFG 126
R + + ASGL +LHM H+ L +L+ + I++ G
Sbjct: 94 RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153
Query: 127 LAKVFPEA--HTHITTSDVVGTAGYIAPEY------QQTLSITYMCDIYSFGVLLAE--- 175
LA A I + VGT Y+APE + DIY+ G++ E
Sbjct: 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213
Query: 176 ----------------EMSLVKWMRNVMTSENPKRAIDSKLLGNGYE-EQMLLVLKTACF 218
++ M ++ + + E + ++ K
Sbjct: 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 273
Query: 219 CTLDDPKER----HVRCMLSQIQQ 238
C + R ++ LSQ+ Q
Sbjct: 274 CWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 97.1 bits (241), Expect = 2e-24
Identities = 32/167 (19%), Positives = 62/167 (37%), Gaps = 16/167 (9%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
+ + +++EI + Q+ H ++ L +L+ EF+ G L D + +
Sbjct: 63 NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AA 119
Query: 82 GRRQLDWLARYRTVRGIASGLEYLHMHQ----------ALVLLDHDMEARISEFGLAKVF 131
++ +R GL+++H H + +I +FGLA
Sbjct: 120 EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
Query: 132 PEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
T TA + APE + + D+++ GVL +S
Sbjct: 180 NPDEIVKVT---TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 3e-24
Identities = 45/237 (18%), Positives = 83/237 (35%), Gaps = 38/237 (16%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLL-AHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
E+ Q +E + + H N+L LL L G L+V +MK+G L++ +
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHN 126
Query: 86 LDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFP--EAH 135
+A G+++L +LD ++++FGLA+ E
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186
Query: 136 THITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE----------EMSLVKWMRN 185
+ + ++A E QT T D++SFGVLL E +++
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246
Query: 186 VMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQQ 238
++ L + + V+ C + R + +S I
Sbjct: 247 LLQGRRL-------LQPEYCPDPLYEVMLK---CWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (234), Expect = 1e-23
Identities = 37/157 (23%), Positives = 62/157 (39%), Gaps = 12/157 (7%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
++ + E + ++ H + L + KNG L +
Sbjct: 50 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSF 105
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
D I S LEYLH +H+ L +LL+ DM +I++FG AKV
Sbjct: 106 DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ VGTA Y++PE S D+++ G ++ +
Sbjct: 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.3 bits (234), Expect = 1e-23
Identities = 41/171 (23%), Positives = 65/171 (38%), Gaps = 18/171 (10%)
Query: 16 ALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDI 75
A+ K L + + +EI L +I+H NI+ L G L+ + + G L D
Sbjct: 38 AIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDR 97
Query: 76 LNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ-----------ALVLLDHDMEARISE 124
+ + R + + ++YLH LD D + IS+
Sbjct: 98 I----VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISD 153
Query: 125 FGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
FGL+K+ S GT GY+APE + D +S GV+
Sbjct: 154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 201
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 3e-23
Identities = 52/243 (21%), Positives = 94/243 (38%), Gaps = 25/243 (10%)
Query: 21 DSKLLTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDIL--- 76
S +++ + SE+ + I +H+NI+ LL + G ++ E+ G+L++ L
Sbjct: 54 KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 113
Query: 77 ---------NDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDME 119
N QL +A G+EYL +H+ L VL+ D
Sbjct: 114 RPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 173
Query: 120 ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179
+I++FGLA+ + T++ ++APE T+ D++SFGVLL E +L
Sbjct: 174 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233
Query: 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235
+ E + + + + C P +R + L +
Sbjct: 234 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 236 IQQ 238
I
Sbjct: 294 IVA 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.4 bits (229), Expect = 7e-23
Identities = 34/163 (20%), Positives = 60/163 (36%), Gaps = 16/163 (9%)
Query: 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRG 82
K+ + + ++ EI L RHRNIL L ++++EF+ + + +N
Sbjct: 39 KVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN---TS 95
Query: 83 RRQLDWLARYRTVRGIASGLEYLHMHQ----------ALVLLDHDMEARISEFGLAKVFP 132
+L+ V + L++LH H + +I EFG A+
Sbjct: 96 AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
Y APE Q ++ D++S G L+
Sbjct: 156 PGDNFRLL---FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYV 195
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 4e-22
Identities = 51/239 (21%), Positives = 83/239 (34%), Gaps = 27/239 (11%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLL--AHLARPGCHLLVYEFMKNGSLQDILND------ 78
E + SE+ L I H + L A G +++ EF K G+L L
Sbjct: 58 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 117
Query: 79 ------VSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISE 124
+ L +A G+E+L + + +LL +I +
Sbjct: 118 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 177
Query: 125 FGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK-WM 183
FGLA+ + ++ D ++APE T D++SFGVLL E SL
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 184 RNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQQ 238
V E R + + + +T C +P +R + L + Q
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 1e-21
Identities = 41/251 (16%), Positives = 90/251 (35%), Gaps = 23/251 (9%)
Query: 3 AIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLL 62
I + P A A+ + + E +T+ Q H +I+ L+ + +
Sbjct: 26 GIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 84
Query: 63 VYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLL 114
+ E G L+ L + LD + +++ L YL + + VL+
Sbjct: 85 IMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 141
Query: 115 DHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174
+ ++ +FGL++ ++ + + ++APE T D++ FGV +
Sbjct: 142 SSNDCVKLGDFGLSRYMEDSTYYKASK-GKLPIKWMAPESINFRRFTSASDVWMFGVCMW 200
Query: 175 EEMSLVKWMRNVMTSENPKRAIDSKL---LGNGYEEQMLLVLKTACFCTLDDPKER---- 227
E + + + + I++ + + ++ C DP R
Sbjct: 201 EILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTK---CWAYDPSRRPRFT 257
Query: 228 HVRCMLSQIQQ 238
++ LS I +
Sbjct: 258 ELKAQLSTILE 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 2e-21
Identities = 39/167 (23%), Positives = 61/167 (36%), Gaps = 15/167 (8%)
Query: 18 VEADSKLLTEEMMQIRSEIVTLG-QIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDIL 76
++ D L+ +++ E L H + + V E++ G L +
Sbjct: 35 LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 94
Query: 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLA 128
+ + D I GL++LH +LLD D +I++FG+
Sbjct: 95 ----QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150
Query: 129 KVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
K T GT YIAPE + D +SFGVLL E
Sbjct: 151 KENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 195
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 85.1 bits (210), Expect = 2e-20
Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 22/179 (12%)
Query: 12 MDATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNG 70
+D T ++ + E E+ L ++ H NI+ L LV++ MK G
Sbjct: 36 IDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG 95
Query: 71 SLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARI 122
L D L + L + +R + + LH +H+ L +LLD DM ++
Sbjct: 96 ELFDYL----TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL 151
Query: 123 SEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT------LSITYMCDIYSFGVLLAE 175
++FG + +V GT Y+APE + D++S GV++
Sbjct: 152 TDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 207
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 84.0 bits (207), Expect = 4e-20
Identities = 30/162 (18%), Positives = 64/162 (39%), Gaps = 17/162 (10%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHL----ARPGCHLLVYEFMKNGSLQDILNDVSRG 82
++ R E + H I+ + +V E++ +L+DI+
Sbjct: 49 SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HT 104
Query: 83 RRQLDWLARYRTVRGIASGLEYLHMHQALV--------LLDHDMEARISEFGLAKVFPEA 134
+ + L + H + + ++ ++ +FG+A+ ++
Sbjct: 105 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164
Query: 135 HTHIT-TSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+T T+ V+GTA Y++PE + S+ D+YS G +L E
Sbjct: 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 206
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.5 bits (203), Expect = 4e-19
Identities = 38/161 (23%), Positives = 63/161 (39%), Gaps = 17/161 (10%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+ R + + I+ + P + + M G L L+ G
Sbjct: 49 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSE 106
Query: 87 DWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTHI 138
+ Y I GLE++H +++ L +LLD RIS+ GLA F + H
Sbjct: 107 ADMRFY--AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 164
Query: 139 TTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMS 178
+ GT GY+APE Q ++ D +S G +L + +
Sbjct: 165 SV----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 201
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 8e-19
Identities = 42/154 (27%), Positives = 60/154 (38%), Gaps = 15/154 (9%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
EI L ++ H NI+ LL LV++FM+ I L
Sbjct: 46 TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSH 101
Query: 91 RYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHITTSD 142
+ GLEYLH H +LLD + ++++FGLAK F + T
Sbjct: 102 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT--H 159
Query: 143 VVGTAGYIAPE-YQQTLSITYMCDIYSFGVLLAE 175
V T Y APE D+++ G +LAE
Sbjct: 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 193
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 80.3 bits (197), Expect = 1e-18
Identities = 36/222 (16%), Positives = 72/222 (32%), Gaps = 31/222 (13%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
Q+ E ++ +P + G + ++ + SL + + R+
Sbjct: 48 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSL---EDLFNFCSRKFSLKT 104
Query: 91 RYRTVRGIASGLEYLH----MHQALV-------LLDHDMEARISEFGLAKVFPEAHTH-- 137
+ S +EY+H +H+ + L I +FGLAK + +A TH
Sbjct: 105 VLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164
Query: 138 ---ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE---------EMSLVKWMRN 185
++ GTA Y + + + D+ S G +L + +
Sbjct: 165 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
Query: 186 VMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227
K + ++L GY + L C ++
Sbjct: 225 YERISEKKMSTPIEVLCKGYPSEFATYLNF---CRSLRFDDK 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.0 bits (199), Expect = 2e-18
Identities = 32/169 (18%), Positives = 62/169 (36%), Gaps = 20/169 (11%)
Query: 23 KLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCH------LLVYEFMKNGSLQDIL 76
K + ++ E+ + ++ H NI+ L G LV +++ +
Sbjct: 51 KKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR 110
Query: 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMH---------QALVLLDHDMEARISEFGL 127
SR ++ L + + + L Y+H Q L+L ++ +FG
Sbjct: 111 -HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
Query: 128 AKVFPEAHTHITTSDVVGTAGYIAP-EYQQTLSITYMCDIYSFGVLLAE 175
AK +++ + + Y AP T D++S G +LAE
Sbjct: 170 AKQLVRGEPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.8 bits (196), Expect = 2e-18
Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 19/157 (12%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
I E+ L +I+H N++ L +L+ E + G L D L + + L
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEE 114
Query: 91 RYRTVRGIASGLEYLHMHQAL--------VLLDHDMEAR----ISEFGLAKVFPEAHTHI 138
++ I +G+ YLH Q ++L + I +FGLA +
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-- 172
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
++ GT ++APE + D++S GV+
Sbjct: 173 -FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYI 208
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.1 bits (189), Expect = 3e-17
Identities = 35/157 (22%), Positives = 63/157 (40%), Gaps = 17/157 (10%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+++ E + L + H I+ + ++ ++++ G L +L ++
Sbjct: 46 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRF 101
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
+ LEYLH + +LLD + +I++FG AK P+
Sbjct: 102 PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT- 160
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ GT YIAPE T D +SFG+L+ E
Sbjct: 161 ----LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 5e-17
Identities = 38/157 (24%), Positives = 64/157 (40%), Gaps = 11/157 (7%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+ EI L + RH NI+ + + P + ++ + L + + + L
Sbjct: 48 TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-L 106
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
+ I GL+Y+H L +LL+ + +I +FGLA+V H H
Sbjct: 107 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166
Query: 139 TT-SDVVGTAGYIAPEY-QQTLSITYMCDIYSFGVLL 173
++ V T Y APE + T DI+S G +L
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 203
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 74.8 bits (183), Expect = 1e-16
Identities = 29/239 (12%), Positives = 84/239 (35%), Gaps = 37/239 (15%)
Query: 31 QIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLA 90
Q+R E T + +P + + + G H ++ + SL+D+L+ R+
Sbjct: 46 QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKT 102
Query: 91 RYRTVRGIASGLEYLH----MHQAL----VLLD-----HDMEARISEFGLAKVFPEAHTH 137
+ + + ++ +H +++ + L+ + + +FG+ K + + T
Sbjct: 103 VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 162
Query: 138 -----ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSE-- 190
++ GTA Y++ + D+ + G + + + + +
Sbjct: 163 QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 222
Query: 191 -------NPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQQ 238
K++ + L G+ E+ + +++ + S++ +
Sbjct: 223 QKYERIGEKKQSTPLRELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.6 bits (180), Expect = 3e-16
Identities = 30/161 (18%), Positives = 57/161 (35%), Gaps = 19/161 (11%)
Query: 27 EEMMQIRSEIVTLGQIR--HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRR 84
++ E+V L ++ ++ LL RP +L+ E + L D R
Sbjct: 49 PNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERG 105
Query: 85 QLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHD-MEARISEFGLAKVFPEAH 135
L + + + H L +L+D + E ++ +FG + +
Sbjct: 106 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 165
Query: 136 THITTSDVVGTAGYIAPEYQQTLS-ITYMCDIYSFGVLLAE 175
D GT Y PE+ + ++S G+LL +
Sbjct: 166 YT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (181), Expect = 4e-16
Identities = 32/158 (20%), Positives = 60/158 (37%), Gaps = 15/158 (9%)
Query: 31 QIRSEIVTLGQI-RHRNILPLL----AHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+ R E+ + + +I+ ++ A C L+V E + G L + D RG +
Sbjct: 50 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQA 107
Query: 86 LDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISEFGLAKVFPEAHTH 137
++ I ++YLH H+ + +L I + E +H
Sbjct: 108 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+ + T Y+APE CD++S GV++
Sbjct: 168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 205
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.1 bits (173), Expect = 3e-15
Identities = 33/171 (19%), Positives = 67/171 (39%), Gaps = 19/171 (11%)
Query: 18 VEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLL-----AHLARPGCHLLVYEFMKNGSL 72
V+ + + ++ + + L H N++ L + R LV+E +
Sbjct: 43 VQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT 102
Query: 73 QDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----MHQAL----VLLDHDMEARISE 124
+ + + + GL++LH +H+ L +L+ + ++++
Sbjct: 103 TYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 159
Query: 125 FGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
FGLA+++ + VV T Y APE S D++S G + AE
Sbjct: 160 FGLARIYSFQMALTS---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 207
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 70.7 bits (172), Expect = 4e-15
Identities = 31/162 (19%), Positives = 61/162 (37%), Gaps = 13/162 (8%)
Query: 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81
K EI L +++H NI+ L + +LV+E + + +
Sbjct: 37 EKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD----V 92
Query: 82 GRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPE 133
L+ + + + +G+ Y H + +L++ + E +I++FGLA+ F
Sbjct: 93 CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI 152
Query: 134 AHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
T +V + + DI+S G + AE
Sbjct: 153 PVRKYTHE-IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.4 bits (174), Expect = 4e-15
Identities = 38/157 (24%), Positives = 54/157 (34%), Gaps = 14/157 (8%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+E+ +E L RH + L V E+ G L L R
Sbjct: 47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVF 102
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
I S LEYLH + ++LD D +I++FGL K
Sbjct: 103 TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-- 160
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
T GT Y+APE + D + GV++ E
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.3 bits (171), Expect = 6e-15
Identities = 37/171 (21%), Positives = 69/171 (40%), Gaps = 23/171 (13%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLL--------AHLARPGCHLLVYEFMKNGSLQDILND 78
+ EI L ++H N++ L+ + G LV++F ++ + N
Sbjct: 51 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV 110
Query: 79 VSRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKV 130
+ L + R ++ + +GL Y+H M A VL+ D ++++FGLA+
Sbjct: 111 --LVKFTLSEIKRV--MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166
Query: 131 FPEAHTHITT--SDVVGTAGYIAPE-YQQTLSITYMCDIYSFGVLLAEEMS 178
F A ++ V T Y PE D++ G ++AE +
Sbjct: 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 217
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.3 bits (171), Expect = 7e-15
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 14/161 (8%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
EI L ++ H NI+ LL + LV+EF+ + + + +
Sbjct: 43 GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGI 99
Query: 87 DWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHI 138
+ + GL + H H+ +L++ + ++++FGLA+ F
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159
Query: 139 TTSDVVGTAGYIAPE-YQQTLSITYMCDIYSFGVLLAEEMS 178
T V T Y APE + DI+S G + AE ++
Sbjct: 160 TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 4e-14
Identities = 30/156 (19%), Positives = 49/156 (31%), Gaps = 12/156 (7%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+ E+ L +RH N++ LL +F +L
Sbjct: 59 LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL 118
Query: 87 DWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHI 138
V + GL Y+H + ++ D E +I +FGLA+
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM--- 175
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174
T VV + T DI+S G ++A
Sbjct: 176 -TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 67.2 bits (163), Expect = 9e-14
Identities = 44/227 (19%), Positives = 80/227 (35%), Gaps = 24/227 (10%)
Query: 23 KLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARP--GCHLLVYEFMKNGSLQDILNDV 79
L + +I+ EI L +R NI+ L + P LV+E + N + +
Sbjct: 67 ILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--- 123
Query: 80 SRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHD-MEARISEFGLAKV 130
+ L + I L+Y H + V++DH+ + R+ ++GLA+
Sbjct: 124 ----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179
Query: 131 FPEAHTHITTSDVVGTAGYIAPEYQQTLS-ITYMCDIYSFGVLLAEEMSLVKWMRNVMTS 189
+ + + V + + PE Y D++S G +LA M K
Sbjct: 180 YHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA-SMIFRKEPFFHGHD 235
Query: 190 ENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKERHVRCMLSQI 236
+ +K+LG + +D RH R +
Sbjct: 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERF 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.1 bits (163), Expect = 1e-13
Identities = 28/157 (17%), Positives = 53/157 (33%), Gaps = 17/157 (10%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
+++ +E L + ++ L +V E++ G + L +
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRF 138
Query: 87 DWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPEAHTHI 138
I EYLH + +L+D ++++FG AK +
Sbjct: 139 SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
GT +APE + D ++ GVL+ E
Sbjct: 199 C-----GTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.4 bits (153), Expect = 1e-12
Identities = 33/157 (21%), Positives = 58/157 (36%), Gaps = 13/157 (8%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQL 86
EI L +++H+NI+ L L LV+EF QD+ L
Sbjct: 43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDL 98
Query: 87 DWLARYRTVRGIASGLEYLHMHQ--------ALVLLDHDMEARISEFGLAKVFPEAHTHI 138
D + + GL + H +L++ + E +++ FGLA+ F
Sbjct: 99 DPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157
Query: 139 TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
+++VV + D++S G + AE
Sbjct: 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 194
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.9 bits (144), Expect = 3e-11
Identities = 38/160 (23%), Positives = 62/160 (38%), Gaps = 16/160 (10%)
Query: 27 EEMMQIRSEIVTLGQIRHR-NILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQ 85
+ R+E L IR ++ L L+ +++ G L L+ R +
Sbjct: 70 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RER 125
Query: 86 LDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAHTH 137
V I LE+LH + +LLD + +++FGL+K F T
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
Query: 138 ITTSDVVGTAGYIAPEYQQTLSITY--MCDIYSFGVLLAE 175
D GT Y+AP+ + + D +S GVL+ E
Sbjct: 186 RAY-DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 224
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.7 bits (133), Expect = 8e-10
Identities = 37/163 (22%), Positives = 62/163 (38%), Gaps = 24/163 (14%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLL------AHLARPGCHLLVYEFMKNGSLQDILNDVS 80
+ E+V + + H+NI+ LL L LV E M Q I
Sbjct: 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----- 112
Query: 81 RGRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFP 132
+ +LD + + G+++LH + +++ D +I +FGLA+
Sbjct: 113 --QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 169
Query: 133 EAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAE 175
T + V T Y APE + DI+S G ++ E
Sbjct: 170 --GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.0 bits (126), Expect = 7e-09
Identities = 28/165 (16%), Positives = 59/165 (35%), Gaps = 22/165 (13%)
Query: 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARP-----GCHLLVYEFMKNGSLQDILNDVSR 81
+ E+ L ++H N++ LL + + + L +I+
Sbjct: 59 IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---- 114
Query: 82 GRRQLDWLARYRTVRGIASGLEYLHMHQAL--------VLLDHDMEARISEFGLAKVFPE 133
++L + I GL+Y+H + + ++ D E +I +FGLA+ +
Sbjct: 115 -CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173
Query: 134 AHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178
T + + DI+S G ++AE ++
Sbjct: 174 EMTGYVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 46.6 bits (109), Expect = 8e-07
Identities = 32/181 (17%), Positives = 65/181 (35%), Gaps = 14/181 (7%)
Query: 6 KIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYE 65
KIV+ T E + KLL ++ + +IL LL H G + +
Sbjct: 44 KIVRGDKVYTEAAEDEIKLLQRVN---DADNTKEDSMGANHILKLLDHFNHKGPNGVHVV 100
Query: 66 FMKNGSLQDILNDVSRGRRQLDWLARYRTV-RGIASGLEYLHMHQALVLLD--------- 115
+ +++L + + + L + + + + GL+Y+H ++ D
Sbjct: 101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160
Query: 116 -HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174
D + + +A + ++ + T Y +PE DI+S L+
Sbjct: 161 IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 220
Query: 175 E 175
E
Sbjct: 221 E 221
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 238 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.31 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 95.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 89.22 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=295.20 Aligned_cols=204 Identities=19% Similarity=0.243 Sum_probs=155.2
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-- 107 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~-- 107 (238)
++|.+|+.++++++||||++++|++..++..++||||+++|+|.+++.. ....+++..+..++.|+++||.|||.
T Consensus 45 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~ 121 (263)
T d1sm2a_ 45 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC 121 (263)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc
Confidence 5789999999999999999999999999999999999999999999865 34668999999999999999999994
Q ss_pred ------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchHH
Q 041655 108 ------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVK 181 (238)
Q Consensus 108 ------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~ 181 (238)
|+.||+++.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+|+..
T Consensus 122 iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~ 200 (263)
T d1sm2a_ 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200 (263)
T ss_dssp CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred eeecccchhheeecCCCCeEecccchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCC
Confidence 4778999999999999999998764433221 234578999999999999999999999999999999999644
Q ss_pred HHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 182 WMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|+............+........+...+.++.+++.+||+.||++| ++++.|++|.
T Consensus 201 ~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 201 IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 4432222222222233333334455556778889999999999999 7788887775
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-46 Score=295.57 Aligned_cols=218 Identities=19% Similarity=0.272 Sum_probs=176.3
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||++..... ..++|.+|+.+|++++||||++++|++.+++..+++|||+++|+|.+++.. .
T Consensus 45 vAvK~i~~~~~---------------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~ 107 (287)
T d1opja_ 45 VAVKTLKEDTM---------------EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--C 107 (287)
T ss_dssp EEEEECCTTCS---------------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--S
T ss_pred EEEEEECCccc---------------hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh--c
Confidence 78887754322 235789999999999999999999999999999999999999999999875 3
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
....+++..+..++.|+++||+|||++ |.|||++.++.+||+|||+++......... .....|++.|+|||
T Consensus 108 ~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~-~~~~~g~~~y~aPE 186 (287)
T d1opja_ 108 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPE 186 (287)
T ss_dssp CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE-ETTEEECGGGCCHH
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCcee-eccccccccccChH
Confidence 456789999999999999999999944 778999999999999999998765443222 23346789999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HV 229 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v 229 (238)
++.+..++.++|||||||++|||++|..|+............+........+...+..+.+++.+||+.||++| ++
T Consensus 187 ~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei 266 (287)
T d1opja_ 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266 (287)
T ss_dssp HHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 99999999999999999999999997666544333333334444455555566677788999999999999999 66
Q ss_pred HHHHHhhh
Q 041655 230 RCMLSQIQ 237 (238)
Q Consensus 230 ~~~L~~~~ 237 (238)
++.|+.+.
T Consensus 267 ~~~L~~~~ 274 (287)
T d1opja_ 267 HQAFETMF 274 (287)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHHH
Confidence 67676653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=293.75 Aligned_cols=220 Identities=19% Similarity=0.291 Sum_probs=165.7
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||++...... +...+.|.+|+.+|.+++||||++++|++.+ +..++||||+++|+|.+++..
T Consensus 33 vAvK~~~~~~~~------------~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~--- 96 (276)
T d1uwha_ 33 VAVKMLNVTAPT------------PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--- 96 (276)
T ss_dssp EEEEECCCSSCC------------TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHT---
T ss_pred EEEEEEEcccCC------------HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhh---
Confidence 688877544332 2346789999999999999999999998755 467999999999999999975
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
....+++..+..++.|+++||+|||++ |.||+++.++.+||+|||+++...............||+.|+|||
T Consensus 97 ~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 176 (276)
T d1uwha_ 97 IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176 (276)
T ss_dssp SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHH
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHH
Confidence 345699999999999999999999954 678999999999999999998765433333335578999999999
Q ss_pred cccc---cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc----cCCChHHHHHHHHHHhhhhcCCCCCc
Q 041655 154 YQQT---LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL----LGNGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 154 ~~~~---~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
++.+ ..++.++|||||||++|||+||..||............+.... ....+.+.+..+.+++.+||+.||++
T Consensus 177 ~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~ 256 (276)
T d1uwha_ 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE 256 (276)
T ss_dssp HHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhH
Confidence 8864 3578899999999999999999999864332222222222221 11234456677889999999999999
Q ss_pred c----hHHHHHHhhh
Q 041655 227 R----HVRCMLSQIQ 237 (238)
Q Consensus 227 R----~v~~~L~~~~ 237 (238)
| ++++.|+.|+
T Consensus 257 RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 257 RPLFPQILASIELLA 271 (276)
T ss_dssp SCCHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHH
Confidence 9 7777777664
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=291.90 Aligned_cols=203 Identities=21% Similarity=0.258 Sum_probs=160.9
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+
T Consensus 46 ~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~ 121 (271)
T d1nvra_ 46 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHG 121 (271)
T ss_dssp ---CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 346789999999999999999999999999999999999999999999864 4679999999999999999999994
Q ss_pred --------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCC-CccCCeeehhHHHHhhcc
Q 041655 108 --------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 --------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~-~~~~DvwslG~~l~~~~t 178 (238)
||.||+++.++.+||+|||+++...............||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 122 ~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~ 201 (271)
T d1nvra_ 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201 (271)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh
Confidence 47789999999999999999987654433333456789999999999988776 578999999999999999
Q ss_pred hHHHHHHhhccCCC-cccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 179 LVKWMRNVMTSENP-KRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 179 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|..||......... ................+.++.+++.+||+.||++| ++.+.|+
T Consensus 202 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 202 GELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99988543222111 11112222223334455667888899999999999 5555553
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-45 Score=292.49 Aligned_cols=209 Identities=22% Similarity=0.316 Sum_probs=159.2
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 24 LLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 24 ~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
......+.|.+|+.+|++++||||++++|++..++..++||||+++|+|.+++.. ....+++..+..++.|+++||.
T Consensus 66 ~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~ 142 (299)
T d1jpaa_ 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMK 142 (299)
T ss_dssp CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHH
Confidence 3445677899999999999999999999999999999999999999999998875 3456899999999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCccccc---ccccccCCCcccCcccccccCCCccCCeeehhHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHI---TTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~ 172 (238)
|||++ +.||+++.++++||+|||+++......... ......||+.|+|||.+.+..++.++|||||||+
T Consensus 143 yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvv 222 (299)
T d1jpaa_ 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIV 222 (299)
T ss_dssp HHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHH
T ss_pred HHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHH
Confidence 99944 678999999999999999998764432211 1122457899999999999999999999999999
Q ss_pred HHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 173 LAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 173 l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+|||+| |..||....... ....+........+.+.+..+.+++.+||+.||++| ++++.|+++
T Consensus 223 l~el~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 223 MWEVMSYGERPYWDMTNQD-VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp HHHHHTTSCCTTTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 999998 788876433221 222233333444556677788899999999999999 777777665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=290.85 Aligned_cols=205 Identities=20% Similarity=0.207 Sum_probs=166.0
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
+...++|.+|+.+|.+++||||++++|++.++ ..|+||||+++|+|.+++.. ....+++..+..++.|+++||+||
T Consensus 50 ~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~yl 125 (285)
T d1u59a_ 50 KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL 125 (285)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999999998754 57899999999999999864 345799999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|++ +.||+++.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 126 H~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~ 205 (285)
T d1u59a_ 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205 (285)
T ss_dssp HHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred HhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHH
Confidence 954 67899999999999999999876543322 223445789999999999988999999999999999999
Q ss_pred cc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 177 MS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 177 ~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
+| |..||..... ......+..+.....+...+.++.+++.+||+.||++| ++.+.|++
T Consensus 206 lt~G~~Pf~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 206 LSYGQKPYKKMKG-PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp HTTSCCTTTTCCT-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhCCCCCCCCCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 98 7888864322 12223333444445566677888999999999999999 56666654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-45 Score=288.88 Aligned_cols=208 Identities=22% Similarity=0.344 Sum_probs=162.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchh
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYL 105 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~l 105 (238)
++...+|.+|+.+|.+++||||++++|++.+.+..+++|||+.++++.+++.. ....+++..+..++.|++.||+||
T Consensus 50 ~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~l 126 (283)
T d1mqba_ 50 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYL 126 (283)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhc
Confidence 34567799999999999999999999999999999999999999999998865 346799999999999999999999
Q ss_pred hcc--------CceeeecCCCceEEcccccccccCCccc-ccccccccCCCcccCcccccccCCCccCCeeehhHHHHhh
Q 041655 106 HMH--------QALVLLDHDMEARISEFGLAKVFPEAHT-HITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 106 H~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~ 176 (238)
|++ |.|||++.++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||
T Consensus 127 H~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el 206 (283)
T d1mqba_ 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206 (283)
T ss_dssp HHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHH
Confidence 944 6789999999999999999987644322 1222345689999999999999999999999999999999
Q ss_pred cchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 177 MSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+++..|+............+..+.....+.+.+..+.+++.+||+.||++| ++++.|+++
T Consensus 207 ~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 207 MTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 997555543333333334444455555666677789999999999999999 777777665
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=287.70 Aligned_cols=199 Identities=21% Similarity=0.233 Sum_probs=162.2
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++
T Consensus 61 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~ 135 (293)
T d1yhwa1 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN 135 (293)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46789999999999999999999999999999999999999999998865 4589999999999999999999944
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcchH
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLV 180 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~ 180 (238)
|.||+++.++++||+|||+++.+..... ......||+.|+|||++.+..++.++||||+||++|+|++|.
T Consensus 136 ~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~ 213 (293)
T d1yhwa1 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (293)
T ss_dssp TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CCcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCC
Confidence 7789999999999999999987644322 224568999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCcccccc-cccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 181 KWMRNVMTSENPKRAIDS-KLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.||............... ......+...+..+.+++.+||+.||++| ++.+.|+
T Consensus 214 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 214 PPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 998543222222222211 11223445566778889999999999999 5555543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=288.94 Aligned_cols=218 Identities=21% Similarity=0.257 Sum_probs=163.3
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhh
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDV 79 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~ 79 (238)
||||.+..... .+...+.+.+|+.+|++++||||+++++++.+ ++.+|+||||+++|+|.+++...
T Consensus 32 vAvK~i~~~~~------------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~ 99 (269)
T d2java1 32 LVWKELDYGSM------------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG 99 (269)
T ss_dssp EEEEEECCTTS------------CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHH
T ss_pred EEEEEEChhhC------------CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhc
Confidence 66776654432 23456778999999999999999999999864 45689999999999999998753
Q ss_pred cCCCcccCHHHHHHHHHHHHHHhchhhc-------------cCceeeecCCCceEEcccccccccCCcccccccccccCC
Q 041655 80 SRGRRQLDWLARYRTVRGIASGLEYLHM-------------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGT 146 (238)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~l~~gl~~lH~-------------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 146 (238)
......+++..++.++.|++.||.|||+ ||.||+++.++.+||+|||+++....... ......||
T Consensus 100 ~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt 177 (269)
T d2java1 100 TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGT 177 (269)
T ss_dssp HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CC
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCCC
Confidence 3335679999999999999999999995 46789999999999999999987644322 12446899
Q ss_pred CcccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCc
Q 041655 147 AGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 147 ~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
+.|+|||++.+..++.++|||||||++|||+||..||...........+... .....+...+.++.+++.+||+.||++
T Consensus 178 ~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~s~~l~~li~~~L~~dp~~ 256 (269)
T d2java1 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYH 256 (269)
T ss_dssp CSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGG
T ss_pred cccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHHHHcCCChhH
Confidence 9999999999999999999999999999999999888543222111122221 122333445566888889999999999
Q ss_pred c-hHHHHHH
Q 041655 227 R-HVRCMLS 234 (238)
Q Consensus 227 R-~v~~~L~ 234 (238)
| ++.+.|+
T Consensus 257 Rps~~ell~ 265 (269)
T d2java1 257 RPSVEEILE 265 (269)
T ss_dssp SCCHHHHHT
T ss_pred CcCHHHHHh
Confidence 9 6655554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=288.68 Aligned_cols=216 Identities=21% Similarity=0.313 Sum_probs=167.9
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||++..... ..+.|.+|+.+|.+++||||++++|++.+ +..++||||+++|+|.+++.. .
T Consensus 40 vAvK~~~~~~~---------------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~--~ 101 (272)
T d1qpca_ 40 VAVKSLKQGSM---------------SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--P 101 (272)
T ss_dssp EEEEEECTTSS---------------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS--H
T ss_pred EEEEEEccCcC---------------CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhh--c
Confidence 78887754332 13578999999999999999999998755 467899999999999998754 1
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
....+++..+..++.|+++||.|||+ |+.||+++.++.+||+|||+++......... .....|++.|+|||
T Consensus 102 ~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~APE 180 (272)
T d1qpca_ 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPE 180 (272)
T ss_dssp HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC-CTTCCCCTTTSCHH
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc-ccccCCcccccChH
Confidence 23458999999999999999999994 4778999999999999999998765433222 24457899999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HV 229 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v 229 (238)
++.+..++.++|||||||++|||+||..|+............+........+...+..+.+++.+||+.||++| ++
T Consensus 181 ~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei 260 (272)
T d1qpca_ 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260 (272)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 99988999999999999999999997655443322222222333333344455666778899999999999999 66
Q ss_pred HHHHHhh
Q 041655 230 RCMLSQI 236 (238)
Q Consensus 230 ~~~L~~~ 236 (238)
++.|+++
T Consensus 261 ~~~L~~~ 267 (272)
T d1qpca_ 261 RSVLEDF 267 (272)
T ss_dssp HHHHHHH
T ss_pred HHHhhhh
Confidence 6666653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=287.16 Aligned_cols=197 Identities=22% Similarity=0.231 Sum_probs=160.8
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.++++++||||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.|+++||+|||+
T Consensus 49 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~ 124 (263)
T d2j4za1 49 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS 124 (263)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 456788999999999999999999999999999999999999999999976 4568999999999999999999994
Q ss_pred --------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 --------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 --------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
||.||+++.++.+||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 125 ~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G 200 (263)
T d2j4za1 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 200 (263)
T ss_dssp TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred CCeeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcC
Confidence 4778999999999999999997654432 2346799999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
..||...........+.... ...+...+.++.+++.+||+.||++| ++.+.|+
T Consensus 201 ~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 201 KPPFEANTYQETYKRISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SCTTCCSSHHHHHHHHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 99985422221122222222 12333455667888889999999999 5555543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-45 Score=287.37 Aligned_cols=214 Identities=19% Similarity=0.209 Sum_probs=168.5
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+..... +..+.+.+|+.+|++++||||+++++++.+++..++||||+++|+|.+++.+
T Consensus 40 vAvK~i~~~~~--------------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~--- 102 (288)
T d2jfla1 40 AAAKVIDTKSE--------------EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--- 102 (288)
T ss_dssp EEEEEEECSSS--------------GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---
T ss_pred EEEEEECcCCH--------------HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh---
Confidence 78887765432 2246788999999999999999999999999999999999999999999765
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
....+++..+..++.|+++||.|||+ ||.||+++.++.+||+|||+++...... .......||+.|+|||
T Consensus 103 ~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE 180 (288)
T d2jfla1 103 LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPE 180 (288)
T ss_dssp HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHH
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--ccccccccccccCCHH
Confidence 24569999999999999999999994 5788999999999999999987643321 1224568999999999
Q ss_pred ccc-----ccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc-cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 154 YQQ-----TLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL-LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 154 ~~~-----~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
++. +..++.++||||+||++|+|++|..||...........+..... ....+...+.++.+++.+||+.||++|
T Consensus 181 ~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 260 (288)
T d2jfla1 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDAR 260 (288)
T ss_dssp HHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHC
Confidence 874 45678999999999999999999999865433222222222221 223455666778899999999999999
Q ss_pred -hHHHHHH
Q 041655 228 -HVRCMLS 234 (238)
Q Consensus 228 -~v~~~L~ 234 (238)
++.+.|+
T Consensus 261 ~t~~ell~ 268 (288)
T d2jfla1 261 WTTSQLLQ 268 (288)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 5555443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=292.80 Aligned_cols=203 Identities=22% Similarity=0.254 Sum_probs=164.4
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC-------------------CCc
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR-------------------GRR 84 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-------------------~~~ 84 (238)
.......+.+|+.+|.++ +||||++++|++.+.+..++||||+++|+|.+++..... ...
T Consensus 80 ~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (325)
T d1rjba_ 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159 (325)
T ss_dssp ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccC
Confidence 344567889999999998 799999999999999999999999999999999975221 123
Q ss_pred ccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccc
Q 041655 85 QLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQ 156 (238)
Q Consensus 85 ~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~ 156 (238)
.+++..+..++.|+++||+|||+ ||.||+++.++++||+|||+|+...............||+.|+|||++.
T Consensus 160 ~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~ 239 (325)
T d1rjba_ 160 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 239 (325)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHc
Confidence 58999999999999999999994 4778999999999999999998765544333334567899999999999
Q ss_pred ccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 157 TLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 157 ~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+..++.++|||||||++|||+| |..||............+......+.+...+.++.+++.+||+.||++|
T Consensus 240 ~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 311 (325)
T d1rjba_ 240 EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311 (325)
T ss_dssp HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999998 7888865433333344555555555666677789999999999999999
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=280.91 Aligned_cols=201 Identities=21% Similarity=0.313 Sum_probs=157.0
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
.....+.|.+|+++|++++||||+++++++.+ ++.+|+||||+++|+|.+++.. ...+++..+..++.|+++
T Consensus 48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~ 123 (270)
T d1t4ha_ 48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILK 123 (270)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHH
Confidence 34456789999999999999999999999864 3567999999999999999976 456899999999999999
Q ss_pred Hhchhhcc----------Cceeeec-CCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeeh
Q 041655 101 GLEYLHMH----------QALVLLD-HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSF 169 (238)
Q Consensus 101 gl~~lH~~----------~~~il~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~Dvwsl 169 (238)
||+|||++ |.||+++ .++.+||+|||+++...... .....||+.|+|||++.+ .++.++||||+
T Consensus 124 gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSl 198 (270)
T d1t4ha_ 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAF 198 (270)
T ss_dssp HHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHH
T ss_pred HHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhH
Confidence 99999954 5679996 47899999999998643322 234689999999998865 58999999999
Q ss_pred hHHHHhhcchHHHHHHhhccCCCccccccccc-CCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 170 GVLLAEEMSLVKWMRNVMTSENPKRAIDSKLL-GNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 170 G~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
||++|+|++|..||............+..... ...+...+.++.+++.+||+.||++| ++.+.|+
T Consensus 199 Gvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 199 GMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 99999999999998543222222222222221 12233345567888999999999999 6655554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=285.27 Aligned_cols=203 Identities=21% Similarity=0.229 Sum_probs=162.5
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...++|.+|+.+|++++||||++++|++.++ ..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 50 ~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH 124 (277)
T d1xbba_ 50 ALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE 124 (277)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHH
Confidence 3457899999999999999999999998654 56899999999999999976 466999999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
++ |.||+++.++.+|++|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 125 ~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell 204 (277)
T d1xbba_ 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204 (277)
T ss_dssp HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence 54 67899999999999999999876443222 2223467899999999999999999999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
| |..||...... .....+..+.....+...+.++.+++.+||+.||++| ++.+.|++
T Consensus 205 t~g~~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 205 SYGQKPYRGMKGS-EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TTTCCSSTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred hCCCCCCCCCCHH-HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 8 78887543221 2223333344445556677788999999999999999 55555654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-44 Score=286.32 Aligned_cols=211 Identities=20% Similarity=0.234 Sum_probs=164.8
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+..... ...+..+.+.+|+.+|++++||||+++++++.+++..|+||||+++|+|..++..
T Consensus 43 vAvK~i~~~~~-----------~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~--- 108 (309)
T d1u5ra_ 43 VAIKKMSYSGK-----------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--- 108 (309)
T ss_dssp EEEEEEECCSS-----------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH---
T ss_pred EEEEEEchhhc-----------cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh---
Confidence 67777754432 2345567899999999999999999999999999999999999999888777654
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
...+++..+..++.|+++||.|||++ |.||+++.++.+||+|||+++..... ....||+.|+|||
T Consensus 109 -~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE 181 (309)
T d1u5ra_ 109 -KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPE 181 (309)
T ss_dssp -TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHH
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC------CccccCccccCHH
Confidence 46799999999999999999999944 67899999999999999999765332 3467999999999
Q ss_pred cccc---cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hH
Q 041655 154 YQQT---LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HV 229 (238)
Q Consensus 154 ~~~~---~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v 229 (238)
++.+ ..|+.++|||||||++|||++|..||.....................+...+..+.+++.+||+.||++| ++
T Consensus 182 ~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~ 261 (309)
T d1u5ra_ 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTS 261 (309)
T ss_dssp HHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCH
Confidence 8854 4588899999999999999999998864332222222222222222233445567888888999999999 44
Q ss_pred HHHH
Q 041655 230 RCML 233 (238)
Q Consensus 230 ~~~L 233 (238)
.+.|
T Consensus 262 ~ell 265 (309)
T d1u5ra_ 262 EVLL 265 (309)
T ss_dssp HHHT
T ss_pred HHHH
Confidence 4443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=279.10 Aligned_cols=215 Identities=20% Similarity=0.261 Sum_probs=171.7
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+.+.... .++|.+|+.++.+++||||++++|++.+++..++||||+++|+|.+++..
T Consensus 31 vAvK~l~~~~~~---------------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~--- 92 (258)
T d1k2pa_ 31 VAIKMIKEGSMS---------------EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--- 92 (258)
T ss_dssp EEEEEEESSSSC---------------HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS---
T ss_pred EEEEEECcCcCC---------------HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc---
Confidence 788887654332 35789999999999999999999999999999999999999999999765
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
....+++..+..++.|+++||+|||.+ +.||+++.++.+||+|||+++........ ......||+.|+|||
T Consensus 93 ~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE 171 (258)
T d1k2pa_ 93 MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPE 171 (258)
T ss_dssp GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHH
T ss_pred cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcH
Confidence 345688999999999999999999955 56799999999999999999866543322 223467899999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
.+.+..++.++||||||+++|||+| |..||....... ....+........+...+..+.+++.+||+.||++| ++-+
T Consensus 172 ~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e 250 (258)
T d1k2pa_ 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKI 250 (258)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-HHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHH
Confidence 9999999999999999999999998 687876543322 223333344445556667788899999999999999 4444
Q ss_pred HHHhh
Q 041655 232 MLSQI 236 (238)
Q Consensus 232 ~L~~~ 236 (238)
.|+.|
T Consensus 251 il~~L 255 (258)
T d1k2pa_ 251 LLSNI 255 (258)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 44443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-44 Score=286.15 Aligned_cols=213 Identities=21% Similarity=0.251 Sum_probs=152.1
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+.+... ......+.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++..
T Consensus 37 vAvK~i~~~~~-------------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~--- 100 (307)
T d1a06a_ 37 VAIKCIAKKAL-------------EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--- 100 (307)
T ss_dssp EEEEEEEC-----------------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT---
T ss_pred EEEEEEchHHh-------------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc---
Confidence 67777754432 22345688999999999999999999999999999999999999999999975
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------Cceeeec---CCCceEEcccccccccCCcccccccccccCCCccc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLD---HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYI 150 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ 150 (238)
...+++..+..++.|++.||+|||++ |.||++. .++.+||+|||+++....... ..+..||+.|+
T Consensus 101 -~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~ 176 (307)
T d1a06a_ 101 -KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYV 176 (307)
T ss_dssp -CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTS
T ss_pred -ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe---eeeeeeCcccc
Confidence 46799999999999999999999954 6678884 578999999999986543322 23467999999
Q ss_pred CcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-
Q 041655 151 APEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER- 227 (238)
Q Consensus 151 apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R- 227 (238)
|||++.+..++.++||||+||++|+|++|..||...........+..... ....+.+.+.++.+++.+||+.||++|
T Consensus 177 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 256 (307)
T d1a06a_ 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF 256 (307)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCc
Confidence 99999999999999999999999999999998854322222222222222 122234455678889999999999999
Q ss_pred hHHHHHH
Q 041655 228 HVRCMLS 234 (238)
Q Consensus 228 ~v~~~L~ 234 (238)
++.+.|+
T Consensus 257 s~~eil~ 263 (307)
T d1a06a_ 257 TCEQALQ 263 (307)
T ss_dssp CHHHHHH
T ss_pred CHHHHhc
Confidence 5555554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-43 Score=283.54 Aligned_cols=212 Identities=20% Similarity=0.272 Sum_probs=169.5
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc--------------------CCCcc
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS--------------------RGRRQ 85 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--------------------~~~~~ 85 (238)
.+..++|.+|+.+|++++||||+++++++.+.+..+++|||+++|+|.+++.... .....
T Consensus 57 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (301)
T d1lufa_ 57 ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136 (301)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CC
T ss_pred hHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCC
Confidence 3456789999999999999999999999999999999999999999999986421 11235
Q ss_pred cCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc
Q 041655 86 LDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT 157 (238)
Q Consensus 86 ~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~ 157 (238)
+++..+..++.|++.||+|||++ +.||+++.++.+||+|||+++...........+...+++.|+|||.+.+
T Consensus 137 l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred CCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 88999999999999999999954 6789999999999999999987655444334455778999999999999
Q ss_pred cCCCccCCeeehhHHHHhhcchH-HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHH
Q 041655 158 LSITYMCDIYSFGVLLAEEMSLV-KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCM 232 (238)
Q Consensus 158 ~~~~~~~DvwslG~~l~~~~t~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~ 232 (238)
..++.++|||||||++|||+++. .||......+.. ..+..+.....+...+.++.+++..||+.||++| +++++
T Consensus 217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~-~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~ 295 (301)
T d1lufa_ 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI-YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295 (301)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHH-HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999999985 455443322222 2233333444555667788999999999999999 88888
Q ss_pred HHhhhC
Q 041655 233 LSQIQQ 238 (238)
Q Consensus 233 L~~~~~ 238 (238)
|++|.+
T Consensus 296 L~~i~~ 301 (301)
T d1lufa_ 296 LQRMCE 301 (301)
T ss_dssp HHHTTC
T ss_pred HHHhcC
Confidence 888764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=278.54 Aligned_cols=201 Identities=25% Similarity=0.302 Sum_probs=155.9
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
.+.|.+|+.++++++||||++++|++.+ .+.+++||||+++|+|.+++.. .....+++..+..++.|+++||.|||+
T Consensus 44 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~l~~~~~~~i~~~i~~al~ylH~ 121 (262)
T d1byga_ 44 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEG 121 (262)
T ss_dssp -HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHH--HHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHhhcccccc
Confidence 3678899999999999999999999865 4668999999999999999865 123458999999999999999999995
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc-
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS- 178 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t- 178 (238)
+ +.||+++.++.+|++|||+++...... ....+++.|+|||++.+..++.++||||||+++|||+|
T Consensus 122 ~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~ 196 (262)
T d1byga_ 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 196 (262)
T ss_dssp TTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CceeccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHC
Confidence 5 667999999999999999998654332 23467889999999999999999999999999999998
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|..|+.. .........+.....+..+...+..+.+++.+||+.||.+| +++++|++++
T Consensus 197 ~~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 197 GRVPYPR-IPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp SCCSCTT-SCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCC-CCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 4665543 22233333334444455566666778899999999999999 7788887775
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-44 Score=286.17 Aligned_cols=162 Identities=22% Similarity=0.275 Sum_probs=139.1
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+..... +...+++.+|+.+|++++||||++++++|.+++..|+||||+++|+|.+++.+
T Consensus 34 vAiK~i~~~~~-------------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~--- 97 (322)
T d1s9ja_ 34 MARKLIHLEIK-------------PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--- 97 (322)
T ss_dssp EEEEEEECCCC-------------TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH---
T ss_pred EEEEEEChhhC-------------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh---
Confidence 67777654322 22356789999999999999999999999999999999999999999999976
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhc---------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHM---------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~---------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
...+++..+..++.|+++||.|||+ ||.|||++.++++||+|||+|+...... ..+..||+.|+||
T Consensus 98 -~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~AP 172 (322)
T d1s9ja_ 98 -AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSP 172 (322)
T ss_dssp -HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCCH
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc----cccccCCccccCc
Confidence 3568999999999999999999994 3678999999999999999998653322 2456899999999
Q ss_pred ccccccCCCccCCeeehhHHHHhhcchHHHHH
Q 041655 153 EYQQTLSITYMCDIYSFGVLLAEEMSLVKWMR 184 (238)
Q Consensus 153 E~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~ 184 (238)
|++.+..|+.++||||+||++|||++|..||.
T Consensus 173 Evl~~~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp HHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred hHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999999998874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=285.14 Aligned_cols=195 Identities=21% Similarity=0.245 Sum_probs=157.3
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
...+.+.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 50 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH 125 (288)
T d1uu3a_ 50 NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH 125 (288)
T ss_dssp TCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhc
Confidence 3457789999999999999999999999999999999999999999999876 467999999999999999999999
Q ss_pred --------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 --------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 --------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.||.||+++.++.+||+|||+++.+.............||+.|+|||++.+..++.++||||+||++|+|++
T Consensus 126 ~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~ 205 (288)
T d1uu3a_ 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205 (288)
T ss_dssp HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh
Confidence 457889999999999999999987754443333455789999999999999999999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||..........++.... ...+...+.++.+++.+||+.||++|
T Consensus 206 g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R 252 (288)
T d1uu3a_ 206 GLPPFRAGNEYLIFQKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKR 252 (288)
T ss_dssp SSCSSCCSSHHHHHHHHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGS
T ss_pred CCCCCCCcCHHHHHHHHHcCC--CCCCccCCHHHHHHHHHHccCCHhHC
Confidence 999986432211122222222 22334455678889999999999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-44 Score=281.28 Aligned_cols=216 Identities=22% Similarity=0.306 Sum_probs=163.1
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||++...... .+.|.+|+.+|.+++||||++++|++.+ +..++||||+++|+|..++...
T Consensus 44 vAiK~l~~~~~~---------------~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~-- 105 (285)
T d1fmka3 44 VAIKTLKPGTMS---------------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-- 105 (285)
T ss_dssp EEEEECCTTSSC---------------HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--
T ss_pred EEEEEECcccCC---------------HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhc--
Confidence 788877543321 3678999999999999999999999855 4578999999999999988652
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
....+++..+..++.|++.||+|||.+ +.||+++.++++||+|||+++........ ......||+.|+|||
T Consensus 106 ~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE 184 (285)
T d1fmka3 106 TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPE 184 (285)
T ss_dssp HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHH
T ss_pred ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCce-eeccccccccccChH
Confidence 234589999999999999999999944 67899999999999999999876433222 223467899999999
Q ss_pred cccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hH
Q 041655 154 YQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HV 229 (238)
Q Consensus 154 ~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v 229 (238)
.+.+..++.++||||||+++|||++|..|+............+........+...+.++.+++.+||+.||++| ++
T Consensus 185 ~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 264 (285)
T d1fmka3 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 264 (285)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHH
Confidence 99999999999999999999999997665544332222223333333444556667788899999999999999 66
Q ss_pred HHHHHhh
Q 041655 230 RCMLSQI 236 (238)
Q Consensus 230 ~~~L~~~ 236 (238)
.++|+..
T Consensus 265 ~~~L~~~ 271 (285)
T d1fmka3 265 QAFLEDY 271 (285)
T ss_dssp HHHHHTT
T ss_pred HHHHhhh
Confidence 6666653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=278.69 Aligned_cols=207 Identities=22% Similarity=0.257 Sum_probs=165.2
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+..++|.+|+.+|++++||||++++|++.++ ..++||||+++|++.+++.. ....+++..+..++.|++.||.|||
T Consensus 53 ~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH 128 (273)
T d1u46a_ 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE 128 (273)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhh
Confidence 4567899999999999999999999999764 67899999999999988765 2456999999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
++ +.||+++.++.+||+|||+++........ .......|+..|+|||++.+..++.++||||||+++|||+
T Consensus 129 ~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~eml 208 (273)
T d1u46a_ 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208 (273)
T ss_dssp HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred hCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHH
Confidence 55 66799999999999999999876544322 2223456788999999999999999999999999999999
Q ss_pred c-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 178 S-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 178 t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
| |..||...........+.......+.+...+..+.+++.+||+.||++| ++.+.|++.+
T Consensus 209 t~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 209 TYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred hCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 8 7888865443333344444444445556666778899999999999999 6777776653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=277.49 Aligned_cols=210 Identities=21% Similarity=0.207 Sum_probs=167.6
Q ss_pred hHHHHHHHHHHHHHhcCCCCCcccceeeeeec-CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhc
Q 041655 25 LTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR-PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLE 103 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~ 103 (238)
.....++|.+|+++|.+++||||++++|++.+ ++..++||||+++|+|.+++.. ....+++..+..++.|+++||.
T Consensus 68 ~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~ 144 (311)
T d1r0pa_ 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMK 144 (311)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhh
Confidence 44567889999999999999999999999865 5678999999999999999875 3456788889999999999999
Q ss_pred hhhcc--------CceeeecCCCceEEcccccccccCCcccc--cccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 104 YLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTH--ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 104 ~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|+|++ +.|||+++++.+||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++
T Consensus 145 ~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl 224 (311)
T d1r0pa_ 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224 (311)
T ss_dssp HHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred hhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHH
Confidence 99954 67799999999999999999876443221 122345789999999999999999999999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|||+||..||............+..+.....+...+..+.+++.+||+.||++| ++++.|+++.
T Consensus 225 ~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 225 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp HHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 999998777655444444444443344444555667778899999999999999 7777777764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=279.15 Aligned_cols=205 Identities=18% Similarity=0.188 Sum_probs=162.0
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+..++|.+|+.+|++++||||++++|+|.+++ .++++||+.+|+|.+++.. ....+++..+..++.|+++||+|||
T Consensus 53 ~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH 128 (317)
T d1xkka_ 53 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE 128 (317)
T ss_dssp CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 34678999999999999999999999998764 5788899999999998875 4567899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ +.||+++.++++||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 129 ~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t 208 (317)
T d1xkka_ 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208 (317)
T ss_dssp HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred HcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHH
Confidence 54 6789999999999999999987654433333344578999999999999999999999999999999999
Q ss_pred -hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 179 -LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 179 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|..||... ........+..+.....+...+..+.+++.+||+.||++| ++++.|..+
T Consensus 209 ~g~~p~~~~-~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 209 FGSKPYDGI-PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp TSCCTTTTS-CGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCC-CHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 56666532 2233334444444455566677788999999999999999 555555544
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=276.04 Aligned_cols=210 Identities=20% Similarity=0.221 Sum_probs=157.2
Q ss_pred hhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 22 SKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 22 ~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
........+.|.+|+.+|++++||||++++|++.+ +..++||||+++|+|.+++.. ....+++..+..++.|+++|
T Consensus 45 ~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~g 120 (273)
T d1mp8a_ 45 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTA 120 (273)
T ss_dssp TTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHH
Confidence 33445567889999999999999999999999864 578999999999999998765 34578999999999999999
Q ss_pred hchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 102 LEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 102 l~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|.|||++ |.||+++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++
T Consensus 121 l~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil 199 (273)
T d1mp8a_ 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 199 (273)
T ss_dssp HHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred hhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHH
Confidence 9999954 77899999999999999999875433222 22446788999999999999999999999999999
Q ss_pred Hhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhhh
Q 041655 174 AEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQIQ 237 (238)
Q Consensus 174 ~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~~ 237 (238)
|||++ |..||....... ....+........+.+.+..+.+++.+||+.||++| ++++.|+++.
T Consensus 200 ~e~lt~g~~P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 200 WEILMHGVKPFQGVKNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHHHTTSCCTTTTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 99987 677776433222 222223333344556677788999999999999999 6666666653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=279.02 Aligned_cols=218 Identities=20% Similarity=0.255 Sum_probs=169.3
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||.+.+...... ......+.+.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++..
T Consensus 38 ~AvK~i~~~~~~~~--------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~--- 106 (293)
T d1jksa_ 38 YAAKFIKKRRTKSS--------RRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--- 106 (293)
T ss_dssp EEEEEEEBCSSTTC--------SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH---
T ss_pred EEEEEEEhhhcchh--------hhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc---
Confidence 78888765543211 1112356789999999999999999999999999999999999999999999976
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCC----ceEEcccccccccCCcccccccccccCCCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDM----EARISEFGLAKVFPEAHTHITTSDVVGTAGY 149 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 149 (238)
...+++..++.++.|++.||+|||+ ||.||+++.++ .+|++|||++........ .....||+.|
T Consensus 107 -~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y 182 (293)
T d1jksa_ 107 -KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEF 182 (293)
T ss_dssp -HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGG
T ss_pred -ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcc
Confidence 3569999999999999999999994 47789998877 499999999987644332 2446789999
Q ss_pred cCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccccccc--CCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 150 IAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLL--GNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 150 ~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|||++.+..++.++||||+||++|+|++|..||...........+...... ...+.+.+..+.+++.+||+.||++|
T Consensus 183 ~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 262 (293)
T d1jksa_ 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262 (293)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGS
T ss_pred cCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHC
Confidence 9999999989999999999999999999999888643222222222222211 11223455678889999999999999
Q ss_pred -hHHHHHH
Q 041655 228 -HVRCMLS 234 (238)
Q Consensus 228 -~v~~~L~ 234 (238)
++.+.|+
T Consensus 263 ~s~~eil~ 270 (293)
T d1jksa_ 263 MTIQDSLQ 270 (293)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHhc
Confidence 5555553
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-42 Score=281.99 Aligned_cols=200 Identities=18% Similarity=0.234 Sum_probs=161.3
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc-
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM- 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~- 107 (238)
.+.+.+|+.+|++++||||++++++|.+++.+|+||||+++|+|.+++.. ....+++..++.++.|++.||+|||+
T Consensus 70 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~ 146 (352)
T d1koba_ 70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH 146 (352)
T ss_dssp HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 46788999999999999999999999999999999999999999988754 34569999999999999999999994
Q ss_pred -------cCceeeec--CCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 108 -------HQALVLLD--HDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 108 -------~~~~il~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
||.|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+..++.++||||+||++|+|++
T Consensus 147 ~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt 223 (352)
T d1koba_ 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223 (352)
T ss_dssp TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred CeeecccccccccccccCCCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh
Confidence 47789997 678999999999987654332 234678999999999999999999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 179 LVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
|..||...........+..... ....+...+.++.+++.+||+.||.+| ++.+.|+
T Consensus 224 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 224 GLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp SCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9998854322222222222211 222334556678889999999999999 6555554
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-42 Score=282.41 Aligned_cols=201 Identities=20% Similarity=0.290 Sum_probs=160.8
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.+|++++||||+++++++.+++..|+||||+++|+|.+++.. ....+++..+..++.|++.||.|||+
T Consensus 66 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~ 142 (350)
T d1koaa2 66 DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE 142 (350)
T ss_dssp HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 356788999999999999999999999999999999999999999999864 24569999999999999999999994
Q ss_pred --------cCceeeecC--CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhc
Q 041655 108 --------HQALVLLDH--DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 --------~~~~il~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~ 177 (238)
||.||+++. ++.+||+|||+++.+..... .....||+.|+|||++.+..++.++||||+||++|+|+
T Consensus 143 ~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell 219 (350)
T d1koaa2 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219 (350)
T ss_dssp TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH
T ss_pred cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH
Confidence 477899954 57899999999987654332 23468899999999999999999999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||...........+..... ........+..+.+++.+||+.||++| ++.+.|+
T Consensus 220 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 220 SGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99998853322222222222221 122233455678889999999999999 6666554
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=276.75 Aligned_cols=208 Identities=22% Similarity=0.241 Sum_probs=162.7
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhh------------cCCCcccCHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDV------------SRGRRQLDWLAR 91 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~ 91 (238)
..+..+.|.+|+.+|.++ +||||++++|++.+++..++||||+++|+|.+++... ......+++..+
T Consensus 50 ~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 129 (309)
T d1fvra_ 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129 (309)
T ss_dssp -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHH
Confidence 344567899999999999 7999999999999999999999999999999998642 122467899999
Q ss_pred HHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCcc
Q 041655 92 YRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM 163 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~ 163 (238)
..++.|+++||.|+|++ +.||+++.++.+||+|||+++....... .....||..|+|||.+.+..++.+
T Consensus 130 ~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~ 206 (309)
T d1fvra_ 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTN 206 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCcc
Confidence 99999999999999954 6779999999999999999976543322 133568999999999999999999
Q ss_pred CCeeehhHHHHhhcchHH-HHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 164 CDIYSFGVLLAEEMSLVK-WMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 164 ~DvwslG~~l~~~~t~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+|||||||++|||++|.. ||.. .........+..+.....+...+..+.+++.+||+.||++| ++++.|+++
T Consensus 207 sDvwSfGvil~ell~~~~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 207 SDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ceeehhHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 999999999999999765 4432 22222222333344455566677788999999999999999 777766665
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=279.75 Aligned_cols=193 Identities=23% Similarity=0.187 Sum_probs=159.8
Q ss_pred HHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 27 EEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 27 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+..+++.+|+.+|++++||||+++++++.+++.+|+||||+++|+|.+++.. ...+++..++.++.|++.||+|||
T Consensus 47 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH 122 (337)
T d1o6la_ 47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLH 122 (337)
T ss_dssp TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhh
Confidence 3467789999999999999999999999999999999999999999999876 467899999999999999999999
Q ss_pred --------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 --------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 --------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
.||.||+++.+|.+||+|||+++....... ......||+.|+|||++.+..|+.++|+||+||++|||++
T Consensus 123 ~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~ 200 (337)
T d1o6la_ 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200 (337)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred hcCccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHH
Confidence 557789999999999999999986543222 2345789999999999999999999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||................ ...+...+.++.+++.+||++||.+|
T Consensus 201 G~~pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R 247 (337)
T d1o6la_ 201 GRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp SSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHhhccCCchhh
Confidence 998885433222222222222 23344455667888899999999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=273.44 Aligned_cols=210 Identities=18% Similarity=0.269 Sum_probs=167.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc------CCCcccCHHHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS------RGRRQLDWLARYRTVRGIA 99 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~~~l~ 99 (238)
......|.+|+.++++++||||++++|++..++..++||||+++|+|.+++.... .....+++..+..++.|++
T Consensus 64 ~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia 143 (308)
T d1p4oa_ 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143 (308)
T ss_dssp HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHH
Confidence 3456779999999999999999999999999999999999999999999986421 1224578999999999999
Q ss_pred HHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhH
Q 041655 100 SGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171 (238)
Q Consensus 100 ~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~ 171 (238)
+||.|||.+ +.|||++.++++||+|||+++...............|++.|+|||.+.+..++.++||||||+
T Consensus 144 ~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~ 223 (308)
T d1p4oa_ 144 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 223 (308)
T ss_dssp HHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHH
Confidence 999999955 667999999999999999998765544444445567899999999999999999999999999
Q ss_pred HHHhhcchH-HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 172 LLAEEMSLV-KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 172 ~l~~~~t~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++|||+||. .|+.. .........+..+...+.+...+..+.+++.+||+.||++| ++++.|++.
T Consensus 224 il~El~t~~~~p~~~-~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 224 VLWEIATLAEQPYQG-LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHhCCCCCCCC-CCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 999999985 44433 22222222222333344455666778999999999999999 666766654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-42 Score=276.09 Aligned_cols=210 Identities=21% Similarity=0.273 Sum_probs=171.6
Q ss_pred HHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC--------------CCcccCHHH
Q 041655 26 TEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR--------------GRRQLDWLA 90 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~ 90 (238)
.....+|.+|+.+++++ +||||++++|++.+++..+++|||+++|+|.+++..... ....+++..
T Consensus 67 ~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (311)
T d1t46a_ 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146 (311)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHH
Confidence 34567899999999999 699999999999999999999999999999999875221 233689999
Q ss_pred HHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCc
Q 041655 91 RYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY 162 (238)
Q Consensus 91 ~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~ 162 (238)
+..++.|+++||+|||++ +.||+++.++.+|++|||.++...............||+.|+|||++.+..++.
T Consensus 147 ~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 226 (311)
T d1t46a_ 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCC
Confidence 999999999999999944 678999999999999999998776544444445678899999999999999999
Q ss_pred cCCeeehhHHHHhhcch-HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 163 MCDIYSFGVLLAEEMSL-VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 163 ~~DvwslG~~l~~~~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
++|||||||++|||+|+ .+|+............+..+.....+...+..+.+++.+||+.||++| +++++|++
T Consensus 227 ~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 227 ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 99999999999999985 554544333333445555566666666777889999999999999999 66667764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.5e-42 Score=269.48 Aligned_cols=221 Identities=19% Similarity=0.251 Sum_probs=174.1
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhc
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVS 80 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 80 (238)
||||++.+...... .........+.+.+|+.++++++ ||||+++++++.+++..|+||||+++|+|.+++..
T Consensus 31 ~AvK~i~~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-- 103 (277)
T d1phka_ 31 YAVKIIDVTGGGSF-----SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-- 103 (277)
T ss_dssp EEEEEEETTCSTTC-----CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH--
T ss_pred EEEEEEecccccch-----hHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh--
Confidence 78998877654432 11223445677899999999997 99999999999999999999999999999999976
Q ss_pred CCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc
Q 041655 81 RGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP 152 (238)
Q Consensus 81 ~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap 152 (238)
...+++..++.++.|+++||+|||.+ |.||+++.++.+||+|||+++.+..... .....||+.|+||
T Consensus 104 --~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~P 178 (277)
T d1phka_ 104 --KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAP 178 (277)
T ss_dssp --HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCH
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCH
Confidence 45689999999999999999999955 6789999999999999999987654322 2446799999999
Q ss_pred ccccc------cCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCC
Q 041655 153 EYQQT------LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDP 224 (238)
Q Consensus 153 E~~~~------~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p 224 (238)
|.+.+ ..++.++||||+||++|+|++|..||...........+..... ......+.+.++.+++.+||+.||
T Consensus 179 E~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p 258 (277)
T d1phka_ 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 258 (277)
T ss_dssp HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSG
T ss_pred HHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCCh
Confidence 98753 3467789999999999999999998864332222222333222 233345666778899999999999
Q ss_pred Ccc-hHHHHHH
Q 041655 225 KER-HVRCMLS 234 (238)
Q Consensus 225 ~~R-~v~~~L~ 234 (238)
++| .+.+.|+
T Consensus 259 ~~R~s~~eil~ 269 (277)
T d1phka_ 259 QKRYTAEEALA 269 (277)
T ss_dssp GGSCCHHHHTT
T ss_pred hHCcCHHHHHc
Confidence 999 6666554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-42 Score=275.25 Aligned_cols=212 Identities=25% Similarity=0.273 Sum_probs=160.7
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecC-CeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHH
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARP-GCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLA 90 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~ 90 (238)
.....+.+.+|...+.++ +|+||+.+++++... +..+++|||+++|+|.+++..... ....+++..
T Consensus 56 ~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 135 (299)
T d1ywna1 56 THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135 (299)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHH
T ss_pred CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHH
Confidence 344567788888888887 589999999987654 568999999999999999975321 123589999
Q ss_pred HHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCc
Q 041655 91 RYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITY 162 (238)
Q Consensus 91 ~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~ 162 (238)
+..++.|+++||+|||+ ||.||+++.++++||+|||+++...........+...||+.|+|||++.+..++.
T Consensus 136 ~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~ 215 (299)
T d1ywna1 136 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 215 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCH
T ss_pred HHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCc
Confidence 99999999999999994 4778999999999999999998765544444445678999999999999999999
Q ss_pred cCCeeehhHHHHhhcchH-HHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 163 MCDIYSFGVLLAEEMSLV-KWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 163 ~~DvwslG~~l~~~~t~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
++|||||||++|||+|+. .||............+..+.....+...+.++.+++.+||+.||++| ++++.|+++
T Consensus 216 ~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 216 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 999999999999999975 45543322222333444444455556667778999999999999999 777777665
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-42 Score=273.03 Aligned_cols=211 Identities=23% Similarity=0.250 Sum_probs=170.5
Q ss_pred hHHHHHHHHHHHHHhcCC-CCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC------------CCcccCHHHH
Q 041655 25 LTEEMMQIRSEIVTLGQI-RHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR------------GRRQLDWLAR 91 (238)
Q Consensus 25 ~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~ 91 (238)
.......+.+|...+.++ +||||++++++|.+++..++||||+++|+|.+++..... ....+++..+
T Consensus 58 ~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~ 137 (299)
T d1fgka_ 58 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137 (299)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHH
T ss_pred ChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHH
Confidence 345567889999999888 799999999999999999999999999999999975321 2346899999
Q ss_pred HHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCcc
Q 041655 92 YRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYM 163 (238)
Q Consensus 92 ~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~ 163 (238)
..++.|++.||+|||+ |+.||+++.++.+||+|||.++...............+++.|+|||.+.+..++.+
T Consensus 138 ~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k 217 (299)
T d1fgka_ 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 217 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch
Confidence 9999999999999995 47789999999999999999987755444444455778999999999999999999
Q ss_pred CCeeehhHHHHhhcc-hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 164 CDIYSFGVLLAEEMS-LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 164 ~DvwslG~~l~~~~t-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
+||||||+++|||++ |..||..... ......+..+.....+...+.++.+++.+||+.||++| ++++.|++|
T Consensus 218 ~DiwS~Gvvl~ell~~g~~p~~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 218 SDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhHHhHHHHHHhccCCCCCCCCCCH-HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 999999999999998 5666643222 22223333444455556667778999999999999999 777777765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-41 Score=273.12 Aligned_cols=189 Identities=21% Similarity=0.294 Sum_probs=157.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
..+.+.+|+.+|++++||||+++++++.+++..|+||||+++|+|..++.. ...+++..+..++.|++.||+|||+
T Consensus 47 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~ 122 (316)
T d1fota_ 47 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS 122 (316)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhcc
Confidence 457789999999999999999999999999999999999999999999876 5668889999999999999999994
Q ss_pred --------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 108 --------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 --------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
||.||+++.+|.+||+|||+++...... ....||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 123 ~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG 197 (316)
T d1fota_ 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197 (316)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred CcEEccccCchheeEcCCCCEEEecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhC
Confidence 4778999999999999999998764432 346899999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||...........+..... ..+...+.++.+++.+||+.||.+|
T Consensus 198 ~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R 243 (316)
T d1fota_ 198 YTPFYDSNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQR 243 (316)
T ss_dssp SCTTCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTC
T ss_pred CCCCCCcCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHhc
Confidence 999854322222222222221 2233445567888888999999999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-42 Score=277.16 Aligned_cols=189 Identities=16% Similarity=0.128 Sum_probs=157.4
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH- 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH- 106 (238)
..+.+.+|+.+|+.++||||+++++++.+.+..++||||+.+|+|.+++.. ...+++..++.++.|++.||.|||
T Consensus 84 ~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~ 159 (350)
T d1rdqe_ 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS 159 (350)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 456789999999999999999999999999999999999999999999876 356899999999999999999999
Q ss_pred -------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 107 -------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 107 -------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
.||.|||++.+|++||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|+||
T Consensus 160 ~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG 234 (350)
T d1rdqe_ 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234 (350)
T ss_dssp TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhC
Confidence 44778999999999999999998764432 346899999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
..||...........+.... ...+...+.++.+++.+||+.||.+|
T Consensus 235 ~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR 280 (350)
T d1rdqe_ 235 YPPFFADQPIQIYEKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTC
T ss_pred CCCCCCcCHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhc
Confidence 99885422111112222221 22334455668888889999999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-41 Score=267.62 Aligned_cols=220 Identities=16% Similarity=0.255 Sum_probs=159.9
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCC----eeEEEEEeCCCCCHHHHHh
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPG----CHLLVYEFMKNGSLQDILN 77 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~ 77 (238)
||||.+..... ...+....|.+|+.++++++||||+++++++...+ ..|+||||+++++|.+++.
T Consensus 35 vAiK~i~~~~~-----------~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~ 103 (277)
T d1o6ya_ 35 VAVKVLRADLA-----------RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH 103 (277)
T ss_dssp EEEEEECSTTT-----------TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHH
T ss_pred EEEEEEchhhc-----------cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhc
Confidence 67787754332 22345678999999999999999999999987543 4789999999999999987
Q ss_pred hhcCCCcccCHHHHHHHHHHHHHHhchhh--------ccCceeeecCCCceEEcccccccccCCcc-cccccccccCCCc
Q 041655 78 DVSRGRRQLDWLARYRTVRGIASGLEYLH--------MHQALVLLDHDMEARISEFGLAKVFPEAH-THITTSDVVGTAG 148 (238)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~~l~~gl~~lH--------~~~~~il~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~ 148 (238)
. ...+++..+..++.|++.||+||| .||.||+++.++..+++|||.+....... .........||+.
T Consensus 104 ~----~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~ 179 (277)
T d1o6ya_ 104 T----EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179 (277)
T ss_dssp H----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------T
T ss_pred c----cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCccc
Confidence 6 456899999999999999999999 44788999999999999999987653322 2223345689999
Q ss_pred ccCcccccccCCCccCCeeehhHHHHhhcchHHHHHHhhccCCCccccccccc--CCChHHHHHHHHHHhhhhcCCCCCc
Q 041655 149 YIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAIDSKLL--GNGYEEQMLLVLKTACFCTLDDPKE 226 (238)
Q Consensus 149 ~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~cl~~~p~~ 226 (238)
|+|||++.+..++.++||||+||++|+|+||..||............+..... .....+.+.++.+++.+||+.||.+
T Consensus 180 Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~ 259 (277)
T d1o6ya_ 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 259 (277)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGG
T ss_pred ccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhH
Confidence 99999999989999999999999999999999988532221111122222111 1122344566888888999999999
Q ss_pred c-----hHHHHHHhh
Q 041655 227 R-----HVRCMLSQI 236 (238)
Q Consensus 227 R-----~v~~~L~~~ 236 (238)
| ++.+.|.++
T Consensus 260 R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 260 RYQTAAEMRADLVRV 274 (277)
T ss_dssp SCSSHHHHHHHHHHH
T ss_pred CHhHHHHHHHHHHHH
Confidence 9 444445544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-40 Score=271.20 Aligned_cols=187 Identities=21% Similarity=0.198 Sum_probs=151.0
Q ss_pred HHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-----
Q 041655 32 IRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH----- 106 (238)
Q Consensus 32 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH----- 106 (238)
..+|+.++..++||||+++++++.+++..|+||||+++|+|.+++.. ...+++..++.++.|++.||.|||
T Consensus 54 e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~ii 129 (364)
T d1omwa3 54 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRFVV 129 (364)
T ss_dssp HHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34568889999999999999999999999999999999999999976 456889999999999999999999
Q ss_pred ---ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcchHHH
Q 041655 107 ---MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSLVKW 182 (238)
Q Consensus 107 ---~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~~~~ 182 (238)
.||.|||++.+|.+||+|||+++...... .....||+.|+|||++.+ ..++.++||||+||++|+|+||..|
T Consensus 130 HrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~P 205 (364)
T d1omwa3 130 YRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205 (364)
T ss_dssp CCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCC
Confidence 44788999999999999999998765432 244679999999999864 5689999999999999999999999
Q ss_pred HHHhhccCCCccccc--ccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 183 MRNVMTSENPKRAID--SKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 183 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|...... ....... .......+...+.++.+++.+||+.||++|
T Consensus 206 f~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 251 (364)
T d1omwa3 206 FRQHKTK-DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 251 (364)
T ss_dssp SCSSCSS-CHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCHH-HHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHh
Confidence 8643211 1111111 111222334455668888899999999999
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=267.29 Aligned_cols=199 Identities=18% Similarity=0.231 Sum_probs=153.8
Q ss_pred HHHHHHHHHhcCC-CCCcccceeeeeec----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhch
Q 041655 30 MQIRSEIVTLGQI-RHRNILPLLAHLAR----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEY 104 (238)
Q Consensus 30 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~ 104 (238)
..+.+|+.++.++ +||||++++++|.+ ++.+|+|||||+||+|.+++.. .+...+++..++.++.|++.||+|
T Consensus 49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~y 126 (335)
T d2ozaa1 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQY 126 (335)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHH
Confidence 3466899887654 79999999999865 4668999999999999999975 334579999999999999999999
Q ss_pred hhc--------cCceeeecC---CCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 105 LHM--------HQALVLLDH---DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 105 lH~--------~~~~il~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
||+ ||.||+++. .+.+||+|||+++....... .....||+.|+|||++.+..|+.++||||+||++
T Consensus 127 lH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvil 203 (335)
T d2ozaa1 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 203 (335)
T ss_dssp HHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHH
T ss_pred HHHcCCccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhH
Confidence 994 477899986 46799999999987644332 2456899999999999999999999999999999
Q ss_pred HhhcchHHHHHHhhccCCCcc----cccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 174 AEEMSLVKWMRNVMTSENPKR----AIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
|+|+||..||........... ...... ........+.++.+++.+||+.||++| ++.+.|
T Consensus 204 y~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 270 (335)
T d2ozaa1 204 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270 (335)
T ss_dssp HHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 999999999965432222111 111111 112234556678899999999999999 554444
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-41 Score=271.20 Aligned_cols=192 Identities=21% Similarity=0.200 Sum_probs=155.1
Q ss_pred HHHHHHHHHHHhc-CCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 28 EMMQIRSEIVTLG-QIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
..+.+.+|..++. .++||||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||
T Consensus 45 ~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH 120 (320)
T d1xjda_ 45 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH 120 (320)
T ss_dssp CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4456677777665 68999999999999999999999999999999999976 456899999999999999999999
Q ss_pred cc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcc
Q 041655 107 MH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMS 178 (238)
Q Consensus 107 ~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t 178 (238)
++ |.||+++.++++||+|||+++....... ......||+.|+|||++.+..++.++||||+||++|+|++
T Consensus 121 ~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemlt 198 (320)
T d1xjda_ 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 198 (320)
T ss_dssp HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred hCCeeeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHh
Confidence 55 6679999999999999999986543322 2344689999999999999999999999999999999999
Q ss_pred hHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 179 LVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
|..||...........+.... ...+...+..+.+++.+||+.||.+|
T Consensus 199 G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R 245 (320)
T d1xjda_ 199 GQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKR 245 (320)
T ss_dssp SSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCCCCCCCCHHHHHHHHHcCC--CCCCccCCHHHHHHHHHhcccCCCCC
Confidence 999985432221122222221 22334445668888999999999999
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=267.38 Aligned_cols=198 Identities=19% Similarity=0.271 Sum_probs=157.6
Q ss_pred HHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 30 MQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 30 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
..+.+|+.+|++++||||+++++++.+++.+|+||||+++|+|.+++.. ....+++..+..++.|+++||+|||++
T Consensus 46 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~ 122 (321)
T d1tkia_ 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN 122 (321)
T ss_dssp HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 4578999999999999999999999999999999999999999999965 344699999999999999999999954
Q ss_pred -------CceeeecCC--CceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHHhhcch
Q 041655 109 -------QALVLLDHD--MEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 -------~~~il~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~ 179 (238)
|.||+++.+ +.+|++|||+++....... .....+++.|+|||...+..++.++||||+||++|+|++|
T Consensus 123 iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred CCcccccccceeecCCCceEEEEcccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhC
Confidence 678999854 4799999999987543322 2346789999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCcccccccccCC--ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHH
Q 041655 180 VKWMRNVMTSENPKRAIDSKLLGN--GYEEQMLLVLKTACFCTLDDPKER-HVRCML 233 (238)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L 233 (238)
..||...........+........ .+...+.++.+++.+||+.||++| ++.+.|
T Consensus 200 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 256 (321)
T d1tkia_ 200 INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 999864332222222332222111 122345567889999999999999 544444
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=260.10 Aligned_cols=200 Identities=27% Similarity=0.298 Sum_probs=150.6
Q ss_pred HHHHHHhcCCCCCcccceeeeeecCC----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc-
Q 041655 33 RSEIVTLGQIRHRNILPLLAHLARPG----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM- 107 (238)
Q Consensus 33 ~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~- 107 (238)
.+|+..+.+++||||++++|++.+.+ .+|+||||+++|+|.+++.+ ..+++..+..++.|++.||+|+|+
T Consensus 45 e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~ 119 (303)
T d1vjya_ 45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHME 119 (303)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 35666777889999999999997543 57899999999999999976 468999999999999999999994
Q ss_pred ---------------cCceeeecCCCceEEcccccccccCCccc--ccccccccCCCcccCcccccccC------CCccC
Q 041655 108 ---------------HQALVLLDHDMEARISEFGLAKVFPEAHT--HITTSDVVGTAGYIAPEYQQTLS------ITYMC 164 (238)
Q Consensus 108 ---------------~~~~il~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~apE~~~~~~------~~~~~ 164 (238)
||.||+++.++.+||+|||+++....... ........||+.|+|||++.+.. ++.++
T Consensus 120 ~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~ 199 (303)
T d1vjya_ 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199 (303)
T ss_dssp BCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHH
T ss_pred hhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcch
Confidence 47789999999999999999987644322 22334578999999999887543 56789
Q ss_pred CeeehhHHHHhhcchHHHHHHhhccCCCc---------------ccccccccCC-----ChHHHHHHHHHHhhhhcCCCC
Q 041655 165 DIYSFGVLLAEEMSLVKWMRNVMTSENPK---------------RAIDSKLLGN-----GYEEQMLLVLKTACFCTLDDP 224 (238)
Q Consensus 165 DvwslG~~l~~~~t~~~~~~~~~~~~~~~---------------~~~~~~~~~~-----~~~~~~~~l~~~~~~cl~~~p 224 (238)
|||||||++|||+||..|+.......... ........+. ...+.+..+.+++.+||+.||
T Consensus 200 Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp 279 (303)
T d1vjya_ 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSG
T ss_pred hhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCH
Confidence 99999999999999976653221111110 0111111111 133456678999999999999
Q ss_pred Ccc----hHHHHHHhhh
Q 041655 225 KER----HVRCMLSQIQ 237 (238)
Q Consensus 225 ~~R----~v~~~L~~~~ 237 (238)
++| ++++.|+++.
T Consensus 280 ~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 280 AARLTALRIKKTLSQLS 296 (303)
T ss_dssp GGSCCHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHH
Confidence 999 7777787765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-40 Score=261.85 Aligned_cols=200 Identities=24% Similarity=0.215 Sum_probs=151.2
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH 108 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~ 108 (238)
.+.+.+|+.+|++++||||+++++++.+++..|+||||+.++++..+.. ....+++..+..++.|++.||+|||++
T Consensus 44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~ 119 (299)
T d1ua2a_ 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH 119 (299)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc
Confidence 4568899999999999999999999999999999999998766555443 356788999999999999999999944
Q ss_pred --------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhhcch
Q 041655 109 --------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 109 --------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~~t~ 179 (238)
|.||+++.++.+||+|||.++........ .....||+.|+|||++.+ ..++.++||||+||++|||++|
T Consensus 120 ~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 197 (299)
T d1ua2a_ 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 197 (299)
T ss_dssp TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred ceecccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhC
Confidence 77899999999999999999765443221 234678999999998764 4579999999999999999999
Q ss_pred HHHHHHhhccCC---------------Cc------ccccccccCCC-----hHHHHHHHHHHhhhhcCCCCCcc-hHHHH
Q 041655 180 VKWMRNVMTSEN---------------PK------RAIDSKLLGNG-----YEEQMLLVLKTACFCTLDDPKER-HVRCM 232 (238)
Q Consensus 180 ~~~~~~~~~~~~---------------~~------~~~~~~~~~~~-----~~~~~~~l~~~~~~cl~~~p~~R-~v~~~ 232 (238)
..||........ .. ........... ......++.+++.+||+.||++| ++.+.
T Consensus 198 ~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~ 277 (299)
T d1ua2a_ 198 VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277 (299)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred cCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 877742211000 00 00000000000 12334568889999999999999 66665
Q ss_pred HH
Q 041655 233 LS 234 (238)
Q Consensus 233 L~ 234 (238)
|+
T Consensus 278 L~ 279 (299)
T d1ua2a_ 278 LK 279 (299)
T ss_dssp HT
T ss_pred hC
Confidence 54
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-38 Score=250.05 Aligned_cols=201 Identities=20% Similarity=0.217 Sum_probs=151.1
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc-
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM- 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~- 107 (238)
.+++.+|+.+|++++||||+++++++.+++..|+||||+.+ .+.+++.. .....+++..+..++.|++.||+|||+
T Consensus 45 ~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~ 121 (298)
T d1gz8a_ 45 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH 121 (298)
T ss_dssp CHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC
Confidence 46789999999999999999999999999999999999965 56666543 234569999999999999999999994
Q ss_pred -------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccC-CCccCCeeehhHHHHhhcch
Q 041655 108 -------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS-ITYMCDIYSFGVLLAEEMSL 179 (238)
Q Consensus 108 -------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~-~~~~~DvwslG~~l~~~~t~ 179 (238)
||.||+++.++++|++|||.++....... ......||+.|+|||++.... ++.++|+||+||++|+|++|
T Consensus 122 ~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G 199 (298)
T d1gz8a_ 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199 (298)
T ss_dssp TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred CEEccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhC
Confidence 47789999999999999999986543322 224468999999999876655 47899999999999999999
Q ss_pred HHHHHHhhcc--------------CCCcccc--cccc-------cCC----ChHHHHHHHHHHhhhhcCCCCCcc-hHHH
Q 041655 180 VKWMRNVMTS--------------ENPKRAI--DSKL-------LGN----GYEEQMLLVLKTACFCTLDDPKER-HVRC 231 (238)
Q Consensus 180 ~~~~~~~~~~--------------~~~~~~~--~~~~-------~~~----~~~~~~~~l~~~~~~cl~~~p~~R-~v~~ 231 (238)
..||...... ....... .... ... .......++.+++.+||..||++| ++.+
T Consensus 200 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e 279 (298)
T d1gz8a_ 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 279 (298)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9887421100 0000000 0000 000 011223567888889999999999 5555
Q ss_pred HHH
Q 041655 232 MLS 234 (238)
Q Consensus 232 ~L~ 234 (238)
.|+
T Consensus 280 ll~ 282 (298)
T d1gz8a_ 280 ALA 282 (298)
T ss_dssp HHT
T ss_pred HhC
Confidence 554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-39 Score=251.73 Aligned_cols=188 Identities=18% Similarity=0.237 Sum_probs=148.5
Q ss_pred HHHHHHHHhcCCC--CCcccceeeeeecCCeeEEEEEeCCC-CCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 31 QIRSEIVTLGQIR--HRNILPLLAHLARPGCHLLVYEFMKN-GSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 31 ~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~v~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
++.+|+.+|++++ ||||+++++++.+++..++||||+.+ +++.+++.. ...+++..++.++.|+++||+|||+
T Consensus 53 ~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~ 128 (273)
T d1xwsa_ 53 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN 128 (273)
T ss_dssp EEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4668999999886 89999999999999999999999975 578888875 4578999999999999999999994
Q ss_pred c--------CceeeecC-CCceEEcccccccccCCcccccccccccCCCcccCcccccccCC-CccCCeeehhHHHHhhc
Q 041655 108 H--------QALVLLDH-DMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSI-TYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 ~--------~~~il~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~-~~~~DvwslG~~l~~~~ 177 (238)
+ |.||+++. ++.+||+|||+++...... .+...||+.|+|||++.+..+ +.++||||+||++|+|+
T Consensus 129 ~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell 204 (273)
T d1xwsa_ 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204 (273)
T ss_dssp TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred CCCccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHh
Confidence 4 77899985 4799999999998654332 245689999999999887665 56799999999999999
Q ss_pred chHHHHHHhhccCCCcccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
+|..||..... ...... ..+...+.++.+++.+||+.||++| ++.+.|+
T Consensus 205 ~g~~Pf~~~~~------i~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 205 CGDIPFEHDEE------IIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HSSCSCCSHHH------HHHCCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCchH------Hhhccc--CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 99988854321 111111 1122334567888888999999999 5555443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.2e-37 Score=244.15 Aligned_cols=215 Identities=19% Similarity=0.197 Sum_probs=155.1
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||++..... .....+++.+|+.+|++++||||+++++++..++..++++|++.++.+..+...
T Consensus 29 vAvK~i~~~~~------------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~--- 93 (286)
T d1ob3a_ 29 FALKKIRLEKE------------DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--- 93 (286)
T ss_dssp EEEEEECCSSG------------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS---
T ss_pred EEEEEEehhhc------------ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhh---
Confidence 67777754322 122346789999999999999999999999999999999999977555555443
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
...+++..+..++.|++.||+|||++ |.||+++.++.+|++|||.+........ ......+++.|+|||
T Consensus 94 -~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE 170 (286)
T d1ob3a_ 94 -EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPD 170 (286)
T ss_dssp -TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHH
T ss_pred -cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHH
Confidence 56799999999999999999999944 7789999999999999999986543322 123456899999999
Q ss_pred cccc-cCCCccCCeeehhHHHHhhcchHHHHHHhhccC---------------CCccc---------c---cccccCCCh
Q 041655 154 YQQT-LSITYMCDIYSFGVLLAEEMSLVKWMRNVMTSE---------------NPKRA---------I---DSKLLGNGY 205 (238)
Q Consensus 154 ~~~~-~~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~---------------~~~~~---------~---~~~~~~~~~ 205 (238)
.+.+ ..++.++|+||+||++|||++|..||....... ..... . .........
T Consensus 171 ~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T d1ob3a_ 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250 (286)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTC
T ss_pred HHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhc
Confidence 8765 456899999999999999999998874211000 00000 0 000000112
Q ss_pred HHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 206 EEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 206 ~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.....++.+++.+||+.||++| ++.+.|+
T Consensus 251 ~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 251 KGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2334567788889999999999 6655553
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=248.49 Aligned_cols=197 Identities=19% Similarity=0.220 Sum_probs=144.3
Q ss_pred HHHHHHHHhcCC---CCCcccceeeeeec-----CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHh
Q 041655 31 QIRSEIVTLGQI---RHRNILPLLAHLAR-----PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGL 102 (238)
Q Consensus 31 ~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl 102 (238)
.+.+|+.+|+.+ +||||++++++|.. ....++++||++++.+...... ....+++..++.++.|++.||
T Consensus 53 ~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL 129 (305)
T d1blxa_ 53 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGL 129 (305)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHH
Confidence 345666665554 89999999999853 3467899999987655444432 456689999999999999999
Q ss_pred chhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcccccccCCCccCCeeehhHHHH
Q 041655 103 EYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLLA 174 (238)
Q Consensus 103 ~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l~ 174 (238)
+|||+ ||.|||++.++.+|++|||.++...... ......||+.|+|||++.+..++.++||||+||++|
T Consensus 130 ~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ 206 (305)
T d1blxa_ 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206 (305)
T ss_dssp HHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHH
Confidence 99994 4778999999999999999987653332 234578999999999999999999999999999999
Q ss_pred hhcchHHHHHHhhccCC---------------------Ccccc-c---ccccCCChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 175 EEMSLVKWMRNVMTSEN---------------------PKRAI-D---SKLLGNGYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 175 ~~~t~~~~~~~~~~~~~---------------------~~~~~-~---~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
||++|..||........ ..... . ..............+.+++.+||+.||++| +
T Consensus 207 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s 286 (305)
T d1blxa_ 207 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286 (305)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC
Confidence 99999988743211000 00000 0 000011122334567788888999999999 5
Q ss_pred HHHHH
Q 041655 229 VRCML 233 (238)
Q Consensus 229 v~~~L 233 (238)
+.+.|
T Consensus 287 a~e~L 291 (305)
T d1blxa_ 287 AYSAL 291 (305)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 55554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=253.72 Aligned_cols=194 Identities=23% Similarity=0.238 Sum_probs=156.1
Q ss_pred HHHHHHHHHHhcCCCC-CcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 29 MMQIRSEIVTLGQIRH-RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
.+.+.+|+.+|++++| |||+++++++.+.+..+++|||+.+|+|.+++.. ...+++..+..++.|++.||+|+|+
T Consensus 72 ~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~ 147 (322)
T d1vzoa_ 72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK 147 (322)
T ss_dssp GGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc
Confidence 4567899999999976 8999999999999999999999999999999976 4567889999999999999999994
Q ss_pred c--------CceeeecCCCceEEcccccccccCCcccccccccccCCCcccCccccccc--CCCccCCeeehhHHHHhhc
Q 041655 108 H--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL--SITYMCDIYSFGVLLAEEM 177 (238)
Q Consensus 108 ~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~--~~~~~~DvwslG~~l~~~~ 177 (238)
+ |.||+++.++.+||+|||+++.+....... .....|++.|++||.+.+. .++.++||||+||++|+|+
T Consensus 148 ~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyell 226 (322)
T d1vzoa_ 148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 226 (322)
T ss_dssp TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHH
T ss_pred CCEEeccCCccceeecCCCCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHH
Confidence 4 678999999999999999998765433322 2456889999999988654 4677999999999999999
Q ss_pred chHHHHHHhhccCCCcccccccc--cCCChHHHHHHHHHHhhhhcCCCCCcc
Q 041655 178 SLVKWMRNVMTSENPKRAIDSKL--LGNGYEEQMLLVLKTACFCTLDDPKER 227 (238)
Q Consensus 178 t~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~cl~~~p~~R 227 (238)
+|..||................. ....+.+.+..+.+++.+||+.||.+|
T Consensus 227 tG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R 278 (322)
T d1vzoa_ 227 TGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 278 (322)
T ss_dssp HSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHc
Confidence 99999875543333333222211 223345566778889999999999999
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=241.31 Aligned_cols=210 Identities=23% Similarity=0.272 Sum_probs=156.3
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCC------eeEEEEEeCCCCCHHHH
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPG------CHLLVYEFMKNGSLQDI 75 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~~v~e~~~~~~L~~~ 75 (238)
||||++.+... .....+.+.+|+.+|++++||||++++++|...+ .+|+||||+ +++|..+
T Consensus 46 vAiK~i~~~~~------------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~ 112 (346)
T d1cm8a_ 46 VAIKKLYRPFQ------------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKL 112 (346)
T ss_dssp EEEEECSSTTS------------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHH
T ss_pred EEEEEEchhhc------------ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHH
Confidence 67777654322 2345678899999999999999999999997654 469999999 5678887
Q ss_pred HhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCC
Q 041655 76 LNDVSRGRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTA 147 (238)
Q Consensus 76 l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 147 (238)
... ..+++..++.++.|++.||+|||+ ||.||+++.++.+|++|||.++...... +...||+
T Consensus 113 ~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~ 182 (346)
T d1cm8a_ 113 MKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTR 182 (346)
T ss_dssp HHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCG
T ss_pred HHh-----ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCcc-----ccccccc
Confidence 764 469999999999999999999994 4778999999999999999998654332 4467899
Q ss_pred cccCccccccc-CCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcc-----------------------------ccc
Q 041655 148 GYIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKR-----------------------------AID 197 (238)
Q Consensus 148 ~~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~-----------------------------~~~ 197 (238)
.|+|||++.+. .++.++||||+||++|+|++|..||........... ...
T Consensus 183 ~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (346)
T d1cm8a_ 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 262 (346)
T ss_dssp GGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCC
T ss_pred cccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCccc
Confidence 99999988764 568899999999999999999887632110000000 000
Q ss_pred ccccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 198 SKLLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 198 ~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.............++.+++.+||..||++| ++.+.|+
T Consensus 263 ~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 263 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000001112334567788889999999999 5555553
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-36 Score=244.59 Aligned_cols=204 Identities=23% Similarity=0.249 Sum_probs=149.8
Q ss_pred HHHHHHHHHHHHHhcCCCCCcccceeeeeecCC----eeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHH
Q 041655 26 TEEMMQIRSEIVTLGQIRHRNILPLLAHLARPG----CHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASG 101 (238)
Q Consensus 26 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~g 101 (238)
+...+++.+|+.+|++++||||+++++++.... ..+++++|+.+|+|.+++.. ..+++..++.++.|++.|
T Consensus 47 ~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~a 121 (345)
T d1pmea_ 47 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRG 121 (345)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHH
Confidence 345678899999999999999999999986543 23455566678999999975 358999999999999999
Q ss_pred hchhhc--------cCceeeecCCCceEEcccccccccCCcccc-cccccccCCCcccCccccc-ccCCCccCCeeehhH
Q 041655 102 LEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTH-ITTSDVVGTAGYIAPEYQQ-TLSITYMCDIYSFGV 171 (238)
Q Consensus 102 l~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~apE~~~-~~~~~~~~DvwslG~ 171 (238)
|+|||+ ||.||++++++.+||+|||++......... .......|++.|+|||++. +..++.++||||+||
T Consensus 122 l~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~ 201 (345)
T d1pmea_ 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHH
T ss_pred HHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCc
Confidence 999994 477899999999999999999866443222 2234567999999999874 456788999999999
Q ss_pred HHHhhcchHHHHHHhhccCCCccc--------------------------ccccccC---CChHHHHHHHHHHhhhhcCC
Q 041655 172 LLAEEMSLVKWMRNVMTSENPKRA--------------------------IDSKLLG---NGYEEQMLLVLKTACFCTLD 222 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~~~~~~--------------------------~~~~~~~---~~~~~~~~~l~~~~~~cl~~ 222 (238)
++|+|++|..||............ ....... ........++.+++.+||+.
T Consensus 202 il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 281 (345)
T d1pmea_ 202 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 281 (345)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred eehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccC
Confidence 999999998887422110000000 0000000 00112234578899999999
Q ss_pred CCCcc-hHHHHHH
Q 041655 223 DPKER-HVRCMLS 234 (238)
Q Consensus 223 ~p~~R-~v~~~L~ 234 (238)
||.+| ++-+.|+
T Consensus 282 dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 282 NPHKRIEVEQALA 294 (345)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 99999 6665554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-35 Score=238.88 Aligned_cols=198 Identities=17% Similarity=0.141 Sum_probs=143.8
Q ss_pred HHHHHHhcCCCCCcccceeeeeec------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 33 RSEIVTLGQIRHRNILPLLAHLAR------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 33 ~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
.+|+.+|++++||||++++++|.. ...+++||||++++ +.+.+.........+++..++.++.|++.||+|||
T Consensus 61 ~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH 139 (350)
T d1q5ka_ 61 NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139 (350)
T ss_dssp CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 379999999999999999999853 23478999999764 54444333334667999999999999999999999
Q ss_pred cc--------CceeeecCCC-ceEEcccccccccCCcccccccccccCCCcccCcccccc-cCCCccCCeeehhHHHHhh
Q 041655 107 MH--------QALVLLDHDM-EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQT-LSITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 107 ~~--------~~~il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~-~~~~~~~DvwslG~~l~~~ 176 (238)
++ |.|||++.++ .+||+|||+++....... ..+..|++.|+|||.+.+ ..++.++||||+||++|||
T Consensus 140 ~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el 216 (350)
T d1q5ka_ 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 216 (350)
T ss_dssp TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred hcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEeh
Confidence 54 6789999875 899999999986644322 234678999999997764 5689999999999999999
Q ss_pred cchHHHHHHhhccCCCc---------------------------ccccccccCCChHHHHHHHHHHhhhhcCCCCCcc-h
Q 041655 177 MSLVKWMRNVMTSENPK---------------------------RAIDSKLLGNGYEEQMLLVLKTACFCTLDDPKER-H 228 (238)
Q Consensus 177 ~t~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~ 228 (238)
++|..||.......... .................++.+++.+||+.||++| +
T Consensus 217 ~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 296 (350)
T d1q5ka_ 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296 (350)
T ss_dssp HHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred hhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC
Confidence 99988873221100000 0000000001112334567888899999999999 6
Q ss_pred HHHHHH
Q 041655 229 VRCMLS 234 (238)
Q Consensus 229 v~~~L~ 234 (238)
+.+.|+
T Consensus 297 a~e~L~ 302 (350)
T d1q5ka_ 297 PLEACA 302 (350)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 555553
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=229.85 Aligned_cols=215 Identities=20% Similarity=0.151 Sum_probs=159.6
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcC
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSR 81 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 81 (238)
||||++...... ....+++.+|+.+|+.++||||+++++++.+.+..+++++++.+++|..++..
T Consensus 30 vAvK~i~~~~~~------------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~--- 94 (292)
T d1unla_ 30 VALKRVRLDDDD------------EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--- 94 (292)
T ss_dssp EEEEEEESSCSS------------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT---
T ss_pred EEEEEEehhhCC------------hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccc---
Confidence 788877544322 23467889999999999999999999999999999999999988888777754
Q ss_pred CCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCcc
Q 041655 82 GRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPE 153 (238)
Q Consensus 82 ~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE 153 (238)
...+++..+..++.|+++||+|||. ||.||+++.++.+|++|||.++........ .....+++.|+|||
T Consensus 95 -~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe 171 (292)
T d1unla_ 95 -NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPD 171 (292)
T ss_dssp -TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHH
T ss_pred -ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhh
Confidence 5678899999999999999999994 477899999999999999999876443322 23356788899999
Q ss_pred cccccC-CCccCCeeehhHHHHhhcchHHHHHHhhcc----------------CCC---cc--------cc-cccccCCC
Q 041655 154 YQQTLS-ITYMCDIYSFGVLLAEEMSLVKWMRNVMTS----------------ENP---KR--------AI-DSKLLGNG 204 (238)
Q Consensus 154 ~~~~~~-~~~~~DvwslG~~l~~~~t~~~~~~~~~~~----------------~~~---~~--------~~-~~~~~~~~ 204 (238)
++.+.. ++.++||||+||++|||++|..||...... ... .. .. ........
T Consensus 172 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (292)
T d1unla_ 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251 (292)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred HhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhc
Confidence 887655 688999999999999999998775211000 000 00 00 00001112
Q ss_pred hHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 205 YEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 205 ~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
.......+.+++.+||+.||++| ++.+.|+
T Consensus 252 ~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22334457788888999999999 5555543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=237.87 Aligned_cols=152 Identities=24% Similarity=0.305 Sum_probs=122.6
Q ss_pred HHHHHHHHHHhcCCCCCcccceeeeeec--------CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHH
Q 041655 29 MMQIRSEIVTLGQIRHRNILPLLAHLAR--------PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIAS 100 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 100 (238)
.+++.+|+.+|++++|||++++++++.. .+..|++|||+.++.+..+.. ....+++..++.++.|+++
T Consensus 53 ~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~ 128 (318)
T d3blha1 53 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLN 128 (318)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHH
Confidence 4667899999999999999999999854 346799999997655443332 3567899999999999999
Q ss_pred Hhchhhc--------cCceeeecCCCceEEcccccccccCCccc--ccccccccCCCcccCccccccc-CCCccCCeeeh
Q 041655 101 GLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHT--HITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSF 169 (238)
Q Consensus 101 gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~apE~~~~~-~~~~~~Dvwsl 169 (238)
||.|||+ |+.||+++.++.+|++|||+++....... ........||+.|+|||++.+. .++.++||||+
T Consensus 129 ~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSl 208 (318)
T d3blha1 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208 (318)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccC
Confidence 9999994 47789999999999999999976543221 1122345799999999988654 68999999999
Q ss_pred hHHHHhhcchHHHHH
Q 041655 170 GVLLAEEMSLVKWMR 184 (238)
Q Consensus 170 G~~l~~~~t~~~~~~ 184 (238)
||++|+|++|..||.
T Consensus 209 Gvil~el~~g~~pf~ 223 (318)
T d3blha1 209 GCIMAEMWTRSPIMQ 223 (318)
T ss_dssp HHHHHHHHHSSCSCC
T ss_pred CceeeeHhhCCCCCC
Confidence 999999999988874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-34 Score=233.77 Aligned_cols=195 Identities=19% Similarity=0.241 Sum_probs=145.7
Q ss_pred HHHHHHHHHhcCCC-CCcccceeeeeec--CCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh
Q 041655 30 MQIRSEIVTLGQIR-HRNILPLLAHLAR--PGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH 106 (238)
Q Consensus 30 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH 106 (238)
+++.+|+.+|++++ ||||++++++|.. ....++||||+++++|..+. ..+++..++.++.|++.||+|||
T Consensus 74 ~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH 146 (328)
T d3bqca1 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH 146 (328)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHh
Confidence 56789999999996 9999999999874 45689999999999887654 34899999999999999999999
Q ss_pred --------ccCceeeecCCC-ceEEcccccccccCCcccccccccccCCCcccCccccccc-CCCccCCeeehhHHHHhh
Q 041655 107 --------MHQALVLLDHDM-EARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTL-SITYMCDIYSFGVLLAEE 176 (238)
Q Consensus 107 --------~~~~~il~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~DvwslG~~l~~~ 176 (238)
.||.|||++.++ .+|++|||+++....... .....+|+.|+|||.+.+. .++.++|+||+||++|+|
T Consensus 147 ~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~ 223 (328)
T d3bqca1 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 223 (328)
T ss_dssp HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred hcccccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHh
Confidence 447789998765 589999999987644332 2456789999999987765 479999999999999999
Q ss_pred cchHHHHHHhhcc-------------------------CCC---cccc--------cccccCCChHHHHHHHHHHhhhhc
Q 041655 177 MSLVKWMRNVMTS-------------------------ENP---KRAI--------DSKLLGNGYEEQMLLVLKTACFCT 220 (238)
Q Consensus 177 ~t~~~~~~~~~~~-------------------------~~~---~~~~--------~~~~~~~~~~~~~~~l~~~~~~cl 220 (238)
++|..||...... ... .... ..............++.+++.+||
T Consensus 224 ~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL 303 (328)
T d3bqca1 224 IFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303 (328)
T ss_dssp HHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHS
T ss_pred ccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHc
Confidence 9987765321100 000 0000 000111122334456788899999
Q ss_pred CCCCCcc-hHHHHHH
Q 041655 221 LDDPKER-HVRCMLS 234 (238)
Q Consensus 221 ~~~p~~R-~v~~~L~ 234 (238)
..||++| ++-+.|+
T Consensus 304 ~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 304 RYDHQSRLTAREAME 318 (328)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhHCcCHHHHhc
Confidence 9999999 6666554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-35 Score=231.92 Aligned_cols=202 Identities=18% Similarity=0.183 Sum_probs=147.2
Q ss_pred HHHHHHHHhcCCCCCcccce-eeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhcc-
Q 041655 31 QIRSEIVTLGQIRHRNILPL-LAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHMH- 108 (238)
Q Consensus 31 ~~~~E~~~l~~l~h~~iv~~-~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~- 108 (238)
++.+|++++++++|+|++.. .+++.+++..++||||+ ++++.+.+.. ....+++..+..++.|++.||+|||++
T Consensus 48 ~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 123 (299)
T d1ckia_ 48 QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN 123 (299)
T ss_dssp CHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 46789999999987765555 55567788889999999 5677777654 356799999999999999999999944
Q ss_pred -------CceeeecC---CCceEEcccccccccCCcccc-----cccccccCCCcccCcccccccCCCccCCeeehhHHH
Q 041655 109 -------QALVLLDH---DMEARISEFGLAKVFPEAHTH-----ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGVLL 173 (238)
Q Consensus 109 -------~~~il~~~---~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~~l 173 (238)
|.||+++. +..++++|||+++.+...... .......||+.|+|||...+..++.++|||||||++
T Consensus 124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203 (299)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHH
T ss_pred eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHH
Confidence 77897654 457999999999876443221 123456899999999999999999999999999999
Q ss_pred HhhcchHHHHHHhhccCCCcccc---cccccCC---ChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHhh
Q 041655 174 AEEMSLVKWMRNVMTSENPKRAI---DSKLLGN---GYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQI 236 (238)
Q Consensus 174 ~~~~t~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~~ 236 (238)
|||++|..||............. ....... .....+.++.+++..||+.||++| ++.+.|+++
T Consensus 204 ~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 204 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 99999999886433322222111 1111111 112345668888889999999999 455555553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.3e-35 Score=231.10 Aligned_cols=201 Identities=14% Similarity=0.126 Sum_probs=151.7
Q ss_pred HHHHHHHHhcCCCC-CcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--
Q 041655 31 QIRSEIVTLGQIRH-RNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM-- 107 (238)
Q Consensus 31 ~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~-- 107 (238)
.+.+|++.++.++| +|++.+++++..++..++||||+ +++|.+++.. ....+++..+..++.|++.||+|||+
T Consensus 46 ~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g 121 (293)
T d1csna_ 46 QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS 121 (293)
T ss_dssp CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC
Confidence 45678888888875 89999999999999999999999 6899999875 34568999999999999999999994
Q ss_pred ------cCceeeecC-----CCceEEcccccccccCCcccc-----cccccccCCCcccCcccccccCCCccCCeeehhH
Q 041655 108 ------HQALVLLDH-----DMEARISEFGLAKVFPEAHTH-----ITTSDVVGTAGYIAPEYQQTLSITYMCDIYSFGV 171 (238)
Q Consensus 108 ------~~~~il~~~-----~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~apE~~~~~~~~~~~DvwslG~ 171 (238)
||.||+++. .+.+||+|||+++........ .......||+.|+|||++.+..++.++|+||||+
T Consensus 122 iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~ 201 (293)
T d1csna_ 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGH 201 (293)
T ss_dssp EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhH
Confidence 477899964 578999999999876432211 1234567999999999999999999999999999
Q ss_pred HHHhhcchHHHHHHhhccCCC---cccccccccC---CChHHHHHHHHHHhhhhcCCCCCcc----hHHHHHHh
Q 041655 172 LLAEEMSLVKWMRNVMTSENP---KRAIDSKLLG---NGYEEQMLLVLKTACFCTLDDPKER----HVRCMLSQ 235 (238)
Q Consensus 172 ~l~~~~t~~~~~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~~~~~cl~~~p~~R----~v~~~L~~ 235 (238)
++|||++|..||......... .......... +...+.+.++.+++..||..+|++| .+.+.|++
T Consensus 202 ~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 202 VFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp HHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 999999999998642221111 0111111101 1112345567888888999999999 44444444
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=235.19 Aligned_cols=160 Identities=24% Similarity=0.324 Sum_probs=124.7
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeec------CCeeEEEEEeCCCCCHHHH
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLAR------PGCHLLVYEFMKNGSLQDI 75 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~~v~e~~~~~~L~~~ 75 (238)
||||++..... ......++.+|+.+|++++||||++++++|.. ....|+||||+.+ ++.+.
T Consensus 45 vAvK~i~~~~~------------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~ 111 (355)
T d2b1pa1 45 VAIKKLSRPFQ------------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQV 111 (355)
T ss_dssp EEEEEEESTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHH
T ss_pred EEEEEEChhhc------------CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHh
Confidence 67887765433 23345678899999999999999999999953 3678999999965 55555
Q ss_pred HhhhcCCCcccCHHHHHHHHHHHHHHhchhhc--------cCceeeecCCCceEEcccccccccCCcccccccccccCCC
Q 041655 76 LNDVSRGRRQLDWLARYRTVRGIASGLEYLHM--------HQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTA 147 (238)
Q Consensus 76 l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~--------~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 147 (238)
+. ..+++..++.++.|++.||.|||+ ||.||+++.++.++++|||+++...... ......+|+
T Consensus 112 ~~------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~ 182 (355)
T d2b1pa1 112 IQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTR 182 (355)
T ss_dssp HT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------------------CC
T ss_pred hh------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc---ccccccccc
Confidence 53 358999999999999999999994 4778999999999999999987654332 224467899
Q ss_pred cccCcccccccCCCccCCeeehhHHHHhhcchHHHH
Q 041655 148 GYIAPEYQQTLSITYMCDIYSFGVLLAEEMSLVKWM 183 (238)
Q Consensus 148 ~~~apE~~~~~~~~~~~DvwslG~~l~~~~t~~~~~ 183 (238)
.|+|||++.+..++.++||||+||++|+|++|..||
T Consensus 183 ~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF 218 (355)
T d2b1pa1 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_dssp TTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred cccChhhhcCCCCCCCcccccccchHHHHhhCCCCC
Confidence 999999999999999999999999999999999887
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-35 Score=236.15 Aligned_cols=211 Identities=19% Similarity=0.243 Sum_probs=150.9
Q ss_pred eeEEeeccCCCChhhHHHhhhhhhHHHHHHHHHHHHHhcCCCCCcccceeeeeecC-----CeeEEEEEeCCCCCHHHHH
Q 041655 2 IAIRKIVQPPMDATALVEADSKLLTEEMMQIRSEIVTLGQIRHRNILPLLAHLARP-----GCHLLVYEFMKNGSLQDIL 76 (238)
Q Consensus 2 vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l 76 (238)
||||++.+... +....+++.+|+.+|++++|||++++++++... ...+++++|+.+|+|.+++
T Consensus 46 vAiK~i~~~~~------------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~ 113 (348)
T d2gfsa1 46 VAVKKLSRPFQ------------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 113 (348)
T ss_dssp EEEEECSCTTS------------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHH
T ss_pred EEEEEECchhc------------ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhc
Confidence 77887764432 223456788999999999999999999998533 3446677788899999998
Q ss_pred hhhcCCCcccCHHHHHHHHHHHHHHhchhhcc--------CceeeecCCCceEEcccccccccCCcccccccccccCCCc
Q 041655 77 NDVSRGRRQLDWLARYRTVRGIASGLEYLHMH--------QALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAG 148 (238)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~~--------~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 148 (238)
.. ..+++..++.++.|++.||+|||++ |.||+++.++.+|++|||.+....... ....|++.
T Consensus 114 ~~-----~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~-----~~~~g~~~ 183 (348)
T d2gfsa1 114 KC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRW 183 (348)
T ss_dssp TT-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGG-----SSSCHHHH
T ss_pred cc-----ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCccc-----cccccccc
Confidence 54 4699999999999999999999944 778999999999999999987643322 44678899
Q ss_pred ccCccccccc-CCCccCCeeehhHHHHhhcchHHHHHHhhccCCCcccc-----------------------c--ccccC
Q 041655 149 YIAPEYQQTL-SITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPKRAI-----------------------D--SKLLG 202 (238)
Q Consensus 149 ~~apE~~~~~-~~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~~~~-----------------------~--~~~~~ 202 (238)
|+|||+..+. .++.++||||+||++|+|++|..||...........+. . .....
T Consensus 184 y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (348)
T d2gfsa1 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 263 (348)
T ss_dssp TSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCC
T ss_pred ccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCC
Confidence 9999986665 46889999999999999999988873211100000000 0 00000
Q ss_pred C----ChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 203 N----GYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 203 ~----~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
. ........+.+++.+||..||++| ++.+.|+
T Consensus 264 ~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 264 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 011234557788899999999999 6666554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=9.4e-28 Score=195.31 Aligned_cols=199 Identities=19% Similarity=0.200 Sum_probs=140.4
Q ss_pred HHHHHHHHHHhcCCC-----------CCcccceeeeeec--CCeeEEEEEeCCCC-CHHHHHhhhcCCCcccCHHHHHHH
Q 041655 29 MMQIRSEIVTLGQIR-----------HRNILPLLAHLAR--PGCHLLVYEFMKNG-SLQDILNDVSRGRRQLDWLARYRT 94 (238)
Q Consensus 29 ~~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~--~~~~~~v~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~ 94 (238)
.+.+.+|+.+++.++ |+||+++++++.. ....+.+++++..+ ........ .....+++..++.+
T Consensus 53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i 130 (362)
T d1q8ya_ 53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQI 130 (362)
T ss_dssp HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHH
T ss_pred hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccccccc--ccccCCcHHHHHHH
Confidence 355677888777764 5789999988754 34566777776543 33333332 34567899999999
Q ss_pred HHHHHHHhchhhc---------cCceeeecCCCc------eEEcccccccccCCcccccccccccCCCcccCcccccccC
Q 041655 95 VRGIASGLEYLHM---------HQALVLLDHDME------ARISEFGLAKVFPEAHTHITTSDVVGTAGYIAPEYQQTLS 159 (238)
Q Consensus 95 ~~~l~~gl~~lH~---------~~~~il~~~~~~------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~ 159 (238)
+.|+++||.|||+ ||.||+++.++. ++++|||.+....... ....||+.|+|||++.+..
T Consensus 131 ~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~ 205 (362)
T d1q8ya_ 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAP 205 (362)
T ss_dssp HHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCC
T ss_pred HHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccC
Confidence 9999999999995 477899987654 8999999987543322 4467899999999999999
Q ss_pred CCccCCeeehhHHHHhhcchHHHHHHhhccCCCc-------------------------------------cccccc---
Q 041655 160 ITYMCDIYSFGVLLAEEMSLVKWMRNVMTSENPK-------------------------------------RAIDSK--- 199 (238)
Q Consensus 160 ~~~~~DvwslG~~l~~~~t~~~~~~~~~~~~~~~-------------------------------------~~~~~~--- 199 (238)
++.++|+||+||++++|++|..||.......... ......
T Consensus 206 ~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
T d1q8ya_ 206 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 285 (362)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCc
Confidence 9999999999999999999987765322110000 000000
Q ss_pred ------ccCCChHHHHHHHHHHhhhhcCCCCCcc-hHHHHHH
Q 041655 200 ------LLGNGYEEQMLLVLKTACFCTLDDPKER-HVRCMLS 234 (238)
Q Consensus 200 ------~~~~~~~~~~~~l~~~~~~cl~~~p~~R-~v~~~L~ 234 (238)
............+.+++.+||..||.+| ++-+.|+
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 286 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred hhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0112234567789999999999999999 6666654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.31 E-value=5.5e-13 Score=97.72 Aligned_cols=118 Identities=14% Similarity=0.088 Sum_probs=81.3
Q ss_pred HHHHHHHHHHHhcCCCCCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhh-
Q 041655 28 EMMQIRSEIVTLGQIRHRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLH- 106 (238)
Q Consensus 28 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH- 106 (238)
....+.+|...+.++.|++++..++... .+++|||+++..+.+ ++......++.|+++++.|||
T Consensus 57 ~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~ 121 (191)
T d1zara2 57 AIRSARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH 121 (191)
T ss_dssp HHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh
Confidence 3455677899999999999988876532 369999998754322 333445678899999999999
Q ss_pred -------ccCceeeecCCCceEEcccccccccCCcccccccccccCCCcccCc------ccccccCCCccCCeeehhHH
Q 041655 107 -------MHQALVLLDHDMEARISEFGLAKVFPEAHTHITTSDVVGTAGYIAP------EYQQTLSITYMCDIYSFGVL 172 (238)
Q Consensus 107 -------~~~~~il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~ap------E~~~~~~~~~~~DvwslG~~ 172 (238)
.||.||+++++ .++|+|||.+......... .|... +.. ...|+.++|+||+.-.
T Consensus 122 ~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 122 RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred CCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 55889999865 4889999998764322110 11111 111 3467889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=95.29 E-value=0.012 Score=43.26 Aligned_cols=68 Identities=10% Similarity=0.039 Sum_probs=43.2
Q ss_pred HHHHHHHHhcCCC-CCcccceeeeeecCCeeEEEEEeCCCCCHHHHHhhhcCCCcccCHHHHHHHHHHHHHHhchhhc
Q 041655 31 QIRSEIVTLGQIR-HRNILPLLAHLARPGCHLLVYEFMKNGSLQDILNDVSRGRRQLDWLARYRTVRGIASGLEYLHM 107 (238)
Q Consensus 31 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~gl~~lH~ 107 (238)
.+.+|...+..+. +--+.+++.+...++..++||++++|.++.+.... .... ..++.++++.+..||.
T Consensus 55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~------~~~~---~~~~~~l~~~l~~lH~ 123 (263)
T d1j7la_ 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQSP---EKIIELYAECIRLFHS 123 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT------CSCH---HHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc------cccH---HHHHHHHHHHHHHHhc
Confidence 4566777766553 33356777777788889999999998877654421 1112 2234566666666773
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=89.22 E-value=0.18 Score=36.29 Aligned_cols=41 Identities=15% Similarity=0.179 Sum_probs=28.9
Q ss_pred HHHHHHHhcCCC--CCcccceeeeeecCCeeEEEEEeCCCCCH
Q 041655 32 IRSEIVTLGQIR--HRNILPLLAHLARPGCHLLVYEFMKNGSL 72 (238)
Q Consensus 32 ~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~~v~e~~~~~~L 72 (238)
+.+|...++.+. .-.+.+++.+..+++..+++|++++|.++
T Consensus 51 l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 51 LQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp HHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred HHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 456666666553 22367778877888888999999987543
|